Citrus Sinensis ID: 023591
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 280 | 2.2.26 [Sep-21-2011] | |||||||
| Q75H77 | 362 | Serine/threonine-protein | yes | no | 0.946 | 0.732 | 0.935 | 1e-147 | |
| Q940H6 | 362 | Serine/threonine-protein | yes | no | 0.964 | 0.745 | 0.906 | 1e-147 | |
| Q7Y0B9 | 371 | Serine/threonine-protein | no | no | 0.942 | 0.711 | 0.916 | 1e-144 | |
| Q39193 | 361 | Serine/threonine-protein | no | no | 0.967 | 0.750 | 0.866 | 1e-142 | |
| Q75V57 | 361 | Serine/threonine-protein | no | no | 0.939 | 0.728 | 0.890 | 1e-140 | |
| Q39192 | 362 | Serine/threonine-protein | no | no | 0.907 | 0.701 | 0.885 | 1e-137 | |
| A2YNT8 | 339 | Serine/threonine-protein | N/A | no | 0.878 | 0.725 | 0.865 | 1e-128 | |
| Q0D4J7 | 339 | Serine/threonine-protein | no | no | 0.878 | 0.725 | 0.861 | 1e-128 | |
| Q7XQP4 | 359 | Serine/threonine-protein | no | no | 0.878 | 0.685 | 0.841 | 1e-126 | |
| Q75LR7 | 342 | Serine/threonine-protein | no | no | 0.878 | 0.719 | 0.853 | 1e-126 |
| >sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 522 bits (1344), Expect = e-147, Method: Compositional matrix adjust.
Identities = 248/265 (93%), Positives = 256/265 (96%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+A+TVGPGMDMPIMHD DRYELVRDIGSGNFGVARLMR + +LVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRSRADGQLVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EPKNFRKTI RIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKNFRKTIQRILGVQY 240
Query: 241 SIPDYVHISPECRHLISRIFVADPA 265
SIPDYVHISPECR LI+RIFVA+PA
Sbjct: 241 SIPDYVHISPECRDLIARIFVANPA 265
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 522 bits (1344), Expect = e-147, Method: Compositional matrix adjust.
Identities = 252/278 (90%), Positives = 265/278 (95%), Gaps = 8/278 (2%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 241 SIPDYVHISPECRHLISRIFVADPAKS------EMHDW 272
+IPDYVHISPECRHLISRIFVADPAK H+W
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 276
|
Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7Y0B9|SAPK8_ORYSJ Serine/threonine-protein kinase SAPK8 OS=Oryza sativa subsp. japonica GN=SAPK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 510 bits (1313), Expect = e-144, Method: Compositional matrix adjust.
Identities = 242/264 (91%), Positives = 255/264 (96%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
DR+A+TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRD++T ELVAVKYIERG+KID
Sbjct: 12 DRAALTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDRRTMELVAVKYIERGEKID 71
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 121
+NVQREIINHRSL+HPNI+RFKEVILTPTHLAIVMEYASGGELFERIC RFSEDEAR+
Sbjct: 72 DNVQREIINHRSLKHPNIIRFKEVILTPTHLAIVMEYASGGELFERICKNVRFSEDEARY 131
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT
Sbjct: 132 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 191
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241
PAYIAPEVLLKKEYDGK ADVWSCGVTLYVM+VGAYPFEDPEEPKNFRKTI RIL+VQYS
Sbjct: 192 PAYIAPEVLLKKEYDGKTADVWSCGVTLYVMVVGAYPFEDPEEPKNFRKTIQRILNVQYS 251
Query: 242 IPDYVHISPECRHLISRIFVADPA 265
IP+ V ISPECRHLISRIFV DP+
Sbjct: 252 IPENVDISPECRHLISRIFVGDPS 275
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1 | Back alignment and function description |
|---|
Score = 505 bits (1300), Expect = e-142, Method: Compositional matrix adjust.
Identities = 241/278 (86%), Positives = 259/278 (93%), Gaps = 7/278 (2%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RILSV+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 241 SIPDYVHISPECRHLISRIFVADPAKS------EMHDW 272
SIPD + ISPEC HLISRIFVADPA + H W
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW 277
|
Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 497 bits (1279), Expect = e-140, Method: Compositional matrix adjust.
Identities = 237/266 (89%), Positives = 254/266 (95%), Gaps = 3/266 (1%)
Query: 1 MDRSAMTVGP-GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK 59
M+R+A GP GM+MPIMHD DRYELV++IGSGNFGVARLMR++ + +LVAVKYI+RG+K
Sbjct: 1 MERAA--AGPLGMEMPIMHDGDRYELVKEIGSGNFGVARLMRNRASGDLVAVKYIDRGEK 58
Query: 60 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
IDENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERIC+AGRFSEDEA
Sbjct: 59 IDENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICSAGRFSEDEA 118
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTV
Sbjct: 119 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI +IL VQ
Sbjct: 179 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIQKILGVQ 238
Query: 240 YSIPDYVHISPECRHLISRIFVADPA 265
YSIPDYVHISPECR LI+RIFV +PA
Sbjct: 239 YSIPDYVHISPECRDLITRIFVGNPA 264
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39192|SRK2D_ARATH Serine/threonine-protein kinase SRK2D OS=Arabidopsis thaliana GN=SRK2D PE=1 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1252), Expect = e-137, Method: Compositional matrix adjust.
Identities = 225/254 (88%), Positives = 248/254 (97%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
+D+PIMHDSDRY+ V+DIGSGNFGVARLM D+ T+ELVAVKYIERG+KIDENVQREIINH
Sbjct: 12 IDLPIMHDSDRYDFVKDIGSGNFGVARLMTDRVTKELVAVKYIERGEKIDENVQREIINH 71
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
RSLRHPNIVRFKEVILTP+HLAIVMEYA+GGEL+ERICNAGRFSEDEARFFFQQLISGVS
Sbjct: 72 RSLRHPNIVRFKEVILTPSHLAIVMEYAAGGELYERICNAGRFSEDEARFFFQQLISGVS 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
YCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE+LL
Sbjct: 132 YCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEILL 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
++EYDGK+ADVWSCGVTLYVMLVGAYPFEDP+EP+++RKTI RILSV YSIP+ +H+SPE
Sbjct: 192 RQEYDGKLADVWSCGVTLYVMLVGAYPFEDPQEPRDYRKTIQRILSVTYSIPEDLHLSPE 251
Query: 252 CRHLISRIFVADPA 265
CRHLISRIFVADPA
Sbjct: 252 CRHLISRIFVADPA 265
|
Together with SRK2I, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 459 bits (1181), Expect = e-128, Method: Compositional matrix adjust.
Identities = 213/246 (86%), Positives = 236/246 (95%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+++DIGSGNFGVA+L+RD +T+EL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI RILSVQY +PDYV +S ECRHL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIF 241
Query: 261 VADPAK 266
VA+P +
Sbjct: 242 VANPEQ 247
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 458 bits (1178), Expect = e-128, Method: Compositional matrix adjust.
Identities = 212/246 (86%), Positives = 236/246 (95%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+++DIGSGNFGVA+L+RD +T+EL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS APRLKICDFGYSKSS+LHSQPKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI RILSVQY +PDYV +S ECRHL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIF 241
Query: 261 VADPAK 266
VA+P +
Sbjct: 242 VANPEQ 247
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7XQP4|SAPK7_ORYSJ Serine/threonine-protein kinase SAPK7 OS=Oryza sativa subsp. japonica GN=SAPK7 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 452 bits (1162), Expect = e-126, Method: Compositional matrix adjust.
Identities = 207/246 (84%), Positives = 235/246 (95%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYEL++DIG+GNFGVARLMR+K+T+ELVA+KYI RG KIDENV REIINHRSLRHPNI+
Sbjct: 2 ERYELLKDIGAGNFGVARLMRNKETKELVAMKYIPRGLKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV++TPTHLAIVMEYA+GGELF+RICNAGRFSEDEAR+FFQQLI GVSYCH MQ+CH
Sbjct: 62 RFKEVVVTPTHLAIVMEYAAGGELFDRICNAGRFSEDEARYFFQQLICGVSYCHFMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYDGKTA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVGAYPFEDP++PKNFRKTI RI+S+QY IP+YVH+S +CR L+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTIGRIMSIQYKIPEYVHVSQDCRQLLSRIF 241
Query: 261 VADPAK 266
VA+PAK
Sbjct: 242 VANPAK 247
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75LR7|SAPK1_ORYSJ Serine/threonine-protein kinase SAPK1 OS=Oryza sativa subsp. japonica GN=SAPK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1161), Expect = e-126, Method: Compositional matrix adjust.
Identities = 210/246 (85%), Positives = 232/246 (94%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE++RDIGSGNFGVA+L+RD T L AVK+IERG KIDE+VQREI+NHRSL+HPNI+
Sbjct: 2 ERYEVMRDIGSGNFGVAKLVRDVATNHLFAVKFIERGLKIDEHVQREIMNHRSLKHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 122 RDLKLENTLLDGSVTPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRKEYDGKVA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVGAYPFEDP++P+NFRKTI RILSVQYSIPDYV +S +CRHL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDDPRNFRKTITRILSVQYSIPDYVRVSADCRHLLSRIF 241
Query: 261 VADPAK 266
V +P +
Sbjct: 242 VGNPEQ 247
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 280 | ||||||
| 356575154 | 364 | PREDICTED: serine/threonine-protein kina | 0.971 | 0.747 | 0.946 | 1e-153 | |
| 255561655 | 363 | Serine/threonine-protein kinase SAPK10, | 0.971 | 0.749 | 0.924 | 1e-152 | |
| 356521207 | 364 | PREDICTED: serine/threonine-protein kina | 0.971 | 0.747 | 0.935 | 1e-152 | |
| 356519681 | 369 | PREDICTED: serine/threonine-protein kina | 0.967 | 0.734 | 0.935 | 1e-151 | |
| 356575156 | 373 | PREDICTED: serine/threonine-protein kina | 0.971 | 0.729 | 0.916 | 1e-151 | |
| 404435147 | 362 | sucrose non-fermenting 1-related protein | 0.971 | 0.751 | 0.917 | 1e-150 | |
| 356521209 | 371 | PREDICTED: serine/threonine-protein kina | 0.971 | 0.733 | 0.912 | 1e-150 | |
| 224123434 | 363 | predicted protein [Populus trichocarpa] | 0.971 | 0.749 | 0.917 | 1e-150 | |
| 225428695 | 363 | PREDICTED: serine/threonine-protein kina | 0.946 | 0.730 | 0.958 | 1e-149 | |
| 147788088 | 363 | hypothetical protein VITISV_025025 [Viti | 0.971 | 0.749 | 0.924 | 1e-149 |
| >gi|356575154|ref|XP_003555707.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 547 bits (1409), Expect = e-153, Method: Compositional matrix adjust.
Identities = 263/278 (94%), Positives = 267/278 (96%), Gaps = 6/278 (2%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILKVQY 240
Query: 241 SIPDYVHISPECRHLISRIFVADPAKS------EMHDW 272
SIPDYVHISPECRHLISRIFVADPA+ H+W
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPAQRISIPEIRNHEW 278
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561655|ref|XP_002521837.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538875|gb|EEF40473.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 542 bits (1396), Expect = e-152, Method: Compositional matrix adjust.
Identities = 257/278 (92%), Positives = 270/278 (97%), Gaps = 6/278 (2%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+T+GPGMD+PIMHDSDRYELV+DIG+GNFGVARLMRDK+T+ELVAVKYIERG+KI
Sbjct: 1 MDRSALTIGPGMDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQTDELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 240
Query: 241 SIPDYVHISPECRHLISRIFVADPAKS------EMHDW 272
SIPDYVHISPEC+HLISRIFVADPAK + H+W
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAKRISIPEIKNHEW 278
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521207|ref|XP_003529248.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 542 bits (1396), Expect = e-152, Method: Compositional matrix adjust.
Identities = 260/278 (93%), Positives = 266/278 (95%), Gaps = 6/278 (2%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSD+YELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDKYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKE+ILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEIILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILKVQY 240
Query: 241 SIPDYVHISPECRHLISRIFVADPAKS------EMHDW 272
SIPDYVHIS ECRHLISRIFVADPA+ H+W
Sbjct: 241 SIPDYVHISSECRHLISRIFVADPAQRISIPEIRNHEW 278
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356519681|ref|XP_003528498.1| PREDICTED: serine/threonine-protein kinase SRK2E-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1390), Expect = e-151, Method: Compositional matrix adjust.
Identities = 259/277 (93%), Positives = 266/277 (96%), Gaps = 6/277 (2%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
DRSAM+VGPGMD+PIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERG+KID
Sbjct: 13 DRSAMSVGPGMDLPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGEKID 72
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 121
ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF
Sbjct: 73 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 132
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
FFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT
Sbjct: 133 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 192
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241
PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQYS
Sbjct: 193 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYS 252
Query: 242 IPDYVHISPECRHLISRIFVADPAKS------EMHDW 272
IPDYVHIS ECRHLISRIFVADPA+ H+W
Sbjct: 253 IPDYVHISSECRHLISRIFVADPARRITIPEIRNHEW 289
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575156|ref|XP_003555708.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 539 bits (1389), Expect = e-151, Method: Compositional matrix adjust.
Identities = 263/287 (91%), Positives = 267/287 (93%), Gaps = 15/287 (5%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVL 171
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK SSVL
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKVHFLRTVISSSVL 180
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231
HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT
Sbjct: 181 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 240
Query: 232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKS------EMHDW 272
IHRIL VQYSIPDYVHISPECRHLISRIFVADPA+ H+W
Sbjct: 241 IHRILKVQYSIPDYVHISPECRHLISRIFVADPAQRISIPEIRNHEW 287
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|404435147|gb|AFR68940.1| sucrose non-fermenting 1-related protein kinase 2 family member [Solanum tuberosum] | Back alignment and taxonomy information |
|---|
Score = 537 bits (1383), Expect = e-150, Method: Compositional matrix adjust.
Identities = 255/278 (91%), Positives = 268/278 (96%), Gaps = 6/278 (2%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+A+TVGPGMD+PIMHDSDRYELVRDIG+GNFGVARLMRD++T ELVAVKYIERG+KI
Sbjct: 1 MDRTAVTVGPGMDVPIMHDSDRYELVRDIGAGNFGVARLMRDRQTNELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVME+ASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEFASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI RIL+VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIQRILNVQY 240
Query: 241 SIPDYVHISPECRHLISRIFVADPAKS------EMHDW 272
SIPDYVHISPECRHLISRIFVADPAK + H+W
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPAKRISIPEIKNHEW 278
|
Source: Solanum tuberosum Species: Solanum tuberosum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521209|ref|XP_003529249.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1378), Expect = e-150, Method: Compositional matrix adjust.
Identities = 260/285 (91%), Positives = 266/285 (93%), Gaps = 13/285 (4%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSD+YELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDKYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKE+ILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEIILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHS 173
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK SSVLHS
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKVYFFLHTSSVLHS 180
Query: 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH
Sbjct: 181 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 240
Query: 234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKS------EMHDW 272
RIL VQYSIPDYVHIS ECRHLISRIFVADPA+ H+W
Sbjct: 241 RILKVQYSIPDYVHISSECRHLISRIFVADPAQRISIPEIRNHEW 285
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123434|ref|XP_002330314.1| predicted protein [Populus trichocarpa] gi|222871349|gb|EEF08480.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1378), Expect = e-150, Method: Compositional matrix adjust.
Identities = 255/278 (91%), Positives = 264/278 (94%), Gaps = 6/278 (2%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRS MTVGPGMDMPIMHD DRYELVRDIGSGNFGVARLMRDK+ +ELVAVKYIERG+KI
Sbjct: 1 MDRSVMTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRDKQADELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN+GRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNSGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP STVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPTSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EP+NFR TIHRIL+VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPRNFRSTIHRILNVQY 240
Query: 241 SIPDYVHISPECRHLISRIFVADPAKS------EMHDW 272
SIPDYVHISPEC+HLISRIFVADPAK HDW
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAKRITIPEIRNHDW 278
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225428695|ref|XP_002284959.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 1 [Vitis vinifera] gi|297741336|emb|CBI32467.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1377), Expect = e-149, Method: Compositional matrix adjust.
Identities = 254/265 (95%), Positives = 260/265 (98%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+TVGP MD+PIMHDSDRYELVRDIGSGNFGVARLMRDK+T ELVAVKYIERG+KI
Sbjct: 1 MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF KTI RIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILKVQY 240
Query: 241 SIPDYVHISPECRHLISRIFVADPA 265
SIPDYVHISPECRHLISRIFVADPA
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPA 265
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147788088|emb|CAN62745.1| hypothetical protein VITISV_025025 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 533 bits (1373), Expect = e-149, Method: Compositional matrix adjust.
Identities = 257/278 (92%), Positives = 265/278 (95%), Gaps = 6/278 (2%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+TVGP MD+PIMHDSDRYELVRDIGSGNFGVARLMRDK+T ELVAVKYIERG+KI
Sbjct: 1 MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCH+MQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSSAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF KTI RIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILKVQY 240
Query: 241 SIPDYVHISPECRHLISRIFVADPAK----SEM--HDW 272
SIPDYVHISPECRHLISRIFVADPA +E+ HDW
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPATRITIAEIRNHDW 278
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 280 | ||||||
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.942 | 0.729 | 0.939 | 9.8e-135 | |
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.942 | 0.731 | 0.901 | 7.3e-130 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.878 | 0.683 | 0.841 | 2.8e-114 | |
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.878 | 0.681 | 0.833 | 1.5e-113 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.878 | 0.696 | 0.829 | 6.6e-113 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.878 | 0.717 | 0.825 | 2e-111 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 0.9 | 0.72 | 0.786 | 2.6e-111 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.871 | 0.719 | 0.778 | 2.2e-105 | |
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.825 | 0.473 | 0.447 | 2.3e-48 | |
| DICTYBASE|DDB_G0277905 | 727 | snfA "AMP-activated protein ki | 0.867 | 0.334 | 0.447 | 3.7e-48 |
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1320 (469.7 bits), Expect = 9.8e-135, P = 9.8e-135
Identities = 250/266 (93%), Positives = 262/266 (98%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 241 SIPDYVHISPECRHLISRIFVADPAK 266
+IPDYVHISPECRHLISRIFVADPAK
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAK 264
|
|
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1274 (453.5 bits), Expect = 7.3e-130, P = 7.3e-130
Identities = 239/265 (90%), Positives = 256/265 (96%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RILSV+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 241 SIPDYVHISPECRHLISRIFVADPA 265
SIPD + ISPEC HLISRIFVADPA
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPA 264
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1127 (401.8 bits), Expect = 2.8e-114, P = 2.8e-114
Identities = 207/246 (84%), Positives = 231/246 (93%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YE+V+D+G+GNFGVARL+R K+T+ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE EAR+FFQQLI GV YCHS+Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVG YPFEDP++P+NFRKTI RI++VQY IPDYVHIS ECRHL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRHLLSRIF 241
Query: 261 VADPAK 266
V + AK
Sbjct: 242 VTNSAK 247
|
|
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1120 (399.3 bits), Expect = 1.5e-113, P = 1.5e-113
Identities = 205/246 (83%), Positives = 231/246 (93%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YELV+DIG+GNFGVARLMR K ++ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTH+AI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVL + EYDGK+A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVGAYPFED E+PKNF+KTI RI++V+Y IPDYVHIS +C+HL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLSRIF 241
Query: 261 VADPAK 266
V + K
Sbjct: 242 VTNSNK 247
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1114 (397.2 bits), Expect = 6.6e-113, P = 6.6e-113
Identities = 204/246 (82%), Positives = 229/246 (93%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+Y++V+D+G+GNFGVARL+R K T+ELVA+KYIERG KIDENV REIINHRSL+HPNI+
Sbjct: 2 DKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEVILTPTHLAIVMEYASGGELF+RIC AGRFSE EAR+FFQQLI GV YCHS+Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVGAYPFEDP +PKNFRKTI RI++VQY IPDYVHIS EC+HL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKHLLSRIF 241
Query: 261 VADPAK 266
V + AK
Sbjct: 242 VTNSAK 247
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1100 (392.3 bits), Expect = 2.0e-111, P = 2.0e-111
Identities = 203/246 (82%), Positives = 229/246 (93%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+V+DIGSGNFGVA+L+RDK ++EL AVK+IERG KIDE+VQREI+NHRSL HPNI+
Sbjct: 2 ERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LT THLA+VMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGV+YCHS+Q+CH
Sbjct: 62 RFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS APR+KICDFGYSKS VLHSQPK+TVGTPAYIAPEVL KEYDGKIA
Sbjct: 122 RDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVGAYPFEDP +PK+FRKTI RIL QY+IPDYV +S ECRHL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRIF 241
Query: 261 VADPAK 266
VA+P K
Sbjct: 242 VANPEK 247
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1099 (391.9 bits), Expect = 2.6e-111, P = 2.6e-111
Identities = 203/258 (78%), Positives = 230/258 (89%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RY+++RD+GSGNFGVA+L+R+K E AVKYIERG KIDE+VQREIINHR L+HPNI+
Sbjct: 2 ERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV +TPTHLAIVMEYA+GGELFERICNAGRFSEDE R++F+QLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSP+ LKICDFGYSKSSVLHSQPKSTVGTPAY+APEVL +KEY+GKIA
Sbjct: 122 RDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKIA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVGAYPFEDPE+P+N R TI RILSV Y+IPDYV IS EC+HL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRILSVHYTIPDYVRISSECKHLLSRIF 241
Query: 261 VADPAKS------EMHDW 272
VADP K E H W
Sbjct: 242 VADPDKRITVPEIEKHPW 259
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1043 (372.2 bits), Expect = 2.2e-105, P = 2.2e-105
Identities = 190/244 (77%), Positives = 219/244 (89%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++YE+V+D+G GNFG+ARLMR+K+T ELVAVK+I+RG KIDENV REIINHR+L HPNIV
Sbjct: 2 EKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHL IVMEYA+GGELFERI + GRFSE EAR+FFQQLI GV Y H++Q+CH
Sbjct: 62 RFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS PKSTVGTPAYIAPEV + EYDGK
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKSV 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGV LYVMLVGAYPFEDP++P+NFRKT+ +I++V Y IP YVHIS +CR L+SRIF
Sbjct: 182 DVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLLSRIF 241
Query: 261 VADP 264
VA+P
Sbjct: 242 VANP 245
|
|
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 505 (182.8 bits), Expect = 2.3e-48, P = 2.3e-48
Identities = 115/257 (44%), Positives = 153/257 (59%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
+YE+ R +G G FG ++ T E VA+K I + D++ E ++REI R +RH
Sbjct: 42 KYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINK-DQVKREGMMEQIKREISIMRLVRH 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIV KEV+ T T + +MEY GGELF +I G+ ED AR +FQQLIS V +CHS
Sbjct: 101 PNIVELKEVMATKTKIFFIMEYVKGGELFSKIVK-GKLKEDSARKYFQQLISAVDFCHSR 159
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYS-------KSSVLHSQPKSTVGTPAYIAPEV 189
V HRDLK EN L+D + LK+ DFG S + +LH+Q GTPAY+APEV
Sbjct: 160 GVSHRDLKPENLLVDENGD--LKVSDFGLSALPEQILQDGLLHTQ----CGTPAYVAPEV 213
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
L KK YDG D+WSCG+ LYV+L G PF+D +N K +I ++ P + S
Sbjct: 214 LRKKGYDGAKGDIWSCGIILYVLLAGFLPFQD----ENLMKMYRKIFKSEFEYPPW--FS 267
Query: 250 PECRHLISRIFVADPAK 266
PE + LIS++ V DP K
Sbjct: 268 PESKRLISKLLVVDPNK 284
|
|
| DICTYBASE|DDB_G0277905 snfA "AMP-activated protein kinase alpha subunit" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 504 (182.5 bits), Expect = 3.7e-48, P = 3.7e-48
Identities = 115/257 (44%), Positives = 150/257 (58%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
Y L + +G G+FG +L +T VA+K + R K+DE ++REI N + RHP+
Sbjct: 31 YRLDKTLGIGSFGKVKLAEHIRTGVKVAIKILNRTKIKNLKMDEKIRREIQNMKLFRHPH 90
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
I++ EVI T T + +VMEY +GGELFE I G+ EDE+R FQQ+ISGV YCH V
Sbjct: 91 IIKLYEVIETTTDIFMVMEYVTGGELFEYIVKNGKLLEDESRRLFQQMISGVDYCHHHMV 150
Query: 139 CHRDLKLENTLLDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
HRDLK EN LLD P + +KI DFG S K++ G+P Y APEV+ K Y G
Sbjct: 151 VHRDLKPENLLLD--PINKCIKIADFGLSNMMQDGDFLKTSCGSPNYAAPEVISGKLYAG 208
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
DVWSCGV LY L PF+D P F+K + +SIPD+V SP C LI
Sbjct: 209 PEVDVWSCGVILYAFLCAKLPFDDESIPMLFKKIREGV----FSIPDFV--SPSCADLIK 262
Query: 258 RIFVADPAKS-EMHDWR 273
++ V DP K +H+ R
Sbjct: 263 KMLVVDPVKRITIHEIR 279
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| A2ZAB5 | SAPK3_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.7945 | 0.9 | 0.7544 | N/A | no |
| Q02066 | AAIP_WHEAT | 2, ., 7, ., 1, 1, ., 1 | 0.8523 | 0.8464 | 0.7138 | N/A | no |
| A2YNT8 | SAPK2_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.8658 | 0.8785 | 0.7256 | N/A | no |
| Q940H6 | SRK2E_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9064 | 0.9642 | 0.7458 | yes | no |
| Q75H77 | SAPKA_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.9358 | 0.9464 | 0.7320 | yes | no |
| Q7Y0B9 | SAPK8_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.9166 | 0.9428 | 0.7115 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 280 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-94 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-81 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-65 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-64 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-61 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-59 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-56 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-52 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-51 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-50 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-46 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-44 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-44 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-44 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-43 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-42 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-42 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-41 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-41 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-41 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-41 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-40 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-40 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-39 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-39 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-38 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-38 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-38 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-38 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-37 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-37 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-37 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-37 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-36 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-36 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-36 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-36 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-36 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-36 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-36 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-35 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-35 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-35 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-35 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-34 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-34 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-34 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-34 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-34 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-34 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-34 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-34 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-34 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-34 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-34 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-34 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-33 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-33 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-33 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-33 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-33 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-33 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-33 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-32 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-32 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-32 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-32 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-31 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-31 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-31 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-31 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-30 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-29 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-29 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-29 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-29 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-28 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-28 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-28 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-27 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-27 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-27 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-27 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-27 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-27 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-27 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-26 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-26 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-26 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-26 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-26 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-26 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-26 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-25 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-25 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-25 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-25 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-25 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-25 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-24 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-24 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-24 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-24 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-24 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-24 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-24 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-23 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-23 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-23 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-23 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-22 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-22 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-22 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-22 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-22 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-22 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-21 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-21 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-21 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-20 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-20 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-20 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-19 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-19 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-19 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-19 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-18 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-18 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-17 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-15 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-12 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.002 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 278 bits (714), Expect = 2e-94
Identities = 103/247 (41%), Positives = 143/247 (57%), Gaps = 9/247 (3%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 80
YE++ +G G+FG L RDKKT +LVA+K I ++ K E + REI + L+HPNIV
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
R +V L +VMEY GG+LF+ + GR SEDEARF+ +Q++S + Y HS + H
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLK EN LLD +K+ DFG ++ + + VGTP Y+APEVLL K Y +
Sbjct: 121 RDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV- 177
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP-DYVHISPECRHLISRI 259
D+WS GV LY +L G PF ++ + +I + P ISPE + LI ++
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLL---ELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 260 FVADPAK 266
V DP K
Sbjct: 235 LVKDPEK 241
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 246 bits (629), Expect = 1e-81
Identities = 104/250 (41%), Positives = 139/250 (55%), Gaps = 9/250 (3%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPNI 79
YEL+R +GSG+FG + K T ++VAVK + K D+ +REI R L HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
VR + HL +VMEY GG+LF+ + G SEDEA+ Q++ G+ Y HS +
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGK 198
HRDLK EN LLD + +KI DFG +K + S +T VGTP Y+APEVLL G
Sbjct: 121 HRDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECRHLI 256
DVWS GV LY +L G PF E + + I RIL +++ P + S E + LI
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 257 SRIFVADPAK 266
+ DP+K
Sbjct: 238 KKCLNKDPSK 247
|
Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 8e-65
Identities = 89/256 (34%), Positives = 136/256 (53%), Gaps = 22/256 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
+YE+++ IG G+FG L+R K +L +K I +K E+ E+ + L HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
I+++ E L IVMEYA GG+L ++I + F E++ +F QL + Y H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
S ++ HRD+K +N L +K+ DFG SK S+V + K+ VGTP Y++PE+
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQ 176
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISP 250
K Y+ K +D+WS G LY + +PFE +N + +IL QY IP S
Sbjct: 177 NKPYNYK-SDIWSLGCVLYELCTLKHPFEG----ENLLELALKILKGQYPPIPS--QYSS 229
Query: 251 ECRHLISRIFVADPAK 266
E R+L+S + DP +
Sbjct: 230 ELRNLVSSLLQKDPEE 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 3e-64
Identities = 86/188 (45%), Positives = 112/188 (59%), Gaps = 5/188 (2%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVI 86
+G G FG L RDKKT + VA+K I++ D E + REI + L HPNIV+ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 87 LTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
HL +VMEY GG L + + N G+ SEDE Q++ G+ Y HS + HRDLK
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 146 ENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
EN LLD S ++K+ DFG SK + S K+ VGTPAY+APEVLL K Y + +D+WS
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 205 CGVTLYVM 212
GV LY +
Sbjct: 180 LGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 3e-61
Identities = 94/245 (38%), Positives = 131/245 (53%), Gaps = 18/245 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 84
+G G+FG L+R K T +L A+K +++ I + R+ + HP IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L +V+EYA GGELF + GRFSE+ ARF+ +++ + Y HS+ + +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 145 LENTLLD--GSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
EN LLD G +K+ DFG +K S+ + GTP Y+APEVLL K Y GK D
Sbjct: 121 PENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVD 175
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261
WS GV LY ML G PF + + +IL P+++ SPE R LIS +
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRK----EIYEKILKDPLRFPEFL--SPEARDLISGLLQ 229
Query: 262 ADPAK 266
DP K
Sbjct: 230 KDPTK 234
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 8e-59
Identities = 85/255 (33%), Positives = 126/255 (49%), Gaps = 18/255 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
+ +G G+FG L DK T EL+AVK +E +E + +REI SL+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 79 IVRFK--EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IVR+ E L I +EY SGG L + G+ E R + +Q++ G++Y HS
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ HRD+K N L+D +K+ DFG +K S GTP ++APEV+ +
Sbjct: 121 GIVHRDIKGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPE 251
EY AD+WS G T+ M G P+ + P +++I S IP+ H+S E
Sbjct: 179 EYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMAA---LYKIGSSGEPPEIPE--HLSEE 232
Query: 252 CRHLISRIFVADPAK 266
+ + + DP K
Sbjct: 233 AKDFLRKCLRRDPKK 247
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 5e-56
Identities = 91/257 (35%), Positives = 142/257 (55%), Gaps = 29/257 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE-IINHR----SLR 75
D +E ++ +G+G+FG L+R K + + A+K + + KI + Q E ++N + S+R
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIR 59
Query: 76 HPNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
HP +V F++ ++L +VMEY GGELF + +GRF E ARF+ Q++ +
Sbjct: 60 HPFLVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y HS+ + +RDLK EN LLD G +KI DFG++K + + + GTP Y+APE+
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEI 169
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
+L K Y GK D W+ G+ +Y ML G PF D + P + +IL + P S
Sbjct: 170 ILSKGY-GKAVDWWALGILIYEMLAGYPPFFD-DNP---IQIYEKILEGKVRFP--SFFS 222
Query: 250 PECRHLISRIFVADPAK 266
P+ + LI + D K
Sbjct: 223 PDAKDLIRNLLQVDLTK 239
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 5e-52
Identities = 77/249 (30%), Positives = 123/249 (49%), Gaps = 14/249 (5%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 81
+E++ IG G FG R K+T + VA+K I + E + EI + +HPNIV+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L L IVME+ SGG L + + + + +E + + ++L+ G+ Y HS + H
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
RD+K N LL DG +K+ DFG S + VGTP ++APEV+ K YD K
Sbjct: 122 RDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-SVQYSIPDYVHISPECRHLIS 257
AD+WS G+T + G P+ + K + +I + + + S E + +
Sbjct: 178 -ADIWSLGITAIELAEGKPPYSEL----PPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232
Query: 258 RIFVADPAK 266
+ +P K
Sbjct: 233 KCLQKNPEK 241
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 5e-51
Identities = 86/251 (34%), Positives = 126/251 (50%), Gaps = 20/251 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKE 84
I G +G L + K T ++ A+K I++ D I +N +++ R + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+L +VMEY GG+L + N G ED AR + +++ + Y HS + HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSK---------SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+N L+D + LK+ DFG SK + + K VGTP YIAPEV+L + +
Sbjct: 121 PDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
K D WS G LY LVG PF E P + IL+ + P+ V +S E L
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPFHG-ETP---EEIFQNILNGKIEWPEDVEVSDEAIDL 233
Query: 256 ISRIFVADPAK 266
IS++ V DP K
Sbjct: 234 ISKLLVPDPEK 244
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 2e-50
Identities = 81/275 (29%), Positives = 130/275 (47%), Gaps = 45/275 (16%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 76
++ + IG G+F L ++K+T + A+K + + K+ +++E++ R H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVL-TRLNGH 61
Query: 77 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
P I++ F++ +L V+EYA GEL + I G E RF+ +++ + Y
Sbjct: 62 PGIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 171
HS + HRDLK EN LLD +KI DFG +K
Sbjct: 118 LHSKGIIHRDLKPENILLDKD--MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231
+ S VGT Y++PE+L +K GK +D+W+ G +Y ML G PF E T
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEY----LT 230
Query: 232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
+IL ++YS P + P+ + LI ++ V DP
Sbjct: 231 FQKILKLEYSFPP--NFPPDAKDLIEKLLVLDPQD 263
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 4e-46
Identities = 90/268 (33%), Positives = 129/268 (48%), Gaps = 28/268 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHP- 77
Y ++R +G G+FG L RD+K VA+K + + + REI SL HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCH 134
NIV+ + L +VMEY GG L + + G SE EA F Q++S + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAP 187
S + HRD+K EN LLD +K+ DFG +K +S + + P ++VGTP Y+AP
Sbjct: 119 SKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 188 EVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------KNFRKTIHRILSV 238
EVLL Y +D+WS G+TLY +L G PFE + K + L+
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 239 QYSIPDYVHISPECRHLISRIFVADPAK 266
S + IS L+ ++ DP
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKN 265
|
Length = 384 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 6e-44
Identities = 88/301 (29%), Positives = 136/301 (45%), Gaps = 53/301 (17%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
++ ++ +G G+ G L+R K T +L A+K +++ + I N ++EI+ +L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATL 58
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 132
HP + T T+L +VM+Y GGELF + SE+ ARF+ +++ + Y
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 133 CHSMQVCHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHSQP 175
H + + +RDLK EN LL S P P K G +SSV
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 176 -----------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
S VGT YIAPEV+ + + D W+ G+ LY ML G PF+
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKG--- 234
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK--------SEM--HDWRR 274
N +T IL + + P +S R LI ++ V DP+K +E+ H + R
Sbjct: 235 -SNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
Query: 275 G 275
G
Sbjct: 294 G 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 7e-44
Identities = 90/255 (35%), Positives = 129/255 (50%), Gaps = 21/255 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL AVK +++ + D++V+ + R L +HP + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L I +GRF E ARF+ +++ G+ + H + +RDL
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N LLD +KI DFG K +L ST GTP YIAPE+L + Y G D
Sbjct: 123 KLDNVLLDSE--GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
W+ GV LY ML G PFE +E + F IL + P +S E + ++
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELF----QSILEDEVRYP--RWLSKEAKSILKSFLTK 233
Query: 263 DPAKSEMHDWRRGCS 277
+P K R GC
Sbjct: 234 NPEK------RLGCL 242
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 8e-44
Identities = 88/269 (32%), Positives = 132/269 (49%), Gaps = 24/269 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGD-KIDENVQREIINHRSLRHPN 78
R++ IG G FG + T EL+AVK I + D K + + E+ L+HPN
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA--RFFFQQLISGVSYCHSM 136
+V++ V + + I MEY SGG L E + GR DE R + QL+ G++Y HS
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSH 118
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLL 191
+ HRD+K N LD + +K+ DFG + ++ + + +S GTPAY+APEV+
Sbjct: 119 GIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 192 KKEYDGKI--ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
+ G AD+WS G + M G P+ E F+ H + IPD + +S
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIMFHVGAGHKPPIPDSLQLS 234
Query: 250 PECRHLISRIFVADPAK----SE--MHDW 272
PE + + R +DP K SE H +
Sbjct: 235 PEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 3e-43
Identities = 76/207 (36%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
YE + +G G +GV RDKKT E+VA+K I R D +E + REI + L+HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ +VI T L +V EY +L + + G S + + QL+ G++YCHS +
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK- 192
+ HRDLK +N L++ LK+ DFG +++ P T V T Y APE+LL
Sbjct: 119 ILHRDLKPQNILINRD--GVLKLADFGLARA---FGIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPF 219
K Y + D+WS G M+ G F
Sbjct: 174 KHYSTAV-DIWSVGCIFAEMITGKPLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-42
Identities = 82/250 (32%), Positives = 129/250 (51%), Gaps = 15/250 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
D E ++ +G+G FG L+RD+ +E A+K + + I ++V E + + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P I+R L ++MEY GGELF + N+GRFS F+ +++ + Y HS
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
++ +RDLK EN LLD +K+ DFG++K L + + GTP Y+APEV+ K +
Sbjct: 121 EIVYRDLKPENILLDKE--GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH- 175
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
K D W+ G+ +Y MLVG PF D N +IL+ + P H+ + LI
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFD----DNPFGIYEKILAGKLEFPR--HLDLYAKDLI 229
Query: 257 SRIFVADPAK 266
++ V D +
Sbjct: 230 KKLLVVDRTR 239
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-42
Identities = 88/247 (35%), Positives = 127/247 (51%), Gaps = 22/247 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSLRHPNIV 80
+G G FG L+R+K T + A+K I + + I + ++ + H ++ RHP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMK-ILKKEVI---IAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
K T L VMEYA+GGELF + FSED ARF+ +++S + Y HS V +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKI 199
RDLKLEN +LD +KI DFG K + T GTP Y+APEVL +Y G+
Sbjct: 119 RDLKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRA 175
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
D W GV +Y M+ G PF + + K F IL + P +SPE + L++ +
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFPR--TLSPEAKSLLAGL 229
Query: 260 FVADPAK 266
DP +
Sbjct: 230 LKKDPKQ 236
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 5e-42
Identities = 73/250 (29%), Positives = 124/250 (49%), Gaps = 14/250 (5%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPN 78
+EL+R IG G FG +++ + T+++ A+KY+ + +++ R ++N R L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V ++ +V++ GG+L + +FSE++ +F+ +++ + Y HS +
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRD+K +N LLD + I DF + + ST GTP Y+APEVL ++ Y
Sbjct: 122 IHRDIKPDNILLDEQ--GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SV 178
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDY-VHISPECRHLI 256
D WS GVT Y L G P+ + R +I + Q + Y S E I
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYR-----GHSRTIRDQIRAKQETADVLYPATWSTEAIDAI 233
Query: 257 SRIFVADPAK 266
+++ DP K
Sbjct: 234 NKLLERDPQK 243
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-41
Identities = 82/250 (32%), Positives = 125/250 (50%), Gaps = 18/250 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---VQREIINHRSLRHPN 78
Y+L IG G FGV + +T + VA+K I +E + +EI ++L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV++ I T L I++EYA G L + I G F E + Q++ G++Y H V
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K N L DG +K+ DFG + K + + S VGTP ++APEV+
Sbjct: 121 IHRDIKAANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRH 254
+D+WS G T+ +L G P+ D N + RI+ + +P+ ISPE +
Sbjct: 177 STA-SDIWSLGCTVIELLTGNPPYYD----LNPMAALFRIVQDDHPPLPE--GISPELKD 229
Query: 255 LISRIFVADP 264
+ + F DP
Sbjct: 230 FLMQCFQKDP 239
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 2e-41
Identities = 90/284 (31%), Positives = 130/284 (45%), Gaps = 52/284 (18%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RH 76
D +E+++ IG G FG L+RDK T ++ A+K + + D I N + R +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 77 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
P IV+ F++ HL +VMEY GG+L + F E+ ARF+ +L+ +
Sbjct: 61 PWIVKLYYSFQDE----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDS 116
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------------------------- 167
H + HRD+K +N L+D +K+ DFG K
Sbjct: 117 VHKLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 168 -SSVLHSQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222
H Q + STVGTP YIAPEVL Y + D WS GV LY ML G PF
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSD 233
Query: 223 EEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADP 264
++T ++I++ + S P +SPE LI R + DP
Sbjct: 234 ----TLQETYNKIINWKESLRFPPDPPVSPEAIDLICR-LLCDP 272
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 2e-41
Identities = 82/244 (33%), Positives = 123/244 (50%), Gaps = 15/244 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-----LRHPNIVRFK 83
IG G+FG L + K + AVK +++ + + Q+ I+ R+ ++HP +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD L DFG K + HS+ ST GTP Y+APEVL K+ YD + D
Sbjct: 123 KPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
W G LY ML G PF + + + +++ L ++ + IS RHL+ +
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN------ISVSARHLLEGLLQK 233
Query: 263 DPAK 266
D K
Sbjct: 234 DRTK 237
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 6e-41
Identities = 70/199 (35%), Positives = 109/199 (54%), Gaps = 10/199 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
IG G G D+ T + VA+K + + E + EI+ + +HPNIV + + L
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 89 PTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VMEY GG L + I N R +E + + ++++ G+ Y HS V HRD+K +N
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDN 146
Query: 148 TLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DGS +K+ DFG++ + + S+ S VGTP ++APEV+ +K+Y K+ D+WS
Sbjct: 147 ILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKV-DIWS 201
Query: 205 CGVTLYVMLVGAYP-FEDP 222
G+ M G P +P
Sbjct: 202 LGIMCIEMAEGEPPYLREP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 6e-41
Identities = 81/261 (31%), Positives = 124/261 (47%), Gaps = 27/261 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
YE++ IG G+FG R +R K +++ K I+ G + E ++++++ R L+HPN
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHPN 60
Query: 79 IVRF--KEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSY 132
IVR+ + + + L IVMEY GG+L + I E+ QL+ +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 133 CH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIA 186
CH V HRDLK N LD + +K+ DFG +K S T VGTP Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDY 245
PE L YD K +D+WS G +Y + + PF +N + +I ++ IP
Sbjct: 179 PEQLNHMSYDEK-SDIWSLGCLIYELCALSPPF----TARNQLQLASKIKEGKFRRIPY- 232
Query: 246 VHISPECRHLISRIFVADPAK 266
S E +I + DP K
Sbjct: 233 -RYSSELNEVIKSMLNVDPDK 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 8e-41
Identities = 90/250 (36%), Positives = 127/250 (50%), Gaps = 12/250 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDEN-VQREIINHRSLRHPN 78
+YE +R +G G FG+ L R K ++LV +K I E+ K + Q E + L HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
I+ + E L L IVMEYA GG L E I ED FF Q++ + + H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK +N LLD +KI DFG SK S+ + VGTP YI+PE+ K Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
K +D+W+ G LY + F E N + +I+S ++ P SP+ R LI
Sbjct: 180 QK-SDIWALGCVLYELASLKRAF----EAANLPALVLKIMSGTFA-PISDRYSPDLRQLI 233
Query: 257 SRIFVADPAK 266
+ DP+K
Sbjct: 234 LSMLNLDPSK 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-40
Identities = 75/237 (31%), Positives = 119/237 (50%), Gaps = 15/237 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 84
+G G FG L++ K A+K +++ ++ Q I + + HP IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
++ ++MEY GGEL+ + + G F E ARF+ ++ Y H+ + +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
EN LLD + +K+ DFG++K + + GTP Y+APE++L K YD D WS
Sbjct: 121 PENLLLDSN--GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWS 177
Query: 205 CGVTLYVMLVGAYPF-EDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISR 258
G+ LY +L G PF ED E+P + + IL + P+Y I + LI +
Sbjct: 178 LGILLYELLTGRPPFGEDDEDP---MEIYNDILKGNGKLEFPNY--IDKAAKDLIKQ 229
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 4e-40
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
RY+++ IG G G+ +D++T E VA+K + I REI ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
+V+ +V + +VMEY +L E + + R E + + + + L+ GV+Y H+
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL-KKE 194
+ HRDLK N L+ S LKI DFG ++ S V T Y APE+L ++
Sbjct: 120 IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 195 YDGKIADVWSCGVTLYVMLVGA 216
YD + D+W+ G +L G+
Sbjct: 178 YDPGV-DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-39
Identities = 89/246 (36%), Positives = 131/246 (53%), Gaps = 19/246 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T E A+K +++ D + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T HL VMEY +GG+L I ++GRF E ARF+ ++I G+ + H + +RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
LKL+N LLD +KI DFG K ++ ST GTP YIAPE+L ++Y+ + D
Sbjct: 122 LKLDNVLLDKD--GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV-D 178
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY-VHISPECRHLISRIF 260
WS GV LY ML+G PF +E + F S+ P + IS E + +S++F
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDELFD-------SILNDRPHFPRWISKEAKDCLSKLF 231
Query: 261 VADPAK 266
DP K
Sbjct: 232 ERDPTK 237
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-39
Identities = 70/207 (33%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+ + L+ IG G+FG DK+T ++VA+K I E D+I++ +Q+EI R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED-IQQEIQFLSQCRSP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
I ++ L + L I+MEY GG + + G+ E F ++++ G+ Y H
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRD+K N LL +G +K+ DFG S + S+ + VGTP ++APEV+ +
Sbjct: 119 KIHRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFED 221
YD K AD+WS G+T + G P D
Sbjct: 175 YDEK-ADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 5e-39
Identities = 77/249 (30%), Positives = 113/249 (45%), Gaps = 12/249 (4%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
E V+ +G G+ GV +R K T ++ A+K I + Q RE+ RS P +V+
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCH 140
++IV+EY GG L + + G+ E + +Q++ G+ Y H+ + H
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K N L+ G KI DFG SK +T VGT Y++PE ++ E
Sbjct: 124 RDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYS 178
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
AD+WS G+TL +G +PF P +P F I SPE R IS
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-ICDGPPPSLPAEEFSPEFRDFIS 237
Query: 258 RIFVADPAK 266
DP K
Sbjct: 238 ACLQKDPKK 246
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 1e-38
Identities = 79/248 (31%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPN 78
+E+ +G+G+FG R+ + K T E A+K +++ + + + + +S L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + ++E+ GGELF + AGRF D A+F+ +L+ Y HS +
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
+RDLK EN LLD +K+ DFG++K + + + GTP Y+APEV+ K + GK
Sbjct: 140 IYRDLKPENLLLDNK--GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKGH-GK 194
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
D W+ GV LY + G PF D + P FR +IL+ + P++ R L+
Sbjct: 195 AVDWWTMGVLLYEFIAGYPPFFD-DTP--FR-IYEKILAGRLKFPNWF--DGRARDLVKG 248
Query: 259 IFVADPAK 266
+ D K
Sbjct: 249 LLQTDHTK 256
|
Length = 329 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-38
Identities = 79/252 (31%), Positives = 139/252 (55%), Gaps = 20/252 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
+Y V+ IG G+FG A L++ K+ + +K I + K E ++E+ +++HPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS 135
IV+++E +L IVM+Y GG+L+++I NA R F ED+ +F Q+ + + H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLK 192
++ HRD+K +N L +K+ DFG ++ VL+S ++ +GTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGT--IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICEN 175
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
+ Y+ K +D+W+ G LY M + F E N + + +I+ Y P H S +
Sbjct: 176 RPYNNK-SDIWALGCVLYEMCTLKHAF----EAGNMKNLVLKIIRGSYP-PVSSHYSYDL 229
Query: 253 RHLISRIFVADP 264
R+L+S++F +P
Sbjct: 230 RNLVSQLFKRNP 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-38
Identities = 75/222 (33%), Positives = 112/222 (50%), Gaps = 15/222 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
++++ +G G +G L + K T E+VA+K +++ N R ++ R + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+ +L + MEY GG+ + N G SED ARF+ ++ V H +
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRDLK EN L+D S +K+ DFG SK V + S VG+P Y+APEVL K YD
Sbjct: 123 IHRDLKPENFLIDAS--GHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFT 178
Query: 199 IADVWSCGVTLYVMLVGAYPF--EDPEEP----KNFRKTIHR 234
+ D WS G LY L G PF P E K +++T+ R
Sbjct: 179 V-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR 219
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 8e-38
Identities = 85/243 (34%), Positives = 125/243 (51%), Gaps = 14/243 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+R+K T A+K + + I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L VMEYA+GGELF + F+E+ ARF+ +++S + Y HS V +RD+K
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
LEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y G+ D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263
GV +Y M+ G PF + + + F IL + P +SPE + L++ + D
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPR--TLSPEAKSLLAGLLKKD 233
Query: 264 PAK 266
P +
Sbjct: 234 PKQ 236
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-37
Identities = 84/256 (32%), Positives = 125/256 (48%), Gaps = 27/256 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE----------RGDKIDENVQREIINHRSLRHPN 78
IGSG+FG L + + EL+AVK +E R + + + REI + L+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV++ L HL I +EY GG + + N G F E R F +Q++ G++Y H+ +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVLL 191
HRD+K N L+D +KI DFG SK S+ + S G+ ++APEV+
Sbjct: 128 IHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-VQYSIPDYVHISP 250
+ Y K AD+WS G + ML G +PF D + + I +I IP +IS
Sbjct: 186 QTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQ----LQAIFKIGENASPEIPS--NISS 238
Query: 251 ECRHLISRIFVADPAK 266
E + + F D K
Sbjct: 239 EAIDFLEKTFEIDHNK 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 4e-37
Identities = 83/245 (33%), Positives = 126/245 (51%), Gaps = 17/245 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K E AVK +++ ID++V+ ++ R L +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T HL VME+ +GG+L I + GRF A F+ +++ G+ + HS + +RDL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N +LD +KI DFG K +V ST GTP YIAPE+L +Y + D
Sbjct: 123 KLDNVMLDRD--GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV-DW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHLISRIFV 261
WS GV LY ML+G PF +E + F S++ P Y I+ E + ++ ++F
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFE-------SIRVDTPHYPRWITKESKDILEKLFE 232
Query: 262 ADPAK 266
DP +
Sbjct: 233 RDPTR 237
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 4e-37
Identities = 81/206 (39%), Positives = 111/206 (53%), Gaps = 14/206 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHR------SLRHPNIVR 81
+G G+FG L KKT EL A+K +++GD I + V+ + R S RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T H+ VMEYA+GG+L I + FSE A F+ ++ G+ Y H ++ +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +KI DFG K + ST GTP ++APEVL + Y +
Sbjct: 126 DLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAV 182
Query: 201 DVWSCGVTLYVMLVGAYPF--EDPEE 224
D W GV +Y MLVG PF +D EE
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 8e-37
Identities = 81/276 (29%), Positives = 124/276 (44%), Gaps = 38/276 (13%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNI 79
Y+ + IG G +GV RDK T E+VA+K I+ + I + REI + L HPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQV 138
++ +V L +V E+ +L++ I + R E + + QL+ G+++CHS +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLKKEY 195
HRDLK EN L++ LK+ DFG ++S S + V T Y APE+LL +
Sbjct: 120 LHRDLKPENLLINTEGV--LKLADFGLARS--FGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL----------------SVQ 239
D+WS G +L F E K I R L + +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK-IFRTLGTPDPEVWPKFTSLARNYK 234
Query: 240 YSIPDYVHI---------SPECRHLISRIFVADPAK 266
+S P + SP+ L+S++ DP K
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHK 270
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 1e-36
Identities = 77/200 (38%), Positives = 109/200 (54%), Gaps = 19/200 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ YEL++ IGSG +G RD T ELVA+K I E GD + +Q+EI + RHPN
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-IQQEISMLKECRHPN 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV + L L IVMEY GG L + G SE + + ++ + G++Y H
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL-- 190
HRD+K N LL DG +K+ DFG S +++ ++ KS +GTP ++APEV
Sbjct: 122 KIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAV 175
Query: 191 -LKKEYDGKIADVWSCGVTL 209
K YDGK D+W+ G+T
Sbjct: 176 ERKGGYDGK-CDIWALGITA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 88/293 (30%), Positives = 135/293 (46%), Gaps = 61/293 (20%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLR---- 75
D +E ++ IG G FG RL++ K T + A+K + + + + ++E + H R+ R
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML----EKEQVAHVRAERDILA 56
Query: 76 ---HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+P +V+ +L ++MEY GG++ + F+E+E RF+ + I +
Sbjct: 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 171
H + HRD+K +N LLD +K+ DFG
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 172 HSQPK------------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
S+P STVGTP YIAPEV L+ Y K D WS GV +Y ML
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEML 233
Query: 214 VGAYPF--EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
VG PF ++P+E +RK I+ ++Q PD V +SPE + LI R +
Sbjct: 234 VGYPPFCSDNPQE--TYRKIINWKETLQ--FPDEVPLSPEAKDLIKR-LCCEA 281
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-36
Identities = 85/243 (34%), Positives = 125/243 (51%), Gaps = 14/243 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+R+K + + A+K +++ I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L VMEY +GGELF + FSED RF+ +++S + Y HS ++ +RDLK
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYDGKIADVW 203
LEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y G+ D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263
GV +Y M+ G PF + + K F IL P +S + + L+S + + D
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEDIKFPRT--LSADAKSLLSGLLIKD 233
Query: 264 PAK 266
P K
Sbjct: 234 PNK 236
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-36
Identities = 81/245 (33%), Positives = 131/245 (53%), Gaps = 17/245 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T + A+K +++ + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T +L VMEY +GG+L I + +F A F+ ++I G+ + HS + +RDL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N LLD +KI DFG K ++L T GTP YIAPE+LL ++Y+ + D
Sbjct: 123 KLDNILLDTD--GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV-DW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHLISRIFV 261
WS GV LY ML+G PF +E + F+ S++ P Y ++ E + ++ ++FV
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQ-------SIRMDNPCYPRWLTREAKDILVKLFV 232
Query: 262 ADPAK 266
+P +
Sbjct: 233 REPER 237
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 5e-36
Identities = 73/204 (35%), Positives = 108/204 (52%), Gaps = 15/204 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKY---IERGDKIDENVQREIINHRSLRHP 77
++YE++ +G G +GV R+K T E+VA+K E + + + RE+ R LRH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV KE L +V EY EL E + G D R + QL+ ++YCHS
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLL 191
+ HRD+K EN L+ S + LK+CDFG++++ L ++P S V T Y APE+L+
Sbjct: 119 HNIIHRDIKPENILV--SESGVLKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLV 174
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
GK DVW+ G + +L G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 6e-36
Identities = 88/244 (36%), Positives = 127/244 (52%), Gaps = 15/244 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+++K T A+K +++ + + V + +R L RHP + K
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDL 143
T L VMEYA+GGELF + FSED ARF+ +++S + Y HS V +RDL
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
KLEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y G+ D
Sbjct: 123 KLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
W GV +Y M+ G PF + + K F IL + P +SPE + L+S +
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPRT--LSPEAKSLLSGLLKK 233
Query: 263 DPAK 266
DP +
Sbjct: 234 DPKQ 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 7e-36
Identities = 79/243 (32%), Positives = 117/243 (48%), Gaps = 14/243 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVRFKE 84
IG G+FG +R + T+ + A+K I + + + + R++ P IV K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+P L +V+ + +GGELF + GRF ARF+ +L+ + H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVW 203
EN LLD + +CDFG K ++ +T GTP Y+APE+LL Y K D W
Sbjct: 121 PENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263
+ GV LY ML G PF D + +RK IL PD + + L+ + D
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRK----ILQEPLRFPD--GFDRDAKDLLIGLLSRD 231
Query: 264 PAK 266
P +
Sbjct: 232 PTR 234
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 85/258 (32%), Positives = 126/258 (48%), Gaps = 23/258 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T+E+ A+K +++ D I D++V + R L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKK-DVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T L VMEY +GG+L +I + +F E +RF+ ++ + + H V +RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
LKL+N LLD K+ DFG K +L+ +T GTP YIAPE+L + EY + D
Sbjct: 122 LKLDNILLDAE--GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV-D 178
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261
W+ GV +Y M+ G PFE E F +H V Y V +S E ++
Sbjct: 179 WWALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYP----VWLSKEAVSILKAFMT 232
Query: 262 ADPAKSEMHDWRRGCSVS 279
+P K R GC S
Sbjct: 233 KNPNK------RLGCVAS 244
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 77/205 (37%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T+EL A+K I + D I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIK-ILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T L VMEY +GG+L I G+F E A F+ ++ G+ + HS + +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
LKL+N +LD +KI DFG K ++ + T GTP YIAPE++ + Y GK D
Sbjct: 127 LKLDNVMLDAE--GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 202 VWSCGVTLYVMLVGAYPF--EDPEE 224
W+ GV LY ML G PF ED +E
Sbjct: 184 WWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 73/209 (34%), Positives = 112/209 (53%), Gaps = 10/209 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV------QREIINHRSLRH-PNIVR 81
IG G FG +R K T + A+K + + + + + +R I+ L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
K T + L +V +Y SGGELF + GRFSED A+F+ +L+ + + H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLK EN LLD + + +CDFG SK+++ ++ +T GT Y+APEVLL ++ K
Sbjct: 121 DLKPENILLDAT--GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
D WS GV ++ M G PF + + +R
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQQMYR 207
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-35
Identities = 75/217 (34%), Positives = 109/217 (50%), Gaps = 9/217 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-----SLRHPNIVRFK 83
IG G+FG L + K AVK +++ + + Q I+ R +L+HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD + + DFG K V + ST GTP Y+APEVL K+ YD + D
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
W G LY ML G PF + + + +H+ L +
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 6e-35
Identities = 78/245 (31%), Positives = 121/245 (49%), Gaps = 21/245 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDEN----VQREIINHRSLRHPNIVRF 82
+G G FG L D T +AVK + + ++ EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
+ L+I MEY GG + +++ G +E R + +Q++ GV Y HS + HRD
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGK 198
+K N L D A +K+ DFG SK + S KS GTP +++PEV+ + Y G+
Sbjct: 130 IKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GR 186
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECRHLI 256
ADVWS G T+ ML P+ + E I +I + +P H+SP+ R+ +
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIATQPTNPQLPS--HVSPDARNFL 240
Query: 257 SRIFV 261
R FV
Sbjct: 241 RRTFV 245
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-34
Identities = 72/257 (28%), Positives = 105/257 (40%), Gaps = 25/257 (9%)
Query: 24 ELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
L + +G G FG + E VAVK + + D ++ ++ RE R L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 134
PNIV+ V L IVMEY GG+L + R S + F Q+ G+ Y
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEV 189
S HRDL N L+ + +KI DFG Y K + ++APE
Sbjct: 121 SKNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPES 175
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
L + ++ K +DVWS GV L+ + E N + L Y +P +
Sbjct: 176 LKEGKFTSK-SDVWSFGVLLWEIF--TLGEEPYPGMSNAE--VLEYLKKGYRLPKPPNCP 230
Query: 250 PECRHLISRIFVADPAK 266
PE L+ + + DP
Sbjct: 231 PELYKLMLQCWAEDPED 247
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 72/210 (34%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----NVQREIINHRSLRHPN 78
YE + IG G +G R+KKT ELVA+K I R + E REI + LRHPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPN 59
Query: 79 IVRFKEVILTPTHLAI--VMEYA----SGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
IVR KE++ + +I V EY +G L + +F+E + + + +QL+ G+ Y
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQY 115
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRD+K N L++ LK+ DFG ++ + T V T Y PE+L
Sbjct: 116 LHSNGILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 191 L-KKEYDGKIADVWSCGVTLYVMLVGAYPF 219
L Y ++ D+WS G L + +G F
Sbjct: 174 LGATRYGPEV-DMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-34
Identities = 80/251 (31%), Positives = 124/251 (49%), Gaps = 23/251 (9%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--------HP 77
++ I G FG L + + T + A+K +++ D I +N ++ N ++ R P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN---QVTNVKAERAIMMIQGESP 57
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ + + +L +VMEY +GG+ I G ED A+ + +++ GV H
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRD+K EN L+D LK+ DFG S++ + K VGTP Y+APE +L D
Sbjct: 118 IIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DD 171
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH--ISPECRHL 255
K++D WS G ++ L G PF E P ILS + + P+ V SPE L
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFH-AETPD---AVFDNILSRRINWPEEVKEFCSPEAVDL 227
Query: 256 ISRIFVADPAK 266
I+R+ DPAK
Sbjct: 228 INRLLCMDPAK 238
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 70/195 (35%), Positives = 105/195 (53%), Gaps = 20/195 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQ-REIINHRSLR----H 76
Y++++ +G G FG L R+K+T ELVA+K +++ +E + RE+ +SLR H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 134
PNIV+ KEV L V EY G L++ + FSE R Q++ G+++ H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK 192
HRDLK EN L+ S +KI DFG ++ + S+P T V T Y APE+LL+
Sbjct: 117 KHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172
Query: 193 -KEYDGKIADVWSCG 206
Y + D+W+ G
Sbjct: 173 STSYSSPV-DIWALG 186
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 2e-34
Identities = 73/259 (28%), Positives = 109/259 (42%), Gaps = 30/259 (11%)
Query: 24 ELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
L + +G G FG + K + VAVK + + D ++ ++ RE R L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
PN+V+ V L IVMEY GG+L + N + S + F Q+ G+ Y S
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVL 190
HRDL N L+ + +KI DFG Y K + ++APE L
Sbjct: 121 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESL 175
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGA---YPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
+ ++ K +DVWS GV L+ + YP EE + K +R+ P
Sbjct: 176 KEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRL-----PQPPNCP 229
Query: 248 ISPECRHLISRIFVADPAK 266
PE L+ + + DP
Sbjct: 230 --PELYDLMLQCWAEDPED 246
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 79/209 (37%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIV 80
R +G G+FG L R K++ L AVK +++ D I D++V+ + R L HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ TP L VME+ +GG+L I + RF E ARF+ ++ S + + H + +
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKI 199
RDLKL+N LLD K+ DFG K + + + ST GTP YIAPE+L + Y G
Sbjct: 120 RDLKLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPS 176
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228
D W+ GV LY ML G PFE E F
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 2e-34
Identities = 83/251 (33%), Positives = 134/251 (53%), Gaps = 19/251 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
+Y ++R +G G+FG A L++ +++ A+K I + E+ ++E + ++HPNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
V FKE HL IVMEY GG+L ++I G+ F ED +F Q+ GV + H +
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLKK 193
V HRD+K +N L + ++K+ DFG S+ L + P + VGTP Y+ PE+
Sbjct: 121 VLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
Y+ K +D+WS G LY + +PF + +++ I ++ Y P H S E R
Sbjct: 176 PYNNK-SDIWSLGCILYELCTLKHPF----QANSWKNLILKVCQGSYK-PLPSHYSYELR 229
Query: 254 HLISRIFVADP 264
LI ++F +P
Sbjct: 230 SLIKQMFKRNP 240
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-34
Identities = 77/246 (31%), Positives = 137/246 (55%), Gaps = 20/246 (8%)
Query: 29 IGSGNFGVARLMRDKKTEE---LVAVKYIERG-----DKIDENVQREIINHRSLRHPNIV 80
+G G+FG L+R + L A+K +++ D++ ++R+I+ + HP IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHPFIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ T L +++++ GG+LF R+ F+E++ +F+ +L + + HS+ + +
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKI 199
RDLK EN LLD +K+ DFG SK S+ H + S GT Y+APEV+ ++ + +
Sbjct: 122 RDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QS 178
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
AD WS GV ++ ML G+ PF+ K+ ++T+ IL + +P + +SPE + L+ +
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSLLRAL 232
Query: 260 FVADPA 265
F +PA
Sbjct: 233 FKRNPA 238
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-34
Identities = 78/254 (30%), Positives = 125/254 (49%), Gaps = 20/254 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHP 77
Y +R +G G FG A L R + + LV K + + E +R+ +N L+HP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHS 135
NI+ + + L I MEYA+GG L+++I F E+ ++ Q++S VSY H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLK 192
+ HRD+K N L + A +K+ DFG SK S ++ + VGTP Y++PE+
Sbjct: 120 AGILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQG 175
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
+Y+ K +D+W+ G LY +L F + N + +I+ Y+ V+ S E
Sbjct: 176 VKYNFK-SDIWALGCVLYELLTLKRTF----DATNPLNLVVKIVQGNYTPVVSVY-SSEL 229
Query: 253 RHLISRIFVADPAK 266
L+ + DP K
Sbjct: 230 ISLVHSLLQQDPEK 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-34
Identities = 81/244 (33%), Positives = 126/244 (51%), Gaps = 15/244 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 83
IG G+FG L R K E+ AVK +++ + + ++ I++ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD + + DFG K ++ H+ ST GTP Y+APEVL K+ YD + D
Sbjct: 123 KPENILLDSQ--GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
W G LY ML G PF + + +++ L ++ P+ I+ RHL+ +
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK---PN---ITNSARHLLEGLLQK 233
Query: 263 DPAK 266
D K
Sbjct: 234 DRTK 237
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-34
Identities = 79/256 (30%), Positives = 130/256 (50%), Gaps = 17/256 (6%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERG-----DKIDENV--QREIINHR 72
+EL++ +G+G +G L+R T +L A+K +++ K E+ +R ++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ P +V T L ++++Y SGGE+F + FSEDE RF+ ++I + +
Sbjct: 62 R-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APE++
Sbjct: 121 LHKLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
K GK D WS G+ ++ +L GA PF E + RIL P + I P
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF--IGP 236
Query: 251 ECRHLISRIFVADPAK 266
E + L+ ++ DP K
Sbjct: 237 EAQDLLHKLLRKDPKK 252
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-34
Identities = 78/244 (31%), Positives = 117/244 (47%), Gaps = 12/244 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVK---YIERGDKIDENVQ---REIINHRSLRHPNIVRF 82
+GSG+FG + + AVK + G E V+ +EI L+HPNIV++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
+L I +E GG L + + G F E R + +Q++ G+ Y H HRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
+K N L+D + +K+ DFG +K V S KS G+P ++APEV+ ++ G AD+
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
WS G T+ M G P+ E K I R + IPD H+S E + I +
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELP-PIPD--HLSDEAKDFILKCLQR 241
Query: 263 DPAK 266
DP+
Sbjct: 242 DPSL 245
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-34
Identities = 85/254 (33%), Positives = 131/254 (51%), Gaps = 23/254 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
RYE+++ IG G+FG L + K E +K I + K E ++E+I ++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS 135
IV F L IVMEY GG+L +RI N R FSED+ +F Q+ G+ + H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 136 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 190
++ HRD+K +N L +G A K+ DFG ++ L+ + VGTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC 174
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
+ Y+ K D+WS G LY + +PFE N + + +I ++ P + S
Sbjct: 175 QNRPYNNK-TDIWSLGCVLYELCTLKHPFEG----NNLHQLVLKICQGYFA-PISPNFSR 228
Query: 251 ECRHLISRIFVADP 264
+ R LIS++F P
Sbjct: 229 DLRSLISQLFKVSP 242
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 76/207 (36%), Positives = 114/207 (55%), Gaps = 9/207 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL A+K +++ I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L +I GRF E A F+ ++ G+ + HS + +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
KL+N +LD +KI DFG K ++ K+ GTP YIAPE++ + Y GK D
Sbjct: 128 KLDNVMLDSE--GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFR 229
W+ GV LY ML G PFE +E + F+
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQ 211
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 36/270 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
+ +E ++ I +G +G L+R K+T + A+K I + + I N V+R+I+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
+P +V T HL +VMEY GG+ + N G D AR +F + + + Y H
Sbjct: 60 -NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------------QPKST 178
+ + HRDLK +N L+ + +K+ DFG SK ++ K
Sbjct: 119 NYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRIL 236
GTP YIAPEV+L++ Y GK D W+ G+ LY LVG PF + PEE F + I
Sbjct: 177 CGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVI---- 229
Query: 237 SVQYSIPDYVH-ISPECRHLISRIFVADPA 265
S P+ + + + LISR+ +P
Sbjct: 230 SDDIEWPEGDEALPADAQDLISRLLRQNPL 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 81/256 (31%), Positives = 114/256 (44%), Gaps = 21/256 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE------RGDKIDENVQREIINHRSLRHPNIVRF 82
+G G FG + K T ++ A K ++ R + +++I+ S R IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSL 58
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCH 140
T L +VM +GG+L I N G F E A F+ Q+I G+ + H ++ +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLK EN LLD R I D G + + K GTP Y+APEVL + YD
Sbjct: 119 RDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-V 175
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
D ++ G TLY M+ G PF +E + R L + PD SPE + L +
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALL 233
Query: 261 VADPAKSEMHDWRRGC 276
DP K R GC
Sbjct: 234 QKDPEK------RLGC 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-33
Identities = 78/258 (30%), Positives = 127/258 (49%), Gaps = 20/258 (7%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGD-----KIDENV--QREIINHR 72
+EL+R +G+G +G L+R +L A+K +++ K E+ +R+++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
R P +V T T L ++++Y +GGELF + F+E E R + +++ + +
Sbjct: 62 R-RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APEV+
Sbjct: 121 LHQLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 191 LKKEYD-GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-HRILSVQYSIPDYVHI 248
K D WS GV + +L GA PF E +N + I RIL + P +
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKSKPPFPK--TM 235
Query: 249 SPECRHLISRIFVADPAK 266
S E R I ++ DP K
Sbjct: 236 SAEARDFIQKLLEKDPKK 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-33
Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 8/205 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ ++++ +G G++G K+T ++VA+K + + + + + +EI + P I
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
V++ T L IVMEY G + + +I N +E+E Q + G+ Y HS +
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
HRD+K N LL+ K+ DFG S + + ++ + +GTP ++APEV+ + Y+
Sbjct: 120 KIHRDIKAGNILLNEEGQA--KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 197 GKIADVWSCGVTLYVMLVGAYPFED 221
K AD+WS G+T M G P+ D
Sbjct: 178 NK-ADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-33
Identities = 82/254 (32%), Positives = 127/254 (50%), Gaps = 21/254 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL A+K +++ I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L I G+F E +A F+ ++ G+ + H + +RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N +LD +KI DFG K ++ T GTP YIAPE++ + Y GK D
Sbjct: 128 KLDNVMLDSE--GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
W+ GV LY ML G PF+ +E + F+ + +S S +S E + +
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS------LSKEAVSICKGLMTK 238
Query: 263 DPAKSEMHDWRRGC 276
P+K R GC
Sbjct: 239 HPSK------RLGC 246
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 6e-33
Identities = 77/203 (37%), Positives = 104/203 (51%), Gaps = 30/203 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ-------REIINHRS 73
D YE + I G +GV RDKKT E+VA+K + K+++ + REI
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREINILLK 60
Query: 74 LRHPNIVRFKEVIL--TPTHLAIVMEYASGGE-----LFERICNAGRFSEDEARFFFQQL 126
L+HPNIV KEV++ + +VMEY E L E + F + E + QL
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQL 115
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAY 184
+SGV++ H + HRDLK N LL + LKICDFG ++ S L + V T Y
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172
Query: 185 IAPEVLL-KKEYDGKIADVWSCG 206
APE+LL KEY I D+WS G
Sbjct: 173 RAPELLLGAKEYSTAI-DMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 8e-33
Identities = 79/250 (31%), Positives = 128/250 (51%), Gaps = 22/250 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRS 73
++ +++++ IG G FG +L+R K ++++ A+K + + + I + +R+I+ H +
Sbjct: 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
IV+ +L +VMEY GG+L + N E ARF+ +++ +
Sbjct: 102 --SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAI 158
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEV 189
HSM HRD+K +N LLD S LK+ DFG + ++ + VGTP YI+PEV
Sbjct: 159 HSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEV 214
Query: 190 LLKKEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
L + D G+ D WS GV LY MLVG PF + K + S+ + PD +
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF--PDDI 272
Query: 247 HISPECRHLI 256
IS + + LI
Sbjct: 273 EISKQAKDLI 282
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-32
Identities = 73/209 (34%), Positives = 110/209 (52%), Gaps = 14/209 (6%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRH--- 76
R EL IG G +G + T +VA+K I D+ ++QRE+ LR
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI ++ L L I+MEYA GG + + AG +E ++++ + Y H +
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK-KE 194
V HRD+K N L+ + +K+CDFG + +S +ST VGTP ++APEV+ + K
Sbjct: 121 GVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPE 223
YD K AD+WS G+T+Y M G P+ D +
Sbjct: 179 YDTK-ADIWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-32
Identities = 80/248 (32%), Positives = 127/248 (51%), Gaps = 22/248 (8%)
Query: 29 IGSGNFG---VARLMRDKKTEELVAVKYIERG-------DKIDENVQREIINHRSLRHPN 78
+G G +G R + T ++ A+K +++ D +R I+ +++HP
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNIL--EAVKHPF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV T L +++EY SGGELF + G F ED A F+ ++ + + H +
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
+RDLK EN LLD +K+ DFG K S+ T GT Y+APE+L++ + G
Sbjct: 122 IYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
K D WS G +Y ML GA PF +N +KTI +IL + ++P Y ++PE R L+
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPF----TAENRKKTIDKILKGKLNLPPY--LTPEARDLLK 232
Query: 258 RIFVADPA 265
++ +P+
Sbjct: 233 KLLKRNPS 240
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-32
Identities = 81/254 (31%), Positives = 121/254 (47%), Gaps = 20/254 (7%)
Query: 22 RYELVRDIGSGNFG-VARLMR--DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+++++ +G G++G V ++ R D + L V K E+ EI S+ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
I+ +KE L L IVMEYA G+L + I + E E F QL+ G+ H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKK 193
++ HRDLK N LL +KI D G SK VL K+ +GTP Y+APEV +
Sbjct: 121 EQKILHRDLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPEC 252
Y K +D+WS G LY M A PF E ++ + +++ +Y IP S +
Sbjct: 177 PYSYK-SDIWSLGCLLYEMATFAPPF----EARSMQDLRYKVQRGKYPPIPP--IYSQDL 229
Query: 253 RHLISRIFVADPAK 266
++ I + P
Sbjct: 230 QNFIRSMLQVKPKL 243
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-32
Identities = 87/296 (29%), Positives = 124/296 (41%), Gaps = 68/296 (22%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRHPN 78
RYEL++ IGSG +GV DK+T VA+K I D ID + + REI R LRH N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 79 IVRFKEVILTPT-----HLAIVMEYA---------SGGELFERICNAGRFSEDEARFFFQ 124
I+ +++ P+ + IV E S L ++D ++F
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL----------TDDHIQYFLY 110
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VG 180
Q++ G+ Y HS V HRDLK N L++ + LKICDFG ++ K V
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 181 TPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVML---------------------VGAYP 218
T Y APE+LL Y I D+WS G +L +G
Sbjct: 169 TRWYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227
Query: 219 FEDPEEPKNFRKTIHRILSVQYS--------IPDYVHISPECRHLISRIFVADPAK 266
ED + + K + + S+ P SPE L+ ++ V DP K
Sbjct: 228 EEDLKFITS-EKARNYLKSLPKKPKKPLSKLFPG---ASPEAIDLLEKMLVFDPKK 279
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 8e-32
Identities = 82/262 (31%), Positives = 120/262 (45%), Gaps = 29/262 (11%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-----------VQREIINHRSLRHP 77
IG G +G L + T E++AVK +E I ++ EI + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV++ T +L+I +EY GG + + GRF E RFF +Q++ G++Y HS
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEV--LLK 192
+ HRDLK +N L+D KI DFG SK S + Q S G+ ++APEV
Sbjct: 129 ILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS---IPDYV--H 247
+ Y K+ D+WS G + M G P+ D E K L + S IP V +
Sbjct: 187 QGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFK-----LGNKRSAPPIPPDVSMN 240
Query: 248 ISPECRHLISRIFVADPAKSEM 269
+SP ++ F +P
Sbjct: 241 LSPVALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-31
Identities = 71/217 (32%), Positives = 112/217 (51%), Gaps = 9/217 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 83
IG G+FG L + K + AVK +++ ++ Q+ I+ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V+++ +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD + + DFG K + S +T GTP Y+APEV+ K+ YD + D
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV-DW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
W G LY ML G PF + + + +H+ L ++
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-31
Identities = 74/252 (29%), Positives = 125/252 (49%), Gaps = 24/252 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV------QREIINHRSL 74
+++ +G G+FG +++R+K T ++ A+K +++ + + +R+I++ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 133
P I + + +L +VMEY GG+L + +F ED A+F+ +L+ +
Sbjct: 60 -SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL 191
H M HRD+K EN L+D + +K+ DFG + ++ K VGTP YIAPEVL
Sbjct: 119 HQMGYVHRDIKPENVLIDRT--GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 192 KKEYDGKIA-----DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PD 244
DGK D WS GV Y M+ G PF + KT + I++ Q + P+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE----GTSAKTYNNIMNFQRFLKFPE 232
Query: 245 YVHISPECRHLI 256
+S + LI
Sbjct: 233 DPKVSSDFLDLI 244
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-31
Identities = 80/242 (33%), Positives = 127/242 (52%), Gaps = 13/242 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + DK T VAVK ++ R + E + E++ R +HPNIV L
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +S+ H+ V HRD+K ++
Sbjct: 87 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDS 145
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y G D+WS
Sbjct: 146 ILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 200
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
G+ + M+ G P+ + E P K I L + + + +SP R + R+ V DP
Sbjct: 201 LGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPK--LKNLHKVSPRLRSFLDRMLVRDP 257
Query: 265 AK 266
A+
Sbjct: 258 AQ 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 78/251 (31%), Positives = 128/251 (50%), Gaps = 20/251 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKIDEN------VQREIINHRSLR 75
+ +R +G+G+FG L K + VA+K E+ I + +R+I+N+ +
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY--IN 89
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HP V ++L +V+E+ GGE F + RF D F+ Q++ Y S
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ + +RDLK EN LLD +K+ DFG++K V+ ++ + GTP YIAPE+LL +
Sbjct: 150 LNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNVGH 205
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
GK AD W+ G+ +Y +LVG PF E ++K + I+ P + + C+HL
Sbjct: 206 -GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII----YFPKF--LDNNCKHL 258
Query: 256 ISRIFVADPAK 266
+ ++ D K
Sbjct: 259 MKKLLSHDLTK 269
|
Length = 340 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 7e-31
Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLRHPN 78
E + ++G+GN GV + + T +++AVK I I+E +Q++I I H+ P
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKC-NSPY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS- 135
IV F ++I MEY GG L + GR E ++ G++Y H
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ ++K+CDFG S V +S K+ VGT +Y+APE + +Y
Sbjct: 120 HKIIHRDVKPSNILVNSR--GQIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDY 176
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
K +D+WS G++L + G +P+ +P
Sbjct: 177 SVK-SDIWSLGLSLIELATGRFPYPPENDP 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-31
Identities = 73/219 (33%), Positives = 113/219 (51%), Gaps = 15/219 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
+E++ IG G+FGV + K + + A+K I+ K++ + E I+ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-SKMNRREREEAIDEARVLAKLDSSY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHSM 136
I+R+ E L L IVMEYA G+L + + GR ED+ FF Q++ G+++ HS
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK 193
++ HRD+K N LD +KI D G +K +L + VGTP Y++PE+ K
Sbjct: 121 KILHRDIKSLNLFLDAY--DNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
Y+ K +DVW+ GV LY G +PF+ + K I
Sbjct: 177 PYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKII 214
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 9e-31
Identities = 79/247 (31%), Positives = 125/247 (50%), Gaps = 16/247 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
+G G +G+ RD T+ +A+K I ER + + + EI H L+H NIV++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 88 TPTHLAIVMEYASGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 145 LENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIAD 201
+N L++ + + +KI DFG SK + ++ ++ GT Y+APEV+ K + Y G AD
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAPAD 193
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKN--FRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
+WS G T+ M G PF + EP+ F+ + +I IP+ +S E ++ I R
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI---HPEIPE--SLSAEAKNFILRC 248
Query: 260 FVADPAK 266
F DP K
Sbjct: 249 FEPDPDK 255
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-30
Identities = 79/252 (31%), Positives = 124/252 (49%), Gaps = 23/252 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 81
+G+G F RD KT L+AVK + +++ E +++EI L HP+I+R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
+H + +E+ +GG + + G F E + +QL+ G+SY H Q+ HR
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVLLKKE 194
D+K N L+D S RL+I DFG ++ L ++ +GT A++APEVL ++
Sbjct: 128 DVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPEC 252
Y G+ DVWS G + M P+ + E+ N I +I S SIP+ H+SP
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIASATTAPSIPE--HLSPGL 240
Query: 253 RHLISRIFVADP 264
R + R P
Sbjct: 241 RDVTLRCLELQP 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 84/293 (28%), Positives = 121/293 (41%), Gaps = 69/293 (23%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRH 76
+ ++ IG G FG L+R T L A+K + + D + N +R+I+ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--N 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ +L VM+Y GG++ + G F ED ARF+ +L + H M
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK---------------S 168
HRD+K +N L+D +K+ DFG Y K S
Sbjct: 121 GFIHRDIKPDNILIDRD--GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 169 SVLHSQPK----------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212
+ + K S VGTP YIAPEVLL+ Y ++ D WS GV LY M
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM 237
Query: 213 LVGAYPFEDPE------EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
LVG PF + N+ T+H IP +S E LI R+
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTLH--------IPSQAKLSREASDLILRL 282
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-29
Identities = 61/211 (28%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
+G G FG +L VAVK ++ +E +E + L HPN+VR
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 84 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GVSYCH 134
V L +V+EY GG+L + R S +++ + L+S G+ Y
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLL 191
S + HRDL N L+ +KI DFG S+ + G I APE L
Sbjct: 123 SKKFVHRDLAARNCLVGED--LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLK 180
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS GV L+ + +GA P+
Sbjct: 181 DGIFTSK-SDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-29
Identities = 83/260 (31%), Positives = 115/260 (44%), Gaps = 20/260 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
D YEL+ IG G V E VA+K I+ +K +V +E+ HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL-EKCQTSVDELRKEVQAMSQCNHP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCH 134
N+V++ + L +VM Y SGG L + G E ++++ G+ Y H
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 135 SMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAP 187
S HRD+K N LL DGS +KI DFG S S K+ VGTP ++AP
Sbjct: 120 SNGQIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 188 EVL-LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
EV+ YD K AD+WS G+T + GA P+ K T+ + DY
Sbjct: 176 EVMEQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234
Query: 247 HISPECRHLISRIFVADPAK 266
S R +IS DP+K
Sbjct: 235 KYSKSFRKMISLCLQKDPSK 254
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-29
Identities = 72/230 (31%), Positives = 110/230 (47%), Gaps = 42/230 (18%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---- 75
+ +ELV IG G +G R KKT +LVA+K ++ + +E ++ E LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY---NILRKYSN 61
Query: 76 HPNIVRFKEVILTPTH------LAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQ 125
HPNI F + L +VME GG +L + + G R E+ + ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 126 LISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST----- 178
+ G++Y H +V HRD+K +N LL + +K+ DFG S +Q ST
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNA----EVKLVDFGVS------AQLDSTLGRRN 171
Query: 179 --VGTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
+GTP ++APEV+ E YD + +DVWS G+T + G P D
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-29
Identities = 81/241 (33%), Positives = 115/241 (47%), Gaps = 26/241 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
++ V IG G +GV R+K T E+VA+K I R D E V REI + L HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ +VI T L +V E+ + F + + QL+ G+++CHS +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLKK 193
V HRDLK +N L++ A +K+ DFG +++ + P T V T Y APE+LL
Sbjct: 121 VLHRDLKPQNLLINTEGA--IKLADFGLARAFGV---PVRTYTHEVVTLWYRAPEILLGC 175
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIPD 244
+Y D+WS G M+ F D E + FR I R L S+PD
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSLPD 233
Query: 245 Y 245
Y
Sbjct: 234 Y 234
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 9e-29
Identities = 74/204 (36%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRHPN 78
+E + IG G +G+ RD + E+VA+K + ER D I + REI +LRHPN
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPN 67
Query: 79 IVRFKEVILTPTHLA---IVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYC 133
IV KEV+ HL +VMEY L + + FSE + + QL+ G+ Y
Sbjct: 68 IVELKEVV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYL 124
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLL- 191
H + HRDLK+ N LL LKI DFG +++ L ++P + V T Y APE+LL
Sbjct: 125 HENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
Y I D+W+ G L +L
Sbjct: 183 CTTYTTAI-DMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-28
Identities = 75/268 (27%), Positives = 133/268 (49%), Gaps = 26/268 (9%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGDKIDE-------NVQREIINHR 72
+EL++ +G+G +G L+R + +L A+K +++ + + +R+++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ P +V T T L ++++Y +GGELF + RF E E + + +++ + +
Sbjct: 62 R-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + + DFG SK + S GT Y+AP+++
Sbjct: 121 LHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 191 LKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
+ +D K D WS GV +Y +L GA PF E + + RIL + P +
Sbjct: 179 RGGDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EM 235
Query: 249 SPECRHLISRIFVADPAKSEMHDWRRGC 276
S + +I R+ + DP K R GC
Sbjct: 236 SALAKDIIQRLLMKDPKK------RLGC 257
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-28
Identities = 84/256 (32%), Positives = 124/256 (48%), Gaps = 22/256 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD-KIDENVQREIINH--RSLR 75
RY L + +G G+FG L++DKK E L +K I G+ +E VQ L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 131
HP IV+F L I+ EY G +L ++ SE++ +F QL+ GV
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
Y H ++ HRDLK +N L + LKI DFG S+ + +T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHIS 249
+ YD K +D+WS G LY M A+ FE +NF + RI+ S+P+ S
Sbjct: 178 KHQGYDSK-SDIWSLGCILYEMCCLAHAFEG----QNFLSVVLRIVEGPTPSLPE--TYS 230
Query: 250 PECRHLISRIFVADPA 265
+ ++ + DP+
Sbjct: 231 RQLNSIMQSMLNKDPS 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 67/227 (29%), Positives = 98/227 (43%), Gaps = 22/227 (9%)
Query: 24 ELVRDIGSGNFGV---ARL-MRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
EL + +G G FG L + TE VAVK ++ G ++ E E + L HP
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIVR V L IV EY GG+L F R + + + + Q+ G+ Y S
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 190
HRDL N L+ + +KI DFG S+ ++ + APE L
Sbjct: 121 KNFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED--PEEPKNFRKTIHR 234
++ K +DVWS GV L+ + +G P+ EE + +R
Sbjct: 177 KDGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYR 222
|
Length = 258 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-28
Identities = 88/282 (31%), Positives = 139/282 (49%), Gaps = 45/282 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D+YE V IG G +GV RD+ T E +A+K I R ++ DE V REI + ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQQLISGVSYCH 134
NIVR ++V+ + L +V EY +L + + ++ F+++ + + Q++ G++YCH
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVL 190
S +V HRDLK +N L+D LK+ DFG +++ + P T V T Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGI---PVRTFTHEVVTLWYRAPEIL 175
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRILSVQY-------- 240
L + D+WS G ++ +V P D E + F+ I RIL
Sbjct: 176 LGSRHYSTPVDIWSVGC-IFAEMVNQKPLFPGDSEIDELFK--IFRILGTPNEETWPGVT 232
Query: 241 SIPDYVH----------------ISPECRHLISRIFVADPAK 266
S+PDY + P L+S++ DP+K
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSK 274
|
Length = 294 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-28
Identities = 93/280 (33%), Positives = 131/280 (46%), Gaps = 46/280 (16%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
Y+ V IG G +GV RDK T E+VA+K I R + DE V REI + L HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 136
IVR +V+ + L +V E+ +L + + ++ D + QL+ G++YCHS
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK 192
+V HRDLK +N L+D A LK+ DFG +++ P T V T Y APE+LL
Sbjct: 119 RVLHRDLKPQNLLIDREGA--LKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLG 173
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILS---------VQYSI 242
D+WS G M+ F D E + FR I R L V S+
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR--IFRTLGTPDEDVWPGVT-SL 230
Query: 243 PDYV----------------HISPECRHLISRIFVADPAK 266
PDY ++ + L+S++ V DPAK
Sbjct: 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAK 270
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 69/196 (35%), Positives = 101/196 (51%), Gaps = 17/196 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHP 77
+ +R+IG G+FG RD +T E+VA+K + K ++II + LRHP
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 78 NIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
N + +K L +VMEY S ++ E + E E + G++Y HS
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---K 192
+ HRD+K N LL + +K+ DFG S+ L S S VGTP ++APEV+L +
Sbjct: 134 HERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAMDE 188
Query: 193 KEYDGKIADVWSCGVT 208
+YDGK DVWS G+T
Sbjct: 189 GQYDGK-VDVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 74/280 (26%), Positives = 119/280 (42%), Gaps = 43/280 (15%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLR 75
RYE + +G G + V RDK+T +VA+K I+ G++ I+ REI + L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
HPNI+ +V +++ +V E+ +L E++ + + + + + G+ Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-DL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEV 189
HS + HRDLK N L+ LK+ DFG ++S P V T Y APE+
Sbjct: 119 HSNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPEL 173
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
L + G D+WS G +L+ PF + + I L S
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232
Query: 242 IPDYVHISP---------------ECRHLISRIFVADPAK 266
+PDYV P + L+ R+ +P K
Sbjct: 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNK 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 80/268 (29%), Positives = 116/268 (43%), Gaps = 51/268 (19%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVK--YIERGDKIDENVQREIINHRSLRHPNIVR 81
E V IGSG G + + T L A+K Y D + + REI R + HPN+V+
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
++ + +++E+ GG L +F D AR Q++SG++Y H + HR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHR 192
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV----LLKKEYD 196
D+K N L++ A +KI DFG S+ P S+VGT AY++PE L YD
Sbjct: 193 DIKPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250
Query: 197 GKIADVWSCGVTLYVMLVGAYPF------------------EDPEEPKNFRKTIHRILSV 238
G D+WS GV++ +G +PF + PE P
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT----------- 299
Query: 239 QYSIPDYVHISPECRHLISRIFVADPAK 266
S E RH IS +PAK
Sbjct: 300 ---------ASREFRHFISCCLQREPAK 318
|
Length = 353 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 73/259 (28%), Positives = 118/259 (45%), Gaps = 22/259 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
+++ + IG G F V +VA+K ++ + +D ++ +EI + L H
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 132
PN++++ + L IV+E A G+L I + + E +F QL S + +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAP 187
HS ++ HRD+K N + + +K+ D G SK++ HS VGTP Y++P
Sbjct: 122 MHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSP 175
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
E + + Y+ K +D+WS G LY M PF + N +I Y H
Sbjct: 176 ERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEKCDYPPLPADH 232
Query: 248 ISPECRHLISRIFVADPAK 266
S E R L+SR DP K
Sbjct: 233 YSEELRDLVSRCINPDPEK 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
D +E++ ++G G FG + K+T A K I+ + D V+ +I++ +HP
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS--ECKHP 62
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
NIV E L I++E+ GG L + R +E + R+ +Q++ +++ HS
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-- 191
+V HRDLK N LL DG +K+ DFG S + Q + T +GTP ++APEV+
Sbjct: 123 KVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 192 ---KKEYDGKIADVWSCGVTLYVM 212
YD K AD+WS G+TL +
Sbjct: 179 TFKDNPYDYK-ADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-27
Identities = 83/248 (33%), Positives = 125/248 (50%), Gaps = 18/248 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
++ YE+V+ IG G FG +L+R K T ++ A+K + + + I + R +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P +V+ +L +VMEY GG+L + N E ARF+ +++ + HS
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 160
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
M HRD+K +N LLD S LK+ DFG +K ++ + VGTP YI+PEVL
Sbjct: 161 MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 216
Query: 192 KK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
+ Y G+ D WS GV LY MLVG PF + K ++ S+ + PD I
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDI 274
Query: 249 SPECRHLI 256
S E ++LI
Sbjct: 275 SKEAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 64/200 (32%), Positives = 104/200 (52%), Gaps = 9/200 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREI-INHRSLRHPNIVR 81
R IG G++ L+ KKT + A+K I++ D+ VQ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L V+E+ SGG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L ++Y +
Sbjct: 121 DLKLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV- 177
Query: 201 DVWSCGVTLYVMLVGAYPFE 220
D W+ GV ++ M+ G PF+
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-27
Identities = 68/196 (34%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+++E++ +G G +GV R K+T+E+VA+K E +++ E RE+ R+L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV KE L +V EY EL E + N ++ R + QLI + +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHK 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 193
+ HRD+K EN L+ S LK+CDFG++++ S T V T Y +PE+LL
Sbjct: 119 NDIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 194 EYDGKIADVWSCGVTL 209
Y GK D+WS G L
Sbjct: 177 PY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKY-IERGDKIDE-NVQREIINHRSLR-HPNI 79
Y+++ IG G F + +KT + A+K + +++ N REI R L HPNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 80 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
+R EV+ LA+V E L+E I R E + + QL+ + + H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 194
+ HRD+K EN L+ LK+ DFG + ++S+P T + T Y APE LL
Sbjct: 120 GIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 195 YDGKIADVWSCGVTLYVML 213
Y G D+W+ G + +L
Sbjct: 175 YYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 66/206 (32%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSLR-- 75
YE + +IG G +G RD T VA+K + E G I + REI + L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58
Query: 76 -HPNIVRFKEVILTP-----THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLIS 128
HPNIVR +V P L +V E+ + C + + +QL+
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 129 GVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
GV + HS ++ HRDLK +N L+ DG ++KI DFG ++ S V T Y A
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMALTSVVVTLWYRA 174
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVM 212
PEVLL+ Y + D+WS G +
Sbjct: 175 PEVLLQSSYATPV-DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K + + E + EI+ R +HPNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 138
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 198 KIADVWSCGVTLYVMLVGAYPF--EDP 222
K+ D+WS G+ M+ G P+ E+P
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 67/201 (33%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIIN 70
D+ + + +EL++ IGSG +G R+ T EL A+K I E G+ VQ+EII
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIM 59
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ +H NIV + L L I ME+ GG L + G SE + + ++ + G+
Sbjct: 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEV 189
Y HS HRD+K N LL + +K+ DFG S + ++ KS +GTP ++APEV
Sbjct: 120 YYLHSKGKMHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177
Query: 190 LLKKEYDG--KIADVWSCGVT 208
+ G ++ D+W+ G+T
Sbjct: 178 AAVERKGGYNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 76/248 (30%), Positives = 125/248 (50%), Gaps = 18/248 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
++ Y++V+ IG G FG +L+R K ++++ A+K + + + I + R +
Sbjct: 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P +V+ +L +VMEY GG+L + N E A+F+ +++ + HS
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHS 160
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
M + HRD+K +N LLD LK+ DFG ++ ++ + VGTP YI+PEVL
Sbjct: 161 MGLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLK 216
Query: 192 KK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
+ Y G+ D WS GV L+ MLVG PF + K + S+ + P+ V I
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF--PEDVEI 274
Query: 249 SPECRHLI 256
S ++LI
Sbjct: 275 SKHAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 74/232 (31%), Positives = 108/232 (46%), Gaps = 23/232 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHP 77
RY+ + +IGSG +GV D ++ + VA+K I + +R E+ R +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 78 NIVRFKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
NI+ ++++ P + +VM+ +L I + +E+ R+F QL+ G+ Y
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ-PKSTVGTPAYIAPE 188
HS V HRDLK N L++ L+I DFG S S H V T Y APE
Sbjct: 124 HSANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV 238
+LL EY I D+WS G ML F P KN+ + ILSV
Sbjct: 182 LLLSLPEYTTAI-DMWSVGCIFAEMLGRRQLF-----PGKNYVHQLKLILSV 227
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-26
Identities = 68/197 (34%), Positives = 106/197 (53%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + AG F E + ++++ G+ Y HS + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEYDGKIADVWS 204
N LL S +K+ DFG + + +Q K + VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK-ADIWS 186
Query: 205 CGVTLYVMLVGAYPFED 221
G+T + G P D
Sbjct: 187 LGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 76/277 (27%), Positives = 126/277 (45%), Gaps = 38/277 (13%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHP 77
+YE + IG G +G ++++T E+VA+K + R D DE V REI + L+H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHS 135
NIVR +V+ + L +V EY + ++ ++ G + + F QL+ G+++CHS
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCD--QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-KK 193
V HRDLK +N L++ + LK+ DFG +++ + + V T Y P+VL K
Sbjct: 118 HNVLHRDLKPQNLLINKN--GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------YSIPDY 245
Y I D+WS G + P + + K I R+L +PDY
Sbjct: 176 LYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234
Query: 246 V----------------HISPECRHLISRIFVADPAK 266
++ R L+ + V +P +
Sbjct: 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQ 271
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 8e-26
Identities = 85/260 (32%), Positives = 125/260 (48%), Gaps = 42/260 (16%)
Query: 14 MPIMHDS-----DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQR- 66
MP +D + YE+++ IG+G FG L++ K+T+E K I RG K E Q
Sbjct: 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV 60
Query: 67 -EIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNA----GRFSEDEA 119
E+ R L+H NIVR+ + L + L I+ME+ G+L I G+ E
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 120 RFFFQQLISGVSYCHSMQ-------VCHRDLKLENTLLDG---------------SPAPR 157
+QL+ ++YCH+++ V HRDLK +N L + P
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVG 215
KI DFG SK+ + S S VGTP Y +PE+LL K YD K +D+W+ G +Y + G
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSG 239
Query: 216 AYPFEDPEEPKNFRKTIHRI 235
PF + NF + I +
Sbjct: 240 KTPF---HKANNFSQLISEL 256
|
Length = 1021 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-26
Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
++ + +G G G R K T + A+K I + + + RE+ ++S + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 79 IVRFKEVILTP--THLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLISGVS 131
IV++ L + + I MEY GG L + I GR E + ++ G+S
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y HS ++ HRD+K N LL +K+CDFG S V S + GT Y+APE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQ 176
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
K Y +DVWS G+TL + +PF EP
Sbjct: 177 GKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEP 209
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-25
Identities = 65/200 (32%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 81
R IG G++ L+R KKTE + A+K +++ + ID + + ++ HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L V+EY +GG+L + + E+ ARF+ ++ ++Y H + +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L ++Y G
Sbjct: 121 DLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 201 DVWSCGVTLYVMLVGAYPFE 220
D W+ GV ++ M+ G PF+
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 79/252 (31%), Positives = 126/252 (50%), Gaps = 21/252 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR------EIINHRSLRH 76
+ L + +G G FG L D T +AVK ++ + E + EI ++L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 77 PNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
IV++ + P L+I ME+ GG + +++ + G +E+ R + +Q++ GVSY H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVL 190
S + HRD+K N L D +K+ DFG SK + + KS GTP +++PEV+
Sbjct: 124 SNMIVHRDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY-VHIS 249
+ Y G+ AD+WS G T+ ML P+ + E K ++ Q + P H+S
Sbjct: 182 SGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-----IATQPTNPVLPPHVS 235
Query: 250 PECRHLISRIFV 261
CR + RIFV
Sbjct: 236 DHCRDFLKRIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-25
Identities = 74/261 (28%), Positives = 126/261 (48%), Gaps = 20/261 (7%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 81
R IG G++ L+R KK +++ A+K +++ + ID + + ++ +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L +V+EY +GG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L +EY G
Sbjct: 121 DLKLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 201 DVWSCGVTLYVMLVGAYPFE---DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
D W+ GV ++ M+ G PF+ D + IL IP + +S + H++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--LSVKASHVLK 235
Query: 258 RIFVADPAKSEMHDWRRGCSV 278
DP + R GC
Sbjct: 236 GFLNKDPKE------RLGCQP 250
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 77/280 (27%), Positives = 128/280 (45%), Gaps = 49/280 (17%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-- 78
D +E ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ +L ++ME+ GG++ + SE+ +F+ + + + H +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK--------- 176
HRD+K +N LLD +K+ DFG ++ H+ P
Sbjct: 121 GFIHRDIKPDNLLLDAK--GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 177 ----------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF- 219
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237
Query: 220 -EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
E P+E +RK ++ ++ + P V IS + + LI R
Sbjct: 238 SETPQE--TYRKVMNWKETLVF--PPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-25
Identities = 81/253 (32%), Positives = 119/253 (47%), Gaps = 28/253 (11%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+E+VA+K I+ + DE ++Q+EI P I R+
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + G E ++++ G+ Y HS + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSC 205
N LL S +K+ DFG + ++T VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSL 187
Query: 206 GVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQYSIP--DYVH--------I 248
G+T + G P D PKN T L QYS P ++V
Sbjct: 188 GITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT----LEGQYSKPFKEFVEACLNKDPRF 243
Query: 249 SPECRHLISRIFV 261
P + L+ F+
Sbjct: 244 RPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-25
Identities = 67/191 (35%), Positives = 104/191 (54%), Gaps = 8/191 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 80
YEL++ +GSG +G R+ T EL AVK I E GD +Q+EI + +H NIV
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIV 69
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L+ L I MEY GG L + G SE + + ++ + G++Y HS H
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG-- 197
RD+K N LL + +K+ DFG +K + ++ KS +GTP ++APEV ++ G
Sbjct: 130 RDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 198 KIADVWSCGVT 208
++ D+W+ G+T
Sbjct: 188 QLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-25
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRHPN 78
++ + +G G + R++ T E+VA+K I E G REI + L+H N
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHEN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IVR +VI T L +V EY + + G + + F QL+ G+++CH
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-KKE 194
+V HRDLK +N L++ LK+ DFG +++ + + + V T Y AP+VLL +
Sbjct: 120 RVLHRDLKPQNLLINKR--GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 195 YDGKIADVWSCGVTLYVMLVG 215
Y I D+WS G + M+ G
Sbjct: 178 YSTSI-DIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 9e-25
Identities = 73/250 (29%), Positives = 125/250 (50%), Gaps = 33/250 (13%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + R+K + VAVK ++ R + E + E++ R +H N+V + L
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L ++ME+ GG L + I + R +E++ + ++ + Y HS V HRD+K ++
Sbjct: 89 VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147
Query: 148 TL--LDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
L LDG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y ++ D+WS
Sbjct: 148 ILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV-DIWS 202
Query: 205 CGVTLYVMLVGAYPF--EDP--------EEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
G+ + M+ G P+ + P + P K H+ ISP R
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHK-------------ISPVLRD 249
Query: 255 LISRIFVADP 264
+ R+ +P
Sbjct: 250 FLERMLTREP 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-24
Identities = 75/209 (35%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D+++++ IG G +G RDK T ELVA+K + R D E REI R L H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNH 65
Query: 77 PNIVRFKEVILTPTHLA-----------IVMEYASG---GELFERICNAGRFSEDEARFF 122
NIV KE I+T A +V EY G L + + FSED + F
Sbjct: 66 RNIVNLKE-IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSF 121
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VG 180
+QL+ G++YCH HRD+K N LL+ ++K+ DFG ++ T V
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNK--GQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTL 209
T Y PE+LL +E G DVWSCG L
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-24
Identities = 79/245 (32%), Positives = 122/245 (49%), Gaps = 19/245 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI------ERGDKIDENVQREIINHRSLRHPNIVRF 82
+G G FG L D T +AVK + + K ++ EI ++LRH IV++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 83 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ P L+I +EY GG + +++ G +E+ R + +Q++ GVSY HS + H
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 196
RD+K N L D A +K+ DFG SK ++ S KS GTP +++PEV+ + Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY- 186
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
G+ ADVWS T+ ML P+ + E K + +PD +S CR +
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPM--LPD--GVSDACRDFL 242
Query: 257 SRIFV 261
+IFV
Sbjct: 243 KQIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-24
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + G E + ++++ G+ Y HS + HRD+K
Sbjct: 72 LKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKIADVWS 204
N LL S +K+ DFG + + +Q K VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWS 186
Query: 205 CGVTLYVMLVGAYPFED 221
G+T + G P +
Sbjct: 187 LGITAIELAKGEPPHSE 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 79/295 (26%), Positives = 132/295 (44%), Gaps = 65/295 (22%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDE----NVQREIINHRSL 74
+ + V+ IG G FG RL++ K T ++ A+K + + + K D+ +R+++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P +V +L ++ME+ GG+L + FSED RF+ + + + H
Sbjct: 60 -SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK-------------- 167
+ HRD+K +N L+D +K+ DFG Y K
Sbjct: 119 KLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 168 --------SSVLHSQPK-------------STVGTPAYIAPEVLLKKEYDGKIADVWSCG 206
+ + S+ + STVGTP YIAPE+ L++ Y G+ D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLG 235
Query: 207 VTLYVMLVGAYPF--EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
++ L+G PF E+ E +RK I+ ++ + PD +H+S E LI R+
Sbjct: 236 AIMFECLIGWPPFCSENSHE--TYRKIINWRETLYF--PDDIHLSVEAEDLIRRL 286
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-24
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---- 65
+ P + +YE + IG G FG R KKT+++VA+K + + EN +
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFP 55
Query: 66 ----REIINHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAG- 112
REI + L+H N+V E+ T +V E+ +L + N
Sbjct: 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNV 114
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSV 170
+F+ E + + L++G+ Y H ++ HRD+K N L+ DG LK+ DFG +++
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFS 170
Query: 171 LHSQPKST-----VGTPAYIAPEVLLKKEYDGKIADVWSCG 206
L K V T Y PE+LL + G D+W G
Sbjct: 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 3e-24
Identities = 77/261 (29%), Positives = 117/261 (44%), Gaps = 27/261 (10%)
Query: 23 YELVRDIGSGNFG-VARLMRDKKTEELVAVKYI------------ERGDKIDENVQREII 69
Y ++ +GSG FG V ++ + + L+A+K I ER I + V I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQ 125
LRHPNIVR+ + L L IVM+ G L E + RF+E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 126 LISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
++ + Y H ++ HRDL N +L ++ I DFG +K S+ S VGT Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IP 243
PE++ + Y G+ ADVW+ G LY M PF N +I+ Y +P
Sbjct: 180 SCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYS----TNMLSLATKIVEAVYEPLP 234
Query: 244 DYVHISPECRHLISRIFVADP 264
+ ++ S + +I+ D
Sbjct: 235 EGMY-SEDVTDVITSCLTPDA 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 4e-24
Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 25 LVRDIGSGNFGVARLMR----DKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
++ +G G+FG L R T E VAVK + ++ + +REI R+L H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 79 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
IV++K V P L ++MEY G L + + + + + F Q+ G+ Y S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA-YIAPEVLL 191
+ HRDL N L++ +KI DFG +K K +P + APE L
Sbjct: 128 QRYIHRDLAARNILVESE--DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
++ +DVWS GVTLY + P + P P F + I
Sbjct: 186 TSKFSSA-SDVWSFGVTLYELFTYGDPSQSP--PAEFLRMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 5e-24
Identities = 76/245 (31%), Positives = 118/245 (48%), Gaps = 19/245 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR------EIINHRSLRHPNIVRF 82
+G G FG L D T +A K ++ + E + EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 83 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L I MEY GG + +++ G +E R + +Q++ G+SY HS + H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 196
RD+K N L D A +K+ DFG SK ++ S +S GTP +++PEV+ + Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY- 186
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
G+ ADVWS G T+ ML P+ + E I +I + + HIS R +
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQPTNPQLPSHISEHARDFL 242
Query: 257 SRIFV 261
IFV
Sbjct: 243 GCIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 5e-24
Identities = 67/192 (34%), Positives = 102/192 (53%), Gaps = 17/192 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
+R+IG G+FG RD +T E+VA+K + K ++II + ++HPN +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+K L +VMEY S +L E + E E + G++Y HS +
Sbjct: 90 YKGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL + ++K+ DFG S+ + S S VGTP ++APEV+L + +YD
Sbjct: 148 HRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQYD 202
Query: 197 GKIADVWSCGVT 208
GK+ DVWS G+T
Sbjct: 203 GKV-DVWSLGIT 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-24
Identities = 83/290 (28%), Positives = 123/290 (42%), Gaps = 65/290 (22%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 79
++ +G G FG L T L A+K + + D ++ N +R+I+ + +
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWV 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
V+ +L VM+Y GG++ + F E ARF+ +L + H M
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123
Query: 140 HRDLKLENTL--LDGSPAPRLKICDFG-------------YSKSSVLHS---QPK----- 176
HRD+K +N L LDG +K+ DFG Y K S + +P
Sbjct: 124 HRDIKPDNILIDLDG----HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 177 ---------------------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTL 209
S VGTP YIAPEVLL+K Y ++ D WS GV L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVIL 238
Query: 210 YVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
+ MLVG PF P + K I+ ++ IP V +SPE LI+++
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLH--IPPQVKLSPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 6e-24
Identities = 66/192 (34%), Positives = 100/192 (52%), Gaps = 17/192 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
+R+IG G+FG RD + E+VA+K + K ++II + LRHPN ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
++ L +VMEY S +L E + E E + G++Y HS +
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL S +K+ DFG S+ + + VGTP ++APEV+L + +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 197 GKIADVWSCGVT 208
GK+ DVWS G+T
Sbjct: 193 GKV-DVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 7e-24
Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 49/278 (17%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN---- 78
+E ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+ +L ++ME+ GG++ + +E+E +F+ + + + H +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK----------- 176
HRD+K +N LLD +K+ DFG ++ HS P
Sbjct: 123 IHRDIKPDNLLLDSK--GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 177 --------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--E 220
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF E
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 221 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
P+E ++K ++ ++ + P V IS + + LI R
Sbjct: 240 TPQE--TYKKVMNWKETLIF--PPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 8e-24
Identities = 76/247 (30%), Positives = 116/247 (46%), Gaps = 14/247 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN---IVRFKE 84
+G G FG + + T +L A K + + K + + ++ R L + IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCH 140
T T L +VM +GG+L I N F E A F+ Q+ISG+ + H ++ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
RDLK EN LLD ++I D G + + S+ K GTP ++APE+L +EYD +
Sbjct: 121 RDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
D ++ GVTLY M+ PF E ++ RIL+ + PD SP + +
Sbjct: 179 -DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCEAL 235
Query: 260 FVADPAK 266
DP K
Sbjct: 236 LAKDPEK 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 9e-24
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 81
+G G +G +L+AVK +E +K E +Q E+ +SL+H NIV+
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
+ L ++I ME+ GG + + G E + +Q++ GV+Y H+ V HR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQP-KSTVGTPAYIAPEVLLKKE 194
D+K N +L P +K+ DFG ++ HS KS GTP ++APEV+ +
Sbjct: 127 DIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
Y G+ +D+WS G T++ M G P
Sbjct: 185 Y-GRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 1e-23
Identities = 62/183 (33%), Positives = 104/183 (56%), Gaps = 17/183 (9%)
Query: 92 LAIVMEYASGGELFERICN---AGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
+A+V++YA+ G+L + I + R F E EA F Q++ V + HS + HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 148 TLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL + +K+ DFG+SK ++V ++ GTP Y+APE+ +K Y K AD++S
Sbjct: 174 ILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFS 230
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRHLISRIFVAD 263
GV LY +L PF+ +N + +H+ L+ +Y +P ISPE + +++ + +D
Sbjct: 231 LGVLLYELLTLKRPFDG----ENMEEVMHKTLAGRYDPLPP--SISPEMQEIVTALLSSD 284
Query: 264 PAK 266
P +
Sbjct: 285 PKR 287
|
Length = 496 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-23
Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 37/277 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRH 76
++RY ++ +G G FG+ RD+ T + VA+K I + + + RE+ + LRH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 77 PNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NI+ ++ ++P + V E G R+ + + ++F Q++ G+ Y HS
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS 126
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KE 194
V HRDLK N L++ + LKICDFG ++ + Q V T Y APE++L ++
Sbjct: 127 AGVVHRDLKPSNILINEN--CDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 195 YDGKIADVWSCGVTLYVMLVGA--YPFEDP------------EEPKNFRKTI--HRILSV 238
YD ++ D+WS G ML G +P +D P + TI L
Sbjct: 183 YDVEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241
Query: 239 QYSIPD---------YVHISPECRHLISRIFVADPAK 266
S+P + + P L+ ++ V DP K
Sbjct: 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQK 278
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 2e-23
Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K + + E + EI+ R ++PNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIH 138
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 198 KIADVWSCGVTLYVMLVGAYPF--EDP 222
K+ D+WS G+ M+ G P+ E+P
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 2e-23
Identities = 71/209 (33%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K I + E + EI+ + L++PNIV
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQV 138
F + L L +VMEY +GG L + + DEA+ ++ + + + H+ QV
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQV 136
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 137 IHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 196 DGKIADVWSCGVTLYVMLVGAYPF--EDP 222
K+ D+WS G+ M+ G P+ E+P
Sbjct: 193 GPKV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-23
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK-YIERGDK--IDENVQREIINHRSLRHP 77
++YE + IG G++GV R+++T ++VA+K ++E D I + REI + L+HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
N+V EV L +V EY L E N E + Q + V++CH
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLKKE 194
HRD+K EN L+ + ++K+CDFG+++ +L V T Y APE+L+
Sbjct: 121 CIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 195 YDGKIADVWSCGVTLYVMLVG 215
G DVW+ G +L G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 2e-23
Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK-YIERGDKIDENVQ----REIINHRSLR 75
++YE + +G G++G+ + K+T ++VA+K ++E D D+ V+ REI + LR
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR 58
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H N+V EV L +V E+ L E+ N E R + Q++ G+ +C
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFC 116
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 191
HS + HRD+K EN L+ S + +K+CDFG+++ ++ T V T Y APE+L+
Sbjct: 117 HSHNIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLV 173
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
G+ D+W+ G + ML G
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-23
Identities = 75/242 (30%), Positives = 126/242 (52%), Gaps = 13/242 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + K + +LVAVK ++ R + E + E++ R +H N+V L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +S H+ V HRD+K ++
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DG R+K+ DFG+ ++ S + KS VGTP ++APE++ + Y G D+WS
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
G+ + M+ G P+ + E P K I L + + + +SP + + R+ V DP
Sbjct: 202 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPK--LKNLHKVSPSLKGFLDRLLVRDP 258
Query: 265 AK 266
A+
Sbjct: 259 AQ 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-23
Identities = 82/282 (29%), Positives = 131/282 (46%), Gaps = 49/282 (17%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
Y + IG G +GV R+KKT ++VA+K I R + +E V REI + L+HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++V++ + L ++ E+ S + + + + + + Q++ G+ +CHS
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVL 190
+V HRDLK +N L+D +K+ DFG +++ H V T Y APEVL
Sbjct: 121 RVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHE-----VVTLWYRAPEVL 173
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRILSVQ--------Y 240
L D+WS G T++ + P D E + FR I RIL
Sbjct: 174 LGSPRYSTPVDIWSIG-TIFAEMATKKPLFHGDSEIDQLFR--IFRILGTPTEDVWPGVT 230
Query: 241 SIPDYVHISPECR----------------HLISRIFVADPAK 266
S+PDY + P+ + L+ ++ + DPAK
Sbjct: 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAK 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-23
Identities = 65/207 (31%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHP 77
RY+ + IG G +G+ K T VA+K I + + REI R +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYC 133
NI+ + I+ P + EL E ++ S D ++F Q++ G+ Y
Sbjct: 64 NIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 189
HS V HRDLK N LL+ LKICDFG ++ + V T Y APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 190 LLK-KEYDGKIADVWSCGVTLYVMLVG 215
+L K Y I D+WS G L ML
Sbjct: 181 MLNSKGYTKAI-DIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (237), Expect = 4e-23
Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA++ + + E + EI+ R ++PNIV
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ ++ + S+ + VGTP ++APEV+ +K Y
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 198 KIADVWSCGVTLYVMLVGAYPF--EDP 222
K+ D+WS G+ M+ G P+ E+P
Sbjct: 196 KV-DIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 6e-23
Identities = 78/259 (30%), Positives = 117/259 (45%), Gaps = 27/259 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 81
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
TP L +++ +GG+L + G FSE E RF+ ++I G+ + H+ V +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 142 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
DLK N LLD R+ CDF K P ++VGT Y+APEVL K
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAYD 174
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
AD +S G L+ +L G PF + K+ + L+V +PD SPE + L+
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTVNVELPD--SFSPELKSLLE 231
Query: 258 RIFVADPAKSEMHDWRRGC 276
+ D +K R GC
Sbjct: 232 GLLQRDVSK------RLGC 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 6e-23
Identities = 67/202 (33%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNI 79
+ +E++ ++G G FG ++K+T L A K I+ + ++ E+ EI S HPNI
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQV 138
V+ + +L I++E+ +GG + + R +E + R +Q + ++Y H ++
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124
Query: 139 CHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL---- 191
HRDLK N L LDG +K+ DFG S + Q + S +GTP ++APEV++
Sbjct: 125 IHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 192 -KKEYDGKIADVWSCGVTLYVM 212
+ YD K ADVWS G+TL M
Sbjct: 181 KDRPYDYK-ADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 8e-23
Identities = 67/192 (34%), Positives = 101/192 (52%), Gaps = 17/192 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQ---REIINHRSLRHPNIVR 81
+ +IG G+FG + T E+VAVK + G + +E Q +E+ + L+HPN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+K L +VMEY S +L E + E E + G++Y HS +
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL + ++K+ DFG S+ S S VGTP ++APEV+L + +YD
Sbjct: 144 HRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 197 GKIADVWSCGVT 208
GK+ DVWS G+T
Sbjct: 199 GKV-DVWSLGIT 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-22
Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 22/255 (8%)
Query: 23 YELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN 78
+++ + IG G F A + D+K L V+ E D K ++ +EI + L HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
++++ + + L IV+E A G+L + I + E +F QL S V + H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 189
S +V HRD+K N + + +K+ D G SK++ H S VGTP Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPER 177
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
+ + Y+ K +D+WS G LY M PF + N +I Y H S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQKIEQCDYPPLPTEHYS 234
Query: 250 PECRHLISRIFVADP 264
+ R L+S DP
Sbjct: 235 EKLRELVSMCIYPDP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-22
Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 15/203 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
++ +E++ ++G G FG ++K+T L A K IE + + E+ EI + HP
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV+ L I++E+ GG + + R +E + + +Q++ + Y HSM+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL--- 191
+ HRDLK N LL DG +K+ DFG S +V Q + S +GTP ++APEV++
Sbjct: 131 IIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 192 --KKEYDGKIADVWSCGVTLYVM 212
YD K AD+WS G+TL M
Sbjct: 187 MKDTPYDYK-ADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 87/282 (30%), Positives = 130/282 (46%), Gaps = 43/282 (15%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKID-ENVQREIINHRSLRHPN 78
+Y ++ IG G +G+ ++ +T E VA+K I ++ID + REI R L H N
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 79 IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++ K+ I+ P H + IV E +L + I ++ S+D ++F QL+ G+ Y
Sbjct: 66 VIAIKD-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLL 191
HS V HRDLK N LL+ + LKICDFG ++ +S V T Y APE+LL
Sbjct: 124 IHSANVLHRDLKPSNLLLNAN--CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 192 K-KEYDGKIADVWSCG---------------------VTLYVMLVGAYPFEDPE--EPKN 227
EY I DVWS G + L L+G+ ED +
Sbjct: 182 NCSEYTTAI-DVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 228 FRKTIHRILSVQYSIP---DYVHISPECRHLISRIFVADPAK 266
R+ I R L + H +P L+ ++ V DP+K
Sbjct: 241 ARRYI-RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSK 281
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-22
Identities = 82/295 (27%), Positives = 122/295 (41%), Gaps = 69/295 (23%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRH 76
+ ++ +G G FG L R T+ L A+K + + D + N +R+I+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--N 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR +L VM+Y GG++ + G F ED ARF+ +L V H M
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 137 QVCHRDLKLENTLLD--------------------------GSPAPRLKICDFGYS---- 166
HRD+K +N L+D R DF
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 167 --------------KSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
+++ H + S VGTP YIAPEVLL+ Y ++ D WS GV LY
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239
Query: 211 VMLVGAYPF--EDPEEPK----NFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
MLVG PF + P E + N++ ++H IP +SPE LI ++
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVINWQTSLH--------IPPQAKLSPEASDLIIKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 5e-22
Identities = 73/234 (31%), Positives = 113/234 (48%), Gaps = 16/234 (6%)
Query: 40 MRDKKTEELVAVKYIERGDKIDENVQR-EIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98
R +E V K++ D+ R E+ + H IV+ + + L ++MEY
Sbjct: 87 TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146
Query: 99 ASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154
SGG+L ++I + F E E F Q++ + HS ++ HRDLK N L P
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MP 204
Query: 155 APRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYV 211
+K+ DFG+SK SV S GTP Y+APE+ +K Y K AD+WS GV LY
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYE 263
Query: 212 MLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 265
+L PF+ P + R+ + ++L +Y P +S + L+ + +PA
Sbjct: 264 LLTLHRPFKGPSQ----REIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPA 312
|
Length = 478 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-22
Identities = 63/262 (24%), Positives = 120/262 (45%), Gaps = 22/262 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-- 76
++ E + D+G+GN G ++ T ++A K + G K +V+++I+ + H
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHEC 60
Query: 77 --PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P IV F L ++ + ME+ G L G + ++ G++Y +
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 135 SM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 193
++ ++ HRD+K N L++ ++K+CDFG S +++S + VGT Y++PE +
Sbjct: 121 NVHRIMHRDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGG 177
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQYSIPDY- 245
+Y K +DVWS G+++ + +G +PF P + +I VQ P
Sbjct: 178 KYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI--VQEPPPRLP 234
Query: 246 -VHISPECRHLISRIFVADPAK 266
+ R + + DP +
Sbjct: 235 SSDFPEDLRDFVDACLLKDPTE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 7e-22
Identities = 69/218 (31%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-D--ENVQ------REI 68
H +YE+++ +G G +G+ D++T+E+VA+K KI D N REI
Sbjct: 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK------KIFDAFRNATDAQRTFREI 57
Query: 69 INHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFF 123
+ + L HPNIV+ VI I + + E E + A + R+
Sbjct: 58 MFLQELGDHPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIM 113
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----- 178
QL+ + Y HS V HRDLK N LL+ R+K+ DFG ++S +
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 179 -VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
V T Y APE+LL K D+WS G L ML+G
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 8e-22
Identities = 47/150 (31%), Positives = 76/150 (50%), Gaps = 6/150 (4%)
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+PN ++ + T ++M+Y G+LF+ + G+ SE E + +QL+ ++ H
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ H D+KLEN L D + R+ +CD+G K P GT Y +PE + Y
Sbjct: 128 HNIIHNDIKLENVLYDRA-KDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNY 183
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFE-DPEE 224
D D W+ GV Y +L G +PF+ D +E
Sbjct: 184 DVSF-DWWAVGVLTYELLTGKHPFKEDEDE 212
|
Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 72/258 (27%), Positives = 120/258 (46%), Gaps = 30/258 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIINHRSL 74
D +E+++ IG G FG +++ K TE + A+K + + + + +R ++ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 133
+ I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 QW--ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
H + HRD+K +N LLD + R LK+ G +SSV VGTP YI+
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-------AVGTPDYIS 171
Query: 187 PEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242
PE+L E G D WS GV +Y ML G PF + + K ++ ++
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EERFQF 229
Query: 243 PDYV-HISPECRHLISRI 259
P ++ +S E + LI R+
Sbjct: 230 PSHITDVSEEAKDLIQRL 247
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-21
Identities = 77/262 (29%), Positives = 123/262 (46%), Gaps = 26/262 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPN 78
+D +E++ IG G +G + +KK L AVK ++ +DE ++ E +SL HPN
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80
Query: 79 IVRFKEVILTPTHLA-----IVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 129
+V+F + L +V+E +GG EL + + G R E + + G
Sbjct: 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPE 188
+ + H+ ++ HRD+K N LL +K+ DFG S + + ++VGTP ++APE
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 189 VL-LKKEYDGKI---ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
V+ +++YD DVWS G+T + G P D K K I R P
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK-IPRNPP-----PT 252
Query: 245 YVHISPECR---HLISRIFVAD 263
+H CR H IS+ + D
Sbjct: 253 LLHPEKWCRSFNHFISQCLIKD 274
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-21
Identities = 74/242 (30%), Positives = 124/242 (51%), Gaps = 13/242 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + +K T + VAVK ++ R + E + E++ R H N+V L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +SY H+ V HRD+K ++
Sbjct: 90 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y G D+WS
Sbjct: 149 ILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 203
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
G+ + M+ G P+ + E P + I L + + D +S R + + V +P
Sbjct: 204 LGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPR--VKDSHKVSSVLRGFLDLMLVREP 260
Query: 265 AK 266
++
Sbjct: 261 SQ 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 69/215 (32%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
RY +R +G G+ G+ D ++ VAVK I D ++ REI R L H N
Sbjct: 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 79 IVRFKEVILT-----------PTHLA---IVMEYASGGELFERICNAGRFSEDEARFFFQ 124
IV+ EV+ T L IV EY + G SE+ AR F
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMY 121
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVG 180
QL+ G+ Y HS V HRDLK N ++ + LKI DFG ++ H K +
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
T Y +P +LL K D+W+ G ML G
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-21
Identities = 75/240 (31%), Positives = 113/240 (47%), Gaps = 23/240 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 81
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
TP L+ +++ +GG+L + G FSE E RF+ ++I G+ + H+ V +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 142 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYD 196
DLK N LLD R+ CDF K P ++VGT Y+APEVL K YD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 174
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
AD +S G L+ +L G PF + K+ + L++ +PD SPE R L+
Sbjct: 175 SS-ADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPD--SFSPELRSLL 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-21
Identities = 67/192 (34%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G + R K TE LVA+K I E + RE+ ++L+H NIV ++I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
T L +V EY +L + + N G S + F QL+ G+SYCH ++ HRDLK
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKP 131
Query: 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVW 203
+N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY I D+W
Sbjct: 132 QNLLINEK--GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI-DMW 188
Query: 204 SCGVTLYVMLVG 215
G LY M G
Sbjct: 189 GVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 8e-21
Identities = 78/257 (30%), Positives = 121/257 (47%), Gaps = 28/257 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK------YIERGDKIDENVQREIINHRSL 74
D +E+++ IG G FG +++ K T ++ A+K ++R + +R+++ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 133
R I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAP 187
H + HRD+K +N LLD + RL DFG S L T VGTP YI+P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISP 172
Query: 188 EVLLKKEYDGK-----IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242
E+L E DGK D WS GV +Y ML G PF + + K ++ Q+
Sbjct: 173 EILQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP- 230
Query: 243 PDYVHISPECRHLISRI 259
PD +S E + LI R+
Sbjct: 231 PDVTDVSEEAKDLIRRL 247
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-20
Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 21/219 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN 78
SD +E++ IG G +G + +KK AVK ++ IDE ++ E ++L HPN
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN 76
Query: 79 IVRF-----KEVILTPTHLAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 129
+V+F K+ + L +V+E +GG +L + G R E + + + G
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAP 187
+ + H + HRD+K N LL + +K+ DFG S +S + ++VGTP ++AP
Sbjct: 137 LQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAP 193
Query: 188 EVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
EV+ L YD + DVWS G+T + G P D
Sbjct: 194 EVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-20
Identities = 66/227 (29%), Positives = 116/227 (51%), Gaps = 19/227 (8%)
Query: 11 GMDMPIMHD-SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI- 68
+D+ + D + +ELV +G+G +G R KT +L A+K ++ + +E ++ EI
Sbjct: 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEIN 64
Query: 69 INHRSLRHPNIVRFKEVILT---PTH---LAIVMEYASGGELFERICN--AGRFSEDEAR 120
+ + H NI + + P H L +VME+ G + + + N ED
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA 124
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-V 179
+ ++++ G+++ H+ +V HRD+K +N LL + +K+ DFG S ++T +
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFI 182
Query: 180 GTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
GTP ++APEV+ E YD + +D+WS G+T M GA P D
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-20
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------REIINHRSLR 75
RY++ IG G++GV D T E VA+K I + + E+V REI R LR
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLR 57
Query: 76 HPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
HP+IV K ++L P+ + +V E +L + I + + +FF QL+ +
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIA 186
Y H+ V HRDLK +N L + +LKICDFG ++ + + V T Y A
Sbjct: 117 KYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 187 PEVL--LKKEYDGKIADVWSCGVTLYVMLVG 215
PE+ +Y I D+WS G +L G
Sbjct: 175 PELCGSFFSKYTPAI-DIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-20
Identities = 73/225 (32%), Positives = 109/225 (48%), Gaps = 21/225 (9%)
Query: 22 RY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIER--GDKIDENVQREIINHRSL 74
RY + +R +G G+FG L + T E+VAVK ++R G + ++EI ++L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 75 RHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
H NIV++K L ++MEY G L + + + + + F QQ+ G++Y
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAY 122
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAY-IAPE 188
HS HRDL N LLD +KI DFG +K+ + + + +P + A E
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 189 VLLKKEYDGKIA-DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
L KE A DVWS GVTLY +L + P PK F + I
Sbjct: 181 CL--KENKFSYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEMI 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-20
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNIVR 81
+G G FG ++ K T ++ A K +++ G+K+ +++EI+ + P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKM-ALLEKEIL--EKVNSPFIVN 57
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYCHSMQVC 139
+ THL +VM +GG+L I N G + R + Q+ G+ + HSM +
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
+RD+K EN LLD RL D G + GT Y+APE+L ++ Y +
Sbjct: 118 YRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEE 224
D ++ G ++Y M+ G PF+D +E
Sbjct: 176 -DWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-20
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV + K + ++A K I +I ++ +II + H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ +D+WS G++L M +G YP P+
Sbjct: 180 SVQ-SDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-20
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV ++ K + ++A K I +I ++ +II + H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV F + ++I ME+ GG L + + A R E+ ++ G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
Q+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ +D+WS G++L + +G YP P+
Sbjct: 180 SVQ-SDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-20
Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 14/215 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G + R K T+ LVA+K I E + RE+ + L+H NIV ++I
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 87 LTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
T L +V EY +L + + + G + + F QL+ G++YCH +V HRDLK
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKP 132
Query: 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVW 203
+N L++ LK+ DFG +++ + ++ S V T Y P++LL +Y +I D+W
Sbjct: 133 QNLLINER--GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI-DMW 189
Query: 204 SCGVTLYVMLVGA--YPFEDPEEPKNFRKTIHRIL 236
G Y M G +P EE +F I RIL
Sbjct: 190 GVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRIL 221
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-19
Identities = 71/257 (27%), Positives = 112/257 (43%), Gaps = 22/257 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
+ + + IG G F VA+K ++ D +D + + I + L HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
++++ + L IV+E A G+L I + + E +F QL S + + H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 189
S +V HRD+K N + + +K+ D G SK++ H S VGTP Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPER 177
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
+ + Y+ K +D+WS G LY M PF + N +I Y H S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYS 234
Query: 250 PECRHLISRIFVADPAK 266
E R L++ DP K
Sbjct: 235 EELRQLVNMCINPDPEK 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-19
Identities = 72/257 (28%), Positives = 124/257 (48%), Gaps = 27/257 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSLRHPNI 79
Y VR +G G++G L+R + + +K + + + ++E L+HPNI
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 80 VRFKEVIL-TPTHLAIVMEYASGGELFERIC-NAGRF-SEDEARFFFQQLISGVSYCHSM 136
V ++E L IVM + GG+L+ ++ G+ E++ +F Q+ + Y H
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK 193
+ HRDLK +N L + +K+ D G ++ VL +Q + +GTP Y++PE+ K
Sbjct: 122 HILHRDLKTQNVFLTRTNI--IKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNK 177
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP----DYVHIS 249
Y+ K +DVW+ G +Y M + F K+ ++RI ++ +P DY S
Sbjct: 178 PYNYK-SDVWALGCCVYEMATLKHAF----NAKDMNSLVYRI--IEGKLPPMPKDY---S 227
Query: 250 PECRHLISRIFVADPAK 266
PE LI+ + P K
Sbjct: 228 PELGELIATMLSKRPEK 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 31/212 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----- 75
DRY+ + +GSG +G D KT VA+K K+ Q I R+ R
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------KLSRPFQSAIHAKRTYRELRLL 68
Query: 76 ----HPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQ 125
H N++ +V + L +V G +L I + S+D +F Q
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQ 126
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 183
++ G+ Y HS + HRDLK N ++ LKI DFG ++ H+ + T V T
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKILDFGLAR----HTDDEMTGYVATRW 180
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
Y APE++L + + D+WS G + +L G
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 24 ELVRDIGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL+ IG + L + K T LVAVK I E++ Q+EII R L+HPN
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 79 IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
I+ + + + L +V M Y S +L + G E F + +++ + Y HS
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPAYIAP 187
HR +K + LL G ++ + YS + V+H PKS+V +++P
Sbjct: 120 KGFIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 188 EVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
EVL + + Y+ K D++S G+T + G PF+D
Sbjct: 178 EVLQQNLQGYNEKS-DIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-19
Identities = 72/223 (32%), Positives = 108/223 (48%), Gaps = 13/223 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRH 76
+ Y+ + +G G++ R K T +LVA+K I E G RE + L+H
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKH 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHS 135
NIV ++I T L +V EY +L + + + G S R F QL+ G++YCH
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KK 193
+V HRDLK +N L+ S LK+ DFG +++ + S+ S V T Y P+VLL
Sbjct: 122 RRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 236
EY + D+W G Y M G F + ++ I R+L
Sbjct: 180 EYSTSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL 221
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-19
Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 19/214 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR--SLRH 76
D + E + +IGSG G MR KKT ++AVK + R +EN +R +++ H
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSH 71
Query: 77 --PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSY 132
P IV+ +T + + I ME S +L +RI G ED ++ + Y
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHY 129
Query: 133 C-HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVL 190
V HRD+K N LLD S +K+CDFG S V S+ K+ + G AY+APE +
Sbjct: 130 LKEKHGVIHRDVKPSNILLDAS--GNVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPERI 186
Query: 191 ----LKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+YD + ADVWS G++L + G +P++
Sbjct: 187 DPPDPNPKYDIR-ADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-19
Identities = 68/254 (26%), Positives = 120/254 (47%), Gaps = 20/254 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIINHRSLRH 76
+E+++ IG G FG +++ K +++ A+K + + + + +R+++ + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS 135
I +L +VM+Y GG+L + R ED ARF+ +++ + H
Sbjct: 63 --ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 193
+ HRD+K +N L+D + RL DFG + +S+ VGTP YI+PE+L
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 194 EYDGK-----IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
E DGK D WS GV +Y ML G PF + + K ++ Q+ +
Sbjct: 179 E-DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP-AQVTDV 236
Query: 249 SPECRHLISRIFVA 262
S + + LI R+ +
Sbjct: 237 SEDAKDLIRRLICS 250
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 4e-19
Identities = 71/306 (23%), Positives = 112/306 (36%), Gaps = 64/306 (20%)
Query: 22 RYELVRDIGSGNFGVARLMRDK--KTEELVAVKYIE----RGDKIDENVQREIINHRSLR 75
+YE+ IG G +G + K K + A+K + + I ++ REI R L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 76 HPNIVRFKEVILTPTHLAIVM--EYASGGEL----FERICNAGRFSEDEARFFFQQLISG 129
H N+V EV L ++ + +YA F R + Q+++G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 130 VSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS------TVGT 181
V Y HS V HRDLK N L+ +G +KI D G ++ + ++ K V T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVT 178
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCG------VTLYVMLVGA------------------- 216
Y APE+LL + K D+W+ G +TL + G
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238
Query: 217 ----YPFED--------PEEPKNFRKTIHRILSVQYSIPDYVHI----SPECRHLISRIF 260
P E PE K S+ ++ + L+ ++
Sbjct: 239 EVLGTPTEKDWPDIKKMPEYDT-LMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297
Query: 261 VADPAK 266
DP K
Sbjct: 298 EYDPTK 303
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-19
Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 26 VRDIGSGNFGVARLMR----DKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNI 79
+RD+G G+FG L R T E VAVK + E G ++++EI R+L H NI
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 80 VRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSM 136
V++K + + ++ME+ G L E + N + + + + Q+ G+ Y S
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLLK 192
Q HRDL N L++ ++KI DFG +K+ + K + +P + APE L++
Sbjct: 129 QYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 193 KEYDGKIADVWSCGVTLYVML 213
++ +DVWS GVTLY +L
Sbjct: 187 SKF-YIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 6e-19
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 81
+ELV +G+G +G R KT +L A+K ++ +E +++EI + + H NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 82 FKEVILTPT------HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 133
+ + L +VME+ G + + I N E+ + ++++ G+S+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK 192
H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++APEV+
Sbjct: 128 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 193 KE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
E YD K +D+WS G+T M GA P D
Sbjct: 186 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-19
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ Y + +G G + R K TE LVA+K I E + RE+ + L+H N
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV +++ T L +V EY +L + + + G S + F Q++ G++YCH +
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEY 195
V HRDLK +N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY
Sbjct: 125 VLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 196 DGKIADVWSCGVTLYVMLVG 215
+I D+W G + M G
Sbjct: 183 STQI-DMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 7e-19
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
++++G+G FGV + + + + VA+K I+ G ++ E L H +V+
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 137
V + IV EY S G C E RF QL+ G++Y S Q
Sbjct: 67 VCTKQRPIYIVTEYMSNG------CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKE 194
HRDL N L+D +K+ DFG S+ VL + S+VG+ + PEVLL +
Sbjct: 121 FIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
+ K +DVW+ GV ++ V +G P+E
Sbjct: 178 FSSK-SDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-18
Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 20/240 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
Y +++ + G+ G + + V +K ++G + E + + +NH P+++R
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNH-----PSVIRM 122
Query: 83 KEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
K+ +++ +V+ + S +L+ + + D+A +Q++ G+ Y H+ ++ HR
Sbjct: 123 KDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
D+K EN ++ ++ I D G ++ V+ GT APEVL + +Y+ K AD
Sbjct: 182 DVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK-AD 238
Query: 202 VWSCGVTLYVMLVGAYP---FEDP----EEP-KNFRKTIHRILSVQYSIPDYVHISPECR 253
+WS G+ L+ ML AYP FEDP EE K+ + +I+S P+ P R
Sbjct: 239 IWSAGIVLFEML--AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296
|
Length = 357 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-18
Identities = 69/245 (28%), Positives = 106/245 (43%), Gaps = 20/245 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLR 75
+D YE + +G G++ + K +LVA+K I E G RE + L+
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLK 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
H NIV ++I T L +V EY + G + + F QL+ G+SY H
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 194
+ HRDLK +N L+ S LK+ DFG +++ + S S V T Y P+VLL
Sbjct: 122 RYILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST 179
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------YSIPDYV 246
D+W G M+ G F ++ ++ + I +L +S+P
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP--- 236
Query: 247 HISPE 251
H PE
Sbjct: 237 HFKPE 241
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 72/223 (32%), Positives = 105/223 (47%), Gaps = 39/223 (17%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKT--EELVAVKYIERGDKIDENVQREIINHRSLR---- 75
RYEL++++G G +G+ R+ +T EE VA+K KI ++I+ R+LR
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIK------KITNVFSKKILAKRALRELKL 54
Query: 76 ------HPNIVRFKEV-ILTPTHLAIVMEYASGGELFE----RICNAG-RFSEDEARFFF 123
H NI ++ I+ P + + Y EL E +I +G ++ + F
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYE---ELMEADLHQIIRSGQPLTDAHFQSFI 111
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKS-SVLH--SQPKST 178
Q++ G+ Y HS V HRDLK N L D LKICDFG ++ S + T
Sbjct: 112 YQILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARGFSENPGENAGFMT 167
Query: 179 --VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
V T Y APE++L + K DVWS G L L+G P
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL-AELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-18
Identities = 81/288 (28%), Positives = 117/288 (40%), Gaps = 49/288 (17%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D YE + IG G +G RDK T +LVA+K R + +E + REI + L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSE 59
Query: 77 -PNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGR-----FSEDEARFFFQQ 125
IVR +V L +V EY +L + + + GR + F Q
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAY 184
L+ GV++CH V HRDLK +N L+D LKI D G ++ S+ + T Y
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWY 177
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-------- 236
APEVLL + D+WS G M F E + I ++L
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH-IFKLLGTPTEQVW 236
Query: 237 ------------------SVQYSIPDYVHISPECRHLISRIFVADPAK 266
+ ++PD +SPE L+ ++ DPAK
Sbjct: 237 PGVSKLRDWHEFPQWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPAK 281
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-18
Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 11/209 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV + + + ++A K I +I ++ +II + H
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL--EIKPAIRNQIIRELKVLHECNS 58
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS- 135
P IV F + ++I ME+ GG L + + AGR E+ ++ G++Y
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 119 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
+ +D+WS G++L M +G YP P+
Sbjct: 176 TVQ-SDIWSLGLSLVEMAIGRYPIPPPDA 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-18
Identities = 66/272 (24%), Positives = 121/272 (44%), Gaps = 28/272 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D E++ ++G GN+G + + T +A+K I ++DE+ +II + H
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVS 58
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYC 133
P IV F + + MEY G +L+ ED R ++ G+ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 134 -HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
+ HRD+K N L++G+ ++K+CDFG S +++ S K+ +G +Y+APE +
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 193 KEYDGKI-----ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-SVQYSIPDYV 246
+ +DVWS G+++ M +G YP+ PE N + I+ ++P
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP-PETYANIFAQLSAIVDGDPPTLPS-- 232
Query: 247 HISPECRHLISRIFVADPAKSE------MHDW 272
S + + +++ P + H W
Sbjct: 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-18
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRFKE 84
+G GN G T ++AVK I I +Q++I++ + + P I+ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 85 VILTPTHLAIVMEYASGGEL--FERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCH 140
++I E+ GG L + +I GR + ++ G++Y S+++ H
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA--------VAVVKGLTYLWSLKILH 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RD+K N L++ ++K+CDFG S V +S K+ VGT AY+APE + ++Y G +
Sbjct: 119 RDVKPSNMLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQY-GIHS 174
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKN 227
DVWS G++ + +G +P+ P+ KN
Sbjct: 175 DVWSLGISFMELALGRFPY--PQIQKN 199
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 8e-18
Identities = 59/187 (31%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 29 IGSGNFGVARL--MRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
IG G FG L R +K VAVK ++ + E +LRHPN+V+ V+
Sbjct: 14 IGKGEFGDVMLGDYRGQK----VAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 87 LTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
L L IV EY + G L + + + GR + + F + G+ Y HRDL
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVW 203
N L+ K+ DFG +K + SQ + + P + APE L +K++ K +DVW
Sbjct: 130 ARNVLVSEDLVA--KVSDFGLAKEA---SQGQDSGKLPVKWTAPEALREKKFSTK-SDVW 183
Query: 204 SCGVTLY 210
S G+ L+
Sbjct: 184 SFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-17
Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 20/226 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPN 78
RY ++ +GSG +G DK+T E VA+K + R + + RE+ + ++H N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 79 IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++ +V + +VM Y ++I SED+ ++ Q++ G+ Y
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLKY 132
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
HS + HRDLK N L + LKI DFG ++ + ++ V T Y APEV+L
Sbjct: 133 IHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILN 188
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
+ + D+WS G + ML G F+ K++ + +IL V
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKV 230
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-17
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
DRY ++ +GSG +G D++T VA+K + R + + RE+ + ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 78 NIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V L +VM + G ++ + SED +F Q++ G+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y H+ + HRDLK N L + LKI DFG ++ + S+ V T Y APEV+L
Sbjct: 133 YIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEVIL 188
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ + D+WS G + ML G F+
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-17
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARL---MRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
LV++IGSG FG+ L + +K VA+K I G +E+ E L
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRK----VAIKTIREGAMSEEDFIEEAQVMMKLS 57
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
HP +V+ V + + +V E+ G L + + G+FS++ + G++Y
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLL 191
S V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV
Sbjct: 118 SSNVIHRDLAARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFS 174
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+Y K +DVWS GV ++ V G P+E+
Sbjct: 175 FSKYSSK-SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-17
Identities = 65/197 (32%), Positives = 95/197 (48%), Gaps = 21/197 (10%)
Query: 29 IGSGNFGVARLMR----DKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFK 83
+G GNFG L R T E+VAVK ++ + +REI +SL+H NIV++K
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 84 EVILTP--THLAIVMEYASGGELFER-ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V + +L +VMEY G L + + R + + Q+ G+ Y S + H
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVH 131
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPA-----YIAPEVLLKK 193
RDL N L++ R+KI DFG +K + Q K V P + APE L +
Sbjct: 132 RDLATRNILVESE--NRVKIGDFGLTK---VLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 194 EYDGKIADVWSCGVTLY 210
++ +DVWS GV LY
Sbjct: 187 KFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-16
Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 85
++++GSG FGV L + + + VA+K I G +E+ E L HP +V+ V
Sbjct: 9 MKELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 86 ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
L IV E+ G L + G+ S+D Q + G+ Y HRDL
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGKIAD 201
N L+ S +K+ DFG ++ VL + S+ G + PEV +Y K +D
Sbjct: 128 ARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-SD 183
Query: 202 VWSCGVTLY-VMLVGAYPFE 220
VWS GV ++ V G PFE
Sbjct: 184 VWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-16
Identities = 73/262 (27%), Positives = 118/262 (45%), Gaps = 29/262 (11%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 79
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + R +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSRF--V 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ 137
V T L +V+ +GG+L I + G F E A F+ ++ G+ H +
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ +RDLK EN LLD ++I D G + K VGT Y+APEV+ + Y
Sbjct: 123 IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---VQYSIPDYVHISPECRH 254
D W+ G LY M+ G PF+ + K R+ + R++ +YS SP+ R
Sbjct: 181 S-PDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVQEEYS----EKFSPDARS 234
Query: 255 LISRIFVADPAKSEMHDWRRGC 276
L + DP + R GC
Sbjct: 235 LCKMLLCKDPKE------RLGC 250
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-16
Identities = 63/201 (31%), Positives = 96/201 (47%), Gaps = 25/201 (12%)
Query: 28 DIGSGNFGVARLMRDKKTEEL-----VAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
+G G+FGV R R + + VAVK + DK+ + + +E SL H N+
Sbjct: 2 KLGDGSFGVVR--RGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNA-GRFSEDEARFFFQQLISGVSYCHSMQ 137
+R V+LT L +V E A G L +R+ +A G F + Q+ +G+ Y S +
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTP-AYIAPEVLL 191
HRDL N LL + ++KI DFG ++ + + V P A+ APE L
Sbjct: 118 FIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173
Query: 192 KKEYDGKIADVWSCGVTLYVM 212
+ + +DVW GVTL+ M
Sbjct: 174 TRTFS-HASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-16
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSLR--- 75
+YE V +IG G +G RD + VA+K + D + + RE+ + L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 76 HPNIVRFKEVILT-----PTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLIS 128
HPNIVR +V T T + +V E+ +++ G + + +Q +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLR 119
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
G+ + H+ + HRDLK EN L+ + ++K+ DFG ++ V T Y APE
Sbjct: 120 GLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177
Query: 189 VLLKKEYDGKIADVWSCGVTLYVML 213
VLL+ Y + D+WS G M
Sbjct: 178 VLLQSTYATPV-DMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-16
Identities = 65/261 (24%), Positives = 108/261 (41%), Gaps = 19/261 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+ R +G G FG + + T ++ A K +E+ + +N + +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
+V T L +V+ +GG+L I N G F E+ A F+ ++ G+ H
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEY 195
++ +RDLK EN LLD ++I D G + + + + VGT Y+APEV+ + Y
Sbjct: 122 RIVYRDLKPENILLDDY--GHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNERY 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
D W G +Y M+ G PF +E + R+ Q + S R +
Sbjct: 179 -TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARSI 235
Query: 256 ISRIFVADPAKSEMHDWRRGC 276
++ DP R GC
Sbjct: 236 CRQLLTKDPGF------RLGC 250
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-16
Identities = 61/179 (34%), Positives = 85/179 (47%), Gaps = 11/179 (6%)
Query: 47 ELVAVKYIERGDKIDENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102
+LVA+K I K +E V RE + L+H NIV ++I T L V EY
Sbjct: 31 QLVALKVISM--KTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTD 88
Query: 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162
I + G R F QL+ G++Y H + HRDLK +N L+ S LK+ D
Sbjct: 89 LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI--SYLGELKLAD 146
Query: 163 FGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPF 219
FG +++ + SQ S+ V T Y P+VLL +Y + D+W G ML G F
Sbjct: 147 FGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL-DIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-16
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 84
IG G FG M K + ++AVK I R ++ +R +++ RS P IV+F
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 85 VILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYC--------- 133
+ I ME S + ++ + + ++++ ++
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNYLK 124
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 191
+++ HRD+K N LLD + +K+CDFG S V S K+ G Y+APE +
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDP 181
Query: 192 --KKEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ YD + +DVWS G+TLY + G +P+
Sbjct: 182 SARDGYDVR-SDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-16
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 10/201 (4%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
++++GSG FGV L + + + VA+K I G +++ E L HPN+V+
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 85 VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
V + IV EY + G L + G+ + + + Y S HRDL
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKKEYDGKIA 200
N L+ +K+ DFG ++ VL Q S+ GT + PEV + K +
Sbjct: 127 AARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK-S 182
Query: 201 DVWSCGVTLY-VMLVGAYPFE 220
DVWS GV ++ V G P+E
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-16
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 27 RDIGSGNFGVAR--LMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRS----LRHPNI 79
+++G GNFG + K +E+ VAVK +++ + I ++E + S L HP I
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ-EHIAAG-KKEFLREASVMAQLDHPCI 58
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
VR V L +VME A G L + + + + Q+ G++Y S
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT--P-AYIAPEVLLKKEY 195
HRDL N LL + KI DFG S++ ++T P + APE + ++
Sbjct: 118 HRDLAARNVLLVNR--HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 196 DGKIADVWSCGVTLYVML-VGAYPFED 221
K +DVWS GVTL+ GA P+ +
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLR 75
D E++ ++G G +GV MR T ++AVK I E Q+ + I+ RS+
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVD 58
Query: 76 HPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE--ARFFFQQLISGVS 131
P V F + + I ME S + ++++ + G ++ + ++ +
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAV-SIVKALE 117
Query: 132 YCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE- 188
Y HS + V HRD+K N L++ ++K+CDFG S V S K+ G Y+APE
Sbjct: 118 YLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPER 174
Query: 189 ---VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
L +K YD K +DVWS G+T+ + G +P++
Sbjct: 175 INPELNQKGYDVK-SDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
+RY+ + +GSG +G D KT VAVK + R + + RE+ + ++H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 78 NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
N++ +V L ++ + G +L I + ++D +F Q++ G+ Y
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRDLK N ++ LKI DFG ++ H+ + T V T Y APE++
Sbjct: 136 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
L + + D+WS G + +L G F
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 6/149 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+ +V+ I G FG L R K +L AVK +++ D I++N+ ++ R + P
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + ++ +VMEY GG++ + G F E+ A + ++ + Y H +
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI 125
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDLK +N L+ S +K+ DFG SK
Sbjct: 126 IHRDLKPDNMLI--SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ Y+L IG+G+FGV T E VA+K + + + RE++ ++L H NI
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK---NRELLIMKNLNHINI 121
Query: 80 VRFKEVILTPT--------HLAIVMEYASGG-----ELFERICNAGRFSEDEARFFFQQL 126
+ K+ T L +VME+ + + R N + + QL
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNHALPLFLVKLYSYQL 179
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKSTVGTPA 183
++Y HS +CHRDLK +N L+D P LK+CDFG +K+ + + S + +
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218
Y APE++L D+WS G + M++G YP
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YP 269
|
Length = 440 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 78/285 (27%), Positives = 111/285 (38%), Gaps = 54/285 (18%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR------ 75
RY+++R IG G G L D VA+K I R D + ++ R LR
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSEN----PLLKKRFLREAKIAA 57
Query: 76 ---HPNIVRFKEVILTPTHLAIVMEYASG---GELFERICNAGRFSEDEAR------FF- 122
HP IV + + M Y G L + + S++ A F
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 123 -FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----------------Y 165
F ++ + + Y HS V HRDLK +N LL + I D+G
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 166 SKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222
+ ++ +S P VGTP Y+APE LL D+++ GV LY ML ++P+
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRR- 233
Query: 223 EEPKNFRKTI--HRILSVQYSIPDYVHISPECRHLISRIFVADPA 265
K RK ILS P Y I P + + DPA
Sbjct: 234 ---KKGRKISYRDVILSPIEVAP-YREIPPFLSQIAMKALAVDPA 274
|
Length = 932 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
+RY+ + +GSG +G D + + VAVK + R + RE+ + ++H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 78 NIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
N++ +V T + E G +L I + S++ +F QL+ G+ Y
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADL-NNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
HS + HRDLK N ++ L+I DFG ++ + + V T Y APE++L
Sbjct: 134 IHSAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DDEMTGYVATRWYRAPEIMLN 189
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ + D+WS G + +L G F
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-15
Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 24/219 (10%)
Query: 19 DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
D+ ++ + IG+G FG RL K E VA+K ++ G E +R+ ++ S+
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIM 59
Query: 76 ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
HPNI+ + V+ + IV EY G L F R + G+F+ + + + SG
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASG 118
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
+ Y M HRDL N L++ + K+ DFG S+ VL P++ T
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 174
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ APE + +++ +DVWS G+ ++ VM G P+ +
Sbjct: 175 WTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-15
Identities = 68/259 (26%), Positives = 111/259 (42%), Gaps = 23/259 (8%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 79
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQF--V 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ 137
V T L +V+ +GG+L I N G F E+ A F+ +++ G+ H
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+RDLK EN LLD ++I D G + + VGT Y+APEVL + Y
Sbjct: 123 TVYRDLKPENILLDDY--GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-T 179
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
D W G +Y M+ G PF +E + R+L + S E + +
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSICK 237
Query: 258 RIFVADPAKSEMHDWRRGC 276
+ DP + R GC
Sbjct: 238 MLLTKDPKQ------RLGC 250
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 77/283 (27%), Positives = 116/283 (40%), Gaps = 47/283 (16%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRHP 77
E R IG G FGV + D + + VA+K + + +N V RE+ +H
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMP---NVFQNLVSCKRVFRELKMLCFFKHD 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFER-----ICNAGRFSEDEARFFFQQLISGVSY 132
N++ + IL P H+ E EL + I + S D + F Q++ G+ Y
Sbjct: 60 NVLSALD-ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRD+K N L++ + LKICDFG ++ T V T Y APE+L
Sbjct: 119 LHSAGILHRDIKPGNLLVNSN--CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 191 L-KKEYDGKIADVWSCGVTLYVMLVGAYPFE----------------DP--EEPKNFRK- 230
+ + Y + D+WS G +L F+ P E ++ +
Sbjct: 177 MGSRHYTSAV-DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235
Query: 231 TIHRILSVQYSIPD----YVHISP---ECRHLISRIFVADPAK 266
IL + P Y S E HL+ R+ V DP K
Sbjct: 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDK 278
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-15
Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRD-KKTEELVAVKYI-----ERGDKIDENVQREIINH-RSL 74
+YE V +IG G +G RD K VA+K + E G + + ++ H +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 75 RHPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLI 127
HPN+VR +V T L +V E+ +++ G +E FQ L+
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 120
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVML 213
EVLL+ Y + D+WS G M
Sbjct: 179 EVLLQSSYATPV-DLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-14
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 35/218 (16%)
Query: 25 LVRDIGSGNFG---VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 79
+ + IG G FG RL K E VA+K ++ G DK + E HPNI
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 80 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLI-------SGV 130
+R + V+ + I+ EY G L F R E++ +F QL+ SG+
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASGM 119
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-----PA-Y 184
Y M HRDL N L++ + K+ DFG S+ L ++T T P +
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSN--LVCKVSDFGLSR--RLED-SEATYTTKGGKIPIRW 174
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
APE + +++ +DVWS G+ ++ VM G P+ D
Sbjct: 175 TAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 21/226 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D VAVK + R + + +R E++ + + H N
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 79 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
I+ V TP + +VME +C D R + Q++ G
Sbjct: 82 IISLLNV-FTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCG 135
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HS + HRDLK N ++ LKI DFG ++++ + V T Y APEV
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
+L Y + D+WS G + ++ G+ F+ + + K I ++
Sbjct: 194 ILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 21/226 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D E VA+K + R + + +R E++ + + H N
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 79 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
I+ V TP + IVME +C + D R + Q++ G
Sbjct: 85 IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HS + HRDLK N ++ LKI DFG ++++ V T Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
+L Y + D+WS G + M+ G F + + K I ++
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 45/228 (19%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRH 76
YE++ +G G FG R KT +VA+K I E+ D REI + L+H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKH 66
Query: 77 PNIVRFKEVIL--------TPTHLAIVMEYA----SGGELFE--RICNAGRFSEDEARFF 122
PN+V ++ + + +V Y SG L E + + +E + + +
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSV----KLTESQIKCY 120
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------ 176
QL+ G++Y H + HRD+K N L+D LKI DFG ++ P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR--PYDGPPPNPKGGG 176
Query: 177 --------STVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
+ V T Y PE+LL ++ Y + D+W G M
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-14
Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 27/262 (10%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQR--EIINHRSLRHP 77
R +G G FG + + T ++ A K +E+ G+ + N +R E +N R
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF---- 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 135
+V T L +V+ +GG+L I N G F E A F+ +L G+
Sbjct: 62 -VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ +RDLK EN LLD ++I D G + + VGT Y+APEV+ ++Y
Sbjct: 121 ERIVYRDLKPENILLDDR--GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
D W G +Y M+ G PF +E + R+ Q + S + + +
Sbjct: 179 TFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAKSI 235
Query: 256 ISRIFVADPAKSEMHDWRRGCS 277
+ +P + R GC
Sbjct: 236 CRMLLTKNPKE------RLGCR 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 18/194 (9%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
R + S N G + E L+A K ++ G + ++ EI+ L H NI++ +E++
Sbjct: 180 RGVNSTNQGKPK------CERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSED-----EARFFFQQLISGVSYCHSMQVCHR 141
+ + ++ + +L+ + + +D + R +QL+ V Y H ++ HR
Sbjct: 233 RSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHR 291
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKI 199
D+KLEN L+ L DFG + + VGT A +PE+L Y +I
Sbjct: 292 DIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEI 348
Query: 200 ADVWSCGVTLYVML 213
D+WSCG+ L ML
Sbjct: 349 TDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-14
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 29 IGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 81
IG+G FG RL K E VA+K ++ G E +R+ ++ S+ HPNI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+ V+ + I+ E+ G L F R N G+F+ + + + +G+ Y M
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLL 191
HRDL N L++ + K+ DFG S+ L T + + APE +
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+++ +DVWS G+ ++ VM G P+ D
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-14
Identities = 55/199 (27%), Positives = 83/199 (41%), Gaps = 26/199 (13%)
Query: 25 LVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
L R +G+G FG V + T+ VAVK ++ G E +E + LRH +V+
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFF-FQQLI-------SGVSYCHS 135
V + IV EY S G L + + E + QL+ G++Y S
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMAYLES 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP-AYIAPEVLL 191
HRDL N L+ + KI DFG ++ ++ + P + APE
Sbjct: 122 RNYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAAN 177
Query: 192 KKEYDGKIADVWSCGVTLY 210
+ K +DVWS G+ L
Sbjct: 178 YGRFTIK-SDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-14
Identities = 67/236 (28%), Positives = 103/236 (43%), Gaps = 30/236 (12%)
Query: 29 IGSGNFGVARLMR--DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G +G + D K E+ A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 87 LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHSM 136
L+ + + ++ +YA F R A + + Q++ G+ Y H+
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 187
V HRDLK N L+ +G R+KI D G+++ L + P V T Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-----RILSV 238
E+LL + K D+W+ G +L F +E H RI SV
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 72/276 (26%), Positives = 120/276 (43%), Gaps = 38/276 (13%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------REIINHRSLR 75
RY+ ++ IGSG G+ D T + VA+K + R +NV RE++ + +
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVN 73
Query: 76 HPNIVRFKEVILTP-------THLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQL 126
H NI+ V TP + +VME A+ ++ + + R S + Q+
Sbjct: 74 HKNIIGLLNV-FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQM 127
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
+ G+ + HS + HRDLK N ++ LKI DFG ++++ V T Y A
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRA 185
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI--------HRILSV 238
PEV+L Y + D+WS G + M+ G F + + K I + +
Sbjct: 186 PEVILGMGYKENV-DIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244
Query: 239 QYSIPDYVHISPECR-HLISRIFVAD--PAKSEMHD 271
Q ++ +YV P+ + +F P SE H+
Sbjct: 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHN 280
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-13
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 29 IGSGNFG-VAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 81
IG+G FG V R L + E VA+K ++ G E +++ ++ S+ H NI+R
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 82 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ V+ I+ EY G L + + + G FS + + + +G+ Y M H
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLKKE 194
RDL N L++ + K+ DFG S+ VL P+ T T + APE + ++
Sbjct: 131 RDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVWS G+ ++ VM G P+ D
Sbjct: 187 FTSA-SDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 73/245 (29%), Positives = 104/245 (42%), Gaps = 25/245 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
IG G FG +++ + T + VAVK I K D Q E L H N+VR V
Sbjct: 14 IGEGEFGA--VLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQVCHRDL 143
IL L IVME S G L + GR + F + G+ Y S ++ HRDL
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADV 202
N L+ S K+ DFG ++ + S P + APE L K++ K +DV
Sbjct: 127 AARNILV--SEDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFSSK-SDV 180
Query: 203 WSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261
WS GV L+ V G P+ PK K + + Y + + L++ +
Sbjct: 181 WSYGVLLWEVFSYGRAPY-----PKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWE 235
Query: 262 ADPAK 266
+P K
Sbjct: 236 TEPKK 240
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 3e-13
Identities = 69/287 (24%), Positives = 118/287 (41%), Gaps = 45/287 (15%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D + VA+K + R + + +R E++ + + H N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
I+ V L + EL + +C + D R + Q++ G+ + HS
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK N ++ LKI DFG ++++ V T Y APEV+L Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDYVH 247
+ D+WS G + M+ F + + K I ++ + +Q ++ +YV
Sbjct: 196 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 248 ISP----------------------------ECRHLISRIFVADPAK 266
P + R L+S++ V DPAK
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-13
Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 17/207 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIV 80
+ L R +GSG FG + K VA+K ++ D + ++ Q+E+ + LRH +++
Sbjct: 8 FTLERKLGSGYFG--EVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQV 138
V + I+ E G L + + A Q+ G++Y
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYS---KSSV-LHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL N L+ K+ DFG + K V L S K + APE
Sbjct: 126 IHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAASHGT 180
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
+ K +DVWS G+ LY + G P+
Sbjct: 181 FSTK-SDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-13
Identities = 49/218 (22%), Positives = 87/218 (39%), Gaps = 34/218 (15%)
Query: 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDE-----N 63
S+RY +G G +G D T ++VA+K + + +
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 64 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 123
RE+ ++H NI+ +V + + +VM+ + +L + + R +E + +
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCIL 125
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------H 172
Q+++G++ H HRDL N ++ KI DFG ++
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDET 183
Query: 173 SQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCG 206
Q + S V T Y APE+L+ E D+WS G
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221
|
Length = 335 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-13
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 29 IGSGNFG-VARLMR-DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G +G V + R D K + A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 87 LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHSM 136
L+ + ++ +YA F R A + + Q++ G+ Y H+
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 187
V HRDLK N L+ +G R+KI D G+++ L + P V T Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
E+LL + K D+W+ G +L F +E
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-12
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 34/225 (15%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-- 73
++ L+R++G G+FG +A+ + + E VA+K + + E E +N S
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63
Query: 74 --LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF-------- 121
++VR V+ T +VME + G+L + R R +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQK 120
Query: 122 FFQ---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
F Q ++ G++Y + + HRDL N ++ +KI DFG ++ +
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKG 178
Query: 179 VGT--PA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPF 219
P ++APE L + K +DVWS GV L+ M + P+
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 21 DRYELVRDIGSGNFGVAR--LMRDKKTEEL-VAVKY--IERGDKIDENVQREIINHRSLR 75
+ L R IG G FG + + E++ VAVK + E +E R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
HP+IV+ VI T + IVME A GEL + N + QL + ++Y
Sbjct: 66 HPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-P-AYIAPEVLLK 192
S + HRD+ N L+ SP +K+ DFG S+ S K++ G P ++APE +
Sbjct: 125 SKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ + +DVW GV ++ ++++G PF
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-12
Identities = 59/193 (30%), Positives = 90/193 (46%), Gaps = 15/193 (7%)
Query: 28 DIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
++GSGNFG + + + KK+E+ VAVK I + D D ++ E++ + L +P IVR
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
I +VME A G L + + +E Q+ G+ Y HR
Sbjct: 61 MIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPA-YIAPEVLLKKEYDG 197
DL N LL KI DFG SK + + + K+ P + APE + ++
Sbjct: 120 DLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 198 KIADVWSCGVTLY 210
K +DVWS GV ++
Sbjct: 178 K-SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-12
Identities = 65/233 (27%), Positives = 93/233 (39%), Gaps = 41/233 (17%)
Query: 24 ELVRDIGSGNFGV----------------ARLMRDKKTEELVAVKYIERG--DKIDENVQ 65
V +G G FG + LVAVK + D E+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER---------ICNAGRF 114
+E+ L PNI R V L ++MEY G+L F + CN+
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
S + Q+ SG+ Y S+ HRDL N L+ +KI DFG S++ L+S
Sbjct: 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG--KNYTIKIADFGMSRN--LYSS 183
Query: 175 PKSTVG--TPAYI---APEVLLKKEYDGKIADVWSCGVTLY--VMLVGAYPFE 220
V P I A E +L ++ K +DVW+ GVTL+ + L P+E
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYE 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-12
Identities = 58/200 (29%), Positives = 85/200 (42%), Gaps = 14/200 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 84
IG GNFG R + VAVK + + +++ + + + HPNIVR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
V + IVME GG+ + G R E + +G+ Y S HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLLKKEYDGKIA 200
N L+ LKI DFG S+ +++ P + APE L Y + +
Sbjct: 121 AARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE-S 177
Query: 201 DVWSCGVTLY-VMLVGAYPF 219
DVWS G+ L+ +GA P+
Sbjct: 178 DVWSFGILLWEAFSLGAVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-12
Identities = 63/217 (29%), Positives = 87/217 (40%), Gaps = 45/217 (20%)
Query: 27 RDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL---RHPNIV 80
IG GNFG L K VAVK R + ++ + L HPNIV
Sbjct: 1 EKIGKGNFGDVYKGVL----KGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIV 55
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYC 133
+ V + + IVME GG L + + + R ++L+ +G+ Y
Sbjct: 56 KLIGVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYL 109
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG---------YSKSSVLHSQP-KSTVGTPA 183
S HRDL N L+ + LKI DFG Y+ S L P K T
Sbjct: 110 ESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWT----- 162
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
APE L Y + +DVWS G+ L+ +G P+
Sbjct: 163 --APEALNYGRYTSE-SDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 8e-12
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 24 ELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL+ IG G + L R K T E V V+ I +E V Q E+ + HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++ + L +V + + G + IC SE + Q ++ + Y H M
Sbjct: 61 IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120
Query: 137 QVCHRDLKLENTL--LDGSPAPRLKICDFGY----------SKSSVLHSQPKSTVGTPAY 184
HR +K + L +DG K+ G + V+H PK +V +
Sbjct: 121 GYVHRSVKASHILISVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPW 174
Query: 185 IAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
++PEVL + + YD K +D++S G+T + G PF+D
Sbjct: 175 LSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 29 IGSGNFG------VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+GSG FG ++ VAVK + +G E ++E + L HPN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVS 131
IV+ V L I+ME GG+L + +A ++L+ G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPR-LKICDFGYSK---SSVLHSQPKSTVGTPAYI 185
Y M HRDL N L+ G A R +KI DFG ++ S + + + ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 186 APEVLLKKEYDGKI---ADVWSCGVTLY-VMLVGAYPF 219
APE LL DGK +DVWS GV ++ ++ +G P+
Sbjct: 181 APESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-11
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 22 RYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINH----RS 73
E ++ +GSG FG + + + ++ VA+K + ++ +EI++ S
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANKEILDEAYVMAS 65
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 132
+ HP++VR + L+ ++ + G L + + + + Q+ G+SY
Sbjct: 66 VDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG-TP-AYIAPEV 189
++ HRDL N L+ +P +KI DFG +K V + + G P ++A E
Sbjct: 125 LEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 190 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+L + Y K +DVWS GVT++ +M GA P+E
Sbjct: 183 ILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 47/161 (29%), Positives = 65/161 (40%), Gaps = 16/161 (9%)
Query: 45 TEELVAVKYIERGDKIDE-----NVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY 98
T VA+K + R D +E +RE L HPNIV P L V EY
Sbjct: 2 TGHEVAIKLL-RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APR 157
G L E + G E Q++ ++ H+ + HRDLK +N ++ + P
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 158 LKICDFGYSK-----SSVLHSQPKST---VGTPAYIAPEVL 190
K+ DFG + T +GTP Y APE L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 23/213 (10%)
Query: 19 DSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP 77
D +L+R +G+G FG V + + T VAVK ++ G ++ E + LRHP
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 130
+++ V + IV E G L E + QLI SG+
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG-----GAGRALKLPQLIDMAAQVASGM 116
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---AP 187
+Y + HRDL N L+ + K+ DFG ++ + ++ G I AP
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLAR-VIKEDIYEAREGAKFPIKWTAP 173
Query: 188 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
E L + K +DVWS G+ L ++ G P+
Sbjct: 174 EAALYNRFSIK-SDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 50/186 (26%), Positives = 76/186 (40%), Gaps = 32/186 (17%)
Query: 72 RSLRHPNIVRFKEVILTPTHLAI--------VMEYASGGEL--FERIC------NAGRFS 115
L H NI L H+ I + Y + G L F + C N S
Sbjct: 63 YGLSHQNI-------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLH 172
+ Q+ G+SY H V H+D+ N ++D ++KI D S+ H
Sbjct: 116 TQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE--LQVKITDNALSRDLFPMDYH 173
Query: 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE--DPEEPKNFR 229
+ ++A E L+ KEY +DVWS GV L+ +M +G P+ DP E +
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL 232
Query: 230 KTIHRI 235
K +R+
Sbjct: 233 KDGYRL 238
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 28 DIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVR 81
++GSGNFG + + + +K + VA+K ++ + +++V+ E++ + H P IVR
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 82 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V L +VME ASGG L + + + Q+ G+ Y H
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLLKKEYD 196
RDL N LL KI DFG SK+ + + +S P + APE + +++
Sbjct: 119 RDLAARNVLLVNQHYA--KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 197 GKIADVWSCGVTLYVML-VGAYPFEDPEEPK 226
+ +DVWS G+T++ G P++ + P+
Sbjct: 177 SR-SDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-10
Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 13/189 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
+G G +G KK VAVK ++ E +E + ++HPN+V+ V
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ--QLISGVSYCHSMQVCHRDLKLE 146
I+ E+ + G L + + R + + Q+ S + Y HRDL
Sbjct: 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 133
Query: 147 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
N L+ +K+ DFG S+ + H+ K + + APE L ++ K +D
Sbjct: 134 NCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 187
Query: 202 VWSCGVTLY 210
VW+ GV L+
Sbjct: 188 VWAFGVLLW 196
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+ +LV+ +G+G FG M VAVK ++ G + E ++L+H +V
Sbjct: 6 ESIKLVKKLGAGQFGEV-WMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 81 RFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
R V+ + I+ EY + G L F + G+ + F Q+ G++Y
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEY 195
HRDL+ N L+ S + KI DFG ++ + ++ + G + APE + +
Sbjct: 125 IHRDLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPF 219
K +DVWS G+ LY ++ G P+
Sbjct: 182 TIK-SDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-10
Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 35/225 (15%)
Query: 18 HDSDRYELVRDIGSGNFGV---ARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIIN 70
+ + E VRDIG G FG AR E +VAVK ++ + + QRE
Sbjct: 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------------------RICN 110
HPNIV+ V + ++ EY + G+L E R C
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 111 AGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK- 167
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRN 179
Query: 168 --SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
S+ + ++ ++ PE + Y + +DVW+ GV L+
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 223
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-10
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 38/227 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEE--------------LVAVKYIERGDKIDENVQ- 65
+ L +G G FG L + E LVAVK + R D + + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RAD-VTKTARN 62
Query: 66 ---REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL------------FERICN 110
+EI L++PNI+R V ++ L ++ EY G+L F N
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--- 167
S + Q+ SG+ Y S+ HRDL N L+ +KI DFG S+
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLY 180
Query: 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214
S + V ++A E +L ++ +DVW+ GVTL+ M
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-10
Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 20/216 (9%)
Query: 19 DSDRYELVRDIGSGNFG-VAR--LMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D+ ++ R +G+G FG + R L K E VA+ + G DK E +
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
H NIVR + VI + IV EY S G L F R + G+ + L SG+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMK 121
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG---YSKSSVLHS--QPKSTVGTPAYIA 186
Y M H+ L L++ KI F KS +++ KS V + A
Sbjct: 122 YLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPV---LWAA 176
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
PE + + +DVWS G+ ++ VM G P+ D
Sbjct: 177 PEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 7e-10
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 25 LVRDIGSGNFGVARLMR-----DKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 78
L R++G G FG L ++ + LVAVK + + D ++ RE +L+H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQ 125
IV+F V + L +V EY G+L + + G ++ + QQ
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 182
+ +G+ Y S HRDL N L+ + +KI DFG S+ S+ + T+
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ PE ++ +++ + +DVWS GV L+ + G P+
Sbjct: 187 RWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-10
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 31/212 (14%)
Query: 25 LVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
L R++G G FG L + + +ELVAVK ++ + ++ +RE + +H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI--------------CNAGRFSEDEARFFF 123
NIV+F V +V EY G+L + + G + +
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
Q+ SG+ Y S HRDL N L+ +KI DFG S+ +++ VG
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRD--VYTTDYYRVGGHT 184
Query: 184 -----YIAPEVLLKKEYDGKIADVWSCGVTLY 210
++ PE ++ +++ + +DVWS GV L+
Sbjct: 185 MLPIRWMPPESIMYRKFTTE-SDVWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 39/202 (19%)
Query: 29 IGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFK 83
+G GNFG ++DK VAVK + D E + + R L+ HPNIV+
Sbjct: 3 LGKGNFGEVFKGTLKDKTP---VAVKTCKE-DLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSM 136
V + IVME GG+ + R +DE + +QL+ +G++Y S
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESK 112
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 188
HRDL N L+ + LKI DFG S+ SS L P + APE
Sbjct: 113 NCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPE 164
Query: 189 VLLKKEYDGKIADVWSCGVTLY 210
L Y + +DVWS G+ L+
Sbjct: 165 ALNYGRYSSE-SDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 65/247 (26%), Positives = 105/247 (42%), Gaps = 46/247 (18%)
Query: 29 IGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVR 81
+G G FG A ++ + VAVK ++ E ++ E + + HP++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FERIC---------------NAGRFSEDEARFFFQ 124
L +++EYA G L F R ++ + DE
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 125 QLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVL 171
LIS G+ Y M++ HRDL N L+ + ++KI DFG S+ S V
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNF 228
S+ + V ++A E L Y + +DVWS GV L+ ++ +G YP PE N
Sbjct: 186 RSKGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL 241
Query: 229 RKTIHRI 235
KT +R+
Sbjct: 242 LKTGYRM 248
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 71/271 (26%), Positives = 111/271 (40%), Gaps = 47/271 (17%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDENVQREI 68
DR L + +G G FG A + + VAVK + + D + E ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 69 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF------- 121
I +H NI+ V L +V+EYA+ G L + + A R + A
Sbjct: 72 IG----KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPE 126
Query: 122 ----------FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171
F Q+ G+ + S + HRDL N L+ + +KI DFG ++ +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLARD--I 182
Query: 172 HSQP---KSTVGTPAY--IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPE 223
H K+T G +APE L + Y + +DVWS GV L+ + +G YP E
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVE 241
Query: 224 EPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
E K +R+ Q + H+ +C H
Sbjct: 242 ELFKLLKEGYRMEKPQNCTQELYHLMRDCWH 272
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 45/230 (19%)
Query: 21 DRYELVRDIGSGNFGVARL-----MRDKKTEE-----------LVAVKYIERGDKIDENV 64
R +G G FG L M ++ LVAVK + R D ++N
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDA-NKNA 62
Query: 65 Q----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC----------- 109
+ +EI L+ PNI+R V +T L ++ EY G+L + +
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 110 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
+ S F Q+ SG+ Y S+ HRDL N L+ + +KI DFG S++
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRN- 179
Query: 170 VLHS------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
L+S Q ++ + +LL K +DVW+ GVTL+ +L
Sbjct: 180 -LYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA--SDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 16/213 (7%)
Query: 24 ELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL +IG G N L R T LV V+ + + +E++ Q E++ RHPN
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60
Query: 79 IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
I+ V T + L ++ M Y S L + G SE + G++Y H
Sbjct: 61 IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQ 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEV 189
HR++K + L+ G L YS K+ V++ P+ + +++PE+
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179
Query: 190 LLKKEYDGKI-ADVWSCGVTLYVMLVGAYPFED 221
L + Y + +D++S G+T + G PF+D
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 24/220 (10%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINH 71
D L+R +G G FG + R E VAVK + D+ D ++ I++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS- 64
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERIC--NAGRFSE---DEARFFFQ 124
H NIVR V I++E +GG+L F R R S + F +
Sbjct: 65 -KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKS---SVLHSQPKSTVG 180
+ G Y HRD+ N LL R+ KI DFG ++ + + + +
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ PE L + K DVWS GV L+ + +G P+
Sbjct: 184 PIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 71/272 (26%), Positives = 118/272 (43%), Gaps = 41/272 (15%)
Query: 21 DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
D+ L + +G G FG + +DK E + VAVK ++ D E ++++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 72
Query: 74 L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEAR--- 120
+ +H NI+ L +++EYAS G L E + A R +S D AR
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIARVPD 131
Query: 121 --FFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SS 169
F+ L+S G+ Y S + HRDL N L+ + +KI DFG ++ ++
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNN 189
Query: 170 VLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV---GAYPFEDPEEP 225
+ + + + P ++APE L + Y + +DVWS GV ++ + YP EE
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
Query: 226 KNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
K HR+ + + +C H I
Sbjct: 249 FKLLKEGHRMDKPANCTNELYMMMRDCWHAIP 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 33/217 (15%)
Query: 29 IGSGNFG-VARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 81
IG GNFG V R M K ++ A+K ++ + EN R+ + HPNI+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA---------RFFFQQLI----- 127
+L I +EYA G L + + + D A QQL+
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 128 --SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 183
+G+ Y Q HRDL N L+ + A KI DFG S+ ++ K T+G P
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMGRLPVR 183
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y K +DVWS GV L+ ++ +G P+
Sbjct: 184 WMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-09
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 29/221 (13%)
Query: 25 LVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN 78
L R++G G FG L + K + LVAVK ++ ++ QRE +L+H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FER--------------ICNAGRFSEDEARFF 122
IV+F V L +V EY G+L F R G +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTV 179
Q+ SG+ Y S HRDL N L+ + +KI DFG S+ S+ + T+
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ PE ++ +++ + +DVWS GV L+ + G P+
Sbjct: 187 LPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-09
Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 39/224 (17%)
Query: 25 LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREI-------INHRSL 74
L + +G G FG +L +D ++ VAVK + K+D + EI +
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDF 58
Query: 75 RHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLI- 127
HPN+++ V + L +++ + G+L + R + Q L+
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLK 117
Query: 128 ------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPK 176
G+ Y + HRDL N +L + +C DFG SK S + Q +
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGR 173
Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+IA E L + Y K +DVW+ GVT++ + G P+
Sbjct: 174 IAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 77/263 (29%), Positives = 115/263 (43%), Gaps = 37/263 (14%)
Query: 27 RDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
R IG G+FG L+ + AVK + R ++E Q +E I + HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 82 FKEVILTPTHLA-IVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVC 139
+ L +V+ Y G+L I + + + F Q+ G+ Y S +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120
Query: 140 HRDLKLENTLLDGSPAPRLKICDFG-----YSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
HRDL N +LD S +K+ DFG Y K S H+ K V ++A E L
Sbjct: 121 HRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESLQ 175
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRILSVQYSIPDYV-- 246
+++ K +DVWS GV L+ +M GA YP D + + R+L +Y PD +
Sbjct: 176 TQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYC-PDPLYE 233
Query: 247 ------HISPECR----HLISRI 259
H PE R L+SRI
Sbjct: 234 VMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 30/223 (13%)
Query: 24 ELVRDIGSGNFG-VAR----LMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
+ ++G G FG V + ++ + VA+K ++ K+ + ++E L+H
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFE------RICNAGRFSED-------EARFFF 123
PNIV V ++ EY + G+L E + G S D + F
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 124 Q---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKS 177
Q+ +G+ Y S HRDL N L+ +KI DFG S+ S+ +
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ ++ PE +L ++ + +D+WS GV L+ + G P+
Sbjct: 186 SLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 29 IGSGNFG-VARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 81
IG GNFG V + K + A+K ++ + ++ R+ + HPNI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFE-----RIC-----------NAGRFSEDEARFFFQQ 125
+L + +EYA G L + R+ A S + F
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 183
+ G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G P
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 176
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y +DVWS GV L+ ++ +G P+
Sbjct: 177 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 32/217 (14%)
Query: 29 IGSGNFGVARLMRDKKTEE-----LVAVKYIERGDKIDENVQ----REIINHRSLRHPNI 79
+G G FG L + K EE LV VK +++ DEN+Q RE+ R L H N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNV 70
Query: 80 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GV 130
VR + +++EY G+L F R + +Q ++ G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 131 SYCHSMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 185
+ + + HRDL N L+ L Y+ + ++
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSL--SKDVYNSEYYKLRNALIPL---RWL 185
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
APE + + ++ K +DVWS GV ++ V G PF
Sbjct: 186 APEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYG 221
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 29/218 (13%)
Query: 27 RDIGSGNFG------VARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPN 78
+IG+G FG R M + V VK + DE + +E+ +R L HPN
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKAR----VVVKELRASATPDEQLLFLQEVQPYRELNHPN 56
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL-----FERICNAGRFSEDEARFFFQQLISGVSYC 133
+++ + +V+E+ G+L R A +D + ++ SG+ +
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTP-AYIAPEVL 190
H H DL L N L + +KI D+G + + K P ++APE++
Sbjct: 117 HQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 191 LKKEYDGKIAD------VWSCGVTLYVML-VGAYPFED 221
+ D D +WS GVT++ + P+ D
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-08
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
+LV+ +G+G FG M VA+K +++G E E + L+HP +VR
Sbjct: 9 KLVKKLGAGQFGEV-WMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLY 67
Query: 84 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
V+ T + I+ EY G L F + + + ++ Q+ G+++ HR
Sbjct: 68 AVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
DL+ N L+ S KI DFG ++ + ++ + G + APE + + K
Sbjct: 127 DLRAANILV--SETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 199 IADVWSCGVTLY-VMLVGAYPF---EDPEEPKNFRK 230
+DVWS G+ L ++ G P+ +PE +N +
Sbjct: 184 -SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER 218
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 28 DIGSGNFGVARL-----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 81
++G G FG L + ++ + LVAVK + E + ++ QRE L+H +IVR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FER-------------ICNAGRFSEDEARFFFQQL 126
F V L +V EY G+L F R G+ + + Q+
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
SG+ Y S+ HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTMLP 187
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLY 210
++ PE +L +++ + +D+WS GV L+
Sbjct: 188 IRWMPPESILYRKFTTE-SDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 74/270 (27%), Positives = 118/270 (43%), Gaps = 41/270 (15%)
Query: 22 RYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL 74
R L + +G G FG + +DK + + VAVK + + D D+++ ++++ +
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLS-DLVSEMEM 70
Query: 75 -----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----EA 119
+H NI+ L +++EYAS G L E + A R +S D E
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEE 129
Query: 120 RFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
+ F+ L+S G+ Y S + HRDL N L+ +KI DFG ++ +
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNI 187
Query: 172 HSQPKSTVGT-PA-YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV---GAYPFEDPEEPK 226
K+T G P ++APE L + Y + +DVWS GV L+ + YP EE
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLI 256
K HR+ + I EC H +
Sbjct: 247 KLLKEGHRMDKPANCTHELYMIMRECWHAV 276
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-08
Identities = 52/228 (22%), Positives = 97/228 (42%), Gaps = 19/228 (8%)
Query: 39 LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98
L+ D +T++ +K + + + + II H PN+V + I++ + +V+++
Sbjct: 11 LVMDTRTQQTFILKGLRKSSEYSRE-RLTIIPHCV---PNMVCLHKYIVSEDSVFLVLQH 66
Query: 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158
A GG+L+ I E+ + + +++ + H + RDL N LLD +L
Sbjct: 67 AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL 126
Query: 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218
+S+ S + Y APEV E + + D WS G L+ +L G
Sbjct: 127 TY----FSRWSEVEDSCDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTL 181
Query: 219 FEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
E N T+ +IP+ +S E R L+ ++ +P +
Sbjct: 182 VECHPSGINTHTTL--------NIPE--WVSEEARSLLQQLLQFNPTE 219
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-08
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ +L++ +G+G FG V + T+ VAVK ++ G E+ E + LRH +
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSE-----DEARFFFQQLISGVSYC 133
V+ V+ + + IV EY S G L + + + GR + D A Q+ +G++Y
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYI 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 188
M HRDL+ N L+ KI DFG ++ L + T A + APE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 173
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLV-GAYPF 219
L + K +DVWS G+ L ++ G P+
Sbjct: 174 AALYGRFTIK-SDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 23/204 (11%)
Query: 16 IMHDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL 74
I +S R E+ +G G FG V + T VA+K ++ G E +E + L
Sbjct: 3 IPRESLRLEV--KLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL 58
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE----DEARFFFQQLISGV 130
RH +V+ V+ + + IV EY S G L + + G + + Q+ SG+
Sbjct: 59 RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGM 115
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YI 185
+Y M HRDL+ N L+ + K+ DFG ++ L + T A +
Sbjct: 116 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLAR---LIEDNEYTARQGAKFPIKWT 170
Query: 186 APEVLLKKEYDGKIADVWSCGVTL 209
APE L + K +DVWS G+ L
Sbjct: 171 APEAALYGRFTIK-SDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 18/219 (8%)
Query: 24 ELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
+L + +G+G FG V +K T+ VAVK ++ G E E ++L+H +V+
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 83 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V+ T + I+ E+ + G L F + + + F Q+ G+++ H
Sbjct: 67 HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
RDL+ N L+ S + KI DFG ++ K + + APE + +
Sbjct: 126 RDLRAANILV--SASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAINFGSF 180
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH 233
K +DVWS G+ L ++ G P+ P+ R
Sbjct: 181 TIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 14/139 (10%)
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K +
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGSAR 237
Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH---RI 235
P ++APE + K Y + +DVWS GV L+ + +GA P+ + + F + + R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 236 LSVQYSIPDYVHISPECRH 254
+ + + P+ I C
Sbjct: 297 RAPENATPEIYRIMLACWQ 315
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 19/182 (10%)
Query: 49 VAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104
VA+K I+ D+ +EI +H SL H IVR + + L +V + + G L
Sbjct: 39 VAIKTIQ--DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSL 95
Query: 105 FERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163
+ + + + Q+ G+ Y ++ HR+L N LL S + ++I DF
Sbjct: 96 LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK-SDS-IVQIADF 153
Query: 164 GYSKSSVLHSQPK----STVGTP-AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAY 217
G + +L+ K S TP ++A E +L Y + +DVWS GVT++ M+ GA
Sbjct: 154 GVA--DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAE 210
Query: 218 PF 219
P+
Sbjct: 211 PY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 42 DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM-EYAS 100
D KT E V +K +RG E I+ R++ HP+I++ K +++ Y +
Sbjct: 113 DNKTCEHVVIKAGQRGGTATE---AHIL--RAINHPSIIQLKGTFTYNKFTCLILPRYKT 167
Query: 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160
+L+ + + + + ++ + Y H ++ HRD+K EN ++ P +
Sbjct: 168 --DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN-HPG---DV 221
Query: 161 C--DFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
C DFG + V + K GT A APE+L + Y G D+WS G+ L+ M
Sbjct: 222 CLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 44/146 (30%), Positives = 62/146 (42%), Gaps = 20/146 (13%)
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSVLHSQP 175
+QL+S + Y H + HRD+K EN L++G IC DFG S S+ H
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN--FRKTI 232
TV T APEVL Y + D+WS G+ ++ V A F + + I
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI 378
Query: 233 HRILSVQYSIPDYVHISPECRHLISR 258
RI+ D R L+S+
Sbjct: 379 LRIIRQAQVHVDEFPQHAGSR-LVSQ 403
|
Length = 461 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 43/139 (30%), Positives = 70/139 (50%), Gaps = 14/139 (10%)
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 236
Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNF-RKTIH--RI 235
P ++APE + K Y + +DVWS GV L+ + +GA P+ + + F R+ R+
Sbjct: 237 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295
Query: 236 LSVQYSIPDYVHISPECRH 254
+ +Y+ P+ I +C H
Sbjct: 296 RAPEYATPEIYSIMLDCWH 314
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 14/139 (10%)
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 242
Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH---RI 235
P ++APE + + Y + +DVWS GV L+ + +GA P+ + + F + + R+
Sbjct: 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 236 LSVQYSIPDYVHISPECRH 254
+ Y+ P+ +C H
Sbjct: 302 RAPDYTTPEMYQTMLDCWH 320
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ R++++ +G G FG D+K +E AVK + K + + EI +R +
Sbjct: 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADP 187
Query: 80 V-RFKEVILT------PTHLAIVMEYASGGELFERICNAGRFSEDE-ARFFFQQLISGVS 131
RF + + H+ IVM G L + I G FS A+ FQ ++ +
Sbjct: 188 ADRFPLMKIQRYFQNETGHMCIVMP-KYGPCLLDWIMKHGPFSHRHLAQIIFQTGVA-LD 245
Query: 132 YCHS-MQVCHRDLKLENTLLDGS-------------PAP-RLKICDFGYSKSSVLHSQPK 176
Y H+ + + H DLK EN L++ S P P R++ICD G HS+
Sbjct: 246 YFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSR-T 303
Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+ V T Y +PEV+L + D+WS G +Y + G
Sbjct: 304 AIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-07
Identities = 52/240 (21%), Positives = 92/240 (38%), Gaps = 31/240 (12%)
Query: 41 RDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100
E V +K + + L H ++V+ V + ++ +V EY
Sbjct: 25 VGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVK 83
Query: 101 GGEL-----FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL----- 150
G L E+ + + D A +QL S + Y ++ H ++ +N L+
Sbjct: 84 FGPLDVFLHREKNNVSLHWKLDVA----KQLASALHYLEDKKLVHGNVCGKNILVARYGL 139
Query: 151 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA-DVWSCGVTL 209
+ P +K+ D G + + + + +IAPE + + IA D WS G TL
Sbjct: 140 NEGYVPFIKLSDPGIPITVLSREERVERI---PWIAPECIRNGQASLTIAADKWSFGTTL 196
Query: 210 Y-VMLVGAYPFE--DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
+ G P E + F + HR+ +PD E +LI++ + DP K
Sbjct: 197 LEICSNGEEPLSTLSSSEKERFYQDQHRL-----PMPD----CAELANLINQCWTYDPTK 247
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 7e-07
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVK----YIERGDKIDENVQREIINHRSLRHPNIVR 81
IG GNFG AR+ +D + A+K Y + D D + E++ + HPNI+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLC-KLGHHPNIIN 72
Query: 82 FKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSEDEARFFFQQ 125
+L + +EYA G L + + A S + F
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 183
+ G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G P
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 188
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y +DVWS GV L+ ++ +G P+
Sbjct: 189 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 9e-07
Identities = 51/211 (24%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 23 YELVRDIGSGNFG-VARLMRDKKTEEL---VAVKYIERGD--KIDENVQREIINHRSLRH 76
++ ++ +GSG FG V + + + E++ VA+K + K ++ + E S+ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHS 135
P++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 69 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVL 190
++ HRDL N L+ +KI DFG +K +L + K ++A E +
Sbjct: 128 RRLVHRDLAARNVLVKT--PQHVKITDFGLAK--LLGADEKEYHAEGGKVPIKWMALESI 183
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
L + Y + +DVWS GVT++ +M G+ P++
Sbjct: 184 LHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 26 VRDIGSGNFGVAR---LMRDKKTEEL-VAVKYIER--GDKIDENVQREIINHRSLRHPNI 79
V+ +GSG FG + + +T ++ VA+K + G K + E + S+ HP++
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQV 138
VR V L+PT + +V + G L + + + + Q+ G+ Y ++
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLKK 193
HRDL N L+ SP +KI DFG ++ +L K ++A E + +
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFE 220
++ + +DVWS GVT++ +M G P++
Sbjct: 187 KFTHQ-SDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 31/210 (14%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-------ENVQREIINHRSLRHP 77
L + +G G FG +M + ++ +K + KI E+ E + + HP
Sbjct: 3 LGKTLGEGEFG--SVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 78 NIVRFKEVILTPTHL------AIVMEYASGGEL-----FERICNAGRFSEDEARF-FFQQ 125
N++R V L +++ + G+L + R+ + ++ + F
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKSTVG 180
+ SG+ Y S HRDL N +L+ + + +C DFG SK + + Q +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNEN----MNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
+IA E L + Y K +DVWS GVT++
Sbjct: 177 PVKWIAIESLADRVYTTK-SDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 15/143 (10%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 178
F Q+ +G+ + S HRDL N L+ +KICDFG ++ + S ST
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKN--FRKTIHRI 235
++APE + Y ++DVWS G+ L+ + +G P+ PE P N F I R
Sbjct: 302 FLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPY--PELPMNEQFYNAIKR- 357
Query: 236 LSVQYSIPDYVHISPECRHLISR 258
Y + H S E ++ +
Sbjct: 358 ---GYRMAKPAHASDEIYEIMQK 377
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 11/182 (6%)
Query: 41 RDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100
+ + V VK + G + REI +++ H I+ + + +VM
Sbjct: 114 HGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169
Query: 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160
+LF + +G ++A ++L+ ++Y H + HRD+K EN LD L
Sbjct: 170 C-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG- 227
Query: 161 CDFGYSKSSVLHS-QPKST--VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217
DFG + H P+ GT +PE+L Y K D+WS G+ L+ M V
Sbjct: 228 -DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNV 285
Query: 218 PF 219
Sbjct: 286 TL 287
|
Length = 392 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 64/261 (24%), Positives = 106/261 (40%), Gaps = 23/261 (8%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINH 71
+ + +G+G FG A + VAVK ++ E + +I++H
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
H NIV + ++ EY G+L F R + ++ F Q+ G
Sbjct: 95 LG-NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA-YIA 186
+++ S HRDL N LL + +KICDFG ++ + S K P ++A
Sbjct: 154 MAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
PE + Y + +DVWS G+ L+ + +G+ P+ F K I Y +
Sbjct: 212 PESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE----GYRMAQP 266
Query: 246 VHISPECRHLISRIFVADPAK 266
H E ++ + ADP K
Sbjct: 267 EHAPAEIYDIMKTCWDADPLK 287
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 64/232 (27%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 21 DRYELVRDIGSGNFG-VARLMR---DKKTEE---LVAVKYIERGDKIDENVQREIINHRS 73
DR L + +G G FG V R DK + VAVK + + + D+++ ++I+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLA-DLISEME 69
Query: 74 L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----E 118
L +H NI+ V L +++EYA+ G L E + A R ++ D E
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPE 128
Query: 119 ARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--S 169
+ F+ L+S G+ Y S + HRDL N L+ +KI DFG ++
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHD 186
Query: 170 VLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ + + S P ++APE L + Y + +DVWS G+ ++ + +G P+
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 26 VRDIGSGNFG-VARLMRDKKTEEL---VAVKYIERGD--KIDENVQREIINHRSLRHPNI 79
V+ +GSG FG V + + E + VA+K + K ++ + E + P +
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQV 138
R + LT T + +V + G L + + N R + + Q+ G+SY +++
Sbjct: 72 CRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLLKKEY 195
HRDL N L+ SP +KI DFG ++ + G ++A E +L + +
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFE 220
+ +DVWS GVT++ +M GA P++
Sbjct: 189 THQ-SDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 69/251 (27%), Positives = 105/251 (41%), Gaps = 43/251 (17%)
Query: 21 DRYELVRDIGSGNFGVARL-----MRDKKTEEL--VAVKYIER-------GDKIDENVQR 66
DR L + +G G FG + + +K + VAVK ++ D I E
Sbjct: 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 77
Query: 67 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED----- 117
++I +H NI+ L +++EYAS G L E R + +
Sbjct: 78 KMIG----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 118 EARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-S 169
E + F+ L+S G+ Y S + HRDL N L+ +KI DFG ++
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIH 191
Query: 170 VLHSQPKSTVGT-PA-YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV---GAYPFEDPEE 224
+ K+T G P ++APE L + Y + +DVWS GV L+ + YP EE
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEE 250
Query: 225 PKNFRKTIHRI 235
K HR+
Sbjct: 251 LFKLLKEGHRM 261
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 23/56 (41%), Positives = 33/56 (58%), Gaps = 1/56 (1%)
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234
+GTP Y+APE+LL K + G D W+ GV L+ L G PF D + F+ ++R
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNR 595
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-06
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 31/222 (13%)
Query: 23 YELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
+ L R +G G FG R L + + + VAVK ++ +++ RE + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 77 PNIVRFKEVIL---TPTHLAIVM---EYASGGELFERICNAGRFSEDEARFFFQQLI--- 127
PN+++ V L L I M + G+L + R E+ Q L+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFM 119
Query: 128 ----SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKST 178
SG+ Y S HRDL N +L+ + + +C DFG SK S + Q ++
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNEN----MTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y +DVW+ GVT++ +M G P+
Sbjct: 176 KLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
F Q+ G+ + S HRDL N LL + +KICDFG ++ ++H + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLAR-DIMHDSNYVSKGS 298
Query: 182 P----AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++APE + Y ++DVWS G+ L+ + +G P+
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPY 340
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 25/202 (12%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
I G G + + K VK I + I + EI + L+HPNIV+ + +
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS---EIADMGKLQHPNIVKLIGLCRS 754
Query: 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS------YCH-SMQVCHR 141
++ EY G L E + N E R +++ G++ +C S V
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRNLSW----ERR---RKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
+L E ++DG P L++ S +L + K + + AY+APE K+ K +D
Sbjct: 808 NLSPEKIIIDGKDEPHLRL-----SLPGLLCTDTKCFISS-AYVAPETRETKDITEK-SD 860
Query: 202 VWSCGVTLYVMLVGAYPFEDPE 223
++ G+ L +L G P D E
Sbjct: 861 IYGFGLILIELLTGKSP-ADAE 881
|
Length = 968 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-06
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 27 RDIGSGNFGVARL--MRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 82
++IG+G FG L + T V VK + + E ++ E +RSL+H N+++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 83 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ---QLISGVSYCHSMQ 137
T +VME+ G+L + R C + + ++ G+ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEV 189
H DL L N LL +KI D+G S H++ K +IAPE+
Sbjct: 121 FIHSDLALRNCLLTADLT--VKIGDYGLS-----HNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 190 LLKKEYDG--------KIADVWSCGVTLYVML-VGAYPF 219
+ E G K ++VWS GVT++ + +G+ P+
Sbjct: 174 V--DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 48 LVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 103
LVAVK I R D ++N + + + L+ PNI+R V + L ++ EY G+
Sbjct: 48 LVAVK-ILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 104 LFERICNAGRFSEDEAR--------------------FFFQQLISGVSYCHSMQVCHRDL 143
L + ++ + E Q+ SG+ Y S+ HRDL
Sbjct: 106 L-NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLKKEYDGK 198
N L+ + +KI DFG S++ L++ + A ++A E +L ++
Sbjct: 165 ATRNCLVGENLT--IKIADFGMSRN--LYAGDYYRIQGRAVLPIRWMAWECILMGKFT-T 219
Query: 199 IADVWSCGVTLY--VMLVGAYPF 219
+DVW+ GVTL+ +ML P+
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQPY 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 47/159 (29%), Positives = 67/159 (42%), Gaps = 28/159 (17%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV 179
F Q+ G+S+ S HRDL N LL + KICDFG ++ S K
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 180 GTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILS 237
P ++APE + Y + +DVWS G+ L+ + +G+ P+ F K I
Sbjct: 277 RLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE--- 332
Query: 238 VQYSIPDYVHISPECRHLISRIFVADPAKSEMHDWRRGC 276
Y +SPEC A SEM+D + C
Sbjct: 333 ------GYRMLSPEC------------APSEMYDIMKSC 353
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 47/197 (23%), Positives = 89/197 (45%), Gaps = 29/197 (14%)
Query: 47 ELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102
+ VA+K ++ DK + E + E + L+HPNIV V+ L+++ Y S
Sbjct: 36 QAVAIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93
Query: 103 ELFERIC------NAGRFSEDE--------ARFF--FQQLISGVSYCHSMQVCHRDLKLE 146
+L E + + G +D+ A F Q+ +G+ + S V H+DL
Sbjct: 94 DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153
Query: 147 NTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
N L+ +KI D G + ++ + +++ +++PE ++ ++ +D+W
Sbjct: 154 NVLV--FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIW 210
Query: 204 SCGVTLY-VMLVGAYPF 219
S GV L+ V G P+
Sbjct: 211 SYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 28/197 (14%)
Query: 47 ELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104
+LVA+K ++ + + Q+E L HPNIV V+ + ++ EY + G+L
Sbjct: 35 QLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94
Query: 105 FERI----------CNAG-----RFSEDEARFFFQ--QLISGVSYCHSMQVCHRDLKLEN 147
E + C++ + S D F Q+ +G+ Y S H+DL N
Sbjct: 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN 154
Query: 148 TLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
L+ +KI D G S+ + QPKS + ++ PE ++ ++ +D+W
Sbjct: 155 ILI--GEQLHVKISDLGLSREIYSADYYRVQPKSLLPI-RWMPPEAIMYGKFSSD-SDIW 210
Query: 204 SCGVTLY-VMLVGAYPF 219
S GV L+ + G P+
Sbjct: 211 SFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 43/135 (31%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQ 174
+D RF Q + G+ + S HRD+ N LL DG A KICDFG ++ + S
Sbjct: 212 DDLLRFSSQ-VAQGMDFLASKNCIHRDVAARNVLLTDGRVA---KICDFGLARDIMNDSN 267
Query: 175 --PKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 230
K P ++APE + Y + +DVWS G+ L+ + +G P+ F K
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326
Query: 231 TIHRILSVQYSIPDY 245
+ R Q S PD+
Sbjct: 327 MVKR--GYQMSRPDF 339
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-05
Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
+G G FG + T + VA+K ++ G + E +E + LRH +V V+ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-S 71
Query: 89 PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
+ IV E+ G L F + + + Q+ G++Y M HRDL+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAA 131
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLKKEYDGKIAD 201
N L+ + KI DFG ++ L + T A + APE L + K +D
Sbjct: 132 NILVGDNLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SD 185
Query: 202 VWSCGVTLYVMLV-GAYPF 219
VWS G+ L ++ G P+
Sbjct: 186 VWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-05
Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 25/170 (14%)
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ----QL 126
+R L+HPNI++ + +V EY G+L + + Q ++
Sbjct: 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI 108
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS----KSSVLHSQPKSTVGTP 182
+GV++ H H DL L N L +K+ D+G K + ++ V
Sbjct: 109 AAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPL- 165
Query: 183 AYIAPEVLLKKEYDG-------KIADVWSCGVTLYVMLVGAYPFEDPEEP 225
++APE L+ + + G K ++VW+ GVTL+ + FE+ +P
Sbjct: 166 RWLAPE-LVGEFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQP 208
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
++ L+R++G G+FG AR + + E VAVK + + E + E +N S+
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63
Query: 76 HP----NIVRFKEVILTPTHLAIVMEYASGGEL--FERIC------NAGRFSE--DEARF 121
++VR V+ +VME + G+L + R N GR E
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 178
++ G++Y ++ + HRDL N ++ +KI DFG ++ + + +
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDIYETDYYRKGGKG 181
Query: 179 VGTPAYIAPEVLLKKEYDGKI---ADVWSCGVTLY 210
+ ++APE L DG +D+WS GV L+
Sbjct: 182 LLPVRWMAPESL----KDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.003
Identities = 27/83 (32%), Positives = 39/83 (46%), Gaps = 13/83 (15%)
Query: 133 CHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+++ HR K N LL DG G SV P+ + P ++APEV+
Sbjct: 27 LGALRELHRQAKSGNILLTWDGLLKL------DG----SVAFKTPEQSRPDPYFMAPEVI 76
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
+ Y K AD++S G+TLY L
Sbjct: 77 QGQSYTEK-ADIYSLGITLYEAL 98
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 280 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.68 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.57 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.56 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.56 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.47 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.45 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.43 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.42 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.35 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.34 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.25 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.24 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.23 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.19 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.08 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.07 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.85 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.84 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.7 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.58 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.56 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.53 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.52 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.5 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.49 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.49 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.43 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.33 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.26 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.13 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.12 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.99 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.94 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.92 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.91 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.85 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.79 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.73 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.7 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.56 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.48 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.43 | |
| PLN02236 | 344 | choline kinase | 97.38 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.34 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.34 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.33 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.3 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.22 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.9 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.78 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.76 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.7 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.67 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.64 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.31 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.24 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.13 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.08 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.68 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.6 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.28 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-58 Score=369.04 Aligned_cols=257 Identities=38% Similarity=0.613 Sum_probs=223.3
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc--------HHHHHHHHHhhhCCCCCeeeeceEEec
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--------ENVQREIINHRSLRHPNIVRFKEVILT 88 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~ 88 (280)
-...+.|.+.+.||+|+||.|-+|..+.+++.||||++++..... ..+.+|+++|++|+|||||++++++..
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 335688999999999999999999999999999999998643222 346799999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC-CCCcEEEeecCCcc
Q 023591 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSK 167 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~-~~~~~~l~df~~~~ 167 (280)
+.+.|+||||+.||+|.+++-.++.+.+..-+.+++|++.|+.|||+.||+||||||+||++..+ ....+|++|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999876 33458999999999
Q ss_pred ccccCCCCCCCcCCCcccCcccccCCc--CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC--C
Q 023591 168 SSVLHSQPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--P 243 (280)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~ 243 (280)
.........+.+|||.|.|||++.+.. +++.+.|+|||||++|-+++|.+||......... ..++..+.+.+ +
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl---~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL---KEQILKGRYAFGPL 404 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH---HHHHhcCcccccCh
Confidence 777777778999999999999997654 3455689999999999999999999876554422 23445555544 3
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 244 DYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.|..+|++..+||.+||..||++|| +||||+..
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 4668999999999999999999999 99999854
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-56 Score=376.76 Aligned_cols=245 Identities=38% Similarity=0.636 Sum_probs=229.6
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeee----CCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER----GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
.+|+..+.||+|+|+.+|.+++..+|+.||+|++.+ .....+.+.+|+++.++|+|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 679999999999999999999999999999999987 5677788999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (280)
|+|..++|..+++++++++|.+++.+++||+.||.|||+++|+|||||..|+|++++-+ +||+|||+|...... ...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCccccc
Confidence 99999999999999999999999999999999999999999999999999999998888 999999999876644 667
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
.+.+|||.|.|||++.....+-+ +||||+||++|.|+.|++||.. ..+.+...++....+.+|. .+|.+.++|
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFet----k~vkety~~Ik~~~Y~~P~--~ls~~A~dL 248 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFET----KTVKETYNKIKLNEYSMPS--HLSAEAKDL 248 (592)
T ss_pred ceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCccc----chHHHHHHHHHhcCccccc--ccCHHHHHH
Confidence 78899999999999998777666 9999999999999999999987 5677788888888999988 799999999
Q ss_pred HHHhcccCCCCcC------CCcccc
Q 023591 256 ISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 256 i~~~l~~dp~~Rp------~h~~~~ 274 (280)
|+++|+.||.+|| .|+||.
T Consensus 249 I~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 249 IRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred HHHHhcCCcccCCCHHHHhcCHhhh
Confidence 9999999999999 999994
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-56 Score=355.46 Aligned_cols=253 Identities=30% Similarity=0.489 Sum_probs=225.7
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeee--CCcccHHHHHHHHHhhhCCCCCeeeeceEEecCC-eEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIV 95 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 95 (280)
...+.+.++.||+|..|+|++++++.+++.+|+|++.. .....+++.+|+++++..+||+||.+|+.|..+. .+.++
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 33578889999999999999999999999999999954 3455578899999999999999999999999998 49999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
||||++|+|.+++...+.+++..+..++.+++++|.|||+ .+|+||||||+|+++...|+ |||+|||.+...... .
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~ 233 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-I 233 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-h
Confidence 9999999999999988999999999999999999999995 99999999999999999888 999999998866555 7
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCC-CCcchHHHHHhhHhccc-ccCCCCCCCCHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIHRILSVQ-YSIPDYVHISPEC 252 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 252 (280)
..+..||..|+|||.+.+..|+.. +||||||+.+.|+++|+.||... .........+..|.... ..+|.. .+|+++
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef 311 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEF 311 (364)
T ss_pred cccccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHH
Confidence 788999999999999999999877 99999999999999999999875 33455666777776644 445542 599999
Q ss_pred HHHHHHhcccCCCCcC------CCcccccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
++||..||+.||.+|| .|||+++-
T Consensus 312 ~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 312 RSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 9999999999999999 99999854
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-55 Score=348.29 Aligned_cols=252 Identities=35% Similarity=0.599 Sum_probs=223.5
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
...+++|++++.||.|+||+|+.|+.+.+++.+|+|++++.. ...+...+|..+|.+++||.||++...|.+++.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 456789999999999999999999999999999999998753 3345677899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc-ccc
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~-~~~ 171 (280)
|+|++|++||.|...+++.+.+++..++.++.+|+.||.|||+.||+||||||+|||++.+|+ ++|+|||++.. ...
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccC
Confidence 999999999999999999999999999999999999999999999999999999999999998 99999999983 344
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
+....+.+||+.|+|||++.+..++.. +|.||||+++|+|++|.+||...+. .+..+.+.......++ ..++.+
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~----~~~~~~I~~~k~~~~p-~~ls~~ 252 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDV----KKMYDKILKGKLPLPP-GYLSEE 252 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccH----HHHHHHHhcCcCCCCC-ccCCHH
Confidence 455667899999999999999988777 9999999999999999999998543 4555555555533322 148999
Q ss_pred HHHHHHHhcccCCCCcC----------CCcccccc
Q 023591 252 CRHLISRIFVADPAKSE----------MHDWRRGC 276 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp----------~h~~~~~~ 276 (280)
.++|++++|+.||++|. .||||++.
T Consensus 253 ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 253 ARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 99999999999999996 99999864
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-54 Score=345.15 Aligned_cols=257 Identities=36% Similarity=0.568 Sum_probs=221.7
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
.+...++|.+.+.||+|+||+||+++++.++..||||.+.+. .+..+.+..|+.+|+.++|||||.++++.+.++.+
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence 445668999999999999999999999999999999999764 34556678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC-CC---CcEEEeecCCccc
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PA---PRLKICDFGYSKS 168 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~-~~---~~~~l~df~~~~~ 168 (280)
++|||||+||+|.+++.+.+.+++..++.++.||+.||++||+++|+||||||+||+++.. +. ..+||.|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999999999999999999999999999999999999999999999999865 33 5699999999999
Q ss_pred cccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC-CCC
Q 023591 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVH 247 (280)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 247 (280)
..+.....+.+|+|.|+|||++....|+.+ +|+||+|+++|+|++|..||...+..+... .+.......+. ...
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~----~~~k~~~~~~~~~~~ 239 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLL----YIKKGNEIVPVLPAE 239 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH----HHhccccccCchhhh
Confidence 888888899999999999999999999888 999999999999999999998765543333 22222222211 124
Q ss_pred CCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 248 ISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.+..+.+++...|+.+|..|. .|+++...+
T Consensus 240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 240 LSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 566777999999999998888 777776543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-53 Score=328.84 Aligned_cols=248 Identities=33% Similarity=0.604 Sum_probs=227.0
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
...++|++++.||.|+||.|.+++.+.+|..+|+|++.+.+ +..+...+|..+|+.+.||.++++.+.+.+.+.++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 45589999999999999999999999999999999998754 33355678999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
+||||.+||.|..++++.+++++...+.++.||+.||+|||+++|++|||||+||++|.+|. +|++|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecCc-
Confidence 99999999999999999999999999999999999999999999999999999999999998 999999999865543
Q ss_pred CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
..+.+|||.|+|||++..+.+... +|.|+||+++|||+.|.+||...+. ..+..+|......+|. .++++++
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynka-vDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v~fP~--~fs~~~k 269 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKA-VDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKVKFPS--YFSSDAK 269 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcc-hhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcccCCc--ccCHHHH
Confidence 667889999999999998888655 9999999999999999999998665 5677788888889988 7999999
Q ss_pred HHHHHhcccCCCCcC-----------CCcccccc
Q 023591 254 HLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+||+.+|+.|-.+|. .||||++.
T Consensus 270 dLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 270 DLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 999999999999996 99999864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-52 Score=350.27 Aligned_cols=251 Identities=51% Similarity=0.829 Sum_probs=227.1
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----C--cccHHHHHHHHHhhhCC-CCCeeeeceEEecCC
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----D--KIDENVQREIINHRSLR-HPNIVRFKEVILTPT 90 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 90 (280)
...++|.+.+.||+|+||+|+.+.+..+++.||+|++.+. . ...+.+.+|+.++++++ ||||+++++++..+.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4568999999999999999999999999999999977653 1 23456778999999998 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC-CCCcEEEeecCCcccc
Q 023591 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSS 169 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~-~~~~~~l~df~~~~~~ 169 (280)
.+++||||+.||+|.+++.+.+++.+.....+++|++.|++|+|++||+||||||+|++++.+ ++ +||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~--~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN--LKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC--EEEecccccccc
Confidence 999999999999999999998899999999999999999999999999999999999999988 65 999999999876
Q ss_pred -ccCCCCCCCcCCCcccCcccccCCc-CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 170 -VLHSQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 170 -~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
.........+|++.|+|||++.+.. |+..++||||+|++||.|++|..||...+ .......+....+.+|.+..
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~----~~~l~~ki~~~~~~~p~~~~ 247 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN----VPNLYRKIRKGEFKIPSYLL 247 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc----HHHHHHHHhcCCccCCCCcC
Confidence 4566778899999999999999988 98888999999999999999999999843 34455557888888888433
Q ss_pred CCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 248 ISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
|+++++|+++||..||.+|+ .||||+.
T Consensus 248 -S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 248 -SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 99999999999999999999 9999997
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-53 Score=351.06 Aligned_cols=250 Identities=32% Similarity=0.547 Sum_probs=221.5
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 92 (280)
....+|.+++.||+|+|++|++|++..+++.||||++.+.. ...+-+..|-..|.+| +||.|++++-.|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 45689999999999999999999999999999999987642 3334566788888888 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
|+|+||+++|+|.+++.+.+.|++...+.++.+|+.||+|||++|||||||||+||+++.++. ++|+|||.|....+.
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPS 227 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChh
Confidence 999999999999999999999999999999999999999999999999999999999999988 999999998643322
Q ss_pred CC------------C--CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc
Q 023591 173 SQ------------P--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238 (280)
Q Consensus 173 ~~------------~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 238 (280)
.. . ....||..|.+||++.....+.. +|||+|||++|.|+.|.+||...++. .++++|...
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-sDiWAlGCilyQmlaG~PPFra~Ney----liFqkI~~l 302 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS-SDLWALGCILYQMLAGQPPFRAANEY----LIFQKIQAL 302 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc-cchHHHHHHHHHHhcCCCCCccccHH----HHHHHHHHh
Confidence 11 1 34679999999999987777666 99999999999999999999987664 345566777
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 239 QYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.+.++. +.++.+++||+++|..||.+|+ .||||.++
T Consensus 303 ~y~fp~--~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 303 DYEFPE--GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred cccCCC--CCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 788888 7999999999999999999999 99999865
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-52 Score=349.12 Aligned_cols=252 Identities=34% Similarity=0.563 Sum_probs=220.7
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++++.||+|+||.||+|+.+.||+.+|+|+++++.. ..+-++.|-.+|....++++|+++..|.+..++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 56899999999999999999999999999999999998653 33557778888888899999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc---
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 171 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~--- 171 (280)
||||++||++..++.+.+.|++..++.++.+++.|++.||+.|++||||||+|++||..|+ +||+|||++.....
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999999998 99999999842110
Q ss_pred --------------------CCC-----C--------------------CCCcCCCcccCcccccCCcCCCccchhhHHH
Q 023591 172 --------------------HSQ-----P--------------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCG 206 (280)
Q Consensus 172 --------------------~~~-----~--------------------~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG 206 (280)
... . ....|||.|+|||++.+..|... +|.||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-ccHHHHH
Confidence 000 0 02258999999999999998777 9999999
Q ss_pred HHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC---------CCcccccc
Q 023591 207 VTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE---------MHDWRRGC 276 (280)
Q Consensus 207 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---------~h~~~~~~ 276 (280)
||+|||+.|.+||...+......++..- ...+.+|.....+++.+|||.+||. ||++|. .||||+++
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nw--r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNW--RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHH--hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 9999999999999998776666665543 2345667767889999999999999 999999 99999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-54 Score=331.57 Aligned_cols=252 Identities=30% Similarity=0.461 Sum_probs=216.0
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeece-EEecCC-e
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKE-VILTPT-H 91 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~-~ 91 (280)
-.....|+++++||.|.||+||+++...+|..+|.|.++-.. +.......|+.+|++|+|||||++++ .+..+. .
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 345578999999999999999999999999999999987543 33456778999999999999999998 343343 4
Q ss_pred EEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--cC--ceecCCCCCcEEEeCCCCCcEEEeec
Q 023591 92 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS--MQ--VCHRDLKLENTLLDGSPAPRLKICDF 163 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~--~~--i~h~dl~~~ni~i~~~~~~~~~l~df 163 (280)
++++||+|..|+|.+.++. ++.+++..+|+++.|++.||.++|. .. ++||||||.|||++.+|. +||+||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDf 172 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDF 172 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccc
Confidence 8999999999999888853 4469999999999999999999998 55 999999999999998887 999999
Q ss_pred CCccccccCCC-CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC
Q 023591 164 GYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242 (280)
Q Consensus 164 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
|+++....... ..+..|||.|++||.+.+.+|+.+ |||||+||++|||..-+.||.+. .+....++|.++.+..
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYPP 247 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCCC
Confidence 99985554433 356679999999999999999777 99999999999999999999984 6677788888887753
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCcC-CCccccc
Q 023591 243 PDYVHISPECRHLISRIFVADPAKSE-MHDWRRG 275 (280)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rp-~h~~~~~ 275 (280)
-+...+|.++..+|..|+.+||+.|| .+|++..
T Consensus 248 ~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 248 LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 33347999999999999999999999 5888754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-52 Score=352.52 Aligned_cols=251 Identities=37% Similarity=0.728 Sum_probs=236.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..+-|++.+.||.|+.|.|-+|++..||+.+|||++.+. +.....+.+|+.+++.+.|||++.+++++++...+|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 346799999999999999999999999999999999765 3444678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
|.||+++|-|.+++-.++++++.+..++++||+.|+.|+|..+|+|||+||+|++++..++ |||.|||+|....++..
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKL 167 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCcc
Confidence 9999999999999999999999999999999999999999999999999999999998888 99999999998888888
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
..+.+|+|.|.|||++.+.+|+..++||||.|+|+|.|++|.+||.+ +.++..+.++..+.+..|. .+|.+.++
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~G~f~MPs--~Is~eaQd 241 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQRGVFEMPS--NISSEAQD 241 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHcCcccCCC--cCCHHHHH
Confidence 89999999999999999999999999999999999999999999985 6678888889999999997 79999999
Q ss_pred HHHHhcccCCCCcC------CCccccccc
Q 023591 255 LISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
||++||.+||++|. .|||+.++.
T Consensus 242 LLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 242 LLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHHHhccCccccccHHHHhhCchhhcCC
Confidence 99999999999999 999998763
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-52 Score=324.15 Aligned_cols=253 Identities=25% Similarity=0.464 Sum_probs=210.7
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|+.+.++|+|+||+|++++++.+|+.||||++..++. ..+-..+|+++|++++|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 579999999999999999999999999999999976543 22446789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-CCCC
Q 023591 98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 175 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~ 175 (280)
||+. ++.+-+.+.. .++.+.+.++++|++.|+.|+|+++++||||||+||+++.++. +||||||+|+.... +..-
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcchh
Confidence 9976 6666665554 5899999999999999999999999999999999999999998 99999999996663 3333
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc----------cc-----c
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS----------VQ-----Y 240 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~-----~ 240 (280)
-....|..|.|||.+.+...+.+..|||++||++.||++|++.|.+..+-+.+..+...... .+ .
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 44567888999999998555555599999999999999999999998776555444432221 11 1
Q ss_pred cCCC----------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 241 SIPD----------YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 241 ~~~~----------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.+|. .+.++.-+.+|+..||+.||++|+ .||||.+.
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 2221 245677899999999999999999 99999653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-51 Score=340.26 Aligned_cols=253 Identities=28% Similarity=0.491 Sum_probs=223.1
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc-HHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
...|+..++||+|+.|.||.++...++..||+|.+....... +-+.+|+.+++..+|+|||.+++.|..++.+++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 368999999999999999999999999999999998765444 4578999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCCC
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (280)
++||+|.+.+... .+++.++..+++++++||+|||.+||+|||||.+||+++.++. +||+|||++....... ....
T Consensus 352 m~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred cCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCcccc
Confidence 9999999998654 4999999999999999999999999999999999999999998 9999999998766655 4456
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHH
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (280)
..|||.|+|||+.....|..+ .||||||++++||+.|++||-..+ .++..+.-...+...+.....+|+.+++|+.
T Consensus 429 mVGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~---PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~ 504 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNEN---PLRALYLIATNGTPKLKNPEKLSPELKDFLD 504 (550)
T ss_pred ccCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCC---hHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence 789999999999988888777 999999999999999999998743 3444544445566666666689999999999
Q ss_pred HhcccCCCCcC------CCcccc-cccCC
Q 023591 258 RIFVADPAKSE------MHDWRR-GCSVS 279 (280)
Q Consensus 258 ~~l~~dp~~Rp------~h~~~~-~~~~~ 279 (280)
+||+.|+++|+ .||||+ .+.++
T Consensus 505 ~cL~~dv~~RasA~eLL~HpFl~~a~p~s 533 (550)
T KOG0578|consen 505 RCLVVDVEQRASAKELLEHPFLKMAKPES 533 (550)
T ss_pred HHhhcchhcCCCHHHHhcChhhhhcCCHH
Confidence 99999999999 999996 44443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=335.13 Aligned_cols=258 Identities=31% Similarity=0.464 Sum_probs=219.3
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHH--HHHHHHHhhhCC-CCCeeeeceEEecCC-eEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREIINHRSLR-HPNIVRFKEVILTPT-HLA 93 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~~ 93 (280)
..-++|+++++||.|+||.||+|+...+++.||||.+++.-..-++ -.||+..|++|+ ||||+++.+++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3448999999999999999999999999999999998775433333 357999999998 999999999998877 999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
+|||||+. +|.++++.+ +.|++..+..|++||+++|+|+|++|++|||+||+||++..... +||+|||+|+.....
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEecccccccccccC
Confidence 99999964 999998654 46999999999999999999999999999999999999986555 999999999976666
Q ss_pred CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc--------------
Q 023591 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------------- 238 (280)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 238 (280)
..--....|..|+|||++....+++.+.|+|++||+++|+.+-++.|.+.++.+++.++..-+...
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 655667788899999999887777777999999999999999999999988877776666433321
Q ss_pred -cccCCC---------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 239 -QYSIPD---------YVHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 239 -~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
.+++|. .+..+.++.++|.+||+.||++|| +||||+-..+
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 233332 135788999999999999999999 9999986543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-50 Score=323.12 Aligned_cols=253 Identities=34% Similarity=0.520 Sum_probs=209.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc-cHHHHHHHHHhhhCCCCCeeeeceEEecCC--eEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIV 95 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 95 (280)
...+|...+.||+|+||.||++.+.++|+..|+|.+...... .+.+.+|+.+|++++|||||++++...... .+++.
T Consensus 15 ~~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 15 EISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred ccchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 356799999999999999999999999999999998765211 456889999999999999999999754444 69999
Q ss_pred EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC-CCCCcEEEeecCCcccccc--
Q 023591 96 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVL-- 171 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~-~~~~~~~l~df~~~~~~~~-- 171 (280)
|||+++|+|.+++.+.+ .+++..+..+.+||+++|+|||++|++|+||||+||+++. ++. +||.|||++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCcccccccccc
Confidence 99999999999998877 7999999999999999999999999999999999999998 566 99999998875553
Q ss_pred --CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc--cccCCCCCC
Q 023591 172 --HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIPDYVH 247 (280)
Q Consensus 172 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 247 (280)
........+++.|+|||++.++......+|||||||++.||+||..||.... .. ......+... .+.+|. .
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--~~-~~~~~~ig~~~~~P~ip~--~ 247 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--EE-AEALLLIGREDSLPEIPD--S 247 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--ch-HHHHHHHhccCCCCCCCc--c
Confidence 2223456799999999999864433345999999999999999999998741 11 1122222222 234555 6
Q ss_pred CCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 248 ISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
+|++.++||.+|++.||++|| .|||+++...
T Consensus 248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 999999999999999999999 9999987653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-50 Score=329.75 Aligned_cols=259 Identities=28% Similarity=0.490 Sum_probs=219.7
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecC--CeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 93 (280)
..+.|+.+++||+|+||.||++++..+|+.||+|++.... ....-..+|+.+|++|+||||+++.++..+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 4578999999999999999999999999999999997653 2234467899999999999999999998876 6899
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
+|+|||+. +|..++... -.|++.+++-+++|++.+|+|+|.+|++|||||.+||+++.+|. +||.|||+|+.+...
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPS 271 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCC
Confidence 99999975 898888663 47999999999999999999999999999999999999999998 999999999965554
Q ss_pred CCC--CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc------cCCC
Q 023591 173 SQP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY------SIPD 244 (280)
Q Consensus 173 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~ 244 (280)
... -....|..|.|||.+.+..-+....|+||.|||+.||+.|++.|.+.++.+++..+++....... .+|.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 432 34457889999999998877677799999999999999999999999887777777654433221 1111
Q ss_pred -----------------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccccCCC
Q 023591 245 -----------------YVHISPECRHLISRIFVADPAKSE------MHDWRRGCSVSC 280 (280)
Q Consensus 245 -----------------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~~~ 280 (280)
...++....+|+..||..||.+|. +|+||...+.+|
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~ 410 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPC 410 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCC
Confidence 135778899999999999999998 999997766665
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=302.58 Aligned_cols=257 Identities=27% Similarity=0.445 Sum_probs=216.9
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|...+.||+|.||.||++++..+|+.||||++...+.. .....+|++.|+.++|+||+.++++|.+.+.+-+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 5899999999999999999999999999999999876433 4578899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
|++. +|...++.. ..++...++.++.+++++|+|||.+.|+|||+||.|++++++|. +|+.|||+++.........
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCccc
Confidence 9965 899888654 46999999999999999999999999999999999999999998 9999999998554333322
Q ss_pred -CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-cCCC----------
Q 023591 177 -STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPD---------- 244 (280)
Q Consensus 177 -~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~---------- 244 (280)
....|..|.|||.+.+...+....|+||.||++.||+.+.+-|.+.++-+++..+++....... .+|+
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 2357788999999998776666699999999999999999999988876666665544333221 1111
Q ss_pred -----------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccccCCC
Q 023591 245 -----------YVHISPECRHLISRIFVADPAKSE------MHDWRRGCSVSC 280 (280)
Q Consensus 245 -----------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~~~ 280 (280)
.+..++++.+|+.+||..||.+|+ .|+||+.-+.+|
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT 291 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence 123567889999999999999999 999999866543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=326.39 Aligned_cols=252 Identities=35% Similarity=0.591 Sum_probs=217.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---------------cccHHHHHHHHHhhhCCCCCeeeec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------------KIDENVQREIINHRSLRHPNIVRFK 83 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~e~~~l~~l~h~~iv~~~ 83 (280)
..++|++.+.||+|.||.|.+|++..+++.||||++.+.+ ...+...+|+.+++++.|+|||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4489999999999999999999999999999999997532 2235788999999999999999999
Q ss_pred eEEecC--CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEe
Q 023591 84 EVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (280)
Q Consensus 84 ~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~ 161 (280)
++..+. +.+|+|+|||..|.+.+.-.....+++.+.++++++++.+|+|||.+||+||||||+|++++++|. +||.
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--VKIs 252 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--VKIS 252 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc--EEee
Confidence 998764 579999999998888765433334999999999999999999999999999999999999998887 9999
Q ss_pred ecCCccccccCCC------CCCCcCCCcccCcccccC---CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHH
Q 023591 162 DFGYSKSSVLHSQ------PKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (280)
Q Consensus 162 df~~~~~~~~~~~------~~~~~~~~~~~aPE~~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (280)
|||.+........ .....|||.|+|||...+ ..+...+.||||+|++||.|+.|+.||-. +......
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~----~~~~~l~ 328 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD----DFELELF 328 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc----chHHHHH
Confidence 9998874422211 123579999999999877 45667778999999999999999999987 4456677
Q ss_pred hhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.+|....+.+|..+.+.+++++||.+||..||++|. .|||..+.
T Consensus 329 ~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 329 DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 788888888998878899999999999999999999 99999765
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-50 Score=335.48 Aligned_cols=245 Identities=34% Similarity=0.611 Sum_probs=222.1
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|.+.+.||+|.||.||+++.+.+.+.||+|++.+..+. ...+.+|+++++.++||||+.+++.|++...+++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 6899999999999999999999999999999999875444 4567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC-C
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-K 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~-~ 176 (280)
|+.| +|..++...+.++++.+..++.+++.||.|||+.+|.|+|+||.||++..++. +|++|||+|+.......- .
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceeee
Confidence 9976 99999999999999999999999999999999999999999999999998887 999999999976665443 3
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (280)
...|+|.|+|||...++.++.. +|+|||||++|||+.|++||.. ..+....+.|......+|. ..|..+.+|+
T Consensus 159 sikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a----~si~~Lv~~I~~d~v~~p~--~~S~~f~nfl 231 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYA----RSITQLVKSILKDPVKPPS--TASSSFVNFL 231 (808)
T ss_pred eccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchH----HHHHHHHHHHhcCCCCCcc--cccHHHHHHH
Confidence 4469999999999998888877 9999999999999999999986 5566677777777777777 7899999999
Q ss_pred HHhcccCCCCcC------CCccccc
Q 023591 257 SRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 257 ~~~l~~dp~~Rp------~h~~~~~ 275 (280)
..+|..||.+|. .|||.++
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhh
Confidence 999999999999 9999874
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=328.68 Aligned_cols=247 Identities=32% Similarity=0.544 Sum_probs=213.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||.||++++..+++.||+|++.+.. ...+.+.+|+.++++++||||+++++++..++..++
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 4588999999999999999999999999999999987542 233567889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
+|||+++++|.+.+.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..... .
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~--~ 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPD--R 171 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCC--C
Confidence 9999999999999988888999999999999999999999999999999999999998887 99999999875432 2
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
.....+++.|+|||.+.+..++.. +||||||+++|+|++|..||..... ......+......++. .++..+++
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~~p~--~~~~~~~~ 244 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTP----FRIYEKILAGRLKFPN--WFDGRARD 244 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCc-ceeechHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCCcCCCC--CCCHHHHH
Confidence 234568899999999988777655 9999999999999999999976443 2333444455555555 58899999
Q ss_pred HHHHhcccCCCCcC-----------CCcccccc
Q 023591 255 LISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 255 li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
||.+||+.||.+|| .||||++.
T Consensus 245 li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 245 LVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999999999997 79999863
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-49 Score=323.90 Aligned_cols=244 Identities=33% Similarity=0.586 Sum_probs=210.2
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999987542 23356788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
||+++++|.+++...+.+++..+..++.|++.||++||++|++||||+|+||+++.++. ++|+|||++..... ...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~--~~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLRD--RTW 156 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEEecCcchhccC--Ccc
Confidence 99999999999988888999999999999999999999999999999999999988776 99999999874432 223
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (280)
...+++.|+|||.+.+..++.. +||||||+++|+|++|..||...... .....+......++. .+++.+++||
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~~~--~~~~~~~~li 229 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPF----GIYEKILAGKLEFPR--HLDLYAKDLI 229 (291)
T ss_pred cccCChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCcCCCc--cCCHHHHHHH
Confidence 3468899999999987777555 99999999999999999999875432 233344444555555 5789999999
Q ss_pred HHhcccCCCCcC-----------CCccccc
Q 023591 257 SRIFVADPAKSE-----------MHDWRRG 275 (280)
Q Consensus 257 ~~~l~~dp~~Rp-----------~h~~~~~ 275 (280)
++||+.||.+|| .||||+.
T Consensus 230 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 230 KKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 999999999999 6999974
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=307.30 Aligned_cols=252 Identities=35% Similarity=0.623 Sum_probs=219.8
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeee---CCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
.+.|++.+.||+|.|+.|+++.+..+|+.+|+|++.. ....-+++.+|+.+.+.|+||||+++++.+.++...++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4789999999999999999999999999999998864 3445678999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-CCcEEEeecCCccccccCCCC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~~~~~l~df~~~~~~~~~~~~ 175 (280)
|++.|++|-.-+-.+.-+++..+-.+++||++||.|+|.+||+|||++|+|+++-+.. ..-+||+|||++.....+...
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~ 169 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW 169 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccc
Confidence 9999999955554445578999999999999999999999999999999999995432 335899999999877766666
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC--CCCCCCHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECR 253 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 253 (280)
.-..|+|.|+|||++...++..+ +|||+.|+++|-|+.|.+||.+.+. .....++..+.++++ .|+.++++.+
T Consensus 170 ~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~----~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 170 HGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQ----HRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred ccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccH----HHHHHHHhccccCCCCcccCcCCHHHH
Confidence 67789999999999988888766 9999999999999999999998443 455666666666554 4789999999
Q ss_pred HHHHHhcccCCCCcC------CCcccccc
Q 023591 254 HLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+||++||..||.+|+ +|||+++-
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999 99999864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=317.94 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=210.2
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
.|++.+.||+|+||.||++.+..+++.||+|.+.+.. .....+.+|+.++++++|++++++.+++..++..+++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4889999999999999999999999999999987542 222356789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 98 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
|+++++|.+.+... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETV 158 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCee
Confidence 99999998877543 36899999999999999999999999999999999999988777 999999998754433333
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....+++.|+|||.+.+..++.. +||||||+++|+|++|..||...............+......++. .+++++.+|
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~l 235 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAKSI 235 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCc--cCCHHHHHH
Confidence 44568899999999988887666 999999999999999999998765543333333333333333433 688999999
Q ss_pred HHHhcccCCCCcC-----------CCccccccc
Q 023591 256 ISRIFVADPAKSE-----------MHDWRRGCS 277 (280)
Q Consensus 256 i~~~l~~dp~~Rp-----------~h~~~~~~~ 277 (280)
|++||+.||.+|| .||||++..
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 9999999999997 899998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=323.96 Aligned_cols=255 Identities=38% Similarity=0.630 Sum_probs=225.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHHhhhCC-CCCeeeeceEEecCCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 93 (280)
....|++.+.||.|.||.||.++.+.+|+.+|+|.+.+... ..+.+.+|+.+++++. |||||.+.+.+++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 44689999999999999999999999999999999987543 3467899999999997 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC--CCcEEEeecCCcccccc
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVL 171 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~--~~~~~l~df~~~~~~~~ 171 (280)
+|||++.||.|.+.+... .+++.....+++|++.+++|||+.|++|+|+||+|+++.... .+.++++|||++.....
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 999999999999998766 499999999999999999999999999999999999997553 34699999999997777
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc--cCCCCCCCC
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHIS 249 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 249 (280)
........|++.|+|||++....+... .|+||+|+++|.|++|..||...++..... .+....+ ..+.|..+|
T Consensus 192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 192 GERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFL----AILRGDFDFTSEPWDDIS 266 (382)
T ss_pred CceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHH----HHHcCCCCCCCCCccccC
Confidence 666778899999999999988888777 999999999999999999999877655544 3444444 445577899
Q ss_pred HHHHHHHHHhcccCCCCcC------CCcccccccCC
Q 023591 250 PECRHLISRIFVADPAKSE------MHDWRRGCSVS 279 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~~ 279 (280)
..+++||+.||..||.+|+ +|||+++...+
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA 302 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence 9999999999999999999 99999976443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=315.46 Aligned_cols=264 Identities=28% Similarity=0.429 Sum_probs=217.1
Q ss_pred CCCCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC--CcccHHHHHHHHHhhhCCCCCeeeeceEEec
Q 023591 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT 88 (280)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 88 (280)
..........+.|++.+.||.|..++||+|+...+++.||||++... ....+.+.+|+..++.++||||++++..|..
T Consensus 16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 34445556779999999999999999999999999999999999764 3445788999999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCc
Q 023591 89 PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~ 166 (280)
++.+|+||.|+.+||+.+.++..- -+++..|..+++++++||.|||++|.+|||||+.||+++.+|. |+|+|||.+
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvs 173 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVS 173 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceee
Confidence 999999999999999999997643 4999999999999999999999999999999999999999998 999999976
Q ss_pred cccccCCC----C-CCCcCCCcccCcccccC--CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-
Q 023591 167 KSSVLHSQ----P-KSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV- 238 (280)
Q Consensus 167 ~~~~~~~~----~-~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 238 (280)
-.....+. . ....++++|+|||++.. ..|+ .++||||||++..||.+|+.||.......-+...+++....
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTL 252 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCc
Confidence 43322221 1 45579999999999543 3454 44999999999999999999998876644333333222110
Q ss_pred ---cccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 239 ---QYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 239 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
..+......++..++++|..||+.||.+|| .|+||++..
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 112222345778999999999999999999 999998653
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=313.51 Aligned_cols=251 Identities=29% Similarity=0.482 Sum_probs=217.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc----cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..+.|++++.||.|.-|+||+++...++..+|+|++.+.... ..++..|.++|+.++||.++.++..++.+...|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 457899999999999999999999999999999999875432 3456679999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-
Q 023591 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~- 171 (280)
+||||+||+|..+++++ +.+++..++.++.+++-||+|||..|||+|||||+||++.++|+ |.|+||+++....-
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRCPVS 232 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccCCCC
Confidence 99999999999888664 46999999999999999999999999999999999999999998 99999998731100
Q ss_pred --------------------------------C-C-----------------------CCCCCcCCCcccCcccccCCcC
Q 023591 172 --------------------------------H-S-----------------------QPKSTVGTPAYIAPEVLLKKEY 195 (280)
Q Consensus 172 --------------------------------~-~-----------------------~~~~~~~~~~~~aPE~~~~~~~ 195 (280)
. . ......||-.|.|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0012347788999999998888
Q ss_pred CCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC-------
Q 023591 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE------- 268 (280)
Q Consensus 196 ~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------- 268 (280)
... .|.|+||+++|||+.|..||.+.+..+ .+..+......++..+.++..++|||+++|..||++|.
T Consensus 313 gsA-VDWWtfGIflYEmLyG~TPFKG~~~~~----Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~ 387 (459)
T KOG0610|consen 313 GSA-VDWWTFGIFLYEMLYGTTPFKGSNNKE----TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAA 387 (459)
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCcCCCCchh----hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchH
Confidence 666 999999999999999999999977654 44556777788888778899999999999999999999
Q ss_pred ---CCcccccc
Q 023591 269 ---MHDWRRGC 276 (280)
Q Consensus 269 ---~h~~~~~~ 276 (280)
+||||+++
T Consensus 388 eIK~HpFF~gV 398 (459)
T KOG0610|consen 388 EIKRHPFFEGV 398 (459)
T ss_pred HhhcCccccCC
Confidence 99999975
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=317.24 Aligned_cols=245 Identities=38% Similarity=0.692 Sum_probs=223.6
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccH----HHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
.+|++.+.||.|.||+|.++.....|+.||||.+.+.....+ .+.+|++++..|+||||+.++++|++.+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 589999999999999999999999999999999987654443 4789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
||..+|.|.+++.+.+.+++.+...+++||..|+.|+|+++++|||||.+||++|.+++ +|+.|||++..+.......
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHHH
Confidence 99999999999999999999999999999999999999999999999999999999888 9999999999888888888
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (280)
+++|+|.|.+||++.+.+|..+..|-||||++||.|+.|..||.+.+ .....+++..+.+.-|. .+.+..-||
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D----hk~lvrQIs~GaYrEP~---~PSdA~gLI 283 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD----HKRLVRQISRGAYREPE---TPSDASGLI 283 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch----HHHHHHHhhcccccCCC---CCchHHHHH
Confidence 99999999999999999998888999999999999999999998843 45566677777765554 567899999
Q ss_pred HHhcccCCCCcC------CCcccc
Q 023591 257 SRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 257 ~~~l~~dp~~Rp------~h~~~~ 274 (280)
++||-+||++|. .|=|++
T Consensus 284 RwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 284 RWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHHhcCcccchhHHHHhhhheee
Confidence 999999999999 676664
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-49 Score=295.84 Aligned_cols=250 Identities=36% Similarity=0.604 Sum_probs=224.4
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
-..++|++.+.||.|.||.||+++.+.++-.||+|++.+++ ....++.+|+++...|+||||+++++++.++...|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 35689999999999999999999999999999999998865 33356788999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 94 IVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~--~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
+++||.+.|++...+. ...++++...+.+++|++.||.|+|..+++||||+|+|++++..+. +|+.|||-+....
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP- 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-
Confidence 9999999999999998 5668999999999999999999999999999999999999998888 9999999988554
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
.....+.++|..|.+||...+...+.. .|+|++|++.||++.|.+||.... ..+..+++......+|. .++.+
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~----~~etYkrI~k~~~~~p~--~is~~ 248 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQS----HSETYKRIRKVDLKFPS--TISGG 248 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhh----hHHHHHHHHHccccCCc--ccChh
Confidence 555677889999999999999998877 999999999999999999998755 34455566666777775 79999
Q ss_pred HHHHHHHhcccCCCCcC------CCccccccc
Q 023591 252 CRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.+|+|.+||..+|.+|. .|||+.+..
T Consensus 249 a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~~ 280 (281)
T KOG0580|consen 249 AADLISRLLVKNPIERLALTEVMDHPWIVANG 280 (281)
T ss_pred HHHHHHHHhccCccccccHHHHhhhHHHHhcC
Confidence 99999999999999999 999997653
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-48 Score=322.38 Aligned_cols=241 Identities=35% Similarity=0.582 Sum_probs=205.1
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (280)
+.||+|+||.||++++..+++.||+|++.+.. .....+.+|+.++++++||||+++++++..++.+++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999987632 22345678999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-CCCCCCCcCC
Q 023591 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 181 (280)
Q Consensus 103 ~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~ 181 (280)
+|.+.+.....+++..+..++.||+.||+|||+.|++||||||+||+++.++. ++|+|||++..... ........++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecC
Confidence 99999988888999999999999999999999999999999999999998877 99999999874322 2223345689
Q ss_pred CcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcc
Q 023591 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261 (280)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 261 (280)
+.|+|||.+.+..++.. +|||||||++|+|++|..||...+. ......+......++. .+++++.+||.+||+
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~ 231 (323)
T cd05571 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILMEEIRFPR--TLSPEAKSLLAGLLK 231 (323)
T ss_pred ccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCH----HHHHHHHHcCCCCCCC--CCCHHHHHHHHHHcc
Confidence 99999999988777665 9999999999999999999976443 2233334444445554 689999999999999
Q ss_pred cCCCCcC-----------CCcccccc
Q 023591 262 ADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 262 ~dp~~Rp-----------~h~~~~~~ 276 (280)
.||++|| .||||++.
T Consensus 232 ~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 232 KDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999998 79999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=321.96 Aligned_cols=251 Identities=30% Similarity=0.501 Sum_probs=212.5
Q ss_pred CCCCCCCCeeeecccccCCceEEEEEEecCCC-cEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecC
Q 023591 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (280)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~-~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 89 (280)
......++|++.+.||+|+||.||+|.+..++ ..||+|.+.+. ....+.+.+|+.+++.++||||+++++++..+
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 34446689999999999999999999876554 68999998653 23345677899999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
...++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++...
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~ 181 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVV 181 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCeec
Confidence 999999999999999999988888999999999999999999999999999999999999988877 999999998743
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
.. ......+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+.. .....+......++. .++
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~~ 252 (340)
T PTZ00426 182 DT--RTYTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEPL----LIYQKILEGIIYFPK--FLD 252 (340)
T ss_pred CC--CcceecCChhhcCHHHHhCCCCCcc-ccccchhhHHHHHhcCCCCCCCCCHH----HHHHHHhcCCCCCCC--CCC
Confidence 22 2234568899999999987777655 99999999999999999999875443 233334444445554 578
Q ss_pred HHHHHHHHHhcccCCCCcC-----------CCcccccc
Q 023591 250 PECRHLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+.+.++|++||+.||.+|+ .||||++.
T Consensus 253 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 253 NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999999995 89999864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=318.13 Aligned_cols=239 Identities=32% Similarity=0.551 Sum_probs=204.6
Q ss_pred cccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCch
Q 023591 29 IGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (280)
Q Consensus 29 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (280)
||+|+||.||++++..+++.||+|.+.+. ......+.+|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999998753 23334567899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCCCcCCCc
Q 023591 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 183 (280)
Q Consensus 105 ~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~ 183 (280)
.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++...... .......+++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcc
Confidence 999988888999999999999999999999999999999999999988887 999999998743222 22334568899
Q ss_pred ccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccC
Q 023591 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263 (280)
Q Consensus 184 ~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 263 (280)
|+|||.+.+..++.. +||||||+++|+|++|..||..... ......+......++. .+++++.+||.+||+.|
T Consensus 159 y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~----~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~d 231 (312)
T cd05585 159 YLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENV----NEMYRKILQEPLRFPD--GFDRDAKDLLIGLLSRD 231 (312)
T ss_pred cCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCH----HHHHHHHHcCCCCCCC--cCCHHHHHHHHHHcCCC
Confidence 999999988777655 9999999999999999999986443 3334444555555555 68999999999999999
Q ss_pred CCCcC---------CCcccccc
Q 023591 264 PAKSE---------MHDWRRGC 276 (280)
Q Consensus 264 p~~Rp---------~h~~~~~~ 276 (280)
|.+|| .||||.+.
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCC
Confidence 99997 89999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=322.78 Aligned_cols=250 Identities=28% Similarity=0.482 Sum_probs=206.4
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|+||+||++++..+++.||+|++.+.. .....+.+|+.++.+++|+||+++++.+.++..+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999987632 23345778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC---
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~--- 173 (280)
||+++++|.+++.+.+.+++..+..++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999998877 9999999986432110
Q ss_pred ---------------------------------CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCC
Q 023591 174 ---------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (280)
Q Consensus 174 ---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 220 (280)
......+++.|+|||.+.+..++.. +|||||||++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCCC
Confidence 0113468899999999988877665 999999999999999999998
Q ss_pred CCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCc---C------CCcccccc
Q 023591 221 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKS---E------MHDWRRGC 276 (280)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---p------~h~~~~~~ 276 (280)
.........++.. ......++....+++++++||.+|+. +|.+| | .||||++.
T Consensus 238 ~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 238 SETPQETYKKVMN--WKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCHHHHHHHHHc--CcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 7554333332221 11233455544678999999999775 55554 5 99999865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=300.09 Aligned_cols=264 Identities=28% Similarity=0.398 Sum_probs=221.0
Q ss_pred CCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc---HHHHHHHHHhhhCCCCCeeeeceEEec--
Q 023591 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILT-- 88 (280)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 88 (280)
+......+.|+.+..|++|+||.||+++++.+++.||+|.++...... =.-.+|+.+|.+.+|||||.+-++..-
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 444556789999999999999999999999999999999997654222 135689999999999999999888764
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 89 PTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
-+.+|+||||+.. +|..++.+.+ ++...+++-++.|++.|++|||++.|+||||||+|++++..|. +|++|||+|+
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR 225 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAR 225 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhh
Confidence 4579999999965 9999997765 8999999999999999999999999999999999999999988 9999999999
Q ss_pred ccccCCCCCC-CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc------
Q 023591 168 SSVLHSQPKS-TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY------ 240 (280)
Q Consensus 168 ~~~~~~~~~~-~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 240 (280)
.+.......+ ..-|..|.|||.+.+.+.+++..|+||+|||+.||+++.+.|.+..+.+++.++++......-
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 7665544433 346888999999998876667699999999999999999999998887777776654433211
Q ss_pred ---------cCCCC-----------CCCCHHHHHHHHHhcccCCCCcC------CCcccccccCCC
Q 023591 241 ---------SIPDY-----------VHISPECRHLISRIFVADPAKSE------MHDWRRGCSVSC 280 (280)
Q Consensus 241 ---------~~~~~-----------~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~~~ 280 (280)
.++.. ..+++...+|+..+|..||.+|. .|+||.+.+.+|
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~ 371 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI 371 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence 11110 12568899999999999999999 999999988776
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=325.31 Aligned_cols=250 Identities=34% Similarity=0.553 Sum_probs=221.5
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCe
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 91 (280)
....++|.+++.||+|.||+|+++..+.+++.+|||.+++.. ...+..+.|..++... +||.++.++..|.++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 335689999999999999999999999999999999999853 4456677888888777 69999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc-
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV- 170 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~- 170 (280)
+++||||+.||++. .+...+.+++..+..++..++.||.|||++||+|||||.+||++|.+|. +||.|||+++...
T Consensus 444 l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCC
Confidence 99999999999943 3445577999999999999999999999999999999999999999998 9999999998655
Q ss_pred cCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCH
Q 023591 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (280)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (280)
.+....+.+|||.|+|||++.+..|+.. .|.|+||++||+|+.|+.||.+.+++ +....|......+|. .+|.
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEe----e~FdsI~~d~~~yP~--~ls~ 593 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEE----EVFDSIVNDEVRYPR--FLSK 593 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHhcCCCCCCC--cccH
Confidence 4456678899999999999999999766 99999999999999999999986654 345566777777777 5999
Q ss_pred HHHHHHHHhcccCCCCcC-----------CCcccccc
Q 023591 251 ECRHLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 251 ~l~~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+..++++++|..||++|. .||||+..
T Consensus 594 ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 594 EAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 999999999999999999 89999864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=314.87 Aligned_cols=244 Identities=33% Similarity=0.491 Sum_probs=203.9
Q ss_pred CCCCCCCCCeeeecccccCCceEEEEEEecCCCcE-EEEEEeeeCCcc---cHHHHHHHHHhhhCCCCCeeeeceEEecC
Q 023591 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEEL-VAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP 89 (280)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~-vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 89 (280)
....++.....+.+.||+|+||+||++.+. |.. ||+|++...... .+.+.+|+.++.+++|||||++++++..+
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 334455677788888999999999999986 444 999999875433 45799999999999999999999999887
Q ss_pred C-eEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcC-ceecCCCCCcEEEeCCC-CCcEEEeecC
Q 023591 90 T-HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ-VCHRDLKLENTLLDGSP-APRLKICDFG 164 (280)
Q Consensus 90 ~-~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~-i~h~dl~~~ni~i~~~~-~~~~~l~df~ 164 (280)
. .+++||||+++|+|.+++.. ...++...+..++.||++|++|||+.+ |+||||||+||+++.+. + +||+|||
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~--~KI~DFG 189 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKT--LKIADFG 189 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCE--EEECCCc
Confidence 7 79999999999999999977 578999999999999999999999999 99999999999999886 5 9999999
Q ss_pred CccccccC-CCCCCCcCCCcccCcccccC--CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc--cc
Q 023591 165 YSKSSVLH-SQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQ 239 (280)
Q Consensus 165 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~ 239 (280)
+++..... .......||+.|+|||++.+ ..++.+ +||||||+++|||+||..||....... ....+.. ..
T Consensus 190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~~----~~~~v~~~~~R 264 (362)
T KOG0192|consen 190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPVQ----VASAVVVGGLR 264 (362)
T ss_pred cceeeccccccccCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhcCCC
Confidence 99855544 33333789999999999984 466555 999999999999999999999876522 2222222 22
Q ss_pred ccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 240 YSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..++. ..++.+..++.+||..||++||
T Consensus 265 p~~p~--~~~~~l~~l~~~CW~~dp~~RP 291 (362)
T KOG0192|consen 265 PPIPK--ECPPHLSSLMERCWLVDPSRRP 291 (362)
T ss_pred CCCCc--cCCHHHHHHHHHhCCCCCCcCC
Confidence 23333 5889999999999999999999
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=318.32 Aligned_cols=251 Identities=32% Similarity=0.555 Sum_probs=208.5
Q ss_pred CeeeecccccCCceEEEEEEec---CCCcEEEEEEeeeCC-----cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeE
Q 023591 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 92 (280)
+|++.+.||+|+||.||++++. .+++.||+|++.+.. ...+.+.+|+.+++++ +|++|+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 468899999987532 2234567899999999 589999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
++||||+++++|.+.+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCcccccc
Confidence 999999999999999988888999999999999999999999999999999999999998877 999999998744322
Q ss_pred CC--CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCH
Q 023591 173 SQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (280)
Q Consensus 173 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (280)
.. .....+++.|+|||.+.+......++||||||+++|+|++|..||...............+......++. .+++
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 236 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS--FIGP 236 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCH
Confidence 22 2234688999999998776544455999999999999999999997654433334444444444444444 6899
Q ss_pred HHHHHHHHhcccCCCCcC-----------CCcccccc
Q 023591 251 ECRHLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 251 ~l~~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
.+.+++.+||+.||++|| .||||++.
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999998 89999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=319.53 Aligned_cols=249 Identities=30% Similarity=0.470 Sum_probs=209.6
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|+||.||++++..+++.||+|++.+.. .....+.+|+.++.+++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987642 23345778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
||+++++|.+++.....+++..+..++.||+.||.+||+.|++||||+|+||+++.++. ++|+|||++..... ...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YAN 156 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccC
Confidence 99999999999988888999999999999999999999999999999999999998877 99999999874433 334
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC----CCCCCHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD----YVHISPEC 252 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l 252 (280)
...+++.|+|||.+.+..++.. +||||||+++|+|++|..||...+..+......... .....+. ...+++++
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~s~~~ 233 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK--ETLQRPVYDDPRFNLSDEA 233 (333)
T ss_pred CcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc--ccccCCCCCccccccCHHH
Confidence 5568899999999988877655 999999999999999999998755433332222111 1111111 12468999
Q ss_pred HHHHHHhcccCCCCcC------CCcccccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.+||.+||+.+|.+|| .||||++.
T Consensus 234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 234 WDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 9999999999999999 99999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-47 Score=317.15 Aligned_cols=241 Identities=34% Similarity=0.573 Sum_probs=203.7
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (280)
+.||+|+||.||++++..++..||+|.+.... .....+.+|+.+++.++||||+++++.+..+...++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999999999999999987632 23345667999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCCCcCC
Q 023591 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 181 (280)
Q Consensus 103 ~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~ 181 (280)
+|...+.....+++..++.++.||+.||+|||++|++|+||+|+||+++.++. ++|+|||++...... .......++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCC
Confidence 99998888888999999999999999999999999999999999999998877 999999987643222 222345688
Q ss_pred CcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcc
Q 023591 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261 (280)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 261 (280)
+.|+|||.+.+..++.. +||||||+++|+|++|..||...+.. .....+......++. .+++++.+||.+||+
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~ 231 (323)
T cd05595 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILMEEIRFPR--TLSPEAKSLLAGLLK 231 (323)
T ss_pred cCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCCCCCCC--CCCHHHHHHHHHHcc
Confidence 99999999988777655 99999999999999999999765432 223333334445554 689999999999999
Q ss_pred cCCCCcC-----------CCcccccc
Q 023591 262 ADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 262 ~dp~~Rp-----------~h~~~~~~ 276 (280)
.||.+|| .||||.+.
T Consensus 232 ~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 232 KDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 9999997 79999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=325.39 Aligned_cols=250 Identities=30% Similarity=0.527 Sum_probs=206.6
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++++.||+|+||.||++++..+++.||+|++.+.. ...+.+.+|+.++++++||||+++++++.+...+++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999987532 23355778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC---
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~--- 173 (280)
||+++++|.+++...+.+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeecccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999998877 9999999885221100
Q ss_pred ---------------------------------------------CCCCCcCCCcccCcccccCCcCCCccchhhHHHHH
Q 023591 174 ---------------------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT 208 (280)
Q Consensus 174 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~ 208 (280)
......+++.|+|||.+.+..++.. +|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecchh
Confidence 0002357889999999988777655 999999999
Q ss_pred HHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC---------CCcccccc
Q 023591 209 LYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE---------MHDWRRGC 276 (280)
Q Consensus 209 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---------~h~~~~~~ 276 (280)
+|+|++|..||...........+.. ......++....++.++.+||.+||. +|.+|+ .||||++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIIN--WRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHc--cCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9999999999976554322222221 12233445545688999999999998 787764 99999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=322.60 Aligned_cols=248 Identities=35% Similarity=0.578 Sum_probs=211.9
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|+||.||++++..+++.||+|++.+.. .....+.+|+.++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999987642 33456778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC---
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~--- 173 (280)
||+++++|.+++.+...+++..++.++.||+.||++||+.|++||||+|+||+++.++. ++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence 99999999999988888999999999999999999999999999999999999998887 9999999987543332
Q ss_pred ---------------------------CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcc
Q 023591 174 ---------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (280)
Q Consensus 174 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (280)
......+++.|+|||.+.+..++.. +|||||||++|+|++|..||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHHH
Confidence 2234468899999999988877665 999999999999999999998765432
Q ss_pred hHHHHHhhHhc--ccccCCCCCCCCHHHHHHHHHhcccCCCCcC-------CCcccccc
Q 023591 227 NFRKTIHRILS--VQYSIPDYVHISPECRHLISRIFVADPAKSE-------MHDWRRGC 276 (280)
Q Consensus 227 ~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-------~h~~~~~~ 276 (280)
... .+.. ....++....+++++.+||.+||+ ||.+|| .||||++.
T Consensus 238 ~~~----~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 238 TYN----KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHH----HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 222 2332 334455544579999999999998 999999 69999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=311.62 Aligned_cols=256 Identities=25% Similarity=0.438 Sum_probs=202.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
..++|++.+.||+|+||.||++++..+++.||+|++.... .....+.+|+.+++.++||||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 3588999999999999999999999999999999987543 22345778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CC
Q 023591 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~ 174 (280)
||++ ++|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++...... ..
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCcc
Confidence 9996 5777776543 56899999999999999999999999999999999999988777 999999988643222 22
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc----------------
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------- 238 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 238 (280)
.....+++.|+|||.+.+......++||||+|+++|+|++|..||....+..............
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 2345578899999998765544455999999999999999999998654322211111111000
Q ss_pred --cccC--C-------CCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 239 --QYSI--P-------DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 239 --~~~~--~-------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.+.. + .....++++.+|+.+||+.||.+|| .||||++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 0000 0 0012457899999999999999999 999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=323.77 Aligned_cols=250 Identities=33% Similarity=0.578 Sum_probs=208.1
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|+||.||++++..+++.||+|++.... .....+.+|+.+++.++|+||+++++.+.++..+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997642 23345678999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC--
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-- 174 (280)
||+++++|.+++.....+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence 99999999999988888999999999999999999999999999999999999998887 99999998864321110
Q ss_pred -------------------------------------CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCC
Q 023591 175 -------------------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217 (280)
Q Consensus 175 -------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~ 217 (280)
.....+++.|+|||.+.+..++.. +|||||||++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCCC
Confidence 012358899999999988777655 999999999999999999
Q ss_pred CCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC---------CCcccccc
Q 023591 218 PFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE---------MHDWRRGC 276 (280)
Q Consensus 218 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---------~h~~~~~~ 276 (280)
||.............. ......++....+++++.+||.+||. +|.+|+ .||||++.
T Consensus 238 Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 238 PFCSDNPQETYRKIIN--WKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCHHHHHHHHHc--CCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9987554322222221 11223444444678999999999997 999999 59999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=301.33 Aligned_cols=255 Identities=29% Similarity=0.419 Sum_probs=213.5
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCC-eeeeceEEecCC-----
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPN-IVRFKEVILTPT----- 90 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~----- 90 (280)
...|+.+++||+|+||+||+|+...+|+.||+|++..... .-....+|+.+++.++|+| |+.+++++..++
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4679999999999999999999999999999999987644 3456789999999999999 999999998877
Q ss_pred -eEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCC
Q 023591 91 -HLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (280)
Q Consensus 91 -~~~lv~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~ 165 (280)
.+++|+||.+. +|..++.... .++...++.+++||+.||+|||++||+||||||.|++++++|. +||.|||+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGL 166 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--Eeeeccch
Confidence 89999999964 9999987654 4788999999999999999999999999999999999999887 99999999
Q ss_pred ccccc-cCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc-ccCC
Q 023591 166 SKSSV-LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIP 243 (280)
Q Consensus 166 ~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 243 (280)
|+... +.........|..|.|||++.+...+....||||+||+++||++++..|.+..+.+....+.+...... ..+|
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 98555 333345667888899999999885555559999999999999999999999887666666554433221 1111
Q ss_pred -------------CC----------CCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 244 -------------DY----------VHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 244 -------------~~----------~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.+ +..+++..+++.+||+.+|.+|. .||||...+
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 11 22345899999999999999999 999998764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=308.91 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=203.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
..++|++.+.||.|+||.||++++..++..||+|.+.... .....+.+|+.++++++||||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 4578999999999999999999999999999999987542 23346778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-C
Q 023591 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~ 174 (280)
||+++ +|.+++.... .+++..+..++.||+.||++||+.|++||||+|+||+++.++. ++|+|||++....... .
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCcc
Confidence 99975 8988876544 5799999999999999999999999999999999999998877 9999999986433222 2
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc---------------c
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------Q 239 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------~ 239 (280)
.....+++.|+|||.+.+......++||||+|+++|+|++|..||...+..+............ .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 2344578899999998765444455999999999999999999998765433333222211100 0
Q ss_pred ccCCC---------CCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 240 YSIPD---------YVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 240 ~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
..++. ...+++++++||.+||+.||.+|| .||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00111 124678999999999999999999 99997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=315.74 Aligned_cols=240 Identities=34% Similarity=0.589 Sum_probs=203.9
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (280)
+.||+|+||.||++++..+++.||+|++.+.. .....+.+|+.+++.++||||+++++.+..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999987642 23345678999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-CCCCCCCcCC
Q 023591 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 181 (280)
Q Consensus 103 ~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~ 181 (280)
+|...+.....+++..+..++.||+.||+|||++|++|+||||+||+++.++. ++|+|||++..... ........++
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCC
Confidence 99999888888999999999999999999999999999999999999998877 99999999874322 2222345688
Q ss_pred CcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcc
Q 023591 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261 (280)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 261 (280)
+.|+|||.+.+..++.. +||||||+++|+|++|..||...+.. .....+......++. .+++++.+||++||+
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~~~----~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~ 231 (328)
T cd05593 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEDIKFPR--TLSADAKSLLSGLLI 231 (328)
T ss_pred cCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCCHH----HHHHHhccCCccCCC--CCCHHHHHHHHHHcC
Confidence 99999999987777655 99999999999999999999765432 233334444445554 689999999999999
Q ss_pred cCCCCcC-----------CCccccc
Q 023591 262 ADPAKSE-----------MHDWRRG 275 (280)
Q Consensus 262 ~dp~~Rp-----------~h~~~~~ 275 (280)
.||++|| .||||.+
T Consensus 232 ~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 232 KDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999995 8999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=325.16 Aligned_cols=203 Identities=33% Similarity=0.475 Sum_probs=183.3
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC-C-----CCeeeeceEEecCCeEEEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-H-----PNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~~lv 95 (280)
+|++.+.||+|+||.|.+|.+..+++.||||++++......+...|+.+|..|+ | -|+|+++++|...+++|+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 889999999999999999999999999999999999888888899999999996 4 3799999999999999999
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 96 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
+|.+ ..+|.++++.+. .++...++.++.||+.||..||+.||||+||||+|||+.......||++|||+++......
T Consensus 267 fELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v 345 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV 345 (586)
T ss_pred ehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc
Confidence 9999 459999998765 5899999999999999999999999999999999999987777789999999998544333
Q ss_pred CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchH
Q 023591 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (280)
. ....+..|.|||++.+.+|+.. .|||||||+++||++|.+.|.+.++.+.+
T Consensus 346 y--tYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl 397 (586)
T KOG0667|consen 346 Y--TYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQL 397 (586)
T ss_pred e--eeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHH
Confidence 2 6778899999999999999877 99999999999999999999887764443
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=308.59 Aligned_cols=250 Identities=27% Similarity=0.422 Sum_probs=202.2
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|++.+.||+|+||.||++++..+++.+|+|.+.... ...+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999999999999999987642 234567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC--CC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 175 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~ 175 (280)
|++++++..+......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccc
Confidence 9988777655555567999999999999999999999999999999999999988877 9999999987543222 12
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc---------------ccc
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQY 240 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~ 240 (280)
....+++.|+|||.+.+..++.. +|+||+|+++|+|++|+.||......+........... ...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKA-VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCCCCc-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 23457889999999988777555 99999999999999999999875543322221111000 000
Q ss_pred cCCC-----------CCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 241 SIPD-----------YVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 241 ~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
..+. ...+|+++.+||.+||+.||++|| .||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0110 113678899999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=313.75 Aligned_cols=253 Identities=26% Similarity=0.462 Sum_probs=208.1
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
.++|++.+.||+|+||.||++++..++..+|+|.+.... ...+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 478999999999999999999999999999999987642 233568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
|+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++. ++|+|||++..... ....
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~ 160 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMAN 160 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCcccccccc-cccc
Confidence 999999999998888899999999999999999999986 6999999999999998887 99999998864432 2233
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHH-------------------------
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT------------------------- 231 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~------------------------- 231 (280)
...+++.|+|||.+.+..++.. +||||||+++|+|++|..||......+ ....
T Consensus 161 ~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred cCCCCcCcCCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCcccccccc
Confidence 4568899999999988777655 999999999999999999996543211 1111
Q ss_pred ------------------HhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 232 ------------------IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 232 ------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
...+............+++++++||.+||+.||++|| .||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 1111111111111224788999999999999999999 999998654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=312.69 Aligned_cols=246 Identities=32% Similarity=0.538 Sum_probs=206.9
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCC-CeeeeceEEecCCeEEEEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 96 (280)
+|++.+.||+|+||.||++++..+++.||+|++.+. ....+.+..|..++..++|+ +++.+++++...+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999998763 22334567788888888764 5888999999899999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-CCCC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~ 175 (280)
||+++++|.+.+.....+++..+..++.||+.||+|||+.|++||||+|+||+++.++. ++|+|||++..... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCce
Confidence 99999999999988888999999999999999999999999999999999999998877 99999998864322 2223
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....+++.|+|||.+.+..++.. +|+||+|+++|+|++|..||...... .....+......++. .+++++.++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~~~~~~~~~--~~~~~~~~l 231 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDED----ELFQSIMEHNVSYPK--SLSKEAVSI 231 (324)
T ss_pred eeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCC--CCCHHHHHH
Confidence 34568899999999988777655 99999999999999999999865432 233334444445554 689999999
Q ss_pred HHHhcccCCCCcC-----------CCcccccc
Q 023591 256 ISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 256 i~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+++||..||.+|+ .||||++.
T Consensus 232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999997 89999763
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=304.96 Aligned_cols=256 Identities=30% Similarity=0.460 Sum_probs=209.6
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeee---CCcccHHHHHHHHHhhhCCCCCeeeeceEEec-----CC
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILT-----PT 90 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 90 (280)
...+|...+.||.|+||.|+.+.++.+|+.||||++.. +....++..+|+.+|+.++|+||+.+.+++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34667778999999999999999999999999999873 45556778899999999999999999999865 24
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
.+|+|+|++ +.+|.+.++.+..+++..+..+++|++.||+|+|+.+++||||||.|++++.+.. +|++|||+|+...
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLD 176 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeecc
Confidence 689999999 5699999988888999999999999999999999999999999999999988877 9999999999665
Q ss_pred cC---CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhH------------
Q 023591 171 LH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI------------ 235 (280)
Q Consensus 171 ~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 235 (280)
.. ..-.....|..|.|||++.+...++++.||||+|||+.||++|++.|.+.+...++..+..-.
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 43 222334578889999998776666666999999999999999999998866533322222111
Q ss_pred -------hcccccCCC------CCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 236 -------LSVQYSIPD------YVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 236 -------~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.......+. .++.++...+|+.+||..||.+|+ .||||.+..
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 110111111 356889999999999999999999 999998643
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=314.26 Aligned_cols=255 Identities=36% Similarity=0.648 Sum_probs=228.7
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---cHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
-+...+=|.+.+.||+|.|++|.++++.-+|+.||+|++.+.+.. ...+..|+.-++.++|||||++|++......+
T Consensus 13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence 334446799999999999999999999999999999999875432 24577899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC-CCCCcEEEeecCCccccc
Q 023591 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~-~~~~~~~l~df~~~~~~~ 170 (280)
|+|+|+-++|+|.+++-+. ..+++....+++.||+.|+.|+|+..+|||||||+||.+.+ .|- +||+|||++....
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGl--VKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGL--VKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCc--eEeeeccccccCC
Confidence 9999999999999998654 46999999999999999999999999999999999998754 444 9999999999999
Q ss_pred cCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCH
Q 023591 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (280)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (280)
++....+.+|+..|.|||++.+..|+.++.||||||+|||.|++|+.||...++.+. +..|....+..|. .+|.
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----LTmImDCKYtvPs--hvS~ 244 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----LTMIMDCKYTVPS--HVSK 244 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh----hhhhhcccccCch--hhhH
Confidence 999999999999999999999999999999999999999999999999998877554 4456677788887 7999
Q ss_pred HHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 251 ECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 251 ~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
+.++||.+||..||.+|. .|+|++....
T Consensus 245 eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 245 ECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 999999999999999999 9999997653
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=322.59 Aligned_cols=250 Identities=32% Similarity=0.507 Sum_probs=206.7
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
.+|++++.||+|+||.||++++..+++.||+|.+.+.. .....+.+|+.++++++|+||+++++.+.++..+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999987642 23346778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC----
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 172 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~---- 172 (280)
||+++++|.+++.+.+.+++..+..++.||+.||++||++||+||||||+||+++.++. ++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCcccccccccc
Confidence 99999999999988788999999999999999999999999999999999999998887 999999987421100
Q ss_pred --------------------------------------------CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHH
Q 023591 173 --------------------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT 208 (280)
Q Consensus 173 --------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~ 208 (280)
.......+++.|+|||.+.+..++.. +|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechHH
Confidence 00012357889999999988888765 999999999
Q ss_pred HHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC---------CCcccccc
Q 023591 209 LYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE---------MHDWRRGC 276 (280)
Q Consensus 209 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---------~h~~~~~~ 276 (280)
+|+|++|..||...+.......... .......+....+++++.++|.+|+. +|.+|+ .||||++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVIN--WQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHc--cCCCcCCCCcccCCHHHHHHHHHHcc-CHhHcCCCCCHHHHhcCCCcCCc
Confidence 9999999999987554322222221 12233444445689999999999874 999997 89999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-48 Score=306.99 Aligned_cols=250 Identities=31% Similarity=0.506 Sum_probs=211.6
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecC--C---eEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--T---HLAIV 95 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~---~~~lv 95 (280)
-+|+-.+.+|.|+||.||.+....+++.||||++-.+.... -+|+++++.++|||||++.-+|... . .+.+|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46899999999999999999999999999999988766533 3699999999999999998888642 2 46799
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 96 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
|||++. +|.+.++. +..++...++-+.+||++||+|||+.||+||||||.|+++|.+.. .+||+|||+|+....
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg-~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTG-VLKICDFGSAKVLVK 178 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCC-eEEeccCCcceeecc
Confidence 999976 89888864 567999999999999999999999999999999999999997632 499999999998888
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-------------
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------- 238 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 238 (280)
+........+..|+|||.+.+...++.+.||||.||++.||+-|++.|.+.+..+.+..+.+-....
T Consensus 179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 8888888899999999999998777777999999999999999999999977666655554322211
Q ss_pred cccCCC----------CCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 239 QYSIPD----------YVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 239 ~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
...++. ....++++.+|+.++|+.+|.+|. .||||..
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE 311 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence 111111 235789999999999999999999 9999964
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=312.01 Aligned_cols=241 Identities=32% Similarity=0.526 Sum_probs=202.6
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|+||.||++++..+++.||+|++.+. ....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999998753 22334556777777766 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCCCcC
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (280)
++|.+.+.....+++..+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence 999999988888999999999999999999999999999999999999998887 999999988743222 22334568
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (280)
++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+.. .....+......++. .+++++.+||++||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~i~~~~~~~~~--~~~~~~~~li~~~L 231 (320)
T cd05590 159 TPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENED----DLFEAILNDEVVYPT--WLSQDAVDILKAFM 231 (320)
T ss_pred CccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHHhcCCCCCCC--CCCHHHHHHHHHHc
Confidence 999999999987777655 99999999999999999999875432 333344444444444 58899999999999
Q ss_pred ccCCCCcC------------CCcccccc
Q 023591 261 VADPAKSE------------MHDWRRGC 276 (280)
Q Consensus 261 ~~dp~~Rp------------~h~~~~~~ 276 (280)
+.||.+|| .||||++.
T Consensus 232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 232 TKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred ccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 99999999 59999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=321.93 Aligned_cols=251 Identities=32% Similarity=0.510 Sum_probs=207.3
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++++.||+|+||.||++++..+++.||+|++.+.. .....+.+|+.++++++|+||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986532 23456778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC----
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 172 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~---- 172 (280)
||+++++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999998887 999999987421100
Q ss_pred ----------------------------------------CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHH
Q 023591 173 ----------------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212 (280)
Q Consensus 173 ----------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l 212 (280)
.......+++.|+|||.+.+..++.. +|||||||++|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeeeh
Confidence 00112358899999999988777655 9999999999999
Q ss_pred HhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC---------CCccccccc
Q 023591 213 LVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE---------MHDWRRGCS 277 (280)
Q Consensus 213 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---------~h~~~~~~~ 277 (280)
++|..||.............. .......+....+++++.++|.+|+ .+|.+|+ .||||++..
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVIN--WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhc--cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 999999987654332222211 1122334444468999999999987 5999998 799998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=306.36 Aligned_cols=249 Identities=26% Similarity=0.385 Sum_probs=208.0
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
.|++.+.||+|+||+||++.+..+++.||+|.+.... .....+.+|+.++++++|+||+++++.+..++..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4899999999999999999999899999999987532 122346689999999999999999999999899999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 98 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
|+.+++|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPEGETI 158 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCCCCcc
Confidence 99999998887543 46899999999999999999999999999999999999988776 999999998754433333
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....+++.|+|||.+.+..++.. +||||+|+++|+|++|..||...............+......++. .+++.+.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 235 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARSI 235 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCc--ccCHHHHHH
Confidence 34567889999999987777655 999999999999999999998765443333333333333333333 588999999
Q ss_pred HHHhcccCCCCcC-----------CCccccc
Q 023591 256 ISRIFVADPAKSE-----------MHDWRRG 275 (280)
Q Consensus 256 i~~~l~~dp~~Rp-----------~h~~~~~ 275 (280)
|.+||+.||++|| .||||.+
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 9999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-48 Score=295.78 Aligned_cols=248 Identities=33% Similarity=0.556 Sum_probs=217.5
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC------c---ccHHHHHHHHHhhhC-CCCCeeeeceEEecCC
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------K---IDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~------~---~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 90 (280)
.+|.-.+.||.|..++|.++.++.++..+|+|++.... . ..+.-.+|+.+|+++ .||+|+.+.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 56888899999999999999999999999999986421 1 113345689999987 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
.+++|+|.++.|.|.+++...-.+++....++++|++++++|||.++|+||||||+||+++++.+ ++|+|||+++...
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccC
Confidence 99999999999999999999889999999999999999999999999999999999999998888 9999999999999
Q ss_pred cCCCCCCCcCCCcccCcccccCC------cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC--
Q 023591 171 LHSQPKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI-- 242 (280)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 242 (280)
++......+|||+|+|||.+... .|+.. .|+|++|+++|.|+.|.+||+.... .-.++.+..+.+.+
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~E-VD~Wa~GVImyTLLaGcpPFwHRkQ----mlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKE-VDEWACGVIMYTLLAGCPPFWHRKQ----MLMLRMIMEGKYQFRS 249 (411)
T ss_pred CchhHHHhcCCCcccChhheeeecccCCCCccch-hhHHHHHHHHHHHHcCCCchhHHHH----HHHHHHHHhcccccCC
Confidence 98888999999999999998532 34334 8999999999999999999986332 23445666666655
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 243 PDYVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
|.|.++|...++||++||+.||.+|. .||||.+
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 56889999999999999999999999 9999954
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-48 Score=299.18 Aligned_cols=253 Identities=34% Similarity=0.538 Sum_probs=220.2
Q ss_pred CCCCeeee-cccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEec----CCeE
Q 023591 19 DSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT----PTHL 92 (280)
Q Consensus 19 ~~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~~ 92 (280)
..++|++. +.||-|-.|+|..+.++.+++.+|+|++..++ ...+|+++.... .|+|||.+++++++ ...+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 45677776 47899999999999999999999999877543 566788877665 89999999999875 3478
Q ss_pred EEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC-CCCcEEEeecCCcccc
Q 023591 93 AIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSS 169 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~-~~~~~~l~df~~~~~~ 169 (280)
.+|||.+.||.|.+.++.++. +++.++..|++||..|+.|||+.+|+||||||+|++.+.. .+..+||+|||+|+..
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 899999999999999987664 9999999999999999999999999999999999999644 3456999999999987
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC--CCC
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVH 247 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 247 (280)
.......+.+.||.|.|||++...+|+-. +|+||+|+++|-|++|.+||........-.....+|..+.+.||. |..
T Consensus 215 ~~~~~L~TPc~TPyYvaPevlg~eKydks-cdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~ 293 (400)
T KOG0604|consen 215 QEPGDLMTPCFTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC 293 (400)
T ss_pred CCCccccCCcccccccCHHHhCchhcCCC-CCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence 77777788899999999999988887655 999999999999999999998877655555566777778887764 789
Q ss_pred CCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 248 ISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+|+..+++|+.+|+.+|.+|. .|||+.+-
T Consensus 294 VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 294 VSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred HHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 999999999999999999999 99999764
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=319.33 Aligned_cols=250 Identities=31% Similarity=0.477 Sum_probs=205.2
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
.|++++.||+|+||+||++++..+++.||+|++.+.. .....+.+|+.++++++|+||+++++++.++..+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 6899999999999999999999999999999997642 233467889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC----
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---- 173 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~---- 173 (280)
|+++++|.+++.+...+++..+..++.||+.||++||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC--EEEeeCcCCccccccccccc
Confidence 9999999999988888999999999999999999999999999999999999988776 9999999864211000
Q ss_pred --------------------------------------------CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHH
Q 023591 174 --------------------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTL 209 (280)
Q Consensus 174 --------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l 209 (280)
......+++.|+|||.+.+..++.. +|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhhHH
Confidence 0112358899999999988777655 9999999999
Q ss_pred HHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc--ccCCCCcC------CCcccccc
Q 023591 210 YVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF--VADPAKSE------MHDWRRGC 276 (280)
Q Consensus 210 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~dp~~Rp------~h~~~~~~ 276 (280)
|+|++|..||.............. ......++....+++++.+||.+|+ ..+|..|| .||||++.
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVIN--WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHc--cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 999999999987654332222221 1223344444468999999999955 44555688 99999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=319.07 Aligned_cols=250 Identities=29% Similarity=0.499 Sum_probs=207.9
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|+||.||++++..+++.||+|++... ......+.+|+.++.+++|++++++++.+.++..+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999999999999999998753 233356778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC---
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~--- 173 (280)
||+++++|.+++.+...+++..+..++.|++.||++||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEeeccCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999988877 9999999876332110
Q ss_pred ---------------------------------CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCC
Q 023591 174 ---------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (280)
Q Consensus 174 ---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 220 (280)
......+++.|+|||++.+..++.. +|+|||||++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCCC
Confidence 0112358899999999988887665 999999999999999999998
Q ss_pred CCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC---------CCcccccc
Q 023591 221 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE---------MHDWRRGC 276 (280)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---------~h~~~~~~ 276 (280)
..........+.. ......++....+++++++||.+|+. ||.+|+ .||||++.
T Consensus 238 ~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 238 SETPQETYRKVMN--WKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCHHHHHHHHHc--CCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 7654333332221 11233444444578999999999875 999997 99999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=312.24 Aligned_cols=245 Identities=30% Similarity=0.487 Sum_probs=202.6
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|+||.||++++..+++.+|+|++.+.. .....+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46899999999999999999999999998642 2234466788887766 899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-CCCCCCCcC
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (280)
++|...+.....+++..++.++.|++.||.|||++|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccC
Confidence 999998888888999999999999999999999999999999999999998887 99999999864322 222334568
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCC-----cchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-----PKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
++.|+|||.+.+..++.. +|+||||+++|+|++|..||..... ..........+......++. .++..+.+|
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~l 235 (329)
T cd05618 159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASV 235 (329)
T ss_pred CccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC--CCCHHHHHH
Confidence 899999999988877655 9999999999999999999953211 11122233344444555555 688999999
Q ss_pred HHHhcccCCCCcC------------CCcccccc
Q 023591 256 ISRIFVADPAKSE------------MHDWRRGC 276 (280)
Q Consensus 256 i~~~l~~dp~~Rp------------~h~~~~~~ 276 (280)
|.+||+.||.+|| .||||++.
T Consensus 236 l~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 9999999999997 79999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=311.68 Aligned_cols=244 Identities=34% Similarity=0.561 Sum_probs=202.7
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHh---hhCCCCCeeeeceEEecCCeEEEE
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINH---RSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
|++.+.||+|++|.||++.+..+++.||+|++.+.. ...+.+.+|..++ +.++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999997542 2234556665554 566899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CC
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~ 174 (280)
|||+++++|...+.. ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence 999999999887744 56999999999999999999999999999999999999998887 999999988643222 22
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
.....+++.|+|||.+.+..++.. +||||||+++|+|++|..||...+.. .....+......++. .+++.+.+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~----~~~~~i~~~~~~~p~--~~~~~~~~ 230 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEE----EVFDSIVNDEVRYPR--FLSREAIS 230 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCC--CCCHHHHH
Confidence 334568899999999988777655 99999999999999999999865432 233334444444554 58999999
Q ss_pred HHHHhcccCCCCcC-----------CCcccccc
Q 023591 255 LISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 255 li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+|.+||+.||.+|| .||||++.
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 99999999999998 79999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=310.61 Aligned_cols=246 Identities=32% Similarity=0.520 Sum_probs=206.7
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
+|++.+.||+|+||.||++++..+++.||+|.+.+.. ........|..++..+ .|++++++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999987642 2223455677777766 5789999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-CCCC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~ 175 (280)
||+++++|.+.+.....+++..+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++..... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCcc
Confidence 99999999999988888999999999999999999999999999999999999998887 99999999874332 2223
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....+++.|+|||.+.+..++.. +|+|||||++|+|++|..||...... .....+......++. .++.++.++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~~l 231 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIMEHNVAYPK--SMSKEAVAI 231 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCC--cCCHHHHHH
Confidence 34568899999999988877655 99999999999999999999865432 233344444455554 689999999
Q ss_pred HHHhcccCCCCcC-----------CCcccccc
Q 023591 256 ISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 256 i~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+.+||+.||++|+ .||||+..
T Consensus 232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999998 79999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=311.19 Aligned_cols=242 Identities=31% Similarity=0.535 Sum_probs=203.3
Q ss_pred ecccccCCceEEEEEEec---CCCcEEEEEEeeeCC-----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 26 VRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++.||+|+||.||++++. .+++.||+|.+.... .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999864 468899999987532 223456789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~ 176 (280)
|+++++|.+.+...+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCccc
Confidence 9999999999988888999999999999999999999999999999999999988877 999999998643222 2233
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (280)
...+++.|+|||.+.+..++.. +||||||+++|+|++|..||...+.. .....+......++. .+++++.+||
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~pf~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~li 231 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRK----KTIDKILKGKLNLPP--YLTPEARDLL 231 (323)
T ss_pred ccCCCccccChhhccCCCCCCc-ceecccHHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCCC--CCCHHHHHHH
Confidence 4568899999999987776555 99999999999999999999875432 333444444555554 6889999999
Q ss_pred HHhcccCCCCcC-----------CCcccccc
Q 023591 257 SRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 257 ~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
.+||+.||++|| .||||+..
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999998 89999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=312.05 Aligned_cols=244 Identities=29% Similarity=0.478 Sum_probs=202.8
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|+||.||++++..+++.||+|++.+.. .....+.+|..++.++ +||||+++++++..+..+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999998632 2234567888888888 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc-cCCCCCCCcC
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 180 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~ 180 (280)
++|..++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++.... .........+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccC
Confidence 999998888888999999999999999999999999999999999999998877 9999999886422 2222334568
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc-----chHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----KNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
++.|+|||.+.+..++.. +|+||||+++|+|++|..||...... .........+......++. .++.++.++
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~l 235 (329)
T cd05588 159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSV 235 (329)
T ss_pred CccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCCHHHHHH
Confidence 899999999988777655 99999999999999999999642211 1112223334444455555 688999999
Q ss_pred HHHhcccCCCCcC------------CCccccc
Q 023591 256 ISRIFVADPAKSE------------MHDWRRG 275 (280)
Q Consensus 256 i~~~l~~dp~~Rp------------~h~~~~~ 275 (280)
|++||+.||.+|| .||||..
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999996 6999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=316.87 Aligned_cols=250 Identities=28% Similarity=0.479 Sum_probs=207.2
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|+||+||++++..+++.||+|.+..... ....+.+|+.+++.++|+||+++++++..+...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 479999999999999999999999999999999986432 3355778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-
Q 023591 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 174 (280)
||+++++|.+++.+. ..+++..+..++.|++.||++||+.|++||||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCce
Confidence 999999999999776 67999999999999999999999999999999999999998877 99999999875433222
Q ss_pred -CCCCcCCCcccCcccccC------CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 175 -PKSTVGTPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
.....+++.|+|||.+.. ..+ ..++||||||+++|+|++|..||..........++... .....++....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~ 235 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTY-GVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDPK 235 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCC-CCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCC
Confidence 223457889999999863 333 34499999999999999999999876543333332221 11233444446
Q ss_pred CCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 248 ISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+++++.+||..||+ ||.+|| .||||++.
T Consensus 236 ~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 236 VSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 89999999999998 999999 99999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=313.34 Aligned_cols=253 Identities=29% Similarity=0.446 Sum_probs=203.2
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
.....++|++++.||+|+||.||++++..+++.||+|++.... .....+.+|+.+++.++|+||+++++++..++.++
T Consensus 69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 3445578999999999999999999999999999999986543 22356889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
+||||+++++|.+. ...++..+..++.||+.||+|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTM 222 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceeccccc
Confidence 99999999988643 23578889999999999999999999999999999999998877 9999999987543222
Q ss_pred -CCCCCcCCCcccCcccccC----CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc-ccccCCCCCC
Q 023591 174 -QPKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-VQYSIPDYVH 247 (280)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 247 (280)
......++..|+|||.+.. +.+...++||||||+++|+|++|..||...... .+......+.. .....+ ..
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~--~~ 299 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAICMSQPPEAP--AT 299 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhccCCCCCC--Cc
Confidence 2234568899999998743 233344699999999999999999999844332 22222222221 111222 26
Q ss_pred CCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 248 ISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
++.++.+||.+||+.||++|| .||||.+..
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 789999999999999999999 999998753
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=313.90 Aligned_cols=241 Identities=36% Similarity=0.587 Sum_probs=203.6
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (280)
+.||+|+||.||++.+..+++.||+|++.+.. .....+.+|+.+++.++||||+++++.+..+...++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999987632 22345667889999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-CCCCCCCcC
Q 023591 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (280)
Q Consensus 103 ~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (280)
+|...+.....+++..+..++.||+.||.|||+ .|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccC
Confidence 999998888889999999999999999999997 89999999999999998887 99999998864322 222234568
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (280)
++.|+|||.+.+..++.. +||||||+++|+|++|..||..... ......+......++. .+++++.+||.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L 231 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILMEEIRFPR--TLSPEAKSLLSGLL 231 (325)
T ss_pred CcccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCCCH----HHHHHHHhcCCCCCCC--CCCHHHHHHHHHHh
Confidence 899999999988777655 9999999999999999999976543 2233334444445554 68999999999999
Q ss_pred ccCCCCcC-----------CCcccccc
Q 023591 261 VADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 261 ~~dp~~Rp-----------~h~~~~~~ 276 (280)
+.||++|+ .||||++.
T Consensus 232 ~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 99999995 99999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=309.52 Aligned_cols=241 Identities=32% Similarity=0.513 Sum_probs=200.7
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|+||.||++++..+++.||+|.+.+.. ...+....|..++..+ +|+||+++++++.+++.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46899999999999999999999999987642 2334456677777654 899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCCCcC
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (280)
++|..++.....+++..+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCC
Confidence 999999988888999999999999999999999999999999999999998876 999999988643222 22234568
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (280)
++.|+|||.+.+..++.. +||||||+++|+|++|..||...... .....+......++. .++.++++||.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~li~~~l 231 (316)
T cd05620 159 TPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDED----ELFESIRVDTPHYPR--WITKESKDILEKLF 231 (316)
T ss_pred CcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCC--CCCHHHHHHHHHHc
Confidence 899999999988877655 99999999999999999999765432 223333333334444 57899999999999
Q ss_pred ccCCCCcC-------CCcccccc
Q 023591 261 VADPAKSE-------MHDWRRGC 276 (280)
Q Consensus 261 ~~dp~~Rp-------~h~~~~~~ 276 (280)
+.||++|| .||||++.
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCC
Confidence 99999999 69999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=314.65 Aligned_cols=251 Identities=29% Similarity=0.438 Sum_probs=218.0
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
......|+..+.||+|.||.||++.+..+++.||+|++.... ...+++++|+.++.+++++||.++++.+..+..+++
T Consensus 9 ~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 9 IDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred CCcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence 344567999999999999999999999999999999998754 455789999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
+|||+.||++.+.++....+++..+..++++++.||.|||..+.+|+|||+.||++..+|. +||.|||.+........
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechhh
Confidence 9999999999999988888899999999999999999999999999999999999999987 99999999875544433
Q ss_pred -CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
..+..|||.|+|||++....|+.+ +||||||++.+||++|.+|+....+...+ ..|....+..- ...+|+.++
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmrvl----flIpk~~PP~L-~~~~S~~~k 240 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMRVL----FLIPKSAPPRL-DGDFSPPFK 240 (467)
T ss_pred ccccccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcceEE----EeccCCCCCcc-ccccCHHHH
Confidence 377889999999999998888777 99999999999999999999887663222 22222222111 227899999
Q ss_pred HHHHHhcccCCCCcC------CCccccc
Q 023591 254 HLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
+|+..||+.||+.|| .|+|++.
T Consensus 241 EFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 241 EFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 999999999999999 9999975
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=303.45 Aligned_cols=243 Identities=31% Similarity=0.437 Sum_probs=200.8
Q ss_pred cccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCch
Q 023591 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (280)
Q Consensus 29 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (280)
||+|+||+||++.+..+++.+|+|.+..... ..+.+..|+.++++++|+|++++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999999999999999999875422 224566799999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-CCCCc
Q 023591 105 FERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV 179 (280)
Q Consensus 105 ~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~~~~ 179 (280)
...+.. ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++. ++|+|||++........ .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccC
Confidence 877642 346899999999999999999999999999999999999988776 99999998864433222 23346
Q ss_pred CCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHh
Q 023591 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259 (280)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 259 (280)
+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...............+......++. .+++.+.+++.+|
T Consensus 159 g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~ 235 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCEAL 235 (280)
T ss_pred CCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcc--cCCHHHHHHHHHH
Confidence 7889999999988877655 999999999999999999998655433333333333333333333 5889999999999
Q ss_pred cccCCCCcC-----------CCcccccc
Q 023591 260 FVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 260 l~~dp~~Rp-----------~h~~~~~~ 276 (280)
|+.||++|| .||||++.
T Consensus 236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 236 LAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred hcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 999999999 99999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=308.05 Aligned_cols=241 Identities=36% Similarity=0.584 Sum_probs=199.7
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhh-CCCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|+||.||++++..+++.||+|.+.... ...+....|..++.. .+||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999987532 222344556666654 4899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCCCcC
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (280)
++|..++.....+++..+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccC
Confidence 999999988888999999999999999999999999999999999999998877 999999998743222 22334568
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (280)
++.|+|||.+.+..++.. +||||||+++|+|++|..||...+... ....+......++. .++.++.+||.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~~----~~~~i~~~~~~~~~--~~~~~~~~ll~~~l 231 (316)
T cd05592 159 TPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDE----LFDSILNDRPHFPR--WISKEAKDCLSKLF 231 (316)
T ss_pred CccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCC--CCCHHHHHHHHHHc
Confidence 999999999988777655 999999999999999999998754422 22333333334444 57899999999999
Q ss_pred ccCCCCcC-------CCcccccc
Q 023591 261 VADPAKSE-------MHDWRRGC 276 (280)
Q Consensus 261 ~~dp~~Rp-------~h~~~~~~ 276 (280)
+.||++|| .||||+..
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 232 ERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred cCCHHHcCCChHHHHcCcccCCC
Confidence 99999999 89999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=315.52 Aligned_cols=253 Identities=30% Similarity=0.485 Sum_probs=208.5
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||.||++++..+++.||+|.+.+.. ...+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4578999999999999999999999999999999987532 223446789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~- 173 (280)
||||+++++|.+++.. ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGM 197 (370)
T ss_pred EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCc
Confidence 9999999999998855 45899999999999999999999999999999999999998887 9999999987543322
Q ss_pred -CCCCCcCCCcccCcccccCCc---CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 174 -QPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
......+++.|+|||.+.+.. ....++|+|||||++|+|++|..||..........++... .....++....+|
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s 275 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH--KNSLTFPDDIEIS 275 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCcCCCCCcCCCC
Confidence 223456899999999986543 2344599999999999999999999875543333332221 1234455555689
Q ss_pred HHHHHHHHHhcccCCCC--cC------CCcccccc
Q 023591 250 PECRHLISRIFVADPAK--SE------MHDWRRGC 276 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~--Rp------~h~~~~~~ 276 (280)
.++.+||.+||+.+|.+ |+ .||||++.
T Consensus 276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 99999999999999987 88 99999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=307.77 Aligned_cols=246 Identities=30% Similarity=0.521 Sum_probs=206.2
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCC-CCCeeeeceEEecCCeEEEEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 96 (280)
+|++.+.||+|+||.||++++..+++.||+|++.+.. ...+.+..|..++..+. |++++++++++..++.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999987532 22345667888887775 577888999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (280)
||+++++|.+++.....+++..+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++...... ...
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccc
Confidence 99999999999988888999999999999999999999999999999999999998887 999999988743222 223
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....+++.|+|||.+.+..++.. +|+||+|+++|+|++|..||...... .....+......++. .++.++.++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~~~~~~~p~--~~~~~~~~l 231 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGEDED----ELFQSIMEHNVSYPK--SLSKEAVSI 231 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCc--cCCHHHHHH
Confidence 34458899999999988777655 99999999999999999999875432 233344444445554 588999999
Q ss_pred HHHhcccCCCCcC-----------CCcccccc
Q 023591 256 ISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 256 i~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+.+||+.||.+|+ .||||++.
T Consensus 232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 9999999999998 79999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=309.63 Aligned_cols=241 Identities=33% Similarity=0.545 Sum_probs=199.7
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHH-HhhhCCCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|+||+||++++..+++.||+|++.+.. .....+.+|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999999999999999987532 12233444444 45778999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCCCcC
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (280)
++|...+.....+++..+..++.||+.||+|||++|++||||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccC
Confidence 999999988888999999999999999999999999999999999999998877 999999988643222 22234468
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (280)
++.|+|||.+.+..++.. +||||||+++|+|++|..||...+. ......+.......+. .+++++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l 231 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDT----AEMYDNILNKPLRLKP--NISVSARHLLEGLL 231 (323)
T ss_pred ChhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCCH----HHHHHHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence 899999999988777655 9999999999999999999986543 2333344444444444 57999999999999
Q ss_pred ccCCCCcC----------CCcccccc
Q 023591 261 VADPAKSE----------MHDWRRGC 276 (280)
Q Consensus 261 ~~dp~~Rp----------~h~~~~~~ 276 (280)
+.||.+|| .||||...
T Consensus 232 ~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 232 QKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred hcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 99999998 79999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=307.66 Aligned_cols=253 Identities=27% Similarity=0.446 Sum_probs=205.5
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
.++|++.+.||+|+||.||++.+..++..+|+|.+.... ...+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999999999999999887642 223568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
|+++++|.+++...+.+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++. ++|+|||++..... ....
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~~~ 160 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMAN 160 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hccc
Confidence 999999999998888899999999999999999999975 7999999999999988877 99999998864322 2223
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHH---------------------------
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR--------------------------- 229 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~--------------------------- 229 (280)
...++..|+|||.+.+..++.. +|+||||+++|+|++|..||..........
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (333)
T cd06650 161 SFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS 239 (333)
T ss_pred cCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence 4467889999999987776655 999999999999999999997543211100
Q ss_pred -------------HHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 230 -------------KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 230 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.....+............+++++++||.+||+.||++|| .||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000111111100111123678999999999999999999 99999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=320.01 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=199.6
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecC--------Ce
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--------TH 91 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~ 91 (280)
.++|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 368999999999999999999999999999999886543 2345799999999999999998876432 24
Q ss_pred EEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 92 LAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
+++||||+++ +|.+++. ....+++..++.++.||+.||+|||+.||+||||||+||+++.++. .+||+|||++.
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla~ 219 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAK 219 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC-ceeeeccccch
Confidence 7799999975 6766653 3457999999999999999999999999999999999999986542 39999999998
Q ss_pred ccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc---------
Q 023591 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------- 238 (280)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 238 (280)
............+++.|+|||.+.+......++|||||||++|+|++|.+||......+............
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence 65544444456678999999998765433455999999999999999999998765544444333221100
Q ss_pred ----cccCCC----------CCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 239 ----QYSIPD----------YVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 239 ----~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
...++. ....++++.+||.+||+.||.+|| .||||+...
T Consensus 300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 001111 114678999999999999999999 999997643
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=306.60 Aligned_cols=241 Identities=33% Similarity=0.550 Sum_probs=199.9
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhh-CCCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|+||.||++++..+++.||+|.+... .........|..+++. ++||||+++++++.+++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999998764 2233445567777765 4999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCCCcC
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (280)
++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecC
Confidence 999999988778999999999999999999999999999999999999998877 999999988643222 22234457
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (280)
++.|+|||.+.+..++.. +|+||+|+++|+|++|..||...+.. .....+......++. .++.++++||.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~----~~~~~i~~~~~~~~~--~~~~~~~~li~~~l 231 (316)
T cd05619 159 TPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEE----ELFQSIRMDNPCYPR--WLTREAKDILVKLF 231 (316)
T ss_pred CccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCCCCc--cCCHHHHHHHHHHh
Confidence 899999999988777655 99999999999999999999765432 222233333333343 57899999999999
Q ss_pred ccCCCCcC-------CCcccccc
Q 023591 261 VADPAKSE-------MHDWRRGC 276 (280)
Q Consensus 261 ~~dp~~Rp-------~h~~~~~~ 276 (280)
+.||++|| .||||+..
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 232 VREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred ccCHhhcCCChHHHHcCcccCCC
Confidence 99999998 89999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=299.96 Aligned_cols=244 Identities=25% Similarity=0.382 Sum_probs=200.0
Q ss_pred cccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCch
Q 023591 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (280)
Q Consensus 29 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (280)
||+|+||.||+++...+++.+|+|.+..... ....+..|++++++++||||+++.+.+..+...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999999999999999999865321 223445689999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcCCC
Q 023591 105 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182 (280)
Q Consensus 105 ~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 182 (280)
.+.+.... .++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++.............+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCC
Confidence 88875433 5889999999999999999999999999999999999998777 9999999887554433334456788
Q ss_pred cccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhccc
Q 023591 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262 (280)
Q Consensus 183 ~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 262 (280)
.|+|||.+.+..++.. +|+||+|+++|+|++|..||........................ ...+++++.+||.+||+.
T Consensus 159 ~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 159 GYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAK 236 (277)
T ss_pred CccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHHhcc
Confidence 9999999988876555 99999999999999999999765443333333333333332222 225789999999999999
Q ss_pred CCCCcC----------CCcccccc
Q 023591 263 DPAKSE----------MHDWRRGC 276 (280)
Q Consensus 263 dp~~Rp----------~h~~~~~~ 276 (280)
||++|| .||||+..
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcCC
Confidence 999999 69999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=307.96 Aligned_cols=241 Identities=31% Similarity=0.509 Sum_probs=202.0
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|+||.||++++..+++.||+|++.+. ....+.+..|..++..+ +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999999999999999999998763 22234466788888765 899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCCCcC
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (280)
++|...+.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcccccccc
Confidence 999999988888999999999999999999999999999999999999998887 999999988743222 22334457
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (280)
++.|+|||.+.+..++.. +||||||+++|+|++|..||...+... ....+......++. .++.++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~ll~~~L 231 (321)
T cd05591 159 TPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNEDD----LFESILHDDVLYPV--WLSKEAVSILKAFM 231 (321)
T ss_pred CccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence 899999999987777655 999999999999999999998755432 33334444444444 57899999999999
Q ss_pred ccCCCCcC-------------CCcccccc
Q 023591 261 VADPAKSE-------------MHDWRRGC 276 (280)
Q Consensus 261 ~~dp~~Rp-------------~h~~~~~~ 276 (280)
+.||++|| .||||.+.
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 99999997 79999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=310.05 Aligned_cols=253 Identities=29% Similarity=0.461 Sum_probs=199.2
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecC-----CeEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLA 93 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 93 (280)
+|++.+.||+|+||.||++++..++..||+|.+.... .....+.+|+.++++++||||+++++++... ..++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6999999999999999999999999999999987432 2234577899999999999999999987643 2589
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
+||||+. ++|.+.+.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCcccccccccc
Confidence 9999995 589999888888999999999999999999999999999999999999998887 9999999987432222
Q ss_pred C----CCCCcCCCcccCcccccC--CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHH---------------
Q 023591 174 Q----PKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI--------------- 232 (280)
Q Consensus 174 ~----~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~--------------- 232 (280)
. .....+++.|+|||.+.+ ..++. ++||||||+++|+|++|..||.............
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCc-hhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 123457889999998865 44544 4999999999999999999997654321111100
Q ss_pred --------hhHhccc-ccC-CCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 233 --------HRILSVQ-YSI-PDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 233 --------~~~~~~~-~~~-~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
....... ..+ .....+++++.++|.+||+.||++|| .||||++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0000000 000 01124678899999999999999999 9999986543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=309.79 Aligned_cols=244 Identities=27% Similarity=0.407 Sum_probs=207.6
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
+-...+.+++++.||+|-||+||.+....+ ..||+|.+.......+.+.+|++++++|+|++||++++++..+..+++|
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 334445667789999999999999999754 3589999998887888999999999999999999999999988899999
Q ss_pred EeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 96 MEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
|||++.|+|.++++. ...++...+..++.||+++++||+++++|||||-+.||+|+.+.. +||+|||+|+......
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIGDDE 357 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccCCCc
Confidence 999999999999986 457999999999999999999999999999999999999998887 9999999999332222
Q ss_pred CC--CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCH
Q 023591 174 QP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (280)
Q Consensus 174 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (280)
.. ...--...|+|||.+.....+.+ |||||||++|+||+| |+.||...+..+.+. . ....++++....+|+
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~----~-le~GyRlp~P~~CP~ 431 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLE----L-LERGYRLPRPEGCPD 431 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHH----H-HhccCcCCCCCCCCH
Confidence 21 12223456999999999999777 999999999999999 899998866543333 2 334456665568999
Q ss_pred HHHHHHHHhcccCCCCcC
Q 023591 251 ECRHLISRIFVADPAKSE 268 (280)
Q Consensus 251 ~l~~li~~~l~~dp~~Rp 268 (280)
++.+++..||..+|++||
T Consensus 432 ~vY~lM~~CW~~~P~~RP 449 (468)
T KOG0197|consen 432 EVYELMKSCWHEDPEDRP 449 (468)
T ss_pred HHHHHHHHHhhCCcccCC
Confidence 999999999999999999
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=307.41 Aligned_cols=245 Identities=29% Similarity=0.490 Sum_probs=203.7
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|+||.||++++..+++.+|+|++.+.. ...+.+.+|..++.++ +|++|+.+++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46899999999999999999999999998642 2234567888888887 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc-cCCCCCCCcC
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 180 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~ 180 (280)
++|...+.....+++..++.++.||+.||+|||++|++||||+|+||+++.++. ++|+|||++.... .........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence 999999888888999999999999999999999999999999999999998887 9999999887422 2222344568
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc---chHHHHHhhHhcccccCCCCCCCCHHHHHHHH
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (280)
++.|+|||.+.+..++.. +|+||||+++|+|++|..||...... .........+......++. .++..+.++|.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~ 235 (327)
T cd05617 159 TPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR--FLSVKASHVLK 235 (327)
T ss_pred CcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC--CCCHHHHHHHH
Confidence 899999999988777655 99999999999999999999643221 1222233344444445554 68899999999
Q ss_pred HhcccCCCCcC------------CCcccccc
Q 023591 258 RIFVADPAKSE------------MHDWRRGC 276 (280)
Q Consensus 258 ~~l~~dp~~Rp------------~h~~~~~~ 276 (280)
+||+.||.+|+ .||||+..
T Consensus 236 ~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 236 GFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred HHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 99999999997 79999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=306.23 Aligned_cols=241 Identities=34% Similarity=0.565 Sum_probs=202.4
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|+||+||++.+..++..||+|.+.+.. .....+.+|..+++.+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999988642 2334566788888777 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCCCcC
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (280)
++|...+.+...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++...... .......+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence 999999988888999999999999999999999999999999999999998887 999999988643222 22233457
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (280)
++.|+|||.+.+..++.. +|+||||+++|+|++|..||..... ......+......++. .+++++.+||.+||
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~----~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l 231 (318)
T cd05570 159 TPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDE----DELFQSILEDEVRYPR--WLSKEAKSILKSFL 231 (318)
T ss_pred CccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCH----HHHHHHHHcCCCCCCC--cCCHHHHHHHHHHc
Confidence 899999999988887665 9999999999999999999976543 2233334444444444 58899999999999
Q ss_pred ccCCCCcC-----------CCcccccc
Q 023591 261 VADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 261 ~~dp~~Rp-----------~h~~~~~~ 276 (280)
+.||++|| .||||+..
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999998 78999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=303.51 Aligned_cols=257 Identities=25% Similarity=0.424 Sum_probs=205.9
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
..++|++.+.||+|+||.||++++..+++.+|+|.+.... .....+.+|+.++++++|+|++++++++..++..++||
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 4478999999999999999999999999999999987543 23345778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-C
Q 023591 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~ 174 (280)
||+++ +|.+.+... ..++...+..++.|++.||++||+.|++||||+|+||+++.++. ++|+|||++....... .
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCccc
Confidence 99975 787777554 45899999999999999999999999999999999999998877 9999999986433222 2
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc---------------cc
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQ 239 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~ 239 (280)
.....+++.|+|||.+.+......++||||||+++|+|++|..||...+..+........... ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 233456889999999876544445599999999999999999999876544333332221110 00
Q ss_pred ccCC---------CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 240 YSIP---------DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 240 ~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
..++ ....+++++.+||.+||+.||.+|| .||||++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 0111 1124788999999999999999999 9999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=313.19 Aligned_cols=253 Identities=30% Similarity=0.477 Sum_probs=206.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||.||++++..+++.+|+|++.+.. .....+.+|+.+++.++||||+++++.+.++..+++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 4578999999999999999999999999999999987532 223456789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~- 173 (280)
||||+++++|.+++... .+++..+..++.||+.||++||+.||+||||||+||+++.++. +||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGM 197 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCc
Confidence 99999999999988654 5899999999999999999999999999999999999998887 9999999987543222
Q ss_pred -CCCCCcCCCcccCcccccCCc---CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 174 -QPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
......+++.|+|||.+.+.. ....++|+||+|+++|+|++|..||...........+... .....++....++
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s 275 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH--KNSLNFPEDVEIS 275 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcccCCCCcccCC
Confidence 123456899999999987543 2344599999999999999999999875543333322221 1234455555679
Q ss_pred HHHHHHHHHhcccCCCC--cC------CCcccccc
Q 023591 250 PECRHLISRIFVADPAK--SE------MHDWRRGC 276 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~--Rp------~h~~~~~~ 276 (280)
..++++|..||+.++.+ |+ .||||++.
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999999999855543 66 99999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=309.97 Aligned_cols=242 Identities=31% Similarity=0.555 Sum_probs=202.8
Q ss_pred ecccccCCceEEEEEEec---CCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 26 VRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
++.||+|+||.||++++. .+++.+|+|++.+.. .....+.+|+.++++++||||+++++++..+...++||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 367999999999999863 578999999987642 22345667999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCCC
Q 023591 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (280)
Q Consensus 100 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~ 178 (280)
++++|.+.+.+...+++..++.++.||+.||+|||+.|++|+||+|+||+++.++. ++|+|||++...... ......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecc
Confidence 99999999988888999999999999999999999999999999999999998877 999999998754333 223345
Q ss_pred cCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHH
Q 023591 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258 (280)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 258 (280)
.+++.|+|||.+.+..++.. +||||||+++|+|++|..||...... .....+......++. .+++++.+||++
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~----~~~~~i~~~~~~~p~--~~~~~~~~li~~ 231 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGKDRK----ETMTMILKAKLGMPQ--FLSPEAQSLLRA 231 (318)
T ss_pred cCChhhcCHHHHcCCCCCCc-cceeccceEeeeeccCCCCCCCCCHH----HHHHHHHcCCCCCCC--CCCHHHHHHHHH
Confidence 68899999999987777555 99999999999999999999865432 233334444444554 588999999999
Q ss_pred hcccCCCCcC-----------CCcccccc
Q 023591 259 IFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 259 ~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
||+.||++|| .||||+..
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 9999999998 79999754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=311.18 Aligned_cols=253 Identities=19% Similarity=0.264 Sum_probs=201.4
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
...++|++++.||+|+||.||++.+..+++.||+|... ...+.+|+.++++++||||+++++++..+...++++|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 34478999999999999999999999999999999643 2356789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC--CCC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQP 175 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~--~~~ 175 (280)
++. ++|..++.....++...++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++...... ...
T Consensus 164 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 164 RYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKY 240 (391)
T ss_pred cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCccccccccccccc
Confidence 995 689888887788999999999999999999999999999999999999998877 999999998643221 122
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc-------chHHHHHhhHh------------
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------KNFRKTIHRIL------------ 236 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~------------ 236 (280)
....+++.|+|||++.+..++.. +||||||+++|+|++|..||...... .....+.....
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 33468999999999988777655 99999999999999999877533210 11111111000
Q ss_pred ----------cccc----cCCC---CCCCCHHHHHHHHHhcccCCCCcC------CCcccccccCC
Q 023591 237 ----------SVQY----SIPD---YVHISPECRHLISRIFVADPAKSE------MHDWRRGCSVS 279 (280)
Q Consensus 237 ----------~~~~----~~~~---~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~~ 279 (280)
.... ..+. ...++.++.+||.+||+.||++|| .||||+....+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 0000 0000 013467899999999999999999 99999886543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=311.29 Aligned_cols=247 Identities=32% Similarity=0.498 Sum_probs=214.6
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCe-EEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIV 95 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv 95 (280)
.++|..++++|+|+||.+++++++.++..+++|.+... +.......+|+.++++++|||||.+.+.|..++. ++++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 37899999999999999999999999999999999764 3444567889999999999999999999999887 9999
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 96 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
|+|++||++.+.+.+.+ .++++.+..|+.|++.|+.|||+++|+|||||+.|||++.++. |+|+|||+|+......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCch
Confidence 99999999999986543 6899999999999999999999999999999999999999998 9999999999777665
Q ss_pred -CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
...+..||+.|++||.+.+.+|..+ +|||||||++|||++-+.+|...+-.....++.+.. ....+ ..++.++
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~---~~Plp--~~ys~el 234 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL---YSPLP--SMYSSEL 234 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHHhhcc---CCCCC--ccccHHH
Confidence 6677889999999999999999777 999999999999999999998765444344333332 12333 3789999
Q ss_pred HHHHHHhcccCCCCcC------CCcccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~ 274 (280)
+.+|+.||+.+|..|| .+|.++
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 9999999999999999 555554
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=311.79 Aligned_cols=252 Identities=33% Similarity=0.486 Sum_probs=204.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||.||++++..+++.+|+|++.+.. .....+.+|+.+++.++||||+++++.+..+...++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 4589999999999999999999999999999999987532 223446788999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~- 173 (280)
||||+++++|.+++... .+++..+..++.||+.||.+||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGM 197 (371)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCCc
Confidence 99999999999988654 5899999999999999999999999999999999999998877 9999999987543322
Q ss_pred -CCCCCcCCCcccCcccccCCc---CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 174 -QPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
......+++.|+|||.+.+.. ....++||||||+++|+|++|..||...+.......+... .....++....++
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s 275 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--KNSLTFPDDNDIS 275 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCcccCCCcCCCC
Confidence 223456899999999987543 2344599999999999999999999875443222222211 1223455555789
Q ss_pred HHHHHHHHHhcccCCCCc---C------CCcccccc
Q 023591 250 PECRHLISRIFVADPAKS---E------MHDWRRGC 276 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~R---p------~h~~~~~~ 276 (280)
..++++|.+||+ +|..| + .||||++.
T Consensus 276 ~~~~~li~~~L~-~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 276 KEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHHcC-ChhhhcCCCCHHHHhcCcccCCC
Confidence 999999999998 55554 4 99999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=299.95 Aligned_cols=249 Identities=29% Similarity=0.415 Sum_probs=197.3
Q ss_pred CCeeeecccccCCceEEEEEEecC-CCcEEEEEEeeeCC---cccHHHHHHHHHhhhC---CCCCeeeeceEEec-----
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILT----- 88 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~----- 88 (280)
++|++.+.||+|+||.||++++.. ++..||+|.+.... .......+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 46889999887532 2223456677776665 69999999998752
Q ss_pred CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCc
Q 023591 89 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~ 166 (280)
...++++|||++ ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccce
Confidence 356899999996 5898888653 35899999999999999999999999999999999999998877 999999998
Q ss_pred cccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-cccCC--
Q 023591 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIP-- 243 (280)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~-- 243 (280)
.............+++.|+|||.+.+..++.. +||||||+++|+|++|..||....+.+....+....... ...++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 75544444445568899999999987777665 999999999999999999998876544444443321100 00000
Q ss_pred ------------------CCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 244 ------------------DYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 244 ------------------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
..+.+++.+.+|+.+||+.||++|| .||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0124678899999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=307.30 Aligned_cols=241 Identities=29% Similarity=0.487 Sum_probs=199.9
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHH-HhhhCCCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|+||.||++++..+++.+|+|++.+.. .....+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999999999999999987532 22233444544 46778999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-CCCCCCCcC
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (280)
++|...+.....+++..+..++.||+.||+|||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccC
Confidence 999999888888999999999999999999999999999999999999998887 99999999874322 222334568
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (280)
++.|+|||.+.+..++.. +||||||+++|+|++|..||...+.. .....+.......+. ..+..+.++|++||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~ll~~ll 231 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVA----EMYDNILHKPLVLRP--GASLTAWSILEELL 231 (325)
T ss_pred ChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHH----HHHHHHHcCCccCCC--CCCHHHHHHHHHHh
Confidence 899999999988877665 99999999999999999999865432 233333333333333 57899999999999
Q ss_pred ccCCCCcC----------CCcccccc
Q 023591 261 VADPAKSE----------MHDWRRGC 276 (280)
Q Consensus 261 ~~dp~~Rp----------~h~~~~~~ 276 (280)
+.||.+|| .||||...
T Consensus 232 ~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 232 EKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred ccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 99999999 89999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=308.29 Aligned_cols=252 Identities=26% Similarity=0.415 Sum_probs=200.3
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCC-----
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 90 (280)
..++|++.+.||+|+||.||++.+..+++.||+|.+... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 458999999999999999999999999999999998653 233456778999999999999999999886543
Q ss_pred -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 91 -~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
..+++|||+++ +|.+.+. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++...
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCcccc
Confidence 47999999965 6666553 34889999999999999999999999999999999999998887 999999998754
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhH--------------
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-------------- 235 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 235 (280)
..........+++.|+|||.+.+..++.. +||||||+++|+|++|..||...+....+.......
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 43333444567889999999988887666 999999999999999999998765432222211110
Q ss_pred ----hcccccC--------------C----CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 236 ----LSVQYSI--------------P----DYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 236 ----~~~~~~~--------------~----~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
....... + .....++++++||.+||+.||++|| .||||+.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 0000000 0 0112467899999999999999999 99999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=297.75 Aligned_cols=246 Identities=36% Similarity=0.631 Sum_probs=210.5
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|++|.||++.+..+++.+|+|.+.... ...+.+.+|++++++++||||+++++++......+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999987642 23456778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
||+++++|.+++.....+++..+..++.|++.+|++||+.|++|+||+|.||+++.++. ++|+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TY 156 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CC
Confidence 99999999999988888999999999999999999999999999999999999998876 999999988754333 33
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (280)
...+++.|+|||.+.+...+.. +|+||||+++|+|++|..||..... ......+......++. ..+..++++|
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~--~~~~~l~~li 229 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAGYPPFFDDNP----IQIYEKILEGKVRFPS--FFSPDAKDLI 229 (290)
T ss_pred CCCCCccccChhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCccCCc--cCCHHHHHHH
Confidence 4457889999999877766544 9999999999999999999976542 2223333344444444 5789999999
Q ss_pred HHhcccCCCCcC-----------CCccccccc
Q 023591 257 SRIFVADPAKSE-----------MHDWRRGCS 277 (280)
Q Consensus 257 ~~~l~~dp~~Rp-----------~h~~~~~~~ 277 (280)
.+||+.||.+|+ .||||+..+
T Consensus 230 ~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 230 RNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred HHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 999999999998 899998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=304.83 Aligned_cols=240 Identities=32% Similarity=0.518 Sum_probs=199.1
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHH-HHhhhCCCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|+||.||++++..+++.||+|++.+.. .....+.+|. .+++.++|+||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999987532 1223344444 356788999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc-cCCCCCCCcC
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 180 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~ 180 (280)
++|...+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++.... .........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccC
Confidence 999998888888999999999999999999999999999999999999998887 9999999886432 2222334568
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (280)
++.|+|||.+.+..++.. +||||||+++|+|++|..||...+. ......+......++. ..+..+.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l 231 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDV----SQMYDNILHKPLQLPG--GKTVAACDLLVGLL 231 (321)
T ss_pred CcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCH----HHHHHHHhcCCCCCCC--CCCHHHHHHHHHHc
Confidence 899999999988777665 9999999999999999999977543 2233344444444444 57899999999999
Q ss_pred ccCCCCcC----------CCccccc
Q 023591 261 VADPAKSE----------MHDWRRG 275 (280)
Q Consensus 261 ~~dp~~Rp----------~h~~~~~ 275 (280)
+.||.+|| .|+||..
T Consensus 232 ~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 232 HKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 99999998 7999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=297.79 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=204.5
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc----cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
.|++.+.||+|+||.||++.+..+++.+|+|.+...... ...+.+|+.++++++|++++++++.+.+++..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 478889999999999999999999999999998764322 2346679999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 98 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
|+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTI 158 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccc
Confidence 99999999888543 35899999999999999999999999999999999999988776 999999988754433333
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....++..|+|||.+.+..++.. +|+||+|+++|+|++|..||......................++. .+++++.+|
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 235 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE--KFSPDARSL 235 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCc--cCCHHHHHH
Confidence 34568899999999988777655 999999999999999999998654322222111111111112222 578999999
Q ss_pred HHHhcccCCCCcC-----------CCcccccc
Q 023591 256 ISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 256 i~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+.+||+.||++|| .||||++.
T Consensus 236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 9999999999998 79999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=305.06 Aligned_cols=240 Identities=33% Similarity=0.554 Sum_probs=197.8
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHH-HHhhhCCCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|+||.||++++..+++.||+|++.+.. .....+.+|. .+++.++|+||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46899999999999999999999999987532 1122333443 346778999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-CCCCCCCcC
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (280)
++|.+.+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCcccccCCCCcccccC
Confidence 999999988888999999999999999999999999999999999999988876 99999999874322 222334568
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (280)
++.|+|||.+.+..++.. +||||||+++|+|++|..||...+... ....+......++. .+++.+.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~--~~~~~~~~li~~~l 231 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNILNKPLQLKP--NITNSARHLLEGLL 231 (325)
T ss_pred CccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHHH----HHHHHHhCCcCCCC--CCCHHHHHHHHHHc
Confidence 999999999988777655 999999999999999999998654332 22333333333333 68999999999999
Q ss_pred ccCCCCcC----------CCccccc
Q 023591 261 VADPAKSE----------MHDWRRG 275 (280)
Q Consensus 261 ~~dp~~Rp----------~h~~~~~ 275 (280)
+.||.+|| .|+||..
T Consensus 232 ~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 232 QKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred ccCHHHCCCCCCCHHHHhcCcccCC
Confidence 99999999 7999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=297.16 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=207.7
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
.|++.+.||+|+||+||++.+..+++.+|+|.+..... ....+.+|+.++++++|+|++.+.+.+..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999875432 22346789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 98 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
|+++++|.+.+... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPEGESI 158 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC--EEEecCCcceecCCCCcc
Confidence 99999998887543 36999999999999999999999999999999999999988776 999999988654333333
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....++..|+|||.+.+..++.. +|+||+|+++|+|++|..||...............+......++. .+++++.+|
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 235 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSA--KFSEEAKSI 235 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCc--cCCHHHHHH
Confidence 44568899999999987777665 999999999999999999998765433333333333333333333 578999999
Q ss_pred HHHhcccCCCCcC-----------CCcccccc
Q 023591 256 ISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 256 i~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+.+||+.||++|| .|+||+..
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 79999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=299.07 Aligned_cols=247 Identities=38% Similarity=0.600 Sum_probs=202.6
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHH---HHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
|++++.||+|+||+||++++..+++.+|+|.+......... ..+|+..+++++|+||+++++++......+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999887544433 345899999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc-ccCCCCCCC
Q 023591 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST 178 (280)
Q Consensus 100 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~-~~~~~~~~~ 178 (280)
++++|.+++.....++...++.++.|++.||++||++|++|+||+|+||+++.++. ++|+|||.+... .........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 99899999987888999999999999999999999999999999999999997777 999999998752 223334456
Q ss_pred cCCCcccCccccc-CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc--cCCCCCCCCHHHHHH
Q 023591 179 VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHL 255 (280)
Q Consensus 179 ~~~~~~~aPE~~~-~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l 255 (280)
.++..|.|||.+. +...+. ++|+||||+++++|++|..||........ ............ ........+..+.++
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~-~~Di~slG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 236 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTR-KSDIWSLGIILYELLTGKLPFEESNSDDQ-LEIIEKILKRPLPSSSQQSREKSEELRDL 236 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBST-HHHHHHHHHHHHHHHHSSSSSTTSSHHHH-HHHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred cccccccccccccccccccc-cccccccccccccccccccccccccchhh-hhhhhhcccccccccccccchhHHHHHHH
Confidence 6788999999987 455544 49999999999999999999987622112 222222121111 111111234899999
Q ss_pred HHHhcccCCCCcC------CCccc
Q 023591 256 ISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 256 i~~~l~~dp~~Rp------~h~~~ 273 (280)
|.+||+.||++|| .||||
T Consensus 237 i~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 237 IKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999 99997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=289.61 Aligned_cols=258 Identities=31% Similarity=0.503 Sum_probs=217.9
Q ss_pred Ceeee-cccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEec
Q 023591 22 RYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 22 ~y~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
-|++. +.||+|+|+.|--+..-.++..||+|++.+.+ ....++.+|++++.+. .|+||++++++|+++..+|+|||-
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 35544 58899999999999999999999999998754 4456788999999988 799999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC-CCCCcEEEeecCCccccccCCC---
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQ--- 174 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~-~~~~~~~l~df~~~~~~~~~~~--- 174 (280)
+.||+|...+.++..+++.+..+++++|+.||.+||++||.|||+||+||+... +....+||+||++.........
T Consensus 158 m~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 158 MRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred ccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999999999999999999999999999999999999999999999999999853 3334589999998754333222
Q ss_pred -----CCCCcCCCcccCccccc----CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCC-----------cchHHHHHhh
Q 023591 175 -----PKSTVGTPAYIAPEVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-----------PKNFRKTIHR 234 (280)
Q Consensus 175 -----~~~~~~~~~~~aPE~~~----~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-----------~~~~~~~~~~ 234 (280)
..++.|+..|+|||+.. ...++.+.+|.||||+++|-|++|.+||.+.-. .......+..
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 23456778899999863 233445559999999999999999999976433 1234567778
Q ss_pred HhcccccCCC--CCCCCHHHHHHHHHhcccCCCCcC------CCcccccccCC
Q 023591 235 ILSVQYSIPD--YVHISPECRHLISRIFVADPAKSE------MHDWRRGCSVS 279 (280)
Q Consensus 235 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~~ 279 (280)
|..+.+.+|+ |..+|.+.+++|+.+|..|+.+|. +|||++.+.+-
T Consensus 318 IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 318 IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 8889998886 778999999999999999999999 99999987653
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=303.41 Aligned_cols=252 Identities=27% Similarity=0.493 Sum_probs=200.8
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|+||.||++++..+++.||+|++.+.. ...+.+.+|+.+++.++|+||+++++++.++..+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999987532 22345778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
||+++++|.+++.+ ...+++..+..++.||+.||+|||++|++||||+|+||+++.++. ++|+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCc
Confidence 99999999999876 457999999999999999999999999999999999999988877 999999998644332221
Q ss_pred --CCCcCCCcccCcccccC----CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC-CCCC
Q 023591 176 --KSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVHI 248 (280)
Q Consensus 176 --~~~~~~~~~~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 248 (280)
....+++.|+|||.+.. ......++||||+|+++|+|++|..||...........+... ...+.++. ...+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 236 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--KEHFQFPPDVTDV 236 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCcccCCCccCCC
Confidence 23458999999999863 222344599999999999999999999765433222222211 11122222 2347
Q ss_pred CHHHHHHHHHhcccCCCC--cC------CCcccccc
Q 023591 249 SPECRHLISRIFVADPAK--SE------MHDWRRGC 276 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~--Rp------~h~~~~~~ 276 (280)
++++++||++||..++++ |+ .||||.+.
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 899999999999764433 55 89999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=307.64 Aligned_cols=241 Identities=32% Similarity=0.496 Sum_probs=197.0
Q ss_pred cccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHHhhhC---CCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL---RHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 29 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
||+|+||+||++++..+++.||+|++.+... .......|..++... +||||+++++.+......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999875321 122334455565544 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-CCCCCCCcC
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (280)
++|.+.+.....+++..++.++.||+.||+|||++|++||||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccC
Confidence 999999988888999999999999999999999999999999999999998877 99999999864322 222334568
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (280)
++.|+|||.+.+......++||||||+++|+|++|..||..... ......+......++.. .+++++.+||++||
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~-~~~~~~~~li~~~L 233 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT----QQMYRNIAFGKVRFPKN-VLSDEGRQFVKGLL 233 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH----HHHHHHHHcCCCCCCCc-cCCHHHHHHHHHHc
Confidence 99999999987655444559999999999999999999976543 22333444444444432 47899999999999
Q ss_pred ccCCCCcC----------CCcccccc
Q 023591 261 VADPAKSE----------MHDWRRGC 276 (280)
Q Consensus 261 ~~dp~~Rp----------~h~~~~~~ 276 (280)
+.||.+|| .||||+..
T Consensus 234 ~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 234 NRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCCHHHCCCCCCCHHHHhcCccccCC
Confidence 99999998 89999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=282.27 Aligned_cols=250 Identities=28% Similarity=0.427 Sum_probs=206.0
Q ss_pred CCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecC---
Q 023591 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP--- 89 (280)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 89 (280)
....+.++||++.+.||+|+|+.|++++.-.+++.+|+|++..+. ...+...+|++..++++|||+++++++...+
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 344567799999999999999999999999999999999998765 6667889999999999999999998876543
Q ss_pred --CeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEeCCCCCcEEEe
Q 023591 90 --THLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKIC 161 (280)
Q Consensus 90 --~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~ni~i~~~~~~~~~l~ 161 (280)
...|++++|...|||.+.+.+. ..+++.++..|+.++++||++||+.. ++|+||||.||++++++. +++.
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl~ 171 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVLM 171 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEEE
Confidence 3589999999999999988542 36999999999999999999999999 999999999999998777 9999
Q ss_pred ecCCccccccCCCCC----------CCcCCCcccCcccccCC---cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchH
Q 023591 162 DFGYSKSSVLHSQPK----------STVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (280)
Q Consensus 162 df~~~~~~~~~~~~~----------~~~~~~~~~aPE~~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (280)
|||++......-... ....+..|+|||.+.-+ ..+.+ +|||||||++|.|+.|..||....+...
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~er-tDIWSLGCtLYa~mf~~sPfe~~~~~Gg- 249 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITER-TDIWSLGCTLYAMMFGESPFERIYQQGG- 249 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccc-cchhhhhHHHHHHHHcCCcchHHhhcCC-
Confidence 999987444332221 23478889999988643 34444 9999999999999999999965322100
Q ss_pred HHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
...-.+....+.+|....+|+.+.+||++||++||.+||
T Consensus 250 -SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP 288 (302)
T KOG2345|consen 250 -SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRP 288 (302)
T ss_pred -eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCC
Confidence 011233455677888778999999999999999999999
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=309.83 Aligned_cols=252 Identities=27% Similarity=0.379 Sum_probs=201.9
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCC-----eEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 93 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 93 (280)
+|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.++|+||+++++++..+. ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999999999999999886532 23356788999999999999999999998766 789
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
+|+||+. ++|.+.+.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCc
Confidence 9999996 588888877788999999999999999999999999999999999999998877 9999999987443222
Q ss_pred C--CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhh-----------------
Q 023591 174 Q--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR----------------- 234 (280)
Q Consensus 174 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------------- 234 (280)
. .....+++.|+|||.+.+......++||||+||++|+|++|..||...........+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 1 223456788999999887654445599999999999999999999876543322222110
Q ss_pred --HhcccccC-------CCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 235 --ILSVQYSI-------PDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 235 --~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+....... ......++++.+||.+||+.||++|| .||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00001111 11124678999999999999999999 99999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=290.42 Aligned_cols=246 Identities=31% Similarity=0.484 Sum_probs=204.5
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc------ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
++|++.+.||+|++|.||.+.+..+++.+++|.+..... ....+.+|+.++++++||||+++++++..+...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 579999999999999999999998999999999875432 22457789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
++||+++++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecccccc
Confidence 9999999999999988888999999999999999999999999999999999999998776 99999999864432211
Q ss_pred C----CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCH
Q 023591 175 P----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (280)
Q Consensus 175 ~----~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (280)
. ....++..|+|||.+.+...+.. +||||||+++|+|++|..||...+.......... ......++. .++.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~--~~~~ 234 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--QPTNPQLPS--HVSP 234 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCch-hhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc--cCCCCCCCc--cCCH
Confidence 1 23446778999999988776555 9999999999999999999976543322222111 111222333 6789
Q ss_pred HHHHHHHHhcccCCCCcC------CCccc
Q 023591 251 ECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 251 ~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.+.++|++||..+|++|| .||||
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 235 DARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 999999999999999999 99997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=305.28 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=201.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecC------
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 89 (280)
..++|++.+.||+|+||.||++.+..+++.||+|++... ......+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 458999999999999999999999999999999998753 23335677899999999999999999987543
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
...++||||+++ +|.+.+.. .++...+..++.|++.||.+||++|++||||+|+||+++.++. ++|+|||++...
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCcccc
Confidence 357999999965 77776643 4889999999999999999999999999999999999998877 999999999755
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc------------
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------ 237 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------ 237 (280)
..........+++.|+|||.+.+..++.. +||||||+++|+|++|..||...+....+.+.......
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 44444445568899999999988877665 99999999999999999999876543333332221110
Q ss_pred ------cccc--------------CC----CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 238 ------VQYS--------------IP----DYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 238 ------~~~~--------------~~----~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.... ++ .....+.++++||.+||+.||.+|| .||||..+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0000 00 0112356789999999999999999 99999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=295.66 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=196.5
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhC---CCCCeeeeceEEec-----CC
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILT-----PT 90 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~ 90 (280)
+|++.+.||+|+||.||++++..+++.||+|.+.... .......+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 6999999999999999999999999999999987532 2223455677766655 79999999998764 24
Q ss_pred eEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 91 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
..+++||++++ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence 58999999975 888887653 34899999999999999999999999999999999999998877 99999999875
Q ss_pred cccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-------ccc
Q 023591 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------QYS 241 (280)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~ 241 (280)
...........++..|+|||.+.+..++.. +||||+|+++|+|++|..||..........+........ ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 544333344567889999999987777665 999999999999999999997765544333333221100 000
Q ss_pred -----CC---------CCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 242 -----IP---------DYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 242 -----~~---------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
+. ..+.++.++.++|.+||+.||++|| .||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0124678899999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=305.94 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=200.7
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecC------
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 89 (280)
..++|++.+.||+|+||.||++.+..+++.+|+|.+.... .....+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4589999999999999999999999999999999987542 2334567899999999999999999988643
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
...+++|||+++ ++.+.+.. .++...+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++...
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~ 169 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 169 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccC
Confidence 357999999965 67666643 4889999999999999999999999999999999999998887 999999998755
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc------------
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------ 237 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------ 237 (280)
..........+++.|+|||.+.+..++.. +||||||+++|+|++|..||........+.........
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 44444445678899999999988777665 99999999999999999999765432222222111100
Q ss_pred ------ccc-----c---------CC----CCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 238 ------VQY-----S---------IP----DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 238 ------~~~-----~---------~~----~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
... . ++ .....+.++++||.+||+.||++|| .||||..+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 000 0 00 0112456889999999999999999 999997553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=296.66 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=205.3
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
..++|++.+.||.|++|.||++.+..+++.||+|.+.... .....+.+|+..++.++|+||+++++++..+...++||
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4578999999999999999999999999999999987543 23345778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-C
Q 023591 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~ 174 (280)
||++ ++|.+++.. ...+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKT 160 (301)
T ss_pred eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCc
Confidence 9997 488888765 346899999999999999999999999999999999999998877 9999999886433222 2
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc---------------cc
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQ 239 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~ 239 (280)
.....+++.|+|||.+.+......++||||||+++|+|++|..||...+..+........... ..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 233456788999999876554455599999999999999999999876543332222111100 00
Q ss_pred ccCCC---------CCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 240 YSIPD---------YVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 240 ~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
...+. ...+++++.+||.+||+.||.+|| .||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 01111 125788999999999999999999 999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=314.66 Aligned_cols=257 Identities=24% Similarity=0.370 Sum_probs=198.5
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCC------CCeeeeceEEecC-CeE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH------PNIVRFKEVILTP-THL 92 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~-~~~ 92 (280)
.++|++.+.||+|+||+||++.+..+++.||||++............|+.+++.++| .+++++++++..+ ..+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 478999999999999999999999999999999997654444556677777776654 4588888888765 478
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCC--------------Cc
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPA--------------PR 157 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~--------------~~ 157 (280)
++||+++ +++|.+++.+.+.+++..+..++.||+.||+|||+ .||+||||||+||+++.++. ..
T Consensus 208 ~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 8999988 66898888888889999999999999999999997 59999999999999986542 24
Q ss_pred EEEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc
Q 023591 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237 (280)
Q Consensus 158 ~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 237 (280)
+||+|||.+.... .......+++.|+|||++.+..++.. +|||||||++|+|++|+.||......+....+......
T Consensus 287 vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~ 363 (467)
T PTZ00284 287 VRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR 363 (467)
T ss_pred EEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Confidence 8999999875322 22334568899999999988888665 99999999999999999999765543222211110000
Q ss_pred cc-------------------ccC-C----------------CCCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 238 VQ-------------------YSI-P----------------DYVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 238 ~~-------------------~~~-~----------------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
.. ..+ + .....++.+.+||.+||+.||.+|| .||||++
T Consensus 364 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence 00 000 0 0001245688999999999999999 9999997
Q ss_pred ccCCC
Q 023591 276 CSVSC 280 (280)
Q Consensus 276 ~~~~~ 280 (280)
.-..|
T Consensus 444 ~~~~~ 448 (467)
T PTZ00284 444 YYPEC 448 (467)
T ss_pred cCCcc
Confidence 65544
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=316.05 Aligned_cols=237 Identities=28% Similarity=0.483 Sum_probs=201.4
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC-CcccHHHHHHHHHhhhC-CCCCeeeeceE-EecC------Ce
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSL-RHPNIVRFKEV-ILTP------TH 91 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~~------~~ 91 (280)
.++++.+.|.+|+|+.||+|++...+..||+|.+... +...+.+.+|+.++++| +|+|||.+++. .... -.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 5788999999999999999999988789999987654 34446788999999999 59999999993 3221 25
Q ss_pred EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 92 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
++|+||||.|+.|.+++..+ ..|++.++++|++|+++|+.+||..+ |+|||||-+|||++.+++ +||||||.+.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCcccccc
Confidence 78999999999999999743 35999999999999999999999998 999999999999999987 9999999987
Q ss_pred ccccCCCCC----------CCcCCCcccCccccc---CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhh
Q 023591 168 SSVLHSQPK----------STVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (280)
Q Consensus 168 ~~~~~~~~~----------~~~~~~~~~aPE~~~---~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (280)
......... ....|+.|+|||.+. +...+ +|+|||+|||+||-|+....||...... .
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~-eKsDIWALGclLYkLCy~t~PFe~sg~l--------a 265 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIG-EKSDIWALGCLLYKLCYFTTPFEESGKL--------A 265 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCc-chhHHHHHHHHHHHHHHhCCCcCcCcce--------e
Confidence 444333211 234789999999973 44554 4499999999999999999999875432 5
Q ss_pred HhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 235 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
|+...+.+|+.+.++..+.+||+.||+.||++||
T Consensus 266 Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP 299 (738)
T KOG1989|consen 266 ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERP 299 (738)
T ss_pred EEeccccCCCCccHHHHHHHHHHHHhccCcccCC
Confidence 7888999999889999999999999999999999
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=323.55 Aligned_cols=259 Identities=29% Similarity=0.454 Sum_probs=206.3
Q ss_pred CCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEec-
Q 023591 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT- 88 (280)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 88 (280)
........++|++++.||.|+||+||++++..++..+|+|.+.... .....+..|+.++++++||||+++++++..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3344455689999999999999999999999999999999987542 234567889999999999999999998854
Q ss_pred -CCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-------CceecCCCCCcEEEeCC---
Q 023591 89 -PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-------QVCHRDLKLENTLLDGS--- 153 (280)
Q Consensus 89 -~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~-------~i~h~dl~~~ni~i~~~--- 153 (280)
...+++||||+++++|.+++.. ...+++..++.|+.||+.||.|||+. +|+|+||+|+|||++.+
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 3578999999999999998864 35699999999999999999999985 49999999999999642
Q ss_pred ------------CCCcEEEeecCCccccccCCCCCCCcCCCcccCcccccCCc-CCCccchhhHHHHHHHHHHhCCCCCC
Q 023591 154 ------------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFE 220 (280)
Q Consensus 154 ------------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~ 220 (280)
+...++|+|||++.............+++.|+|||++.+.. ....++|||||||++|+|++|..||.
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 23348999999987554444444557899999999986432 22344999999999999999999997
Q ss_pred CCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 221 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.......+.. .+.. ...++. ...+.++.+||..||+.+|.+|| .|||++..
T Consensus 245 ~~~~~~qli~---~lk~-~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 245 KANNFSQLIS---ELKR-GPDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred cCCcHHHHHH---HHhc-CCCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 6544322222 2221 122221 24689999999999999999999 89999754
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=293.49 Aligned_cols=252 Identities=27% Similarity=0.472 Sum_probs=204.9
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
++|++.+.||+|+||.||++.+..++..+++|.+..... ....+.+|++++++++||||+++++.+..++.++++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 479999999999999999999999999999998875422 234577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCC
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (280)
+++++|.+++.+...+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++. ++|+|||++..... .....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS 157 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCcccccc-ccccc
Confidence 9999999999888889999999999999999999997 59999999999999998877 99999998764322 22334
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHh------------------------
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------------------------ 233 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------------------ 233 (280)
..++..|+|||.+.+..++.. +|+||||+++|+|++|..||...+.. .......
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred CCCCcCccChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccCCCCCccc
Confidence 567889999999877766555 99999999999999999998654321 1111110
Q ss_pred ---------hHhcc-cccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 234 ---------RILSV-QYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 234 ---------~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
..... ....+. ..++.++++|+.+||+.||++|| .||||.++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 295 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL 295 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence 00000 011111 13678999999999999999999 9999987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=299.56 Aligned_cols=251 Identities=26% Similarity=0.504 Sum_probs=200.8
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|+||.||+++...+++.+|+|.+.+.. .....+.+|+.++..++|++|+++++.+.++..+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999986522 22234677888999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-
Q 023591 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 174 (280)
||+++++|.+++.+ ...+++..+..++.||+.||.+||+.|++||||||+||+++.++. ++|+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcc
Confidence 99999999999976 457899999999999999999999999999999999999988777 99999998864322221
Q ss_pred -CCCCcCCCcccCcccccC-----CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC-CCC
Q 023591 175 -PKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVH 247 (280)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 247 (280)
.....+++.|+|||.+.. ..+ ..++||||||+++|+|++|..||...........+.... ....++. ...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~ 235 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--ERFQFPAQVTD 235 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCC-CCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--ccccCCCcccc
Confidence 223468999999999862 234 444999999999999999999998654333333222111 1122222 235
Q ss_pred CCHHHHHHHHHhcccCCCC--cC------CCcccccc
Q 023591 248 ISPECRHLISRIFVADPAK--SE------MHDWRRGC 276 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~--Rp------~h~~~~~~ 276 (280)
+++++++||++||..++++ |+ .||||++.
T Consensus 236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 7899999999999776555 44 99999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=288.97 Aligned_cols=246 Identities=29% Similarity=0.482 Sum_probs=207.8
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
+|++.+.||.|+||.||++.+..++..+++|.+.+.. ...+.+.+|++.+++++|||++++++.+..+...++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999999899999999987643 334678889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (280)
|+.+++|.+.+....++++..+..++.|++++|.+||+.|++|+||+|+||++++++. ++|+|||.+...........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence 9999999999987778999999999999999999999999999999999999998887 99999999876555444455
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHH
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (280)
..++..|.|||.+.+..++.. +|+||+|+++|+|++|..||...... ................+. ..+.++.++|.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~ 234 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQETADVLYPA--TWSTEAIDAIN 234 (258)
T ss_pred cCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhccccccCcc--cCcHHHHHHHH
Confidence 667888999999987776555 99999999999999999999876542 122222222212233333 57899999999
Q ss_pred HhcccCCCCcC--------CCccc
Q 023591 258 RIFVADPAKSE--------MHDWR 273 (280)
Q Consensus 258 ~~l~~dp~~Rp--------~h~~~ 273 (280)
+||+.||.+|| .||||
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 57775
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=289.54 Aligned_cols=251 Identities=27% Similarity=0.445 Sum_probs=202.4
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|++.+.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+.++++++|+|++++++++......+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 57999999999999999999999899999999987543 223457789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (280)
|+++++|..+......+++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc--EEECccccceecCCCccccc
Confidence 9999888887766677999999999999999999999999999999999999998876 9999999987544332 222
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc---------------ccc
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QYS 241 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------~~~ 241 (280)
...++..|+|||.+.+......++|+||||+++|+|++|..||......+............ ...
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 34567789999998765444455999999999999999999998655433322221111000 000
Q ss_pred CCC----------CCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 242 IPD----------YVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 242 ~~~----------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.+. ...++..+.+||.+||+.||++|| .||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 124678899999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=288.74 Aligned_cols=248 Identities=23% Similarity=0.384 Sum_probs=200.7
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
++|++.+.||+|++|.||++.+..++..+|+|.+.... .....+.+|+.++++++|||++++++.+..+...+++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46899999999999999999999999999999987642 2234577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCC
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~ 178 (280)
+++++|..+ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... .....
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~-~~~~~ 153 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS-IAKTY 153 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceecccc-cccCC
Confidence 999988654 34789999999999999999999999999999999999998887 999999988744322 23345
Q ss_pred cCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcch---HHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN---FRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
.++..|+|||.+.+..++.. +|+||||+++|+|++|..||........ .......+.............++++.++
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence 67889999999987777655 9999999999999999999975432211 1111222111111111122478899999
Q ss_pred HHHhcccCCCCcC------CCcccccc
Q 023591 256 ISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 256 i~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
|.+||+.||++|| .||||+..
T Consensus 233 i~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 233 ITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHhhCChhhCCCHHHHhcCcccccc
Confidence 9999999999999 89999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=299.07 Aligned_cols=251 Identities=27% Similarity=0.497 Sum_probs=201.0
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|+||.||++++..+++.||+|.+.+.. .....+.+|..++..++|++|+++++++..++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999987532 22234677888999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-
Q 023591 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 174 (280)
||+++++|.+++.. ...+++..+..++.|++.||++||+.|++|+||||+||+++.++. ++|+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCce
Confidence 99999999999976 467899999999999999999999999999999999999988777 99999999864432222
Q ss_pred -CCCCcCCCcccCcccccC-----CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC-CCC
Q 023591 175 -PKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVH 247 (280)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 247 (280)
.....+++.|+|||.+.+ +.++ .++|+||||+++|+|++|..||...+.......+... ...+.++. ...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~ 235 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EERFQFPSHITD 235 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCC-CcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC--CCcccCCCcccc
Confidence 123458899999999865 3344 4499999999999999999999865443322222211 11122222 235
Q ss_pred CCHHHHHHHHHhcccCCCCc--C------CCcccccc
Q 023591 248 ISPECRHLISRIFVADPAKS--E------MHDWRRGC 276 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~R--p------~h~~~~~~ 276 (280)
++++++++|.+||..++.++ + .||||++.
T Consensus 236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 78999999999999766542 2 89999763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=309.78 Aligned_cols=249 Identities=29% Similarity=0.441 Sum_probs=203.9
Q ss_pred CCCCeeeecccccCCceEEEEEEecCC-CcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~-~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
....|.+.+.||+|++|.||++.+..+ ++.|++|.+.... .....+.+|+.+++.++||||+++++++..++.+++||
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 345699999999999999999998877 7888999775543 22345678999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 97 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
||+++++|.+.+.. ..++++..+..++.|++.||.+||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDS 222 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCc
Confidence 99999999887643 446899999999999999999999999999999999999998877 999999998754332
Q ss_pred C---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 173 S---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 173 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
. ......+++.|+|||.+.+..++.. +|||||||++|+|++|..||...... .....+...... +....++
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~Pf~~~~~~----~~~~~~~~~~~~-~~~~~~s 296 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQR----EIMQQVLYGKYD-PFPCPVS 296 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCCC-CCCccCC
Confidence 2 1234458999999999988777655 99999999999999999999764432 223333322221 1122578
Q ss_pred HHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 250 PECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
+++.+||.+||+.||++|| .|+|++.
T Consensus 297 ~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 297 SGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999999 7888864
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=289.24 Aligned_cols=243 Identities=31% Similarity=0.454 Sum_probs=201.9
Q ss_pred cccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCch
Q 023591 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (280)
Q Consensus 29 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (280)
||+|+||+||++.+..+++.+++|.+.... .....+.+|+.++++++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999999999999999987532 2233456799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcCCC
Q 023591 105 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182 (280)
Q Consensus 105 ~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 182 (280)
.+++.+.. .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+.............++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTP 158 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCC
Confidence 99987655 6999999999999999999999999999999999999998877 9999999887554433444456778
Q ss_pred cccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhccc
Q 023591 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262 (280)
Q Consensus 183 ~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 262 (280)
.|+|||.+.+..++.. +|+||+|+++|+|++|..||.......................+. .+++++.++|.+||+.
T Consensus 159 ~y~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~ 235 (277)
T cd05577 159 GYMAPEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALLQK 235 (277)
T ss_pred CcCCHHHhcCCCCCch-hhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCc--cCCHHHHHHHHHHccC
Confidence 8999999887776545 999999999999999999997765433333333333333333333 5789999999999999
Q ss_pred CCCCcC-----------CCcccccc
Q 023591 263 DPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 263 dp~~Rp-----------~h~~~~~~ 276 (280)
||++|| .||||...
T Consensus 236 ~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 236 DPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred ChhHccCCCcccHHHHHhChhhhcC
Confidence 999999 89999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=287.10 Aligned_cols=244 Identities=34% Similarity=0.502 Sum_probs=202.2
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc----------cHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
+|.+.+.||+|++|.||++.+..++..+++|.+...... .+.+.+|+.++++++||||+++++++..+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 588899999999999999999888999999988654322 1457789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
.++++||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccc
Confidence 9999999999999999988888999999999999999999999999999999999999988776 99999998875432
Q ss_pred CCC-------CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC
Q 023591 172 HSQ-------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (280)
Q Consensus 172 ~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (280)
... .....++..|+|||.+.+..++.. +|+||||+++|+|++|..||............. .......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~ 234 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG---ENASPEIPS 234 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh---ccCCCcCCc
Confidence 111 112346788999999987777655 999999999999999999998654332222111 111122222
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 245 YVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.++..+.++|++||+.||++|| .||||
T Consensus 235 --~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 235 --NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred --ccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 5789999999999999999999 99997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=292.78 Aligned_cols=250 Identities=33% Similarity=0.530 Sum_probs=208.0
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|++|.||++.+..+++.+|+|.+..... ....+.+|++.++.++|+||+++++.+......+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 479999999999999999999999999999999976532 2345778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 97 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
||+.+++|.+++... ..+++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhccccccc
Confidence 999999999988654 46899999999999999999999999999999999999998776 99999998764322111
Q ss_pred ------------------------------CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCC
Q 023591 175 ------------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (280)
Q Consensus 175 ------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 224 (280)
.....++..|+|||.+.+..++.. +||||||+++|+|++|..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCch-HHHHHHHHHHHHHhhCCCCCCCCch
Confidence 112346778999999987777555 9999999999999999999986654
Q ss_pred cchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC----------CCccccccc
Q 023591 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE----------MHDWRRGCS 277 (280)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp----------~h~~~~~~~ 277 (280)
..... .+......++.....++.++++|.+||+.||++|| .||||++..
T Consensus 238 ~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 238 DETFS----NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred HHHHH----HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 33332 23333444444434789999999999999999999 899998753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=290.64 Aligned_cols=251 Identities=24% Similarity=0.403 Sum_probs=203.6
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
++|++++.||+|+||.||++++..++..+|+|.+.... .....+.+|+.++++++|+|++++++.+..+...+++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 47999999999999999999999899999999886532 2235678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 99 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
+++++|.+++... ..+++..+..++.|++.+|.+||+ .|++|+||+|+||+++.++. ++|+|||.+..... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVA-SL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC--EEEeecCCcccccC-Cc
Confidence 9999999888663 368999999999999999999996 59999999999999998766 99999998864322 22
Q ss_pred CCCCcCCCcccCcccccCCcC-----CCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-cccCCCCCCC
Q 023591 175 PKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHI 248 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~-----~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 248 (280)
.....+++.|+|||.+.+... ...++|+||+|+++|+|++|..||....... .......+... ....+. .+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~--~~ 234 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQLSAIVDGDPPTLPS--GY 234 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHHHHHHhhcCCCCCCc--cc
Confidence 233456778999999865432 2345999999999999999999997654322 22222222222 223333 58
Q ss_pred CHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 249 SPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
++++.+||.+||+.+|++|| .||||....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 89999999999999999999 999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=288.99 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=198.1
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+|++.+.||+|++|.||++.+..++..|++|.+.... .....+.+|+.++++++|||++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5899999999999999999999999999999986542 2235678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-C
Q 023591 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (280)
Q Consensus 99 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~ 174 (280)
++ ++|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence 97 5888877542 46899999999999999999999999999999999999998887 9999999886432221 1
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc--------------cc
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------------QY 240 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------~~ 240 (280)
.....+++.|+|||.+.+......++|+||||+++|+|++|..||................... ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 1233467889999988765543455999999999999999999998654432222211111000 00
Q ss_pred cC---------CCCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 241 SI---------PDYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 241 ~~---------~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.. .....+++++.++|++||+.||++|| .||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00 01124789999999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=284.44 Aligned_cols=248 Identities=32% Similarity=0.517 Sum_probs=206.0
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+|++.+.||+|++|.||++.+..+++.+++|.+..... ..+.+.+|+.++++++|+||+++++.....+..++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 69999999999999999999988899999999876544 456788999999999999999999999888999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC--
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-- 176 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~-- 176 (280)
+++++|.+++.....+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccc
Confidence 999999999988777999999999999999999999999999999999999998776 9999999887544332221
Q ss_pred ---CCcCCCcccCcccccCCc--CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 177 ---STVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 177 ---~~~~~~~~~aPE~~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
...++..|+|||.+.+.. ....++|+||||+++++|++|..||.......... ..........++....+++.
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM--FHVGAGHKPPIPDSLQLSPE 236 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH--HHHhcCCCCCCCcccccCHH
Confidence 235678899999987665 12344999999999999999999997654322111 11111223344554456899
Q ss_pred HHHHHHHhcccCCCCcC------CCccc
Q 023591 252 CRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
+.++|.+||+.+|++|| .||||
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 237 GKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99999999999999999 99996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=287.42 Aligned_cols=248 Identities=29% Similarity=0.482 Sum_probs=206.6
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
++|++.+.||.|++|.||++++..+++.+++|.+.... .....+.+|+.+++.++|+|++++.+++..+...++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47999999999999999999999999999999987643 2234677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCC
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~ 177 (280)
+++++|.+++... ++++..++.++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++...... .....
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence 9999999988665 7899999999999999999999999999999999999998877 999999998755433 22334
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-cccCCCCCCCCHHHHHHH
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLI 256 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 256 (280)
..+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+..... ..+... ....+. ..++.++.+++
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~l 231 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVL----FLIPKNNPPSLEG-NKFSKPFKDFV 231 (274)
T ss_pred ccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCchHHHH----HHhhhcCCCCCcc-cccCHHHHHHH
Confidence 557788999999988776555 99999999999999999999765432211 111111 112222 12788999999
Q ss_pred HHhcccCCCCcC------CCccccccc
Q 023591 257 SRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 257 ~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.+||..||++|| .||||++..
T Consensus 232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 232 SLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 999999999999 999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=298.56 Aligned_cols=243 Identities=24% Similarity=0.419 Sum_probs=191.9
Q ss_pred CCCCeeeecccccCCceEEEEEEec-----CCCcEEEEEEeeeCC--cccHHHHHHHHHhhhC-CCCCeeeeceEEecC-
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP- 89 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~- 89 (280)
..++|++.+.||+|+||.||++.+. .+++.||+|.+.... .....+.+|+.+++++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4478999999999999999999752 345689999987532 2234678899999999 899999999988754
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------------------------------------------------------
Q 023591 90 THLAIVMEYASGGELFERICNA---------------------------------------------------------- 111 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~---------------------------------------------------------- 111 (280)
..++++|||+++++|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4689999999999999888642
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC---CCCCCcCCCcc
Q 023591 112 ----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAY 184 (280)
Q Consensus 112 ----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~ 184 (280)
.+++...+..++.||+.||+|||+.|++|+||||+||+++.++. ++|+|||++....... ......+++.|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcchhcccCCCCCccc
Confidence 23778889999999999999999999999999999999988776 9999999987432211 11223345789
Q ss_pred cCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccC
Q 023591 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263 (280)
Q Consensus 185 ~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 263 (280)
+|||.+.+..++.. +||||||+++|+|++ |..||............... ......+ ...++++.+++.+||+.|
T Consensus 243 ~aPE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~l~~li~~cl~~d 317 (338)
T cd05102 243 MAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD--GTRMRAP--ENATPEIYRIMLACWQGD 317 (338)
T ss_pred cCcHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc--CCCCCCC--CCCCHHHHHHHHHHccCC
Confidence 99999988777655 999999999999997 99999875543322222111 1112222 367899999999999999
Q ss_pred CCCcC
Q 023591 264 PAKSE 268 (280)
Q Consensus 264 p~~Rp 268 (280)
|++||
T Consensus 318 p~~RP 322 (338)
T cd05102 318 PKERP 322 (338)
T ss_pred hhhCc
Confidence 99999
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=290.14 Aligned_cols=249 Identities=26% Similarity=0.464 Sum_probs=197.0
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+|++.+.||+|++|.||++++..+|+.+++|.+.... .....+.+|+.++++++|+|++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5899999999999999999999999999999987532 2234577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCC
Q 023591 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (280)
Q Consensus 99 ~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (280)
+++ +|.+.+.. ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcC
Confidence 975 78777654 567999999999999999999999999999999999999998876 9999999887443221 122
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcch-HHHHHhhHhc-------------ccccC
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILS-------------VQYSI 242 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~-------------~~~~~ 242 (280)
...+++.|+|||.+.+....+.++||||||+++|+|++|..|+........ .......... ....+
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 345678899999987765445559999999999999999988654433221 1111111000 00000
Q ss_pred C----------CCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 243 P----------DYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 243 ~----------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
+ ....+++++.+||.+||+.||.+|| .||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0124788999999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=291.24 Aligned_cols=250 Identities=30% Similarity=0.515 Sum_probs=205.4
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|+||.||++.+..+++.|++|.+.... .....+.+|+.+++.++|+||+++++.+..+...+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987643 22345678999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC---
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~--- 173 (280)
||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCcccc
Confidence 99999999999988888999999999999999999999999999999999999998777 9999999875321100
Q ss_pred -------------CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc
Q 023591 174 -------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240 (280)
Q Consensus 174 -------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
......++..|+|||.+.+..++.. +|+||||+++|+|++|..||....... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~~----~~~~~~~~~~ 233 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEE----LFGQVISDDI 233 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhccc
Confidence 0012345778999999887777655 999999999999999999997654322 2222222222
Q ss_pred cCCC-CCCCCHHHHHHHHHhcccCCCCcC---------CCccccccc
Q 023591 241 SIPD-YVHISPECRHLISRIFVADPAKSE---------MHDWRRGCS 277 (280)
Q Consensus 241 ~~~~-~~~~~~~l~~li~~~l~~dp~~Rp---------~h~~~~~~~ 277 (280)
..+. ...+++++.++|.+||+.||++|| .||||.++.
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 234 EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 2221 125789999999999999999999 899997653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=298.09 Aligned_cols=247 Identities=23% Similarity=0.399 Sum_probs=194.2
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
..+|++.+.||+|+||.||++++..+++.||+|+.... ....|+.++++++|+||+++++++......++|++++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 35799999999999999999999999999999975432 2356899999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCC
Q 023591 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (280)
Q Consensus 100 ~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~ 178 (280)
. ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++............
T Consensus 140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCcccccc
Confidence 5 478777754 457999999999999999999999999999999999999988777 999999998744333333445
Q ss_pred cCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCC-CCCCCc---------chHHHHHhhHhcccccCC-----
Q 023591 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEP---------KNFRKTIHRILSVQYSIP----- 243 (280)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~-~~~~~~---------~~~~~~~~~~~~~~~~~~----- 243 (280)
.+++.|+|||.+.+..++.. +||||||+++|+|+++..++ ...... ..+.............++
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 295 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295 (357)
T ss_pred cccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCcc
Confidence 68899999999988877665 99999999999999865444 332111 001111111100000011
Q ss_pred -----------------------CCCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 244 -----------------------DYVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 244 -----------------------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
....++.++.+||.+||+.||.+|| +||||++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 296 RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1124567888999999999999999 9999986
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=308.79 Aligned_cols=248 Identities=30% Similarity=0.475 Sum_probs=203.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCC-----
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 90 (280)
..++|++.+.||+|+||+||++++..+++.||+|.+..... ....+.+|+..+..++|+|++++++.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 44799999999999999999999999999999999876432 2345678999999999999999987765322
Q ss_pred ---eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeec
Q 023591 91 ---HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (280)
Q Consensus 91 ---~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df 163 (280)
.+++||||+++++|.+.+.. ...+++..+..++.|++.+|.|||+.|++||||||+||+++.++. ++|+||
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DF 187 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDF 187 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEec
Confidence 36899999999999998854 246899999999999999999999999999999999999998877 999999
Q ss_pred CCccccccC---CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc
Q 023591 164 GYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240 (280)
Q Consensus 164 ~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
|+++..... .......+++.|+|||.+.+..++.. +||||||+++|+|++|..||..... ......+.....
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~----~~~~~~~~~~~~ 262 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENM----EEVMHKTLAGRY 262 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhcCCC
Confidence 998644322 22234568899999999988777655 9999999999999999999976443 223333333222
Q ss_pred -cCCCCCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 241 -SIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 241 -~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
.++. .+++++.+++.+||+.||.+|| .|||++.
T Consensus 263 ~~~~~--~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 263 DPLPP--SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCC--CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 2233 6889999999999999999999 8999764
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=288.72 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=208.4
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
.+....+|++.+.||+|++|.||++.+..++..+++|.+..... ..+.+.+|+.+++.++|+|++++++.+..+...++
T Consensus 15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 34455799999999999999999999998999999999876432 33567789999999999999999999999899999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
||||+++++|.+++.+ ..++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 171 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhcccccc
Confidence 9999999999998854 46899999999999999999999999999999999999988876 99999998774332221
Q ss_pred -CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
.....+++.|+|||.+.+...+.. +|+||||+++|+|++|..||............. .......+....++..+.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~ 247 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFR 247 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh---cCCCCCCCCccccCHHHH
Confidence 223457889999999887776555 999999999999999999997654322222111 111122222235788999
Q ss_pred HHHHHhcccCCCCcC------CCccccccc
Q 023591 254 HLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
++|.+||+.||++|| .||||..+.
T Consensus 248 ~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred HHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 999999999999999 999997553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=285.10 Aligned_cols=248 Identities=31% Similarity=0.452 Sum_probs=204.5
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
++|++.+.||.|++|.||++....++..+++|++.... .....+.+|++.++.++|+|++++++.+..+...++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47999999999999999999998889999999986543 2446788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 99 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
+++++|.+++... ..+++..+..++.|++.||++||+.|++|+||+|+||++++++. ++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDR 158 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccc
Confidence 9999999998764 35899999999999999999999999999999999999998776 999999988644332222
Q ss_pred -----CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC---CCC
Q 023591 176 -----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD---YVH 247 (280)
Q Consensus 176 -----~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 247 (280)
....++..|+|||.+......+.++|+||||+++++|++|..||..........+.... ....++. ...
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 235 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGADYKK 235 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCcccccc
Confidence 23357788999999877633445599999999999999999999876544333333222 1111111 235
Q ss_pred CCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 248 ISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
+++.+.+++.+||+.||++|| .||||
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 789999999999999999999 99997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=286.47 Aligned_cols=251 Identities=29% Similarity=0.433 Sum_probs=202.8
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
...++|++.+.||+|++|.||++++..+++.|++|.+..... ....+.+|+.+++.++|||++++++.+..+...+++|
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 345789999999999999999999999999999999876532 2345778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~ 175 (280)
||+++++|.+++...+.+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAKR 163 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCccccc
Confidence 99999999999988888999999999999999999999999999999999999987776 9999999876433221 22
Q ss_pred CCCcCCCcccCccccc---CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 176 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~---~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
....++..|+|||.+. ...++ .++|+||||+++|+|++|..||............... ............++..+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~-~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS-NFQPPKLKDKMKWSNSF 241 (267)
T ss_pred ccccCcccccChhhhccccCCCCC-chhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-CCCCCcccccCCCCHHH
Confidence 3446788999999874 33344 4599999999999999999998765432222211111 00011111222477899
Q ss_pred HHHHHHhcccCCCCcC------CCcc
Q 023591 253 RHLISRIFVADPAKSE------MHDW 272 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~ 272 (280)
.++|.+||+.||++|| .|||
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcCCC
Confidence 9999999999999999 8888
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=287.65 Aligned_cols=252 Identities=27% Similarity=0.500 Sum_probs=207.9
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
++|++.+.||+|++|.||++.+..+++.+++|.+.... .....+.+|++.+++++|+|++++++.+..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46889999999999999999999999999999987653 2335678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 99 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
+++++|.+++... ..+++..+..++.|++.+|++||+ .|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC--EEEeecccchhhHHHHhh-
Confidence 9989999999776 789999999999999999999999 99999999999999998776 999999987644322222
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCC-cchHHHHHhhHhccc-ccCCCCCCCCHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRILSVQ-YSIPDYVHISPECRH 254 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 254 (280)
...++..|+|||.+.+..++.. +|+||||+++++|++|..||..... ..........+.... ...+. ..+++++.+
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 235 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS-GKFSPDFQD 235 (265)
T ss_pred cccCChhccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh-hhcCHHHHH
Confidence 2667888999999988776655 9999999999999999999976531 122233333332222 12222 127889999
Q ss_pred HHHHhcccCCCCcC------CCccccccc
Q 023591 255 LISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
+|.+||..||++|| .||||++..
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~~ 264 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEHPFIKKYE 264 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence 99999999999999 999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=284.97 Aligned_cols=247 Identities=27% Similarity=0.457 Sum_probs=205.8
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
.++|++.+.||+|++|.||++....++..+++|.+..... .+.+.+|++.+++++|+|++++++.+..+...++++||+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 3689999999999999999999998899999999876543 677889999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCCC
Q 023591 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (280)
Q Consensus 100 ~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (280)
++++|.+++.. ...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCcccccc
Confidence 99999999865 456899999999999999999999999999999999999998887 9999999887544333 2233
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHH
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (280)
..++..|+|||.+.+..++.. +||||+|+++++|++|..||.............. .....+.....++.++.++|.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred ccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CCCCCCCchhhcCHHHHHHHH
Confidence 457788999999887777555 9999999999999999999976543322221111 111112222257789999999
Q ss_pred HhcccCCCCcC------CCccc
Q 023591 258 RIFVADPAKSE------MHDWR 273 (280)
Q Consensus 258 ~~l~~dp~~Rp------~h~~~ 273 (280)
+||+.||++|| .||||
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 99999999999 99997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=290.40 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=203.8
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc------cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
+|++.+.||+|++|.||++.+..+++.|++|.+...... ...+.+|+..+++++|+|++++++++.++...++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999989999999999765322 34567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-
Q 023591 96 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~- 173 (280)
|||+ +++|.+++.... .+++..+..++.||++||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc
Confidence 9999 889999997766 7999999999999999999999999999999999999998877 9999999987543322
Q ss_pred CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-c-----------
Q 023591 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-S----------- 241 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~----------- 241 (280)
.......++.|.|||.+.+......++|+||||+++|+|++|..+|....+.....+.......... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 2223345778999998866554455599999999999999998888765543333332221100000 0
Q ss_pred -------CC---CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 242 -------IP---DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 242 -------~~---~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
.+ .....+..+.++|.+||+.||++|| .||||++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 00 0124578899999999999999999 9999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=288.29 Aligned_cols=251 Identities=27% Similarity=0.445 Sum_probs=207.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
...+|++.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++|+|++++++++......++|+|
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 3478999999999999999999999999999999987543 334567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-CC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~ 176 (280)
|+++++|..++.. ..+++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++........ ..
T Consensus 97 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 97 YLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred ecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccCC
Confidence 9999999998854 46899999999999999999999999999999999999988776 99999998764433222 22
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (280)
...++..|+|||.+.+..++.. +|+||||+++|+|++|..||.............. ...........+++.+.++|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li 249 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSPIFRDFL 249 (296)
T ss_pred CcCCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCcccCCcccCCHHHHHHH
Confidence 3457788999999887777655 9999999999999999999977554222222111 11112222336889999999
Q ss_pred HHhcccCCCCcC------CCcccccc
Q 023591 257 SRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 257 ~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.+||..||++|| .||||+.+
T Consensus 250 ~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 250 NRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHhhcChhhCCCHHHHhhChHhhhc
Confidence 999999999999 99999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=298.48 Aligned_cols=252 Identities=24% Similarity=0.402 Sum_probs=198.5
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecC------
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 89 (280)
..++|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4589999999999999999999999999999999987542 2234567899999999999999999887533
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
...+++++++ +++|.+++. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceec
Confidence 3578999988 678887764 456999999999999999999999999999999999999998887 999999998754
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-----------
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----------- 238 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 238 (280)
.. ......+++.|+|||.+.+......++||||||+++|+|++|..||...................
T Consensus 169 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 169 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred CC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 32 22344678899999998775444455999999999999999999997654332222221110000
Q ss_pred --------cccCCC------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 239 --------QYSIPD------YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 239 --------~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
....+. ....++.+.+||.+||+.||++|| .||||.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 000000 123567889999999999999999 99999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=282.98 Aligned_cols=243 Identities=30% Similarity=0.469 Sum_probs=202.9
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+|++.+.||+|++|.||++.+..+++.|++|.+... ......+.+|++++++++|+|++++++++..+...+++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 488999999999999999999999999999998753 23445677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-C
Q 023591 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (280)
Q Consensus 99 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (280)
+++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchh
Confidence 9999999998664 57899999999999999999999999999999999999998877 99999998875433222 2
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-cCCCCCCCCHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPECRH 254 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 254 (280)
....+++.|+|||...+..++.. +|+||||+++++|++|..||........ ...+..... ..+. .++.++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~ 231 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGAL----ILKIIRGVFPPVSQ--MYSQQLAQ 231 (256)
T ss_pred hccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCcc--ccCHHHHH
Confidence 23457788999999988777655 9999999999999999999976553222 222222221 2222 57889999
Q ss_pred HHHHhcccCCCCcC------CCccc
Q 023591 255 LISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~ 273 (280)
++.+||+.+|++|| .|||+
T Consensus 232 ~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 232 LIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHccCCcccCcCHHHHhhCCCC
Confidence 99999999999999 89886
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=287.05 Aligned_cols=251 Identities=27% Similarity=0.425 Sum_probs=202.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEecC-----CeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP-----THL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-----~~~ 92 (280)
..++|++.+.||+|++|.||++.+..+++.+++|.+.......+.+.+|+.+++++ +|+|++++++++... ...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 46889999999999999999999999999999999876655556788899999988 899999999998753 358
Q ss_pred EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 93 AIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
++||||+++++|.+++.. ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~ 177 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQ 177 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchh
Confidence 999999999999988752 456899999999999999999999999999999999999988876 99999998875
Q ss_pred cccCC-CCCCCcCCCcccCcccccCCcC----CCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC
Q 023591 169 SVLHS-QPKSTVGTPAYIAPEVLLKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243 (280)
Q Consensus 169 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~----~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (280)
..... ......++..|+|||.+..... ...++|+||||+++|+|++|..||............... ......
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~ 254 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PPPTLL 254 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CCCCCC
Confidence 43322 2233457788999998754331 234599999999999999999999865443333222111 111222
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCcC------CCcccc
Q 023591 244 DYVHISPECRHLISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~ 274 (280)
....++..+.+||.+||+.||++|| .||||+
T Consensus 255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2224678899999999999999999 999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=287.96 Aligned_cols=252 Identities=28% Similarity=0.422 Sum_probs=203.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
..++|++++.||.|++|.||++++..++..+++|.+.... ...+.+.+|+.+++.++|+|++++++.+..+...++|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 3478999999999999999999999999999999987543 234567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCC
Q 023591 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (280)
Q Consensus 98 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (280)
|+++++|..++.+ ...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~ 167 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTLQRR 167 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC--EEEccCccceecccccccc
Confidence 9999999887654 456899999999999999999999999999999999999987776 999999987643222 122
Q ss_pred CCCcCCCcccCcccccC-----CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCH
Q 023591 176 KSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (280)
....+++.|+|||.+.+ ..++ .++|+||||+++|+|++|..||..........+.. ............++.
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 243 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPTLSQPSKWSM 243 (292)
T ss_pred ceecCCccccCceeeccccccCCCCC-chhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh---cCCCccCCCCcccCH
Confidence 33457788999999853 2233 34999999999999999999997654322222111 111112222336788
Q ss_pred HHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 251 ECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 251 ~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
++.++|.+||+.||++|| .||||...
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 999999999999999999 99999754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=290.18 Aligned_cols=259 Identities=29% Similarity=0.461 Sum_probs=205.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---cHHHHHHHHHhhhCCCCCeeeeceEEecC--CeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP--THLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 93 (280)
..++|++.+.||.|++|.||++.+..+++.||+|.+...... .....+|+.++++++|+|++++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 558899999999999999999999999999999998754322 23456899999999999999999998754 5689
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
+||||+.+ +|.+++.. ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecCCc
Confidence 99999965 88887765 357899999999999999999999999999999999999998876 999999988754433
Q ss_pred CC-CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc--------------
Q 023591 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------------- 237 (280)
Q Consensus 173 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 237 (280)
.. ......++.|+|||.+.+......++|+||+|+++|+|++|..||...+..............
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 21 222335677999999876554455599999999999999999999876544333332221110
Q ss_pred -ccccCCC---------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccccCCC
Q 023591 238 -VQYSIPD---------YVHISPECRHLISRIFVADPAKSE------MHDWRRGCSVSC 280 (280)
Q Consensus 238 -~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~~~ 280 (280)
..+..+. ....++++.+||.+||+.||++|| .||||++..++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~ 300 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC 300 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCC
Confidence 0001110 113588899999999999999999 999999888776
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=322.90 Aligned_cols=251 Identities=32% Similarity=0.502 Sum_probs=215.0
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|.+++.||+|+||.|.+++.+.+++.||+|++.+- .....-|..|-.++-.-+.+-|+.++..|.++.++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 347899999999999999999999999999999999872 2223446677777777788999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~- 173 (280)
||||++||+|..++.+..++++..++.++..|+.||..||+.|+|||||||+||++|..|+ ++|.|||.+-.....+
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADGT 230 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCCc
Confidence 9999999999999999889999999999999999999999999999999999999999998 9999999887555333
Q ss_pred -CCCCCcCCCcccCcccccC-----CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc--cccCCCC
Q 023591 174 -QPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIPDY 245 (280)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 245 (280)
.+....|||.|.+||++.. +.|... +|.||+|+++|||+.|..||... .+...+.+|... .+.||+.
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~e-cDwWSlGV~~YEMlyG~TPFYad----slveTY~KIm~hk~~l~FP~~ 305 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRE-CDWWSLGVFMYEMLYGETPFYAD----SLVETYGKIMNHKESLSFPDE 305 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCc-cchhhhHHHHHHHHcCCCcchHH----HHHHHHHHHhchhhhcCCCcc
Confidence 3567889999999999852 345455 99999999999999999999874 444455555444 6677766
Q ss_pred CCCCHHHHHHHHHhcccCCCCcC---------CCccccccc
Q 023591 246 VHISPECRHLISRIFVADPAKSE---------MHDWRRGCS 277 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rp---------~h~~~~~~~ 277 (280)
..+|.+.++||.+++. +|+.|. .||||.++.
T Consensus 306 ~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 306 TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence 6899999999999875 677887 999998753
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=283.15 Aligned_cols=241 Identities=31% Similarity=0.550 Sum_probs=202.9
Q ss_pred cccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCch
Q 023591 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (280)
Q Consensus 29 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (280)
||.|++|.||++.+..++..+++|.+.+.. ...+.+.+|+.++++++|+|++++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999999889999999987643 2335688899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcCCCcc
Q 023591 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184 (280)
Q Consensus 105 ~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 184 (280)
.+++.+...+++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++.............+++.|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEY 158 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCc
Confidence 999988888999999999999999999999999999999999999998876 999999998755443333345678889
Q ss_pred cCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHh--cccccCCCCCCCCHHHHHHHHHhccc
Q 023591 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL--SVQYSIPDYVHISPECRHLISRIFVA 262 (280)
Q Consensus 185 ~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~ 262 (280)
++||.+.+..++.. +|+||+|+++|+|++|..||...... .......+. .....++. ..++++.++|.+||+.
T Consensus 159 ~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 159 VAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRR 233 (262)
T ss_pred cChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHccC
Confidence 99999877777655 99999999999999999999876531 122222333 22333444 4589999999999999
Q ss_pred CCCCcC-----------CCcccccc
Q 023591 263 DPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 263 dp~~Rp-----------~h~~~~~~ 276 (280)
||++|| +||||++.
T Consensus 234 ~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 234 NPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred ChhhCcCCcccCHHHHhcChhhhCC
Confidence 999999 89999853
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=284.04 Aligned_cols=248 Identities=30% Similarity=0.493 Sum_probs=203.7
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-------ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
+|+..+.||+|++|.||++.+..+++.+++|.+..... ..+.+.+|+..+++++|+|++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 58889999999999999999999999999999875431 23567889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
++||+++++|.+++.+..++++..+..++.|++.||++||++|++|+||+|+||+++.++. .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccc
Confidence 9999999999999988888999999999999999999999999999999999999976543 389999998865433211
Q ss_pred -----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc--ccccCCCCCC
Q 023591 175 -----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVH 247 (280)
Q Consensus 175 -----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 247 (280)
.....++..|+|||.+.+..++.. +|+||+|+++++|++|..||............. .... .....+. .
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~ 235 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-KIASATTAPSIPE--H 235 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH-HHhccCCCCCCch--h
Confidence 122356788999999877766555 999999999999999999997554322222221 2111 1122222 5
Q ss_pred CCHHHHHHHHHhcccCCCCcC------CCcccc
Q 023591 248 ISPECRHLISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp------~h~~~~ 274 (280)
+++++.+++.+||+.||++|| .||||+
T Consensus 236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred hCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 789999999999999999999 999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=284.74 Aligned_cols=247 Identities=27% Similarity=0.414 Sum_probs=200.9
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEecC------CeE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP------THL 92 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~~~ 92 (280)
.+.|++.+.||+|+||.||++....+++.+|+|.+.........+.+|+.+++++ +|+|++++++++... ...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 4679999999999999999999999999999999987766667788999999988 799999999998653 468
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 93 AIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
+++|||+++++|.+++... ..+++..+..++.|++.+|+|||+.+++|+||+|+||+++.++. ++|+|||++....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~ 162 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceecc
Confidence 9999999999999988753 36899999999999999999999999999999999999998877 9999999987443
Q ss_pred cC-CCCCCCcCCCcccCcccccC-----CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC
Q 023591 171 LH-SQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (280)
Q Consensus 171 ~~-~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (280)
.. .......+++.|+|||.+.+ ..++. ++|+||+|+++|+|++|..||.......... ...........
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~ 237 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMHPMRALF----LIPRNPAPRLK 237 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCc-hhhHHHHHHHHHHHHhCCCCccccCHHHHHH----HHhcCCCCCCC
Confidence 22 22234557888999999863 23434 4999999999999999999997543322111 11111112222
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 245 YVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
...++.++.+|+.+||+.||.+|| .||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 235788999999999999999999 99997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=301.37 Aligned_cols=248 Identities=40% Similarity=0.698 Sum_probs=226.7
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc---HHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
..+.|.+.+.||.|.|++|.++++..++..||||.+.+..-.. ..+.+|+.+++.++|||||+++.+.+.+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4578999999999999999999999999999999998764333 4477899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
|||+.++.+.+++.+++.+.+.....++.|+..|++|+|+++|+|||||++|++++.+.+ +||+|||++.........
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLML 211 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccccc
Confidence 999999999999999999999999999999999999999999999999999999998888 999999999988888888
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
.+.++++.|.|||++.+..++.+..|+||+|+++|.|+.|.+||.+.+ +.....+.....++++. .++-+..++
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~----lk~Lr~rvl~gk~rIp~--~ms~dce~l 285 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN----LKELRPRVLRGKYRIPF--YMSCDCEDL 285 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc----cccccchheeeeecccc--eeechhHHH
Confidence 999999999999999999999888999999999999999999998744 33344456667777777 688999999
Q ss_pred HHHhcccCCCCcC------CCcccc
Q 023591 256 ISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 256 i~~~l~~dp~~Rp------~h~~~~ 274 (280)
|+++|-++|.+|+ .|.|..
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n 310 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRN 310 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccc
Confidence 9999999999999 888875
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=289.27 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=207.4
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
....++|++++.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++|+|++++++++......++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 334589999999999999999999999899999999987643 2335577899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 174 (280)
|||+++++|.+++.+ ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSK 171 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCccC
Confidence 999999999998854 45899999999999999999999999999999999999998876 99999998864433222
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
.....+++.|+|||.+.+..++.. +|+||||+++|+|++|..||............. ............++..+++
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPERLSAVFRD 247 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCcchheeeec---cCCCCCCCCccccCHHHHH
Confidence 223457788999999987777555 999999999999999999997654322111111 1111122222357889999
Q ss_pred HHHHhcccCCCCcC------CCccccccc
Q 023591 255 LISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
|+.+||+.||++|| .||||+...
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 99999999999999 999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=285.61 Aligned_cols=249 Identities=28% Similarity=0.415 Sum_probs=199.9
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
.++|++.+.||+|+||.||++++..+++.+++|++.... .....+.+|+.++++++|+|++++++.+..+...++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 368999999999999999999999999999999987543 2334577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-CCC
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~~ 177 (280)
+++++|.+++....++++..+..++.|++.+|.+||+.|++|+|++|+||+++.++. ++|+|||++........ ...
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRKS 165 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccCc
Confidence 999999999887788999999999999999999999999999999999999988777 99999999875432221 233
Q ss_pred CcCCCcccCcccccC---CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 178 TVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
..+++.|+|||.+.. ..++ .++|+||+|+++|+|++|..||................. ..........++..+.+
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~-~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 243 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF-QPPKLKDKTKWSSTFHN 243 (267)
T ss_pred cccCccccCHhHcccccCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCC-CCCCCccccccCHHHHH
Confidence 457788999998753 2343 459999999999999999999965432211111111000 01111112257889999
Q ss_pred HHHHhcccCCCCcC------CCcc
Q 023591 255 LISRIFVADPAKSE------MHDW 272 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~ 272 (280)
||++||+.||++|| .|+|
T Consensus 244 li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 244 FVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999 6665
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=294.39 Aligned_cols=251 Identities=29% Similarity=0.431 Sum_probs=226.3
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
+.|+.-+.||.|+||.||-++...+|+.+|+|.+.+. .....-..+|-.+|.++..+.||.+-..|++++.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 6788999999999999999999999999999988642 223344668999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 97 EYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
..|+||+|.-.+.+.+ -+++..+..++.+|+.+|++||+.+||+||+||+||++|+.|+ +.|+|+|+|+.......
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGKP 342 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCCCc
Confidence 9999999988776655 6999999999999999999999999999999999999999998 99999999998887777
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
.....||.+|+|||++.+..|+.. .|.|||||+||+|+.|+.||..........++.+++......+++ ..|++.++
T Consensus 343 ~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~--kFS~eaks 419 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD--KFSEEAKS 419 (591)
T ss_pred cccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc--ccCHHHHH
Confidence 777799999999999999998766 999999999999999999998877766677777888888888886 79999999
Q ss_pred HHHHhcccCCCCcC-----------CCcccccc
Q 023591 255 LISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 255 li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+.+.+|+.||.+|. .||||+..
T Consensus 420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 99999999999999 99999853
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=286.66 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=202.9
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
+-|++.+.||+|+||.||++.+..++..+++|.+.... ...+.+.+|+++++.++|+|++++++++..+...++++||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 34789999999999999999999999999999886543 33456778999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCC
Q 023591 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (280)
Q Consensus 100 ~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~ 177 (280)
++++|..++.+ ..++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++++|||++...... .....
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEcccccccccccccccccc
Confidence 99999887754 457999999999999999999999999999999999999988776 999999988643322 12234
Q ss_pred CcCCCcccCcccccC-----CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 178 TVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
..+++.|+|||.+.. ..++ .++|+||+|+++|+|++|..||.............. ...........++.++
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 238 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSEF 238 (282)
T ss_pred ccccccccCHhhccccCCCCCCCC-ccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh---cCCCCCCCccccCHHH
Confidence 457889999999742 2343 459999999999999999999976543222222211 1111222223578999
Q ss_pred HHHHHHhcccCCCCcC------CCccccccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.+||.+||+.||++|| .||||+..+
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 9999999999999999 999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=287.72 Aligned_cols=250 Identities=27% Similarity=0.409 Sum_probs=203.9
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
++|++.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|++++++++|+|++++++.+..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 67999999999999999999998889999999987643 23356778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCCC
Q 023591 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (280)
Q Consensus 100 ~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (280)
++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~ 162 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKRDT 162 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhcccccccce
Confidence 999999988664 46999999999999999999999999999999999999988877 9999999876433222 2233
Q ss_pred CcCCCcccCcccccCC----cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc-ccCCCCCCCCHHH
Q 023591 178 TVGTPAYIAPEVLLKK----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISPEC 252 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 252 (280)
..+++.|.|||.+... .....++|+||||+++|+|++|..||........... +.... ..+.....++.++
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK----ILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH----HhcCCCCCcCCcccCCHHH
Confidence 4578889999987532 2223449999999999999999999976543222222 22211 1222223578999
Q ss_pred HHHHHHhcccCCCCcC------CCcccccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.++|.+||+.||++|| .||||.+.
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 9999999999999999 99999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=297.84 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=199.9
Q ss_pred CCCeeeecccccCCceEEEEEEec--CCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
..+|++++.||+|+||.||++... .+++.|++|.+... ....+|+.++++++|+||+++++++..+...+++|+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 357999999999999999999764 35678999987653 235689999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC---
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 174 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~--- 174 (280)
++. ++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++........
T Consensus 167 ~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 167 KYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred hcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCccccccc
Confidence 995 588888877788999999999999999999999999999999999999998877 99999999864433222
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHhhHhccc------------
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---NFRKTIHRILSVQ------------ 239 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~------------ 239 (280)
.....+++.|+|||.+.+..++.. +|||||||++|+|++|..||....... .+..+........
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred ccccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 223468899999999988777665 999999999999999999997654321 1111111111100
Q ss_pred -------------ccCCC---CCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 240 -------------YSIPD---YVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 240 -------------~~~~~---~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
+..+. ...++.++.+||.+||..||++|| .||||++.+
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 00110 113567899999999999999999 999998654
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=281.75 Aligned_cols=243 Identities=24% Similarity=0.443 Sum_probs=196.2
Q ss_pred CCeeeeccc--ccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDI--GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~l--g~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|++.+.+ |+|+||.||++.+..++..+++|.+........ |+.....+ +|+|++++++.+..++..++|||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 567777776 999999999999999999999999876432211 22222222 79999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-CCcEEEeecCCccccccCCCCC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~~~~~l~df~~~~~~~~~~~~~ 176 (280)
|+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ . ++++|||++.... ...
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~--~~l~dfg~~~~~~---~~~ 164 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDR--IYLCDYGLCKIIG---TPS 164 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCe--EEEecCccceecC---CCc
Confidence 999999999998877899999999999999999999999999999999999999877 5 9999999876432 223
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (280)
...++..|+|||.+.+..++.. +|+||+|+++|+|++|..||.......................+ ...++.+.+||
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li 241 (267)
T PHA03390 165 CYDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFI--KNVSKNANDFV 241 (267)
T ss_pred cCCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcc--cccCHHHHHHH
Confidence 3457889999999988777655 99999999999999999999865443322222222222222222 26899999999
Q ss_pred HHhcccCCCCcC-------CCccccc
Q 023591 257 SRIFVADPAKSE-------MHDWRRG 275 (280)
Q Consensus 257 ~~~l~~dp~~Rp-------~h~~~~~ 275 (280)
.+||+.||.+|| .||||+.
T Consensus 242 ~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 242 QSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHhccChhhCCchHHHHhcCCcccC
Confidence 999999999999 7999974
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=285.65 Aligned_cols=250 Identities=27% Similarity=0.451 Sum_probs=203.0
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+.++++++|+|++++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 6899999999999999999999899999999987643 2345788899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC--CC
Q 023591 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 175 (280)
Q Consensus 99 ~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~ 175 (280)
+ +++|.+++.. ...+++..++.++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCCcc
Confidence 9 8999998854 456899999999999999999999999999999999999998776 9999999887544332 12
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc---------------cc
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QY 240 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------~~ 240 (280)
....++..|+|||.+.+......++||||+|+++++|++|.++|....+.............. ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 344578889999998766554556999999999999999988887655433333322211100 00
Q ss_pred cCCC---------CCCCCHHHHHHHHHhcccCCCCcC------CCcccc
Q 023591 241 SIPD---------YVHISPECRHLISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 241 ~~~~---------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~ 274 (280)
.++. ....+..+.++|.+||+.||++|| .||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0000 124678999999999999999999 999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=282.50 Aligned_cols=245 Identities=27% Similarity=0.417 Sum_probs=199.6
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-------ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
+|++.+.||.|+||.||++... +++.+|+|.+..... ....+.+|++.+++++|+|++++++++......++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5889999999999999999874 688899998875422 12457789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC--
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 172 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-- 172 (280)
++||+++++|.+++.+..++++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccc
Confidence 9999999999999988788999999999999999999999999999999999999998876 999999987643211
Q ss_pred -----CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 173 -----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 173 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
.......++..|+|||.+.+..++.. +|+||||+++|+|++|..||...+........... .......+ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~--~~ 233 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH-RGLMPRLP--DS 233 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc-cCCCCCCC--CC
Confidence 11123457788999999987777655 99999999999999999999765432221111110 01111222 25
Q ss_pred CCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 248 ISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
++.++.++|++||+.+|++|| .||||
T Consensus 234 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 234 FSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 889999999999999999999 99997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=281.47 Aligned_cols=252 Identities=30% Similarity=0.495 Sum_probs=210.7
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
++|++.+.||.|++|.||++++..+++.+++|.+..... ....+.+|+..+++++|+|++++++++..+...++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468999999999999999999999999999999876543 346788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC-
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 176 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~- 176 (280)
+++++|.+++.....+++..++.++.|++.+|.+||+ .|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCN 158 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCccc
Confidence 9999999999887889999999999999999999999 99999999999999998877 9999999887554333332
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCC-CCHHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHL 255 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l 255 (280)
...++..|.|||.+.+..++.. +|+||||+++|+|++|..||...... ........+...... ..... ++..+.++
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 235 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYA-ADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPPP-SLPAEEFSPEFRDF 235 (264)
T ss_pred ceeecccccCHhhhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcCCCC-CCCcccCCHHHHHH
Confidence 3456788999999887766555 99999999999999999999876531 222233333322211 11123 78999999
Q ss_pred HHHhcccCCCCcC------CCccccccc
Q 023591 256 ISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 256 i~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
|.+||..+|++|| .|||++...
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 9999999999999 999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=281.52 Aligned_cols=248 Identities=33% Similarity=0.467 Sum_probs=202.9
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
++|++.+.||.|++|.||++.+..+++.+++|.+..... ..+.+.+|+.++++++|||++++++.+.....++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 689999999999999999999998899999999876532 3467888999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCCC
Q 023591 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (280)
Q Consensus 100 ~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (280)
++++|.+++... ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhcccc
Confidence 999999988765 68999999999999999999999999999999999999998877 9999999887543322 2233
Q ss_pred CcCCCcccCcccccCC---cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 178 TVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
..++..|+|||.+.+. .++. ++|+||||+++|+|++|..||................. ..........++.++.+
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~-~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDG-KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF-PPPKLKDKEKWSPVFHD 238 (262)
T ss_pred ccCCccccCchhhcccccCCcCc-hhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCccccchhhhhHHHHH
Confidence 4577789999998766 5654 49999999999999999999976543322222111100 01111112246788999
Q ss_pred HHHHhcccCCCCcC------CCcc
Q 023591 255 LISRIFVADPAKSE------MHDW 272 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~ 272 (280)
|+++||+.||.+|| .|+|
T Consensus 239 li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 239 FIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHcCCChhhCCCHHHHhcCCC
Confidence 99999999999999 8877
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=280.26 Aligned_cols=243 Identities=27% Similarity=0.496 Sum_probs=199.7
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEec-CCeEEEEEe
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME 97 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 97 (280)
+|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|++.+++++|+|++++++.+.. +..++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5999999999999999999999999999999987543 233457789999999999999999988764 446899999
Q ss_pred ccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CC
Q 023591 98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (280)
Q Consensus 98 ~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~ 174 (280)
|+++++|.+.+.. ...+++..++.++.+++.+|++||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCc
Confidence 9999999998865 345899999999999999999999999999999999999988776 999999988644322 22
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-cCCCCCCCCHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPECR 253 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 253 (280)
.....+++.|+|||.+.+..++.. +|+||||+++++|++|..||...+.. .....+..... ..+ ..+++++.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~ 231 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMN----SLVYRIIEGKLPPMP--KDYSPELG 231 (257)
T ss_pred cccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHhcCCCCCc--cccCHHHH
Confidence 234457889999999988877665 99999999999999999999754322 22222222222 222 25789999
Q ss_pred HHHHHhcccCCCCcC------CCccc
Q 023591 254 HLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp------~h~~~ 273 (280)
+++.+||+.||++|| .||||
T Consensus 232 ~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 232 ELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999999999 99997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=285.52 Aligned_cols=250 Identities=28% Similarity=0.432 Sum_probs=202.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEecCC------e
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPT------H 91 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~------~ 91 (280)
..++|++.+.||+|++|.||++.+..+++.+++|.+.......+.+.+|+.+++++ +|+|++++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 35899999999999999999999998899999999887766667888999999998 7999999999987544 4
Q ss_pred EEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 92 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
.+++|||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~ 161 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSA 161 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCccce
Confidence 8999999999999988754 357999999999999999999999999999999999999998776 9999999876
Q ss_pred ccccC-CCCCCCcCCCcccCcccccCCc----CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC
Q 023591 168 SSVLH-SQPKSTVGTPAYIAPEVLLKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242 (280)
Q Consensus 168 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~----~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
..... .......++..|+|||.+.... ....++||||||+++|+|++|..||............... .....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~ 238 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PPPTL 238 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CCCCC
Confidence 43322 2223445788899999875422 2234499999999999999999999765433222222211 11122
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 243 PDYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.....++.++++||.+||..||++|| .|||+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 22224778999999999999999999 99996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=283.68 Aligned_cols=248 Identities=31% Similarity=0.459 Sum_probs=200.1
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-----------ccHHHHHHHHHhhhCCCCCeeeeceEEecCC
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 90 (280)
+|.+.+.||+|++|.||++.+..+++.+|+|.+..... ..+.+.+|+..+++++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 68899999999999999999988899999998864211 1235678999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
..++||||+++++|.+++.+...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++++|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeecccccccc
Confidence 99999999999999999988788999999999999999999999999999999999999998776 9999999887433
Q ss_pred cCCC---CCCCcCCCcccCcccccCCc-CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC--
Q 023591 171 LHSQ---PKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-- 244 (280)
Q Consensus 171 ~~~~---~~~~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 244 (280)
.... .....++..|.|||.+.... ....++|+||||+++++|++|..||................ ....++.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~ 237 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR--SAPPIPPDV 237 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc--cCCcCCccc
Confidence 2111 12334678899999987654 23445999999999999999999996544322222211111 1111111
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 245 YVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
...++.++.++|.+||+.||++|| .|||+
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 225689999999999999999999 99996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=285.74 Aligned_cols=253 Identities=23% Similarity=0.399 Sum_probs=206.9
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
..++|++.+.||+|++|+||++.+..++..||+|++.... ...+.+.+|+++++.++|+|++++++.+.....+++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3578999999999999999999999899999999887543 23457889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
||+++++|.+++.+.+.++...+..++.+++.+|.|||+ .+++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~~-~~~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGELIN-SIA 159 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc--EEEccCCcccchhh-hcc
Confidence 999999999998887889999999999999999999997 58999999999999988776 99999998764322 222
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc-------chHHHHHhhHhcccccCCCCCCC
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------KNFRKTIHRILSVQYSIPDYVHI 248 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 248 (280)
....++..|+|||.+.+..++.. +|+||||+++|+|++|..||...... .........+............+
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF 238 (284)
T ss_pred CccccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhc
Confidence 34567889999999887776655 99999999999999999999865432 11122222222221111111237
Q ss_pred CHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 249 SPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
+.++.+|+.+||+.||++|| .|+||.+
T Consensus 239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 239 PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 78999999999999999999 8888854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=292.64 Aligned_cols=251 Identities=24% Similarity=0.405 Sum_probs=194.0
Q ss_pred eeecccccC--CceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 24 ELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 24 ~~~~~lg~G--~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
++++.||+| ++++||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 357889999 67899999999999999999987643 2234577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC---
Q 023591 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (280)
Q Consensus 99 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~--- 173 (280)
+++++|.+++... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++. +++.||+.+.......
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhccccccccc
Confidence 9999999998653 45899999999999999999999999999999999999998876 9999997543221111
Q ss_pred -----CCCCCcCCCcccCcccccCC--cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc-------
Q 023591 174 -----QPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------- 239 (280)
Q Consensus 174 -----~~~~~~~~~~~~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 239 (280)
......++..|+|||.+.+. .++ .++||||||+++|+|++|..||....................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 11223356679999998763 344 449999999999999999999976443222211111100000
Q ss_pred ---------------------------------ccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 240 ---------------------------------YSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 240 ---------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
...+....+++++.+||.+||+.||++|| .||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 00001123577899999999999999999 999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=279.73 Aligned_cols=245 Identities=36% Similarity=0.534 Sum_probs=204.1
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+|++.+.||+|++|.||++.+..+++.+++|.+.... .....+.+|+..+++++|+|++++++.+..+...++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 6999999999999999999999999999999987643 2345678899999999999999999999988999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 99 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
+++++|.+++... ..+++..+..++.+++.+|++||++|++|+||+|+||+++.++. .++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCcccc
Confidence 9999999998663 35899999999999999999999999999999999999975543 37999999987655444444
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (280)
...++..|+|||.+.+..++.. +|+||||+++++|++|..||...+.......... .....++. .++.++.+++
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--~~~~~l~~li 233 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKIMS---GTFAPISD--RYSPDLRQLI 233 (256)
T ss_pred ccccCCcccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh---cCCCCCCC--CcCHHHHHHH
Confidence 4567889999999987766555 9999999999999999999976544332222211 11112233 5789999999
Q ss_pred HHhcccCCCCcC------CCccc
Q 023591 257 SRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 257 ~~~l~~dp~~Rp------~h~~~ 273 (280)
.+||+.||++|| .||||
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 999999999999 99986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=279.72 Aligned_cols=245 Identities=31% Similarity=0.479 Sum_probs=203.7
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC------cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
+|+..+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+.+++.++|+|++++++++..+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5888899999999999999998889999999987643 2335678899999999999999999999998999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
+||+++++|.+++.+...+++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccc
Confidence 999999999999988888999999999999999999999999999999999999998876 999999988754443333
Q ss_pred CCCcCCCcccCcccccCCc-CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
....++..|++||.+.... ++ .++|+||||+++|+|++|..||.............. ......++. .+++.+.+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~-~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~--~~~~~~~~ 233 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYG-LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR--SKELPPIPD--HLSDEAKD 233 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCC-chhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--cccCCCcCC--CcCHHHHH
Confidence 4556788899999987666 54 449999999999999999999976543222221111 011112222 57899999
Q ss_pred HHHHhcccCCCCcC------CCccc
Q 023591 255 LISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~ 273 (280)
++.+||+.+|++|| .|||+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 99999999999999 99996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=282.93 Aligned_cols=243 Identities=30% Similarity=0.452 Sum_probs=192.7
Q ss_pred ccccCCceEEEEEEecCCCcEEEEEEeeeCCcc----cHHHHHHHHHhh---hCCCCCeeeeceEEecCCeEEEEEeccC
Q 023591 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHR---SLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (280)
Q Consensus 28 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~---~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (280)
.||+|+||.||++.+..+++.+|+|.+.+.... .....++..+++ ...|++++.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998764321 122334443333 3479999999999998899999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcC
Q 023591 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (280)
Q Consensus 101 ~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 180 (280)
+++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ......+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-CccCcCC
Confidence 9999999988888999999999999999999999999999999999999988876 999999988644322 2233468
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (280)
++.|+|||.+.++.....++|+||+|+++|+|++|..||....... ..............++. .+++++.++|.+||
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l 234 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTVNVELPD--SFSPELKSLLEGLL 234 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-HHHHHHHhhcCCcCCcc--ccCHHHHHHHHHHh
Confidence 8899999998654433445999999999999999999997654322 12222222222333333 58899999999999
Q ss_pred ccCCCCcC-----------CCcccccc
Q 023591 261 VADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 261 ~~dp~~Rp-----------~h~~~~~~ 276 (280)
+.||.+|| .||||++.
T Consensus 235 ~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred cCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 99999998 69999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=281.16 Aligned_cols=246 Identities=29% Similarity=0.446 Sum_probs=199.5
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC------cccHHHHHHHHHhhhCCCCCeeeeceEEec--CCeE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILT--PTHL 92 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 92 (280)
.+|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+.++++++|+|++++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999886532 122457789999999999999999998875 3578
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
++++||+++++|.+.+.....+++..++.++.|++.+|++||+.+++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccc
Confidence 899999999999999988778999999999999999999999999999999999999988776 999999988643321
Q ss_pred ----CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCC
Q 023591 173 ----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (280)
Q Consensus 173 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (280)
.......++..|+|||.+.+..++.. +|+||+|+++|+|++|..||............. .......++. .+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~--~~ 234 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA--TQPTNPQLPS--HI 234 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCch-hhhHHHHHHHHHHHHCCCCccccchHHHHHHHh--cCCCCCCCch--hc
Confidence 11122446788999999987776555 999999999999999999998654332222111 1111222232 46
Q ss_pred CHHHHHHHHHhcccCCCCcC------CCcccc
Q 023591 249 SPECRHLISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp------~h~~~~ 274 (280)
++.+++++ +||..+|++|| .||||+
T Consensus 235 ~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 235 SEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 78899999 68888999999 999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=277.17 Aligned_cols=244 Identities=30% Similarity=0.496 Sum_probs=204.2
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+|++.+.||.|++|.|+.+++..+++.+++|.+... ......+.+|+.++++++|+|++++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 699999999999999999999999999999988754 23345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CC
Q 023591 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (280)
Q Consensus 99 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~ 175 (280)
+++++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccc
Confidence 9999999998764 46899999999999999999999999999999999999998877 9999999887443333 23
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....+++.|.|||.+.+..++.. +|+||||+++++|++|..||....... ....+....+.... ..++.++.++
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~~~-~~~~~~~~~~ 232 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLN----LVVKIVQGNYTPVV-SVYSSELISL 232 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHcCCCCCCc-cccCHHHHHH
Confidence 34567889999999887776555 999999999999999999997654332 22223333322211 3578999999
Q ss_pred HHHhcccCCCCcC------CCccc
Q 023591 256 ISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 256 i~~~l~~dp~~Rp------~h~~~ 273 (280)
|.+||+.+|++|| .|||+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 9999999999999 77775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=286.55 Aligned_cols=251 Identities=26% Similarity=0.467 Sum_probs=200.9
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|++.+.||+|++|.||++.+..+++.+|+|.+..... ..+.+.+|+.+++.++|+|++++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 579999999999999999999998899999998765332 23567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-CC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~ 176 (280)
|+++++|..+......++...++.++.|++.+|+|||+.|++|+||+|+||++++++. ++|+|||++........ ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccC
Confidence 9999888887766667999999999999999999999999999999999999998877 99999998875433222 22
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc---------------cccc
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYS 241 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~~ 241 (280)
...++..|+|||.+.+......++||||||+++++|++|..||......+........... ....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 3446788999999876554445599999999999999999999755432222221110000 0000
Q ss_pred CC----------CCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 242 IP----------DYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 242 ~~----------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.+ ..+.++..+.+|+.+||+.||++|| .||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 0235688999999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=298.01 Aligned_cols=248 Identities=20% Similarity=0.270 Sum_probs=195.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
...+|.+.+.||+|+||.||++.+..+++.||+|... .....+|+.++++++|+||+++++++..+...+++|++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3468999999999999999999999999999999632 23467899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC---
Q 023591 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 174 (280)
Q Consensus 99 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~--- 174 (280)
+. ++|.+++... ..++...++.++.|++.||.|||+.||+|+||||+||+++.++. ++|+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceeccccccccc
Confidence 95 5888877553 46999999999999999999999999999999999999988776 99999999874432211
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc-------chHHHHHhhHhcc--c------
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------KNFRKTIHRILSV--Q------ 239 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~--~------ 239 (280)
.....+++.|+|||.+.+..++.. +|||||||++|+|++|..++-..... ....++....... .
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 123458899999999988877665 99999999999999987655332210 1111221111000 0
Q ss_pred ------------------cc---CCCCCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 240 ------------------YS---IPDYVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 240 ------------------~~---~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
.. +.....++.++.+||.+||+.||.+|| .||||+.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 001113566899999999999999999 9999974
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=288.03 Aligned_cols=246 Identities=23% Similarity=0.333 Sum_probs=191.9
Q ss_pred CCCeeeecccccCCceEEEEEEecC----------------CCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeee
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKK----------------TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVR 81 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~----------------~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~ 81 (280)
.++|++.+.||+|+||.||++.+.. ++..||+|.+.... .....+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3689999999999999999998532 34479999887642 22346788999999999999999
Q ss_pred eceEEecCCeEEEEEeccCCCchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecC
Q 023591 82 FKEVILTPTHLAIVMEYASGGELFERICNAG-------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRD 142 (280)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~d 142 (280)
+++++...+..+++|||+++++|.+++.... .++...++.++.||+.||.+||+.|++|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 9999999899999999999999999885431 357788999999999999999999999999
Q ss_pred CCCCcEEEeCCCCCcEEEeecCCccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh--CCC
Q 023591 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAY 217 (280)
Q Consensus 143 l~~~ni~i~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~--g~~ 217 (280)
|+|+||+++.++. ++|+|||++....... ......++..|+|||.+.+..++.. +||||||+++|+|++ +..
T Consensus 164 lkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 164 LATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHHHHHccCCC
Confidence 9999999998876 9999999987443221 1223344678999999887777665 999999999999986 567
Q ss_pred CCCCCCCcchHHHHHhhHhcc--cccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 218 PFEDPEEPKNFRKTIHRILSV--QYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 218 p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
||................... .........++..+.+|+.+||+.||++||
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP 293 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP 293 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCc
Confidence 887655433322221111111 111111225789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=283.47 Aligned_cols=251 Identities=29% Similarity=0.479 Sum_probs=201.6
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|++.+.||+|++|.||++.+..+++.|++|.+... ....+.+.+|++++++++|+|++++++++..++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4799999999999999999999999999999988653 2334678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC--CC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 175 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~ 175 (280)
|++++.+..+..+...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPL 158 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccc
Confidence 9988777666666667999999999999999999999999999999999999998777 9999999887544433 22
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc------------c---
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------------Y--- 240 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------~--- 240 (280)
....++..|+|||.+.+......++|+||||+++|+|++|..||......+............. .
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 3345678899999998773444559999999999999999999976544322222111000000 0
Q ss_pred cCC-----------CCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 241 SIP-----------DYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 241 ~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.++ ....++.++.+||.+||+.+|++|| .||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000 0113488999999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=276.91 Aligned_cols=244 Identities=35% Similarity=0.537 Sum_probs=207.0
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecC--CeEEEEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 96 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 96 (280)
+|++.+.||+|++|.||++.+..+++.+++|.+.... ...+.+.+|+..+++++|+|++++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5889999999999999999999899999999987655 3456788999999999999999999999888 8899999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC--
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-- 174 (280)
|++++++|.+++.+...+++..++.++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEcccccEEecccccccc
Confidence 99999999999988778999999999999999999999999999999999999998776 99999998875554443
Q ss_pred -CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc--ccccCCCCCCCCHH
Q 023591 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPE 251 (280)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 251 (280)
.....++..|.|||.+.+...+.. +|+||||+++++|++|..||...... ......+.. .....+. ..+..
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~--~~~~~ 232 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNP---MAALYKIGSSGEPPEIPE--HLSEE 232 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHhccccCCCcCCCc--ccCHH
Confidence 445567889999999877776555 99999999999999999999876521 111122221 2222333 56899
Q ss_pred HHHHHHHhcccCCCCcC------CCccc
Q 023591 252 CRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
+.+||.+||+.||++|| .||||
T Consensus 233 l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 233 AKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 99999999999999999 99997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=295.25 Aligned_cols=243 Identities=23% Similarity=0.367 Sum_probs=193.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecC-----CCcEEEEEEeeeCCc--ccHHHHHHHHHhhhC-CCCCeeeeceEEecCC
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 90 (280)
..++|++.+.||+|+||.||++++.. ++..||+|.+..... ..+.+.+|+.+++.+ +|+||+++++.+....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 34689999999999999999998643 345799999875432 234577899999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc-----------------------------------------------------------
Q 023591 91 HLAIVMEYASGGELFERICNA----------------------------------------------------------- 111 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~----------------------------------------------------------- 111 (280)
..++||||+++++|.+++...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 999999999999999887532
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC---CCC
Q 023591 112 -----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKS 177 (280)
Q Consensus 112 -----------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~---~~~ 177 (280)
.+++...+.+++.||+.||.|||++|++||||||+||+++.++. ++|+|||++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccCCcceeeccC
Confidence 24778889999999999999999999999999999999998776 99999999864332211 112
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHH
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (280)
..++..|+|||.+.+..++.. +||||||+++|+|++ |..||.............. ...........++++.+++
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK----RGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred CCCccceeCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH----cccCccCCCCCCHHHHHHH
Confidence 234567999999987777665 999999999999997 9999987544332222221 1122222225689999999
Q ss_pred HHhcccCCCCcC
Q 023591 257 SRIFVADPAKSE 268 (280)
Q Consensus 257 ~~~l~~dp~~Rp 268 (280)
.+||+.||++||
T Consensus 349 ~~cl~~dp~~RP 360 (374)
T cd05106 349 KMCWNLEPTERP 360 (374)
T ss_pred HHHcCCChhhCc
Confidence 999999999999
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=281.65 Aligned_cols=242 Identities=22% Similarity=0.334 Sum_probs=195.6
Q ss_pred CCCCeeeecccccCCceEEEEEEec---CCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
+.++|++.+.||+|+||.||++... ..+..||+|.+.... .....+.+|+..+++++|||++++++++..+...+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 5678999999999999999999764 446789999987643 22346778999999999999999999999989999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
+||||+++++|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++++|||.+......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~~ 160 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSE 160 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc--EEECCCccccccccc
Confidence 999999999999988764 47899999999999999999999999999999999999988776 999999976543222
Q ss_pred CCC--CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 173 SQP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 173 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
... ....++..|+|||.+.+..++.. +||||||+++|++++ |..||.......... .+.. ....+....++
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~ 234 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIK----AVED-GFRLPAPRNCP 234 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH----HHHC-CCCCCCCCCCC
Confidence 111 12234567999999888777665 999999999999875 999998765432222 2221 12223334688
Q ss_pred HHHHHHHHHhcccCCCCcC
Q 023591 250 PECRHLISRIFVADPAKSE 268 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp 268 (280)
..+.+++.+||+.+|++||
T Consensus 235 ~~~~~li~~c~~~~p~~RP 253 (266)
T cd05064 235 NLLHQLMLDCWQKERGERP 253 (266)
T ss_pred HHHHHHHHHHcCCCchhCC
Confidence 9999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=293.16 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=199.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecC------
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 89 (280)
..++|++.+.||+|++|.||++.+..+++.||+|.+.+.. .....+.+|+.++++++|+|++++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3588999999999999999999999999999999986532 2334567899999999999999999987643
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
...++||||+.+ +|.+.+... ++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeC
Confidence 357999999965 888877544 899999999999999999999999999999999999998877 999999998755
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc------------
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------ 237 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------ 237 (280)
..........++..|+|||.+.+..++.. +||||||+++|+|++|..||...+....+.........
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 44333344557888999999988877655 99999999999999999999765432222222111000
Q ss_pred ------ccc--------------cCCC-----CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 238 ------VQY--------------SIPD-----YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 238 ------~~~--------------~~~~-----~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
... .++. ....+++++++|.+||+.||++|| .||||+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 000 0000 113466789999999999999999 99999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=277.40 Aligned_cols=246 Identities=32% Similarity=0.475 Sum_probs=198.7
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC------cccHHHHHHHHHhhhCCCCCeeeeceEEecC--CeE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 92 (280)
.+|++.+.||+|++|.||.+.+..+++.|++|.+.... ...+.+.+|+.++++++|+|++++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 67999999999999999999999999999999886432 1224577899999999999999999988653 468
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
+++|||+++++|.+++.+...+++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCccccccccc
Confidence 899999999999999988778999999999999999999999999999999999999998776 999999988743321
Q ss_pred C----CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCC
Q 023591 173 S----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (280)
Q Consensus 173 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (280)
. ......++..|+|||.+.+..++.. +|+||||+++|+|++|..||.......... ...............
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~ 234 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAEFEAMAAIF----KIATQPTNPVLPPHV 234 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcc-hhHHHHHHHHHHHhhCCCCCCccchHHHHH----HHhcCCCCCCCchhh
Confidence 1 1223347788999999987776555 999999999999999999997653322221 112111111112256
Q ss_pred CHHHHHHHHHhcccCCCCcC------CCcccc
Q 023591 249 SPECRHLISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp------~h~~~~ 274 (280)
+..+.++|++||. +|++|| .|||+.
T Consensus 235 ~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 235 SDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred CHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 7889999999995 999999 999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=279.61 Aligned_cols=243 Identities=29% Similarity=0.546 Sum_probs=201.9
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+|++.+.||+|+||.+|++++..+++.+++|.+.... ...+++.+|+..+++++|+|++++.+++...+..++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 6999999999999999999999999999999987532 2335688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-C
Q 023591 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (280)
Q Consensus 99 ~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (280)
+.+++|.+.+.... .+++..+..++.|++.+|.+||++|++|+||+|+||+++.++. ++++|||.+........ .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence 99999999886543 5789999999999999999999999999999999999988776 99999998864433221 2
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-cCCCCCCCCHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPECRH 254 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 254 (280)
....+++.|.|||.+.+...+.. +|+||||+++++|++|..||......... ..+..... ..+ ..++.++.+
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~ 231 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLV----LKIIRGSYPPVS--SHYSYDLRN 231 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCCHHHHH----HHHhcCCCCCCc--ccCCHHHHH
Confidence 23457788999999887776555 99999999999999999999764432222 22222222 222 257899999
Q ss_pred HHHHhcccCCCCcC------CCccc
Q 023591 255 LISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~ 273 (280)
+|.+||+.+|++|| .||||
T Consensus 232 li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 232 LVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHhhCChhhCcCHHHHhhCcCC
Confidence 99999999999999 99997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=280.36 Aligned_cols=248 Identities=35% Similarity=0.600 Sum_probs=218.4
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc----HHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
-++|..++.||.|.||+|-+++.+.+++.+|+|++++.-... .--..|-.+|+..+||.+..+-..|...+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 378999999999999999999999999999999998753322 2234577888999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc-ccCCC
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQ 174 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~-~~~~~ 174 (280)
|||.+||.|.-.+.+.+-+++...+.+-..|+.||.|||+++|++||+|.+|.++|.+|+ +|+.|||+++.. ..+..
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhcccccce
Confidence 999999999988888888999999999999999999999999999999999999999998 999999999743 34455
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
..+.+|+|.|+|||++....|... .|.|.+|+++|||++|++||...+. .+....+......+|. .++++.+.
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgra-VDWWG~GVVMYEMmCGRLPFyn~dh----~kLFeLIl~ed~kFPr--~ls~eAkt 397 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRA-VDWWGVGVVMYEMMCGRLPFYNKDH----EKLFELILMEDLKFPR--TLSPEAKT 397 (516)
T ss_pred eccccCChhhcCchhhccccccce-eehhhhhHHHHHHHhccCcccccch----hHHHHHHHhhhccCCc--cCCHHHHH
Confidence 678899999999999988888666 9999999999999999999988554 4455556666777777 79999999
Q ss_pred HHHHhcccCCCCcC-----------CCcccccc
Q 023591 255 LISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 255 li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
|+..+|..||.+|. .|+||...
T Consensus 398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 99999999999999 89999754
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=282.84 Aligned_cols=249 Identities=28% Similarity=0.430 Sum_probs=199.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEe-----cCCeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVIL-----TPTHL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~~~~ 92 (280)
..++|++.+.||+|++|.||++.+..+++.+++|++.........+.+|+.+++.+ +|+|++++++++. .....
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 55899999999999999999999999999999998876555556788899999998 7999999999874 34578
Q ss_pred EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 93 AIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
+++|||+++++|.+++.. ...+++..++.++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++..
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~ 173 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQ 173 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceee
Confidence 999999999999887642 346889999999999999999999999999999999999998877 99999999875
Q ss_pred cccCC-CCCCCcCCCcccCcccccCC-----cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC
Q 023591 169 SVLHS-QPKSTVGTPAYIAPEVLLKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242 (280)
Q Consensus 169 ~~~~~-~~~~~~~~~~~~aPE~~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
..... ......+++.|+|||.+... .++ .++|+||+|+++|+|++|..||.............. ......
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~ 249 (286)
T cd06638 174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR---NPPPTL 249 (286)
T ss_pred cccCCCccccccCCCcccChhhhchhhhcccccc-chhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc---cCCCcc
Confidence 43322 22344578899999987532 243 449999999999999999999976543222221111 111111
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 243 PDYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.....++.++.+||.+||+.||++|| .|+||
T Consensus 250 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 250 HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 12224678999999999999999999 89986
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=281.51 Aligned_cols=248 Identities=29% Similarity=0.485 Sum_probs=202.2
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC--CcccHHHHHHHHHhhhCC---CCCeeeeceEEecCCeEEEEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~ 96 (280)
.|++.+.||+|++|.||++.+..+++.+++|.+... ....+.+.+|+.++++++ |+|++++++++..+...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 588899999999999999999999999999998654 233456778999998886 999999999999889999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-C
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (280)
||+++++|.+++.. ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC--EEEccCCceeecCCCcccc
Confidence 99999999998865 47899999999999999999999999999999999999998776 99999998875443322 2
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc-ccCCCCCCCCHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISPECRH 254 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 254 (280)
....++..|+|||.+.++.....++|+||||+++|+|++|..||......... ..+.... ..++. ..++.++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~ 233 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM----MLIPKSKPPRLED-NGYSKLLRE 233 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh----hccccCCCCCCCc-ccCCHHHHH
Confidence 33457788999999876554445599999999999999999999765432111 1111111 11211 137889999
Q ss_pred HHHHhcccCCCCcC------CCccccccc
Q 023591 255 LISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
++.+||+.||++|| .||||++..
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999 999998654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=279.62 Aligned_cols=242 Identities=21% Similarity=0.333 Sum_probs=199.7
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
...+|++.+.||+|++|.||++.+..+++.+++|.+.........+.+|+..+++++|+|++++++++..+...+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 45679999999999999999999998999999999887665566788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 99 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
+++++|.+++... ..++...+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++..........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceeec
Confidence 9999999988653 35899999999999999999999999999999999999988776 9999999987544322211
Q ss_pred --CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 177 --STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 177 --~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
....+..|+|||.+.+..++.. +||||||+++|+|++ |..||......... ..+.. .+.......++.++.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~ 235 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY----ELLEK-GYRMERPEGCPPKVY 235 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHC-CCCCCCCCCCCHHHH
Confidence 1223557999999887777655 999999999999998 99998764432222 22211 122222236889999
Q ss_pred HHHHHhcccCCCCcC
Q 023591 254 HLISRIFVADPAKSE 268 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp 268 (280)
++|.+||+.||++||
T Consensus 236 ~li~~cl~~~p~~Rp 250 (263)
T cd05052 236 ELMRACWQWNPSDRP 250 (263)
T ss_pred HHHHHHccCCcccCC
Confidence 999999999999999
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=282.12 Aligned_cols=247 Identities=28% Similarity=0.438 Sum_probs=194.8
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc--HHHHHHHHHhhhC-CCCCeeeeceEEecC--CeEEEEEe
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSL-RHPNIVRFKEVILTP--THLAIVME 97 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e 97 (280)
|++.+.||+|++|.||++.+..+++.+|+|.+....... ....+|+..+.++ +|+|++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 788999999999999999999999999999987643222 2344688888888 599999999999887 88999999
Q ss_pred ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
|+++ +|.+.+.. ...+++..+..++.|++.||++||+.|++|+||+|+||+++. +. ++|+|||++..........
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~--~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DI--LKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CC--eEEEecccccccccCCCcC
Confidence 9975 77777765 457899999999999999999999999999999999999998 54 9999999987554443334
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHh--------------cccccC
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL--------------SVQYSI 242 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------~~~~~~ 242 (280)
...++..|+|||.+........++|+||||+++|+|++|..||...+..+.......... ...+.+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 455788899999875554445559999999999999999999977554332222211110 011111
Q ss_pred CC---------CCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 243 PD---------YVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 243 ~~---------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
+. ...++.++.++|.+||+.||++|| .||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 11 124689999999999999999999 99997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=282.32 Aligned_cols=231 Identities=20% Similarity=0.206 Sum_probs=189.5
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCCccc----HHHHHHHHHhhhCCCCCeeeeceEEec----CCeEEEEEec
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEY 98 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~ 98 (280)
..|++|+++.||++.. +|+.||+|.+....... +.+.+|+.++++++||||+++++++.+ ...++++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5789999999999998 58899999987654433 556799999999999999999999876 3468999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCC
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (280)
+++++|.+++.+.+.++......++.|++.+|.+||+ .+++|+||+|+||+++.++. +||+|||++..... ....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~~--~~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKILSS--PPFK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhhhcc--cccc
Confidence 9999999999888889999999999999999999998 49999999999999998877 99999998874322 2233
Q ss_pred CcCCCcccCcccccC--CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 178 TVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
..++..|+|||.+.+ ..++.. +||||||+++|+|++|..||...+... ....+.......+.....++++.+|
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k-~Di~SlGvil~el~~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~l~~l 254 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIK-DDIYSLGVVLWEIFTGKIPFENLTTKE----IYDLIINKNNSLKLPLDCPLEIKCI 254 (283)
T ss_pred ccCcccccCHHHhhhccccccch-hhhhHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhcCCCCCCCCcCcHHHHHH
Confidence 457789999999875 455544 999999999999999999998754332 2223322222222222578999999
Q ss_pred HHHhcccCCCCcC
Q 023591 256 ISRIFVADPAKSE 268 (280)
Q Consensus 256 i~~~l~~dp~~Rp 268 (280)
+.+||+.||++||
T Consensus 255 i~~cl~~dp~~Rp 267 (283)
T PHA02988 255 VEACTSHDSIKRP 267 (283)
T ss_pred HHHHhcCCcccCc
Confidence 9999999999999
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=282.47 Aligned_cols=256 Identities=29% Similarity=0.439 Sum_probs=201.6
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|++.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|+.++++++|+|++++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 68999999999999999999999999999999986543 223567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-C
Q 023591 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~ 174 (280)
|+++ +|.+.+.... .+++..++.++.||+.||++||++|++|+||+|+||+++.++. .++|+|||++....... .
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC-EEEEcccccccccCCCccc
Confidence 9964 7877775543 3588899999999999999999999999999999999985442 38999999886433221 1
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc--------------
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-------------- 240 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 240 (280)
.....+++.|+|||.+.+......++|+||+|+++|+|++|..||..........+..........
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 223346788999998876554445599999999999999999999876544333332221110000
Q ss_pred ---cCC------CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 241 ---SIP------DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 241 ---~~~------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
.++ ....+++++.+++.+||+.||++|| .||||++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 000 0124688999999999999999999 9999987654
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=282.21 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=200.8
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEec------CC
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT------PT 90 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~ 90 (280)
...+.|++.+.||.|+||.||++.+..+++.+++|.+.........+..|+.+++++ +|+|++++++++.. ..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 345789999999999999999999999999999999877665666788899999888 79999999998853 45
Q ss_pred eEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 91 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
..+++|||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~ 170 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQ 170 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhh
Confidence 789999999999999988653 35889999999999999999999999999999999999998877 99999998764
Q ss_pred cccC-CCCCCCcCCCcccCcccccC-----CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC
Q 023591 169 SVLH-SQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242 (280)
Q Consensus 169 ~~~~-~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
.... .......+++.|+|||.+.. ..++. ++|+||||+++|+|++|..||............ .......
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~-~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~----~~~~~~~ 245 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDY-RSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI----PRNPPPK 245 (282)
T ss_pred hhccccCCCcccccccccCHhhcCcccCcCcCCCc-ccchhHHHHHHHHHHhCCCCccccCHHhhhhhH----hhCCCCC
Confidence 3322 22234557888999998753 33444 499999999999999999999765432222211 1111111
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 243 PDYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.....++.++.+||++||+.||.+|| .||||
T Consensus 246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 11225789999999999999999999 99997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=281.84 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=195.9
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc--ccHHHHHHHHH-hhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|++.+.||+|+||.||++.+..+++.||+|.+..... ...++..|+.. ++.++|+|++++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 479999999999999999999999999999999876432 22344455554 556689999999999999999999999
Q ss_pred ccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 98 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 98 ~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
|++ ++|.+++.. ...+++..++.++.|++.||++||++ +++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence 996 588777643 34689999999999999999999997 9999999999999998877 999999998754333
Q ss_pred CCCCCCcCCCcccCcccccCCc---CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 173 SQPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
.......++..|+|||.+.+.. ....++|+||+|+++|+|++|..||...... ...............+. ..+|
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~ 234 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEPSPQLPA-EKFS 234 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHHHHHHhcCCCCCCc-cccC
Confidence 2223345778899999886422 1234499999999999999999999754322 11111111111222222 2578
Q ss_pred HHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 250 PECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.++.++|.+||+.+|++|| .||||+++.
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999999999999 999998654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=283.45 Aligned_cols=251 Identities=32% Similarity=0.443 Sum_probs=201.0
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---cHHHHHHHHHhhhCCCCCeeeeceEEecC--CeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP--THLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 93 (280)
..++|++.+.||.|++|.||++.+..+++.+++|.+...... ...+.+|+.++++++|||++++++++..+ ...+
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 346899999999999999999999999999999998754322 23467899999999999999999998877 7899
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
+++||+++ +|.+++.... .+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~ 159 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSP 159 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCC
Confidence 99999975 8988886544 5899999999999999999999999999999999999998877 999999988754433
Q ss_pred -CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc--------------
Q 023591 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------------- 237 (280)
Q Consensus 173 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 237 (280)
.......+++.|+|||.+.+......++|+||+|+++++|++|..||..........+.......
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 22233456788999999876654455599999999999999999999876544333332221110
Q ss_pred ---cc----------ccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 238 ---VQ----------YSIPDYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 238 ---~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.. ..++. ..+++.+.++|.+||+.||++|| .||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPA-LSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccc-cCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00 00111 01588899999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=282.32 Aligned_cols=251 Identities=30% Similarity=0.392 Sum_probs=197.0
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCC-CCCeeeeceEEecCCe-----
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTH----- 91 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~----- 91 (280)
++|++.+.||+|++|.||++.+..+++.||+|.+.... .....+.+|+.+++++. |+|++++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999999999999999876542 23356788999999994 6999999999877655
Q ss_pred EEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC-CCCCcEEEeecCC
Q 023591 92 LAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGY 165 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~-~~~~~~~l~df~~ 165 (280)
.+++|||+++ +|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++. ++. ++|+|||.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~--~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--LKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe--EEEeeccc
Confidence 8999999976 788877542 35899999999999999999999999999999999999987 555 99999998
Q ss_pred ccccccC-CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-c--
Q 023591 166 SKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-S-- 241 (280)
Q Consensus 166 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~-- 241 (280)
+...... .......+++.|.|||.+.+......++|+||||+++|+|++|..||...++................ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 8744322 11223346778999998866544445599999999999999999999876544333333221110000 0
Q ss_pred ----------CC---------CCCCCCHHHHHHHHHhcccCCCCcC------CCcccc
Q 023591 242 ----------IP---------DYVHISPECRHLISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 242 ----------~~---------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~ 274 (280)
.+ ....++.++.+||.+||+.||.+|| .||||+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 0124788999999999999999999 999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=311.31 Aligned_cols=242 Identities=28% Similarity=0.401 Sum_probs=196.6
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|+||.||++.+..+++.||+|++..... ..+++.+|+.++++++|||++++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 689999999999999999999999999999999875422 2346788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCC
Q 023591 97 EYASGGELFERICNA-----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (280)
Q Consensus 97 e~~~~~~L~~~~~~~-----------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~ 165 (280)
||+++++|.+++... ..++...+..++.||+.||++||+.|++||||||+||+++.++. ++|+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecCc
Confidence 999999999988531 23556778899999999999999999999999999999998887 99999999
Q ss_pred ccccccC-------------------CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcc
Q 023591 166 SKSSVLH-------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (280)
Q Consensus 166 ~~~~~~~-------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (280)
+...... .......+++.|+|||.+.+..++.. +||||||+++|+|++|..||.......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k-SDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 8744111 01112358899999999988777555 999999999999999999997643321
Q ss_pred hHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
... ...............+++.+.+++.+||+.||++||
T Consensus 239 i~~---~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ 277 (932)
T PRK13184 239 ISY---RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERY 277 (932)
T ss_pred hhh---hhhccChhhccccccCCHHHHHHHHHHccCChhhCc
Confidence 111 111112222223346889999999999999999998
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=281.72 Aligned_cols=249 Identities=30% Similarity=0.453 Sum_probs=198.9
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+|++.+.||.|++|.||++++..++..|++|.+.... .....+.+|+..+++++|||++++++++.++...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4899999999999999999999999999999886532 2235678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CC
Q 023591 99 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (280)
Q Consensus 99 ~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~ 175 (280)
++ ++|..++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence 96 588888754 346899999999999999999999999999999999999998887 9999999876433221 12
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc--------------ccc
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------------QYS 241 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------~~~ 241 (280)
....+++.|+|||.+.+......++|+||||+++|+|++|..||....+.....+........ ...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 233457789999988766554555999999999999999999998765433333222111100 000
Q ss_pred CCC---------CCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 242 IPD---------YVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 242 ~~~---------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
++. ...++++++++|.+||+.||.+|| .||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 110 124678999999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=278.59 Aligned_cols=240 Identities=33% Similarity=0.500 Sum_probs=193.8
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCCcc----cHHHHHHHHH-hhhCCCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|++|.||+|.+..+++.||+|.+.+.... ...+..|... ....+|+|++++++++..++..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999999999999999998754321 1223344443 3445899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcCC
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 181 (280)
++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..... .....++
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~~ 156 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVGT 156 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCCC
Confidence 999999988888999999999999999999999999999999999999998776 99999998764322 3344577
Q ss_pred CcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC--CCCCCCHHHHHHHHHh
Q 023591 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRI 259 (280)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 259 (280)
..|++||.+.+..++.. +|+||+|+++|+|++|..||...+...... .+......++ ....+++++.++|.+|
T Consensus 157 ~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 157 PDYLAPETILGVGDDKM-SDWWSLGCVIFEFLFGYPPFHAETPDAVFD----NILSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred cCccChhhhcCCCCcch-hhhHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhcccCCCCcccccCCHHHHHHHHHH
Confidence 88999999887775544 999999999999999999997654432222 2222222221 1225789999999999
Q ss_pred cccCCCCcC---------CCcccccc
Q 023591 260 FVADPAKSE---------MHDWRRGC 276 (280)
Q Consensus 260 l~~dp~~Rp---------~h~~~~~~ 276 (280)
|+.||++|| .||||++.
T Consensus 232 l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 232 LCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred ccCCHHHccCCCcHHHHHcChHhhcC
Confidence 999999999 79999763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=280.70 Aligned_cols=252 Identities=29% Similarity=0.507 Sum_probs=205.9
Q ss_pred CeeeecccccCCceEEEEEEec---CCCcEEEEEEeeeCC-----cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeE
Q 023591 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 92 (280)
+|++.+.||.|+||.||++.+. .+|+.||+|.+.... ...+.+.+|+.+++++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999875 478899999987532 2335677899999999 689999999999988999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
++|+||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccc
Confidence 999999999999999988888999999999999999999999999999999999999998776 999999988754332
Q ss_pred CC--CCCCcCCCcccCcccccCCc-CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 173 SQ--PKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 173 ~~--~~~~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
.. .....++..|+|||.+.+.. ....++|+||+|+++|+|++|..||...............+......++. .++
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 236 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMS 236 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCc--cCC
Confidence 21 12345778899999986532 22345999999999999999999997654444444444444433333443 578
Q ss_pred HHHHHHHHHhcccCCCCcC-----------CCccccccc
Q 023591 250 PECRHLISRIFVADPAKSE-----------MHDWRRGCS 277 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp-----------~h~~~~~~~ 277 (280)
+.+.+++.+||+.||++|| .||||+...
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999999999999999996 999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=292.50 Aligned_cols=242 Identities=25% Similarity=0.375 Sum_probs=192.9
Q ss_pred CCCeeeecccccCCceEEEEEEe-----cCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCe
Q 023591 20 SDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 91 (280)
.++|++.+.||+|+||.||++.+ ..++..||+|++.... ...+.+.+|+.+++.+ +||||+++++++.....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45899999999999999999974 3456789999986543 2334677899999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-----------------------------------------------------------
Q 023591 92 LAIVMEYASGGELFERICNAG----------------------------------------------------------- 112 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~----------------------------------------------------------- 112 (280)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999998885421
Q ss_pred ----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC--
Q 023591 113 ----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (280)
Q Consensus 113 ----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-- 174 (280)
.++...+..++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccCccccc
Confidence 3678889999999999999999999999999999999997776 99999999874432221
Q ss_pred -CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
......+..|+|||.+.+..++.. +||||||+++|+|++ |..||..........+.... ..........+.++
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l 346 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE----GYRMLSPECAPSEM 346 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh----CccCCCCCCCCHHH
Confidence 112234567999999988777665 999999999999998 89999765543333332221 11111122567899
Q ss_pred HHHHHHhcccCCCCcC
Q 023591 253 RHLISRIFVADPAKSE 268 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp 268 (280)
.+||.+||+.||++||
T Consensus 347 ~~li~~cl~~dP~~RP 362 (375)
T cd05104 347 YDIMKSCWDADPLKRP 362 (375)
T ss_pred HHHHHHHccCChhHCc
Confidence 9999999999999999
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=280.16 Aligned_cols=252 Identities=29% Similarity=0.470 Sum_probs=197.0
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
..++|++.+.||+|++|.||++.+..+++.|++|.+..... ....+.+|+.++++++|+||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 34789999999999999999999998999999999875432 2345678999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-
Q 023591 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 174 (280)
||+++ +|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCcc
Confidence 99975 898887654 46899999999999999999999999999999999999998877 99999998864332211
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcch-HHHHHhhHhc---------------c
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILS---------------V 238 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~---------------~ 238 (280)
.....++..|+|||.+.+......++|+||+|+++|+|++|..||........ .......... .
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 12234577899999987654444559999999999999999999976542111 1111110000 0
Q ss_pred cccCC---------CCCCCC--HHHHHHHHHhcccCCCCcC------CCccc
Q 023591 239 QYSIP---------DYVHIS--PECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 239 ~~~~~---------~~~~~~--~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
....+ .....+ .++.+++.+||+.||++|| .||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00000 001233 7889999999999999999 99997
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=279.44 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=195.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
..++|++.+.||+|++|.||++.+..+++.+++|.+.... .....+.+|+..++.++|+||+++++++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3478999999999999999999999999999999987543 22345678999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CC
Q 023591 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~ 174 (280)
||+. +++.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQT 159 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCC
Confidence 9996 577666544 356788999999999999999999999999999999999998876 999999988643222 12
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcch-HHHHHhhHh--------------c--
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRIL--------------S-- 237 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~--------------~-- 237 (280)
.....+++.|+|||.+.+......++|+||||+++|+|++|..||....+... ..+...... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 23344678899999987654334449999999999999999999976543211 111110000 0
Q ss_pred -ccccC--C-------CCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 238 -VQYSI--P-------DYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 238 -~~~~~--~-------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
..... + .....++++.+++.+||+.||.+|| .||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 0 0012357899999999999999999 99997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=279.45 Aligned_cols=253 Identities=29% Similarity=0.466 Sum_probs=201.2
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecC--CeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 96 (280)
++|...+.||.|++|.||++.+..+++.+++|.+..... ....+.+|++++++++|+||+++++++... ..++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 479999999999999999999999999999999876433 345688999999999999999999988653 4789999
Q ss_pred eccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 97 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
||+++++|.+++.. ...+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS 158 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence 99999999887643 345899999999999999999999999999999999999998776 999999987643322
Q ss_pred CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc-chHHHHHhhHhc-ccccCCC----CC
Q 023591 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILS-VQYSIPD----YV 246 (280)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~~~~----~~ 246 (280)
. .....++..|+|||.+.+..++.. +|+||||+++|+|++|..||...... ....+....+.. ....++. ..
T Consensus 159 ~-~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 159 L-AGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred c-cccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 2 223456778999999988777665 99999999999999999999865321 111112222111 1111111 12
Q ss_pred CCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 247 HISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.+++.+.+||.+||+.||++|| .||||++..
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 3567899999999999999999 999997543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=276.82 Aligned_cols=241 Identities=24% Similarity=0.379 Sum_probs=196.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
++++|++.+.||+|+||.||++.... +..+++|.+.......+.+.+|+.++++++||||+++++++..+...+++|||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 35789999999999999999998754 56799998876665567888999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC--
Q 023591 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (280)
Q Consensus 99 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~-- 175 (280)
+++++|.+++... ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++++|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceecc
Confidence 9999999988653 46899999999999999999999999999999999999988776 999999988643222211
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
....++..|+|||.+.+..++.. +|+||||+++|+|++ |..||...+....... +..... .......+.++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~----i~~~~~-~~~~~~~~~~~~~ 232 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM----ISRGFR-LYRPKLASMTVYE 232 (256)
T ss_pred CCCCCchhhCChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HHCCCC-CCCCCCCCHHHHH
Confidence 12234457999999887777655 999999999999999 8999976554333222 222211 1111246789999
Q ss_pred HHHHhcccCCCCcC
Q 023591 255 LISRIFVADPAKSE 268 (280)
Q Consensus 255 li~~~l~~dp~~Rp 268 (280)
++.+||+.||++||
T Consensus 233 li~~c~~~~p~~Rp 246 (256)
T cd05114 233 VMYSCWHEKPEGRP 246 (256)
T ss_pred HHHHHccCCcccCc
Confidence 99999999999999
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=290.65 Aligned_cols=249 Identities=26% Similarity=0.369 Sum_probs=196.6
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeee---CCcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 94 (280)
.+..|+++++||+|+.+.||++...+. ..+|+|.+.. .......+.+|+..|.+| +|.+|+++++|-..++.+|+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 557899999999999999999998654 4466665543 334456788999999999 68999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 95 VMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
|||+- ..+|...+++... ++...++.++.||+.|+.++|+.||||.||||.|+++-.+ ++||+|||.|.......
T Consensus 438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG---~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG---RLKLIDFGIANAIQPDT 513 (677)
T ss_pred Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee---eEEeeeechhcccCccc
Confidence 99986 5699999977654 4447999999999999999999999999999999998633 39999999998665554
Q ss_pred CC---CCCcCCCcccCcccccCCcCC----------CccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc--
Q 023591 174 QP---KSTVGTPAYIAPEVLLKKEYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-- 238 (280)
Q Consensus 174 ~~---~~~~~~~~~~aPE~~~~~~~~----------~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 238 (280)
.. ....||+.|++||.+.....+ .+++||||||||||+|+.|..||..-.. ....+..+...
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---~~aKl~aI~~P~~ 590 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---QIAKLHAITDPNH 590 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---HHHHHHhhcCCCc
Confidence 43 566799999999998643322 3349999999999999999999975321 12222233332
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 239 QYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
...++..+.. .++.++++.||+.||.+|| +|||++..
T Consensus 591 ~Iefp~~~~~-~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 591 EIEFPDIPEN-DELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred cccccCCCCc-hHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 2244442222 3399999999999999999 99999853
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=277.73 Aligned_cols=241 Identities=35% Similarity=0.567 Sum_probs=201.9
Q ss_pred cccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCch
Q 023591 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (280)
Q Consensus 29 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (280)
||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+..+++++|+|++++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999999889999999987643 2345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC---------CC
Q 023591 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------QP 175 (280)
Q Consensus 105 ~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~---------~~ 175 (280)
.+++.+...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence 999988778999999999999999999999999999999999999998887 9999999886443321 12
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....++..|++||...+...+.. +|+||||+++|+|++|..||...... .....+......++....+++.+.++
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGHSKT-VDWWSLGCILYEFLVGIPPFHGETPE----EIFQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred cCcccCccccCHHHhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCCcCCCccccCCHHHHHH
Confidence 23446778999999877775444 99999999999999999999765432 22333333444455433458999999
Q ss_pred HHHhcccCCCCcC---------CCcccccc
Q 023591 256 ISRIFVADPAKSE---------MHDWRRGC 276 (280)
Q Consensus 256 i~~~l~~dp~~Rp---------~h~~~~~~ 276 (280)
+.+||+.+|.+|| .||||++.
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 9999999999999 99999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=277.07 Aligned_cols=242 Identities=23% Similarity=0.361 Sum_probs=198.7
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
+..++|++.++||+|++|.||++... ++..|++|.+.......+.+.+|+.++++++|+|++++++.+...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 45689999999999999999999975 45679999887666556788899999999999999999999998889999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 98 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
|+++++|.+++... ..++...+..++.|++.||++||+.+++|+||+|+||+++.++. ++|+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEYT 159 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCcee
Confidence 99999999988653 46888999999999999999999999999999999999998876 999999998754322211
Q ss_pred --CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 176 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 176 --~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
....++..|+|||.+.+..++.. +|+||||+++|+|++ |..||............ . .....+....++.++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~ 233 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL----Q-RGYRMPRMENCPDEL 233 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH----H-cCCCCCCCCCCCHHH
Confidence 12234567999999887777655 999999999999998 99999765433222221 1 122333334688999
Q ss_pred HHHHHHhcccCCCCcC
Q 023591 253 RHLISRIFVADPAKSE 268 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp 268 (280)
.+++.+||+.+|++||
T Consensus 234 ~~li~~~l~~~p~~Rp 249 (261)
T cd05072 234 YDIMKTCWKEKAEERP 249 (261)
T ss_pred HHHHHHHccCCcccCc
Confidence 9999999999999999
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=285.81 Aligned_cols=257 Identities=22% Similarity=0.347 Sum_probs=204.5
Q ss_pred CCCeee-ecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc---------------HHHHHHHHHhhhCCCCCeeeec
Q 023591 20 SDRYEL-VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---------------ENVQREIINHRSLRHPNIVRFK 83 (280)
Q Consensus 20 ~~~y~~-~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---------------~~~~~e~~~l~~l~h~~iv~~~ 83 (280)
.++|.. .+.||+|++|.||++.+..+++.||+|.+....... ..+.+|+.++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 367865 577999999999999999999999999987543222 2467899999999999999999
Q ss_pred eEEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeec
Q 023591 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (280)
Q Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df 163 (280)
+++..+...+++|||++ ++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~df 163 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADF 163 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECCc
Confidence 99999999999999996 589999888778999999999999999999999999999999999999998877 999999
Q ss_pred CCccccccC---------------CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchH
Q 023591 164 GYSKSSVLH---------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (280)
Q Consensus 164 ~~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (280)
|.+...... .......+++.|+|||.+.+......++|+||||+++|+|++|..||...++....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 988643310 11112335678999999876554455599999999999999999999877654443
Q ss_pred HHHHhhHhcccc-cCC---------------------CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccccCC
Q 023591 229 RKTIHRILSVQY-SIP---------------------DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCSVS 279 (280)
Q Consensus 229 ~~~~~~~~~~~~-~~~---------------------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~~ 279 (280)
..+......... .++ .....+.++.++|.+||+.||++|| .||||+++...
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 333222111000 000 0124578899999999999999999 99999987653
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=269.43 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=208.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 95 (280)
+.+..+.+..||.|..|.||+++...+|..+|+|...+.. ...+++.+++.+.... .+|+||+++++|..+..+++.
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 4466778899999999999999999999999999998754 3335677777776655 589999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
||.+. .-+..++.+ .+++++..+-++...++.||.||.+ +|++|||+||+||++|+.|+ +||+|||.+.+.....
T Consensus 170 MelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 170 MELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeeccc
Confidence 99984 355555544 4579999999999999999999985 68999999999999999998 9999999998877777
Q ss_pred CCCCCcCCCcccCcccccC---CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc-ccccCCCCCCCC
Q 023591 174 QPKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-VQYSIPDYVHIS 249 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 249 (280)
......|.+.|+|||.+.- ..|+.. +||||||+.++||.||+.||....-+ ...+..+.. ....++....+|
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~td---Fe~ltkvln~ePP~L~~~~gFS 322 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTD---FEVLTKVLNEEPPLLPGHMGFS 322 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCcc---HHHHHHHHhcCCCCCCcccCcC
Confidence 7777788999999999863 456666 99999999999999999999876543 233333333 234555555699
Q ss_pred HHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 250 PECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+++++|+..||+.|+.+|| .|||++.-
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 9999999999999999999 99998643
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=285.09 Aligned_cols=246 Identities=26% Similarity=0.393 Sum_probs=184.2
Q ss_pred ecccccCCceEEEEEEec--CCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEec--CCeEEEEEeccCC
Q 023591 26 VRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG 101 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 101 (280)
.++||+|+||.||++++. .+++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 468999999999999965 467889999886543 34567889999999999999999998864 4568999999954
Q ss_pred CchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC--CCCcEEEeecCCccccc
Q 023591 102 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV 170 (280)
Q Consensus 102 ~~L~~~~~~~---------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~--~~~~~~l~df~~~~~~~ 170 (280)
+|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.+ ..+.+||+|||++....
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 887776422 248999999999999999999999999999999999999532 22359999999987543
Q ss_pred cCC----CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcc---------hHHHHHhh---
Q 023591 171 LHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---------NFRKTIHR--- 234 (280)
Q Consensus 171 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---------~~~~~~~~--- 234 (280)
... ......+++.|+|||.+.+......++||||+||++|+|++|..||....... ........
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence 221 12334578899999998876544555999999999999999999997543210 01111000
Q ss_pred --------Hhc-------------ccccC--------CCCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 235 --------ILS-------------VQYSI--------PDYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 235 --------~~~-------------~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
+.. ..... ......+.++.+||.+||+.||.+|| .||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 000 00000 00012356789999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=276.27 Aligned_cols=243 Identities=28% Similarity=0.423 Sum_probs=196.8
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|+||.||++++..+++.||+|.+.... .....+.+|+.+++.++|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999876532 22245778999999999999999999999989999999
Q ss_pred eccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 97 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
||+++++|.+++.. ...+++..+..++.|++.||++||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccch
Confidence 99999999888743 345899999999999999999999999999999999999998877 999999987644322
Q ss_pred CC-CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 173 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
.. .....+++.|+|||.+.+..++.. +|+||+|+++|+|++|..||...... .......+............++..
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYSEK 236 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCCCChhhcCHH
Confidence 21 123457788999999987777655 99999999999999999999654322 122222222222211112256789
Q ss_pred HHHHHHHhcccCCCCcC
Q 023591 252 CRHLISRIFVADPAKSE 268 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp 268 (280)
+.+++.+||+.+|++||
T Consensus 237 ~~~li~~cl~~~p~~Rp 253 (267)
T cd08228 237 LRELVSMCIYPDPDQRP 253 (267)
T ss_pred HHHHHHHHCCCCcccCc
Confidence 99999999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=275.32 Aligned_cols=238 Identities=33% Similarity=0.554 Sum_probs=197.8
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC--CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
+|++.+.||.|++|.||++.+..++..+++|.+... ....+.+.+|+.+++.++|+|++++++.+..+..++++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 589999999999999999999999999999998653 233456778999999999999999999999999999999999
Q ss_pred CCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCC
Q 023591 100 SGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (280)
Q Consensus 100 ~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (280)
++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++++|||.+....... ...
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccc
Confidence 99999988764 345899999999999999999999999999999999999988776 9999999886443222 223
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccccc-CCCCCCCCHHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRHL 255 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 255 (280)
...+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+. ......+...... .+. .++..+.+|
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~--~~~~~~~~l 231 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSW----KNLILKVCQGSYKPLPS--HYSYELRSL 231 (255)
T ss_pred cccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCH----HHHHHHHhcCCCCCCCc--ccCHHHHHH
Confidence 3457888999999887776555 9999999999999999999976432 2222222222222 222 578899999
Q ss_pred HHHhcccCCCCcC
Q 023591 256 ISRIFVADPAKSE 268 (280)
Q Consensus 256 i~~~l~~dp~~Rp 268 (280)
|.+||+.||++||
T Consensus 232 i~~~l~~~P~~Rp 244 (255)
T cd08219 232 IKQMFKRNPRSRP 244 (255)
T ss_pred HHHHHhCCcccCC
Confidence 9999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=272.46 Aligned_cols=245 Identities=31% Similarity=0.504 Sum_probs=204.9
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccC
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (280)
.|++.+.||+|++|.||++.+..+++.+++|.+..... ....+.+|+..+++++|+|++++++.+..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 48899999999999999999998999999999877543 45678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCc
Q 023591 101 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179 (280)
Q Consensus 101 ~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 179 (280)
+++|.+++... ..+++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||.+.............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeecccccccccccccccee
Confidence 99999998776 57999999999999999999999999999999999999998776 9999999887554443234556
Q ss_pred CCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHh
Q 023591 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259 (280)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 259 (280)
++..|+|||.+.+...+.. +|+||||+++++|++|..||...+.......... ......+....++..+.++|.+|
T Consensus 159 ~~~~~~~PE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGLRNPEKWSDEFKDFLKKC 234 (253)
T ss_pred cCCcccCHHHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---cCCCCcCcccccCHHHHHHHHHH
Confidence 7888999999887776555 9999999999999999999976543222222111 11222223223589999999999
Q ss_pred cccCCCCcC------CCcc
Q 023591 260 FVADPAKSE------MHDW 272 (280)
Q Consensus 260 l~~dp~~Rp------~h~~ 272 (280)
|+.||++|| .|||
T Consensus 235 l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 235 LQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ccCChhhCCCHHHHhcCCC
Confidence 999999999 8888
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=279.77 Aligned_cols=252 Identities=29% Similarity=0.487 Sum_probs=209.8
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
...+.|++.+.||+|++|.||++.+..++..+++|.+.......+.+.+|++.+++++|+|++++++.+..+...++++|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45578999999999999999999999889999999998765555678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-C
Q 023591 98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (280)
|+++++|.+++.... .++...+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~ 173 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKR 173 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhhh
Confidence 999999999998776 8999999999999999999999999999999999999998877 99999998764332221 1
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....++..|+|||.+.+..++.. +|+||||+++|+|++|..||............. ............++..+.++
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT---TKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCCCcchhhCCHHHHHH
Confidence 23346788999999887777655 999999999999999999997654322222111 11112222323478999999
Q ss_pred HHHhcccCCCCcC------CCccccc
Q 023591 256 ISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 256 i~~~l~~dp~~Rp------~h~~~~~ 275 (280)
|.+||+.+|.+|| .|+||++
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHhccChhhCcCHHHHhhChHhhc
Confidence 9999999999999 9999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=275.06 Aligned_cols=241 Identities=23% Similarity=0.338 Sum_probs=197.6
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
..++|++.+.||+|++|.||++.+.. +..||+|.+.......+.+.+|+..+++++|+|++++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 44789999999999999999999754 56799999887665667788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 99 ~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
+++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCcccc
Confidence 99999999987644 6899999999999999999999999999999999999998887 9999999887544222111
Q ss_pred C--CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 177 S--TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 177 ~--~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
. ......|+|||.+.+..++.. +|+||||+++|+|++ |+.||.......... .+.. ....+.....+..+.
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~ 234 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ----QVDQ-GYRMPCPPGCPKELY 234 (261)
T ss_pred cCCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHc-CCCCCCCCcCCHHHH
Confidence 1 112357999999887777655 999999999999999 999997654332222 2211 122222236789999
Q ss_pred HHHHHhcccCCCCcC
Q 023591 254 HLISRIFVADPAKSE 268 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp 268 (280)
+++.+||+.||++||
T Consensus 235 ~li~~~l~~~P~~Rp 249 (261)
T cd05068 235 DIMLDCWKEDPDDRP 249 (261)
T ss_pred HHHHHHhhcCcccCC
Confidence 999999999999999
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=281.40 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=205.0
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC-CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
..++|++.+.||+|+||.||++.+..++..|++|.+... ....+.+.+|+.++++++|||++++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 348999999999999999999999888999999998643 2334567889999999999999999999999899999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-CC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~ 176 (280)
|+++++|.+++.+ ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++........ ..
T Consensus 97 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 97 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred cCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceecccccccccc
Confidence 9999999998865 35789999999999999999999999999999999999998776 99999998764333222 22
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (280)
...+++.|++||.+.+..++.. +|+||||+++|++++|..||...+......... ......+.....++..++++|
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li 249 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFRDFL 249 (293)
T ss_pred cccCChhhcCchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChhhheeehh---cCCCCCCCCccccCHHHHHHH
Confidence 3457788999999887776555 999999999999999999997654322211111 111222223335788999999
Q ss_pred HHhcccCCCCcC------CCcccccc
Q 023591 257 SRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 257 ~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
++||+.+|++|| .||||+..
T Consensus 250 ~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 250 NRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred HHHccCChhhCcCHHHHhcCHHHhcC
Confidence 999999999999 99999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=287.60 Aligned_cols=254 Identities=29% Similarity=0.452 Sum_probs=199.9
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecC-----Ce
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 91 (280)
.++|++.+.||+|++|.||++++..+++.|++|.+... ......+.+|+.+++.++|+|++++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46899999999999999999999999999999998653 22334567899999999999999999987643 34
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
.++++||+. ++|.+++.....+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCC
Confidence 899999995 689988888888999999999999999999999999999999999999998876 99999999875433
Q ss_pred C-CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHh-----------------
Q 023591 172 H-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------------- 233 (280)
Q Consensus 172 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------------- 233 (280)
. .......++..|+|||.+.+......++|+||||+++|+|++|..||...+..........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 3 2223345678899999886543344559999999999999999999976432111111100
Q ss_pred ------hHhccc-ccC-CCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 234 ------RILSVQ-YSI-PDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 234 ------~~~~~~-~~~-~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
...... ..+ .....+++++.+||.+||+.||++|| .||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000 000 01235789999999999999999999 99999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=288.00 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=201.4
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEec----CCeEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHLA 93 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~ 93 (280)
++|++.+.||+|++|.||++.+..+++.|++|.+.... .....+.+|+.++++++|+||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 78999999999999999999999999999999987642 334567789999999999999999988753 34689
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
+||||+. ++|.+++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSP 161 (334)
T ss_pred EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccC
Confidence 9999995 589998877778999999999999999999999999999999999999998887 9999999986443222
Q ss_pred CC-----CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhh--------------
Q 023591 174 QP-----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-------------- 234 (280)
Q Consensus 174 ~~-----~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 234 (280)
.. ....++..|.|||.+.+......++|+||||+++|+|++|..||...............
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 11 23457788999999866443455599999999999999999999765432221111110
Q ss_pred -----H---hcccccCC---CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 235 -----I---LSVQYSIP---DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 235 -----~---~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
. .......+ .....++++.++|.+||+.||++|| .||||++...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 0 00000000 0124689999999999999999999 9999976543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=285.38 Aligned_cols=251 Identities=26% Similarity=0.452 Sum_probs=203.8
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
..-|.....||+|+||.||++.+..+++.|++|.+.... ...+.+.+|+..++.++|||++++++.+..+...++++||
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 355667779999999999999999899999999986533 3345677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCCC
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (280)
+++++|.+++.. ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccc
Confidence 999999887644 56899999999999999999999999999999999999998877 9999999876433222 2233
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHH
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (280)
..++..|+|||.+.+..++.. +|+||||+++|+|++|..||............ .... .........++..+.++|.
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~l~~~i~ 252 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-RDSP--PPKLKNAHKISPVLRDFLE 252 (297)
T ss_pred eecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hccC--CCCccccCCCCHHHHHHHH
Confidence 457889999999987776555 99999999999999999999765432222211 1111 1111222357889999999
Q ss_pred HhcccCCCCcC------CCccccccc
Q 023591 258 RIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 258 ~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
+||+.+|++|| .||||.++.
T Consensus 253 ~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 253 RMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHhcCCcccCcCHHHHhhChhhccCC
Confidence 99999999999 999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=275.58 Aligned_cols=241 Identities=24% Similarity=0.378 Sum_probs=195.9
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
..++|++.+.||+|++|.||.+.... +..+|+|.+.......+.+.+|+..+++++||||+++++++......+++|||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 35789999999999999999998754 44599998876655567789999999999999999999999888889999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC--
Q 023591 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (280)
Q Consensus 99 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~-- 175 (280)
+.+++|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC--EEECCCccceecCCCceeec
Confidence 9999999998764 36899999999999999999999999999999999999987776 999999987644322211
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
....++..|+|||.+.+..++.. +|+||||+++|+|++ |..||............ ..... .......+..+.+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~ 232 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV----SQGLR-LYRPHLASEKVYA 232 (256)
T ss_pred CCCccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH----hcCCC-CCCCCCCCHHHHH
Confidence 11224467999999987777655 999999999999998 99999765543222222 22211 1112246899999
Q ss_pred HHHHhcccCCCCcC
Q 023591 255 LISRIFVADPAKSE 268 (280)
Q Consensus 255 li~~~l~~dp~~Rp 268 (280)
++.+||+.||.+||
T Consensus 233 li~~cl~~~p~~Rp 246 (256)
T cd05113 233 IMYSCWHEKAEERP 246 (256)
T ss_pred HHHHHcCCCcccCC
Confidence 99999999999999
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=283.72 Aligned_cols=249 Identities=27% Similarity=0.458 Sum_probs=202.7
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
+.|.....||+|++|.||++.+..++..||+|.+.... ...+.+.+|+..++.++|+|++++++.+...+..+++|||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 56777889999999999999999899999999986533 33356778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCCCC
Q 023591 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 178 (280)
Q Consensus 100 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~~ 178 (280)
++++|.+++.. ..+++..+..++.||+.+|++||+.|++|+||+|+||+++.++. ++|+|||++....... .....
T Consensus 102 ~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~ 178 (292)
T cd06658 102 EGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRKSL 178 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccCcee
Confidence 99999887744 46899999999999999999999999999999999999998876 9999999876432221 12234
Q ss_pred cCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHH
Q 023591 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258 (280)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 258 (280)
.++..|+|||.+.+..++.. +|+||+|+++|+|++|..||............. ... ....+....++..+.+++.+
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR-DNL--PPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hcC--CCccccccccCHHHHHHHHH
Confidence 57888999999877777655 999999999999999999998654432222211 111 11222223578899999999
Q ss_pred hcccCCCCcC------CCcccccc
Q 023591 259 IFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 259 ~l~~dp~~Rp------~h~~~~~~ 276 (280)
||..||++|| .||||+..
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhcc
Confidence 9999999999 99999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=291.87 Aligned_cols=245 Identities=36% Similarity=0.635 Sum_probs=211.9
Q ss_pred eeee--cccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 23 YELV--RDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 23 y~~~--~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
|++. +.||+|-||+||-++++++|+.||+|++.+. .+....+.+|+.+|+++.||.||.+.-.+++.+.+++|||
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME 643 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME 643 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence 4443 6899999999999999999999999999763 4555778899999999999999999999999999999999
Q ss_pred ccCCCchHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC-CCCcEEEeecCCccccccCCC
Q 023591 98 YASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 98 ~~~~~~L~~~~--~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~-~~~~~~l~df~~~~~~~~~~~ 174 (280)
-+.| +..+.+ .+.+++++...+.++.||+.||.|||.++|+|+||||+||++.+. .-+.+||+|||+|+.......
T Consensus 644 Kl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 644 KLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 9965 665555 345689999999999999999999999999999999999999643 335699999999997777777
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC--CCCCCCCHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPEC 252 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 252 (280)
.....|||.|+|||++.++.|... .|+||.|+|+|.-++|..||....+ +-.++....+-+ .+|..++++.
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEd------IndQIQNAaFMyPp~PW~eis~~A 795 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDED------INDQIQNAAFMYPPNPWSEISPEA 795 (888)
T ss_pred hhhhcCCccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccc------hhHHhhccccccCCCchhhcCHHH
Confidence 778889999999999999999766 8999999999999999999975432 333444445444 4577899999
Q ss_pred HHHHHHhcccCCCCcC------CCccccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
.+||..+|+..-.+|. .|||+++
T Consensus 796 idlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 796 IDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred HHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 9999999999999999 9999985
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=283.33 Aligned_cols=242 Identities=24% Similarity=0.346 Sum_probs=192.0
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcE--EEEEEeeeC--CcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~--vaiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 93 (280)
..++|++.+.||+|+||.||+|.+..++.. +++|.+... ......+.+|+.++.++ +|+|++++++++..++..+
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 457899999999999999999998777654 466665532 22334677899999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCc
Q 023591 94 IVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~ 157 (280)
++|||+++++|.+++.... .+++..++.++.|++.||++||+.|++||||+|+||+++.++.
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~-- 162 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-- 162 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--
Confidence 9999999999999986432 4789999999999999999999999999999999999988776
Q ss_pred EEEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHh
Q 023591 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRIL 236 (280)
Q Consensus 158 ~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 236 (280)
++|+|||++..............+..|+|||.+.+..++.. +||||||+++|+|++ |..||......+.. ....
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~----~~~~ 237 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELY----EKLP 237 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCccc-ccchhhhhHHHHHHhcCCCCcccCChHHHH----HHHh
Confidence 99999998863322222222233567999998877766555 999999999999998 99999765432222 2221
Q ss_pred cccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 237 SVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 237 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
...........++++.+|+.+||+.+|++||
T Consensus 238 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 268 (303)
T cd05088 238 -QGYRLEKPLNCDDEVYDLMRQCWREKPYERP 268 (303)
T ss_pred -cCCcCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 1222222225788999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=278.69 Aligned_cols=248 Identities=31% Similarity=0.453 Sum_probs=198.5
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
|++.+.||.|++|.||++.+..++..|++|.+.... ...+.+.+|+..+++++|+|++++++++..+...++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678899999999999999999999999999987543 22356778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCC
Q 023591 100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (280)
Q Consensus 100 ~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (280)
+ ++|.+++.... .+++..+..++.|++.+|++||+.+++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc--EEEeecccccccCCCccccC
Confidence 5 58998887665 6899999999999999999999999999999999999998776 9999999986433221 112
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc--------------ccccC
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------------VQYSI 242 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------~~~~~ 242 (280)
...++..|+|||.+.+......++|+||||+++|+|++|..||..........+..+.... ....+
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 2345778999998876544344599999999999999999999765543333222221000 00000
Q ss_pred ---------CCCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 243 ---------PDYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 243 ---------~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.....++.++.++|.+||+.||++|| .||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01235778999999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=280.34 Aligned_cols=241 Identities=23% Similarity=0.371 Sum_probs=195.7
Q ss_pred CCCeeeecccccCCceEEEEEEecCCC-----cEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTE-----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~-----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
.++|++.+.||+|++|.||++.....+ ..+++|.+..... ....+.+|+..+++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 468999999999999999999976554 6799998865432 234578899999999999999999999988899
Q ss_pred EEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCC
Q 023591 93 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~ 156 (280)
+++|||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~- 162 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT- 162 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc-
Confidence 9999999999999998654 35788999999999999999999999999999999999998876
Q ss_pred cEEEeecCCccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHH
Q 023591 157 RLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (280)
Q Consensus 157 ~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 232 (280)
++|+|||++....... ......+++.|+|||.+.+..++.. +|+||||+++|+|++ |..||......+. .
T Consensus 163 -~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~il~el~~~g~~p~~~~~~~~~----~ 236 (283)
T cd05048 163 -VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEV----I 236 (283)
T ss_pred -EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh-hhHHHHHHHHHHHHcCCCCCCCCCCHHHH----H
Confidence 9999999987433221 1223345678999999887777655 999999999999998 9999976554322 2
Q ss_pred hhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..+..... .+....+++++.+|+.+||+.||.+||
T Consensus 237 ~~i~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~Rp 271 (283)
T cd05048 237 EMIRSRQL-LPCPEDCPARVYALMIECWNEIPARRP 271 (283)
T ss_pred HHHHcCCc-CCCcccCCHHHHHHHHHHccCChhhCc
Confidence 22222221 111236889999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=278.26 Aligned_cols=250 Identities=28% Similarity=0.482 Sum_probs=203.6
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
..|...+.||+|++|.||++.+..+++.+++|.+..... ..+.+.+|+.+++.++|+|++++++++...+..++++||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 456777899999999999999988999999998865432 2345778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCCCC
Q 023591 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 178 (280)
Q Consensus 100 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~~ 178 (280)
++++|.+++.. .+++...+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||.+....... .....
T Consensus 99 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 99 EGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCcccccc
Confidence 99999998876 67899999999999999999999999999999999999998876 9999999776332221 12234
Q ss_pred cCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc-ccCCCCCCCCHHHHHHHH
Q 023591 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISPECRHLIS 257 (280)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 257 (280)
.+++.|+|||.+.+..++.. +|+||+|+++|+|++|..||...+....... +.... ........++..+.+|+.
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~ 250 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR----IRDNLPPKLKNLHKVSPRLRSFLD 250 (285)
T ss_pred cCCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH----HHhcCCCCCcccccCCHHHHHHHH
Confidence 57888999999877776555 9999999999999999999976543222222 22111 111222247889999999
Q ss_pred HhcccCCCCcC------CCcccccccC
Q 023591 258 RIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 258 ~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
+||+.+|++|| .||||+++..
T Consensus 251 ~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 251 RMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHcccChhhCcCHHHHccCcccccCCC
Confidence 99999999999 9999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=277.75 Aligned_cols=249 Identities=28% Similarity=0.470 Sum_probs=199.2
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
+|++.+.||.|++|.||++++..+++.|++|.+.... ...+.+.+|+.++++++|+|++++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5899999999999999999999999999999987643 23456778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CC
Q 023591 100 SGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (280)
Q Consensus 100 ~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~ 175 (280)
++ +|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++. ++|+|||++....... ..
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTF 157 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCcccc
Confidence 75 888877543 35899999999999999999999999999999999999998877 9999999886433221 12
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc--------------ccc
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------------QYS 241 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------~~~ 241 (280)
....++..|++||.+.+......++|+||||+++|+|++|..||...+............... ...
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 234467789999988665544455999999999999999999998765543333322211000 000
Q ss_pred CCC---------CCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 242 IPD---------YVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 242 ~~~---------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.+. .+..+..+.+++.+||+.||.+|| .||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000 013578899999999999999999 99997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=279.25 Aligned_cols=246 Identities=28% Similarity=0.442 Sum_probs=202.4
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
..|+..+.||.|++|.||++.+..++..+|+|.+.... .....+.+|+.++++++|+|++++++.+..+...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 46889999999999999999999889999999987543 2335678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-CCC
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~~ 177 (280)
+++++|.+++.. .++++..+..++.|++.+|++||+.+++|+||+|+||+++.++. ++++|||++........ ...
T Consensus 84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCcccccc
Confidence 999999998864 56899999999999999999999999999999999999998776 99999998864433221 223
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-cccCCCCCCCCHHHHHHH
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLI 256 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 256 (280)
..++..|.|||.+.+...+.. +|+||||+++|+|++|..||.......... .+... .... ...++..+.+++
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~~li 233 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVLF----LIPKNNPPTL--TGEFSKPFKEFI 233 (277)
T ss_pred ccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChHhHhh----hhhcCCCCCC--chhhhHHHHHHH
Confidence 356778999999887776555 999999999999999999997654322111 11111 1111 124678899999
Q ss_pred HHhcccCCCCcC------CCcccccc
Q 023591 257 SRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 257 ~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.+||+.+|++|| .||||.+.
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 234 DACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred HHHcccCcccCcCHHHHHhChHhhhc
Confidence 999999999999 99999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=275.23 Aligned_cols=243 Identities=30% Similarity=0.433 Sum_probs=193.3
Q ss_pred ccccCCceEEEEEEecCCCcEEEEEEeeeCCcc----cHHHHHHH---HHhhhCCCCCeeeeceEEecCCeEEEEEeccC
Q 023591 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREI---INHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (280)
Q Consensus 28 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (280)
.||+|+||.||++.+..+++.||+|.+.+.... ......|. ..++...|++++.+.+.+..+...++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 479999999999999999999999998764221 11223333 33444589999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcC
Q 023591 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (280)
Q Consensus 101 ~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 180 (280)
+++|..++.....+++..+..++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||++...... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~~-~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCcc-CCcCcCC
Confidence 9999999888888999999999999999999999999999999999999998776 999999988643322 2234568
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (280)
+..|+|||.+.++.....++|+||+|+++|+|++|..||....... ..............++. .+|.++.+++.+||
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~--~~s~~~~~li~~~l 234 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPD--SFSPELRSLLEGLL 234 (278)
T ss_pred CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-hHHHHHHhhccCCCCCC--cCCHHHHHHHHHHh
Confidence 8899999998755333344999999999999999999997653321 12222222333334444 57899999999999
Q ss_pred ccCCCCcC-----------CCcccccc
Q 023591 261 VADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 261 ~~dp~~Rp-----------~h~~~~~~ 276 (280)
..||.+|| .||||+..
T Consensus 235 ~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 235 QRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred hcCHHhccCCCCCCHHHHHhCccccCC
Confidence 99999999 79999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=282.38 Aligned_cols=246 Identities=28% Similarity=0.433 Sum_probs=202.1
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+.|+..+.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+.++++++|+|++++++.+..+...++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 56888999999999999999999889999999887543 3335688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-CCC
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~~ 177 (280)
+++++|.+++.. ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++++|||++........ ...
T Consensus 84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhc
Confidence 999999988754 56899999999999999999999999999999999999998877 99999998864433221 123
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-cccCCCCCCCCHHHHHHH
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLI 256 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 256 (280)
..++..|+|||.+.+..++.. +|+||||+++++|++|..||........... +... ..... ...+.++.++|
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~li 233 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLFL----IPKNSPPTLE--GQYSKPFKEFV 233 (277)
T ss_pred ccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchhhHHhh----hhcCCCCCCC--cccCHHHHHHH
Confidence 356788999999987776555 9999999999999999999975443221111 1111 11111 24678999999
Q ss_pred HHhcccCCCCcC------CCcccccc
Q 023591 257 SRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 257 ~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.+||+.+|++|| .||||..+
T Consensus 234 ~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 234 EACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHccCCcccCcCHHHHHHhHHHHHH
Confidence 999999999999 89999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=288.37 Aligned_cols=259 Identities=25% Similarity=0.356 Sum_probs=200.5
Q ss_pred CcccccCCCCCCCCCC----CCCCeeeecccccCCceEEEEEEecCC-----CcEEEEEEeeeCCc--ccHHHHHHHHHh
Q 023591 3 RSAMTVGPGMDMPIMH----DSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINH 71 (280)
Q Consensus 3 ~~~~~~~~~~~~~~~~----~~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l 71 (280)
++.+-+...++++... ..++|++.+.||+|+||.||++.+... +..||+|.+..... ..+.+.+|+.++
T Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l 94 (400)
T cd05105 15 GHEYIYVDPMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIM 94 (400)
T ss_pred CceeeeeccccCCCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHH
Confidence 3444455555665443 346899999999999999999987433 34699999865432 235678899999
Q ss_pred hhCC-CCCeeeeceEEecCCeEEEEEeccCCCchHHHHHhc---------------------------------------
Q 023591 72 RSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--------------------------------------- 111 (280)
Q Consensus 72 ~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------------------------------------- 111 (280)
+++. ||||+++++++......++||||+++++|.+++...
T Consensus 95 ~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (400)
T cd05105 95 THLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENK 174 (400)
T ss_pred HhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccc
Confidence 9995 999999999999889999999999999998887532
Q ss_pred ---------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHH
Q 023591 112 ---------------------------------------------------------GRFSEDEARFFFQQLISGVSYCH 134 (280)
Q Consensus 112 ---------------------------------------------------------~~l~~~~~~~~~~~i~~~l~~Lh 134 (280)
..++...+..++.|++.||+|||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 254 (400)
T cd05105 175 GDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA 254 (400)
T ss_pred ccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 13677888999999999999999
Q ss_pred hcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHH
Q 023591 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYV 211 (280)
Q Consensus 135 ~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~ 211 (280)
+.+++|+||+|+||+++.++. ++|+|||++........ .....+++.|+|||.+.+..++.. +||||||+++|+
T Consensus 255 ~~~ivH~dikp~Nill~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwSlGvil~e 331 (400)
T cd05105 255 SKNCVHRDLAARNVLLAQGKI--VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL-SDVWSYGILLWE 331 (400)
T ss_pred hCCeeCCCCChHhEEEeCCCE--EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCch-hhHHHHHHHHHH
Confidence 999999999999999998776 99999999874322211 222345678999999987777655 999999999999
Q ss_pred HHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 212 MLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 212 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
|++ |..||............. . .....+....++.++.+++.+||+.||++||
T Consensus 332 llt~g~~P~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 385 (400)
T cd05105 332 IFSLGGTPYPGMIVDSTFYNKI---K-SGYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385 (400)
T ss_pred HHHCCCCCCcccchhHHHHHHH---h-cCCCCCCCccCCHHHHHHHHHHCccCHhHCc
Confidence 997 999997654322222211 1 1222222336789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=280.24 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=197.3
Q ss_pred CCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecC
Q 023591 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (280)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 89 (280)
.++.....++|++.+.||+|++|.||++.+..+++.||+|.+..... ......+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred cCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 34455566899999999999999999999999999999998865322 223456799999999999999999987654
Q ss_pred C--------eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEE
Q 023591 90 T--------HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (280)
Q Consensus 90 ~--------~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l 160 (280)
. ..+++|||+.+ +|.+.+... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl 160 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LKL 160 (310)
T ss_pred cccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EEE
Confidence 3 45999999964 787777554 36899999999999999999999999999999999999988876 999
Q ss_pred eecCCccccccCCCC-----CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhH
Q 023591 161 CDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235 (280)
Q Consensus 161 ~df~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (280)
+|||++......... ....++..|+|||.+.+......++|+||||+++|+|++|..||.......... ....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~-~~~~~ 239 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT-LISQL 239 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHH
Confidence 999988744332211 123456789999988765533455999999999999999999997654322211 11111
Q ss_pred hcc----------------cccCCC-----------CCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 236 LSV----------------QYSIPD-----------YVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 236 ~~~----------------~~~~~~-----------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
... ....+. ....++.+.+||.+||..||++|| .||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 100 000000 012356788999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=286.35 Aligned_cols=254 Identities=29% Similarity=0.455 Sum_probs=196.4
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC--CcccHHHHHHHHHhhhCCCCCeeeeceEEecC-----CeE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----THL 92 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 92 (280)
.++|++.+.||+|++|.||++.+..+++.||+|.+... ......+.+|+.++++++|+|++++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 47899999999999999999999999999999998642 23345677899999999999999999887543 357
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
++++||+.+ +|.+.+. ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 84 ~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~ 159 (336)
T cd07849 84 YIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPE 159 (336)
T ss_pred EEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeecccc
Confidence 999999964 7877764 456999999999999999999999999999999999999998877 999999988644322
Q ss_pred CC----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHh-----------hHhc
Q 023591 173 SQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-----------RILS 237 (280)
Q Consensus 173 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-----------~~~~ 237 (280)
.. .....+++.|+|||.+.+....+.++||||+|+++|+|++|..||.............. .+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 12245678899999876544334559999999999999999999976432211111110 0000
Q ss_pred -----------ccccCC---CCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 238 -----------VQYSIP---DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 238 -----------~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.....+ ..+..++++.++|.+||+.||++|| .||||+..-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000000 0124678899999999999999999 999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=274.86 Aligned_cols=241 Identities=23% Similarity=0.389 Sum_probs=196.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+..+|++.+.||+|++|.||++.+. ++..+++|.+.........+.+|+.++++++|+|++++++++...+..+++|||
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 3467999999999999999999886 466799999876655566788999999999999999999999988899999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC--
Q 023591 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (280)
Q Consensus 99 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~-- 175 (280)
+++++|.+++... ..+++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceeccccccccc
Confidence 9999999998653 46899999999999999999999999999999999999998877 999999988644322111
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
.....+..|+|||.+.+..++.. +|+||||+++|+|++ |..||........... +.. ....+....++.++.+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~ 232 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVES----VSA-GYRLYRPKLAPTEVYT 232 (256)
T ss_pred CCCCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH----HHc-CCcCCCCCCCCHHHHH
Confidence 11123347999999988777665 999999999999998 8999976544332222 211 1122222357899999
Q ss_pred HHHHhcccCCCCcC
Q 023591 255 LISRIFVADPAKSE 268 (280)
Q Consensus 255 li~~~l~~dp~~Rp 268 (280)
++.+||+.+|++||
T Consensus 233 li~~cl~~~p~~Rp 246 (256)
T cd05059 233 IMYSCWHEKPEDRP 246 (256)
T ss_pred HHHHHhcCChhhCc
Confidence 99999999999999
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=282.92 Aligned_cols=249 Identities=23% Similarity=0.413 Sum_probs=211.3
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccC
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (280)
+-|.++++||+|+||.|+++.++.+|..+|||.+.... ...++..|+.++++++.+++|++++.+.....+++|||||.
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 35788999999999999999999999999999987653 55778899999999999999999999988899999999999
Q ss_pred CCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCCC
Q 023591 101 GGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (280)
Q Consensus 101 ~~~L~~~~~-~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~ 178 (280)
.|+..+.++ +++++++.++..+++..+.+|+|||...-+|||||+.||++..+|. .||.|||.+...... ...++.
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHHhhCcc
Confidence 999999885 4668999999999999999999999999999999999999998887 999999988643322 233566
Q ss_pred cCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHH
Q 023591 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258 (280)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 258 (280)
.|+|.|+|||++..-.|+.. +||||||++..||..|++||.+-.....+.- -.......+.....+|+++.+||++
T Consensus 190 IGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---IPT~PPPTF~KPE~WS~~F~DFi~~ 265 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---IPTKPPPTFKKPEEWSSEFNDFIRS 265 (502)
T ss_pred ccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccccceeEe---ccCCCCCCCCChHhhhhHHHHHHHH
Confidence 79999999999988888777 9999999999999999999987554322211 1111222333333689999999999
Q ss_pred hcccCCCCcC------CCcccccc
Q 023591 259 IFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 259 ~l~~dp~~Rp------~h~~~~~~ 276 (280)
||-.+|++|- +|||+++-
T Consensus 266 CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 266 CLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred HhcCCHHHHHHHHHHhhhhhhcCC
Confidence 9999999999 99999854
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=279.17 Aligned_cols=241 Identities=25% Similarity=0.361 Sum_probs=196.6
Q ss_pred CCCeeeecccccCCceEEEEEEecC-----CCcEEEEEEeeeCCcc--cHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
.++|.+.+.||+|++|.||++.... +++.||+|.+...... .+.+.+|+++++.++|+|++++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4679999999999999999998743 3578999998764332 35788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcE
Q 023591 93 AIVMEYASGGELFERICNAG--------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~--------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~ 158 (280)
+++|||+++++|.+++...+ .+++..+..++.|++.+|.+||++|++|+||+|+||+++.++. +
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~ 161 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV--V 161 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--E
Confidence 99999999999999986542 3788899999999999999999999999999999999998877 9
Q ss_pred EEeecCCccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhh
Q 023591 159 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHR 234 (280)
Q Consensus 159 ~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (280)
+|+|||++....... .......++.|+|||.+.+..++.. +||||||+++|+|++ |..||...........
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~---- 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC---- 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----
Confidence 999999886432221 1223334678999999988887665 999999999999998 9999976554332222
Q ss_pred HhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 235 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
+........ ...++..+.+++.+||+.||++||
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp 269 (280)
T cd05049 237 ITQGRLLQR-PRTCPSEVYDIMLGCWKRDPQQRI 269 (280)
T ss_pred HHcCCcCCC-CCCCCHHHHHHHHHHcCCCcccCC
Confidence 222222211 225789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=278.30 Aligned_cols=244 Identities=34% Similarity=0.567 Sum_probs=204.9
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCC-CCCeeeeceEEecCCeEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 95 (280)
++|++.+.||+|++|.||++.+..++..+++|++.+.. ...+.+.+|+.++++++ |+||+++++++..++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999987632 23356778999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 174 (280)
||++.+++|.+++.....++...++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCcccc
Confidence 999999999999988888999999999999999999999999999999999999998877 99999998864432221
Q ss_pred --------------------CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhh
Q 023591 175 --------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (280)
Q Consensus 175 --------------------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (280)
.....++..|+|||...+..++.. +|+||||++++++++|..||....... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~ 233 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSNEYL----TFQK 233 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh-hhHHHHHHHHHHHHhCCCCCCCccHHH----HHHH
Confidence 122345778999999877766555 999999999999999999998765322 2223
Q ss_pred HhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC----------CCccc
Q 023591 235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKSE----------MHDWR 273 (280)
Q Consensus 235 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp----------~h~~~ 273 (280)
+......++. .+++.+.+||.+||+.||++|| .||||
T Consensus 234 ~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCCCCC--ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 3333444444 6789999999999999999999 68886
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=281.04 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=197.3
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCC-CCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|+..+.||+|+||.||++.+..+++.+|+|.+.... .....+.+|+..+.++. |+||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 56788899999999999999999999999999987543 23345778998898885 9999999999998889999999
Q ss_pred ccCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 98 YASGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 98 ~~~~~~L~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
|+.. ++.++.. ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhcc
Confidence 9854 6554432 245799999999999999999999974 9999999999999998776 99999999875443
Q ss_pred CCCCCCCcCCCcccCcccccCC---cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc-ccCCC--C
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPD--Y 245 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~--~ 245 (280)
........++..|+|||.+.+. .++ .++||||+|+++|+|++|..||..... ............ ..++. .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYD-VRSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCc-chhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhcCCCCCcCCCcCC
Confidence 3333444678889999998766 344 449999999999999999999976431 112222222111 11111 2
Q ss_pred CCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 246 VHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
..++.++.+||.+||+.||++|| .||||++.
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 24789999999999999999999 99999754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=286.70 Aligned_cols=253 Identities=31% Similarity=0.457 Sum_probs=204.1
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCC-----eEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 93 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 93 (280)
+|++.+.||+|++|.||++++..+++.+++|.+.... ...+.+.+|+..++.++|+|++++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6999999999999999999999889999999987643 23456888999999999999999999987764 789
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
++|+|++ ++|.+.+....++++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccCceEeecccc
Confidence 9999997 489888887778999999999999999999999999999999999999998876 9999999987554432
Q ss_pred ----CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc----------
Q 023591 174 ----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------- 239 (280)
Q Consensus 174 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 239 (280)
......++..|+|||.+.+......++|+||||+++|+|++|..||...........+........
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 123345678899999998773334559999999999999999999977654332222221110000
Q ss_pred --------------ccCC-CCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 240 --------------YSIP-DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 240 --------------~~~~-~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
..+. ....++.++.+||.+||+.||++|| .||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0000 0124688999999999999999999 999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=299.13 Aligned_cols=250 Identities=28% Similarity=0.440 Sum_probs=211.8
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeee-CCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
+-|.|+..||.|+||+||++.++.++-..|.|++.. +....+.+.-|+++|..++||+||++++.|..++.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 568999999999999999999998888888888764 4455677888999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc-cccCCCCCC
Q 023591 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKS 177 (280)
Q Consensus 100 ~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~-~~~~~~~~~ 177 (280)
+||-++..+-. ...+++..|.-+++|++.||.|||+++|+|||||+.||+++.+|. ++|.|||.+.. .........
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhcc
Confidence 99998887644 567999999999999999999999999999999999999999999 99999997642 223334467
Q ss_pred CcCCCcccCccccc-----CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 178 TVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 178 ~~~~~~~~aPE~~~-----~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
+.|||+|+|||+.. ..+|+.. +||||||++|.+|..+.+|....+....+.++.+ .....+-....++..+
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDyk-aDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---SePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLLQPSHWSRSF 265 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhh-hhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---cCCCcccCcchhhhHH
Confidence 78999999999875 3456555 9999999999999999999987766544444333 2333443444789999
Q ss_pred HHHHHHhcccCCCCcC------CCcccccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.||+.+||..||..|| .|||+++.
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 9999999999999999 99999854
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=270.46 Aligned_cols=244 Identities=32% Similarity=0.500 Sum_probs=205.5
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+|++.+.||+|++|.||++.+..+++.+++|.+..... ..+.+.+|++++++++|+|++++++++..+...++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58999999999999999999998999999999977543 446688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-CCC
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~~ 177 (280)
+++++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+........ ...
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC--EEEeccccceecCCCcccccc
Confidence 999999999988888999999999999999999999999999999999999998776 99999998875543332 233
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHH
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (280)
..++..|.|||...+..++.. +|+|++|+++++|++|..||........... ........++. .+++.+.+++.
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~-~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~--~~~~~~~~~i~ 232 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFR---IVQDDHPPLPE--GISPELKDFLM 232 (254)
T ss_pred cccchhhcCHhhhcCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHH---HhccCCCCCCC--CCCHHHHHHHH
Confidence 457888999999877765544 9999999999999999999976543222222 11222223333 67899999999
Q ss_pred HhcccCCCCcC------CCccc
Q 023591 258 RIFVADPAKSE------MHDWR 273 (280)
Q Consensus 258 ~~l~~dp~~Rp------~h~~~ 273 (280)
+||+.+|++|| .||||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 99999999999 89987
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=273.13 Aligned_cols=243 Identities=34% Similarity=0.538 Sum_probs=200.4
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEec--CCeEEEEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVM 96 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 96 (280)
+|++.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|+..+++++|+|++++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999987543 233457789999999999999999997754 45689999
Q ss_pred eccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 97 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh-----~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
||+++++|.+++.. ..++++..++.++.|++.+|++|| +.+++|+||+|+||+++.++. ++|+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC--EEEecccccc
Confidence 99999999988865 357899999999999999999999 899999999999999998776 9999999987
Q ss_pred ccccCCC-CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-cCCCC
Q 023591 168 SSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDY 245 (280)
Q Consensus 168 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 245 (280)
....... .....+++.|+|||.+.+..++.. +|+||||+++++|++|..||...... .....+..... .++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~- 232 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQL----QLASKIKEGKFRRIPY- 232 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCch-hHHHHHHHHHHHHHHCCCcccCcCHH----HHHHHHhcCCCCCCcc-
Confidence 5543332 334567889999999987776555 99999999999999999999875422 22222222222 2222
Q ss_pred CCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 246 VHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.++..+.+++.+||+.+|++|| .|||+
T Consensus 233 -~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 -RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 6789999999999999999999 99996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=271.87 Aligned_cols=243 Identities=33% Similarity=0.517 Sum_probs=199.3
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC------cccHHHHHHHHHhhhCCCCCeeeeceEEecC--CeE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 92 (280)
.+|++.+.||+|++|.||++.+..+++.+++|.+.... .....+.+|+.++++++|+|++++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 67999999999999999999999999999999875421 2234677899999999999999999998754 468
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
++++||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECccccccccccc
Confidence 899999999999999988778999999999999999999999999999999999999988776 999999998744321
Q ss_pred C----CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc--ccCCCCC
Q 023591 173 S----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--YSIPDYV 246 (280)
Q Consensus 173 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 246 (280)
. ......++..|+|||.+.+..++.. +|+||||+++++|++|..||......... . .+.... ..++.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~---~-~~~~~~~~~~~p~-- 232 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYEAMAAI---F-KIATQPTKPMLPD-- 232 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccCHHHHH---H-HHHcCCCCCCCCc--
Confidence 1 1122357788999999988776555 99999999999999999999765433222 2 222221 22333
Q ss_pred CCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 247 HISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.+++.+.++|.+||+ +|.+|| .|||+
T Consensus 233 ~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 233 GVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 688999999999999 579999 89884
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=275.59 Aligned_cols=243 Identities=28% Similarity=0.416 Sum_probs=197.9
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|++|.||++++..+++.+++|.+.... .....+.+|+.+++.++|+|++++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999998899999999886532 22346778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 97 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
||+++++|.+++.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhccccC
Confidence 99999999988753 345899999999999999999999999999999999999988776 999999987644332
Q ss_pred CC-CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 173 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
.. .....++..|+|||.+.+...+.. +|+||||+++|+|++|..||...... .......+.............++.
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEE 236 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccHH
Confidence 22 223457788999999977777655 99999999999999999999754321 222222222222221122357889
Q ss_pred HHHHHHHhcccCCCCcC
Q 023591 252 CRHLISRIFVADPAKSE 268 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp 268 (280)
+.+++.+||+.||++||
T Consensus 237 ~~~li~~~l~~~p~~Rp 253 (267)
T cd08229 237 LRQLVNMCINPDPEKRP 253 (267)
T ss_pred HHHHHHHhcCCCcccCC
Confidence 99999999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=277.86 Aligned_cols=251 Identities=20% Similarity=0.323 Sum_probs=198.2
Q ss_pred CCCCCeeeecccccCCceEEEEEEecC-----CCcEEEEEEeeeCCcc--cHHHHHHHHHhhhCCCCCeeeeceEEecCC
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPT 90 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 90 (280)
...++|++.+.||+|+||.||++.... .+..||+|.+...... ...+.+|+..+++++|+|++++++++....
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 356899999999999999999987542 3457999987654322 234678999999999999999999998888
Q ss_pred eEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEE
Q 023591 91 HLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l 160 (280)
..+++|||+++++|.+++... ..++...+..++.|++.||.+||++|++|+||+|+||+++.++. ++|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L 160 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKI 160 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEE
Confidence 999999999999999998642 23466788999999999999999999999999999999998776 999
Q ss_pred eecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHh
Q 023591 161 CDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRIL 236 (280)
Q Consensus 161 ~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 236 (280)
+|||++........ .....++..|+|||.+.+..++.. +|+||||+++|+|++ |..||......+ ....+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~~~~~~p~~~~~~~~----~~~~~~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQ----VLKFVM 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH
Confidence 99998864322211 122234567999999887777655 999999999999998 788987654322 222222
Q ss_pred cc-cccCCCCCCCCHHHHHHHHHhcccCCCCcC------------CCccccccc
Q 023591 237 SV-QYSIPDYVHISPECRHLISRIFVADPAKSE------------MHDWRRGCS 277 (280)
Q Consensus 237 ~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------------~h~~~~~~~ 277 (280)
.. ....+. ..++.+.+++.+||+.||++|| .||||++.+
T Consensus 236 ~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 236 DGGYLDQPD--NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred cCCCCCCCC--CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 22 122222 5678999999999999999999 599998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=278.25 Aligned_cols=242 Identities=25% Similarity=0.378 Sum_probs=195.4
Q ss_pred CCCCeeeecccccCCceEEEEEEec-----CCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
...+|.+.+.||+|+||+||++... .++..+++|.+.... .....+.+|+.++++++|+|++++++++......
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4578999999999999999999852 345678999886543 3345688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEE
Q 023591 93 AIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~-------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~ 159 (280)
+++|||+++++|.+++...+ .+++..+..++.|++.||++||++|++|+||+|+||+++.++. ++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~k 160 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VK 160 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EE
Confidence 99999999999999986543 3899999999999999999999999999999999999998876 99
Q ss_pred EeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhH
Q 023591 160 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRI 235 (280)
Q Consensus 160 l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 235 (280)
|+|||++........ .....++..|+|||.+.+..++.. +|+||||+++|+|++ |..||......... ..+
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~t~g~~p~~~~~~~~~~----~~i 235 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVI----ECI 235 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHH
Confidence 999999874432211 122334668999999987777655 999999999999998 89999765543322 222
Q ss_pred hcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
...... +.....+.++.+|+.+||+.||.+||
T Consensus 236 ~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp 267 (288)
T cd05093 236 TQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRL 267 (288)
T ss_pred HcCCcC-CCCCCCCHHHHHHHHHHccCChhhCC
Confidence 222211 11225789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=276.75 Aligned_cols=248 Identities=32% Similarity=0.515 Sum_probs=198.7
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecC--CeEEEEEe
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVME 97 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 97 (280)
|++.+.||+|++|.||++.+..+++.+++|.+.... .....+.+|+.++++++|+|++++++++... ...++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 788999999999999999999899999999998753 3335677899999999999999999999887 78999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC--
Q 023591 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (280)
Q Consensus 98 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-- 174 (280)
|+++ +|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence 9975 888888665 57999999999999999999999999999999999999998877 99999998875543321
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc-ccCCC---------
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPD--------- 244 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~--------- 244 (280)
......+..|+|||.+.+....+.++||||||+++++|++|..||...+................ ..++.
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 22234567899999876654444559999999999999999999987664433333222111000 00000
Q ss_pred --------------CCC-CCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 245 --------------YVH-ISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 245 --------------~~~-~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
... +++.+.+++.+||+.||.+|| .||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 011 388999999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=273.34 Aligned_cols=240 Identities=23% Similarity=0.348 Sum_probs=194.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
..++|++.+.||+|++|.||++++..++ .|++|.+.......+.+.+|+.++++++|+||+++++.+. +...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 3478999999999999999999887654 5999998876555677889999999999999999999874 4568999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC-
Q 023591 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (280)
Q Consensus 99 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~- 175 (280)
+++++|.+++... ..++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeecccccccc
Confidence 9999999998753 35789999999999999999999999999999999999998776 999999988644322211
Q ss_pred -CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 176 -~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
....++..|+|||...+..++.. +|+||||+++|+|++ |..||.......... .+.. ....+....++..+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~l~ 233 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVER-GYRMPCPPECPESLH 233 (262)
T ss_pred ccCCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHHH----HHhc-CCCCCCccccCHHHH
Confidence 12334567999999877777655 999999999999999 888987654432222 2211 111222235789999
Q ss_pred HHHHHhcccCCCCcC
Q 023591 254 HLISRIFVADPAKSE 268 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp 268 (280)
+++.+||+.||++||
T Consensus 234 ~li~~~l~~~p~~Rp 248 (262)
T cd05071 234 DLMCQCWRKEPEERP 248 (262)
T ss_pred HHHHHHccCCcccCC
Confidence 999999999999999
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=272.62 Aligned_cols=249 Identities=31% Similarity=0.466 Sum_probs=196.1
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
+.......||+|+||.||++++..++..|++|.+.... ...+.+.+|+.++++++|+||+++++++..++..++++||+
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 34444568999999999999999899999999887643 23456889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-C
Q 023591 100 SGGELFERICNA-GRF--SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (280)
Q Consensus 100 ~~~~L~~~~~~~-~~l--~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (280)
++++|.+++... ..+ ++..+..++.|++.||++||+.|++|+||+|+||+++.+. ..++|+|||.+........ .
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccCCCcc
Confidence 999999988754 445 8889999999999999999999999999999999997633 2499999998864432222 2
Q ss_pred CCCcCCCcccCcccccCCc-CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
....+++.|+|||.+.+.. ....++|+||+|+++|+|++|..||........... ..........++. .+++++.+
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~ 243 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-KVGMFKIHPEIPE--SLSAEAKN 243 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh-hhhhhccCCCCCc--ccCHHHHH
Confidence 2345788999999986543 233459999999999999999999975433211111 1111112222333 57889999
Q ss_pred HHHHhcccCCCCcC------CCccc
Q 023591 255 LISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~ 273 (280)
|+.+||+.+|++|| .||||
T Consensus 244 li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 244 FILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999 99997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=280.36 Aligned_cols=240 Identities=24% Similarity=0.343 Sum_probs=190.9
Q ss_pred CCeeeecccccCCceEEEEEEecCCCc--EEEEEEeeeC--CcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~--~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 95 (280)
++|++.+.||+|+||.||++....++. .+++|.+... ....+.+.+|+.+++++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 689999999999999999999876654 4688877632 22335678899999999 799999999999988899999
Q ss_pred EeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEE
Q 023591 96 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~ 159 (280)
+||+++++|.+++.+.. .++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~k 159 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--SK 159 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--EE
Confidence 99999999999986532 4788999999999999999999999999999999999988776 99
Q ss_pred EeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcc
Q 023591 160 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV 238 (280)
Q Consensus 160 l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 238 (280)
|+|||++..............+..|+|||.+.+..++.. +||||||+++|+|++ |..||.......... .+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~t~g~~pf~~~~~~~~~~----~~~~- 233 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYE----KLPQ- 233 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHhc-
Confidence 999998863322111122223456999999877777655 999999999999997 999997654432222 2222
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 239 QYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....+....++.++.+|+.+||+.||.+||
T Consensus 234 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 263 (297)
T cd05089 234 GYRMEKPRNCDDEVYELMRQCWRDRPYERP 263 (297)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 112222235889999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=280.56 Aligned_cols=249 Identities=26% Similarity=0.355 Sum_probs=194.1
Q ss_pred CeeeecccccCCceEEEEEEecC--CCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecC--CeEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKK--TEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLA 93 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~--~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 93 (280)
+|++.+.||+|++|.||++.+.. ++..||+|.+.... ...+.+.+|+.++++++|||++++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 88999999987632 3345678899999999999999999999887 7899
Q ss_pred EEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC----CCCCcEEEeecC
Q 023591 94 IVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG----SPAPRLKICDFG 164 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~----~~~~~~~l~df~ 164 (280)
+||||+++ ++.+.+... ..+++..++.++.|++.||+|||+.+++|+||+|+||+++. ++. ++|+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~--~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV--VKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce--EEECCCc
Confidence 99999965 676665321 26899999999999999999999999999999999999987 555 9999999
Q ss_pred CccccccCCC----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcc---------hHHHH
Q 023591 165 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---------NFRKT 231 (280)
Q Consensus 165 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---------~~~~~ 231 (280)
++........ .....++..|+|||.+.+......++|+||||+++++|++|..||....... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 8874433222 2233467789999988765544455999999999999999999997654432 01111
Q ss_pred HhhHh----------------------cccccCC---------CCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 232 IHRIL----------------------SVQYSIP---------DYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 232 ~~~~~----------------------~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
..... .....++ .....+.++.+++.+||+.||++|| .||||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00000 0000011 0114677899999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=276.87 Aligned_cols=252 Identities=31% Similarity=0.530 Sum_probs=203.6
Q ss_pred CeeeecccccCCceEEEEEEec---CCCcEEEEEEeeeCC-----cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeE
Q 023591 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 92 (280)
+|++.+.||.|++|.||++++. .+++.|++|.+.+.. .....+.+|+.+++++ +|+|++++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 457889999987532 2334577899999999 699999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
++||||+++++|.+.+.....+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEEECccccccccc
Confidence 999999999999999887778999999999999999999999999999999999999988776 999999988643332
Q ss_pred CC--CCCCcCCCcccCcccccCCc-CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 173 SQ--PKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 173 ~~--~~~~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
.. .....++..|++||.+.+.. ....++|+||||+++|+|++|..||...............+.......+. .++
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 236 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK--TMS 236 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCc--ccC
Confidence 21 12234788899999986654 12344999999999999999999997544332333333333333333333 578
Q ss_pred HHHHHHHHHhcccCCCCcC---------CCccccccc
Q 023591 250 PECRHLISRIFVADPAKSE---------MHDWRRGCS 277 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp---------~h~~~~~~~ 277 (280)
..+.++|.+||+.||++|| .||||++..
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 8999999999999999999 899998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=275.29 Aligned_cols=239 Identities=23% Similarity=0.352 Sum_probs=198.0
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
.+|++.+.||.|++|.||++.+.. +..+++|.+..... ....+.+|+.+++.++|+|++++++++......+++|||+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 579999999999999999999987 88899999876544 4567888999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC-C
Q 023591 100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-K 176 (280)
Q Consensus 100 ~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~-~ 176 (280)
++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+......... .
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCcccccc
Confidence 999999998753 46899999999999999999999999999999999999998877 999999988644322211 1
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
...++..|+|||.+.+..++.. +|+||||+++|+|++ |..||......+...... .....+.....++.+.++
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-----AGYRMPCPAKCPQEIYKI 236 (261)
T ss_pred CCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-----hCCcCCCCCCCCHHHHHH
Confidence 2234567999999877776555 999999999999998 899997655433333222 122233334688999999
Q ss_pred HHHhcccCCCCcC
Q 023591 256 ISRIFVADPAKSE 268 (280)
Q Consensus 256 i~~~l~~dp~~Rp 268 (280)
+.+||+.||.+||
T Consensus 237 i~~~l~~~p~~Rp 249 (261)
T cd05148 237 MLECWAAEPEDRP 249 (261)
T ss_pred HHHHcCCCchhCc
Confidence 9999999999999
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=270.63 Aligned_cols=243 Identities=29% Similarity=0.443 Sum_probs=197.9
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|++|.||++.+..+++.+++|.++... ...+.+.+|++++++++|+|++++++.+..++..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999899999999886422 22456788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 97 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
||+++++|.+++.. ...+++..++.++.+++.+|++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccCC
Confidence 99999999988854 345899999999999999999999999999999999999998776 999999987643322
Q ss_pred CC-CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 173 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
.. .....+++.|.|||.+.+..++.. +|+||||+++|+|++|..||..... ........+............++..
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEKCDYPPLPADHYSEE 236 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCc--cHHHHHhhhhcCCCCCCChhhcCHH
Confidence 21 233457788999999887777655 9999999999999999999965432 1222222222222211112257789
Q ss_pred HHHHHHHhcccCCCCcC
Q 023591 252 CRHLISRIFVADPAKSE 268 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp 268 (280)
+.++|.+||..+|++||
T Consensus 237 ~~~~i~~cl~~~p~~Rp 253 (267)
T cd08224 237 LRDLVSRCINPDPEKRP 253 (267)
T ss_pred HHHHHHHHcCCCcccCC
Confidence 99999999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=271.54 Aligned_cols=243 Identities=35% Similarity=0.586 Sum_probs=203.7
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+|++.+.||.|++|.||++.+..++..+++|.+.... .....+.+|++.++.++|+|++++.+.+......++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5899999999999999999999899999999987643 3445678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-
Q 023591 99 ASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (280)
Q Consensus 99 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~- 173 (280)
+++++|.+.+.+. ..+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcc
Confidence 9999999988763 67999999999999999999999999999999999999998776 9999999886443332
Q ss_pred CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-cCCCCCCCCHHH
Q 023591 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPEC 252 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 252 (280)
......+++.|+|||.+.+..++.. +|+||+|+++++|++|..||....... .......... ..+. .++..+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~--~~~~~~ 231 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLE----LALKILKGQYPPIPS--QYSSEL 231 (258)
T ss_pred eecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcHHH----HHHHHhcCCCCCCCC--CCCHHH
Confidence 2334467888999999877776555 999999999999999999997654322 2222222221 2222 578999
Q ss_pred HHHHHHhcccCCCCcC------CCccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.+++.+||..+|++|| .||||
T Consensus 232 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 232 RNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999 99997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=279.39 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=195.8
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecC----
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP---- 89 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 89 (280)
....++|++.+.||+|++|.||++.+..+++.+++|.+..... ......+|++++++++|+||+++++++...
T Consensus 4 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred CcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 3446899999999999999999999999999999999865422 234567899999999999999999887543
Q ss_pred ----CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 90 ----THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 90 ----~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
..++++++|+.+ ++...+.. ...+++..+..++.|+++||++||+.|++|+||+|+||++++++. ++|+|||
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg 160 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFG 160 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCc
Confidence 346999999965 67666644 457999999999999999999999999999999999999998887 9999999
Q ss_pred CccccccCCCC------------CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHH
Q 023591 165 YSKSSVLHSQP------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (280)
Q Consensus 165 ~~~~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (280)
++......... ....+++.|+|||.+.+......++||||||+++|+|++|..||.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 88643322211 112346779999988665444455999999999999999999997665533333222
Q ss_pred hhHhccc-------------------ccCC-----CCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 233 HRILSVQ-------------------YSIP-----DYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 233 ~~~~~~~-------------------~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
....... ...+ .....++.+.+||.+||+.||.+|| .||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 2111000 0000 0123457899999999999999999 99997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=272.34 Aligned_cols=234 Identities=27% Similarity=0.385 Sum_probs=188.5
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCch
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (280)
+.||+|+||.||++++..+++.+|+|.+.... .....+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999999899999999876432 2335688899999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC---CCCcC
Q 023591 105 FERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 180 (280)
Q Consensus 105 ~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~ 180 (280)
.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCCCCCC
Confidence 99986544 6899999999999999999999999999999999999988776 999999988743322111 11122
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHh
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 259 (280)
+..|+|||.+.++.++.. +|+||||+++|+|++ |..||.......... .+.. ....+....++..+.+|+.+|
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li~~~ 232 (252)
T cd05084 159 PVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQTRE----AIEQ-GVRLPCPELCPDAVYRLMERC 232 (252)
T ss_pred ceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHHHHH----HHHc-CCCCCCcccCCHHHHHHHHHH
Confidence 456999999887777665 999999999999998 888887654322111 1111 111222235789999999999
Q ss_pred cccCCCCcC
Q 023591 260 FVADPAKSE 268 (280)
Q Consensus 260 l~~dp~~Rp 268 (280)
|+.||++||
T Consensus 233 l~~~p~~Rp 241 (252)
T cd05084 233 WEYDPGQRP 241 (252)
T ss_pred cCCChhhCc
Confidence 999999999
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=276.67 Aligned_cols=247 Identities=27% Similarity=0.399 Sum_probs=198.1
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
.++|++.+.||+|++|.||++.+..+++.|++|.+..... ....+.+|+.+++.++|||++++.+++..+...++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 3679999999999999999999998999999999865332 224577899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
+||+++ ++.+.+.. ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~--- 167 (307)
T cd06607 94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSP--- 167 (307)
T ss_pred HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCC---
Confidence 999975 77666643 457999999999999999999999999999999999999998877 99999998764332
Q ss_pred CCCCcCCCcccCcccccC---CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 175 PKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
.....+++.|+|||.+.+ ..++ .++||||||+++|+|++|..||...+......... .......+ ...++.+
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~-~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~ 242 (307)
T cd06607 168 ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QNDSPTLS-SNDWSDY 242 (307)
T ss_pred CCCccCCccccCceeeeccCCCCCC-cccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh---cCCCCCCC-chhhCHH
Confidence 233457788999998742 3344 44999999999999999999997654322211111 11111111 1246789
Q ss_pred HHHHHHHhcccCCCCcC------CCccccccc
Q 023591 252 CRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
+.++|.+||+.||++|| .||||....
T Consensus 243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 99999999999999999 999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=278.64 Aligned_cols=246 Identities=25% Similarity=0.379 Sum_probs=195.5
Q ss_pred CCCeeeecccccCCceEEEEEEecCCC----------------cEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeee
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTE----------------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVR 81 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~----------------~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~ 81 (280)
.++|++++.||+|+||.||++.+...+ ..|++|.+.... ...+.+.+|+.++++++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 478999999999999999999876533 557999887543 23456788999999999999999
Q ss_pred eceEEecCCeEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEE
Q 023591 82 FKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (280)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i 150 (280)
+++++..+...+++||++++++|.+++.... .+++..++.++.|++.||++||+.|++|+||+|+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 9999999899999999999999999987655 68999999999999999999999999999999999999
Q ss_pred eCCCCCcEEEeecCCccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh--CCCCCCCCCCc
Q 023591 151 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEP 225 (280)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~--g~~p~~~~~~~ 225 (280)
+.++. ++|+|||++....... .......++.|+|||.+.+..++.. +||||||+++|+|++ +..||......
T Consensus 164 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 164 GKNYT--IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred cCCCc--eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc-chhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 98876 9999999886433222 1223345678999999887776655 999999999999998 77888765443
Q ss_pred chHHHHHhhHh--cccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 226 KNFRKTIHRIL--SVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 226 ~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..+........ ......+.....+.++.+++.+||+.||++||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 285 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRP 285 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCC
Confidence 32222221100 11111222235678999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=276.31 Aligned_cols=237 Identities=32% Similarity=0.489 Sum_probs=187.3
Q ss_pred eeecccccCCceEEEEEEec----CCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 24 ELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 24 ~~~~~lg~G~~g~v~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++.+.||.|.||.||+|... ..+..|++|.+..... ..+.+.+|++.+++++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999987 4467799999855322 34678899999999999999999999998888999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC---
Q 023591 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--- 172 (280)
Q Consensus 98 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~--- 172 (280)
|+++++|.+++... ..++...+..++.||+.||.|||+.+++|++|+++||+++.++. +||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccc
Confidence 99999999999876 67999999999999999999999999999999999999998886 999999988754211
Q ss_pred CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
...........|.|||.+.+..++.+ +||||||+++||+++ |..||....... ....+.. ....+....++..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~k-sDVysfG~~l~ei~~~~~~p~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~ 233 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKK-SDVYSFGMLLYEILTLGKFPFSDYDNEE----IIEKLKQ-GQRLPIPDNCPKD 233 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHH-HHHHHHHHHHHHHHTTSSGTTTTSCHHH----HHHHHHT-TEETTSBTTSBHH
T ss_pred cccccccccccccccccccccccccc-cccccccccccccccccccccccccccc----ccccccc-cccceeccchhHH
Confidence 11233446678999999987776555 999999999999999 789987764322 2222211 1222222368999
Q ss_pred HHHHHHHhcccCCCCcC
Q 023591 252 CRHLISRIFVADPAKSE 268 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp 268 (280)
+.++|.+||+.||++||
T Consensus 234 ~~~li~~C~~~~p~~RP 250 (259)
T PF07714_consen 234 IYSLIQQCWSHDPEKRP 250 (259)
T ss_dssp HHHHHHHHT-SSGGGS-
T ss_pred HHHHHHHHcCCChhhCc
Confidence 99999999999999999
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=271.75 Aligned_cols=245 Identities=32% Similarity=0.526 Sum_probs=200.9
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+|++.+.||.|++|.||++.+..++..+++|.+... ....+.+.+|+.++++++|+|++++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 589999999999999999999999999999998654 23345677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-C
Q 023591 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (280)
Q Consensus 99 ~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (280)
+++++|.+++.... .+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++. .++++|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence 99999999886543 4799999999999999999999999999999999999987654 369999998864433222 2
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....+++.|+|||.+.+..++.. +|+||||+++++|++|..||...+...... ....... .+....++.++.++
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~ 233 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVL----KICQGYF-APISPNFSRDLRSL 233 (257)
T ss_pred cccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHH----HHhcccC-CCCCCCCCHHHHHH
Confidence 23457888999999877776555 999999999999999999997644322222 2222211 11123578899999
Q ss_pred HHHhcccCCCCcC------CCccc
Q 023591 256 ISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 256 i~~~l~~dp~~Rp------~h~~~ 273 (280)
|.+||+.+|++|| .||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 9999999999999 99997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=277.47 Aligned_cols=252 Identities=30% Similarity=0.475 Sum_probs=198.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCC-----
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 90 (280)
..++|++.+.||+|++|.||++.+..+++.|++|.+.... .....+.+|+.++++++|||++++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3478999999999999999999999999999999987542 22345678999999999999999999887654
Q ss_pred -----eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 91 -----HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 91 -----~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
.+++++||+++ ++.+.+... ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg 161 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFG 161 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCccc
Confidence 78999999976 676666543 46899999999999999999999999999999999999998877 9999999
Q ss_pred CccccccCCC--CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-c
Q 023591 165 YSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-S 241 (280)
Q Consensus 165 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~ 241 (280)
.+........ ......+..|+|||.+.+......++||||||+++++|++|..||..................... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 8874433221 122345677999998865543345599999999999999999999865543333333222111100 0
Q ss_pred C-----------------------CCCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 242 I-----------------------PDYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 242 ~-----------------------~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
+ .....+++.+.+++.+||+.||++|| .||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0 01124689999999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=270.30 Aligned_cols=231 Identities=27% Similarity=0.384 Sum_probs=185.8
Q ss_pred ccccCCceEEEEEEe--cCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCC
Q 023591 28 DIGSGNFGVARLMRD--KKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (280)
Q Consensus 28 ~lg~G~~g~v~~~~~--~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (280)
.||+|+||.||++.. ..++..+|+|++..... ..+.+.+|+.+++.++|+||+++++++. ....+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 45678899998865432 2356788999999999999999999875 45678999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC----CCC
Q 023591 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KST 178 (280)
Q Consensus 103 ~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~----~~~ 178 (280)
+|.+++.....+++..+..++.|++.||++||+.|++|+||+|.||+++.++. ++|+|||++......... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe--EEECCCccccccCCCCCeeeecCCC
Confidence 99999988788999999999999999999999999999999999999998776 999999998744322211 112
Q ss_pred cCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcc-cccCCCCCCCCHHHHHHH
Q 023591 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLI 256 (280)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 256 (280)
.++..|+|||.+.+..++.. +|+||||+++|+|++ |..||....... ....+... ....+. .+++++.++|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~i~~~~~~~~~~--~~~~~l~~li 231 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSSK-SDVWSFGVLMWEAFSYGQKPYKGMKGNE----VTQMIESGERMECPQ--RCPPEMYDLM 231 (257)
T ss_pred CCCccccCHhHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHCCCCCCCCC--CCCHHHHHHH
Confidence 23468999999876666555 999999999999998 999997654322 22222222 223333 6899999999
Q ss_pred HHhcccCCCCcC
Q 023591 257 SRIFVADPAKSE 268 (280)
Q Consensus 257 ~~~l~~dp~~Rp 268 (280)
.+||+.||++||
T Consensus 232 ~~~~~~~p~~Rp 243 (257)
T cd05116 232 KLCWTYGVDERP 243 (257)
T ss_pred HHHhccCchhCc
Confidence 999999999999
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=276.07 Aligned_cols=248 Identities=31% Similarity=0.476 Sum_probs=199.2
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
|++.+.||+|++|.||++.+..+++.+++|.+..... ....+.+|+..+++++|+|++++++++..+...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 6788999999999999999998999999999876432 2456778999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCCC
Q 023591 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (280)
Q Consensus 100 ~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (280)
++ ++.+.+.. ...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCcccccC
Confidence 75 88877765 457999999999999999999999999999999999999998776 9999999886554433 2223
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc---------------ccC
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------------YSI 242 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------~~~ 242 (280)
..++..|.|||.+.+....+.++|+||||+++|+|++|+.||...+..+............. ..+
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 45677899999987763344559999999999999999999977654333332222111100 000
Q ss_pred C---------CCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 243 P---------DYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 243 ~---------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
+ ....++.++.+||.+||+.||.+|| .||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0 0124678999999999999999999 99997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=272.10 Aligned_cols=240 Identities=24% Similarity=0.371 Sum_probs=193.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
..++|++.+.||+|++|.||++... ++..+++|.+.......+.+.+|+.++++++|+|++++++++. +...+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 4578999999999999999999876 4566999998876666677899999999999999999999875 4568899999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC-
Q 023591 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (280)
Q Consensus 99 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~- 175 (280)
+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIEDNEYTA 159 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce--EEeCCceeeeeccCccccc
Confidence 9999999998653 35899999999999999999999999999999999999998776 999999998644322211
Q ss_pred -CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 176 -~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
....++..|+|||.+.+..++.. +|+||||+++|+|++ |..||......+... .+.. ....+.....+..+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~ 233 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLE----QVER-GYRMPCPQDCPISLH 233 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHc-CCCCCCCCcCCHHHH
Confidence 12234457999999877777655 999999999999999 899997654322222 2221 112222236789999
Q ss_pred HHHHHhcccCCCCcC
Q 023591 254 HLISRIFVADPAKSE 268 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp 268 (280)
+|+.+||+.||++||
T Consensus 234 ~li~~~l~~~p~~Rp 248 (260)
T cd05070 234 ELMLQCWKKDPEERP 248 (260)
T ss_pred HHHHHHcccCcccCc
Confidence 999999999999999
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=273.73 Aligned_cols=244 Identities=28% Similarity=0.408 Sum_probs=189.3
Q ss_pred CCe-eeecccccCCceEEEEEE----ecCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecC--Ce
Q 023591 21 DRY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (280)
Q Consensus 21 ~~y-~~~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 91 (280)
++| ++.+.||+|+||+||++. ...++..||+|.+..... ....+.+|+..+++++|||++++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 456 999999999999998765 335678899999876432 345678899999999999999999987653 46
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
.+++|||+++++|.+++... .+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccCC
Confidence 89999999999999988654 5999999999999999999999999999999999999988776 99999999875433
Q ss_pred CCC----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcch-H---------HHHHhhHhc
Q 023591 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-F---------RKTIHRILS 237 (280)
Q Consensus 172 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~---------~~~~~~~~~ 237 (280)
... .....++..|+|||.+.+..++.. +||||||+++|+|++|..||........ . .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 221 122234566999999877777655 9999999999999999999865432100 0 000000011
Q ss_pred ccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 238 VQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 238 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.....+....++.++.+++.+||+.||++||
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 269 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRP 269 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCC
Confidence 1112222235789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=273.84 Aligned_cols=241 Identities=21% Similarity=0.350 Sum_probs=192.5
Q ss_pred CCCeeeecccccCCceEEEEEEec----CCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
.+.|++.+.||+|+||.||++... .++..+++|.+..... ....+.+|+.++++++|+|++++++++..+...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 468999999999999999999853 4567899999875332 2246778999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCC
Q 023591 94 IVMEYASGGELFERICNA-----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~ 156 (280)
++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~- 162 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH- 162 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc-
Confidence 999999999999988532 23788899999999999999999999999999999999998876
Q ss_pred cEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHH
Q 023591 157 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (280)
Q Consensus 157 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 232 (280)
++|+|||++........ .....++..|+|||.+.+..++.. +|+||||+++|+|++ |..||...... ...
T Consensus 163 -~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~g~~p~~~~~~~----~~~ 236 (283)
T cd05090 163 -VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQ----EVI 236 (283)
T ss_pred -EEeccccccccccCCcceecccCCCccceecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHH----HHH
Confidence 99999999875432221 222334567999999887777655 999999999999998 99999764432 112
Q ss_pred hhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..+.... ..+....+++.+.+++.+||+.||++||
T Consensus 237 ~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp 271 (283)
T cd05090 237 EMVRKRQ-LLPCSEDCPPRMYSLMTECWQEGPSRRP 271 (283)
T ss_pred HHHHcCC-cCCCCCCCCHHHHHHHHHHcccCcccCc
Confidence 2221111 1222236789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=270.54 Aligned_cols=241 Identities=24% Similarity=0.346 Sum_probs=197.9
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
..++|++.+.||+|++|.||++.+. ++..+++|.+.......+.+.+|+..+++++|+|++++++++......+++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4578999999999999999999976 457799999987766677899999999999999999999999888899999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC--
Q 023591 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (280)
Q Consensus 99 ~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-- 174 (280)
+++++|.+++.... .++...+..++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||++........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYTA 160 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhhh
Confidence 99999999986643 6899999999999999999999999999999999999998877 99999998864432111
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
......+..|+|||.+.+...+.. +|+||+|+++++|++ |..||........... +.. .+..+.....+.++.
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~ 234 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ----VER-GYRMPRPPNCPEELY 234 (261)
T ss_pred hhccCCCccccCHHHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHHHH
Confidence 112223467999999987776555 999999999999998 9999976543322222 221 122222235688999
Q ss_pred HHHHHhcccCCCCcC
Q 023591 254 HLISRIFVADPAKSE 268 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp 268 (280)
+++.+||+.+|++||
T Consensus 235 ~~i~~~l~~~p~~Rp 249 (261)
T cd05034 235 DLMLQCWDKDPEERP 249 (261)
T ss_pred HHHHHHcccCcccCC
Confidence 999999999999999
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=274.13 Aligned_cols=244 Identities=27% Similarity=0.442 Sum_probs=200.0
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
-|++.+.||.|+||.||++.+..+++.+|+|.+..... ....+.+|+..+++++|+|++++++.+..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 47888999999999999999988899999998765432 2356778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-CCCC
Q 023591 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKST 178 (280)
Q Consensus 100 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~~~ 178 (280)
++++|.+++.. ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++. ++++|||++........ ....
T Consensus 85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06641 85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhccc
Confidence 99999988754 46899999999999999999999999999999999999988876 99999998764432221 2234
Q ss_pred cCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-cccCCCCCCCCHHHHHHHH
Q 023591 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLIS 257 (280)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~ 257 (280)
.++..|+|||.+.+...+.. +|+||||+++++|++|..||......... ..+... ...++ ..++.++.++|.
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~~i~ 234 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKVL----FLIPKNNPPTLE--GNYSKPLKEFVE 234 (277)
T ss_pred cCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccchHHHH----HHHhcCCCCCCC--cccCHHHHHHHH
Confidence 56778999999877766555 99999999999999999999754432111 112111 11222 257889999999
Q ss_pred HhcccCCCCcC------CCccccc
Q 023591 258 RIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 258 ~~l~~dp~~Rp------~h~~~~~ 275 (280)
+||+.+|++|| .||||.+
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~~~~~~ 258 (277)
T cd06641 235 ACLNKEPSFRPTAKELLKHKFIVR 258 (277)
T ss_pred HHccCChhhCcCHHHHHhCHHHhh
Confidence 99999999999 9999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=282.76 Aligned_cols=255 Identities=30% Similarity=0.424 Sum_probs=200.0
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhC-CCCCeeeeceEEecC--CeEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTP--THLA 93 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~ 93 (280)
.++|++.+.||+|++|.||++.+..+++.+++|.+... ......+.+|+.+++++ +|+||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 47899999999999999999999988999999988642 22334567899999999 999999999988653 3689
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
+||||++ ++|..++... .+++..++.++.||+.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELE 161 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhcccccc
Confidence 9999997 4898888665 7889999999999999999999999999999999999998887 9999999887443322
Q ss_pred C------CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhH------------
Q 023591 174 Q------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI------------ 235 (280)
Q Consensus 174 ~------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 235 (280)
. .....++..|+|||.+.+......++|+||||+++|+|++|+.||................
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 1 1223467889999988665544555999999999999999999997654332222211110
Q ss_pred -----------hcccc-c-CCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 236 -----------LSVQY-S-IPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 236 -----------~~~~~-~-~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
..... . ......++.++.++|.+||+.||++|| .|||+++...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 00000 0 001124688999999999999999999 9999987644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=270.39 Aligned_cols=234 Identities=27% Similarity=0.421 Sum_probs=194.8
Q ss_pred cccccCCceEEEEEEecCC---CcEEEEEEeeeCCcc--cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|+||.||++.+... +..+++|.+...... .+.+.+|+..++.++|+|++++++++......+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4689999999999999866 889999998875443 46788899999999999999999999998999999999999
Q ss_pred CchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 102 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 102 ~~L~~~~~~~---------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
++|.+++... ..+++..++.++.|++.||++||++|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 158 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDD 158 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccccccccc
Confidence 9999999775 67999999999999999999999999999999999999998876 999999998755433
Q ss_pred C---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCC
Q 023591 173 S---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (280)
Q Consensus 173 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (280)
. ......++..|+|||.+.+..++.. +||||+|+++|+|++ |..||.......... .+.. .........+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~ 232 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLE----YLRK-GYRLPKPEYC 232 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHc-CCCCCCCccC
Confidence 2 2334456788999999887766555 999999999999999 699998764322222 2221 1122222367
Q ss_pred CHHHHHHHHHhcccCCCCcC
Q 023591 249 SPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp 268 (280)
+.++.+++.+||+.||++||
T Consensus 233 ~~~~~~li~~~l~~~p~~Rp 252 (262)
T cd00192 233 PDELYELMLSCWQLDPEDRP 252 (262)
T ss_pred ChHHHHHHHHHccCCcccCc
Confidence 89999999999999999999
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=269.44 Aligned_cols=238 Identities=27% Similarity=0.419 Sum_probs=196.9
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
..++|++.+.||.|++|.||++... ++.|++|.+.......+.+.+|+.+++.++|+|++++++++..+...+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 4578999999999999999999874 78899999987655556788999999999999999999999888899999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 99 ~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
+++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEcccccccccccccc--
Confidence 99999999987655 6899999999999999999999999999999999999998776 99999998875532222
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....+..|.|||.+.+..++.. +|+||||+++++|++ |..||........ ...+.. .+........++++.++
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~l 231 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDV----VPHVEK-GYRMEAPEGCPPEVYKV 231 (256)
T ss_pred cCCCcccccCchhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCCCCCHHHH----HHHHhc-CCCCCCccCCCHHHHHH
Confidence 2334567999999877776655 999999999999997 9999976543222 111111 11111222578999999
Q ss_pred HHHhcccCCCCcC
Q 023591 256 ISRIFVADPAKSE 268 (280)
Q Consensus 256 i~~~l~~dp~~Rp 268 (280)
|.+||+.+|++||
T Consensus 232 i~~~l~~~p~~Rp 244 (256)
T cd05039 232 MKDCWELDPAKRP 244 (256)
T ss_pred HHHHhccChhhCc
Confidence 9999999999999
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=297.64 Aligned_cols=253 Identities=22% Similarity=0.337 Sum_probs=185.7
Q ss_pred CCeeeecccccCCceEEEEEEecCCC-cEEEE------------------EEeeeCCcccHHHHHHHHHhhhCCCCCeee
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTE-ELVAV------------------KYIERGDKIDENVQREIINHRSLRHPNIVR 81 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~-~~vai------------------K~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 81 (280)
++|++++.||+|+||+||++..+... +..+. |.+.........+.+|+.++++++|+||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 68999999999999999998764322 11122 222222233345778999999999999999
Q ss_pred eceEEecCCeEEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCC
Q 023591 82 FKEVILTPTHLAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (280)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~ 156 (280)
+++++..++..+++++++. ++|.+++... .......+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~- 305 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK- 305 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-
Confidence 9999999999999999985 4777766432 22446678889999999999999999999999999999988877
Q ss_pred cEEEeecCCccccccCCC--CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc---chHHHH
Q 023591 157 RLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKT 231 (280)
Q Consensus 157 ~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~ 231 (280)
+||+|||++........ .....++..|+|||.+.+..++.. +|||||||++|+|++|..++...... ....+.
T Consensus 306 -vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 306 -IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred -EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 99999999875433222 223468999999999988877665 99999999999999987544322211 111211
Q ss_pred HhhHhcccccCC--------------------------CCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 232 IHRILSVQYSIP--------------------------DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 232 ~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
...+......++ .....+.++.++|.+||+.||.+|| .||||.+..
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 111100000000 0123567888999999999999999 999998654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=268.06 Aligned_cols=236 Identities=39% Similarity=0.645 Sum_probs=199.7
Q ss_pred cccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCch
Q 023591 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (280)
Q Consensus 29 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (280)
||.|++|.||++.+..+++.+++|.+..... ..+.+.+|+.++++++|+|++++++.+..+...+++||++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999998899999999876543 334678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCCCcCCCc
Q 023591 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 183 (280)
Q Consensus 105 ~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~ 183 (280)
.+++.....+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++...... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCcc
Confidence 999988878999999999999999999999999999999999999998876 999999988754433 22334557788
Q ss_pred ccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccC
Q 023591 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263 (280)
Q Consensus 184 ~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 263 (280)
|++||...+...+.. +|+||||+++|+|++|..||..... ......+......++. ..+..+.+++.+||..|
T Consensus 159 ~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~--~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 159 YLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILKDPLRFPE--FLSPEARDLISGLLQKD 231 (250)
T ss_pred ccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhcCC
Confidence 999999877776555 9999999999999999999976543 2233333334444444 56899999999999999
Q ss_pred CCCcC---------CCccc
Q 023591 264 PAKSE---------MHDWR 273 (280)
Q Consensus 264 p~~Rp---------~h~~~ 273 (280)
|++|| .||||
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 99999 68886
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=270.48 Aligned_cols=243 Identities=22% Similarity=0.371 Sum_probs=196.5
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
..++|++.+.||+|+||.||++... +++.+|+|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 3578999999999999999999865 5678999998877666678899999999999999999999874 5678999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC--
Q 023591 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (280)
Q Consensus 99 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-- 174 (280)
+.+++|.+++... ..++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCccc
Confidence 9999999988653 36899999999999999999999999999999999999998877 99999998864432211
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
.....++..|+|||.+.+..++.. +|+||||+++|+|++ |..||...+....... .. .....+.....+.++.
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN----LE-RGYRMPRPDNCPEELY 233 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCChHHHHHH----HH-cCCCCCCCCCCCHHHH
Confidence 112234567999999877776555 999999999999998 9999976554322222 11 1122222235788999
Q ss_pred HHHHHhcccCCCCcCCCc
Q 023591 254 HLISRIFVADPAKSEMHD 271 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp~h~ 271 (280)
+++.+||+.+|++||...
T Consensus 234 ~li~~~l~~~p~~Rp~~~ 251 (260)
T cd05067 234 ELMRLCWKEKPEERPTFE 251 (260)
T ss_pred HHHHHHccCChhhCCCHH
Confidence 999999999999999433
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=279.78 Aligned_cols=245 Identities=26% Similarity=0.400 Sum_probs=182.5
Q ss_pred cccccCCceEEEEEEecC--CCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEec--CCeEEEEEeccCCC
Q 023591 27 RDIGSGNFGVARLMRDKK--TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGG 102 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~ 102 (280)
.+||+|+||.||+++... ++..||+|.+.... ....+.+|+.++++++|||++++++++.. +...++++||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 579999999999999653 56789999886543 34567889999999999999999998854 4578999999965
Q ss_pred chHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC--CCCcEEEeecCCcccccc
Q 023591 103 ELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 103 ~L~~~~~~~---------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~--~~~~~~l~df~~~~~~~~ 171 (280)
+|.+++... ..+++..++.++.|++.||.+||+.|++|+||||+||++..+ ..++++|+|||++.....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence 777776421 248899999999999999999999999999999999999432 223599999999874432
Q ss_pred CCC----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcch---------HHHHHh-----
Q 023591 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN---------FRKTIH----- 233 (280)
Q Consensus 172 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---------~~~~~~----- 233 (280)
... .....+++.|+|||.+.+....+.++||||||+++|+|++|..||....+... ......
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T cd07867 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244 (317)
T ss_pred CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCC
Confidence 221 22345688899999987755445559999999999999999999975432100 000000
Q ss_pred ------hHh-------------ccccc-------C-CCCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 234 ------RIL-------------SVQYS-------I-PDYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 234 ------~~~-------------~~~~~-------~-~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.+. ..... . ......+..+.+|+.+||+.||.+|| .||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 245 ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred ChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 00000 0 00112456789999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=279.72 Aligned_cols=241 Identities=21% Similarity=0.357 Sum_probs=193.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcE----EEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~----vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
...+|++.+.||+|+||.||++.+..+++. ||+|.+.... ....++.+|+.+++.++|+||+++++++... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 346799999999999999999997665553 8999886532 2345678899999999999999999998754 57
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
+++++|+++++|.+++... ..++...+..++.||+.||+|||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~ 161 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGA 161 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccC
Confidence 7999999999999998764 46899999999999999999999999999999999999988777 99999999875443
Q ss_pred CCCC---CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 172 HSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 172 ~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
.... .....+..|+|||.+.+..++.. +||||||+++|+|++ |..||....... .. .+.......+....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~~-~~----~~~~~~~~~~~~~~ 235 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE-IS----SILEKGERLPQPPI 235 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHH-HH----HHHhCCCCCCCCCC
Confidence 2221 11223567999999988777655 999999999999997 999997643321 11 22222233333346
Q ss_pred CCHHHHHHHHHhcccCCCCcC
Q 023591 248 ISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+.++.+++.+||+.||++||
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rp 256 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRP 256 (316)
T ss_pred CCHHHHHHHHHHccCChhhCc
Confidence 788999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=273.47 Aligned_cols=241 Identities=19% Similarity=0.303 Sum_probs=191.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecC-----CCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
..++|++.+.||+|++|.||++.+.. ++..+|+|.+..... ....+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999998642 356799998765332 23457789999999999999999999988889
Q ss_pred EEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEe
Q 023591 92 LAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~----------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~ 161 (280)
.+++|||+++++|.+++.... .++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l~ 161 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIG 161 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEEC
Confidence 999999999999999886522 3567889999999999999999999999999999999998776 9999
Q ss_pred ecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhc
Q 023591 162 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILS 237 (280)
Q Consensus 162 df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 237 (280)
|||++........ .....+++.|+|||.+.+..++.. +|+||||+++|+|++ |..||....... ....+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~~~~~~~~----~~~~~~~ 236 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQ----VLRFVME 236 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHc
Confidence 9998864322111 112334678999999987777655 999999999999999 788987654322 2222222
Q ss_pred cc-ccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 238 VQ-YSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 238 ~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.. ...+. ..++.+.+++.+||+.||++||
T Consensus 237 ~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp 266 (277)
T cd05062 237 GGLLDKPD--NCPDMLFELMRMCWQYNPKMRP 266 (277)
T ss_pred CCcCCCCC--CCCHHHHHHHHHHcCCChhhCc
Confidence 22 12222 5788999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=270.08 Aligned_cols=242 Identities=32% Similarity=0.493 Sum_probs=202.0
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+|++.+.||+|++|.||++.+..+++.+++|.+.... .....+.+|+..+++++|+|++++.+++......++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999999999999999987643 2334567899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 99 ASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 99 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
+++++|.+++.. ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~-~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL--VKIGDLGISKVLKKN-M 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc--EEEeeccchhhhccC-C
Confidence 999999988865 356899999999999999999999999999999999999998776 999999998755443 3
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-cCCCCCCCCHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPECR 253 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 253 (280)
.....+++.|+|||.+.+..++.. +|+||+|+++++|++|..||...+... ....+....+ ..+. .++.+++
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~ 230 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQD----LRYKVQRGKYPPIPP--IYSQDLQ 230 (256)
T ss_pred cccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCCCCCCch--hhCHHHH
Confidence 334557889999999987777655 999999999999999999997654322 2222222222 1222 5788999
Q ss_pred HHHHHhcccCCCCcC------CCccc
Q 023591 254 HLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp------~h~~~ 273 (280)
+++.+||+.+|++|| .||++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 231 NFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 999999999999999 88874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=270.29 Aligned_cols=242 Identities=24% Similarity=0.395 Sum_probs=195.7
Q ss_pred CCCCeeeecccccCCceEEEEEEecCC---CcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
..++|++.+.||+|+||.||++....+ ...|++|.+..... ....+.+|+..+++++|+||+++++.+......+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 357899999999999999999998643 45799998865432 2345778999999999999999999999889999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
++|||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhccccc
Confidence 999999999999998654 46899999999999999999999999999999999999998877 999999998755311
Q ss_pred CC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCC
Q 023591 173 SQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (280)
Q Consensus 173 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (280)
.. ......+..|+|||.+.+..++.. +|+||||+++|+|++ |..||........ ...+.. ....+....+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~~~ 233 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDV----IKAVED-GYRLPPPMDC 233 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHH----HHHHHc-CCCCCCCCCC
Confidence 11 112234567999999987777655 999999999999998 9999976543322 222222 1222223367
Q ss_pred CHHHHHHHHHhcccCCCCcC
Q 023591 249 SPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp 268 (280)
++.+.+++.+||+.+|++||
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp 253 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERP 253 (266)
T ss_pred CHHHHHHHHHHcCCCcccCc
Confidence 89999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=269.30 Aligned_cols=240 Identities=23% Similarity=0.340 Sum_probs=193.4
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
.++|++.+.||+|++|.||++.+..+ ..+++|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 36799999999999999999988655 45899988766655677889999999999999999998875 45688999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC--
Q 023591 100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (280)
Q Consensus 100 ~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~-- 175 (280)
++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCccccc
Confidence 9999999986543 4789999999999999999999999999999999999998877 999999988644322211
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
....++..|+|||...+...+.. +|+||||+++|+|++ |..||............ .. ....+.....+..+.+
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMVNREVLEQV----ER-GYRMPCPQGCPESLHE 234 (260)
T ss_pred CCCccchhhCCHHHhccCCcChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----Hc-CCCCCCCcccCHHHHH
Confidence 12234567999999877776555 999999999999999 89999875543322222 11 1222222357899999
Q ss_pred HHHHhcccCCCCcCC
Q 023591 255 LISRIFVADPAKSEM 269 (280)
Q Consensus 255 li~~~l~~dp~~Rp~ 269 (280)
++++||+.||++||.
T Consensus 235 li~~~l~~~p~~Rp~ 249 (260)
T cd05069 235 LMKLCWKKDPDERPT 249 (260)
T ss_pred HHHHHccCCcccCcC
Confidence 999999999999993
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=274.85 Aligned_cols=253 Identities=29% Similarity=0.412 Sum_probs=199.4
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 94 (280)
...++|++.+.||+|++|.||++.+..++..+|+|.+..... ....+.+|+..+.+. .|+||+++++++..+...++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 356889999999999999999999998899999999876532 223455677666666 59999999999999999999
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
+|||+++ ++.+++.. ...+++..+..++.|++.+|+|||+ .|++|+||+|+||+++.++. ++|+|||++......
T Consensus 92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~--~kL~dfg~~~~~~~~ 168 (296)
T cd06618 92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN--VKLCDFGISGRLVDS 168 (296)
T ss_pred EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC--EEECccccchhccCC
Confidence 9999854 77776654 4578999999999999999999997 59999999999999987776 999999988754433
Q ss_pred CCCCCCcCCCcccCcccccCCc----CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-cccCCCCCC
Q 023591 173 SQPKSTVGTPAYIAPEVLLKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVH 247 (280)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~----~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 247 (280)
.......++..|+|||.+.+.. ++. ++|+||||+++|+|++|..||...... ......+... ....+....
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDI-RADVWSLGISLVELATGQFPYKNCKTE---FEVLTKILQEEPPSLPPNEG 244 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCcccccc-chhHHHHHHHHHHHHhCCCCCCcchhH---HHHHHHHhcCCCCCCCCCCC
Confidence 3333345677899999986553 444 499999999999999999999754322 1122222222 222333335
Q ss_pred CCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 248 ISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
++.++.+|+.+||+.||++|| .|||++...
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 789999999999999999999 999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=282.67 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=200.0
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCC--
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-- 90 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 90 (280)
.....++|++++.||+|++|.||++.+..++..||+|.+.... .....+.+|+.++++++|+||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445688999999999999999999999999999999986532 22345778999999999999999999887543
Q ss_pred ----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCc
Q 023591 91 ----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (280)
Q Consensus 91 ----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~ 166 (280)
.+++||+|+ +++|.+++. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~~ 165 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLA 165 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccc
Confidence 458999999 668887775 457899999999999999999999999999999999999998776 999999988
Q ss_pred cccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc---------
Q 023591 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------- 237 (280)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------- 237 (280)
..... ......+++.|+|||.+.+....+.++|+||||+++|+|++|..||..........+.......
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 166 RQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred ccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 74432 2223456788999999876443445599999999999999999999865432222221110000
Q ss_pred --c--------cccC------CCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 238 --V--------QYSI------PDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 238 --~--------~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
. -... .....+++++.++|.+||+.||++|| .||||+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0 0000 00125788899999999999999999 99999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=273.20 Aligned_cols=243 Identities=22% Similarity=0.331 Sum_probs=195.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecC-----CCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
..++|++.+.||+|++|.||++.+.. ++..|++|.+..... ....+.+|+..++.++|+|++++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34789999999999999999999976 678899998764332 23457889999999999999999999988888
Q ss_pred EEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC-CcEEEeec
Q 023591 92 LAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDF 163 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~-------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~-~~~~l~df 163 (280)
.+++|||+++++|.+++.... .+++..+..++.||+.+|++||+.+++|+||+|+||+++.++. ..++|+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 999999999999999986543 4889999999999999999999999999999999999986552 34899999
Q ss_pred CCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhc-c
Q 023591 164 GYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILS-V 238 (280)
Q Consensus 164 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~-~ 238 (280)
|++........ ......+..|+|||.+.+..++.. +||||||+++|+|++ |..||.......... .+.. .
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~~~----~~~~~~ 238 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVME----FVTGGG 238 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHcCC
Confidence 99875422111 112233467999999988877665 999999999999997 999998655432221 2211 1
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 239 QYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....+ ..++..+.+++.+||+.||++||
T Consensus 239 ~~~~~--~~~~~~~~~~i~~cl~~~p~~Rp 266 (277)
T cd05036 239 RLDPP--KGCPGPVYRIMTDCWQHTPEDRP 266 (277)
T ss_pred cCCCC--CCCCHHHHHHHHHHcCCCcccCc
Confidence 22222 36789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=274.42 Aligned_cols=242 Identities=25% Similarity=0.389 Sum_probs=193.8
Q ss_pred CCCCeeeecccccCCceEEEEEEec-----CCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
...+|.+.+.||+|+||.||++... .++..+++|.+.... .....+.+|++.++.++|+||+++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 3468899999999999999999742 346678899876533 3345688899999999999999999999998999
Q ss_pred EEEEeccCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCc
Q 023591 93 AIVMEYASGGELFERICNAG---------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~---------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~ 157 (280)
+++|||+++++|.+++.... .++...+..++.|++.||+|||+.|++|+||+|+||+++.++.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~-- 160 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV-- 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC--
Confidence 99999999999999986543 3788999999999999999999999999999999999998776
Q ss_pred EEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHh
Q 023591 158 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (280)
Q Consensus 158 ~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 233 (280)
++|+|||++........ .....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||............
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-- 237 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-- 237 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH--
Confidence 99999998864332211 122234578999999888777665 999999999999998 89999765443322222
Q ss_pred hHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.... .......+++.+.++|.+||+.||++||
T Consensus 238 --~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp 269 (280)
T cd05092 238 --TQGR-ELERPRTCPPEVYAIMQGCWQREPQQRM 269 (280)
T ss_pred --HcCc-cCCCCCCCCHHHHHHHHHHccCChhhCC
Confidence 1111 1122226789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=268.65 Aligned_cols=233 Identities=27% Similarity=0.337 Sum_probs=188.3
Q ss_pred cccccCCceEEEEEEecCCC---cEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKTE---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|+||.||++....++ ..+++|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999876544 7899999876554 4456888999999999999999999875 4568999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC----C
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----S 177 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~----~ 177 (280)
++|.+++.....+++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++.......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccC
Confidence 999999988888999999999999999999999999999999999999998877 9999999987543332211 1
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHH
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (280)
..++..|+|||.+.+..++.. +|+||||+++|+|++ |..||...+..... ..+... ...+....++..+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~l~~li 231 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAEVI----AMLESG-ERLPRPEECPQEIYSIM 231 (257)
T ss_pred ccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHHHH----HHHHcC-CcCCCCCCCCHHHHHHH
Confidence 112357999999987777665 999999999999998 99999765442221 122111 12222236789999999
Q ss_pred HHhcccCCCCcC
Q 023591 257 SRIFVADPAKSE 268 (280)
Q Consensus 257 ~~~l~~dp~~Rp 268 (280)
.+||+.||++||
T Consensus 232 ~~cl~~~p~~Rp 243 (257)
T cd05060 232 LSCWKYRPEDRP 243 (257)
T ss_pred HHHhcCChhhCc
Confidence 999999999999
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=272.80 Aligned_cols=241 Identities=21% Similarity=0.341 Sum_probs=194.5
Q ss_pred CCCCeeeecccccCCceEEEEEEecCC-----CcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
..++|++.+.||+|+||.||++.+... +..+++|.+..... ....+.+|+.+++.++|+|++++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 457899999999999999999998643 37899999865432 22457789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEe
Q 023591 92 LAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~----------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~ 161 (280)
.+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl~ 161 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIG 161 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEEC
Confidence 999999999999999885432 3678899999999999999999999999999999999998887 9999
Q ss_pred ecCCccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhc
Q 023591 162 DFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILS 237 (280)
Q Consensus 162 df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 237 (280)
|||++....... ......++..|.|||.+.+..++.. +||||||+++|+|++ |..||.......... .+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~----~~~~ 236 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVLK----FVID 236 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCCHHHHHH----HHhc
Confidence 999886443221 1223345678999999887777655 999999999999998 999997654322222 2221
Q ss_pred -ccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 238 -VQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 238 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.....+. ..+.++.+++.+||+.+|++||
T Consensus 237 ~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp 266 (277)
T cd05032 237 GGHLDLPE--NCPDKLLELMRMCWQYNPKMRP 266 (277)
T ss_pred CCCCCCCC--CCCHHHHHHHHHHcCCChhhCC
Confidence 1223333 5789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=245.33 Aligned_cols=255 Identities=27% Similarity=0.476 Sum_probs=211.8
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
.+|...++||+|.||+||++++..+++.||+|.+...+ ....+..+|+-+++.++|.|||+++++...+..+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35777899999999999999999999999999998754 333678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CC
Q 023591 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (280)
Q Consensus 98 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~ 175 (280)
||.. +|..+... ++.++.+.++.++.|++++|.++|+.++.|||+||.|.++..+|. +||.|||+++...... .-
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcy 158 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEee
Confidence 9964 88877744 678999999999999999999999999999999999999998888 9999999998443332 23
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccc-cCCC------C--
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQY-SIPD------Y-- 245 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~------~-- 245 (280)
....-+..|.+|.++.+.+.++.+.|+||-||++.|+.. |.+.|.+.+-.+.+.+++........ .+|. .
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 445678889999999999887777999999999999997 66777776666666666654433221 1221 1
Q ss_pred --------------CCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 246 --------------VHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 246 --------------~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
+.++..-++++.++|.-+|.+|+ +||||...+.
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s~ 291 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFSP 291 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccCC
Confidence 23445679999999999999999 9999987664
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=274.41 Aligned_cols=247 Identities=28% Similarity=0.416 Sum_probs=198.7
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
+.|...+.||+|++|.||++++..+++.+++|.+..... ....+.+|+.+++.++|+|++++++++.+....+++|
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 457778899999999999999999999999999875432 2245778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
||+.+ ++.+.+.. ..++++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++... ...
T Consensus 101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~---~~~ 174 (313)
T cd06633 101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKS---SPA 174 (313)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCccc---CCC
Confidence 99965 77776654 457899999999999999999999999999999999999988776 999999987632 223
Q ss_pred CCCcCCCcccCcccccC---CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 176 KSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
....++..|+|||.+.. ..++. ++|+||||+++|+|++|..||...+.......... ..........++..+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~-~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l 249 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NDSPTLQSNEWTDSF 249 (313)
T ss_pred CCccccccccChhhccccCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----cCCCCCCccccCHHH
Confidence 34567888999999742 34444 49999999999999999999977544332222211 111111123567889
Q ss_pred HHHHHHhcccCCCCcC------CCcccccccC
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
++|+.+||+.+|.+|| .||||+.+.+
T Consensus 250 ~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~ 281 (313)
T cd06633 250 RGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281 (313)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccCCCch
Confidence 9999999999999999 9999987543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=283.40 Aligned_cols=254 Identities=25% Similarity=0.407 Sum_probs=200.5
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCe---
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH--- 91 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 91 (280)
...++|++.+.||+|++|.||++++..+++.||+|.+... ......+.+|+.++++++|+|++++.+++..+..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3457899999999999999999999999999999988653 2233456789999999999999999988765544
Q ss_pred ---EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 92 ---LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 92 ---~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~ 167 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARH 167 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEcccccccc
Confidence 89999999 5699888765 56999999999999999999999999999999999999998776 99999999875
Q ss_pred cccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc---------
Q 023591 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------- 239 (280)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 239 (280)
.... .....++..|+|||.+.+......++|+||||+++|+|++|..||....................
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 168 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred cccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 4322 23345677899999986644444559999999999999999999976554333222221110000
Q ss_pred -----------c----cC-CCCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 240 -----------Y----SI-PDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 240 -----------~----~~-~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
. .+ ......++++.+||++||+.||++|| .||||++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0 00 00124688999999999999999999 999998654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=280.47 Aligned_cols=243 Identities=24% Similarity=0.400 Sum_probs=191.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecC-----CCcEEEEEEeeeCCc--ccHHHHHHHHHhhhC-CCCCeeeeceEEecC-
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP- 89 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~- 89 (280)
..++|++.+.||+|+||.||++.... +++.||+|.+..... ..+.+.+|+.+++++ +|+||+++++++...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 45799999999999999999997533 457899998875322 224567899999999 899999999987654
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------------------------------------------------------
Q 023591 90 THLAIVMEYASGGELFERICNA---------------------------------------------------------- 111 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~---------------------------------------------------------- 111 (280)
..+++++||+++++|.+++...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5788999999999999887532
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC---CCCCcCCCccc
Q 023591 112 ---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYI 185 (280)
Q Consensus 112 ---~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~ 185 (280)
.+++...+..++.||+.||+|||++|++||||+|+||+++.++. ++|+|||++........ .....++..|+
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCcccc
Confidence 25788999999999999999999999999999999999998776 99999999875432211 12233456799
Q ss_pred CcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCC
Q 023591 186 APEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264 (280)
Q Consensus 186 aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 264 (280)
|||.+.+..++.. +|||||||++|+|++ |..||......+......... .....+ ...++++.+++.+||+.+|
T Consensus 243 aPE~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~l~~~cl~~~p 317 (337)
T cd05054 243 APESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG--TRMRAP--EYATPEIYSIMLDCWHNNP 317 (337)
T ss_pred CcHHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc--CCCCCC--ccCCHHHHHHHHHHccCCh
Confidence 9999988888766 999999999999998 999997654333222222111 111122 2578899999999999999
Q ss_pred CCcC
Q 023591 265 AKSE 268 (280)
Q Consensus 265 ~~Rp 268 (280)
++||
T Consensus 318 ~~RP 321 (337)
T cd05054 318 EDRP 321 (337)
T ss_pred hhCc
Confidence 9999
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=290.21 Aligned_cols=240 Identities=24% Similarity=0.357 Sum_probs=194.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
..+...+.+.||+|.||+||++++.++ ||||++... +...+.|++|+..+++-+|.||+-+.|++..+.. .+|
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred CHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 345667889999999999999999765 899998754 3455679999999999999999999999987766 999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc---ccc
Q 023591 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVL 171 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~---~~~ 171 (280)
+.+|.|.+|..++.- ..+|+...+..|++||++++.|||.++|+|+|||..|||+.+++. |||+|||++.. ...
T Consensus 466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTRWSG 543 (678)
T ss_pred ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeeeecc
Confidence 999999999888753 346899999999999999999999999999999999999998876 99999999852 223
Q ss_pred CCCCCCCcCCCcccCcccccCC--cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc--cC-CCCC
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SI-PDYV 246 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~ 246 (280)
........+...|+|||++... .+.+.++|||+||+++|||++|..||.....+ +++..+..+.. +. ....
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d----qIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD----QIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh----heEEEecccccCccchhhhc
Confidence 3334556678899999998643 33455699999999999999999999954332 33333333321 11 1133
Q ss_pred CCCHHHHHHHHHhcccCCCCcC
Q 023591 247 HISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..+.++++|+..||..++++||
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP 641 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERP 641 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCc
Confidence 5778999999999999999999
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=274.48 Aligned_cols=248 Identities=27% Similarity=0.461 Sum_probs=199.8
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccC
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (280)
.|+....||+|++|.||++....+++.+|+|.+.... .....+.+|+.+++.++|+|++++++.+...+..+++|||++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 4455678999999999999999999999999876432 233457789999999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCCCCc
Q 023591 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 179 (280)
Q Consensus 101 ~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~~~ 179 (280)
+++|.+++. ...+++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++....... ......
T Consensus 101 ~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 101 GGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceecccccccccccc
Confidence 999988764 446899999999999999999999999999999999999998876 9999999876443221 123345
Q ss_pred CCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHh
Q 023591 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259 (280)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 259 (280)
+++.|+|||.+.+..++.. +|+||+|+++|+|++|..||.......... ....... ..+.....+++.+.+++.+|
T Consensus 178 ~~~~y~~pE~~~~~~~~~~-~Dv~slGvil~el~tg~~p~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~l~~li~~~ 253 (292)
T cd06657 178 GTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRDNLP--PKLKNLHKVSPSLKGFLDRL 253 (292)
T ss_pred cCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhhCC--cccCCcccCCHHHHHHHHHH
Confidence 7788999999877666554 999999999999999999997644322222 1111111 12222235789999999999
Q ss_pred cccCCCCcC------CCcccccc
Q 023591 260 FVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 260 l~~dp~~Rp------~h~~~~~~ 276 (280)
|+.||.+|| .||||...
T Consensus 254 l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 254 LVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred HhCCcccCcCHHHHhcChHHhcc
Confidence 999999999 99999744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=271.56 Aligned_cols=247 Identities=29% Similarity=0.431 Sum_probs=196.2
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---cHHHHHHHHHhhhC---CCCCeeeeceEEecCCe-----
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSL---RHPNIVRFKEVILTPTH----- 91 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~----- 91 (280)
|++.+.||+|++|.||++++..++..+|+|.+...... ...+.+|+.+++++ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78899999999999999999988999999998753221 23455677776655 69999999999987766
Q ss_pred EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 92 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
.+++||++++ +|.+++.... .+++..++.++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC--EEEeccCcceec
Confidence 9999999975 8888876643 5899999999999999999999999999999999999998876 999999988765
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-cccCC-----
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIP----- 243 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~----- 243 (280)
..........++..|+|||.+.+..++.+ +|+||+|+++|+|++|..||......+...++....... ...++
T Consensus 158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 158 SFEMALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred cCCcccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 44433344456788999999988777665 999999999999999999998766544444433321110 00000
Q ss_pred ------C---------CCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 244 ------D---------YVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 244 ------~---------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
. ...+++.+.++|.+||+.||++|| .||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 013567889999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=274.13 Aligned_cols=242 Identities=25% Similarity=0.354 Sum_probs=194.0
Q ss_pred CCCCeeeecccccCCceEEEEEEecC-----CCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
...+|.+.+.||+|+||.||++++.. ++..+++|.+..... ....+.+|+..+++++|+||+++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 34679999999999999999998542 445688888765432 224678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCC
Q 023591 93 AIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~ 156 (280)
++||||+++++|.+++.... .+++..++.++.||+.||++||++|++|+||+|+||+++.++.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~- 161 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL- 161 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc-
Confidence 99999999999999986532 3788999999999999999999999999999999999998876
Q ss_pred cEEEeecCCccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHH
Q 023591 157 RLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (280)
Q Consensus 157 ~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 232 (280)
++|+|||++....... ......++..|+|||.+.+..++.. +||||||+++|+|++ |..||..........
T Consensus 162 -~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~--- 236 (291)
T cd05094 162 -VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIE--- 236 (291)
T ss_pred -EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---
Confidence 9999999886433221 1223345678999999888777655 999999999999998 999987654432222
Q ss_pred hhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+...... ......+..+.+++.+||+.||++||
T Consensus 237 -~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp 270 (291)
T cd05094 237 -CITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRL 270 (291)
T ss_pred -HHhCCCCC-CCCccCCHHHHHHHHHHcccChhhCc
Confidence 22222221 11225788999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=279.88 Aligned_cols=253 Identities=30% Similarity=0.424 Sum_probs=195.4
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecC---------
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP--------- 89 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------- 89 (280)
..+|++.+.||.|++|.||++.+..++..|++|.+.... ...+.+.+|+.++++++|||++++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 378999999999999999999999999999999986644 3335678899999999999999999776543
Q ss_pred -----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 90 -----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 90 -----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
...++++||++ ++|.+++.. ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++. .++++|||
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFG 160 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCcc
Confidence 35789999996 488887753 46899999999999999999999999999999999999975432 38999999
Q ss_pred CccccccCCC----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc---
Q 023591 165 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--- 237 (280)
Q Consensus 165 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--- 237 (280)
.+........ .....++..|+|||.+.+......++||||||+++|+|++|..||..................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 8864322111 122346778999998765444455599999999999999999999765543222222111000
Q ss_pred ------------------ccccCC---CCCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 238 ------------------VQYSIP---DYVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 238 ------------------~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
.....+ ....++.++.+||.+||+.||.+|| .||||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 000000 0124778999999999999999999 9999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=286.12 Aligned_cols=246 Identities=27% Similarity=0.377 Sum_probs=204.1
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCC---cE-EEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEe
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTE---EL-VAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVIL 87 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~---~~-vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 87 (280)
+....++-.+.++||+|+||.||+++....+ .. ||+|..... .....++.+|.+++++++|||||+++|+..
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 3334456666799999999999999976432 23 899988742 344467889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCc
Q 023591 88 TPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (280)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~ 166 (280)
.+..+++|||+|+||+|.+++++.+ .++..+...++.+.+.+|+|||+++++||||-+.|++++.++. +|++|||++
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs 309 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLS 309 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccc
Confidence 9999999999999999999998887 4999999999999999999999999999999999999998886 899999998
Q ss_pred cccccCCCCC-CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCC
Q 023591 167 KSSVLHSQPK-STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (280)
Q Consensus 167 ~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (280)
+......... ..--...|+|||.+..+.++.+ +||||+|+++||+++ |..||.+.... .....+....++.+.
T Consensus 310 ~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 310 RAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVKNGYRMPI 384 (474)
T ss_pred cCCcceeeccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHHhcCccCCC
Confidence 8554333333 3335678999999998877666 999999999999998 78899886543 344444444555554
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 245 YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....+.++..++.+|+..||++||
T Consensus 385 ~~~~p~~~~~~~~~c~~~~p~~R~ 408 (474)
T KOG0194|consen 385 PSKTPKELAKVMKQCWKKDPEDRP 408 (474)
T ss_pred CCCCHHHHHHHHHHhccCChhhcc
Confidence 447889999999999999999999
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=279.67 Aligned_cols=244 Identities=24% Similarity=0.327 Sum_probs=194.2
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc-cHHHHHHHHHhhhCCCCCeeeeceEEecCC-eEEEEEe
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVME 97 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 97 (280)
.++|.-...||+|+||.||++.-.++ ..||||.+...... ..++.+|+.++.+++|||+|+++|+|.+.+ ..++|+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 35777778999999999999998654 88999988776554 667999999999999999999999999888 5999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---ceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-
Q 023591 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~---i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~- 171 (280)
|++.|+|.+.+.... ++++....+|+.++|+||+|||+.. |+||||||+||++|++.+ .||+|||+|.....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEG 230 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCcc
Confidence 999999999987654 8999999999999999999999854 999999999999998888 99999999965444
Q ss_pred CCCCCCC-cCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCC--CcchHHHHH-hhHhcccc------c
Q 023591 172 HSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--EPKNFRKTI-HRILSVQY------S 241 (280)
Q Consensus 172 ~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~-~~~~~~~~------~ 241 (280)
....... .++..|.+||+...+..+.+ +||||||+++.||++|+.+..... ......... ..+..... .
T Consensus 231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~ 309 (361)
T KOG1187|consen 231 DTSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPR 309 (361)
T ss_pred ccceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCC
Confidence 3333333 78999999999988777666 999999999999999998887543 222222211 11111111 1
Q ss_pred CCCCCCCC--H---HHHHHHHHhcccCCCCcC
Q 023591 242 IPDYVHIS--P---ECRHLISRIFVADPAKSE 268 (280)
Q Consensus 242 ~~~~~~~~--~---~l~~li~~~l~~dp~~Rp 268 (280)
+.. ..++ . .+..+..+|++.+|..||
T Consensus 310 l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP 340 (361)
T KOG1187|consen 310 LKE-GEYPDEKEVKKLAELALRCLRPDPKERP 340 (361)
T ss_pred ccC-CCCChHHHHHHHHHHHHHHcCcCCCcCc
Confidence 110 1233 2 356677799999999999
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=270.47 Aligned_cols=241 Identities=23% Similarity=0.392 Sum_probs=194.2
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCc---EEEEEEeeeC--CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
...|++.+.||+|+||.||++....+++ .|++|.+... ......+..|+..+++++|||++++.+++..+...++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 4679999999999999999999876654 5999998753 2234568889999999999999999999998889999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
+|||+++++|.+++... +.++...+..++.|++.||++||++|++|+||+|+||+++.++. ++|.|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc--EEECCCccccccccCc
Confidence 99999999999988653 46899999999999999999999999999999999999987766 9999999876433222
Q ss_pred CCCCC---c---CCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCC
Q 023591 174 QPKST---V---GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (280)
Q Consensus 174 ~~~~~---~---~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (280)
..... . .+..|+|||.+.+..++.. +||||||+++|+|++ |..||....... ....+. .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~----~~~~i~-~~~~~~~~~ 234 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQD----VINAIE-QDYRLPPPM 234 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHH----HHHHHH-cCCcCCCcc
Confidence 21111 1 1346999999987777665 999999999999886 999997654322 222221 222333333
Q ss_pred CCCHHHHHHHHHhcccCCCCcC
Q 023591 247 HISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.++..+.+++.+||+.+|++||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp 256 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARP 256 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCc
Confidence 6789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=270.44 Aligned_cols=242 Identities=24% Similarity=0.383 Sum_probs=194.9
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCC---cEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
...+|++.+.||+|+||.||++.+..++ ..+++|.+.... ...+.+.+|+..+++++||||+++++++..++..+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 3578999999999999999999876444 368999886532 23356788999999999999999999999889999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
++|||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe--EEeCCCCcccccccc
Confidence 999999999999998664 46899999999999999999999999999999999999988776 999999988754332
Q ss_pred CCCC----CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 173 SQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 173 ~~~~----~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
.... ....+..|++||.+.+..++.. +|+||||+++|++++ |..||......+.... +.. ....+....
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~ 233 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA----IEE-GYRLPAPMD 233 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH----HhC-CCcCCCCCC
Confidence 2111 1112457999999987777655 999999999999886 9999976544322222 221 122333346
Q ss_pred CCHHHHHHHHHhcccCCCCcC
Q 023591 248 ISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp 268 (280)
+++.+.+++.+||+.+|.+||
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp 254 (267)
T cd05066 234 CPAALHQLMLDCWQKDRNERP 254 (267)
T ss_pred CCHHHHHHHHHHcccCchhCC
Confidence 789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=273.33 Aligned_cols=245 Identities=24% Similarity=0.376 Sum_probs=195.8
Q ss_pred CCCCCCeeeecccccCCceEEEEEEec-----CCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhC-CCCCeeeeceEEec
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 88 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 88 (280)
....++|++.+.||+|+||.||++.+. .++..+|+|.+..... ..+.+.+|+.+++++ +|+||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 345578999999999999999999752 3456799998875432 234678899999999 79999999999998
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCc
Q 023591 89 PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~ 166 (280)
.+..+++|||+++++|.+++.... .+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++. ++++|||++
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~dfg~~ 188 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI--VKICDFGLA 188 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe--EEECCCccc
Confidence 899999999999999999986543 3899999999999999999999999999999999999987766 999999998
Q ss_pred cccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccC
Q 023591 167 KSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSI 242 (280)
Q Consensus 167 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
........ .....++..|+|||.+.+..++.. +||||+|+++|+|++ |..||..........+... .....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~ 263 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----EGYRM 263 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH----cCCcC
Confidence 74432211 122345678999999988777665 999999999999998 9999976554332222221 11222
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 243 PDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
......++++.+|+.+||+.+|++||
T Consensus 264 ~~~~~~~~~~~~li~~cl~~~p~~Rp 289 (302)
T cd05055 264 AQPEHAPAEIYDIMKTCWDADPLKRP 289 (302)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCc
Confidence 22225789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=270.30 Aligned_cols=241 Identities=21% Similarity=0.355 Sum_probs=192.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCc----EEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
..++|++.+.||+|+||.||++++..+++ .||+|.+.... .....+.+|+.+++.+.|+|++++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 45789999999999999999999876665 47899886532 223567789999999999999999999865 457
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
+++++|+++++|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~ 161 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDI 161 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeeccc
Confidence 7999999999999998764 46899999999999999999999999999999999999987776 99999999875433
Q ss_pred CCCC---CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 172 HSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 172 ~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
.... .....++.|+|||...+..++.. +||||||+++|+|++ |..||....... ..... . .....+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~---~-~~~~~~~~~~ 235 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPARE-IPDLL---E-KGERLPQPPI 235 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH---H-CCCcCCCCcc
Confidence 2221 12234567999999987777665 999999999999998 899987644322 11111 1 1122222336
Q ss_pred CCHHHHHHHHHhcccCCCCcC
Q 023591 248 ISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+.++.+++.+||+.||++||
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp 256 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRP 256 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCc
Confidence 789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=274.19 Aligned_cols=240 Identities=21% Similarity=0.355 Sum_probs=193.1
Q ss_pred CCCeeeecccccCCceEEEEEEecCC-----CcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
..+|++.+.||.|+||.||++.+..+ +..||+|.+..... ..+.+.+|+.++..++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 45789999999999999999987543 57799999875432 234577899999999999999999999998999
Q ss_pred EEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCC
Q 023591 93 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~ 156 (280)
++++||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||||+||+++.++.
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~- 162 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN- 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc-
Confidence 9999999999999987532 24788899999999999999999999999999999999987776
Q ss_pred cEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHH
Q 023591 157 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (280)
Q Consensus 157 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 232 (280)
++|+|||++........ .....+++.|+|||.+.++.++.. +||||||+++|+|++ |..||...... ...
T Consensus 163 -~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~ 236 (283)
T cd05091 163 -VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQ----DVI 236 (283)
T ss_pred -eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCHH----HHH
Confidence 99999998774332211 123345678999999987777655 999999999999998 88888765432 222
Q ss_pred hhHhcccc-cCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 233 HRILSVQY-SIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 233 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..+..... ..+. .++..+.+|+.+||+.+|.+||
T Consensus 237 ~~i~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~RP 271 (283)
T cd05091 237 EMIRNRQVLPCPD--DCPAWVYTLMLECWNEFPSRRP 271 (283)
T ss_pred HHHHcCCcCCCCC--CCCHHHHHHHHHHhCCCcccCC
Confidence 33333222 2222 6889999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=274.20 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=192.1
Q ss_pred CCCeeeecccccCCceEEEEEEecCC--------------CcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeec
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKT--------------EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFK 83 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~--------------~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~ 83 (280)
.++|++.+.||+|+||.||++.+..+ ...||+|.+.... .....+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 46899999999999999999987543 2358999887532 2234678899999999999999999
Q ss_pred eEEecCCeEEEEEeccCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEe
Q 023591 84 EVILTPTHLAIVMEYASGGELFERICNAG------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (280)
Q Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~ 151 (280)
+++......+++|||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 99999999999999999999999885432 367889999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh--CCCCCCCCCCcc
Q 023591 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEPK 226 (280)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~--g~~p~~~~~~~~ 226 (280)
.++. ++|+|||++........ .....++..|+|||.+.++.++.. +|+||||+++|+|++ +..||.......
T Consensus 164 ~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 164 NHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred CCCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCch-hhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 8776 99999998864332211 122234568999999888777655 999999999999988 667887655433
Q ss_pred hHHHHHhhHhc--ccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 227 NFRKTIHRILS--VQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 227 ~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
........... ...........++.+.+|+.+||+.||++||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP 284 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRP 284 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCc
Confidence 32222111111 1111112235789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=278.71 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=197.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecC------
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 89 (280)
..++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 4589999999999999999999999899999999987542 2235577899999999999999999987643
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
...+++++++ +++|.+.+.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEecccccccc
Confidence 3468888887 6788877754 46899999999999999999999999999999999999998887 999999988743
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc------------
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------ 237 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------ 237 (280)
.. ......++..|+|||.+.+......++|+||||+++|+|++|..||..................
T Consensus 171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T cd07877 171 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248 (345)
T ss_pred cc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence 22 2233456788999998866433344599999999999999999999765433222221111000
Q ss_pred -------ccccCCC------CCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 238 -------VQYSIPD------YVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 238 -------~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.....+. ....++++.+||.+||+.||.+|| .||||++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 0000000 113578899999999999999999 999998654
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=271.26 Aligned_cols=248 Identities=31% Similarity=0.470 Sum_probs=197.4
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc--HHHHHHHHHhhhCC-CCCeeeeceEEecCCeEEEEEecc
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
|++.+.||+|++|+||++....+++.+++|.+....... ....+|+..+++++ |+|++++++++..+...++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 788999999999999999999889999999986543322 23456888899998 999999999999999999999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCC
Q 023591 100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (280)
Q Consensus 100 ~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (280)
+++|.+.+.... .+++..+..++.|++.+|.+||++|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCC
Confidence 678988887654 7899999999999999999999999999999999999998777 99999999875544444444
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc---------------ccccC
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYSI 242 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~~~~~ 242 (280)
..++..|+|||.+.+......++|+||||+++++|++|..||......+...+....... .....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 567788999998865444445599999999999999999999766543333222211000 00000
Q ss_pred CC---------CCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 243 PD---------YVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 243 ~~---------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
+. ....+.++.++|++||+.||++|| .||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 012368899999999999999999 99997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=271.66 Aligned_cols=248 Identities=33% Similarity=0.515 Sum_probs=199.3
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
|++.+.||+|.+|.||+++...+++.+++|.+... ....+.+.+|+..+++++|+|++++++++......++++|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67889999999999999999999999999998864 333456778999999999999999999999889999999999
Q ss_pred CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCCC
Q 023591 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (280)
Q Consensus 100 ~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (280)
+ ++|.+++.+. ..+++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCc
Confidence 7 4899998776 57999999999999999999999999999999999999998776 9999999887443322 1223
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc-----------c---cccCC
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-----------V---QYSIP 243 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----------~---~~~~~ 243 (280)
...+..|+|||.+.+....+.++|+||||+++++|++|..||..........+....... . ...++
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 345677999999877633344599999999999999999999776543333322211100 0 00001
Q ss_pred C---------CCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 244 D---------YVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 244 ~---------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
. .+..+..+.++|++||+.||++|| .||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0 123578899999999999999999 99997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=266.45 Aligned_cols=240 Identities=23% Similarity=0.377 Sum_probs=193.9
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
..++|++.+.||+|+||.||++... .+..+++|.+.......+.+.+|+.++++++|+|++++++++.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 4578999999999999999999865 45569999887765556778899999999999999999999877 778999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC-
Q 023591 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (280)
Q Consensus 99 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~- 175 (280)
+++++|.+++.+. ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCCcceeeccCCCccc
Confidence 9999999998653 35788899999999999999999999999999999999988776 999999988643322111
Q ss_pred -CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 176 -~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
....++..|+|||.+....++.. +|+||||+++|++++ |..||.......... .+. ..+..+.....+.++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIR----ALE-RGYRMPRPENCPEELY 233 (260)
T ss_pred ccCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHh-CCCCCCCcccCCHHHH
Confidence 12234467999999977776555 999999999999998 999997654322222 111 2222233336789999
Q ss_pred HHHHHhcccCCCCcC
Q 023591 254 HLISRIFVADPAKSE 268 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp 268 (280)
+++.+||+.||++||
T Consensus 234 ~~i~~~l~~~p~~Rp 248 (260)
T cd05073 234 NIMMRCWKNRPEERP 248 (260)
T ss_pred HHHHHHcccCcccCc
Confidence 999999999999999
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=268.49 Aligned_cols=242 Identities=23% Similarity=0.368 Sum_probs=195.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCc---EEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
..++|+..+.||+|++|.||++....++. .+++|.+.... ...+.+.+|+.++++++|+|++++.+++......+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 35689999999999999999999876554 68999886542 23356788999999999999999999999989999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
++|||+++++|.+++... ..++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++++|||++......
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~ 160 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc--EEECCCccceecccc
Confidence 999999999999998653 57899999999999999999999999999999999999988776 999999988644322
Q ss_pred CCCC----CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 173 SQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 173 ~~~~----~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
.... ....+..|+|||.+.+..++.. +|+||||+++|+|++ |..||....... ....+.. ....+....
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~----~~~~i~~-~~~~~~~~~ 234 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHE----VMKAIND-GFRLPAPMD 234 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHH----HHHHHhc-CCCCCCCCC
Confidence 2111 1122356999999887777555 999999999999997 999997654422 2222222 123333335
Q ss_pred CCHHHHHHHHHhcccCCCCcC
Q 023591 248 ISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+.++.+++.+||+.+|++||
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp 255 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRP 255 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCc
Confidence 789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=286.90 Aligned_cols=244 Identities=28% Similarity=0.448 Sum_probs=207.7
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc----HHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
..|+-++.||.|+||-||.+++..+.+.||||++.-+.+.. .++..|+..|++++|||++.+-++|..+...++||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 35777899999999999999999999999999987654333 45788999999999999999999999999999999
Q ss_pred eccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 97 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~-~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
|||- |+..+++. ..+++.+-+|..|+.+.+.+|+|||+.+.+|||||+.||++++.|. |||.|||++.. ....
T Consensus 106 EYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi---~~PA 179 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASI---MAPA 179 (948)
T ss_pred HHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhh---cCch
Confidence 9995 58888775 3467999999999999999999999999999999999999999988 99999998763 3445
Q ss_pred CCCcCCCcccCccccc---CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 176 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~---~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
..+.|||.|+|||++. .+.|+.+ .||||||++..+|....+|+-+.+....+-.+.. ...+.++ .+.+|+.+
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ---NesPtLq-s~eWS~~F 254 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---NESPTLQ-SNEWSDYF 254 (948)
T ss_pred hcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHHHh---cCCCCCC-CchhHHHH
Confidence 6889999999999975 5678777 9999999999999999999887665443333322 2233333 33789999
Q ss_pred HHHHHHhcccCCCCcC------CCccccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
++|+..||+.-|.+|| .|+|+..
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 9999999999999999 9999864
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=269.07 Aligned_cols=242 Identities=22% Similarity=0.393 Sum_probs=196.7
Q ss_pred CCCeeeecccccCCceEEEEEEecC-----CCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
.++|++.+.||+|+||.||+++... +...+++|.+..... ....+.+|+.++++++|+|++++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 3789999999999999999999753 346789998865433 245788999999999999999999999888899
Q ss_pred EEEEeccCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeec
Q 023591 93 AIVMEYASGGELFERICNAG---------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df 163 (280)
+++|||+++++|.+++.... .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++. ++++||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~ 161 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLL 161 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEccc
Confidence 99999999999999987655 6899999999999999999999999999999999999998887 999999
Q ss_pred CCccccccCC--CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccc
Q 023591 164 GYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQY 240 (280)
Q Consensus 164 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
|++....... ......++..|+|||.+.+...... +||||||+++|+|++ |..||....... ....+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~~~~~p~~~~~~~~----~~~~~~~~~~ 236 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDEE----VLNRLQAGKL 236 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccchHH----HHHHHHcCCc
Confidence 9876332211 1122345667999999877776555 999999999999998 888997644322 2333333333
Q ss_pred cCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 241 SIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.++....++..+.+++.+||+.||++||
T Consensus 237 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp 264 (275)
T cd05046 237 ELPVPEGCPSRLYKLMTRCWAVNPKDRP 264 (275)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCC
Confidence 3333346889999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=269.32 Aligned_cols=246 Identities=27% Similarity=0.418 Sum_probs=190.5
Q ss_pred CCCeeeecccccCCceEEEEEE----ecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEec--CCeE
Q 023591 20 SDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILT--PTHL 92 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 92 (280)
..+|++.+.||+|+||.||.+. +..+++.|++|.+.... ...+.+.+|+.++++++|||++++++++.. ...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 3689999999999999999997 34578899999987543 234567889999999999999999998654 3468
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
++++||+++++|.+++... ..++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~ 160 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCcccccccC
Confidence 9999999999999998654 46899999999999999999999999999999999999988876 99999999875433
Q ss_pred CCCC----CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcc-----------hHHHHHhhHh
Q 023591 172 HSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-----------NFRKTIHRIL 236 (280)
Q Consensus 172 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-----------~~~~~~~~~~ 236 (280)
.... .....+..|+|||.+.+..++.. +|+||||+++++|++|..++....... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChH-HHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 2211 11123345999999887776555 999999999999999877654332110 0000111112
Q ss_pred cccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 237 SVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 237 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.....++....++.++.+||.+||+.+|++||
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 271 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRP 271 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCC
Confidence 22223333346789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=287.01 Aligned_cols=250 Identities=25% Similarity=0.428 Sum_probs=206.0
Q ss_pred CCCCCe-eeecccccCCceEEEEEEecCCCcEEEEEEee-----eCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCC-
Q 023591 18 HDSDRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-----RGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT- 90 (280)
Q Consensus 18 ~~~~~y-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 90 (280)
...++| +....||+|+|-+||+|.+..+|-.||--.++ +.+...+++..|+.+|+.|+|+||+++++++.+..
T Consensus 36 ~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n 115 (632)
T KOG0584|consen 36 DPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN 115 (632)
T ss_pred CCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence 344677 55679999999999999999999888854443 34455588999999999999999999999998765
Q ss_pred -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 91 -~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
...+|+|.+..|+|..++++.+.++...++.|++||+.+|.|||++. |+|||||-+||||+.+ .+.|||+|+|+|.
T Consensus 116 ~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~-~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 116 KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN-LGEVKIGDLGLAT 194 (632)
T ss_pred ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC-cCceeecchhHHH
Confidence 48899999999999999999999999999999999999999999876 9999999999999743 3459999999997
Q ss_pred ccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc-chHHHHHhhHhcccccCCCCC
Q 023591 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPDYV 246 (280)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 246 (280)
..... ......|||.|+|||... ..|+.. .||||||+++.||+|+..||...... ..++++..++.+..+..
T Consensus 195 l~r~s-~aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k---- 267 (632)
T KOG0584|consen 195 LLRKS-HAKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK---- 267 (632)
T ss_pred Hhhcc-ccceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc----
Confidence 44332 333478999999999875 667655 99999999999999999999766443 33444444444433322
Q ss_pred CCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 247 HISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
--.+++++||.+||.. ..+|| .||||+.+
T Consensus 268 V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 268 VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 3368999999999999 99999 99999865
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=272.15 Aligned_cols=245 Identities=24% Similarity=0.385 Sum_probs=191.8
Q ss_pred CCeeeecccccCCceEEEEEEecC----------------CCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeee
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKK----------------TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRF 82 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~----------------~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~ 82 (280)
++|++.+.||+|+||.||++.+.. ++..+|+|.+.... .....+.+|+..++.++|+|++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 679999999999999999986432 34568999887543 233568899999999999999999
Q ss_pred ceEEecCCeEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEe
Q 023591 83 KEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (280)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~ 151 (280)
++++..++..+++|||+++++|.+++.... .++...+..++.|++.||++||+.|++|+||+|+||+++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~ 164 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG 164 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence 999999999999999999999999886532 366778999999999999999999999999999999998
Q ss_pred CCCCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh--CCCCCCCCCCcc
Q 023591 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEPK 226 (280)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~--g~~p~~~~~~~~ 226 (280)
.++. ++|+|||++........ ......+..|++||...++.++.. +|+||||+++|+|++ |..||.......
T Consensus 165 ~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 165 KNYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA-SDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred CCCC--EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccch-hhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 7776 99999999874432221 112233567999998877777655 999999999999998 778887655433
Q ss_pred hHHHHHhhHhc--ccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 227 NFRKTIHRILS--VQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 227 ~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
........... .....+....+++.+.+|+.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 285 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP 285 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCC
Confidence 33222111111 1112222335789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=278.65 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=195.6
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecC------C
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 90 (280)
.++|++.+.||+|++|.||++.+..+++.||+|.+.+. ......+.+|+.++++++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999999989999999998753 22334577899999999999999999988654 2
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
.++++++|+.. +|.... ...+++..+..++.|++.||++||+.|++||||+|+||+++.++. ++|+|||++....
T Consensus 94 ~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~~ 168 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHAD 168 (342)
T ss_pred eEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCCC
Confidence 46899999964 676654 346899999999999999999999999999999999999998876 9999999887432
Q ss_pred cCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHh--------------
Q 023591 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-------------- 236 (280)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------- 236 (280)
. ......+++.|+|||.+.+......++|+||||+++|+|++|..||...+.............
T Consensus 169 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 169 A--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred C--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 2 222335677899999987644344559999999999999999999986543322222211000
Q ss_pred -----cccccCCC------CCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 237 -----SVQYSIPD------YVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 237 -----~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
......+. .+..++++.+||.+||+.||++|| .||||++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00000000 124678899999999999999999 999998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=271.27 Aligned_cols=245 Identities=27% Similarity=0.415 Sum_probs=197.6
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
..|+..+.||+|+||.||++++..++..+++|.+..... ....+.+|+..+++++|+|++++++++..+...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 458899999999999999999998999999999875432 2245778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
||+++ +|.+.+.. ..++++..+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++.... ..
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~---~~ 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIAS---PA 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccC---Cc
Confidence 99975 77776643 557899999999999999999999999999999999999988776 9999999876332 22
Q ss_pred CCCcCCCcccCccccc---CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 176 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~---~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
....+++.|+|||.+. .+..+. ++|+||+|+++|+|++|..||........... +............+++.+
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~-~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l 253 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPTLQSNEWSDYF 253 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCc-cccHHHHHHHHHHHHhCCCCCCCccHHHHHHH----HHhccCCCCCCccccHHH
Confidence 3445778899999874 234444 49999999999999999999976543222222 222222222223578899
Q ss_pred HHHHHHhcccCCCCcC------CCcccccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
++++.+||+.+|.+|| .|+|+...
T Consensus 254 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 254 RNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 9999999999999999 99998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=278.02 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=190.0
Q ss_pred ecccccC--CceEEEEEEecCCCcEEEEEEeeeCCcc---cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccC
Q 023591 26 VRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (280)
Q Consensus 26 ~~~lg~G--~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (280)
...||.| ++|+||++++..+++.||+|.+...... .+.+.+|+.+++.++||||+++++++..+...++++||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3567766 8899999999999999999998754322 3567789999999999999999999999999999999999
Q ss_pred CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC---
Q 023591 101 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--- 175 (280)
Q Consensus 101 ~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~--- 175 (280)
++++.+++.+. ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++. +++.||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccCccccc
Confidence 99999988764 35899999999999999999999999999999999999998876 999999754322111111
Q ss_pred -----CCCcCCCcccCcccccCCcC-CCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHh-------------
Q 023591 176 -----KSTVGTPAYIAPEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL------------- 236 (280)
Q Consensus 176 -----~~~~~~~~~~aPE~~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------- 236 (280)
....++..|+|||.+.+... ...++||||+|+++|+|++|..||.................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 11223556999999876432 23449999999999999999999976543222211111000
Q ss_pred ----------------------------cccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 237 ----------------------------SVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 237 ----------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
......+....+++.+.+|+++||+.||++|| .||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00001111123567899999999999999999 89999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=265.37 Aligned_cols=241 Identities=25% Similarity=0.412 Sum_probs=195.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
...+|++.+.||+|++|.||++.+. ++..+++|.+.........+.+|++++++++|+|++++++++......++++||
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 3568999999999999999999875 466799999877665567788999999999999999999999888899999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC--C
Q 023591 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (280)
Q Consensus 99 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~--~ 175 (280)
+++++|.+++... ..+++..++.++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe--EEECCCcceeecccCccccc
Confidence 9999999988654 46899999999999999999999999999999999999987776 99999998764322211 1
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
.....+..|+|||.+.++.++.. +|+||||+++|+|++ |..||....... ....+... .........+..+.+
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~~ 232 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYENRSNSE----VVETINAG-FRLYKPRLASQSVYE 232 (256)
T ss_pred CCCccchhhcCHhHhccCCcChH-HHHHHHHHHHHHHHcCCCCCCCcCCHHH----HHHHHhCC-CCCCCCCCCCHHHHH
Confidence 12234567999999887777655 999999999999998 999997644322 22222111 111112246899999
Q ss_pred HHHHhcccCCCCcC
Q 023591 255 LISRIFVADPAKSE 268 (280)
Q Consensus 255 li~~~l~~dp~~Rp 268 (280)
|+.+||+.+|++||
T Consensus 233 l~~~~l~~~p~~Rp 246 (256)
T cd05112 233 LMQHCWKERPEDRP 246 (256)
T ss_pred HHHHHcccChhhCC
Confidence 99999999999999
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=270.59 Aligned_cols=239 Identities=23% Similarity=0.359 Sum_probs=190.1
Q ss_pred CeeeecccccCCceEEEEEEecC-----CCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
+|++.+.||+|+||.||++.+.. ....+++|.+..... ....+.+|+..++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 235688888765432 23467789999999999999999999998899999
Q ss_pred EEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEE
Q 023591 95 VMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~------------------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i 150 (280)
++||+++++|.+++... .+++...++.++.|++.+|.+||+.|++|+||+|+||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999987542 247889999999999999999999999999999999999
Q ss_pred eCCCCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcc
Q 023591 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (280)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~ 226 (280)
+.++. ++|+|||++........ ......+..|+|||.+.+..++.. +||||||+++++|++ |..||.......
T Consensus 161 ~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 161 AEGRK--MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred cCCCc--EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH-hHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 88776 99999999864322211 122234567999999877776655 999999999999998 999997654322
Q ss_pred hHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..+... .....+....++.++.+++.+||+.||++||
T Consensus 238 -~~~~~~----~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp 274 (290)
T cd05045 238 -LFNLLK----TGYRMERPENCSEEMYNLMLTCWKQEPDKRP 274 (290)
T ss_pred -HHHHHh----CCCCCCCCCCCCHHHHHHHHHHccCCcccCC
Confidence 222211 1122222236889999999999999999999
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=269.80 Aligned_cols=244 Identities=27% Similarity=0.406 Sum_probs=190.8
Q ss_pred CCeeeecccccCCceEEEEEEe----cCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecC--CeE
Q 023591 21 DRYELVRDIGSGNFGVARLMRD----KKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 92 (280)
.-|++++.||+|+||.||+++. ..++..|++|.+.... .....+.+|+.++++++|+|++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4579999999999999999984 4568889999986542 2335688899999999999999999998765 568
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
+++|||+++++|.+++.+.. .++...+..++.|++.||++||++|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~ 161 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIET 161 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCcccccccc
Confidence 99999999999999986643 5899999999999999999999999999999999999988776 99999999875433
Q ss_pred CCC----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCC-----------cchHHHHHhhHh
Q 023591 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-----------PKNFRKTIHRIL 236 (280)
Q Consensus 172 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~ 236 (280)
... .....++..|+|||.+.+..++.. +||||||+++|+|+++..|+..... ............
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCcc-ccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 221 123345667999999887777655 9999999999999998766432111 111111111111
Q ss_pred cccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 237 SVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 237 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.....+....++..+.+|+.+||+.||++||
T Consensus 241 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 271 (284)
T cd05079 241 -EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRT 271 (284)
T ss_pred -cCccCCCCCCCCHHHHHHHHHHccCCcccCc
Confidence 1112222336889999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=275.12 Aligned_cols=253 Identities=27% Similarity=0.415 Sum_probs=195.8
Q ss_pred CeeeecccccCCceEEEEEEecCC--CcEEEEEEeeeCC---cccHHHHHHHHHhhhC-CCCCeeeeceEEecC----Ce
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKT--EELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTP----TH 91 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~--~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~----~~ 91 (280)
+|++.+.||+|+||.||++.+..+ +..||+|.+.... .....+.+|+.+++++ +|+||+++++..... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999887 8899999886532 2234567899999988 699999999875432 45
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
.+++++++. ++|.+.+.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE 157 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence 789999985 589998888888999999999999999999999999999999999999998877 99999999874432
Q ss_pred CCC-----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhH-----------
Q 023591 172 HSQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI----------- 235 (280)
Q Consensus 172 ~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 235 (280)
... .....+++.|+|||.+.+......++|+||+|+++|+|++|..||................
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 221 1223578889999987664433455999999999999999999997654322221111100
Q ss_pred hc------------c-cccCC-CCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 236 LS------------V-QYSIP-DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 236 ~~------------~-~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.. . ...+. .....+..+.+|+.+||+.||.+|| .|||++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 00 0 00000 1124678999999999999999999 999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=271.50 Aligned_cols=243 Identities=24% Similarity=0.383 Sum_probs=193.7
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCC-----CcEEEEEEeeeCC--cccHHHHHHHHHhhhC-CCCCeeeeceEEecC
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 89 (280)
...++|++.+.||+|++|.||++..... ...+++|.+.... .....+.+|+.+++++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 3457899999999999999999987643 3679999887542 2234577899999999 899999999999998
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC
Q 023591 90 THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~ 153 (280)
..++++|||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 9999999999999999998542 358899999999999999999999999999999999999887
Q ss_pred CCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHH
Q 023591 154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (280)
Q Consensus 154 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~ 229 (280)
+. ++|+|||++........ ......+..|+|||.+.+..++.. +||||||+++|+|++ |..||..........
T Consensus 169 ~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 169 HV--MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred Ce--EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 76 99999999875433221 111223467999999877777655 999999999999997 999997654322222
Q ss_pred HHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 230 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+.. ..........+.++.+|+.+||+.||++||
T Consensus 246 ----~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 279 (293)
T cd05053 246 ----LLKE-GYRMEKPQNCTQELYHLMRDCWHEVPSQRP 279 (293)
T ss_pred ----HHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCc
Confidence 1111 112222225788999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=265.58 Aligned_cols=238 Identities=26% Similarity=0.393 Sum_probs=191.3
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEe-cCCeEEEEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVM 96 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~ 96 (280)
...++|++.+.||+|++|.||++... +..+++|.+... ...+.+.+|+.++++++|+|++++++++. .++..++++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 34578999999999999999999774 677999987643 33457889999999999999999998764 456789999
Q ss_pred eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 97 EYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
||+++++|.+++.+.. .+++..+..++.|++.+|++||++|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQ- 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceeccccC-
Confidence 9999999999987644 4889999999999999999999999999999999999998876 9999999887443222
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
.....+..|+|||.+.+..++.. +||||||+++|+|++ |..||..... ......+... ........+++.+.
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~~ 229 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRVEKG-YKMDAPDGCPPVVY 229 (256)
T ss_pred -CCCccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHhcC-CCCCCCCCCCHHHH
Confidence 23334567999999877777655 999999999999997 9999875432 2222222211 11112236789999
Q ss_pred HHHHHhcccCCCCcC
Q 023591 254 HLISRIFVADPAKSE 268 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp 268 (280)
+++.+||+.||++||
T Consensus 230 ~li~~~l~~~p~~Rp 244 (256)
T cd05082 230 DVMKQCWHLDAATRP 244 (256)
T ss_pred HHHHHHhcCChhhCc
Confidence 999999999999999
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=267.77 Aligned_cols=238 Identities=22% Similarity=0.337 Sum_probs=187.9
Q ss_pred eeeecccccCCceEEEEEEecC---CCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCe-----
Q 023591 23 YELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH----- 91 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 91 (280)
|++.+.||+|+||.||++.... ++..||+|.+..... ..+.+.+|+..++.++|+|++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6788999999999999998764 347899999875432 23467889999999999999999998765443
Q ss_pred -EEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 92 -LAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 92 -~~lv~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
.++++||+++++|..++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT--VCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe--EEECCcc
Confidence 79999999999998887432 35899999999999999999999999999999999999988776 9999999
Q ss_pred CccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccc
Q 023591 165 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQY 240 (280)
Q Consensus 165 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
+++....... ......+..|.|||.+.+..++.. +||||||+++|+|++ |..||............. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~---~~~~~ 234 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR---HGNRL 234 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCC
Confidence 9875433221 111224567999999877777655 999999999999999 889997654432222111 11122
Q ss_pred cCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 241 SIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..+. .+++++.+++.+||+.||++||
T Consensus 235 ~~~~--~~~~~~~~li~~~l~~~p~~Rp 260 (273)
T cd05035 235 KQPE--DCLDELYDLMYSCWRADPKDRP 260 (273)
T ss_pred CCCc--CCCHHHHHHHHHHcCCChhhCc
Confidence 2222 6789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=272.19 Aligned_cols=241 Identities=24% Similarity=0.347 Sum_probs=190.9
Q ss_pred CCCeeeecccccCCceEEEEEEecC-------CCcEEEEEEeeeCC--cccHHHHHHHHHhhhC-CCCCeeeeceEEecC
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 89 (280)
.++|.+.+.||+|+||.||++++.. +...+|+|.+.... .....+.+|+.+++.+ +|+|++++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4789999999999999999998643 23469999887542 2234577899999999 799999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC
Q 023591 90 THLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~ 153 (280)
...+++|||+++++|.+++.... .++...+..++.|++.||++||+.|++|+||+|+||+++.+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence 99999999999999999986532 37888999999999999999999999999999999999988
Q ss_pred CCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHH
Q 023591 154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (280)
Q Consensus 154 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~ 229 (280)
+. ++|+|||.+........ ......++.|+|||.+.+..++.. +|+||||+++|+|++ |..||..... ..
T Consensus 177 ~~--~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~~~g~~p~~~~~~-~~-- 250 (307)
T cd05098 177 NV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPV-EE-- 250 (307)
T ss_pred Cc--EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH-HHHHHHHHHHHHHHcCCCCCCCcCCH-HH--
Confidence 76 99999998864432111 111223467999999987777655 999999999999998 8888865432 22
Q ss_pred HHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 230 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....+.. ..........+.++.+||.+||..+|++||
T Consensus 251 -~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 287 (307)
T cd05098 251 -LFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRP 287 (307)
T ss_pred -HHHHHHc-CCCCCCCCcCCHHHHHHHHHHcccChhhCc
Confidence 2222211 112222235789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=267.73 Aligned_cols=234 Identities=24% Similarity=0.349 Sum_probs=185.1
Q ss_pred cccccCCceEEEEEEecCCCc--EEEEEEeeeC--CcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~--~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|+||.||+++...++. .+++|.+... ....+.+.+|+..++++ +|||++++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999987765 4678877642 23335678899999999 899999999999998999999999999
Q ss_pred CchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCC
Q 023591 102 GELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (280)
Q Consensus 102 ~~L~~~~~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~ 165 (280)
++|.+++.... .++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++++|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCC
Confidence 99999986532 3788999999999999999999999999999999999988776 99999998
Q ss_pred ccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCC
Q 023591 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (280)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (280)
+..............+..|+|||.+.+..++.. +|+||||+++|+|++ |..||....... ....+.. ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~----~~~~~~~-~~~~~~ 232 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLPQ-GYRLEK 232 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCccccCHHH----HHHHHhC-CCCCCC
Confidence 863322222222233567999999877776555 999999999999997 999997644322 2222222 122222
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 245 YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....+.++.+++.+||+.||.+||
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp 256 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERP 256 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCC
Confidence 235788999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=272.10 Aligned_cols=247 Identities=26% Similarity=0.401 Sum_probs=197.7
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
...|+..+.||.|++|.||++++..+++.+++|.+.... .....+.+|+.+++.++|+|++++.+++..+...++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 356889999999999999999999899999999986432 2224567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 96 MEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 96 ~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
|||+. +++.+.+. ...++++..+..++.|++.+|.+||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~--- 167 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP--- 167 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc--EEECCcccceeecC---
Confidence 99996 47777664 3456899999999999999999999999999999999999988776 99999998764322
Q ss_pred CCCCcCCCcccCcccccC---CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 175 PKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
.....+++.|+|||.+.+ ...+ .++||||||+++|+|++|..||........... +............++..
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 242 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHWSEY 242 (308)
T ss_pred cccccCCccccCHHHHhhcccCCCC-cccchHHHHHHHHHHHcCCCCCccccHHHHHHH----HhhcCCCCcCcccccHH
Confidence 233457788999999753 3343 449999999999999999999876433222221 11111111112257889
Q ss_pred HHHHHHHhcccCCCCcC------CCccccccc
Q 023591 252 CRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
+.+||++||+.+|++|| .|||+....
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 99999999999999999 999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=266.93 Aligned_cols=241 Identities=20% Similarity=0.310 Sum_probs=188.7
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCc----EEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
..++|++.+.||.|+||+||++.+..+++ .+++|.+.... ....++..|+..+.+++||||+++++++. ....
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~ 83 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL 83 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence 34789999999999999999999877666 46777764322 12245667777888999999999999875 4557
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
++++||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~~ 161 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVADLLYP 161 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEEcCCccceeccC
Confidence 889999999999999865 456899999999999999999999999999999999999988776 99999999875432
Q ss_pred CCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 172 HSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 172 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
... .....++..|+|||.+.+..++.. +||||||+++|+|++ |..||...... ...+.. ......+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~-~~~~~~----~~~~~~~~~~~ 235 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPH-EVPDLL----EKGERLAQPQI 235 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH----HCCCcCCCCCC
Confidence 221 122335567999999987777655 999999999999998 99999765432 111211 11112222224
Q ss_pred CCHHHHHHHHHhcccCCCCcC
Q 023591 248 ISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+.++.+++.+||..||++||
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp 256 (279)
T cd05111 236 CTIDVYMVMVKCWMIDENVRP 256 (279)
T ss_pred CCHHHHHHHHHHcCCCcccCc
Confidence 678899999999999999999
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=265.68 Aligned_cols=240 Identities=30% Similarity=0.480 Sum_probs=192.5
Q ss_pred CeeeecccccCCceEEEEEEecC-CCcEEEEEEeeeCC-----------cccHHHHHHHHHhhh-CCCCCeeeeceEEec
Q 023591 22 RYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD-----------KIDENVQREIINHRS-LRHPNIVRFKEVILT 88 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~-----------~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 88 (280)
.|++.+.||+|+||.||++.+.. +++.+++|.+.... ....++.+|+.++.+ ++|+|++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 67889999875421 112345567777754 799999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeec
Q 023591 89 PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDF 163 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df 163 (280)
++..+++|||+++++|.+++.. ...+++..++.++.|++.+|.+||+ .|++|+||+|+||+++.++. ++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecc
Confidence 9999999999999999887732 3468999999999999999999996 78999999999999998876 999999
Q ss_pred CCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC
Q 023591 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243 (280)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (280)
|.+.............++..|++||.+.+..++.. +|+||||+++|+|++|..||....... ....+........
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~ll~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~ 233 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLS----LATKIVEAVYEPL 233 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchH-HHHHHHHHHHHHHHhCCCcccccCHHH----HHHHHhhccCCcC
Confidence 99875544433344567888999999987776555 999999999999999999997644322 2222222222222
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 244 DYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....+++++.++|.+||+.||++||
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp 258 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARP 258 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCC
Confidence 2225789999999999999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=279.15 Aligned_cols=246 Identities=25% Similarity=0.371 Sum_probs=194.3
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEec-----CCCcEEEEEEeeeCCcc--cHHHHHHHHHhhhCC-CCCeeeeceEEe
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKI--DENVQREIINHRSLR-HPNIVRFKEVIL 87 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 87 (280)
.....++|.+.+.||+|+||.||++++. .+++.||+|++...... ...+.+|+.++.++. ||||+++++.+.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4445578999999999999999999864 34568999999754322 246778999999997 999999999999
Q ss_pred cCCeEEEEEeccCCCchHHHHHhcC-------------------------------------------------------
Q 023591 88 TPTHLAIVMEYASGGELFERICNAG------------------------------------------------------- 112 (280)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~~------------------------------------------------------- 112 (280)
.+...++||||+++++|.+++.+.+
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 8889999999999999999885431
Q ss_pred -------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEE
Q 023591 113 -------------------------------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (280)
Q Consensus 113 -------------------------------------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~ 149 (280)
.++...+..++.|++.||+|||+.+++|+||+|+||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 2566778899999999999999999999999999999
Q ss_pred EeCCCCCcEEEeecCCccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCc
Q 023591 150 LDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (280)
Q Consensus 150 i~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~ 225 (280)
++.++. ++|+|||++....... ......++..|+|||.+.+..++.. +|+||||+++|+|++ |..||......
T Consensus 272 l~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 272 ICEGKL--VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL-SDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred EeCCCE--EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH-hHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 988776 9999999987432211 1122345678999999987777655 999999999999998 88999765433
Q ss_pred chHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 226 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....... ......+....++.++.+|+.+||..+|.+||
T Consensus 349 ~~~~~~~----~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RP 387 (401)
T cd05107 349 EQFYNAI----KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRP 387 (401)
T ss_pred HHHHHHH----HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCc
Confidence 3222221 11222222235789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=271.79 Aligned_cols=242 Identities=23% Similarity=0.340 Sum_probs=191.0
Q ss_pred CCCCeeeecccccCCceEEEEEEec-------CCCcEEEEEEeeeCC--cccHHHHHHHHHhhhC-CCCCeeeeceEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILT 88 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 88 (280)
..++|.+.+.||+|++|.||++++. .....+|+|.+.... .....+.+|+.+++++ +|+||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3479999999999999999999863 234568999887533 2234577899999999 69999999999998
Q ss_pred CCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC
Q 023591 89 PTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~ 152 (280)
+...+++|||+++++|.+++... ..++...+..++.|++.||.+||++|++|+||+|+||+++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 88999999999999999998653 24788899999999999999999999999999999999988
Q ss_pred CCCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchH
Q 023591 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (280)
Q Consensus 153 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~ 228 (280)
++. ++|+|||.+........ ......+..|+|||.+.+..++.. +||||||+++|+|++ |..||.......
T Consensus 170 ~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~~~~~~-- 244 (314)
T cd05099 170 DNV--MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIPVEE-- 244 (314)
T ss_pred CCc--EEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc-chhhHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 776 99999999874432211 112223457999999987777655 999999999999999 889986644322
Q ss_pred HHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....+.... .......++.++.+++.+||+.||++||
T Consensus 245 --~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rp 281 (314)
T cd05099 245 --LFKLLREGH-RMDKPSNCTHELYMLMRECWHAVPTQRP 281 (314)
T ss_pred --HHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCc
Confidence 222222211 1111225788999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=293.77 Aligned_cols=240 Identities=26% Similarity=0.398 Sum_probs=202.6
Q ss_pred CCeeeecccccCCceEEEEEEecC-----CCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
.+-+..+.||+|+||+||+++-.. ....||||.++.... ...+|++|++++..++|||||+++|++..++.++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 456778999999999999998642 346799999876543 4568999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEE
Q 023591 94 IVMEYASGGELFERICNAG--------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~--------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~ 159 (280)
+|+||+..|+|.+++.... +++..+...++.||+.++.||.++.+|||||-+.|++|.++-. ||
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--VK 643 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--VK 643 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--EE
Confidence 9999999999999985322 2888999999999999999999999999999999999988887 99
Q ss_pred EeecCCccccccCCCC---CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhH
Q 023591 160 ICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRI 235 (280)
Q Consensus 160 l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 235 (280)
|+|||+++.......- ....-..+|+|||.+..++++++ |||||+|++|||+++ |..||....+++.+. .+
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn~EVIe----~i 718 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE----CI 718 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccchHHHHH----HH
Confidence 9999999855443322 23345678999999999999888 999999999999998 899999877654433 33
Q ss_pred hcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..+.. ++-..+.|.++.+|+..||+.+|.+||
T Consensus 719 ~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RP 750 (774)
T KOG1026|consen 719 RAGQL-LSCPENCPTEVYSLMLECWNENPKRRP 750 (774)
T ss_pred HcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCC
Confidence 33333 333337999999999999999999999
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=272.08 Aligned_cols=252 Identities=29% Similarity=0.475 Sum_probs=196.6
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEec-CCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 94 (280)
..++|++.+.||.|+||.||++.+..+++.+|+|.+.+. ....+.+.+|+.++++++|||++++.+++.. ....++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 458899999999999999999999999999999988643 2234567789999999999999999999875 457899
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
++||+ +++|.+++.. .++++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..... .
T Consensus 88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~~--~ 161 (328)
T cd07856 88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQDP--Q 161 (328)
T ss_pred Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCccccccccCC--C
Confidence 99999 4588877753 46889999999999999999999999999999999999988776 99999998874322 1
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhh-----------H--------
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-----------I-------- 235 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------~-------- 235 (280)
.....++..|+|||.+.+......++|+||||+++|+|++|..||............... .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 223456778999998766443345599999999999999999999764421111110000 0
Q ss_pred ---hcccccCC---CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 236 ---LSVQYSIP---DYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 236 ---~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.......+ ....+++++.++|++||+.+|++|| .||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00000001 0124678999999999999999999 99999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=281.93 Aligned_cols=229 Identities=31% Similarity=0.460 Sum_probs=201.7
Q ss_pred eecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCch
Q 023591 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (280)
-++-||+|+.|-||+++.. ++.||||++.. ....+++-|++|+|+||+.+.+++.....+++|||||..|.|
T Consensus 128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~e------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVRE------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc--CceehhHHHhh------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3677999999999999985 67799997653 334688999999999999999999988899999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcCCCcc
Q 023591 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184 (280)
Q Consensus 105 ~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 184 (280)
...++...+++...+..|..+|+.++.|||.+.|+|||||.-||+|+-+.. |||+|||-++........-.+.||..|
T Consensus 200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGTVaW 277 (904)
T KOG4721|consen 200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGTVAW 277 (904)
T ss_pred HHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhhHhh
Confidence 999999999999999999999999999999999999999999999998777 999999988766555556678899999
Q ss_pred cCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCC
Q 023591 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264 (280)
Q Consensus 185 ~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 264 (280)
+|||++.+.+.+.+ .||||||++||||+||..||.+-+.. .++.++....+.++-...+++.++-||++||+..|
T Consensus 278 MAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKp 352 (904)
T KOG4721|consen 278 MAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKP 352 (904)
T ss_pred hCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccchh----eeEEeccCCcccccCcccCchHHHHHHHHHHhcCC
Confidence 99999998888766 99999999999999999999875543 34445555566666656789999999999999999
Q ss_pred CCcC
Q 023591 265 AKSE 268 (280)
Q Consensus 265 ~~Rp 268 (280)
..||
T Consensus 353 RNRP 356 (904)
T KOG4721|consen 353 RNRP 356 (904)
T ss_pred CCCc
Confidence 9999
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=310.68 Aligned_cols=249 Identities=31% Similarity=0.470 Sum_probs=212.1
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
-+|+...+||.|.||.||.+.+..+|+..|+|-+... .+....+.+|..++..++|||+|+++++-.+.+.+++.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 4788899999999999999999999999999987653 3445678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC---
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 174 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~--- 174 (280)
||.+|+|.+.+...+-.++.....+..|++.+++|||+.|||||||||.||+++.+|. +|++|||.|........
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCC
Confidence 9999999999988888888999999999999999999999999999999999999987 99999999975554421
Q ss_pred --CCCCcCCCcccCcccccCCcC--CCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc-ccccCCCCCCCC
Q 023591 175 --PKSTVGTPAYIAPEVLLKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-VQYSIPDYVHIS 249 (280)
Q Consensus 175 --~~~~~~~~~~~aPE~~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 249 (280)
.....||+.|+|||++.+.+. ...+.|||||||++.||+||+.||...+.+ ..++..+.. ..+.+|. .+|
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy~V~~gh~Pq~P~--~ls 1467 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMYHVAAGHKPQIPE--RLS 1467 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHhHHhccCCCCCch--hhh
Confidence 234569999999999987542 344589999999999999999999876543 344444433 3446666 599
Q ss_pred HHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 250 PECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.+.++||..||..||.+|+ .|.|-+-+
T Consensus 1468 ~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1468 SEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 9999999999999999998 67766544
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=264.32 Aligned_cols=238 Identities=29% Similarity=0.415 Sum_probs=194.2
Q ss_pred eeeecccccCCceEEEEEEecCCC----cEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
+++.+.||.|+||.||++.+...+ ..+|+|.+..... ..+.+.+|+..++.++|+|++++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 367889999999999999998766 8899999876544 4567888999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 97 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
|++++++|.+++..... +++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDY 158 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceecccccc
Confidence 99999999999876554 999999999999999999999999999999999999998886 99999999875443322
Q ss_pred CC--CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 175 PK--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 175 ~~--~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
.. ...+++.|+|||.+.+..++.. +|+||||+++++|++ |..||........ ...+.... ........+.+
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~i~~~l~~~g~~p~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~ 232 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSK-SDVWSFGVLLWEIFTLGESPYPGMSNEEV----LEYLKKGY-RLPKPENCPPE 232 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHhcCC-CCCCCCcCCHH
Confidence 11 1235678999999876666555 999999999999998 7888876433222 22222221 11222257899
Q ss_pred HHHHHHHhcccCCCCcC
Q 023591 252 CRHLISRIFVADPAKSE 268 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp 268 (280)
+.+++.+||+.||++||
T Consensus 233 ~~~~i~~~l~~~p~~Rp 249 (258)
T smart00219 233 IYKLMLQCWAEDPEDRP 249 (258)
T ss_pred HHHHHHHHCcCChhhCc
Confidence 99999999999999999
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=263.05 Aligned_cols=234 Identities=26% Similarity=0.385 Sum_probs=188.7
Q ss_pred cccccCCceEEEEEEecC-CC--cEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 27 RDIGSGNFGVARLMRDKK-TE--ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~-~~--~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.||+|++|.||++.+.. ++ ..+|+|.+..... ..+.+.+|+..+++++|+|++++++++.. ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 33 3689999876544 34578889999999999999999999887 889999999999
Q ss_pred CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC----CC
Q 023591 102 GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QP 175 (280)
Q Consensus 102 ~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~----~~ 175 (280)
++|.+.+.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE--EEeccccccccccccccceecc
Confidence 99999987654 6899999999999999999999999999999999999998876 9999999887543321 11
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
....++..|+|||.+.+..++.. +||||||+++|+|++ |..||......+..... .......+.....+..+.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 232 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI----DKEGERLERPEACPQDIYN 232 (257)
T ss_pred cCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HhcCCcCCCCccCCHHHHH
Confidence 22345678999999887777665 999999999999998 99999765443322222 2112222222357899999
Q ss_pred HHHHhcccCCCCcC
Q 023591 255 LISRIFVADPAKSE 268 (280)
Q Consensus 255 li~~~l~~dp~~Rp 268 (280)
++.+||+.+|++||
T Consensus 233 li~~~l~~~p~~Rp 246 (257)
T cd05040 233 VMLQCWAHNPADRP 246 (257)
T ss_pred HHHHHCCCCcccCC
Confidence 99999999999999
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=263.25 Aligned_cols=231 Identities=27% Similarity=0.408 Sum_probs=183.1
Q ss_pred ccccCCceEEEEEEec--CCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCc
Q 023591 28 DIGSGNFGVARLMRDK--KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 103 (280)
Q Consensus 28 ~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (280)
.||+|+||.||++... ..+..||+|.+..... ..+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999998765 4456799998865432 2355788999999999999999999875 457899999999999
Q ss_pred hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC----CCC
Q 023591 104 LFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KST 178 (280)
Q Consensus 104 L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~----~~~ 178 (280)
|.+++.. ...+++..++.++.|++.||++||++|++|+||+|+||+++.++. ++|+|||++......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCC
Confidence 9998864 457899999999999999999999999999999999999988776 999999988643322111 111
Q ss_pred cCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhc-ccccCCCCCCCCHHHHHHH
Q 023591 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILS-VQYSIPDYVHISPECRHLI 256 (280)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li 256 (280)
..+..|+|||.+.+..++.. +|+||||+++|+|++ |..||......... ..+.. .....+. ..++++.++|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~--~~~~~l~~li 231 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEVM----SFIEQGKRLDCPA--ECPPEMYALM 231 (257)
T ss_pred CCCcccCCHHHHccCCCCch-hhHHHHHHHHHHHhcCCCCCcCcCCHHHHH----HHHHCCCCCCCCC--CCCHHHHHHH
Confidence 22467999999877776555 999999999999996 99999875443222 22211 1222233 5789999999
Q ss_pred HHhcccCCCCcC
Q 023591 257 SRIFVADPAKSE 268 (280)
Q Consensus 257 ~~~l~~dp~~Rp 268 (280)
.+||+.||++||
T Consensus 232 ~~c~~~~~~~Rp 243 (257)
T cd05115 232 KDCWIYKWEDRP 243 (257)
T ss_pred HHHcCCChhhCc
Confidence 999999999999
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=266.47 Aligned_cols=238 Identities=23% Similarity=0.351 Sum_probs=186.5
Q ss_pred eeeecccccCCceEEEEEEecCCCc--EEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecC------Ce
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEE--LVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------TH 91 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~--~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 91 (280)
+.+.+.||+|+||.||++++..++. .+|+|.+... ....+.+.+|+..++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999877665 5899988654 23345677899999999999999999876432 24
Q ss_pred EEEEEeccCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCC
Q 023591 92 LAIVMEYASGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~------~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~ 165 (280)
.+++|||+.+++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence 6899999999999887742 234889999999999999999999999999999999999988776 99999999
Q ss_pred ccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhccccc
Q 023591 166 SKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYS 241 (280)
Q Consensus 166 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
+........ ......++.|++||.+.+..++.. +|+||||+++|+|++ |..||....... ....+.... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~~~~~~-~ 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSE----IYDYLRQGN-R 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHcCC-C
Confidence 875433221 122345667999999987777655 999999999999999 889997644322 222222221 1
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 242 IPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+....++..+.++|.+||+.||++||
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp 259 (272)
T cd05075 233 LKQPPDCLDGLYSLMSSCWLLNPKDRP 259 (272)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCc
Confidence 222236789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=287.39 Aligned_cols=243 Identities=31% Similarity=0.522 Sum_probs=201.7
Q ss_pred ccccCCceEEEEEEecCCCcEEEEEEeeeC-CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCchHH
Q 023591 28 DIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 106 (280)
Q Consensus 28 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 106 (280)
.||.|.||+||.+++..+...+|||.+... .....-+.+|+.+.++|+|.|||+++|.+..++.+-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 789999999999999999999999998643 3444567889999999999999999999999999999999999999999
Q ss_pred HHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc-cCCCCCCCcCCC
Q 023591 107 RICNA-GRF--SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGTP 182 (280)
Q Consensus 107 ~~~~~-~~l--~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~~~ 182 (280)
+++.. +++ ++..+..+.+||+++|.|||++.|||||||-+||++..- .+.+|++|||-+++.. ......+..||.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy-SGvlKISDFGTsKRLAginP~TETFTGTL 740 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY-SGVLKISDFGTSKRLAGINPCTETFTGTL 740 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec-cceEEecccccchhhccCCccccccccch
Confidence 99765 466 889999999999999999999999999999999999632 2349999999887543 344556778999
Q ss_pred cccCcccccCCc-CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc--ccccCCCCCCCCHHHHHHHHHh
Q 023591 183 AYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECRHLISRI 259 (280)
Q Consensus 183 ~~~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~ 259 (280)
.|+|||++..+. -+.+++|||||||++.||.||++||....... ..+.++.- .-..+|. .+|.+.+.||.+|
T Consensus 741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---AAMFkVGmyKvHP~iPe--elsaeak~Filrc 815 (1226)
T KOG4279|consen 741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---AAMFKVGMYKVHPPIPE--ELSAEAKNFILRC 815 (1226)
T ss_pred hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---HhhhhhcceecCCCCcH--HHHHHHHHHHHHH
Confidence 999999997543 33556999999999999999999998765432 22222222 2223333 6788999999999
Q ss_pred cccCCCCcC------CCcccccc
Q 023591 260 FVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 260 l~~dp~~Rp------~h~~~~~~ 276 (280)
+.+||..|| ..||++..
T Consensus 816 Fepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred cCCCcccCccHHHhccCcccccC
Confidence 999999999 89999754
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=268.25 Aligned_cols=246 Identities=27% Similarity=0.423 Sum_probs=195.6
Q ss_pred CCCeeeecccccCCceEEEEEEec----CCCcEEEEEEeeeCCcc--cHHHHHHHHHhhhCCCCCeeeeceEEec--CCe
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILT--PTH 91 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~----~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 91 (280)
.+.|++.+.||+|+||.||++... .++..+|+|.+...... .+.+.+|++.++.++|+|++++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 367899999999999999999864 34788999999876553 5678899999999999999999999877 557
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
.+++|||+++++|.+++.... .++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccccccccc
Confidence 899999999999999987654 6899999999999999999999999999999999999998876 9999999887554
Q ss_pred cCCCC----CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcc----------hHHHHHhhHh
Q 023591 171 LHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK----------NFRKTIHRIL 236 (280)
Q Consensus 171 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~----------~~~~~~~~~~ 236 (280)
..... .....+..|.+||.+.+..++.. +|+||||+++++|++|..|+....... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 22111 12234456999999877777655 999999999999999999986543211 0111112222
Q ss_pred cccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 237 SVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 237 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
......+.....+.++.+++.+||+.+|++||
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 271 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRP 271 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCC
Confidence 22223333335778999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=272.62 Aligned_cols=242 Identities=25% Similarity=0.419 Sum_probs=187.3
Q ss_pred CceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCchHHHHH
Q 023591 33 NFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 109 (280)
Q Consensus 33 ~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 109 (280)
+++.||.++...+++.||+|.+... ....+.+.+|+..+++++|+||+++++++..+...+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4566777777778999999998764 3344578899999999999999999999999999999999999999999987
Q ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC--------CCCCc
Q 023591 110 NA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTV 179 (280)
Q Consensus 110 ~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~ 179 (280)
.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++. +++.||+.+........ .....
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeecccccccccccccccccc
Confidence 53 45899999999999999999999999999999999999998777 99999998764332111 12234
Q ss_pred CCCcccCcccccCC--cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-------------------
Q 023591 180 GTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------------- 238 (280)
Q Consensus 180 ~~~~~~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 238 (280)
++..|+|||.+.+. .++. ++|+||+|+++++|++|..||...................
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~-~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNE-KSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS 248 (314)
T ss_pred ccccccCHHHhcCCCCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccc
Confidence 56679999998653 3444 4999999999999999999998654332222211110000
Q ss_pred ---------cccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 239 ---------QYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 239 ---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.........++.++.+|+.+||+.||++|| .||||+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000000112356789999999999999999 999998774
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=264.98 Aligned_cols=242 Identities=31% Similarity=0.487 Sum_probs=194.1
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC------cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
+|.+.+.||+|++|.||++.+..++..+++|..+... .....+..|+.+++.++|||++++++.+......+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 6999999999999999999998777767777665421 2223456788899999999999999999888899999
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 96 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
+||+++++|.+.+.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++. +. ++|+|||.+.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~--~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NL--LKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CC--EeecccCceeecCC
Confidence 999999999888753 346899999999999999999999999999999999999974 33 99999998865433
Q ss_pred CC-CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc-ccCCCCCCCC
Q 023591 172 HS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHIS 249 (280)
Q Consensus 172 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 249 (280)
.. ......+++.|.|||.+.+..++.. +|+||+|+++++|++|..||..... ......+.... ...+ ..++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~----~~~~~~~~~~~~~~~~--~~~~ 230 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNF----LSVVLRIVEGPTPSLP--ETYS 230 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHcCCCCCCc--chhc
Confidence 22 2233457788999999877776655 9999999999999999999965332 22222222221 1222 2678
Q ss_pred HHHHHHHHHhcccCCCCcC------CCccc
Q 023591 250 PECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
.++.++|.+||+.||++|| .||||
T Consensus 231 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 231 RQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 8999999999999999999 99997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=266.97 Aligned_cols=243 Identities=23% Similarity=0.286 Sum_probs=194.3
Q ss_pred CCCCCeeeecccccCCceEEEEEEecC----CCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEec-CC
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKK----TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PT 90 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~----~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 90 (280)
...++|++.+.||+|+||.||++.+.. ++..|++|.+.... ...+.+.+|+..+++++|+|++++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 456899999999999999999999875 35778999876432 223557789999999999999999998766 46
Q ss_pred eEEEEEeccCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEee
Q 023591 91 HLAIVMEYASGGELFERICNA--------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~--------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~d 162 (280)
..+++++|+++++|.+++... ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++. ++++|
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kl~d 160 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITD 160 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc--EEECC
Confidence 789999999999999988653 35899999999999999999999999999999999999988776 99999
Q ss_pred cCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcc
Q 023591 163 FGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV 238 (280)
Q Consensus 163 f~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 238 (280)
||+++....... .....++..|+|||.+.+..++.. +||||||+++|++++ |..||....... .... ...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~----~~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFE-MAAY----LKD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHHH----HHc
Confidence 999874432211 122334567999999987777655 999999999999998 999997654322 2111 112
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 239 QYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
...++....+++++.+++.+||+.||++||
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 264 (280)
T cd05043 235 GYRLAQPINCPDELFAVMACCWALDPEERP 264 (280)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhhCC
Confidence 223333335789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=281.62 Aligned_cols=239 Identities=33% Similarity=0.501 Sum_probs=201.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
..+.|++...+|.|+|+.|-.+.+..++...++|++.+... +..+|+.++... +|||++++.+++.+....++|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 45789999999999999999999999999999999987622 233566555444 89999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEe-CCCCCcEEEeecCCccccccCCCCC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~-~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
.+.|+-+.+.+...+.+. .++..|+.+|+.|+.+||.+|++||||+|+||+++ ..++ ++|+|||.+...... ..
T Consensus 397 ~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~--lrltyFG~a~~~~~~--~~ 471 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGH--LRLTYFGFWSELERS--CD 471 (612)
T ss_pred hccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCc--EEEEEechhhhCchh--hc
Confidence 999988888886665555 78888999999999999999999999999999995 6666 999999988744433 44
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (280)
..+-+..|.|||++....++.. +|+||||++||+|++|+.||...... .++..++....+. ..+|+..++||
T Consensus 472 tp~~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s----~~vS~~AKdLl 543 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS----ECVSDEAKDLL 543 (612)
T ss_pred ccchhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc----cccCHHHHHHH
Confidence 5567888999999997777666 99999999999999999999887654 4444555444443 37999999999
Q ss_pred HHhcccCCCCcC------CCccc
Q 023591 257 SRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 257 ~~~l~~dp~~Rp------~h~~~ 273 (280)
++||+.||.+|| .|||+
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 999999999999 99999
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=269.19 Aligned_cols=251 Identities=31% Similarity=0.506 Sum_probs=214.6
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCe
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 91 (280)
.....+|..+..||.|+||+|.++..+.+.+.+|||++++.- ...+--..|-++|... +-|.+++++..+.+-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 445578999999999999999999999999999999988742 1122223355555544 56789999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc-c
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-V 170 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~-~ 170 (280)
+|+||||++||+|--.+++-+++.+.....++.+|+-+|-+||++||++||||.+||+++.+|+ +||.|||++... .
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeeccccccccc
Confidence 9999999999999989999999999999999999999999999999999999999999999988 999999999743 3
Q ss_pred cCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCH
Q 023591 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (280)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (280)
......+.+|||.|.|||++..++|... .|.||+|++||||+.|+.||.+.++.+... .+...+..+|. .+|.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgks-vDWWa~GVLLyEmlaGQpPFdGeDE~elF~----aI~ehnvsyPK--slSk 575 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQ----AIMEHNVSYPK--SLSK 575 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHHHccCcCcc--cccH
Confidence 4455678899999999999999988655 999999999999999999999877654444 44555566666 6899
Q ss_pred HHHHHHHHhcccCCCCcC-----------CCcccccc
Q 023591 251 ECRHLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 251 ~l~~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+..++....|...|.+|. .||||+..
T Consensus 576 EAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 576 EAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 999999999999999999 89999854
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=268.43 Aligned_cols=242 Identities=25% Similarity=0.386 Sum_probs=193.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecC-----CCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
..++|++.+.||+|+||.||++.+.. ++..+++|.+..... ....+.+|+.++++++|||++++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 34789999999999999999998743 577899998875432 23567889999999999999999999998889
Q ss_pred EEEEEeccCCCchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEE
Q 023591 92 LAIVMEYASGGELFERICNAG----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~----------------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~ 149 (280)
.++++||+++++|.+++.... .+++..++.++.|++.||++||+.|++|+||+|+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 999999999999999986432 3678889999999999999999999999999999999
Q ss_pred EeCCCCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCc
Q 023591 150 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (280)
Q Consensus 150 i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~ 225 (280)
++.++. ++|+|||++........ ......+..|+|||.+.+..++.. +|+||||+++|+|++ |..||......
T Consensus 163 ~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 163 VGENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred ecCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 988777 99999998864332221 122234567999999887777655 999999999999997 88888754432
Q ss_pred chHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 226 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
. ....+..... .+.....+.++.+||.+||+.||++||
T Consensus 240 ~----~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp 277 (288)
T cd05050 240 E----VIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRP 277 (288)
T ss_pred H----HHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCC
Confidence 2 2222222221 111225789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=260.62 Aligned_cols=223 Identities=22% Similarity=0.319 Sum_probs=182.4
Q ss_pred CCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCchHHHHHhc
Q 023591 32 GNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 111 (280)
Q Consensus 32 G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 111 (280)
|.+|.||++++..+++.+|+|.+..... ..+|...+....|||++++++++......+++|||+++++|.+.+.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 8999999999999999999999876532 233444455567999999999999999999999999999999998877
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcCCCcccCccccc
Q 023591 112 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191 (280)
Q Consensus 112 ~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 191 (280)
..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. +++.|||.+..... .......+..|+|||.+.
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~--~~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVED--SCDGEAVENMYCAPEVGG 155 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhcccc--ccccCCcCccccCCcccC
Confidence 78999999999999999999999999999999999999998877 99999997653322 122334566799999987
Q ss_pred CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC---
Q 023591 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE--- 268 (280)
Q Consensus 192 ~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp--- 268 (280)
+..++.. +|+||+|+++|+|++|..|+....... . ......++. .+++.++++|.+||+.||++||
T Consensus 156 ~~~~~~~-~DvwslG~il~el~~g~~~~~~~~~~~------~--~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 156 ISEETEA-CDWWSLGAILFELLTGKTLVECHPSGI------N--THTTLNIPE--WVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CCCCCch-hhHHHHHHHHHHHHHCcchhhcCchhc------c--cccccCCcc--cCCHHHHHHHHHHccCCHHHhcCCC
Confidence 7777555 999999999999999998875432110 0 011122333 5789999999999999999998
Q ss_pred --------CCccc
Q 023591 269 --------MHDWR 273 (280)
Q Consensus 269 --------~h~~~ 273 (280)
.||||
T Consensus 225 ~~~~~~~~~h~~~ 237 (237)
T cd05576 225 VAGVEDIKSHPFF 237 (237)
T ss_pred ccchHHHHcCCCC
Confidence 89997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=268.43 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=192.9
Q ss_pred CCCCCeeeecccccCCceEEEEEEec-------CCCcEEEEEEeeeC--CcccHHHHHHHHHhhhC-CCCCeeeeceEEe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVIL 87 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~-------~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 87 (280)
...++|++.+.||+|+||.||+++.. .++..+++|.+... ......+.+|+..++.+ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 45689999999999999999999752 23457999988653 23345688899999999 8999999999999
Q ss_pred cCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEe
Q 023591 88 TPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (280)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~ 151 (280)
.....+++|||+++++|.+++... ..++...+..++.||+.||.|||+.|++|+||+|+||+++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 999999999999999999998653 2467788999999999999999999999999999999998
Q ss_pred CCCCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcch
Q 023591 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (280)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (280)
.++. ++|+|||++........ .....++..|+|||.+.+..++.. +||||||+++|+|++ |..||.....
T Consensus 172 ~~~~--~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~--- 245 (304)
T cd05101 172 ENNV--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPV--- 245 (304)
T ss_pred CCCc--EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence 7776 99999999875433221 122234567999999987777655 999999999999998 7888865432
Q ss_pred HHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 228 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
......+... ........++.++.+|+.+||+.+|++||
T Consensus 246 -~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 284 (304)
T cd05101 246 -EELFKLLKEG-HRMDKPANCTNELYMMMRDCWHAIPSHRP 284 (304)
T ss_pred -HHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcccChhhCC
Confidence 2222222221 12222236789999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=264.19 Aligned_cols=241 Identities=22% Similarity=0.351 Sum_probs=193.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCc----EEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
...+|++.+.||+|+||.||++.+..+++ .+++|....... ....+.+|+..+++++|+|++++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 45789999999999999999999876654 588888765532 23567789999999999999999999876 788
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
++++||+++++|.+++... ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~ 161 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDV 161 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccC
Confidence 9999999999999998764 46899999999999999999999999999999999999987776 99999998875432
Q ss_pred CCCCC---CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 172 HSQPK---STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 172 ~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
..... ....+..|+|||.+....++.. +|+||||+++|++++ |..||......+.. ..+.. ....+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~ 235 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVEIP----DLLEK-GERLPQPPI 235 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHHHH----HHHhC-CCCCCCCCC
Confidence 22111 1123457999999877777655 999999999999998 99999765432222 12221 112222235
Q ss_pred CCHHHHHHHHHhcccCCCCcC
Q 023591 248 ISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+.++.+++.+||..||++||
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp 256 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRP 256 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCC
Confidence 778999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=295.06 Aligned_cols=242 Identities=25% Similarity=0.386 Sum_probs=202.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCc-----EEEEEEeeeC--CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~-----~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
...+-+..+.||+|+||.||.+......- .||+|.+.+. .....++.+|..+++.++|||||+++|++.+...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 45778899999999999999999764332 3899988775 3444678999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 92 LAIVMEYASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
.++++|||.+|+|..++++. ..++...+..++.||+++.+||+++++|||||.+.|+|++.... +|++|||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~--VKIaDFG 847 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV--VKIADFG 847 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc--EEEcccc
Confidence 99999999999999999875 24899999999999999999999999999999999999998866 9999999
Q ss_pred CccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccc
Q 023591 165 YSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQY 240 (280)
Q Consensus 165 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
+|+...... ......-...|+|||.+..+.++++ +||||||+++||+++ |..||...+..+.... +..+.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~~----~~~gg- 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD----VLEGG- 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHHH----HHhCC-
Confidence 998333222 1222334568999999999888776 999999999999999 8999988765433332 22222
Q ss_pred cCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 241 SIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
+++....+++.+.+++..||+.+|++||
T Consensus 922 RL~~P~~CP~~ly~lM~~CW~~~pe~RP 949 (1025)
T KOG1095|consen 922 RLDPPSYCPEKLYQLMLQCWKHDPEDRP 949 (1025)
T ss_pred ccCCCCCCChHHHHHHHHHccCChhhCc
Confidence 4444458999999999999999999999
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=259.11 Aligned_cols=233 Identities=24% Similarity=0.343 Sum_probs=186.7
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCch
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (280)
+.||+|++|.||++... ++..+|+|.+.... .....+.+|+.++++++|+|++++++++......+++|||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46899999999999865 67889999876542 2234577899999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC--CCCcCC
Q 023591 105 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGT 181 (280)
Q Consensus 105 ~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~ 181 (280)
.+++... ..+++..+..++.|++.+|.++|+.|++|+||+|+||+++.++. ++|+|||++......... .....+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCc
Confidence 9988653 46899999999999999999999999999999999999988776 999999988643322211 122335
Q ss_pred CcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc
Q 023591 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (280)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (280)
..|+|||.+.+..++.. +|+||||+++|++++ |..||.......... .+.. .........++.++.+++.+||
T Consensus 158 ~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li~~~l 231 (250)
T cd05085 158 IKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQARE----QVEK-GYRMSCPQKCPDDVYKVMQRCW 231 (250)
T ss_pred ccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH----HHHc-CCCCCCCCCCCHHHHHHHHHHc
Confidence 67999999877776555 999999999999998 999997654332222 2211 1122222357899999999999
Q ss_pred ccCCCCcC
Q 023591 261 VADPAKSE 268 (280)
Q Consensus 261 ~~dp~~Rp 268 (280)
+.+|++||
T Consensus 232 ~~~p~~Rp 239 (250)
T cd05085 232 DYKPENRP 239 (250)
T ss_pred ccCcccCC
Confidence 99999999
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=269.43 Aligned_cols=253 Identities=30% Similarity=0.437 Sum_probs=206.7
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC-C-CC----eeeeceEEecCCeEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-H-PN----IVRFKEVILTPTHLA 93 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h-~~----iv~~~~~~~~~~~~~ 93 (280)
.++|++++.+|+|.||.|..+.+..++..||||+++.-.+..+...-|+++++++. + |+ ++.+.+++...+..+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 58999999999999999999999999999999999988888888888999999993 2 33 777778888899999
Q ss_pred EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-----------------
Q 023591 94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP----------------- 154 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~----------------- 154 (280)
+|+|.+ |.|+.+++.++. +++...+..+.+|+++++++||+.+++|.||||+||++.+..
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 999998 669999997654 799999999999999999999999999999999999984211
Q ss_pred -CCcEEEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHh
Q 023591 155 -APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (280)
Q Consensus 155 -~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (280)
+..|+++|||.|..... .......|..|.|||++.+-.|+.+ +||||+||||+||.+|...|...++.+.+ ..+.
T Consensus 247 ks~~I~vIDFGsAtf~~e--~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL-aMMe 322 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHE--HHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL-AMME 322 (415)
T ss_pred CCcceEEEecCCcceecc--CcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH-HHHH
Confidence 23489999999874332 2355678899999999999999888 99999999999999999999887754433 3444
Q ss_pred hHhcc------------------cccCCCC-----------------------CCCCHHHHHHHHHhcccCCCCcC----
Q 023591 234 RILSV------------------QYSIPDY-----------------------VHISPECRHLISRIFVADPAKSE---- 268 (280)
Q Consensus 234 ~~~~~------------------~~~~~~~-----------------------~~~~~~l~~li~~~l~~dp~~Rp---- 268 (280)
++... ..+++.. ..-..+|.+|+++||..||.+|+
T Consensus 323 rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~E 402 (415)
T KOG0671|consen 323 RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLRE 402 (415)
T ss_pred HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHH
Confidence 33331 1111110 01123689999999999999999
Q ss_pred --CCccccccc
Q 023591 269 --MHDWRRGCS 277 (280)
Q Consensus 269 --~h~~~~~~~ 277 (280)
.||||+...
T Consensus 403 AL~HpFF~~~~ 413 (415)
T KOG0671|consen 403 ALSHPFFARLT 413 (415)
T ss_pred HhcCHHhhcCC
Confidence 999998754
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=260.99 Aligned_cols=236 Identities=27% Similarity=0.374 Sum_probs=190.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
..++|++.+.||+|+||.||.+.. +++.+++|.+... ...+.+.+|+..+++++|+|++++++++..+ ..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 347899999999999999999864 5778999988653 2346788899999999999999999998654 57999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 99 ~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
+++++|.+++.... .++...+..++.|++.||.+||+.|++||||+|+||+++.++. ++|+|||++...... ..
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~~--~~ 155 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSMG--VD 155 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceecccc--CC
Confidence 99999999986543 5799999999999999999999999999999999999988776 999999988643321 12
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....+..|+|||.+.+..++.. +|+||||+++|+|++ |..||......... ..+.. .........+++++.++
T Consensus 156 ~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 156 NSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVK----ECVEK-GYRMEPPEGCPADVYVL 229 (254)
T ss_pred CCCCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHHHH----HHHhC-CCCCCCCCcCCHHHHHH
Confidence 2334567999999877777655 999999999999997 99999765432221 11111 12222223678999999
Q ss_pred HHHhcccCCCCcC
Q 023591 256 ISRIFVADPAKSE 268 (280)
Q Consensus 256 i~~~l~~dp~~Rp 268 (280)
+.+||+.+|++||
T Consensus 230 i~~~l~~~p~~Rp 242 (254)
T cd05083 230 MTSCWETEPKKRP 242 (254)
T ss_pred HHHHcCCChhhCc
Confidence 9999999999999
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=263.89 Aligned_cols=241 Identities=25% Similarity=0.351 Sum_probs=191.6
Q ss_pred CCCCeeeecccccCCceEEEEEEecCC---CcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
..++|++.+.||+|++|.||++.+... ...+++|...... ...+.+.+|+..+++++|+|++++++++.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 356799999999999999999987543 3568999876543 234568889999999999999999998865 4578
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
++|||+++++|.+++.+.. .++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~ 160 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeecccc
Confidence 9999999999999997644 5899999999999999999999999999999999999998776 999999988644332
Q ss_pred CCC--CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 173 SQP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 173 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
... ........|+|||.+....++.. +||||||+++++|++ |..||............ ... ...+....++
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~----~~~-~~~~~~~~~~ 234 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI----ENG-ERLPMPPNCP 234 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----HcC-CcCCCCCCCC
Confidence 211 11223457999999877776555 999999999999986 99999766543322221 111 1222223678
Q ss_pred HHHHHHHHHhcccCCCCcC
Q 023591 250 PECRHLISRIFVADPAKSE 268 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp 268 (280)
.++.++|.+||..+|++||
T Consensus 235 ~~~~~li~~~l~~~P~~Rp 253 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRP 253 (270)
T ss_pred HHHHHHHHHHcCCChhhCc
Confidence 9999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=258.98 Aligned_cols=233 Identities=27% Similarity=0.367 Sum_probs=188.4
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCch
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (280)
+.||+|++|.||++.+.. ++.|++|.+..... ....+.+|+.++++++|+||+++++++......+++|||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 478999999999999987 89999998876433 345688899999999999999999999999999999999999999
Q ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC---CCCcC
Q 023591 105 FERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 180 (280)
Q Consensus 105 ~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~ 180 (280)
.+++.. ...++...+..++.+++.+|++||+++++|+||+|+||+++.++. ++|+|||.+......... .....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcceeccccCcc
Confidence 998865 346899999999999999999999999999999999999988776 999999988744321111 11223
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHh
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 259 (280)
+..|+|||.+.+..++.. +|+||||+++|+|++ |..||........... +.. ....+.....+.++.+++.+|
T Consensus 158 ~~~y~~PE~~~~~~~~~~-~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~li~~~ 231 (251)
T cd05041 158 PIKWTAPEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTRER----IES-GYRMPAPQLCPEEIYRLMLQC 231 (251)
T ss_pred eeccCChHhhccCCCCcc-hhHHHHHHHHHHHHhccCCCCccCCHHHHHHH----Hhc-CCCCCCCccCCHHHHHHHHHH
Confidence 456999999877776555 999999999999999 8889876553222221 111 112222235789999999999
Q ss_pred cccCCCCcC
Q 023591 260 FVADPAKSE 268 (280)
Q Consensus 260 l~~dp~~Rp 268 (280)
|+.+|++||
T Consensus 232 l~~~p~~Rp 240 (251)
T cd05041 232 WAYDPENRP 240 (251)
T ss_pred hccChhhCc
Confidence 999999999
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=284.85 Aligned_cols=249 Identities=31% Similarity=0.416 Sum_probs=198.7
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC--CcccHHHHHHHHHhhhCCCCCeeeeceEEecCC------e
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPT------H 91 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~ 91 (280)
+.-|...+.||+|+||.||+++++.+|+.||+|.+.+. ....+..-+|++++++++|+|||++.++-++.. .
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 36678899999999999999999999999999999874 455577889999999999999999998865433 3
Q ss_pred EEEEEeccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC--CCCCcEEEeecCCc
Q 023591 92 LAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG--SPAPRLKICDFGYS 166 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~--~~~~~~~l~df~~~ 166 (280)
-.++||||.||||...+.+ ...+++.++..++.++..||.|||++||+||||||.||++.. +|..-.||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 5799999999999999854 335999999999999999999999999999999999999854 34445799999999
Q ss_pred cccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc---------
Q 023591 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------- 237 (280)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------- 237 (280)
+....+.......||+.|++||......+++...|.||+|+++|+++||.+||...........+.-.+..
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 98888888888899999999999986444444499999999999999999999766544321111111111
Q ss_pred ----------ccccCCCCCCCCH----HHHHHHHHhcccCCCCcC
Q 023591 238 ----------VQYSIPDYVHISP----ECRHLISRIFVADPAKSE 268 (280)
Q Consensus 238 ----------~~~~~~~~~~~~~----~l~~li~~~l~~dp~~Rp 268 (280)
....+|.....+. .+...+..+|..+|.+|.
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 0112222223333 456677788999999998
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=261.40 Aligned_cols=236 Identities=23% Similarity=0.335 Sum_probs=180.2
Q ss_pred cccccCCceEEEEEEec--CCCcEEEEEEeeeCCcc--cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCC
Q 023591 27 RDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (280)
+.||+|+||.||++... .++..+++|.+...... ...+.+|+.++++++|||++++++.+.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999864 34567899987654322 235778999999999999999999998888899999999999
Q ss_pred chHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC---C
Q 023591 103 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q 174 (280)
Q Consensus 103 ~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~---~ 174 (280)
+|.+++.... ..+...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEECCccccccccCcceeec
Confidence 9999886432 3567788899999999999999999999999999999998776 9999999886332211 1
Q ss_pred CCCCcCCCcccCcccccCCc------CCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCC---
Q 023591 175 PKSTVGTPAYIAPEVLLKKE------YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD--- 244 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~------~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 244 (280)
.....++..|+|||.+.+.. ..+.++|+||||+++|+|++ |..||............. .......+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~ 235 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV---REQQLKLPKPRL 235 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh---hcccCCCCCCcc
Confidence 12234567899999886432 12345999999999999996 999997665433222211 111111111
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 245 YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....++.+.+++..|+ .+|++||
T Consensus 236 ~~~~~~~~~~l~~~c~-~~P~~Rp 258 (269)
T cd05087 236 KLPLSDRWYEVMQFCW-LQPEQRP 258 (269)
T ss_pred CCCCChHHHHHHHHHh-cCcccCC
Confidence 1246788999999999 6899999
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=271.15 Aligned_cols=241 Identities=23% Similarity=0.338 Sum_probs=190.5
Q ss_pred CCCeeeecccccCCceEEEEEEecCC-------CcEEEEEEeeeCC--cccHHHHHHHHHhhhC-CCCCeeeeceEEecC
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKT-------EELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~-------~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 89 (280)
..+|++.+.||+|+||.||++++... +..+++|.+.... ...+.+.+|+.+++++ +|+||+++++++..+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 35799999999999999999986432 2368999876532 2345678899999999 899999999999988
Q ss_pred CeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC
Q 023591 90 THLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~ 153 (280)
...++++||+++++|.+++.+.. .++...+..++.|++.||++||++|++|+||+|+||+++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 89999999999999999986532 36778899999999999999999999999999999999887
Q ss_pred CCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHH
Q 023591 154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (280)
Q Consensus 154 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~ 229 (280)
+. ++|+|||+++....... ......+..|+|||.+.+..++.. +||||||+++|+|++ |..||......
T Consensus 171 ~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~---- 243 (334)
T cd05100 171 NV--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVE---- 243 (334)
T ss_pred Cc--EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCCCCHH----
Confidence 76 99999999874432221 111223457999999988777666 999999999999998 88998764332
Q ss_pred HHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 230 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.....+... ...+.....+.++.+++.+||+.+|++||
T Consensus 244 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 281 (334)
T cd05100 244 ELFKLLKEG-HRMDKPANCTHELYMIMRECWHAVPSQRP 281 (334)
T ss_pred HHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccChhhCc
Confidence 222222221 11222225788999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=260.45 Aligned_cols=230 Identities=20% Similarity=0.215 Sum_probs=183.7
Q ss_pred cccccCCceEEEEEEecCCC----------cEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 27 RDIGSGNFGVARLMRDKKTE----------ELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
+.||+|+||.||++.+..++ ..+++|.+.........+.+|+.++++++|+|++++++++.. ...+++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999998766 357888776655446778899999999999999999999887 7789999
Q ss_pred eccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCC-----cEEEeecCCccccc
Q 023591 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSKSSV 170 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~-----~~~l~df~~~~~~~ 170 (280)
||+++++|.+++.... .++...+..++.||+.||.|||+.|++|+||+|+||+++.++.. .++|+|||++....
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~ 159 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence 9999999999997765 78999999999999999999999999999999999999877622 49999999887433
Q ss_pred cCCCCCCCcCCCcccCcccccCC--cCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 171 LHSQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
. .....+...|+|||.+.+. .++ .++|+||||+++++|++ |..||...... ....... .....+. .
T Consensus 160 ~---~~~~~~~~~y~aPE~~~~~~~~~~-~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~~~~~~----~~~~~~~--~ 228 (259)
T cd05037 160 S---REERVERIPWIAPECIRNGQASLT-IAADKWSFGTTLLEICSNGEEPLSTLSSS-EKERFYQ----DQHRLPM--P 228 (259)
T ss_pred c---ccccccCCCccChhhhcCCCCCcc-hhhHHHHHHHHHHHHHhCCCCCcccCCch-hHHHHHh----cCCCCCC--C
Confidence 2 2334456779999998776 444 44999999999999999 57888665422 2221111 1111111 1
Q ss_pred CCHHHHHHHHHhcccCCCCcC
Q 023591 248 ISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+..+.++|.+||..+|.+||
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rp 249 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRP 249 (259)
T ss_pred CchHHHHHHHHHhccChhhCC
Confidence 237899999999999999999
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=263.33 Aligned_cols=236 Identities=24% Similarity=0.380 Sum_probs=186.8
Q ss_pred cccccCCceEEEEEEecCCC------cEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 27 RDIGSGNFGVARLMRDKKTE------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~------~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+.||+|++|.||+++..... ..+++|.+.... .....+.+|+..++.++||||+++++++......+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999976433 678999886543 3345678899999999999999999999988899999999
Q ss_pred cCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC---CCcEEEeecCCccc
Q 023591 99 ASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKS 168 (280)
Q Consensus 99 ~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~---~~~~~l~df~~~~~ 168 (280)
+++++|.+++... ..++...+..++.|++.+|+|||+.+++|+||+|+||+++.++ ...++++|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999988542 2378899999999999999999999999999999999998766 12499999998864
Q ss_pred cccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCC
Q 023591 169 SVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (280)
Q Consensus 169 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (280)
...... ......+..|+|||.+.+..++.. +||||||+++|+|++ |..||....... ....+.. ...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~-~~~~~~ 234 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQE----VLQHVTA-GGRLQK 234 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccc-hhHHHHHHHHHHHHHcCCCCCcccCHHH----HHHHHhc-CCccCC
Confidence 432211 122334678999999988777655 999999999999998 999997654322 1112111 112222
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 245 YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
...+|..+.++|.+||+.+|++||
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp 258 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERP 258 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCC
Confidence 236789999999999999999999
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=259.99 Aligned_cols=232 Identities=21% Similarity=0.231 Sum_probs=179.1
Q ss_pred cccccCCceEEEEEEecCC------------CcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 27 RDIGSGNFGVARLMRDKKT------------EELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~------------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
+.||+|++|.||++..... ...+++|.+..... ....+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999985422 23588888765432 2345677889999999999999999999888899
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC-----CcEEEeecCCcc
Q 023591 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-----PRLKICDFGYSK 167 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~-----~~~~l~df~~~~ 167 (280)
++|||+++++|..++.. ...+++..++.++.||+.||+|||+.|++|+||+|+||+++.++. ..++++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 99999999999888865 356899999999999999999999999999999999999976543 238999999876
Q ss_pred ccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHH-hCCCCCCCCCCcchHHHHHhhHhcccccCCCCC
Q 023591 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (280)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (280)
... ......++..|+|||.+.+....+.++||||||+++|+|+ .|..||....... ... ..........
T Consensus 161 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~----~~~~~~~~~~-- 230 (262)
T cd05077 161 TVL---SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-KER----FYEGQCMLVT-- 230 (262)
T ss_pred ccc---CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-HHH----HHhcCccCCC--
Confidence 432 2233456778999998875443445599999999999997 5888886543221 111 1111222211
Q ss_pred CCCHHHHHHHHHhcccCCCCcC
Q 023591 247 HISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..++++.+||.+||+.||++||
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp 252 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRP 252 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCc
Confidence 3568899999999999999999
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=270.55 Aligned_cols=243 Identities=24% Similarity=0.414 Sum_probs=188.7
Q ss_pred CCCCeeeecccccCCceEEEEEEec-----CCCcEEEEEEeeeCC--cccHHHHHHHHHhhhC-CCCCeeeeceEEecC-
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP- 89 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~- 89 (280)
..++|++.+.||+|+||.||+|.+. .+++.||+|.+.... .....+.+|+.++.++ +|+|++++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 3478999999999999999999853 457889999987533 2234577899999999 689999999987654
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------------------------------------------------------
Q 023591 90 THLAIVMEYASGGELFERICNA---------------------------------------------------------- 111 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~---------------------------------------------------------- 111 (280)
...+++|||+++++|.+++...
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4688999999999999888542
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC---CCCCc
Q 023591 112 ---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTV 179 (280)
Q Consensus 112 ---------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~ 179 (280)
..++...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++........ .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCCCC
Confidence 13577788899999999999999999999999999999998776 99999998864322111 11223
Q ss_pred CCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHH
Q 023591 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258 (280)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 258 (280)
++..|+|||.+.+..++.. +|+||||+++|+|++ |..||............... ......+. ..++++.+++.+
T Consensus 243 ~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~ 317 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--GTRMRAPD--YTTPEMYQTMLD 317 (343)
T ss_pred CCcceECcHHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc--cCCCCCCC--CCCHHHHHHHHH
Confidence 4567999999887777655 999999999999997 99999765433222222111 11112222 467899999999
Q ss_pred hcccCCCCcC
Q 023591 259 IFVADPAKSE 268 (280)
Q Consensus 259 ~l~~dp~~Rp 268 (280)
||+.||++||
T Consensus 318 cl~~~p~~Rp 327 (343)
T cd05103 318 CWHGEPSQRP 327 (343)
T ss_pred HccCChhhCc
Confidence 9999999999
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=260.98 Aligned_cols=236 Identities=20% Similarity=0.354 Sum_probs=179.2
Q ss_pred cccccCCceEEEEEEecC--CCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCC
Q 023591 27 RDIGSGNFGVARLMRDKK--TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (280)
+.||+|+||.||++.... ....+++|.+..... ....+.+|+..++.++|+||+++++.+......+++|||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 468999999999996533 345688887654322 2245678999999999999999999999889999999999999
Q ss_pred chHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC---C
Q 023591 103 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q 174 (280)
Q Consensus 103 ~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~---~ 174 (280)
+|.+++.... ..++..+..++.||+.||+|||++|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheec
Confidence 9999986543 2467788999999999999999999999999999999998877 9999999886432221 1
Q ss_pred CCCCcCCCcccCcccccCC------cCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCC---
Q 023591 175 PKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD--- 244 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~------~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 244 (280)
.....++..|+|||.+... .....++||||||+++|+|++ |..||....+.+........ ....++.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~ 235 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE---QDIKLPKPQL 235 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc---cCccCCCCcc
Confidence 1223345679999987432 222445999999999999999 78888766543333322221 1111111
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 245 YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
...++..+.+++..|+ .||++||
T Consensus 236 ~~~~~~~~~~~~~~~~-~dp~~Rp 258 (269)
T cd05042 236 DLKYSDRWYEVMQFCW-LDPETRP 258 (269)
T ss_pred cccCCHHHHHHHHHHh-cCccccc
Confidence 2257888999999998 5999999
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=262.92 Aligned_cols=232 Identities=18% Similarity=0.204 Sum_probs=182.5
Q ss_pred cccccCCceEEEEEEecCCCc-------EEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 27 RDIGSGNFGVARLMRDKKTEE-------LVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~-------~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
+.||+|+||.||++.+...+. .+++|.+.... ...+.+.+|+.+++.+.|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999999865443 38888876543 2335677899999999999999999999988899999999
Q ss_pred cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCC------cEEEeecCCcccccc
Q 023591 99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP------RLKICDFGYSKSSVL 171 (280)
Q Consensus 99 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~------~~~l~df~~~~~~~~ 171 (280)
+++++|.+++...+ .+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.. .++++|||.+.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 99999999987644 58999999999999999999999999999999999999876642 379999998764322
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCC-CCCCCCCCcchHHHHHhhHhcccccCCCCCCCCH
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (280)
.....++..|+|||.+.+......++|+||||+++|+|++|. .||..... ...... ......++. ..+.
T Consensus 161 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~~~~~----~~~~~~~~~--~~~~ 230 (258)
T cd05078 161 ---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKKLQF----YEDRHQLPA--PKWT 230 (258)
T ss_pred ---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HHHHHH----HHccccCCC--CCcH
Confidence 223456778999999876543344599999999999999984 56554332 111111 122223333 4568
Q ss_pred HHHHHHHHhcccCCCCcC
Q 023591 251 ECRHLISRIFVADPAKSE 268 (280)
Q Consensus 251 ~l~~li~~~l~~dp~~Rp 268 (280)
++.+++.+||+.||++||
T Consensus 231 ~~~~li~~~l~~~p~~Rp 248 (258)
T cd05078 231 ELANLINQCMDYEPDFRP 248 (258)
T ss_pred HHHHHHHHHhccChhhCC
Confidence 899999999999999999
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=279.17 Aligned_cols=251 Identities=28% Similarity=0.493 Sum_probs=226.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
...+.+++..||-|+||.|-++..+.....+|+|++++.. +..+-+..|-.++...+.|.||++|..|.+...+|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 4467888999999999999999988776678999887643 344557788899999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
+||-|-||.|+..+..++.+++...+.++.-+++|++|||.+||++|||||+|.+++.+|. +||.|||+|+....+..
T Consensus 498 LmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCc
Confidence 9999999999999999999999999999999999999999999999999999999999998 99999999998888888
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
..+.+|||.|.|||++.++..+.. .|.|+||+++|||++|.+||...++...+..+++++-.. .+|. .++....+
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--~~Pr--~I~k~a~~ 650 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--EFPR--RITKTATD 650 (732)
T ss_pred eeeecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--hccc--ccchhHHH
Confidence 999999999999999999998777 999999999999999999999988877777777765433 3443 68899999
Q ss_pred HHHHhcccCCCCcC-----------CCcccccc
Q 023591 255 LISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 255 li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
||+++...+|.+|. .|.||.+.
T Consensus 651 Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 651 LIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 99999999999999 89999864
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=261.45 Aligned_cols=249 Identities=16% Similarity=0.146 Sum_probs=185.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCC---CcEEEEEEeeeCCccc--H----------HHHHHHHHhhhCCCCCeeeec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKID--E----------NVQREIINHRSLRHPNIVRFK 83 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~--~----------~~~~e~~~l~~l~h~~iv~~~ 83 (280)
..++|++.+.||+|+||.||++....+ +..+++|......... + ....+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 347999999999999999999998877 6677777644322111 1 111233344566899999999
Q ss_pred eEEecCC----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEE
Q 023591 84 EVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (280)
Q Consensus 84 ~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~ 159 (280)
+.+.... ..+++++++. .++.+.+......++..+..++.|++.||++||+.+++||||||+||+++.++. ++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~~ 166 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--GY 166 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--EE
Confidence 8766543 3467888774 467777766556788999999999999999999999999999999999987776 99
Q ss_pred EeecCCccccccCC--------CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHH-
Q 023591 160 ICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK- 230 (280)
Q Consensus 160 l~df~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~- 230 (280)
|+|||+++...... ......+++.|+|||.+.+..++.. +||||||+++++|++|..||...........
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-GDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999987443211 1123458899999999988777655 9999999999999999999987643322211
Q ss_pred ----HHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcCCCcccc
Q 023591 231 ----TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSEMHDWRR 274 (280)
Q Consensus 231 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp~h~~~~ 274 (280)
....+.......+ ..++.+.+++..|++.+|++||....+.
T Consensus 246 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~rp~~~~l~ 290 (294)
T PHA02882 246 AKCDFIKRLHEGKIKIK---NANKFIYDFIECVTKLSYEEKPDYDALI 290 (294)
T ss_pred hHHHHHHHhhhhhhccC---CCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence 1223333323332 4688999999999999999999655544
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=263.68 Aligned_cols=241 Identities=20% Similarity=0.347 Sum_probs=190.5
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCc----EEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
..++|++.+.||+|+||.||++.+..+++ .+++|.+..... ....+.+|+.++++++|+||+++++++..+ ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 45789999999999999999999877665 468887765432 123577899999999999999999988654 46
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
+++++|+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. +||+|||++.....
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~ 161 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEG 161 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEccccccccccC
Confidence 78999999999999986644 6899999999999999999999999999999999999987776 99999999875432
Q ss_pred CCCC---CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 172 HSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 172 ~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
.... .....+..|+|||.+.+..++.. +||||||+++|+|++ |..||..... ....... .....++....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~----~~~~~~~~~~~ 235 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLL----EKGERLPQPPI 235 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH----HCCCCCCCCCC
Confidence 2211 12234567999999877777655 999999999999997 8999976432 1122221 22222333335
Q ss_pred CCHHHHHHHHHhcccCCCCcC
Q 023591 248 ISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+.++.+++.+||..+|++||
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp 256 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRP 256 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCc
Confidence 788999999999999999999
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=287.98 Aligned_cols=146 Identities=31% Similarity=0.473 Sum_probs=133.7
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc----cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
.++|++.+.||+|+||.||++.+..+++.||+|++...... ...+.+|+.++..++|+||+++++.+......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999998764322 25677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
|||+.+++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||+++.++. ++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~--vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH--IKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC--EEEEeCCCCc
Confidence 999999999999988788999999999999999999999999999999999999988776 9999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=260.98 Aligned_cols=231 Identities=22% Similarity=0.257 Sum_probs=179.2
Q ss_pred ccccCCceEEEEEEecC------------------------CCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeee
Q 023591 28 DIGSGNFGVARLMRDKK------------------------TEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRF 82 (280)
Q Consensus 28 ~lg~G~~g~v~~~~~~~------------------------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~ 82 (280)
.||+|+||.||++.... ....|++|.+..... ....+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 68999999999987432 123588888765432 23457778889999999999999
Q ss_pred ceEEecCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC-----C
Q 023591 83 KEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-----P 156 (280)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~-----~ 156 (280)
++++..+...++||||+++++|..++.+ .+.+++..+..++.|++.||+|||++|++|+||+|+||+++..+. .
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 9999999999999999999999988865 457899999999999999999999999999999999999976432 2
Q ss_pred cEEEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHH-hCCCCCCCCCCcchHHHHHhhH
Q 023591 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRI 235 (280)
Q Consensus 157 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~ 235 (280)
.++++|||.+..... .....++..|+|||.+.+......++|+||||+++|+|+ +|..||........ ....
T Consensus 162 ~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~~--- 234 (274)
T cd05076 162 FIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFY--- 234 (274)
T ss_pred eeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHHH---
Confidence 479999998753321 122346778999998876443345599999999999985 69999976543221 1111
Q ss_pred hcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
......+. ..++.+.++|.+||+.+|++||
T Consensus 235 -~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rp 264 (274)
T cd05076 235 -EKKHRLPE--PSCKELATLISQCLTYEPTQRP 264 (274)
T ss_pred -HhccCCCC--CCChHHHHHHHHHcccChhhCc
Confidence 11222222 3567899999999999999999
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=274.24 Aligned_cols=251 Identities=31% Similarity=0.483 Sum_probs=207.3
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
.-|..++.||-|+||+|+++....+...||+|.+.+.+ ....-++.|-.+|..-+.+-+|+++..|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 34778899999999999999999999999999988754 33344667888888889999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc-------
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS------- 169 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~------- 169 (280)
+|.+||++-.++.+.+-|.+...+.++.++..|+++.|+.|++||||||+||+||.+|+ |||+|||++...
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceeccccc
Confidence 99999999999999999999999999999999999999999999999999999999998 999999998511
Q ss_pred --ccCCCC----------------------------------CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHH
Q 023591 170 --VLHSQP----------------------------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213 (280)
Q Consensus 170 --~~~~~~----------------------------------~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~ 213 (280)
..+... ....||+.|.|||++....++.. +|.||.|++||+|+
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEML 865 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHHh
Confidence 000000 01248899999999999998777 99999999999999
Q ss_pred hCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC---------CCccccccc
Q 023591 214 VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE---------MHDWRRGCS 277 (280)
Q Consensus 214 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---------~h~~~~~~~ 277 (280)
.|++||...+..+...++.. ....+.++.-.++|.+..++|.++. -+++.|. .||||++..
T Consensus 866 ~g~~pf~~~tp~~tq~kv~n--w~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVIN--WRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred hCCCCccCCCCCcceeeeee--hhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccc
Confidence 99999987665433222211 1222344444578999999998754 4788888 999999865
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=254.47 Aligned_cols=261 Identities=29% Similarity=0.493 Sum_probs=217.6
Q ss_pred CCCCCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhC-CCCCeeeece
Q 023591 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKE 84 (280)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 84 (280)
-|.........++|.+++.||+|+|++|.+++.+++.+.+|+|++++. +...+=...|-.+..+- +||.+|.++.
T Consensus 239 ~g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs 318 (593)
T KOG0695|consen 239 DGIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS 318 (593)
T ss_pred cccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh
Confidence 344555566678999999999999999999999999999999998763 22333344565555544 8999999999
Q ss_pred EEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
+|.+++.+++|.||++||+|--.+++..+++++....+...|+.||.|||++||++||||.+||+++..|+ +||+|+|
T Consensus 319 cfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdyg 396 (593)
T KOG0695|consen 319 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYG 396 (593)
T ss_pred hhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccc
Confidence 99999999999999999999888888889999999999999999999999999999999999999998888 9999999
Q ss_pred Cccc-cccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCC---CCCcchHHHH-HhhHhccc
Q 023591 165 YSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED---PEEPKNFRKT-IHRILSVQ 239 (280)
Q Consensus 165 ~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~---~~~~~~~~~~-~~~~~~~~ 239 (280)
+++. ..++....+.++||.|.|||++.+..|.-. .|.|+||++++||+.|+.||.- .+.+...... .+-+....
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq 475 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ 475 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc
Confidence 9873 344555678899999999999999888655 9999999999999999999953 2222222222 33445556
Q ss_pred ccCCCCCCCCHHHHHHHHHhcccCCCCcC------------CCccccc
Q 023591 240 YSIPDYVHISPECRHLISRIFVADPAKSE------------MHDWRRG 275 (280)
Q Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------------~h~~~~~ 275 (280)
.++|. .+|-....+++.-|+.||.+|. .|+||+.
T Consensus 476 iripr--slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 476 IRIPR--SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred ccccc--eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 66666 5778889999999999999998 8999974
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=255.13 Aligned_cols=234 Identities=24% Similarity=0.313 Sum_probs=179.5
Q ss_pred cccccCCceEEEEEEecC---CCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEe-cCCeEEEEEeccC
Q 023591 27 RDIGSGNFGVARLMRDKK---TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYAS 100 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~ 100 (280)
+.||+|+||.||++.+.. .+..+|+|.+.... ...+.+.+|+.+++.++|||++++++++. .+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 34579999875432 23356778999999999999999999765 4556889999999
Q ss_pred CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-----C
Q 023591 101 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----Q 174 (280)
Q Consensus 101 ~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-----~ 174 (280)
+++|.+++.+. ..++...+..++.|++.||++||+.+++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecc
Confidence 99999998654 35678888999999999999999999999999999999998776 9999999886433211 1
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhC-CCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
.....++..|+|||.+.+..++.. +||||||+++|+|++| .+||...... .....+.... ..+.....++.+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~ 232 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSF----DITVYLLQGR-RLLQPEYCPDPLY 232 (262)
T ss_pred cccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHhcCC-CCCCCCcCCHHHH
Confidence 112234567999999877777655 9999999999999995 5666543321 1222222211 1222225688999
Q ss_pred HHHHHhcccCCCCcC
Q 023591 254 HLISRIFVADPAKSE 268 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp 268 (280)
+++.+||+.+|++||
T Consensus 233 ~li~~cl~~~p~~Rp 247 (262)
T cd05058 233 EVMLSCWHPKPEMRP 247 (262)
T ss_pred HHHHHHcCCChhhCC
Confidence 999999999999999
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=252.92 Aligned_cols=265 Identities=26% Similarity=0.366 Sum_probs=209.6
Q ss_pred CCCCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeee---CCcccHHHHHHHHHhhhCCCCCeeeeceEEe
Q 023591 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVIL 87 (280)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 87 (280)
.+..|.....+.|+...++|+|.||.||+|+.+++++.||+|++.- .........+|+.+|..++|+|++.+++++.
T Consensus 7 s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 7 SMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred cccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 4567778888999999999999999999999999999999887643 2233355779999999999999999988876
Q ss_pred c--------CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcE
Q 023591 88 T--------PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (280)
Q Consensus 88 ~--------~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~ 158 (280)
. ...+|+||++|.. +|..++.+. .+++..+|.+++.+++.+|.|+|...|+|||+||.|++|+.++. +
T Consensus 87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--l 163 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--L 163 (376)
T ss_pred hccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--E
Confidence 4 2358999999965 898888765 57999999999999999999999999999999999999999988 9
Q ss_pred EEeecCCccccccCCCCCC-----CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHh
Q 023591 159 KICDFGYSKSSVLHSQPKS-----TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (280)
Q Consensus 159 ~l~df~~~~~~~~~~~~~~-----~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (280)
+|.|||+++..+....... ..-|..|.+||.+.+...+.++.|||..||++.+|+++.+.+...++...+.-+..
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 9999999975544332211 22477899999998877666669999999999999999999988765443332221
Q ss_pred hHhcccc-cCCC-------------------CC---------CCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 234 RILSVQY-SIPD-------------------YV---------HISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 234 ~~~~~~~-~~~~-------------------~~---------~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
....... .+|. .. .-+++..+|+.++|..||.+|+ +|.||..++.
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 1111110 0000 00 1245788999999999999999 9999987654
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=253.73 Aligned_cols=239 Identities=21% Similarity=0.281 Sum_probs=179.0
Q ss_pred cccccCCceEEEEEEecCC--CcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCC
Q 023591 27 RDIGSGNFGVARLMRDKKT--EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (280)
+.||+|+||.||+++...+ ...+++|.+.... ...+.+.+|+..++.++|||++++++.+......+++|||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3689999999999975433 3346677665432 23356888999999999999999999999888999999999999
Q ss_pred chHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC---CCC
Q 023591 103 ELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP 175 (280)
Q Consensus 103 ~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~---~~~ 175 (280)
+|.+++.+. ..++...++.++.||+.||+|||+.+++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcc
Confidence 999988653 24677788999999999999999999999999999999988777 999999987532211 112
Q ss_pred CCCcCCCcccCcccccCCc------CCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCC
Q 023591 176 KSTVGTPAYIAPEVLLKKE------YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~------~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (280)
....++..|+|||.+.... ..+.++||||||+++|+|++ |..||.....................+......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 2345678899999875321 12345999999999999997 5678866554333333332211111111112257
Q ss_pred CHHHHHHHHHhcccCCCCcC
Q 023591 249 SPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp 268 (280)
++.+.+++..|| .+|++||
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp 257 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRA 257 (268)
T ss_pred cHHHHHHHHHHh-hCcccCC
Confidence 889999999999 6899999
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=253.17 Aligned_cols=260 Identities=28% Similarity=0.394 Sum_probs=202.7
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCc----EEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEec-C
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-P 89 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~ 89 (280)
.+...|+.+.+||+|.||.||+|..++++. .+|||.++... ....+.-+|+.+++.++|+|++.+..++.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 345789999999999999999997665432 78999987653 344678899999999999999999999887 7
Q ss_pred CeEEEEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC--CCcEEEee
Q 023591 90 THLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICD 162 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~--~~~~~l~d 162 (280)
..+++++||.+. +|.+.+.- ...++...++.+++||+.++.|||++=++||||||.||++..++ .+++|++|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 899999999965 89888743 23589999999999999999999999999999999999998763 25699999
Q ss_pred cCCccccccCCCC----CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc---------chHH
Q 023591 163 FGYSKSSVLHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFR 229 (280)
Q Consensus 163 f~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---------~~~~ 229 (280)
+|+++........ ....-|..|.|||.+.+...++++.|+|+.|||+.||++..+.|...... +.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999855443322 33346778999999999988888899999999999999999888764421 1111
Q ss_pred HHHhhHhc-ccccCCC------------------------------CCCCCHHHHHHHHHhcccCCCCcC------CCcc
Q 023591 230 KTIHRILS-VQYSIPD------------------------------YVHISPECRHLISRIFVADPAKSE------MHDW 272 (280)
Q Consensus 230 ~~~~~~~~-~~~~~~~------------------------------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~ 272 (280)
+++.-... ....+|. +..-++...+|+.+||+.||.+|. +|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 11111100 0001111 122456688999999999999999 9999
Q ss_pred cccccC
Q 023591 273 RRGCSV 278 (280)
Q Consensus 273 ~~~~~~ 278 (280)
|..++.
T Consensus 340 F~~d~l 345 (438)
T KOG0666|consen 340 FTEDPL 345 (438)
T ss_pred cccCCC
Confidence 998743
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=256.21 Aligned_cols=238 Identities=23% Similarity=0.360 Sum_probs=184.9
Q ss_pred eeeecccccCCceEEEEEEec---CCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCC------
Q 023591 23 YELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 90 (280)
|++.+.||+|++|.||++... .++..+|+|.+.... ...+.+.+|+..+++++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 357889999987542 23346778999999999999999999886532
Q ss_pred eEEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 91 HLAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
..+++++|+.+++|.+++... ..++...+..++.|++.+|+|||+.|++|+||+|+||+++.++. ++++|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECccc
Confidence 247889999999998876422 24789999999999999999999999999999999999987776 9999999
Q ss_pred CccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccc
Q 023591 165 YSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQY 240 (280)
Q Consensus 165 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
++....... .......++.|++||.+.+...+.. +||||||+++|+|++ |..||....... ....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~~~~----~~~~~~~~~- 232 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSE----IYNYLIKGN- 232 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCCHHH----HHHHHHcCC-
Confidence 887543222 1122234567999999877776655 999999999999999 889987644322 222222211
Q ss_pred cCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 241 SIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
........+..+.+++.+||+.+|++||
T Consensus 233 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp 260 (273)
T cd05074 233 RLKQPPDCLEDVYELMCQCWSPEPKCRP 260 (273)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 1111225788999999999999999999
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=274.63 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=213.4
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEec-----CCeEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT-----PTHLAI 94 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-----~~~~~l 94 (280)
+.|++.+.||.|.+|.||+++...+++..|+|+........++++.|+++++.+ .|||++.+++++.. ++.++|
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 689999999999999999999999999999999999888899999999999988 79999999999863 468999
Q ss_pred EEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc-cc
Q 023591 95 VMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VL 171 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~-~~ 171 (280)
|||||.+||..+++++ ...+.++.+..|++.++.+|.+||++.++|||++-.||+++.++. +||+|||.+... ..
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDST 176 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeeecc
Confidence 9999999999999975 457999999999999999999999999999999999999998887 999999987533 33
Q ss_pred CCCCCCCcCCCcccCcccccCC-----cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCC
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (280)
-....+..|+|.|+|||++... .++.. +|+||||++..||..|.+|+.+......+..+. ....+.+..+.
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip---RNPPPkLkrp~ 252 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RNPPPKLKRPK 252 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchhhhhccCC---CCCCccccchh
Confidence 3445677899999999998643 34555 899999999999999999998766543333222 22223333345
Q ss_pred CCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 247 HISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
.++.++.+||..||..|-.+|| .|||+..
T Consensus 253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 253 KWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred hHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 7899999999999999999999 9999973
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=242.56 Aligned_cols=252 Identities=22% Similarity=0.420 Sum_probs=204.5
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC-CCCeeeeceEEecCC--eEEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPT--HLAI 94 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~~l 94 (280)
...++|++++++|+|.++.||.+..-.+++.++||++++-. .+.+.+|+.+|+.|. ||||++++++..++. ...+
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 35689999999999999999999999999999999988654 367899999999994 999999999998764 4679
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
|+||.+..+...+. +.++...+..++.+++.||.|+|+.||+|||+||.|++++... .+++|+|+|+|..+.+...
T Consensus 113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~-rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh-ceeeeeecchHhhcCCCce
Confidence 99999887666554 4588999999999999999999999999999999999998544 4699999999998888888
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCC-CCcchHHHHHhhHhcc---------cccCC-
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIHRILSV---------QYSIP- 243 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~---------~~~~~- 243 (280)
-+....+..|--||.+..-+....+.|+|||||++..|+....||-.. +..+++.++.+-.... ...++
T Consensus 189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp 268 (338)
T KOG0668|consen 189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP 268 (338)
T ss_pred eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence 888888889999999887655555589999999999999998888544 3333433332211110 00000
Q ss_pred --------------------CC-CCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 244 --------------------DY-VHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 244 --------------------~~-~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
.+ .-++++..+|+.++|..|.++|+ .||||.-
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 00 12569999999999999999999 9999963
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=260.45 Aligned_cols=256 Identities=27% Similarity=0.377 Sum_probs=212.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHH--------HHHHHHHhhhCCCCCeeeeceEEecC-
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--------VQREIINHRSLRHPNIVRFKEVILTP- 89 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~--------~~~e~~~l~~l~h~~iv~~~~~~~~~- 89 (280)
-+++|-++..||+|+|+.||++.+-...+.||+|+-+.+..+.++ ..+|..+.+.|+||.||++++++.-+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 358999999999999999999999999999999987666555433 45789999999999999999999754
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEeCCC-CCcEEEeecCCc
Q 023591 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSP-APRLKICDFGYS 166 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~ni~i~~~~-~~~~~l~df~~~ 166 (280)
+.+|-|+|||+|.+|+-+++.++.+++.+...|+-||+.||.||.+.. |+|-||||.||++-... .+.+|++|||++
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 578999999999999999999999999999999999999999999765 99999999999985432 245999999999
Q ss_pred cccccCCCC--------CCCcCCCcccCcccccCCc---CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhH
Q 023591 167 KSSVLHSQP--------KSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235 (280)
Q Consensus 167 ~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (280)
......... ....||..|++||.+.-++ --+.+.||||+|+|+|.++.|+.||........+...-.-+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 755443322 2345788899999875432 12445899999999999999999998866544444444444
Q ss_pred hcccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccc
Q 023591 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~ 274 (280)
......||..+.++.+.++||++||+..-+.|. .||||.
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 556668888889999999999999999999999 899885
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=243.51 Aligned_cols=235 Identities=43% Similarity=0.671 Sum_probs=196.2
Q ss_pred CceEEEEEEecCCCcEEEEEEeeeCCcc--cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCchHHHHHh
Q 023591 33 NFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 110 (280)
Q Consensus 33 ~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 110 (280)
+||.||++....+++.+++|.+...... .+.+.+|++.+++++|+|++++++.+......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 5799999999988999999998765433 47788999999999999999999999988999999999999899999877
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcCCCcccCcccc
Q 023591 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190 (280)
Q Consensus 111 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~ 190 (280)
...++...++.++.+++.++.+||+.+++|+||+|+||+++.++. ++++|||.+.............++..|++||.+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH--VKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc--EEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 666899999999999999999999999999999999999998876 999999998765554444556678889999999
Q ss_pred cCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCC-CCCHHHHHHHHHhcccCCCCcC-
Q 023591 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV-HISPECRHLISRIFVADPAKSE- 268 (280)
Q Consensus 191 ~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rp- 268 (280)
.+...+. ++|+|++|+++++|++|..||.......... .............. .++.++.+++.+||..+|++||
T Consensus 159 ~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 159 LGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQLLELF---KKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred ccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 8777766 4999999999999999999997643322222 22222222222211 1788999999999999999999
Q ss_pred -----CCccc
Q 023591 269 -----MHDWR 273 (280)
Q Consensus 269 -----~h~~~ 273 (280)
.||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 99986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=280.78 Aligned_cols=245 Identities=29% Similarity=0.418 Sum_probs=189.5
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC--CcccHHHHHHHHHhhhCCCCCeeeeceEEe-----------
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVIL----------- 87 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----------- 87 (280)
.+|+.++.||+|+||.||+|+++-+|+.||||++... ......+.+|+..+.+|+|||+|+++..+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 4678899999999999999999999999999999775 556677999999999999999999872110
Q ss_pred -------------------------------------------------------c------------------------
Q 023591 88 -------------------------------------------------------T------------------------ 88 (280)
Q Consensus 88 -------------------------------------------------------~------------------------ 88 (280)
.
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0
Q ss_pred ---------------------C--------CeEEEEEeccCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhcCc
Q 023591 89 ---------------------P--------THLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQV 138 (280)
Q Consensus 89 ---------------------~--------~~~~lv~e~~~~~~L~~~~~~~~~l-~~~~~~~~~~~i~~~l~~Lh~~~i 138 (280)
+ ..+|+-||||+..++.+++..+... .....|+++++|++||.|+|+.|+
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 0 1358899999887777777655443 588999999999999999999999
Q ss_pred eecCCCCCcEEEeCCCCCcEEEeecCCccccc-------------------cCCCCCCCcCCCcccCcccccCCc--CCC
Q 023591 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-------------------LHSQPKSTVGTPAYIAPEVLLKKE--YDG 197 (280)
Q Consensus 139 ~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~~~--~~~ 197 (280)
+||||||.|||++++.+ |||+|||+|.... .....-...||..|.|||.+.+.. .+.
T Consensus 719 IHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred eeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999998887 9999999997511 000112345888999999998766 334
Q ss_pred ccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC---CCCCCCHHHHHHHHHhcccCCCCcC------
Q 023591 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP---DYVHISPECRHLISRIFVADPAKSE------ 268 (280)
Q Consensus 198 ~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rp------ 268 (280)
.+.|+||||++++||+. ||... .....++.....+.+..+ .. .--+.-..+|++||+.||++||
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~Ts---MERa~iL~~LR~g~iP~~~~f~~-~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGTS---MERASILTNLRKGSIPEPADFFD-PEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCch---HHHHHHHHhcccCCCCCCccccc-ccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 45999999999999974 46543 334444444444444444 11 2234567999999999999999
Q ss_pred CCcccc
Q 023591 269 MHDWRR 274 (280)
Q Consensus 269 ~h~~~~ 274 (280)
++.||-
T Consensus 870 ~s~llp 875 (1351)
T KOG1035|consen 870 NSELLP 875 (1351)
T ss_pred hccCCC
Confidence 666664
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=246.37 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=199.6
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
.++.+-+..||.|+||+|++..++.+|+..|+|.+.... ....++..|.+...+- ++||||++++....++..++.|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 355666789999999999999999999999999997653 3334566777665554 7899999999999999999999
Q ss_pred eccCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 97 EYASGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 97 e~~~~~~L~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
|.++ .||..+.. +...++++.+..+..-.+.||.||.+ ..|+|||+||+||+++..|. +||||||.+....
T Consensus 143 ELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQLV 219 (361)
T ss_pred HHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHhHH
Confidence 9995 47765542 34569999999999999999999985 68999999999999999998 9999999987555
Q ss_pred cCCCCCCCcCCCcccCcccccCC--cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC-CC---
Q 023591 171 LHSQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI-PD--- 244 (280)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~--- 244 (280)
..-......|...|+|||.+... .++-. ||+||||+++||+.||..||.... ...+....+..+.+.. ..
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~---svfeql~~Vv~gdpp~l~~~~~ 295 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWD---SVFEQLCQVVIGDPPILLFDKE 295 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHH---HHHHHHHHHHcCCCCeecCccc
Confidence 54444555678889999998643 36666 999999999999999999997653 3444455555444322 11
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC------CCcccc
Q 023591 245 YVHISPECRHLISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~ 274 (280)
..+++..+..||..||..|-+.|| .+||.+
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr 331 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYR 331 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhh
Confidence 235899999999999999999999 777765
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=259.54 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=206.1
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
++..++++||+|-||.|.+++... +..||+|.++... ....++.+|+++|.+|+||||+.+++++..++.+++|+||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 577889999999999999999754 6889999998754 3346789999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC-
Q 023591 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (280)
Q Consensus 99 ~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~- 175 (280)
+..|+|.+++.++. ........+++.||+.+++||.+.++||||+.+.|++++.+.+ +|++|||+++....+..-
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCcee
Confidence 99999999998764 3455667789999999999999999999999999999988877 999999999854433322
Q ss_pred --CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh--CCCCCCCCCCcchHHHHHhhHhccc--ccCCCCCCCC
Q 023591 176 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEPKNFRKTIHRILSVQ--YSIPDYVHIS 249 (280)
Q Consensus 176 --~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 249 (280)
....-..+|+|+|.+..++.++. +|+|++|+++||+++ .+.||....+++...+.......+. .-++..+-++
T Consensus 695 vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp 773 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP 773 (807)
T ss_pred eecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence 23345678999999999999777 999999999999765 7899988877555444332221111 1122233678
Q ss_pred HHHHHHHHHhcccCCCCcC----CCcccccc
Q 023591 250 PECRHLISRIFVADPAKSE----MHDWRRGC 276 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp----~h~~~~~~ 276 (280)
.++.+++.+||..|..+|| -|.+|++.
T Consensus 774 ~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 774 QGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 9999999999999999999 77777653
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=269.71 Aligned_cols=242 Identities=24% Similarity=0.408 Sum_probs=206.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCC---cEEEEEEeeeC--CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
+...-+|.+.||.|.||.|++++.+..+ ..||||.++.. ++...+|..|..++-+++||||+++.++......++
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 3455678899999999999999987554 56999999864 456678999999999999999999999998888999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
+|+|||..|+|+.+++++ +.++..++..+++.|+.+++||.+.|+|||||.+.||+++.+-. +|+.|||+++.....
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvledd 784 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDD 784 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeecccC
Confidence 999999999999999754 57999999999999999999999999999999999999987766 999999999855443
Q ss_pred CCC-CCCc---CCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 173 SQP-KSTV---GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 173 ~~~-~~~~---~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
... .+.. ...+|+|||.+..++.++. |||||+|++|||.++ |..||++..+.+.+.. ....+++|....
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-----Ie~gyRLPpPmD 858 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-----IEQGYRLPPPMD 858 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHHHH-----HHhccCCCCCCC
Confidence 311 1111 2468999999999999777 999999999999776 9999998776443333 345567777778
Q ss_pred CCHHHHHHHHHhcccCCCCcC
Q 023591 248 ISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp 268 (280)
+|..|.+|+..||+.|-.+||
T Consensus 859 CP~aL~qLMldCWqkdR~~RP 879 (996)
T KOG0196|consen 859 CPAALYQLMLDCWQKDRNRRP 879 (996)
T ss_pred CcHHHHHHHHHHHHHHhhcCC
Confidence 999999999999999999999
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=262.00 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=210.0
Q ss_pred cCCCCCCCCCCCCCCeeeecccccCCceEEEEEEecCC---CcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeee
Q 023591 8 VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRF 82 (280)
Q Consensus 8 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~ 82 (280)
.+|...+...+-.++..+.+.||+|.||+|+++.+... --.||||.+..... ...+|.+|+..+.+|+|+|++++
T Consensus 97 ~~p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRL 176 (1039)
T KOG0199|consen 97 ANPSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRL 176 (1039)
T ss_pred CCcCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEE
Confidence 56778888888889999999999999999999998743 24689999876532 44789999999999999999999
Q ss_pred ceEEecCCeEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEE
Q 023591 83 KEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (280)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l 160 (280)
|++..+ ....+|||+++.|+|.+.+.+ ...|....+..++.||+.|+.||..+++|||||-..|+++-.... |||
T Consensus 177 yGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI 253 (1039)
T KOG0199|consen 177 YGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKI 253 (1039)
T ss_pred eeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eee
Confidence 999876 678999999999999999876 346889999999999999999999999999999999999987655 999
Q ss_pred eecCCccccccCCCCC----CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhH
Q 023591 161 CDFGYSKSSVLHSQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRI 235 (280)
Q Consensus 161 ~df~~~~~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 235 (280)
+|||+.+....+.... ...-...|+|||.+...+.+.. +|+|++|++||||++ |+.||.+...... ++.+
T Consensus 254 ~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~qI----L~~i 328 (1039)
T KOG0199|consen 254 CDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQI----LKNI 328 (1039)
T ss_pred ecccceeccCCCCcceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHHH----HHhc
Confidence 9999988544333322 2223456999999999999777 999999999999998 8899988665433 3333
Q ss_pred hcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
. ...+++....+|.++.+++..||..+|++||
T Consensus 329 D-~~erLpRPk~csedIY~imk~cWah~paDRp 360 (1039)
T KOG0199|consen 329 D-AGERLPRPKYCSEDIYQIMKNCWAHNPADRP 360 (1039)
T ss_pred c-ccccCCCCCCChHHHHHHHHHhccCCccccc
Confidence 3 3334444447999999999999999999999
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=245.43 Aligned_cols=255 Identities=26% Similarity=0.356 Sum_probs=201.6
Q ss_pred ccCCCCCCCCCC---CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhh--CCCCCeee
Q 023591 7 TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVR 81 (280)
Q Consensus 7 ~~~~~~~~~~~~---~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~ 81 (280)
+.|.|+.+|... ...+-++.+.||+|.||+||++.+. |+.||+|+|...+ .+++.+|.++.+. |+|+||+.
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhh
Confidence 567787777664 3478899999999999999999996 7789999998643 3567788888865 49999999
Q ss_pred eceEEecCC----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------cCceecCCCCCcEE
Q 023591 82 FKEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------MQVCHRDLKLENTL 149 (280)
Q Consensus 82 ~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~--------~~i~h~dl~~~ni~ 149 (280)
+++.-..+. .++||++|.+.|||.|++.+ ..++.+...+++..++.+|++||. -.|+|||||..||+
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 998765432 68999999999999999977 679999999999999999999994 24999999999999
Q ss_pred EeCCCCCcEEEeecCCccccccCC-----CCCCCcCCCcccCcccccCCcC-----CCccchhhHHHHHHHHHHh-----
Q 023591 150 LDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLV----- 214 (280)
Q Consensus 150 i~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~-----~~~~~DiwslG~~l~~l~~----- 214 (280)
+..++. +.|.|+|+|....... ..+...||.+|+|||++....- +.+.+||||||.++||++.
T Consensus 349 VKkn~~--C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g 426 (513)
T KOG2052|consen 349 VKKNGT--CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG 426 (513)
T ss_pred EccCCc--EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence 999998 9999999997554432 2356679999999999865421 2334899999999999875
Q ss_pred -----CCCCCCCCCCcchHHHHHhhHhcccccCCCCC-CC-----CHHHHHHHHHhcccCCCCcC
Q 023591 215 -----GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV-HI-----SPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 215 -----g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-----~~~l~~li~~~l~~dp~~Rp 268 (280)
-++||.+..+.+.-.+.++.+.-.....|..+ .+ -..+..+++.||..||..|.
T Consensus 427 gi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRl 491 (513)
T KOG2052|consen 427 GIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARL 491 (513)
T ss_pred CEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhh
Confidence 26899887776666666666544333222211 11 13567889999999999997
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=266.97 Aligned_cols=254 Identities=17% Similarity=0.187 Sum_probs=169.2
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCC----CcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceE------Ee
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKT----EELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV------IL 87 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~ 87 (280)
...++|++.+.||+|+||.||++.+..+ +..||+|.+..... .+...++ .++...+.++..+... ..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3568999999999999999999999988 89999998764321 1111111 1122222222222111 13
Q ss_pred cCCeEEEEEeccCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCc
Q 023591 88 TPTHLAIVMEYASGGELFERICNAGR--------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147 (280)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~n 147 (280)
.+...++|+||+++++|.+++..... .....+..++.|++.+|+|||+.||+||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 45678999999999999988864321 1234567899999999999999999999999999
Q ss_pred EEEeCC-CCCcEEEeecCCccccccC--CCCCCCcCCCcccCcccccCCcCC---------------------Cccchhh
Q 023591 148 TLLDGS-PAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLKKEYD---------------------GKIADVW 203 (280)
Q Consensus 148 i~i~~~-~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~---------------------~~~~Diw 203 (280)
|+++.+ +. +||+|||++...... .......+++.|+|||.+...... +.++|||
T Consensus 286 ILl~~~~~~--~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 286 IIFSEGSGS--FKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred EEEeCCCCc--EEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 999853 44 999999998743322 223445678999999976432211 1236999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcchHHHHHhh----------Hhcccc--c----CCCCCCCCHHHHHHHHHhcccCCCCc
Q 023591 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR----------ILSVQY--S----IPDYVHISPECRHLISRIFVADPAKS 267 (280)
Q Consensus 204 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------~~~~~~--~----~~~~~~~~~~l~~li~~~l~~dp~~R 267 (280)
|+||++|+|+++..++... .......... ...... . +......+...++||.+||+.||++|
T Consensus 364 SlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 9999999999877664321 1111111110 000000 0 00000123456699999999999999
Q ss_pred C------CCcccccccC
Q 023591 268 E------MHDWRRGCSV 278 (280)
Q Consensus 268 p------~h~~~~~~~~ 278 (280)
| .||||++...
T Consensus 442 ~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 442 ISAKAALAHPYFDREGL 458 (566)
T ss_pred CCHHHHhCCcCcCCCCc
Confidence 9 9999987543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=258.13 Aligned_cols=200 Identities=28% Similarity=0.394 Sum_probs=175.3
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCC------CCeeeeceEEecCCeEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH------PNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~~~~~l 94 (280)
++|.+....|.|-|++|..|.+..-|..||||++..++...+.=..|+++|++|+. -|++.++..|.+.+++|+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl 511 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL 511 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence 58999999999999999999999888999999999887777777889999999953 479999999999999999
Q ss_pred EEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 95 VMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
|+|-+. .+|.+.+++.+ .|....+..++.|++.||..|.++|++|.||||+||++.+..+ .+||||||.|.....
T Consensus 512 VFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~e 589 (752)
T KOG0670|consen 512 VFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFASE 589 (752)
T ss_pred Eehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCcccccccc
Confidence 999884 58999998765 3888999999999999999999999999999999999987665 589999998875443
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCC
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 224 (280)
+... ...-+..|.|||++.+-+|+.. .|+||.||+||||.||...|.+.+.
T Consensus 590 neit-PYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 590 NEIT-PYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred cccc-HHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCc
Confidence 3322 2334567999999999999988 9999999999999999999988765
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=254.36 Aligned_cols=236 Identities=25% Similarity=0.367 Sum_probs=192.3
Q ss_pred eeecccccCCceEEEEEEecCC--C--cEEEEEEeeeC--CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 24 ELVRDIGSGNFGVARLMRDKKT--E--ELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 24 ~~~~~lg~G~~g~v~~~~~~~~--~--~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
+..+.||.|-||.||.+....- | --||||.-+.+ ....+.|..|..++++++||||++++|++. +...++|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEEEe
Confidence 3457899999999999987532 2 34788887763 334567899999999999999999999986 467899999
Q ss_pred ccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
.++.|.|..+++.++ .++...+..++.||+.||+|||+.++|||||-..||++.+..- +||+|||+++.......-.
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccccchhh
Confidence 999999999997654 6999999999999999999999999999999999999987765 9999999998655444332
Q ss_pred CCc--CCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 177 STV--GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 177 ~~~--~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
... -..-|+|||.+.-...++. +|||.||+++||++. |..||..-.+.+.+-. ....-++|-.+++|+.+.
T Consensus 549 aS~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-----iEnGeRlP~P~nCPp~LY 622 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-----IENGERLPCPPNCPPALY 622 (974)
T ss_pred ccccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCccccccccceEEE-----ecCCCCCCCCCCCChHHH
Confidence 222 3456999999988888666 999999999999876 9999987655433222 222234444448999999
Q ss_pred HHHHHhcccCCCCcC
Q 023591 254 HLISRIFVADPAKSE 268 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp 268 (280)
.|+.+||+.||.+||
T Consensus 623 slmskcWayeP~kRP 637 (974)
T KOG4257|consen 623 SLMSKCWAYEPSKRP 637 (974)
T ss_pred HHHHHHhccCcccCC
Confidence 999999999999999
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=245.45 Aligned_cols=131 Identities=26% Similarity=0.404 Sum_probs=116.7
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC-----C---CCeeeeceEEec---
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----H---PNIVRFKEVILT--- 88 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~~--- 88 (280)
.++|.+.++||.|-|++||++.+..+.+.||+|+++..+...+....|+++|++++ | .+||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 37999999999999999999999999999999999988888888889999999882 2 369999999975
Q ss_pred -CCeEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEe
Q 023591 89 -PTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLD 151 (280)
Q Consensus 89 -~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~ 151 (280)
..++++|+|++ |-+|..++.. .+-++...+++|++||+.+|.|||. +||+|.||||+||++.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 35899999999 5688888865 3469999999999999999999995 7999999999999983
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=252.75 Aligned_cols=256 Identities=18% Similarity=0.205 Sum_probs=183.8
Q ss_pred CCCCCeeeecccccCCceEEEEEEec----------------CCCcEEEEEEeeeCCcc---------------cHHHHH
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDK----------------KTEELVAVKYIERGDKI---------------DENVQR 66 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~----------------~~~~~vaiK~~~~~~~~---------------~~~~~~ 66 (280)
...++|++.++||+|+||.||++... ..++.||||.+...... .+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 35789999999999999999998642 24567999998643211 112234
Q ss_pred HHHHhhhCCCCCe-----eeeceEEec--------CCeEEEEEeccCCCchHHHHHhcC---------------------
Q 023591 67 EIINHRSLRHPNI-----VRFKEVILT--------PTHLAIVMEYASGGELFERICNAG--------------------- 112 (280)
Q Consensus 67 e~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~--------------------- 112 (280)
|+.++.+++|.++ +++++++.. +...++|+||+++++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 5666666766543 566666542 356899999999999988875321
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC--CCcCCCcccCc
Q 023591 113 ---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAP 187 (280)
Q Consensus 113 ---~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~aP 187 (280)
.++...++.++.|++.+|.+||+.+++|+||||+||+++.++. ++|+|||++.......... ....++.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 2355678899999999999999999999999999999998776 9999999986443322211 22347899999
Q ss_pred ccccCCcCC---------------------CccchhhHHHHHHHHHHhCCC-CCCCCCCc-------chHHHHHhhHhcc
Q 023591 188 EVLLKKEYD---------------------GKIADVWSCGVTLYVMLVGAY-PFEDPEEP-------KNFRKTIHRILSV 238 (280)
Q Consensus 188 E~~~~~~~~---------------------~~~~DiwslG~~l~~l~~g~~-p~~~~~~~-------~~~~~~~~~~~~~ 238 (280)
|.+...... ....|+||+||++++|+++.. ||.....- ......++.....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 987543211 123699999999999999875 66532110 1112223334445
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCC---CCcC------CCccccc
Q 023591 239 QYSIPDYVHISPECRHLISRIFVADP---AKSE------MHDWRRG 275 (280)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rp------~h~~~~~ 275 (280)
.+.++.....++..++|+.+||..+| .+|+ .||||..
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 55666566789999999999999866 6899 9999963
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=237.84 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=203.4
Q ss_pred CCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecC--
Q 023591 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP-- 89 (280)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 89 (280)
...+...+|.-++.+|.|+. .|..+-+.-.++.|++|+.... ....++..+|...+..++|+||++++.++.-.
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 45567789999999999999 7888999989999999998653 34446778899999999999999999988633
Q ss_pred ----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCC
Q 023591 90 ----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (280)
Q Consensus 90 ----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~ 165 (280)
..+|+|||++. .+|.+.+. -.++=..+..+++|++.|+++||+.||+||||||+||++..+.. +|+.|||+
T Consensus 90 l~~~~e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ 164 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGL 164 (369)
T ss_pred HHHHHhHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchh
Confidence 35799999995 48888776 34777899999999999999999999999999999999998887 99999999
Q ss_pred ccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc------
Q 023591 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------ 239 (280)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 239 (280)
++.....-.......+..|.|||++.+..+... .||||+||++.||++|...|.+...-+.+.++........
T Consensus 165 ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 165 ARTEDTDFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred hcccCcccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 987666544555667888999999999887666 9999999999999999999987554333333222111100
Q ss_pred ---------------------ccCCC---------CCCCCHHHHHHHHHhcccCCCCcC------CCcccc
Q 023591 240 ---------------------YSIPD---------YVHISPECRHLISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 240 ---------------------~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~ 274 (280)
..+|+ ...-+..+++++.+||..||++|. .|||++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 01111 012345789999999999999999 999997
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=249.82 Aligned_cols=239 Identities=22% Similarity=0.328 Sum_probs=205.6
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
+.+...+||-|-||.||.+.+++-.-.||+|.++......++|..|..+++.++|||+|+++++|..+..+|+|+|||..
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 45567899999999999999999888999999999999999999999999999999999999999999999999999999
Q ss_pred CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCc
Q 023591 102 GELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179 (280)
Q Consensus 102 ~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 179 (280)
|+|.+++++. ..++.-.+..++.||..|++||..++++||||-..|.++.++-. +|+.|||+++............
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTYTAHAG 425 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTYTAHAG 425 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCceecccC
Confidence 9999999764 35778889999999999999999999999999999999987776 9999999998665544433322
Q ss_pred --CCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHH
Q 023591 180 --GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (280)
Q Consensus 180 --~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (280)
-..-|+|||.+.....+.+ +|||+||++|||+.| |-.||.+-+. . ..-......++.....++++.+.+|+
T Consensus 426 AKFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidl----S-qVY~LLEkgyRM~~PeGCPpkVYeLM 499 (1157)
T KOG4278|consen 426 AKFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDL----S-QVYGLLEKGYRMDGPEGCPPKVYELM 499 (1157)
T ss_pred ccCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccH----H-HHHHHHhccccccCCCCCCHHHHHHH
Confidence 3456999999998888777 999999999999998 7788876432 1 22334445555554458999999999
Q ss_pred HHhcccCCCCcC
Q 023591 257 SRIFVADPAKSE 268 (280)
Q Consensus 257 ~~~l~~dp~~Rp 268 (280)
+.||+.+|..||
T Consensus 500 raCW~WsPsDRP 511 (1157)
T KOG4278|consen 500 RACWNWSPSDRP 511 (1157)
T ss_pred HHHhcCCcccCc
Confidence 999999999999
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=251.52 Aligned_cols=198 Identities=29% Similarity=0.475 Sum_probs=177.0
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc---------HHHHHHHHHhhhCC---CCCeeeeceEEec
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---------ENVQREIINHRSLR---HPNIVRFKEVILT 88 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~e~~~l~~l~---h~~iv~~~~~~~~ 88 (280)
..|+.++.+|+|+||.|++|.++.+...|+||.+.++.... -.+-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 56999999999999999999999999999999998753222 23557999999996 9999999999999
Q ss_pred CCeEEEEEecc-CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 89 PTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 89 ~~~~~lv~e~~-~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
++.+|++||.. ++.+|.+++..++.+++.+.+.|++|++.++++||+.||+|||||-+||.++.+|- +||+|||.+.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgsaa 718 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGSAA 718 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccchh
Confidence 99999999976 57889999999999999999999999999999999999999999999999998887 9999999886
Q ss_pred ccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCC
Q 023591 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (280)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (280)
.. -.+......||..|.|||++.+.+|-.+.-|||+||+++|.++....||.+
T Consensus 719 ~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 33 344556788999999999999999988878999999999999988888864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=272.72 Aligned_cols=234 Identities=22% Similarity=0.243 Sum_probs=177.3
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCC
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
.|+..+.||+|+||.||++++..++..||+|.+...... ..+|+..+++++||||+++++++.++...++||||+++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence 455667899999999999999889999999988654332 23568889999999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCC
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCH---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh---~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~ 178 (280)
++|.+++.. ++...+..++.|++.||+||| +.+++|||+||+||+++.+.. .++. ++...... .....
T Consensus 768 g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~---~~~~~ 838 (968)
T PLN00113 768 KNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC---TDTKC 838 (968)
T ss_pred CcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc---cCCCc
Confidence 999999853 888999999999999999999 679999999999999988776 4433 44332111 12233
Q ss_pred cCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc-chHHHHHhhHhcc-------cccCCCC----C
Q 023591 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV-------QYSIPDY----V 246 (280)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~-------~~~~~~~----~ 246 (280)
.+++.|+|||.+.+..++.+ +||||+|+++|||++|+.||...... ....+..+..... ....... .
T Consensus 839 ~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (968)
T PLN00113 839 FISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917 (968)
T ss_pred cccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence 57789999999988777665 99999999999999999999543221 1111111111000 0001000 0
Q ss_pred CCCHHHHHHHHHhcccCCCCcC
Q 023591 247 HISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....++.+++.+||+.||++||
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RP 939 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARP 939 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCc
Confidence 1123577899999999999999
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=236.43 Aligned_cols=243 Identities=25% Similarity=0.314 Sum_probs=182.6
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhh--hCCCCCeeeeceEEecCC----eE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR--SLRHPNIVRFKEVILTPT----HL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~--~l~h~~iv~~~~~~~~~~----~~ 92 (280)
.....++.+.||+|+||.||+++.. ++.||||++...+. +++.+|-.+.. .++|+||+++++.-.... .+
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~k--qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEK--QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHH--HHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 3577889999999999999999985 58899999986543 45666666555 459999999998866544 78
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------cCceecCCCCCcEEEeCCCCCcEEEeec
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS---------MQVCHRDLKLENTLLDGSPAPRLKICDF 163 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~---------~~i~h~dl~~~ni~i~~~~~~~~~l~df 163 (280)
+||++|.+.|+|.+++..+ .++.....+++..|+++|+|||+ ..|+|||||+.||++..|.+ +.|+||
T Consensus 284 wLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDF 360 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADF 360 (534)
T ss_pred eEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeecc
Confidence 9999999999999999654 58999999999999999999996 35999999999999999998 999999
Q ss_pred CCccccccCCC---CCCCcCCCcccCcccccCCcCCC-----ccchhhHHHHHHHHHHhCCC------------CCCCCC
Q 023591 164 GYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDG-----KIADVWSCGVTLYVMLVGAY------------PFEDPE 223 (280)
Q Consensus 164 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~-----~~~DiwslG~~l~~l~~g~~------------p~~~~~ 223 (280)
|+|....+... .....||.+|+|||++.+..--. ++.||||+|.++|||++.-. ||...-
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 99976654433 33467999999999997654322 34799999999999998532 222110
Q ss_pred Cc-chHHHHHhhHhc--ccccCCC-CC--CCCHHHHHHHHHhcccCCCCcC
Q 023591 224 EP-KNFRKTIHRILS--VQYSIPD-YV--HISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 224 ~~-~~~~~~~~~~~~--~~~~~~~-~~--~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.. -.+.+....+.. .+..+++ |. .....+++.+..||..||+.|.
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARL 491 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARL 491 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhh
Confidence 00 111222222211 2222222 10 2335689999999999999999
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=230.39 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=192.9
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCC-----eEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 93 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 93 (280)
+.+-.+.||.|+||.||.+.+..+|+.|++|++..- -...+.+.+|+.+|+..+|.|++..+++..-.. .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 344467999999999999999999999999998653 233467889999999999999999988865432 467
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
+++|.+. .+|...+-.-..++...++-+++||+++|+|||+.+|.||||||.|.++.++.. +|++|||+++......
T Consensus 134 V~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhh
Confidence 8888884 477777766678999999999999999999999999999999999999987766 9999999998544332
Q ss_pred CC--CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHh------------------
Q 023591 174 QP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------------------ 233 (280)
Q Consensus 174 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------------ 233 (280)
.. -...-|..|.|||++.+..-++.+.||||.||++.||+..+..|.....-+.+.-+..
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 22 2234678899999999987777779999999999999999888876554222211111
Q ss_pred -hHhcccccCCCC---------CCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 234 -RILSVQYSIPDY---------VHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 234 -~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
.+.......|+. .....+..+++.++|..||++|. .|+|+.+
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 111111222211 12335678899999999999999 7777653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=249.75 Aligned_cols=239 Identities=29% Similarity=0.355 Sum_probs=187.1
Q ss_pred eeeecccccCCce-EEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEeccC
Q 023591 23 YELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYAS 100 (280)
Q Consensus 23 y~~~~~lg~G~~g-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (280)
|.-.+.+|.|+.| .||++.. .++.||+|.+-.. ..+.+.+|+..|+.- +|||||++++.-.++...|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 3445788999998 6788887 5889999987543 234567899999988 79999999999888899999999995
Q ss_pred CCchHHHHHhc-CC---CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC---CCCCcEEEeecCCccccccCC
Q 023591 101 GGELFERICNA-GR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 101 ~~~L~~~~~~~-~~---l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~---~~~~~~~l~df~~~~~~~~~~ 173 (280)
.+|.+++... .. ......+....|++.||++||+.+|+||||||.||+|+. ++..+++|.|||+++......
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 5999999763 11 122456788999999999999999999999999999986 566689999999998665554
Q ss_pred CC----CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhC-CCCCCCCCCcchHHHHHhhHhcccccCCCC-CC
Q 023591 174 QP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDY-VH 247 (280)
Q Consensus 174 ~~----~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 247 (280)
.. ....|+-+|.|||++........ .|||||||++|+.++| ..||...-. ....|....+.+-.- +.
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~a-vDiFslGCvfyYvltgG~HpFGd~~~------R~~NIl~~~~~L~~L~~~ 738 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQA-VDIFSLGCVFYYVLTGGSHPFGDSLE------RQANILTGNYTLVHLEPL 738 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcc-cchhhcCceEEEEecCCccCCCchHH------hhhhhhcCccceeeeccC
Confidence 43 34568999999999987776554 9999999999998885 899986422 222334443322110 01
Q ss_pred CCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 248 ISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
...+..+||.+|++++|..|| .||+|
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 112899999999999999999 99998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=220.11 Aligned_cols=255 Identities=23% Similarity=0.386 Sum_probs=196.8
Q ss_pred CCCCCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceE-Ee
Q 023591 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEV-IL 87 (280)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~ 87 (280)
|.-.++.+.-.+.|.+.+.||+|.||.+.+++++.++..+++|.++......+++.+|...--.| -|.||+.-+++ |.
T Consensus 13 ~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq 92 (378)
T KOG1345|consen 13 PMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ 92 (378)
T ss_pred ccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence 44455666667899999999999999999999999999999999999998999999998876666 58999987765 55
Q ss_pred cCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
..+.+.+++||++.|+|.+-+.. ..+-+...+.++.|++.||.|+|++++||||||.+||+|-.....++||+|||...
T Consensus 93 t~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 93 TSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred cCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccc
Confidence 66788899999999999887754 34788899999999999999999999999999999999966555589999999876
Q ss_pred ccccCCCCCCCcCCCcccCcccccCC---cC-CCccchhhHHHHHHHHHHhCCCCCCCCCCcc-hHHHHHhhHhcccccC
Q 023591 168 SSVLHSQPKSTVGTPAYIAPEVLLKK---EY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-NFRKTIHRILSVQYSI 242 (280)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~~---~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 242 (280)
..... -........|.+||..... .+ ..+.+|+|.||++++.+++|.+||......+ .+.+...=........
T Consensus 172 k~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 172 KVGTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred ccCce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 32211 1122234568889876432 21 1334899999999999999999998554322 2222222222222233
Q ss_pred CC-CCCCCHHHHHHHHHhcccCCCCc
Q 023591 243 PD-YVHISPECRHLISRIFVADPAKS 267 (280)
Q Consensus 243 ~~-~~~~~~~l~~li~~~l~~dp~~R 267 (280)
|. ...+++.+..+.++-|..+|++|
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCccccc
Confidence 32 34678999999999999999998
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=245.13 Aligned_cols=237 Identities=23% Similarity=0.344 Sum_probs=194.1
Q ss_pred eeeecccccCCceEEEEEEecCCCc----EEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
.+..++||+|+||+||++.+-..|+ +||||++.... +...++.+|...+.+++|||++++++++.... +.+|+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3446799999999999999876665 57777776543 33567889999999999999999999997654 88999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
+|+++|+|.++++.+ .++.......|..||++++.|||+++++||||-+.||++.+-.. +|+.|||+++........
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCccccc
Confidence 999999999999764 47999999999999999999999999999999999999998777 999999999865554443
Q ss_pred CCCc---CCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 176 KSTV---GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 176 ~~~~---~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
.... -.+-|+|-|.+....++.. +||||+|+++||++| |..||.....+ .+.+ ......+++..+..+-+
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~~-eI~d----lle~geRLsqPpiCtiD 928 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPAE-EIPD----LLEKGERLSQPPICTID 928 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCHH-HhhH----HHhccccCCCCCCccHH
Confidence 3322 3456899999988888777 999999999999998 99999875432 2222 22223335555579999
Q ss_pred HHHHHHHhcccCCCCcC
Q 023591 252 CRHLISRIFVADPAKSE 268 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp 268 (280)
+..++.+||-.|++.||
T Consensus 929 Vy~~mvkCwmid~~~rp 945 (1177)
T KOG1025|consen 929 VYMVMVKCWMIDADSRP 945 (1177)
T ss_pred HHHHHHHHhccCcccCc
Confidence 99999999999999999
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=245.36 Aligned_cols=243 Identities=25% Similarity=0.409 Sum_probs=193.6
Q ss_pred CCCCeeeecccccCCceEEEEEEec---C----CCcEEEEEEeeeCCc--ccHHHHHHHHHhhhC-CCCCeeeeceEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDK---K----TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 88 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~---~----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 88 (280)
..++.++.+.||+|.||.|+++.-. . ....||+|....... ..+.+..|+.+++.+ .|+|++.+++.+..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 3345567789999999999999743 1 145689998876433 346788899999998 69999999999998
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC
Q 023591 89 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~ 152 (280)
.+.+++|.||+..|+|..+++..+ .++...+..+++||+.+++||++..++||||-..||+++.
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 899999999999999999997655 3888999999999999999999999999999999999998
Q ss_pred CCCCcEEEeecCCccccccCCCCCC--Cc--CCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcch
Q 023591 153 SPAPRLKICDFGYSKSSVLHSQPKS--TV--GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (280)
Q Consensus 153 ~~~~~~~l~df~~~~~~~~~~~~~~--~~--~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (280)
+.. +|++|||+++.......... .. -...|+|||.+....++.+ +||||+|+++||+++ |..||..-.....
T Consensus 454 ~~~--~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 454 NKV--IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred CCE--EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 876 99999999984433222211 11 3445999999999777666 999999999999999 8899977332222
Q ss_pred HHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 228 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.... .....+......+++++.++++.||+.+|++||
T Consensus 531 ---l~~~-l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP 567 (609)
T KOG0200|consen 531 ---LLEF-LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRP 567 (609)
T ss_pred ---HHHH-HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCC
Confidence 2222 223333333336799999999999999999999
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=207.20 Aligned_cols=201 Identities=28% Similarity=0.422 Sum_probs=165.3
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC--CcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
+...-+..||+|++|.|-+.++..+|...|+|.+... ....++..+|+.+..+. .+|.+|.+++....+..+++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3444567899999999999999999999999998653 33345566777776655 79999999999888999999999
Q ss_pred ccCCCchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 98 YASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 98 ~~~~~~L~~~~----~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
.++ .||..+. .....+++..+-+++..++.||.+||+ ..++|||+||+||+++.+|. +|+||||.+-.....
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccceeehhh
Confidence 995 4776553 456789999999999999999999996 57999999999999999988 999999988755444
Q ss_pred CCCCCCcCCCcccCcccccC----CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc
Q 023591 173 SQPKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (280)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (280)
-......|...|+|||.+.. ..|+-+ +||||||+.+.||.+++.||.....+
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCCH
Confidence 33333567788999999753 345555 99999999999999999999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=243.36 Aligned_cols=252 Identities=30% Similarity=0.423 Sum_probs=210.2
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
.++|+.+..+|+|.||.||++++..+++..|+|+++.... ...-+..|+.+++..+|+||+.+++.+.....+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 4789999999999999999999999999999999987643 345577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-CCCCCC
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKS 177 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~-~~~~~~ 177 (280)
|.+|+|++.-.-.+++++.++...+++.+++|+|||+.|-+|||||-.||+++..|+ +|+.|||.+-.... -.....
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhhhc
Confidence 999999998888889999999999999999999999999999999999999999998 99999998753322 234466
Q ss_pred CcCCCcccCccccc---CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 178 TVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 178 ~~~~~~~~aPE~~~---~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
..|++.|+|||+.. .+.|... +|||++|+...|+-..+.|--....... ...+.+-......+.+...+++.+.+
T Consensus 172 fiGtpywmapEvaaverkggynql-cdiwa~gitAiel~eLqpplfdlhpmr~-l~LmTkS~~qpp~lkDk~kws~~fh~ 249 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQL-CDIWALGITAIELGELQPPLFDLHPMRA-LFLMTKSGFQPPTLKDKTKWSEFFHN 249 (829)
T ss_pred ccCCccccchhHHHHHhccccccc-ccccccccchhhhhhcCCcccccchHHH-HHHhhccCCCCCcccCCccchHHHHH
Confidence 78999999999863 3445444 9999999999999888877654333211 11222222233344455578999999
Q ss_pred HHHHhcccCCCCcC------CCccccc
Q 023591 255 LISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
|++.+|..+|.+|| .|||+.+
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeecc
Confidence 99999999999999 9999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-31 Score=210.42 Aligned_cols=196 Identities=44% Similarity=0.718 Sum_probs=171.2
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccC
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (280)
|.+.+.||+|++|.||++....+++.+++|.+..... ..+.+.+|++.+++++|+|++++++.+......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 6778999999999999999998899999999986543 35678889999999999999999999988889999999999
Q ss_pred CCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC--CCCC
Q 023591 101 GGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKS 177 (280)
Q Consensus 101 ~~~L~~~~~~~~~-l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~--~~~~ 177 (280)
+++|.+++..... +++..++.++.+++.++.+||+.+++|+|++|.||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL--VKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeCceeeEecCcccccccc
Confidence 9999999987666 899999999999999999999999999999999999988765 9999999887554432 2344
Q ss_pred CcCCCcccCcccc-cCCcCCCccchhhHHHHHHHHHHhCCCCCCC
Q 023591 178 TVGTPAYIAPEVL-LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (280)
Q Consensus 178 ~~~~~~~~aPE~~-~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (280)
..+...|++||.+ ....++. ++|+|+||+++++|++|..||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccc
Confidence 5567789999998 4455555 59999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-31 Score=205.87 Aligned_cols=201 Identities=45% Similarity=0.702 Sum_probs=174.5
Q ss_pred cccCCceEEEEEEecCCCcEEEEEEeeeCCcc--cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCchHH
Q 023591 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 106 (280)
Q Consensus 29 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 106 (280)
||+|.+|.||++....+++.+++|.+...... .+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999998876542 5678899999999999999999999998899999999999899999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC-CCCCcEEEeecCCccccccCC-CCCCCcCCCc
Q 023591 107 RICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPA 183 (280)
Q Consensus 107 ~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~-~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~ 183 (280)
++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++. ++|+||+.+....... ..........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc--EEEecCCceEEccCCcchhhcccCCCC
Confidence 98765 57899999999999999999999999999999999999997 555 9999999887443332 1333557788
Q ss_pred ccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccC
Q 023591 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263 (280)
Q Consensus 184 ~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 263 (280)
|.+||...........+|+|++|+++++| ..+.+++.+|++.|
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~ 201 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKD 201 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCC
Confidence 99999987762334449999999999998 46899999999999
Q ss_pred CCCcC
Q 023591 264 PAKSE 268 (280)
Q Consensus 264 p~~Rp 268 (280)
|++||
T Consensus 202 p~~R~ 206 (215)
T cd00180 202 PEKRP 206 (215)
T ss_pred cccCc
Confidence 99999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=220.72 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=196.9
Q ss_pred CCCeeeecccccCCceEEEEEEecC---CCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 95 (280)
.+.|..+.+||+|.|++||++.+.. .++.||+|.+..... -..+.+|+++|..+ .+.||+++.+.+..++...+|
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 3678999999999999999999887 788999999887543 35688999999998 789999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC--
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-- 173 (280)
+||++..+..++... ++...+..+++.++.||.++|.+||+||||||.|++.+.... +-.|.|||+|.......
T Consensus 114 lp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred ecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC-CceEEechhHHHHHhhhhh
Confidence 999998888887755 789999999999999999999999999999999999986655 57899999986110000
Q ss_pred ------------C--C-----------------------------CCCcCCCcccCcccccCCcCCCccchhhHHHHHHH
Q 023591 174 ------------Q--P-----------------------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210 (280)
Q Consensus 174 ------------~--~-----------------------------~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~ 210 (280)
. . ....||++|.|||++..-+-.+++.||||.|+++.
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L 269 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL 269 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence 0 0 01237899999999987776667799999999999
Q ss_pred HHHhCCCCCCCCCCcc-hHHHHH------------------------------------hhH-----hccc---ccCC-C
Q 023591 211 VMLVGAYPFEDPEEPK-NFRKTI------------------------------------HRI-----LSVQ---YSIP-D 244 (280)
Q Consensus 211 ~l~~g~~p~~~~~~~~-~~~~~~------------------------------------~~~-----~~~~---~~~~-~ 244 (280)
.++++..||-...++- ...++. ..+ .... .... .
T Consensus 270 slls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~ 349 (418)
T KOG1167|consen 270 SLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG 349 (418)
T ss_pred hhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence 9999999996544311 110000 000 0000 0000 0
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 245 YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
....+..+.+|+.+||..||.+|. .||||...
T Consensus 350 ~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 350 SDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 123456899999999999999999 99999754
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=202.05 Aligned_cols=240 Identities=18% Similarity=0.227 Sum_probs=188.5
Q ss_pred CCeeeecccccCCceEEEEEEecCC-----CcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecC-CeE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP-THL 92 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (280)
.|++....+.+|.||.||.+.+... .+.|.+|.++... .....+..|--++..+.|||+..+.++..++ ...
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 5677788899999999999976532 2345667665433 3334566677777778999999999987654 467
Q ss_pred EEEEeccCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 93 AIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~--------~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
++++.+.+-++|+.++.. .+.++..++..++.|++.|++|||+.|++|.||-+.|.+|++.-. +||+|-.
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq--VkltDsa 441 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ--VKLTDSA 441 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee--EEeccch
Confidence 888999999999999862 124778889999999999999999999999999999999987755 9999999
Q ss_pred CccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccc
Q 023591 165 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQY 240 (280)
Q Consensus 165 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
+++...+... .........|++||.+.+..++.. +|+||||+++|||++ |+.||..-++. .+.......+
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPf-----Em~~ylkdGy 515 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPF-----EMEHYLKDGY 515 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHH-----HHHHHHhccc
Confidence 8875444332 233445678999999999999776 999999999999998 89999765442 1222333444
Q ss_pred cCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 241 SIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
++.+.-++|+++..++.-||..+|++||
T Consensus 516 RlaQP~NCPDeLf~vMacCWallpeeRP 543 (563)
T KOG1024|consen 516 RLAQPFNCPDELFTVMACCWALLPEERP 543 (563)
T ss_pred eecCCCCCcHHHHHHHHHHHhcCcccCC
Confidence 4544448999999999999999999999
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-27 Score=197.56 Aligned_cols=245 Identities=24% Similarity=0.207 Sum_probs=187.3
Q ss_pred CeeeecccccCCceEEEEEEecCCC-cEEEEEEeeeCCccc-HHHHHHHHHhhhCC----CCCeeeeceEE-ecCCeEEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKID-ENVQREIINHRSLR----HPNIVRFKEVI-LTPTHLAI 94 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~-~~vaiK~~~~~~~~~-~~~~~e~~~l~~l~----h~~iv~~~~~~-~~~~~~~l 94 (280)
+|++.+.||+|+||.||.+.+..++ +.+|+|......... ..+..|..++..+. ..++..+++.+ ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999988764 578899877643222 26778888888886 36899999999 47778999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-C--CcEEEeecCCcc--
Q 023591 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-A--PRLKICDFGYSK-- 167 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~--~~~~l~df~~~~-- 167 (280)
||+.+ |.+|.++.... +.++..++..++.|++.+|++||+.|++||||||.|+.+.... . ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99998 77999988554 4799999999999999999999999999999999999997653 1 359999999998
Q ss_pred ccccCC--------C-CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc
Q 023591 168 SSVLHS--------Q-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238 (280)
Q Consensus 168 ~~~~~~--------~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 238 (280)
...... . .....||..|.++..+.+...... .|+|||++++.+++.|..||..........+........
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~ 256 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL 256 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence 321111 1 123348999999999988888666 999999999999999999997765433322222111111
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCcCC
Q 023591 239 QYSIPDYVHISPECRHLISRIFVADPAKSEM 269 (280)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp~ 269 (280)
... ......+.++.++...+-..+...+|.
T Consensus 257 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~Pd 286 (322)
T KOG1164|consen 257 LTD-RFGDLKPEEFAKILEYIDSLDYEDKPD 286 (322)
T ss_pred ccc-cccCCChHHHHHHHHHhhccCCcCCCC
Confidence 111 011134567778777777788888883
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=185.89 Aligned_cols=258 Identities=22% Similarity=0.250 Sum_probs=197.5
Q ss_pred CCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCC-CCeeeeceEEecCCe
Q 023591 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTH 91 (280)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~ 91 (280)
.++.....++|.++++||+|+||.+|.+..-.+|+.||||+-... .....+..|..+.+.|++ ..|..+.-++.+...
T Consensus 7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 345566779999999999999999999999999999999975443 334456778888888854 778888888888888
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC-CcEEEeecCCcccc
Q 023591 92 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSS 169 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~-~~~~l~df~~~~~~ 169 (280)
-.+||+.+ |.||.++..- ...++..++.-++-|++.-++|+|.++++||||||+|++..-+.. .++.|+|||++...
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999999 7799998753 346899999999999999999999999999999999999864443 25899999999755
Q ss_pred ccC--------CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccccc
Q 023591 170 VLH--------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241 (280)
Q Consensus 170 ~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
... .......||.+|.+--.+.+...+.. .|+-|+|+++.++--|.+||.+...... .+...++......
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk-~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATK-KQKYEKISEKKMS 242 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhhH-HHHHHHHHHhhcC
Confidence 433 33344568889998888777666666 8999999999999999999988654322 2223333333222
Q ss_pred CCC---CCCCCHHHHHHHHHhcccCCCCcCCCcccc
Q 023591 242 IPD---YVHISPECRHLISRIFVADPAKSEMHDWRR 274 (280)
Q Consensus 242 ~~~---~~~~~~~l~~li~~~l~~dp~~Rp~h~~~~ 274 (280)
.+. =.++|.++.-.+.-|=..-=++-|.|.|++
T Consensus 243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylr 278 (341)
T KOG1163|consen 243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLR 278 (341)
T ss_pred CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHH
Confidence 221 125678888888888777666666444443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=232.37 Aligned_cols=193 Identities=16% Similarity=0.204 Sum_probs=137.2
Q ss_pred CCC-CCeeeeceEE-------ecCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCC
Q 023591 74 LRH-PNIVRFKEVI-------LTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144 (280)
Q Consensus 74 l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~ 144 (280)
+.| .||+.+++.+ .....++.++|++ +++|.+++.. ...+++..++.+++||+.||+|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 445 4666677765 2234678888988 5699999965 3469999999999999999999999999999999
Q ss_pred CCcEEEeCCC-----------------CCcEEEeecCCccccccCC-----------------CCCCCcCCCcccCcccc
Q 023591 145 LENTLLDGSP-----------------APRLKICDFGYSKSSVLHS-----------------QPKSTVGTPAYIAPEVL 190 (280)
Q Consensus 145 ~~ni~i~~~~-----------------~~~~~l~df~~~~~~~~~~-----------------~~~~~~~~~~~~aPE~~ 190 (280)
|+||+++..+ ...+|++|||+++...... ......+++.|+|||.+
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 9999996432 2336777777765321100 00112467789999999
Q ss_pred cCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC--
Q 023591 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE-- 268 (280)
Q Consensus 191 ~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-- 268 (280)
.+..++.. +|||||||++|||++|..|+..... ........... +......+...+++.+||+.||.+||
T Consensus 188 ~~~~~~~~-sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 188 NGSSSNCA-SDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLP-----PQILLNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred ccCCCCch-hhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcC-----hhhhhcCHHHHHHHHHhCCCChhhCcCh
Confidence 88888655 9999999999999998888653211 11111111111 11011245678999999999999999
Q ss_pred ----CCccccc
Q 023591 269 ----MHDWRRG 275 (280)
Q Consensus 269 ----~h~~~~~ 275 (280)
.||||.+
T Consensus 260 ~eil~h~~~~~ 270 (793)
T PLN00181 260 SELLQSEFINE 270 (793)
T ss_pred HHHhhchhhhh
Confidence 9999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=186.70 Aligned_cols=204 Identities=24% Similarity=0.321 Sum_probs=175.1
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
...-.|++.++||+|.||+++.+.+--+++.||||+ .+......++..|....+.| ..++|..++.++....+-.+|+
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKf-EPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKF-EPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEe-ccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 345689999999999999999999999999999995 44455667888899999888 6799999999998888889999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC---CcEEEeecCCccccccC
Q 023591 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLH 172 (280)
Q Consensus 97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~---~~~~l~df~~~~~~~~~ 172 (280)
|++ |.||.++..- .+.|+..++..++.|++.-++++|++.+|+|||||+|++|...++ ..|.++|||+|+.+...
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 999 7899998865 456999999999999999999999999999999999999975443 24889999999755443
Q ss_pred CCC--------CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCC
Q 023591 173 SQP--------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (280)
Q Consensus 173 ~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 224 (280)
... ....||.+|++--.+.+...+.. .|+-+||.++.+.+-|.+||.+...
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccC
Confidence 333 44568999999999888888777 9999999999999999999988654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=180.66 Aligned_cols=158 Identities=21% Similarity=0.234 Sum_probs=118.8
Q ss_pred CchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcC
Q 023591 102 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (280)
Q Consensus 102 ~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 180 (280)
|+|.+++.. ...+++..++.++.|++.||.|||+.+ ||+||+++.++. +++ ||++...... ...+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc----cCCC
Confidence 588899876 456999999999999999999999998 999999988876 787 9987644322 2257
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchH-HHHHhhHhccccc-CCCCCCCCH--HHHHHH
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF-RKTIHRILSVQYS-IPDYVHISP--ECRHLI 256 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~--~l~~li 256 (280)
++.|+|||.+.+..++.+ +||||||+++|+|++|..||......... ............. .+....++. ++.++|
T Consensus 67 ~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred cccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999988887665 99999999999999999999765432222 2222221111110 011112333 699999
Q ss_pred HHhcccCCCCcC------CCcccc
Q 023591 257 SRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 257 ~~~l~~dp~~Rp------~h~~~~ 274 (280)
.+||+.||.+|| .|+|+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999 788765
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=188.91 Aligned_cols=160 Identities=16% Similarity=0.128 Sum_probs=124.2
Q ss_pred CCCeeeecccccCCceEEEEEEecC-CCcEEEEEEeeeC------CcccHHHHHHHHHhhhCCCCCeee-eceEEecCCe
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVR-FKEVILTPTH 91 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~ 91 (280)
.++|++.+.||+|+||+||++++.. +++.+|+|+.... ....+.+.+|++++++++|+|+++ +++. +.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 4789999999999999999999876 6777899986532 112356889999999999999985 4332 45
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCC-CCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl-~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
.++||||++|++|.. .. +.. ...++.+++++|.+||+.||+|||| ||+||+++.++. ++|+|||++....
T Consensus 93 ~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFGlA~~~~ 163 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQLASVFR 163 (365)
T ss_pred cEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECccceecc
Confidence 799999999988863 21 111 2467899999999999999999999 999999987766 9999999997543
Q ss_pred cCCCC---------CCCcCCCcccCcccccC
Q 023591 171 LHSQP---------KSTVGTPAYIAPEVLLK 192 (280)
Q Consensus 171 ~~~~~---------~~~~~~~~~~aPE~~~~ 192 (280)
..... ....+++.|.+||.+..
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 32211 12345677899998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=210.88 Aligned_cols=253 Identities=32% Similarity=0.530 Sum_probs=192.1
Q ss_pred CCe-eeecccccCCceEEEEEEecCCCcEEEEEEee----eCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 21 DRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIE----RGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 21 ~~y-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~----~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
+.| .....+|.|++|.|+.+......+.+..|.+. .... ....+..|+.+-..+.|+|++.......+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 446 45678899999988888877666656666543 1111 112244566666778999998877776665555
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
.-.||||++ +|..++.....++..++..+++|++.+++|+|+.|+.|+|+|++|++++.++. +|++|||.+......
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYP 473 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccC
Confidence 555999998 99999988778999999999999999999999999999999999999999987 999999987633322
Q ss_pred CC-----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc---cCCC
Q 023591 173 SQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY---SIPD 244 (280)
Q Consensus 173 ~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 244 (280)
.. .....++..|.|||.+.+..|++...||||.|+++..|.+|+.||......+.............. ..+.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL 553 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence 22 234568889999999999999999999999999999999999999876544332111100000000 1111
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 245 YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
...++...+.+|.+||++||.+|. +.+||+..
T Consensus 554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 554 LSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 235778899999999999999999 99999865
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-23 Score=175.58 Aligned_cols=242 Identities=37% Similarity=0.604 Sum_probs=189.5
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHHhhhCCCC-CeeeeceEEecCCeEEEEEe
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e 97 (280)
|.+.+.||.|+|+.||.+.+. ..+++|.+..... ....+.+|+..+..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999997 6689998876533 355788899999999888 79999999977777899999
Q ss_pred ccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-
Q 023591 98 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~- 173 (280)
++.++++.+.+.... .++......++.|++.++.++|+.+++|+|++|+||+++..+. .+++.|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence 999999997776664 7999999999999999999999999999999999999987762 38999999886333332
Q ss_pred ------CCCCCcCCCcccCcccccCC--cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccccc-C--
Q 023591 174 ------QPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-I-- 242 (280)
Q Consensus 174 ------~~~~~~~~~~~~aPE~~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~-- 242 (280)
......++..|.+||.+.+. .......|+|++|++++++++|..||...............+...... .
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 23566789999999999874 344444999999999999999999977655311112222222222211 1
Q ss_pred CCCCCC----CHHHHHHHHHhcccCCCCcC
Q 023591 243 PDYVHI----SPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 243 ~~~~~~----~~~l~~li~~~l~~dp~~Rp 268 (280)
...... ...+.+++..++..+|..|.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~ 267 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRL 267 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcC
Confidence 111111 25789999999999999998
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=175.98 Aligned_cols=232 Identities=21% Similarity=0.240 Sum_probs=148.0
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHHhhhCC----------CCCeeeeceEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLR----------HPNIVRFKEVI 86 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~----------h~~iv~~~~~~ 86 (280)
..+...+.||.|+++.||.+++..+++.+++|++..... ..+++++|......+. |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 456778899999999999999999999999999876432 2244555554444432 22344444443
Q ss_pred ecC------------C-----eEEEEEeccCCCchHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHhcCceecC
Q 023591 87 LTP------------T-----HLAIVMEYASGGELFERIC---NAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRD 142 (280)
Q Consensus 87 ~~~------------~-----~~~lv~e~~~~~~L~~~~~---~~~~----l~~~~~~~~~~~i~~~l~~Lh~~~i~h~d 142 (280)
... . +.+++|+-+ .++|.+++. .... +.......+..|+++.+++||..|++|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 311 1 236777777 458877753 2222 22233455668999999999999999999
Q ss_pred CCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcCCCcccCcccccCC-------cCCCccchhhHHHHHHHHHHhC
Q 023591 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-------EYDGKIADVWSCGVTLYVMLVG 215 (280)
Q Consensus 143 l~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~DiwslG~~l~~l~~g 215 (280)
|+|+|++++.+|. +.|+||+........... ...+..|.|||..... ...+.+.|.|+||+++|.|.++
T Consensus 171 i~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGG--VFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS---EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCC--EEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999988 999999876543332222 3445778999976432 1224448999999999999999
Q ss_pred CCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCc
Q 023591 216 AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKS 267 (280)
Q Consensus 216 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 267 (280)
..||........... .+..=.++|+.+++||+.+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~----------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW----------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG----------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc----------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999986543211111 111111588999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-26 Score=204.05 Aligned_cols=236 Identities=23% Similarity=0.368 Sum_probs=178.2
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHH--hhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIIN--HRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
.|...+.||++.|=+|.++++.+ |. |++|++-+.. ...+.+.++++- ...+++||.+++..+.+.+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 78999999999999999999864 44 8999986644 333444443333 344599999999998888888899999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC-
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~- 176 (280)
|... +|.|.+..++-+..-+.+.|+.|++.||..+|+.||+|||||.+||++++-.- +.|+||...++........
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech--hhhhcccccCCccCCCCCcc
Confidence 9954 99999988888999999999999999999999999999999999999997776 9999998776443332221
Q ss_pred -------CCcCCCcccCcccccCCc---------C-CCccchhhHHHHHHHHHHh-CCCCCCCCC-------CcchHHHH
Q 023591 177 -------STVGTPAYIAPEVLLKKE---------Y-DGKIADVWSCGVTLYVMLV-GAYPFEDPE-------EPKNFRKT 231 (280)
Q Consensus 177 -------~~~~~~~~~aPE~~~~~~---------~-~~~~~DiwslG~~l~~l~~-g~~p~~~~~-------~~~~~~~~ 231 (280)
+.....+|.|||.+.... + -.++-||||+||++.||++ |++||.... ........
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 223556899999875422 1 1334799999999999998 688885311 01111222
Q ss_pred HhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC-CCcccc
Q 023591 232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE-MHDWRR 274 (280)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-~h~~~~ 274 (280)
+.++ -+..++.+|..|++.||++|. ...|++
T Consensus 259 Le~I------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~ 290 (1431)
T KOG1240|consen 259 LEKI------------EDVSLRNLILSMIQRDPSKRLSAEDYLQ 290 (1431)
T ss_pred HHhC------------cCccHHHHHHHHHccCchhccCHHHHHH
Confidence 2221 235799999999999999999 444443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=164.94 Aligned_cols=137 Identities=20% Similarity=0.191 Sum_probs=109.0
Q ss_pred ecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc----------cH-----------------HHHHHHHHhhhCCCCC
Q 023591 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------DE-----------------NVQREIINHRSLRHPN 78 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----------~~-----------------~~~~e~~~l~~l~h~~ 78 (280)
...||+|++|.||++.+. +|+.||+|++...... .. ...+|+..+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 8999999999764211 01 1234889999998877
Q ss_pred eeeeceEEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCceecCCCCCcEEEeCCCCCc
Q 023591 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLLDGSPAPR 157 (280)
Q Consensus 79 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~L-h~~~i~h~dl~~~ni~i~~~~~~~ 157 (280)
+.....+... ..++||||++++++.........++...+..++.|++.+|.++ |+.|++|+||||+||+++. + +
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~--~ 155 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G--K 155 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--c
Confidence 7544443322 2389999999877765544556799999999999999999999 7999999999999999984 3 3
Q ss_pred EEEeecCCccc
Q 023591 158 LKICDFGYSKS 168 (280)
Q Consensus 158 ~~l~df~~~~~ 168 (280)
++|+|||++..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999998873
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=168.20 Aligned_cols=169 Identities=15% Similarity=0.170 Sum_probs=128.7
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHH----------HHHHHHHhhhCCCCCeeeeceEEecC
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----------VQREIINHRSLRHPNIVRFKEVILTP 89 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~----------~~~e~~~l~~l~h~~iv~~~~~~~~~ 89 (280)
.++|++.+.||.|+||.||++.. ++..+|+|.+.......+. +.+|+..+.++.|+++..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 47999999999999999999766 3667999999754333322 46888899999999999998886633
Q ss_pred --------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEe
Q 023591 90 --------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (280)
Q Consensus 90 --------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~ 161 (280)
...+++|||++|.+|.+... +++ ....+++.++..+|+.|++|||++|.||+++.++ ++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~li 176 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRII 176 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEE
Confidence 35789999999999987632 333 2456999999999999999999999999998766 8999
Q ss_pred ecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHH
Q 023591 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213 (280)
Q Consensus 162 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~ 213 (280)
|||........... ..+.....+. .++|+|+||+++..+.
T Consensus 177 Dfg~~~~~~e~~a~-----------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAK-----------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhH-----------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 99976533211100 1123344455 4599999999987553
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-26 Score=192.64 Aligned_cols=231 Identities=29% Similarity=0.514 Sum_probs=190.5
Q ss_pred ccccCCceEEEEEEec---CCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCC-CCCeeeeceEEecCCeEEEEEeccC
Q 023591 28 DIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYAS 100 (280)
Q Consensus 28 ~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (280)
.+|+|++|.|++++.. ..+..+++|+..+.. ........|..++...+ ||.+++++..+..+..++++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3789999999988743 456778898876532 11112334666666675 9999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcC
Q 023591 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (280)
Q Consensus 101 ~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 180 (280)
++.|...+.+...+++.....+...++-+++++|+.+++|+|+|++||+++.+|+ +++.|||+++........ ++
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~~---cg 155 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKIA---CG 155 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhhc---cc
Confidence 9999888888888999999999999999999999999999999999999999998 999999998744433322 88
Q ss_pred CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhc
Q 023591 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (280)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (280)
+..|+|||++. ..... .|.||+|+++++|++|..||.. ....++....+..|. ..+..+++++..++
T Consensus 156 t~eymApEI~~--gh~~a-~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~ 222 (612)
T KOG0603|consen 156 TYEYRAPEIIN--GHLSA-ADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMPR--ELSAEARSLFRQLF 222 (612)
T ss_pred chhhhhhHhhh--ccCCc-ccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCch--hhhHHHHHHHHHHH
Confidence 99999999987 22233 8999999999999999999987 355556655666665 68899999999999
Q ss_pred ccCCCCcC-----------CCcccccc
Q 023591 261 VADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 261 ~~dp~~Rp-----------~h~~~~~~ 276 (280)
..+|..|. +|+||++.
T Consensus 223 ~r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 223 KRNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred hhCHHHHhccCcchhHHHhccchheee
Confidence 99999998 88888753
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=167.78 Aligned_cols=239 Identities=22% Similarity=0.341 Sum_probs=187.7
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeee---CCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
++.++..+..+|.+...|+.|++++.++ .++.|++.. ......++..|.-.|+-+.||||+++++.+..+..+.+
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 3445667778899999999999999754 366676654 23444667788888888899999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 95 VMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
+..|++.++|...+.+... .+..+..+++.+++++++|||+.. |.---++...|+++++-+.++...|--++.
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--- 341 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--- 341 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---
Confidence 9999999999999976543 577889999999999999999875 444478899999999988777777743322
Q ss_pred cCCCCCCCcCCCcccCcccccCCcCC--CccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCC
Q 023591 171 LHSQPKSTVGTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (280)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (280)
......-.|.|++||.+...+.+ ..++|+|||++++|||.|...||......+.--++.- ......+|+ ++
T Consensus 342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial--eglrv~ipp--gi 414 (448)
T KOG0195|consen 342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL--EGLRVHIPP--GI 414 (448)
T ss_pred ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh--ccccccCCC--Cc
Confidence 22334457889999999876654 3458999999999999999999988766543332221 122334444 78
Q ss_pred CHHHHHHHHHhcccCCCCcC
Q 023591 249 SPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp 268 (280)
+..+..|+.-|++.||.+||
T Consensus 415 s~hm~klm~icmnedpgkrp 434 (448)
T KOG0195|consen 415 SRHMNKLMNICMNEDPGKRP 434 (448)
T ss_pred cHHHHHHHHHHhcCCCCcCC
Confidence 99999999999999999999
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=170.59 Aligned_cols=199 Identities=29% Similarity=0.428 Sum_probs=147.5
Q ss_pred CCCCeeeeceEEec---------------------------CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHH
Q 023591 75 RHPNIVRFKEVILT---------------------------PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127 (280)
Q Consensus 75 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~ 127 (280)
+|||||.+...|.+ ...+|+||...+. +|.+++..+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 59999998876532 2368999998854 999988543 357777788899999
Q ss_pred HHHHHHHhcCceecCCCCCcEEE--eCCCCCcEEEeecCCcccccc-------CCCCCCCcCCCcccCcccccCC-----
Q 023591 128 SGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVL-------HSQPKSTVGTPAYIAPEVLLKK----- 193 (280)
Q Consensus 128 ~~l~~Lh~~~i~h~dl~~~ni~i--~~~~~~~~~l~df~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~----- 193 (280)
+|+.|||++|+.|||+|.+||++ ++|+.+.+.+.|||++-.... ........|+...+|||+....
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999998 566667899999998742221 1112234467788999987532
Q ss_pred cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc-ccCCCCCCCCHHHHHHHHHhcccCCCCcC----
Q 023591 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISPECRHLISRIFVADPAKSE---- 268 (280)
Q Consensus 194 ~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---- 268 (280)
..+..++|.|+.|.+.||++....||....+....... +.+.+ ..+++ .+++.+++++..+|+.||++|+
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---Yqe~qLPalp~--~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---YQESQLPALPS--RVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhh---hhhhhCCCCcc--cCChHHHHHHHHHhcCCccccCCccH
Confidence 23455699999999999999999999874332111111 11111 23333 6899999999999999999999
Q ss_pred -----------CCcccccccCCC
Q 023591 269 -----------MHDWRRGCSVSC 280 (280)
Q Consensus 269 -----------~h~~~~~~~~~~ 280 (280)
+|.|+++....|
T Consensus 507 AANvl~LsLw~~~~~vka~~~~~ 529 (598)
T KOG4158|consen 507 AANVLNLSLWRMGEDVKAMMEKC 529 (598)
T ss_pred HHhHHHHHHhcCchHHHHhcccc
Confidence 788887655444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-23 Score=159.41 Aligned_cols=137 Identities=18% Similarity=0.146 Sum_probs=109.7
Q ss_pred ecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---------------------------cHHHHHHHHHhhhCCCCC
Q 023591 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------------------------DENVQREIINHRSLRHPN 78 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~~ 78 (280)
.+.||+|++|.||++.+. +|+.||+|++...... .....+|...+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 8999999998764211 112356888899999988
Q ss_pred eeeeceEEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCc
Q 023591 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPR 157 (280)
Q Consensus 79 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~ 157 (280)
+.....+.... .++||||++++++.........++......++.|++.++.++|+ .|++|+||+|+||+++ ++.
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~-- 155 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK-- 155 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC--
Confidence 76555444332 48999999887654433344568889999999999999999999 9999999999999998 554
Q ss_pred EEEeecCCccc
Q 023591 158 LKICDFGYSKS 168 (280)
Q Consensus 158 ~~l~df~~~~~ 168 (280)
++|+|||++..
T Consensus 156 ~~liDFG~a~~ 166 (190)
T cd05145 156 PYIIDVSQAVE 166 (190)
T ss_pred EEEEEccccee
Confidence 99999998874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-23 Score=187.54 Aligned_cols=195 Identities=24% Similarity=0.341 Sum_probs=159.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC---CCCeeeeceEEecCCeEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv 95 (280)
.+++|.|.+.||+|+||+||.|...+ |+.||||+-.+..-+.--+- .+++.+|+ -+.|..+...+...+...+|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~--~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC--LQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh--HHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 45789999999999999999999987 99999998766543332221 23333443 24567777777777888999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC-----CCCCcEEEeecCCccccc
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~-----~~~~~~~l~df~~~~~~~ 170 (280)
++|.+.|||.+++...+-+++..+..++.||+..+++||..+||||||||+|+++.. .+..-++|+|||.+....
T Consensus 773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 999999999999998888999999999999999999999999999999999999942 223349999999887554
Q ss_pred cCCCC---CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCC
Q 023591 171 LHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217 (280)
Q Consensus 171 ~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~ 217 (280)
..... ....++..|-++|...|..|+.. .|.|.++.+++.|+.|..
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHH
Confidence 43333 44567888999999999999877 999999999999999864
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-22 Score=152.45 Aligned_cols=185 Identities=17% Similarity=0.167 Sum_probs=136.5
Q ss_pred eeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccH-----HHHHHHHHhhhCC-CCCeeeeceEEecCCeEEEEEe
Q 023591 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-----NVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 24 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 97 (280)
.+...|++|+||+|+.+.. .+.+++.+.+.......+ .+.+|++++++|. ++++++++++ +..+++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999997766 577788887777665444 5788999999995 5889898886 34699999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCC-CCCcEEEeCCCCCcEEEeecCCccccccCCCC-
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl-~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~- 175 (280)
|+.|.+|.+.... ....++.|++.+|.++|+.|++|+|| +|+||+++.++. ++|+|||++.........
T Consensus 79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC--EEEEECCCceecCCcchHH
Confidence 9999888654321 12357889999999999999999999 799999987776 999999999744332210
Q ss_pred ---C----------CCcCCCcccCcccccC-CcCCCccchhhHHHHHHHHHHhCCCCCCCCC
Q 023591 176 ---K----------STVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (280)
Q Consensus 176 ---~----------~~~~~~~~~aPE~~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 223 (280)
. ....++.++.|+...- ...+-...+.++.|+.+|.++|+..++....
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0113555666654321 1122122688899999999999999887654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-23 Score=183.05 Aligned_cols=217 Identities=30% Similarity=0.517 Sum_probs=159.6
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
.+...+|..++.+..|+||-||.++++.+...+|+|. ++... +.+- ++.....|.+|
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc--cccccCCccee----------------
Confidence 3445789999999999999999999999999999953 33221 1110 12222222222
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC---
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~--- 173 (280)
|+=...++.-++++... +.+++|||+.||+|+|++|+|.+|+.-|. +|++|||+++......
T Consensus 136 -----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccch
Confidence 23344444445554443 78899999999999999999999998887 9999999986222111
Q ss_pred -------------CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc
Q 023591 174 -------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240 (280)
Q Consensus 174 -------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
.....+++|.|.|||++..+.|.-. .|.|++|+++|+.+-|..||...+.++.+..+... ..
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkp-vdwwamGiIlyeFLVgcvpffGdtpeelfg~visd----~i 275 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD----DI 275 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCC-ccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh----hc
Confidence 1123368999999999998888666 99999999999999999999987775554444332 22
Q ss_pred cCCC-CCCCCHHHHHHHHHhcccCCCCcC---------CCcccccc
Q 023591 241 SIPD-YVHISPECRHLISRIFVADPAKSE---------MHDWRRGC 276 (280)
Q Consensus 241 ~~~~-~~~~~~~l~~li~~~l~~dp~~Rp---------~h~~~~~~ 276 (280)
.++. ...++++++++|.++|+.+|..|. +|+||+..
T Consensus 276 ~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 276 EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred cccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 3322 235789999999999999999999 99999753
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.4e-21 Score=147.95 Aligned_cols=134 Identities=19% Similarity=0.243 Sum_probs=106.2
Q ss_pred eecccccCCceEEEEEEecCCCcEEEEEEeeeC-CcccHHHHHHHHHhhhC-----CCCCeeeeceEEecCC---eEE-E
Q 023591 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSL-----RHPNIVRFKEVILTPT---HLA-I 94 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~~~-l 94 (280)
-.+.||+|++|.||. +..++.. +||++... ....+.+.+|+..++.+ .||||++++++++++. .++ +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 357899999999995 6666665 69988764 22346788999999999 5799999999998864 333 7
Q ss_pred EEec--cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhcCceecCCCCCcEEEeCC--CCCcEEEeecC
Q 023591 95 VMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFG 164 (280)
Q Consensus 95 v~e~--~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l-~~Lh~~~i~h~dl~~~ni~i~~~--~~~~~~l~df~ 164 (280)
|+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++|+|+||||+||+++.. +..+++|+|++
T Consensus 83 I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 4478999999664 46655 35678888777 99999999999999999999853 33469999954
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.4e-21 Score=151.42 Aligned_cols=139 Identities=17% Similarity=0.103 Sum_probs=110.3
Q ss_pred CeeeecccccCCceEEEEEE-ecCCCcEEEEEEeeeCCcc-------------------------cHHHHHHHHHhhhCC
Q 023591 22 RYELVRDIGSGNFGVARLMR-DKKTEELVAVKYIERGDKI-------------------------DENVQREIINHRSLR 75 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~-~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~e~~~l~~l~ 75 (280)
-|++.+.||+|++|.||+|. +..+|+.||+|++...... ...+.+|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 6678999999998754210 012457999999886
Q ss_pred CCC--eeeeceEEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC-ceecCCCCCcEEEeC
Q 023591 76 HPN--IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-VCHRDLKLENTLLDG 152 (280)
Q Consensus 76 h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~-i~h~dl~~~ni~i~~ 152 (280)
+.+ +.++++. ...++||||+++.+|.........+....+..++.|++.++.+||+.| ++|+||+|+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 533 3333332 235899999999888665544456677778899999999999999999 99999999999998
Q ss_pred CCCCcEEEeecCCcc
Q 023591 153 SPAPRLKICDFGYSK 167 (280)
Q Consensus 153 ~~~~~~~l~df~~~~ 167 (280)
++. ++|+|||.+.
T Consensus 184 ~~~--i~LiDFg~a~ 196 (237)
T smart00090 184 DGK--VVIIDVSQSV 196 (237)
T ss_pred CCC--EEEEEChhhh
Confidence 444 9999999766
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.6e-20 Score=158.02 Aligned_cols=196 Identities=24% Similarity=0.333 Sum_probs=152.0
Q ss_pred hhhCCCCCeeeeceEEecCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCc-eecCCCCCcE
Q 023591 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQV-CHRDLKLENT 148 (280)
Q Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i-~h~dl~~~ni 148 (280)
++.+.|.|+.++++.+.++...+.|.+||..|+|.+.+.. ...++......++++|+.+|+|||...| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4568999999999999999999999999999999999977 4578999999999999999999999877 9999999999
Q ss_pred EEeCCCCCcEEEeecCCccccccC---CCCCCCcCCCcccCcccccCCcC------CCccchhhHHHHHHHHHHhCCCCC
Q 023591 149 LLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEY------DGKIADVWSCGVTLYVMLVGAYPF 219 (280)
Q Consensus 149 ~i~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~------~~~~~DiwslG~~l~~l~~g~~p~ 219 (280)
+++.... +|++|||+....... ...........|.|||.+..... .+.+.|+||+|++++|+++...||
T Consensus 81 lvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 81 LVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred eeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9998887 999999987644321 11111224456999999876422 244489999999999999999999
Q ss_pred CCCCCcchHHHHHhhHhc-cc----ccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 220 EDPEEPKNFRKTIHRILS-VQ----YSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..........++...+.. .. .........++++..++++||..+|..||
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rP 212 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRP 212 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCc
Confidence 876544332333333322 11 11111224566899999999999999999
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-19 Score=142.15 Aligned_cols=133 Identities=23% Similarity=0.210 Sum_probs=110.2
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---------cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
+.||+|++|.||++.. .+..+++|........ .....+|+.++..+.|+++.....++......+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999987 5667899976532211 1346678999999999998877777767778899999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|+|++|.||+++ ++. ++++|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~--~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGK--IYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCC--EEEEECCcccC
Confidence 9999999998865332 8889999999999999999999999999999998 444 99999998763
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.4e-19 Score=137.18 Aligned_cols=129 Identities=21% Similarity=0.178 Sum_probs=103.4
Q ss_pred ccccCCceEEEEEEecCCCcEEEEEEeeeCCc---------ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 28 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
.||+|++|.||++.. ++..+++|....... ..+++.+|+.+++.+.++++.....++..+...+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999985 467789998653211 114466899999999888766655555566677899999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ ++. ++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~--~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDK--LYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCc--EEEEECCCCcC
Confidence 999999887754321 7899999999999999999999999999998 444 99999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.2e-21 Score=168.52 Aligned_cols=255 Identities=31% Similarity=0.503 Sum_probs=200.3
Q ss_pred CCCCeeeecccccCCceEEEEEEecCC-CcEEEEEEeeeCC---cccHHHHHHHHHhhhCC-CCCeeeeceEEecCCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~-~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 93 (280)
....|.+.+.||+|+++.|-.+....+ ...+|.|.+.... ...+.+..|..+.+.+. |.|++.+++...+....+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 357899999999999999988887543 4456666655432 33344555777777775 999999999999999999
Q ss_pred EEEeccCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 94 IVMEYASGGELFERI-CNAG-RFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 94 lv~e~~~~~~L~~~~-~~~~-~l~~~~~~~~~~~i~~~l~~Lh-~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
+.+++..++++.+.+ .... ..+......++.|+..++.|+| ..++.|+|++|+|.+++..+. .+++.|||+|....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYR 176 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhcccc
Confidence 999999999998877 5444 6788889999999999999999 999999999999999998883 39999999997554
Q ss_pred c-CCC---CCCCcC-CCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCC
Q 023591 171 L-HSQ---PKSTVG-TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245 (280)
Q Consensus 171 ~-~~~---~~~~~~-~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (280)
. .+. .....+ ++.|.|||...+..+..+..|+||.|+++..+++|..|+............+.... .......+
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 255 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-GRFTQLPW 255 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-cccccCcc
Confidence 4 222 233456 99999999998877777779999999999999999999987655432221111111 22234445
Q ss_pred CCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 246 VHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
...+....+++.+++..+|..|. .+||+..
T Consensus 256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccCChhhhhcccccccCCchhccccccccccccccc
Confidence 57889999999999999999999 8888865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9e-19 Score=136.51 Aligned_cols=133 Identities=22% Similarity=0.253 Sum_probs=104.5
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc-----------------------cHHHHHHHHHhhhCCCCC
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-----------------------DENVQREIINHRSLRHPN 78 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----------------------~~~~~~e~~~l~~l~h~~ 78 (280)
.|.+.+.||+|++|.||++... +++.+|+|++..+... .....+|+..+..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888999999999999999875 7899999987653210 112456888888887764
Q ss_pred --eeeeceEEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCC
Q 023591 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (280)
Q Consensus 79 --iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~ 156 (280)
++.+++ ....+++|||+++++|..... ......++.+++.++.++|+.|++|+||+|.||+++.++.
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~- 163 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK- 163 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc-
Confidence 333333 234589999999988876532 1456778899999999999999999999999999987766
Q ss_pred cEEEeecCCcc
Q 023591 157 RLKICDFGYSK 167 (280)
Q Consensus 157 ~~~l~df~~~~ 167 (280)
++|+|||.+.
T Consensus 164 -~~liDfg~~~ 173 (198)
T cd05144 164 -IYIIDWPQMV 173 (198)
T ss_pred -EEEEECCccc
Confidence 9999999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.2e-18 Score=152.46 Aligned_cols=134 Identities=21% Similarity=0.172 Sum_probs=107.1
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeee-CC--------cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-GD--------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~-~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
.|...+.||+|+||+||++...... +++|.... .. ...+.+.+|++++++++|++++.+..+...+...
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3456789999999999999875433 44443221 11 1124577899999999999998887777777778
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
++||||+++++|.+++. ....++.+++.+|.+||+.|++|||++|+||+++ ++. ++|+|||++..
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~~--~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DDR--LYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CCc--EEEEeCccccc
Confidence 99999999999998874 4567899999999999999999999999999994 444 99999998873
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-19 Score=151.99 Aligned_cols=169 Identities=25% Similarity=0.349 Sum_probs=126.1
Q ss_pred eEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 91 HLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
++++.|++|...+|.+.+.... ..+......++.|++.+++| +|.+|+|++|.||+...+.. ++++|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhhee
Confidence 5789999999999999996543 36777899999999999999 99999999999999988886 9999999986
Q ss_pred ccccCC-------CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhccc
Q 023591 168 SSVLHS-------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQ 239 (280)
Q Consensus 168 ~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 239 (280)
...... ......++..|++||.+.+..|..+ +|||+||.+++||+. =..++.. ......+..+.
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~~f~T~~er-------~~t~~d~r~g~ 476 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLIQFSTQFER-------IATLTDIRDGI 476 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHHHhccHHHH-------HHhhhhhhcCC
Confidence 444433 2233458999999999999999777 999999999999987 2222211 11122222222
Q ss_pred ccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 240 YSIPDYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
++......+ ++-.+|+.+||...|.+|| .|+|+
T Consensus 477 ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 477 IPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred CChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 210011122 4456999999999999999 66664
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-16 Score=127.96 Aligned_cols=132 Identities=20% Similarity=0.240 Sum_probs=101.2
Q ss_pred cccc-cCCceEEEEEEecCCCcEEEEEEeeeCC--------------cccHHHHHHHHHhhhCCCCCe--eeeceEEecC
Q 023591 27 RDIG-SGNFGVARLMRDKKTEELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNI--VRFKEVILTP 89 (280)
Q Consensus 27 ~~lg-~G~~g~v~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~ 89 (280)
..|| .|+.|+||.+... +..+++|.+.... .....+.+|+.++.++.|+++ +.++++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 8888999998874 6678999885421 122457789999999988775 5666654332
Q ss_pred C----eEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 90 T----HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 90 ~----~~~lv~e~~~~-~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
. ..++|||++++ .+|.+++.. .++++.. +.+++.+|.+||+.||+|+||+|.||+++.++. ++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEECC
Confidence 2 23599999987 688888754 3455543 578999999999999999999999999987765 9999999
Q ss_pred Ccc
Q 023591 165 YSK 167 (280)
Q Consensus 165 ~~~ 167 (280)
.+.
T Consensus 188 ~~~ 190 (239)
T PRK01723 188 RGE 190 (239)
T ss_pred Ccc
Confidence 776
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=127.66 Aligned_cols=133 Identities=22% Similarity=0.272 Sum_probs=93.8
Q ss_pred ecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHH-------------------------HHHHHHhhhCCCCC--
Q 023591 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV-------------------------QREIINHRSLRHPN-- 78 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-------------------------~~e~~~l~~l~h~~-- 78 (280)
.+.||+|++|.||++.+. +++.||+|++.......... ..|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999986 78899999987643221111 23444555543332
Q ss_pred eeeeceEEecCCeEEEEEeccCCCchHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCC
Q 023591 79 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAP 156 (280)
Q Consensus 79 iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~ 156 (280)
+.++++. ...+++|||++++++.. .+... .. ......++.+++.++.++|. .|++|+||+|+||+++ ++.
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~- 152 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK- 152 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc-
Confidence 3333332 23589999998843321 11111 01 16788999999999999999 9999999999999999 555
Q ss_pred cEEEeecCCccc
Q 023591 157 RLKICDFGYSKS 168 (280)
Q Consensus 157 ~~~l~df~~~~~ 168 (280)
++++|||.+..
T Consensus 153 -~~liDfg~a~~ 163 (187)
T cd05119 153 -VYIIDVPQAVE 163 (187)
T ss_pred -EEEEECccccc
Confidence 99999998763
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=119.01 Aligned_cols=131 Identities=24% Similarity=0.276 Sum_probs=109.6
Q ss_pred eecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCC--CCeeeeceEEecCCeEEEEEeccCCC
Q 023591 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGG 102 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (280)
+++.||+|.++.||++...+ ..+++|....... ...+.+|+..++.+++ .++++++.+....+..++++||+++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 46789999999999999854 6789998866544 5678889999999976 58888888887777899999999887
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---CceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 103 ~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~---~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
++..+ +......++.+++.+++.+|.. +++|+|++|.||+++..+. +++.||+.+.
T Consensus 79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~--~~l~Df~~~~ 137 (155)
T cd05120 79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI--LGIIDWEYAG 137 (155)
T ss_pred ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE--EEEEeccccc
Confidence 76543 5567778899999999999985 6999999999999987555 9999999766
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-15 Score=132.24 Aligned_cols=167 Identities=19% Similarity=0.270 Sum_probs=130.4
Q ss_pred EEEecCCCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCchHHHHHhcCCCCHH
Q 023591 39 LMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 117 (280)
Q Consensus 39 ~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~ 117 (280)
.+..+.++.+|.+........ ..+.+.+.++.++.++||||+++++.++.+...|+|+|.+. .|..++++ +...
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---l~~~ 104 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---LGKE 104 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---hHHH
Confidence 355566788888887766543 33557788899999999999999999999999999999884 57777765 4578
Q ss_pred HHHHHHHHHHHHHHHHH-hcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-CCCCcCCCcccCcccccCCcC
Q 023591 118 EARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEY 195 (280)
Q Consensus 118 ~~~~~~~~i~~~l~~Lh-~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~ 195 (280)
.+...++||+.||.+|| +.+++|++|....|+++..|. .||++|.++........ .......-.|..|+.+....+
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~ 182 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEW 182 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCcccc
Confidence 89999999999999997 688999999999999999998 99999998764433332 122222334666776533332
Q ss_pred CCccchhhHHHHHHHHHHhC
Q 023591 196 DGKIADVWSCGVTLYVMLVG 215 (280)
Q Consensus 196 ~~~~~DiwslG~~l~~l~~g 215 (280)
..|.|.||+++++++.|
T Consensus 183 ---s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 ---SIDSWGLGCLIEELFNG 199 (690)
T ss_pred ---chhhhhHHHHHHHHhCc
Confidence 26999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.8e-15 Score=119.69 Aligned_cols=195 Identities=18% Similarity=0.273 Sum_probs=136.2
Q ss_pred HHhhhCCCCCeeeeceEEecC-----CeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC--
Q 023591 69 INHRSLRHPNIVRFKEVILTP-----THLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ-- 137 (280)
Q Consensus 69 ~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~~-- 137 (280)
..+.++-|.|+|+++.++.+. ....++.||+..|++.+++++. ..+......+|+.||+.||.|||+..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 455566899999999988653 3578999999999999998654 35889999999999999999999876
Q ss_pred ceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-----CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHH
Q 023591 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212 (280)
Q Consensus 138 i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l 212 (280)
++|+++.-+.|++..++- +|++.-.......... ......+-+.|.+||.=........ +|||++|++..+|
T Consensus 199 iihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAlem 275 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALEM 275 (458)
T ss_pred cccCCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHHHH
Confidence 999999999999997775 6655322111000000 1122335678999997655555555 9999999999999
Q ss_pred HhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccc
Q 023591 213 LVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 213 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~ 274 (280)
..+..--............. ....+.+. .+.-++++..||+..|+.|| .||-+-
T Consensus 276 ailEiq~tnseS~~~~ee~i---a~~i~~le-----n~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENI---ANVIIGLE-----NGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred HHheeccCCCcceeehhhhh---hhheeecc-----CccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 98876543332221111111 11111111 23457899999999999999 787653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.7e-15 Score=126.66 Aligned_cols=242 Identities=20% Similarity=0.192 Sum_probs=181.4
Q ss_pred CCeeeeccccc--CCceEEEEEEe--cCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeE
Q 023591 21 DRYELVRDIGS--GNFGVARLMRD--KKTEELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 21 ~~y~~~~~lg~--G~~g~v~~~~~--~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 92 (280)
..+.+.+.+|. |.+|.+|.+.. ..++..+|+|.-+.. ......-.+|+.....+ .|+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 46677888999 99999999998 788899999985432 22233345666666666 589999988888888999
Q ss_pred EEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhcCceecCCCCCcEEEeCC-CCCcEEEeecCCc
Q 023591 93 AIVMEYASGGELFERICNAGR-FSEDEARFFFQQLIS----GVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYS 166 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~----~l~~Lh~~~i~h~dl~~~ni~i~~~-~~~~~~l~df~~~ 166 (280)
++-+|.+. .+|..+...-.. +++..++..+.+... ||.++|..+++|-|++|.||+...+ .. ++++||++.
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s--~~~~df~~v 270 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTS--CKLTDFGLV 270 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccce--eecCCccee
Confidence 99999995 588777755444 899999999999999 9999999999999999999999888 54 899999988
Q ss_pred cccccCCCCC------CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCC--CCcchHHHHHhhHhcc
Q 023591 167 KSSVLHSQPK------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP--EEPKNFRKTIHRILSV 238 (280)
Q Consensus 167 ~~~~~~~~~~------~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~ 238 (280)
.....+.... ...+...|++||...+ .+ ...+|++++|.++.+-.++..++... .......... .+.
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~-~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---ip~ 345 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LA-TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---IPL 345 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhcc-cc-chHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---Cch
Confidence 7555544322 2256778999998633 33 44489999999999998887766554 2222222111 111
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccc
Q 023591 239 QYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~ 274 (280)
++ -...+.++...+.+|++.+|-.|+ .|+++.
T Consensus 346 e~----~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 346 EF----CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred hh----hcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 11 114567788899999999999999 666654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.3e-13 Score=105.53 Aligned_cols=136 Identities=15% Similarity=0.169 Sum_probs=97.4
Q ss_pred ecccccCCceEEEEEEecC------CCcEEEEEEeeeC-------------C----------cccHHH----HHHHHHhh
Q 023591 26 VRDIGSGNFGVARLMRDKK------TEELVAVKYIERG-------------D----------KIDENV----QREIINHR 72 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~------~~~~vaiK~~~~~-------------~----------~~~~~~----~~e~~~l~ 72 (280)
...||.|.-+.||.+.... .+..+|+|+...+ + .....+ ++|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998653 3578999987531 0 011122 37888988
Q ss_pred hCCC--CCeeeeceEEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCceecCCCCCcEE
Q 023591 73 SLRH--PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTL 149 (280)
Q Consensus 73 ~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~L-h~~~i~h~dl~~~ni~ 149 (280)
++.. -++..++++ ...++||||+.+..+..-.-+...+++.....+..+++.++..+ |+.|++||||++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8844 345555554 35689999997643321111223456667788889999999998 8999999999999999
Q ss_pred EeCCCCCcEEEeecCCccc
Q 023591 150 LDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 150 i~~~~~~~~~l~df~~~~~ 168 (280)
++. +. +.++||+.+..
T Consensus 158 ~~~-~~--v~iIDF~qav~ 173 (197)
T cd05146 158 WHD-GK--VWFIDVSQSVE 173 (197)
T ss_pred EEC-Cc--EEEEECCCcee
Confidence 974 33 99999997763
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.5e-14 Score=107.87 Aligned_cols=127 Identities=20% Similarity=0.247 Sum_probs=95.1
Q ss_pred ecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCee-eeceEEecCCeEEEEEeccCCCch
Q 023591 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYASGGEL 104 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~L 104 (280)
++.|+.|.++.||+++.. +..+++|.............+|+..++.+.+.+++ +++... ....++|||+++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467889999999999874 67799998766543334567889999888655544 444443 3345799999999877
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCc-----eecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQV-----CHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 105 ~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i-----~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
.+. ......++.+++++|+.||+.++ +|+|++|.||+++ ++. ++++||+.+.
T Consensus 79 ~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~--~~liDf~~a~ 135 (170)
T cd05151 79 LTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGR--LWLIDWEYAG 135 (170)
T ss_pred ccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCe--EEEEeccccc
Confidence 543 01123456789999999999885 9999999999998 443 8999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.5e-14 Score=130.91 Aligned_cols=252 Identities=26% Similarity=0.364 Sum_probs=188.1
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccH----HHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----NVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
...+.+.+.+-+.+|.++.++.+.-..++...++|+......... .+..+-.++....+|-++.....+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 466888999999999999999999888887777776554332221 1222222222223344444333333456789
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc---
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--- 170 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~--- 170 (280)
|+++|.++++|...+.+.+..+.+-....+..+..++++||...+.|+|++|.|.+...++. .++.||+......
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCcccccccccccc
Confidence 99999999999999988888888888899999999999999999999999999999988887 8888887321000
Q ss_pred -------------------------cC----CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCC
Q 023591 171 -------------------------LH----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (280)
Q Consensus 171 -------------------------~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (280)
.. .......+++.|.+||.+.+...... +|.|+.|.++++.++|..||..
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCC
Confidence 00 00122347889999999988888666 8999999999999999999988
Q ss_pred CCCcchHHHHHhhHhcccccCCC-CCCCCHHHHHHHHHhcccCCCCcC---------CCcccccc
Q 023591 222 PEEPKNFRKTIHRILSVQYSIPD-YVHISPECRHLISRIFVADPAKSE---------MHDWRRGC 276 (280)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rp---------~h~~~~~~ 276 (280)
..... +.+.+......++. ....+.+.++++...|..+|.+|. .||||+..
T Consensus 1038 ~tpq~----~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1038 ETPQQ----IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred cchhh----hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 66543 44555555555554 235788999999999999999999 89999754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.1e-13 Score=116.99 Aligned_cols=137 Identities=18% Similarity=0.186 Sum_probs=93.2
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCCccc-------------------------------H----------HHH
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-------------------------------E----------NVQ 65 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-------------------------------~----------~~~ 65 (280)
+.||+|++|.||+|+.. +|+.||||+.++.-... + ++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999875 68999999986531000 0 122
Q ss_pred HHHHHhhhC----CCCCeeeeceEEe-cCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhcCc
Q 023591 66 REIINHRSL----RHPNIVRFKEVIL-TPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLIS-GVSYCHSMQV 138 (280)
Q Consensus 66 ~e~~~l~~l----~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~-~l~~Lh~~~i 138 (280)
+|...+.++ ++.+-+.+-.++. ..+..+++|||++|.+|.+..... ...+ ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 344444333 2333333333332 234578999999999998876432 1222 3345555555 4778999999
Q ss_pred eecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 139 ~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
+|+|++|.||+++.++. ++++|||++...
T Consensus 279 ~H~D~hPgNilv~~~g~--i~liDfG~~~~l 307 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGK--IIALDFGIVGRL 307 (437)
T ss_pred eeCCCCcccEEECCCCc--EEEEeCCCeeEC
Confidence 99999999999987776 999999988644
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.6e-14 Score=122.03 Aligned_cols=141 Identities=23% Similarity=0.332 Sum_probs=94.9
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc-----------------------------------cH---
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-----------------------------------DE--- 62 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----------------------------------~~--- 62 (280)
..|.. +.||+|++|.|++|+...+|+.||||+.++.-.. .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 7899999999999999888999999998754100 01
Q ss_pred ---HHHHHHHHhhhC----CCCCeeeeceEEec-CCeEEEEEeccCCCchHHHH--HhcC----CCCHHHHHHHHHHHHH
Q 023591 63 ---NVQREIINHRSL----RHPNIVRFKEVILT-PTHLAIVMEYASGGELFERI--CNAG----RFSEDEARFFFQQLIS 128 (280)
Q Consensus 63 ---~~~~e~~~l~~l----~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~~--~~~~----~l~~~~~~~~~~~i~~ 128 (280)
++.+|...+.++ .+.+.+.+-.++.+ ....++||||++|+++.+.. ...+ .+.+..+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 122333333333 24444444444433 34578999999999997742 2222 234444444555554
Q ss_pred HHHHHHhcCceecCCCCCcEEEeCCC--CCcEEEeecCCcccc
Q 023591 129 GVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSS 169 (280)
Q Consensus 129 ~l~~Lh~~~i~h~dl~~~ni~i~~~~--~~~~~l~df~~~~~~ 169 (280)
..|++|+|++|.||+++.++ .+++++.|||++...
T Consensus 278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 58999999999999998776 234999999987633
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.45 E-value=7e-12 Score=106.22 Aligned_cols=204 Identities=18% Similarity=0.224 Sum_probs=144.3
Q ss_pred CceEEEEEEecCCCcEEEEEEeeeCCcccH-HHHHHHHHhhhCCCCCeeeeceEEec----CCeEEEEEeccCC-CchHH
Q 023591 33 NFGVARLMRDKKTEELVAVKYIERGDKIDE-NVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEYASG-GELFE 106 (280)
Q Consensus 33 ~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~-~~L~~ 106 (280)
...+.|++....+|..|++|.++-...... ..-.-+++++++.|.|+|++.+++.. +..+++|++|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 345889999999999999999954332222 33456889999999999999998873 5689999999875 56665
Q ss_pred HHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 107 RICN---------------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 107 ~~~~---------------~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
+.-. +...+++.+|.++.|+..||.++|+.|+..+-|.+.+|+++.+. ++++...|.......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQE 445 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecC
Confidence 5421 22368899999999999999999999999999999999998655 588887665442222
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
.. . |.+.. ..+-|.-.||.++..|.+|..--...+..... ..+.+.. .+|.+
T Consensus 446 d~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~~~~I~~---------~yS~D 497 (655)
T KOG3741|consen 446 DP-----------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS--HLTRITT---------TYSTD 497 (655)
T ss_pred CC-----------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHH--HHHHhhh---------hhhHH
Confidence 11 0 11111 22379999999999999986432211111111 1112111 47888
Q ss_pred HHHHHHHhcccCCCC
Q 023591 252 CRHLISRIFVADPAK 266 (280)
Q Consensus 252 l~~li~~~l~~dp~~ 266 (280)
++++|.-+...++++
T Consensus 498 ~rn~v~yl~s~~~~~ 512 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE 512 (655)
T ss_pred HHHHHHHHHhcCccc
Confidence 999999888888883
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=4e-12 Score=94.41 Aligned_cols=129 Identities=23% Similarity=0.213 Sum_probs=98.4
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeee----CCccc-----HHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER----GDKID-----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~----~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
..+.+|+-+.++.+... |..+++|.-.+ .+..+ ++-.+|..++.++.-..+....-+..+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 45788999999998663 44467775322 11222 234578888888876676666666667788899999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
|.+|..|.+.+... ...+++.+-..+.-||..||+||||.++|+++..+. +.++|||++.
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCccc
Confidence 99998888888654 255677788888889999999999999999998655 8999999876
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.8e-12 Score=94.92 Aligned_cols=141 Identities=16% Similarity=0.105 Sum_probs=107.5
Q ss_pred eecccccCCceEEEEEEecCCCcEEEEEEeeeC---------CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
....+.+|+-+.|+++.. .|+.++||.-... +-...+-++|...+.++.--.|.-..-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 466788999999999987 4777788864321 12224566788888888666776666667777778999
Q ss_pred EeccCC-CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCC-cEEEeecCCcc
Q 023591 96 MEYASG-GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSK 167 (280)
Q Consensus 96 ~e~~~~-~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~-~~~l~df~~~~ 167 (280)
|||.+| .++.+++.... .........++++|-+.+.-||..+++||||.++||++.++++. .+.++|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999976 47788775532 33444457899999999999999999999999999999877653 25899999876
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.1e-13 Score=113.58 Aligned_cols=239 Identities=20% Similarity=0.188 Sum_probs=167.7
Q ss_pred CCCCCeeeecccccCCceEEEEEEec-CCCcEEEEEEeeeCCccc-H--HHHHHHHHhhhC-CCCCeeeeceEEecCCeE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGDKID-E--NVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~-~--~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 92 (280)
....+|..+..||.|.|+.|+.+... .++..|++|-..+.-... . .-..|+.+...+ .|.+.+.....+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34568899999999999999887765 677888888776532111 1 123455555555 588888888887777777
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
++--||+.++++.....-...+++...+++..|++.++.++|+..++|+|++|+||++..++ ...+++||+.... ..
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~--~~ 418 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTR--LA 418 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccc--cc
Confidence 89999999888866654444588899999999999999999999999999999999998764 2378999997764 11
Q ss_pred CCCCCCcCCCccc-CcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 173 SQPKSTVGTPAYI-APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 173 ~~~~~~~~~~~~~-aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
...........+. ..|++........+.|++|||..+.+..++...-...... . .+.... .+...+.+.+
T Consensus 419 ~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~----~i~~~~--~p~~~~~~~~ 489 (524)
T KOG0601|consen 419 FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---L----TIRSGD--TPNLPGLKLQ 489 (524)
T ss_pred eecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---e----eeeccc--ccCCCchHHh
Confidence 1222222333344 2455544444455599999999999999887554433221 1 111111 1221234578
Q ss_pred HHHHHHHhcccCCCCcC
Q 023591 252 CRHLISRIFVADPAKSE 268 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp 268 (280)
+..+...++..++..||
T Consensus 490 ~q~~~kv~~~~~~~~~~ 506 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRP 506 (524)
T ss_pred hhhhhhhhcCCccccch
Confidence 88889999999999998
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.35 E-value=5e-11 Score=96.37 Aligned_cols=130 Identities=13% Similarity=0.042 Sum_probs=94.0
Q ss_pred EEEEEEecCCCcEEEEEEeeeCC------------cccHHHHHHHHHhhhCCCCCee--eeceEEec-----CCeEEEEE
Q 023591 36 VARLMRDKKTEELVAVKYIERGD------------KIDENVQREIINHRSLRHPNIV--RFKEVILT-----PTHLAIVM 96 (280)
Q Consensus 36 ~v~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv--~~~~~~~~-----~~~~~lv~ 96 (280)
.|+++.. .|+.+.+|...... .....+.+|...+.++...+|. .++++++. ....++||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555544 46678999664322 1111467888888888544433 34555543 23578999
Q ss_pred eccCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC-----CCCCcEEEeecCCcc
Q 023591 97 EYASGG-ELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSK 167 (280)
Q Consensus 97 e~~~~~-~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~-----~~~~~~~l~df~~~~ 167 (280)
|++++. +|.+++.. ..+.+......++.+++..+..||+.|++|+|+++.||+++. ++...+.++||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999875 78888753 345667788899999999999999999999999999999985 234569999999764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.3e-11 Score=97.90 Aligned_cols=139 Identities=20% Similarity=0.270 Sum_probs=102.1
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCC--eeeeceEEecC---CeEEEEEecc
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPN--IVRFKEVILTP---THLAIVMEYA 99 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~---~~~~lv~e~~ 99 (280)
+.|+.|..+.+|++...+ |+.+++|....... ....+.+|...++.+.+.+ +.+++.+.... +..++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568899999999998753 57899998766543 4567889999999986543 56666665543 2568999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 023591 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------- 135 (280)
Q Consensus 100 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-------------------------------------------- 135 (280)
+|.++.+.+.. ..+++.....++.+++++|..||+
T Consensus 83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 98877664421 346666777777777777777773
Q ss_pred ------------cCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 136 ------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 136 ------------~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
..++|+|+.+.||+++.+....+.++||+.+.
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23689999999999987422237899998665
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.1e-10 Score=93.62 Aligned_cols=237 Identities=13% Similarity=0.102 Sum_probs=152.1
Q ss_pred eeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeee----ece--EEecCC-eEEEE
Q 023591 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVR----FKE--VILTPT-HLAIV 95 (280)
Q Consensus 24 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~----~~~--~~~~~~-~~~lv 95 (280)
...+.||+|+-+.+|-.-...+ .+.|+++...-.....+ +..|-.. .||-+-. ... ++-+.. ...++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk--~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQK--VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchhhc---hhheeecCCCchHHHHH--HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3467899999999997765433 47788876543332221 1222222 4443222 111 111222 36788
Q ss_pred EeccCCCc-hHHHH------HhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 96 MEYASGGE-LFERI------CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 96 ~e~~~~~~-L~~~~------~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
|..+++.. ...+. +.....+...+.+..+.++.+.+.||+.|.+-||++++|+++++++. +.|.|-+....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi 166 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQI 166 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceee
Confidence 88876632 22222 12234678899999999999999999999999999999999998887 99999776554
Q ss_pred cccCCCCCCCcCCCcccCccccc-----CCcCCCccchhhHHHHHHHHHHhC-CCCCCCCCC----cchHH-HHH-----
Q 023591 169 SVLHSQPKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEE----PKNFR-KTI----- 232 (280)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~----~~~~~-~~~----- 232 (280)
...+.......+...|++||... +..-+.+ +|.|.||+++++++.| +.||.+-.. ..... .+.
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 44555556778999999999865 2233455 8999999999998886 999975321 11111 000
Q ss_pred --hhHhcc---cccCCCCCCCCHHHHHHHHHhccc--CCCCcC
Q 023591 233 --HRILSV---QYSIPDYVHISPECRHLISRIFVA--DPAKSE 268 (280)
Q Consensus 233 --~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~--dp~~Rp 268 (280)
.....+ ...-.++.-+++++..+..+|+.. ++.-||
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP 288 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRP 288 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCC
Confidence 000000 001112345788999999999987 356788
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.7e-12 Score=111.33 Aligned_cols=148 Identities=16% Similarity=0.279 Sum_probs=103.7
Q ss_pred HHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC----------CCCCcCCCcccCcccccCC
Q 023591 125 QLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----------PKSTVGTPAYIAPEVLLKK 193 (280)
Q Consensus 125 ~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~----------~~~~~~~~~~~aPE~~~~~ 193 (280)
+.+.|+.++|. .++||++|.|++|.++..+. .|++.|+++........ .........|.|||.+.+.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 44489999995 68999999999999998888 99999998864443111 1112345679999999885
Q ss_pred cCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC----
Q 023591 194 EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE---- 268 (280)
Q Consensus 194 ~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---- 268 (280)
..... +|+||+|+++|.+.. |...+....................+..+ ..++.++++=+.++|..++..||
T Consensus 185 ~~~~~-sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s--~~~p~el~~~l~k~l~~~~~~rp~~~~ 261 (700)
T KOG2137|consen 185 TNTPA-SDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYS--NNLPSELRESLKKLLNGDSAVRPTLDL 261 (700)
T ss_pred ccccc-ccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccccccc--ccCcHHHHHHHHHHhcCCcccCcchhh
Confidence 55444 999999999999985 54444443332222221111111122222 47899999999999999999999
Q ss_pred --CCccccccc
Q 023591 269 --MHDWRRGCS 277 (280)
Q Consensus 269 --~h~~~~~~~ 277 (280)
..|||..-.
T Consensus 262 l~~~~ff~D~~ 272 (700)
T KOG2137|consen 262 LLSIPFFSDPG 272 (700)
T ss_pred hhcccccCCch
Confidence 777776543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.8e-10 Score=87.97 Aligned_cols=122 Identities=25% Similarity=0.268 Sum_probs=79.1
Q ss_pred EEEEEEecCCCcEEEEEEeeeC--------------Cc--------cc-----HHHHHHHHHhhhCCCCC--eeeeceEE
Q 023591 36 VARLMRDKKTEELVAVKYIERG--------------DK--------ID-----ENVQREIINHRSLRHPN--IVRFKEVI 86 (280)
Q Consensus 36 ~v~~~~~~~~~~~vaiK~~~~~--------------~~--------~~-----~~~~~e~~~l~~l~h~~--iv~~~~~~ 86 (280)
.||.|... ++..+|+|+.... .. .. ....+|.+.|.++...+ +.+++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 37888874 5778999987531 00 01 23567999999997654 55565543
Q ss_pred ecCCeEEEEEeccC--CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhcCceecCCCCCcEEEeCCCCCcEEEeec
Q 023591 87 LTPTHLAIVMEYAS--GGELFERICNAGRFSEDEARFFFQQLISGVSY-CHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (280)
Q Consensus 87 ~~~~~~~lv~e~~~--~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~-Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df 163 (280)
...+||||++ |..+..+.... ++......++.+++..+.. +|..|++|||+++.||+++.+ . +.++||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~--~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K--VYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C--EEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e--EEEEec
Confidence 2479999998 65555443221 2245566777788884444 689999999999999999877 3 999999
Q ss_pred CCcc
Q 023591 164 GYSK 167 (280)
Q Consensus 164 ~~~~ 167 (280)
+.+.
T Consensus 151 ~qav 154 (188)
T PF01163_consen 151 GQAV 154 (188)
T ss_dssp TTEE
T ss_pred Ccce
Confidence 9776
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.4e-10 Score=90.12 Aligned_cols=132 Identities=20% Similarity=0.235 Sum_probs=100.4
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEeeeC-------------------C----cccHHHHHHHHHhhhCCCC--
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-------------------D----KIDENVQREIINHRSLRHP-- 77 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-------------------~----~~~~~~~~e~~~l~~l~h~-- 77 (280)
+.+..+||-|.-+.||.+.+. .|.++|+|+=... . -......+|.+.|++|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 356789999999999999986 6888999963211 0 1113466899999988654
Q ss_pred CeeeeceEEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCc
Q 023591 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (280)
Q Consensus 78 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~ 157 (280)
.+.+.+++ +...+|||+.+|..|.... ++.+....++..|++.+..+-..|++|||+++-||+++++|.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~-- 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD-- 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence 66777664 4678999999886665432 345666677777777777777999999999999999999987
Q ss_pred EEEeecCCc
Q 023591 158 LKICDFGYS 166 (280)
Q Consensus 158 ~~l~df~~~ 166 (280)
+.++||=.+
T Consensus 241 ~~vIDwPQ~ 249 (304)
T COG0478 241 IVVIDWPQA 249 (304)
T ss_pred EEEEeCccc
Confidence 999999543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.5e-09 Score=83.69 Aligned_cols=107 Identities=18% Similarity=0.188 Sum_probs=84.4
Q ss_pred cHHHHHHHHHhhhCCCCC--eeeeceEEecC----CeEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 023591 61 DENVQREIINHRSLRHPN--IVRFKEVILTP----THLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYC 133 (280)
Q Consensus 61 ~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~----~~~~lv~e~~~~-~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~L 133 (280)
.....+|...+.+|...+ .++++++.+.. ...++|+|++++ .+|.+++.....++......++.+++..++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 346778888888774433 44555555542 246899999987 47898887755577888899999999999999
Q ss_pred HhcCceecCCCCCcEEEeCCC-CCcEEEeecCCcc
Q 023591 134 HSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK 167 (280)
Q Consensus 134 h~~~i~h~dl~~~ni~i~~~~-~~~~~l~df~~~~ 167 (280)
|+.|++|+|+++.||+++.++ ...+.++||+-+.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 999999999999999998775 4459999998655
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.1e-09 Score=80.17 Aligned_cols=136 Identities=10% Similarity=0.055 Sum_probs=99.9
Q ss_pred ccCCceEEEEEEecCCCcEEEEEEeeeC-------CcccHHHHHHHHHhhhCCCCC--eeeeceEEec----CCeEEEEE
Q 023591 30 GSGNFGVARLMRDKKTEELVAVKYIERG-------DKIDENVQREIINHRSLRHPN--IVRFKEVILT----PTHLAIVM 96 (280)
Q Consensus 30 g~G~~g~v~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~----~~~~~lv~ 96 (280)
|+|+-+.|+..... |..+-+|..... +.....+.+|+..++++...+ +.++...... ....++|+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 34888889988764 336888876421 345578999999999885433 4444422111 12468999
Q ss_pred eccC-CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 97 EYAS-GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 97 e~~~-~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
|-++ ..+|.+.+.+. .+.++.....++.+++.+++-||+.|+.|+|+.+.||+++.++...+.++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 9664 36888877553 35678888899999999999999999999999999999986665569999997554
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.4e-08 Score=76.40 Aligned_cols=135 Identities=16% Similarity=0.194 Sum_probs=88.5
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccH----------HHHHHHHHhhhCCC---CCeeeeceEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----------NVQREIINHRSLRH---PNIVRFKEVI 86 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~e~~~l~~l~h---~~iv~~~~~~ 86 (280)
.++|++.+.+.......|.+... ++..+++|.......-.+ ...+++....+++. ..+..++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 46788888888877777777765 467799998765321111 12233333333322 2333333222
Q ss_pred ec-----CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEe
Q 023591 87 LT-----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (280)
Q Consensus 87 ~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~ 161 (280)
+- -...+++|||++|..|.+... +++ .+...+.+++.-||+.|++|||.+|.|++++.++ ++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iI 176 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRII 176 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEE
Confidence 21 235678999999988766432 333 2445677788999999999999999999998655 8999
Q ss_pred ecCCcc
Q 023591 162 DFGYSK 167 (280)
Q Consensus 162 df~~~~ 167 (280)
|++..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 997443
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2e-10 Score=99.86 Aligned_cols=239 Identities=21% Similarity=0.236 Sum_probs=161.8
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCC-eeeeceEEecCCeEEEEEecc
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~ 99 (280)
..|......+.|+++++++.+...+.... .+++... ....-++++|.+++||| .+..++-+..+...++.++++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 34577888999999999999987765544 6666544 45567889999999999 566666666677889999999
Q ss_pred CCC-chHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCC
Q 023591 100 SGG-ELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (280)
Q Consensus 100 ~~~-~L~~~~-~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (280)
.++ +..... .....+...+...+.+.-+++++++|+.--+|+| ||+.++.. .+..||+.............
T Consensus 317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~~t 389 (829)
T KOG0576|consen 317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQLTRTMKPRT 389 (829)
T ss_pred cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc---cccccccCCcccCccccccc
Confidence 776 221111 1111245556667777888899999998778887 77776544 68999987765555445677
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc--cccCCCCCCCCHHHH-H
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIPDYVHISPECR-H 254 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~-~ 254 (280)
..+++.++|||......+... .|.|++|.-..+|..|.+|-...... ...+... ...+......++... +
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~P~~~------~~~~g~~p~s~~L~~~~aw~~~~~~~ 462 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSSPPAV------LPMIGNGPNSPMLTDKSAWSPVFHRD 462 (829)
T ss_pred CCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCCCccc------cCCCCCCCCccccchhhhcCcccccC
Confidence 789999999999888888776 89999998777887777765442110 0000000 000000001112222 4
Q ss_pred HHHHhcccCCCCcC------CCcccccccC
Q 023591 255 LISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
+...|+.--|..|+ .|.+|.+|+.
T Consensus 463 ~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 463 FPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred CcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 66778888888877 7788877764
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.84 E-value=6.6e-08 Score=75.69 Aligned_cols=132 Identities=17% Similarity=0.150 Sum_probs=89.2
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCCcc--------------------cHH-----HHHHHHHhhhCC--CCCe
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--------------------DEN-----VQREIINHRSLR--HPNI 79 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------------------~~~-----~~~e~~~l~~l~--h~~i 79 (280)
..|++|.-+.||+|.. .++..+|+|++...... ... ..+|+..|+++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3677888889999986 46788999998643111 011 235777777773 3445
Q ss_pred eeeceEEecCCeEEEEEeccCCCch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCc
Q 023591 80 VRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPR 157 (280)
Q Consensus 80 v~~~~~~~~~~~~~lv~e~~~~~~L-~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~ 157 (280)
.+.+.+. ...+||||++.... .-.++ .-++...+...+..++++.+.-|-. .++||+||+.-||++. ++.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~-- 204 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE-- 204 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe--
Confidence 5555554 34799999854211 11111 1123444677778888888877776 9999999999999998 444
Q ss_pred EEEeecCCcc
Q 023591 158 LKICDFGYSK 167 (280)
Q Consensus 158 ~~l~df~~~~ 167 (280)
+.++|++.|.
T Consensus 205 p~iID~~QaV 214 (268)
T COG1718 205 PYIIDVSQAV 214 (268)
T ss_pred EEEEECcccc
Confidence 8999999776
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.5e-07 Score=71.90 Aligned_cols=72 Identities=17% Similarity=0.168 Sum_probs=53.8
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCC--eeeeceEEecCCeEEEEEeccCCCc
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGGE 103 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (280)
..|++|..+.||+. .+..+++|...... ....+.+|.+.++.+..-+ +.+++++....+...++|++++|.+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 56799999999974 24457899876533 4456789999998886444 4567777777777889999998853
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=9.5e-07 Score=65.63 Aligned_cols=128 Identities=19% Similarity=0.202 Sum_probs=91.9
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCee-eeceEEecCCeEEEEEeccCC
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~ 101 (280)
-+..+.|+.|.+|.||++.+. +..+|+|+ ...+.....+..|.++|..++..++. +++.+..+ .+.|||..|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kv-rr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKV-RRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEE-ecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 355789999999999999985 55789994 55566778899999999988776655 45555433 344999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCC--CcEEEeCCCCCcEEEeecCCcc
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL--ENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~--~ni~i~~~~~~~~~l~df~~~~ 167 (280)
..|....... +... +..++++-.-|-..||-|+.++- .||++. +.. +.|+||..|.
T Consensus 97 ~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~~--~~iIDFd~At 154 (201)
T COG2112 97 RPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DRD--VYIIDFDSAT 154 (201)
T ss_pred cchhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEec-CCc--EEEEEccchh
Confidence 8887654321 2333 34455555567789999999975 455554 434 8999998765
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=7.1e-07 Score=78.44 Aligned_cols=137 Identities=19% Similarity=0.183 Sum_probs=87.5
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCC-----------------------c---c-----c----H------HHH
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------------------K---I-----D----E------NVQ 65 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-----------------------~---~-----~----~------~~~ 65 (280)
+.|+.++-|.|++|+... |+.||||+.+++- . . . + ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 577899999999999864 9999999986531 0 0 0 0 122
Q ss_pred HHHHHhhhC----C-CCCeeeeceEEecCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCce
Q 023591 66 REIINHRSL----R-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVC 139 (280)
Q Consensus 66 ~e~~~l~~l----~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~ 139 (280)
+|...+.++ + .+++.-..-+.+..+.-.++|||++|..+.+.... ...++...+.....++. +..+-..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 333333333 2 23333222232234567899999999888777422 23455444433322221 2333458999
Q ss_pred ecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 140 HRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 140 h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
|+|.+|-||+++.++. +.+.|||+...
T Consensus 288 HaDpHpGNi~v~~~g~--i~~lDfGi~g~ 314 (517)
T COG0661 288 HADPHPGNILVRSDGR--IVLLDFGIVGR 314 (517)
T ss_pred ccCCCccceEEecCCc--EEEEcCcceec
Confidence 9999999999998876 99999998753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.53 E-value=2e-06 Score=69.19 Aligned_cols=75 Identities=12% Similarity=0.050 Sum_probs=52.0
Q ss_pred ccccCCc-eEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC-CCCeeeeceEEecCCeEEEEEeccCCCchH
Q 023591 28 DIGSGNF-GVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELF 105 (280)
Q Consensus 28 ~lg~G~~-g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (280)
.|..|.+ +.||++... +..+++|...... ...+.+|+.+++.+. +--+.+++++....+..++||++++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 688999753 3678888776543 345678888888873 333556777766666788999999987765
Q ss_pred H
Q 023591 106 E 106 (280)
Q Consensus 106 ~ 106 (280)
.
T Consensus 81 ~ 81 (244)
T cd05150 81 A 81 (244)
T ss_pred H
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.52 E-value=5.6e-06 Score=63.91 Aligned_cols=129 Identities=21% Similarity=0.233 Sum_probs=92.2
Q ss_pred ecccccCCceEEEEEEecCCCcEEEEEEeeeCC-----------------cccHHHHHHHHHhhhCC------CCCeeee
Q 023591 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------------KIDENVQREIINHRSLR------HPNIVRF 82 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~~~~e~~~l~~l~------h~~iv~~ 82 (280)
...||+|+.-.||.--+ ....+||+..... ....+..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35789999999885433 3336899887654 22355667777666665 7789999
Q ss_pred ceEEecCCeEEEEEeccC------CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCC
Q 023591 83 KEVILTPTHLAIVMEYAS------GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (280)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~------~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~ 156 (280)
+|+.+++....+|+|... ..||.+++.+ +.+++ .+.+.+.+ ...+|-+.+|+.+|++|.||++.....+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~~---f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALDE---FKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHHH---HHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 999999999999998752 2467888844 34655 44444444 4556788999999999999999765543
Q ss_pred --cEEEee
Q 023591 157 --RLKICD 162 (280)
Q Consensus 157 --~~~l~d 162 (280)
++.++|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.6e-06 Score=80.18 Aligned_cols=79 Identities=19% Similarity=0.226 Sum_probs=55.9
Q ss_pred eecccccCCceEEEEEEecCCC--cEEEEEEeeeCC--cccHHHHHHHHHhhhCC-CCCe--eeeceEEecC---CeEEE
Q 023591 25 LVRDIGSGNFGVARLMRDKKTE--ELVAVKYIERGD--KIDENVQREIINHRSLR-HPNI--VRFKEVILTP---THLAI 94 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~~~--~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~l 94 (280)
-++.++.|.+..+|++.....+ ..+++|+..... .....+.+|..+++.+. |.++ .+++.++.+. +..++
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3677889999999998875432 467888765433 22346889999999985 6664 5666666543 35789
Q ss_pred EEeccCCCc
Q 023591 95 VMEYASGGE 103 (280)
Q Consensus 95 v~e~~~~~~ 103 (280)
|||+++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998754
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.5e-06 Score=67.99 Aligned_cols=78 Identities=18% Similarity=0.199 Sum_probs=55.1
Q ss_pred ecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCC--eeeeceEEe---cCCeEEEEEeccC
Q 023591 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVIL---TPTHLAIVMEYAS 100 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~---~~~~~~lv~e~~~ 100 (280)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.+.... +..++.... .....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999999865 47899986655 45567778888888774332 445555332 2335789999999
Q ss_pred CCchHH
Q 023591 101 GGELFE 106 (280)
Q Consensus 101 ~~~L~~ 106 (280)
|.++..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 877766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.9e-05 Score=60.61 Aligned_cols=135 Identities=19% Similarity=0.293 Sum_probs=90.7
Q ss_pred CCCCCCCCCC-CCCeeeecccccCCc-eEEEEEEecCCCcEEEEEEeee---C------------C-------cccHHHH
Q 023591 10 PGMDMPIMHD-SDRYELVRDIGSGNF-GVARLMRDKKTEELVAVKYIER---G------------D-------KIDENVQ 65 (280)
Q Consensus 10 ~~~~~~~~~~-~~~y~~~~~lg~G~~-g~v~~~~~~~~~~~vaiK~~~~---~------------~-------~~~~~~~ 65 (280)
+|..+..... ..+++.++.||.|.- |.||+++-. |+.+|+|++.. . . ...+.+.
T Consensus 25 ~gPKL~~F~~h~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~ 102 (207)
T PF13095_consen 25 PGPKLEPFTHHGDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFN 102 (207)
T ss_pred CCCCcCCcCCCCCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHH
Confidence 3444444433 378999999999999 999999984 67899999421 0 0 1123456
Q ss_pred HHHHHhhhC---CCCCe--eeeceEEecC------------------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHH
Q 023591 66 REIINHRSL---RHPNI--VRFKEVILTP------------------THLAIVMEYASGGELFERICNAGRFSEDEARFF 122 (280)
Q Consensus 66 ~e~~~l~~l---~h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~ 122 (280)
.|....-+| .+.++ |+++++..-. ....+|.||.+... .++...
T Consensus 103 ~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~---- 169 (207)
T PF13095_consen 103 CECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD---- 169 (207)
T ss_pred HHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----
Confidence 677766666 44555 8888887321 12356777665432 233344
Q ss_pred HHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCc
Q 023591 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (280)
Q Consensus 123 ~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~ 166 (280)
+.+|.+-+..+|..||+-+|+++.|.. + =+|+|||.+
T Consensus 170 ~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~----G~lvDfs~~ 206 (207)
T PF13095_consen 170 IPQMLRDLKILHKLGIVPRDVKPRNYR---G----GKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHCCeeeccCcccccc---C----CEEEecccC
Confidence 445666667799999999999999985 2 389999854
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1e-06 Score=82.26 Aligned_cols=194 Identities=21% Similarity=0.262 Sum_probs=137.4
Q ss_pred HHHHHHHhhhCCCCCeeeeceEEecCCeEE----EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCce
Q 023591 64 VQREIINHRSLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139 (280)
Q Consensus 64 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~----lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~ 139 (280)
..-|+..+.+..|+|++.+..+...+.... +..++++..++...+..-...+.+.++.+..++..+|+++|+....
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 344666777889999999998887654333 4557888889999998888999999999999999999999999766
Q ss_pred ecCCCCC---cEEEeCCCCCcEEEe--ecCCccccccCCCCCCCcCCCcccCcccccCCcCC-CccchhhHHHHHHHHHH
Q 023591 140 HRDLKLE---NTLLDGSPAPRLKIC--DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD-GKIADVWSCGVTLYVML 213 (280)
Q Consensus 140 h~dl~~~---ni~i~~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~~DiwslG~~l~~l~ 213 (280)
|.-+..+ +...+..+. +..+ ||+.+.................+.++|........ ....|+|++|.....+.
T Consensus 309 ~v~L~~s~~~~~~~~~e~~--~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGV--VAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred eeEEecccccccccCccce--eecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 6665555 333444444 4444 88887766666666666666777888876554443 22369999999999988
Q ss_pred hCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccc
Q 023591 214 VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 214 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~ 274 (280)
.|..+-..... ........ .. ..+.+...+|+..++++|+ .|+|++
T Consensus 387 ~~~~i~~~~~~-------~~~~l~~~-------~~-~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~ 438 (1351)
T KOG1035|consen 387 QGEDISEKSAV-------PVSLLDVL-------ST-SELLDALPKCLDEDSEERLSALELLTHPFLR 438 (1351)
T ss_pred hcCcccccccc-------hhhhhccc-------cc-hhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence 87654332111 11111100 11 2678899999999999999 788875
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.33 E-value=4.9e-06 Score=66.57 Aligned_cols=72 Identities=11% Similarity=-0.011 Sum_probs=44.5
Q ss_pred cccccCCce-EEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCC---CeeeeceEEecC---CeEEEEEecc
Q 023591 27 RDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVILTP---THLAIVMEYA 99 (280)
Q Consensus 27 ~~lg~G~~g-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~---~~~~lv~e~~ 99 (280)
+.++.|+.. .||++. ..+++|+... ......+.+|.+.+..+... -+..+++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456666666 588762 2478887554 33445788899999887532 233344333222 2347899999
Q ss_pred CCCch
Q 023591 100 SGGEL 104 (280)
Q Consensus 100 ~~~~L 104 (280)
+|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 88665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.4e-05 Score=70.25 Aligned_cols=139 Identities=19% Similarity=0.169 Sum_probs=87.9
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCCc--------------------------------ccHH------HHHHH
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--------------------------------IDEN------VQREI 68 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--------------------------------~~~~------~~~e~ 68 (280)
+.|+..+.|.|++|+.+. |+.||+|+.++.-. ..++ +.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 578899999999999876 99999998764210 0011 22222
Q ss_pred HHh----hhCCCCC---eeeeceEEecC-CeEEEEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCce
Q 023591 69 INH----RSLRHPN---IVRFKEVILTP-THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVC 139 (280)
Q Consensus 69 ~~l----~~l~h~~---iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~ 139 (280)
+.. +.++|-+ -|.+-.++++- ..-.|+|||++|..+.+.-. ....++...+..-+.+... .-|=..|++
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~Gff 323 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGFF 323 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCCc
Confidence 222 2234444 23344444432 35789999999987755432 1223566644443333222 234468899
Q ss_pred ecCCCCCcEEEeCC--CCCcEEEeecCCccc
Q 023591 140 HRDLKLENTLLDGS--PAPRLKICDFGYSKS 168 (280)
Q Consensus 140 h~dl~~~ni~i~~~--~~~~~~l~df~~~~~ 168 (280)
|+|=.|-||+++.+ +...+.+.|||+...
T Consensus 324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred cCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 99999999999864 355699999998763
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.13 E-value=7.8e-05 Score=59.58 Aligned_cols=75 Identities=15% Similarity=0.272 Sum_probs=48.6
Q ss_pred ecccccCCceEEEEEEecC-CCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCee-eeceEEecCCeEEEEEeccCCCc
Q 023591 26 VRDIGSGNFGVARLMRDKK-TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYASGGE 103 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~ 103 (280)
++.|..|-...+|++.... +++.+++|.........-...+|..+++.+...+++ +++... ++ .++|||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~--~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF--QN--GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe--CC--cEEEEeeCCCc
Confidence 4567778888999997643 356789997765433223345788888888544443 444332 22 47999998866
Q ss_pred h
Q 023591 104 L 104 (280)
Q Consensus 104 L 104 (280)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.8e-05 Score=63.01 Aligned_cols=131 Identities=15% Similarity=0.097 Sum_probs=75.5
Q ss_pred ccccCCceEEEEEEecCCCcEEEEEEeeeCCccc-HHHHHHHHHhhhCCCCCee-eeceEEecCCeEEEEEeccCCCchH
Q 023591 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYASGGELF 105 (280)
Q Consensus 28 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (280)
.+..|-.+.+|++.. +++.+++|......... -...+|..+++.+...+++ +++... + -++|++|++|.++.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence 345677788998873 46678888765443221 2357788888888544333 343332 2 36899999886542
Q ss_pred H-----------H---HH---hc----CCCCH-HHHHHHHHHH---------HHHHHHHHh--------cCceecCCCCC
Q 023591 106 E-----------R---IC---NA----GRFSE-DEARFFFQQL---------ISGVSYCHS--------MQVCHRDLKLE 146 (280)
Q Consensus 106 ~-----------~---~~---~~----~~l~~-~~~~~~~~~i---------~~~l~~Lh~--------~~i~h~dl~~~ 146 (280)
. + +. .. .+++. ..+..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 1 1 11 10 11221 1222222111 111222211 24899999999
Q ss_pred cEEEeCCCCCcEEEeecCCcc
Q 023591 147 NTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 147 ni~i~~~~~~~~~l~df~~~~ 167 (280)
||+++.++ +.++||..+.
T Consensus 157 Nil~~~~~---~~lIDwE~a~ 174 (256)
T TIGR02721 157 NLVVTPQG---LKLIDWEYAS 174 (256)
T ss_pred cEEEeCCC---CEEEeccccC
Confidence 99998765 6899998765
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.0004 Score=59.53 Aligned_cols=76 Identities=18% Similarity=0.110 Sum_probs=52.8
Q ss_pred ecccccCCceEEEEEEecCCCcEEEEEEeeeC--------CcccHHHHHHHHHhhhCC---CCCeeeeceEEecCCeEEE
Q 023591 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERG--------DKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~l 94 (280)
.+.||.|.+..||++.....++.++||.-.+. ....++...|.+.|+.+. ...+++++.+ ++...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 56899999999999998654457999985421 123355667888887762 2345666665 4456789
Q ss_pred EEeccCCCc
Q 023591 95 VMEYASGGE 103 (280)
Q Consensus 95 v~e~~~~~~ 103 (280)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999987643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00013 Score=60.77 Aligned_cols=75 Identities=13% Similarity=0.158 Sum_probs=48.5
Q ss_pred ecccccCCceEEEEEEecC------CCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCee-eeceEEecCCeEEEEEec
Q 023591 26 VRDIGSGNFGVARLMRDKK------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~ 98 (280)
++.|..|-...+|++.... .++.+++|+............+|..++..+...++. +++.... + ..|++|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 3455667777888887643 257899999776544445667888888887543433 4444442 1 357888
Q ss_pred cCCCch
Q 023591 99 ASGGEL 104 (280)
Q Consensus 99 ~~~~~L 104 (280)
++|.++
T Consensus 79 i~G~~l 84 (302)
T cd05156 79 IPSRTL 84 (302)
T ss_pred eCCCcC
Confidence 877655
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.92 E-value=7.9e-06 Score=66.72 Aligned_cols=132 Identities=14% Similarity=0.157 Sum_probs=90.9
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-------------------cc----HHHHHHHHHhhhCCCC-
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------------------ID----ENVQREIINHRSLRHP- 77 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-------------------~~----~~~~~e~~~l~~l~h~- 77 (280)
=+.+..+||-|.-+.+|.+-+. .|.+.++|+=..... +. -...+|...++.|...
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3567889999999999999885 577788886321110 00 1233566666666322
Q ss_pred -CeeeeceEEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCC
Q 023591 78 -NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (280)
Q Consensus 78 -~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~ 156 (280)
-+.+.+++ +..++||+++.+.+|.+... ...+..+...+...+--|..+|++|||++--||+++.++.
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~- 240 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK- 240 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC-
Confidence 23344443 46799999999888765431 1233445556666777888999999999999999998776
Q ss_pred cEEEeecCCc
Q 023591 157 RLKICDFGYS 166 (280)
Q Consensus 157 ~~~l~df~~~ 166 (280)
++++||=..
T Consensus 241 -i~vIDFPQm 249 (465)
T KOG2268|consen 241 -IVVIDFPQM 249 (465)
T ss_pred -EEEeechHh
Confidence 999999543
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00021 Score=59.18 Aligned_cols=137 Identities=18% Similarity=0.131 Sum_probs=80.4
Q ss_pred eecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCC--eeeeceE------EecCCeEEEEE
Q 023591 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAIVM 96 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv~ 96 (280)
-++.+..|....+|++... +..+++|.... ...+.+..|+.++..+.+.+ +.+++.. ...++..++++
T Consensus 18 ~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 18 SFEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred heecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 3667778888899998753 34689998764 33456677888777774322 3343321 12345678999
Q ss_pred eccCCCchHH-----------HH---Hh-cCCCCH--------HHHH------------HHHHHHHHHHHHHHh------
Q 023591 97 EYASGGELFE-----------RI---CN-AGRFSE--------DEAR------------FFFQQLISGVSYCHS------ 135 (280)
Q Consensus 97 e~~~~~~L~~-----------~~---~~-~~~l~~--------~~~~------------~~~~~i~~~l~~Lh~------ 135 (280)
++++|.++.. .+ .. ...+.. .... .....+..++..+.+
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998865421 11 00 000000 0000 011112233344432
Q ss_pred -cCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 136 -~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
.+++|+|+.|.||+++.++. +.++||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDEL--SGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCce--EEEeehhhhc
Confidence 46999999999999987654 6899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.0001 Score=56.61 Aligned_cols=96 Identities=15% Similarity=0.062 Sum_probs=75.0
Q ss_pred HHHHHhhhCCC-CCeeeeceEEecCCeEEEEEeccCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---cCc
Q 023591 66 REIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHS---MQV 138 (280)
Q Consensus 66 ~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~---~~~~~~l~~~~~~~~~~~i~~~l~~Lh~---~~i 138 (280)
.|..+++.+.+ +++++++|++- .+++.|+.+.+++... +......+.....+++.++++.+.+++. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 47788888865 68999999983 3678899876655321 1111235788999999999999999997 448
Q ss_pred eecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 139 ~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
.-.|++++|+-++.++. +|+.|.+.+.
T Consensus 84 ~lcDv~~~nfgv~~~~~--lk~iDld~v~ 110 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGR--LKLIDLDDVF 110 (188)
T ss_pred EEeecchHHeEEeCCCc--EEEEechhcc
Confidence 88999999999998877 9999998654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00025 Score=59.19 Aligned_cols=137 Identities=19% Similarity=0.204 Sum_probs=91.1
Q ss_pred eecccccCCceEEEEEEecCCCcEEEEEEeeeCC-----------------------ccc---HH-HHHHHHHhhhCCCC
Q 023591 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------------------KID---EN-VQREIINHRSLRHP 77 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-----------------------~~~---~~-~~~e~~~l~~l~h~ 77 (280)
+-..|..|.-+.||.|... +|+.+|||+++.+- ... .- ...|+..|.++...
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3456788999999998865 57779999986320 000 11 34588888888766
Q ss_pred CeeeeceEEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhcCceecCCCCCcEEEeCCCCC
Q 023591 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLLDGSPAP 156 (280)
Q Consensus 78 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~L-h~~~i~h~dl~~~ni~i~~~~~~ 156 (280)
.|.-.--+.. ....|||+|+....-..=.-+.-.++...+..+-.+++.-+.-| +.+++||.||+--|+++..+.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG~-- 302 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDGK-- 302 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECCE--
Confidence 6443322222 24579999985321111111233577777777777777776665 578999999999999997443
Q ss_pred cEEEeecCCcc
Q 023591 157 RLKICDFGYSK 167 (280)
Q Consensus 157 ~~~l~df~~~~ 167 (280)
+.++|.+.+.
T Consensus 303 -lyiIDVSQSV 312 (520)
T KOG2270|consen 303 -LYIIDVSQSV 312 (520)
T ss_pred -EEEEEccccc
Confidence 8999988665
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.0013 Score=54.89 Aligned_cols=140 Identities=16% Similarity=0.170 Sum_probs=80.1
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCC--eeeeceE------EecCCeEEE
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAI 94 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~l 94 (280)
.+.++.++.|....+|++... ++ .+++|+..... ..+.+..|..++..|...+ +.+++.. ....+..++
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred ceeccccCCccccceEEEEeC-CC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 444667788888899998753 33 57889775532 2345566777777663322 3333321 112356789
Q ss_pred EEeccCCCchH-----------HHHH---h-cCCC--------CHHH-----HH----------HHHHHHHHHHHHHH--
Q 023591 95 VMEYASGGELF-----------ERIC---N-AGRF--------SEDE-----AR----------FFFQQLISGVSYCH-- 134 (280)
Q Consensus 95 v~e~~~~~~L~-----------~~~~---~-~~~l--------~~~~-----~~----------~~~~~i~~~l~~Lh-- 134 (280)
++++++|.++. ..+. . ...+ .... .. .....+...++++.
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 99999874421 1110 0 0000 0000 00 00112233444443
Q ss_pred -----hcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 135 -----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 135 -----~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
..+++|+|+.+.||+++.++. +.++||+.+.
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~ 216 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSV--KGVIDFYFAC 216 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCce--EEEeeccccc
Confidence 368999999999999987764 6899999765
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.0018 Score=54.31 Aligned_cols=74 Identities=11% Similarity=0.041 Sum_probs=43.8
Q ss_pred ecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCC--eeeece------EEecCCeEEEEEe
Q 023591 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKE------VILTPTHLAIVME 97 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~------~~~~~~~~~lv~e 97 (280)
.+.|+.|....+|.+... +| .+++|++.. ...+.+..+...+..|...+ +.+++. +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 456777888899998764 33 589998762 22344445555555552212 223222 1122456789999
Q ss_pred ccCCCc
Q 023591 98 YASGGE 103 (280)
Q Consensus 98 ~~~~~~ 103 (280)
+++|..
T Consensus 103 ~l~G~~ 108 (319)
T PRK05231 103 FLEGKW 108 (319)
T ss_pred ecCCCC
Confidence 998864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0011 Score=54.94 Aligned_cols=106 Identities=13% Similarity=0.086 Sum_probs=73.9
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCC---CCeeeeceEEec---CCeEEEEE
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---PNIVRFKEVILT---PTHLAIVM 96 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv~ 96 (280)
-.-.+.||.|..+.||.....+ + .+++|+. +.......+.+|...++.+.. -.+.++++++.. .+..++||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~-~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQ-G-NPMPLMA-RSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCC-C-CEEEEEe-cccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 3446789999999999997643 3 3677764 332244678899999988843 356677776654 35689999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~ 136 (280)
|++++.++.+. ..+......+..+++++|+.||+.
T Consensus 93 E~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 93 ERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred eccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 99998777641 133444556667788888888874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0031 Score=53.12 Aligned_cols=72 Identities=19% Similarity=0.188 Sum_probs=47.3
Q ss_pred ccccCCceEEEEEEecCCCcEEEEEEeee-----C---CcccHHHHHHHHHhhhCC--CCC-eeeeceEEecCCeEEEEE
Q 023591 28 DIGSGNFGVARLMRDKKTEELVAVKYIER-----G---DKIDENVQREIINHRSLR--HPN-IVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 28 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~-----~---~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~lv~ 96 (280)
.||.|....||++.+...++.++||.-.+ . +...++..-|...|+... .|. +++++.+ ++....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999999864446799997532 1 233345566777776653 343 4444433 556677999
Q ss_pred eccCC
Q 023591 97 EYASG 101 (280)
Q Consensus 97 e~~~~ 101 (280)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0019 Score=53.53 Aligned_cols=145 Identities=12% Similarity=0.093 Sum_probs=80.1
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeee---CCcccHHHHHHHHHhhhCCCCCe--eeeceEEecCC--eEEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNI--VRFKEVILTPT--HLAI 94 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~--~~~l 94 (280)
...+++....|....+|..... ++.+++. ... .........+|+..++.+.---+ ...++++..+. ..+.
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 3455556555666667766664 6778888 331 12333456678888887743222 23344444443 5689
Q ss_pred EEeccCCCchHHHH----------H--------h--------cC------CCCHHHHHHHHHHH--------------HH
Q 023591 95 VMEYASGGELFERI----------C--------N--------AG------RFSEDEARFFFQQL--------------IS 128 (280)
Q Consensus 95 v~e~~~~~~L~~~~----------~--------~--------~~------~l~~~~~~~~~~~i--------------~~ 128 (280)
||+++.|..+.+.. . . .. .....++..+..+. ..
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 99999773321111 0 0 00 00111111111111 11
Q ss_pred HHHHHHh--------cCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 129 GVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 129 ~l~~Lh~--------~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
...+|+. ..++|||+.+.|++++.++- +-+.||+++....+
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~lGDP 231 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP--TGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe--eEEEeccccccCCc
Confidence 1223332 23799999999999998776 89999998874443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0021 Score=54.47 Aligned_cols=138 Identities=16% Similarity=0.188 Sum_probs=78.6
Q ss_pred eecccccCCceEEEEEEecC----CCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCee-eeceEEecCCeEEEEEecc
Q 023591 25 LVRDIGSGNFGVARLMRDKK----TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~ 99 (280)
-++.|..|-...+|++.... .++.+++|+........-+..+|..+++.+...++. ++++.+.. ..|.+|+
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~efi 115 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEFI 115 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC----ceEEEee
Confidence 34455558888999987532 246799998866433322336788888888544443 45555532 2578888
Q ss_pred CCCchHHH----------H----H---hcC-C----CC-HHHHHHHHHHH-----------------HHHHHHH------
Q 023591 100 SGGELFER----------I----C---NAG-R----FS-EDEARFFFQQL-----------------ISGVSYC------ 133 (280)
Q Consensus 100 ~~~~L~~~----------~----~---~~~-~----l~-~~~~~~~~~~i-----------------~~~l~~L------ 133 (280)
++.++... + . ... + .+ ...+..+..++ ...+..|
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 77665311 1 0 000 0 11 12222332211 1111111
Q ss_pred --HhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 134 --HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 134 --h~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
+...++|+|+++.||+++.+. ..+.++||..+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence 123589999999999998532 249999998765
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0055 Score=52.62 Aligned_cols=73 Identities=16% Similarity=0.186 Sum_probs=49.6
Q ss_pred eecccccCCceEEEEEEecCCCcEEEEEEeee-----CC---cccHHHHHHHHHhhhCC---CCCeeeeceEEecCCeEE
Q 023591 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GD---KIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~-----~~---~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~ 93 (280)
..+.||.|....||++.+. +..++||.-.. +. ....+...|...|+.+. ...+.+++.++. +...
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4778899999999999874 34589998652 21 13344455666666553 246667777765 4467
Q ss_pred EEEeccCC
Q 023591 94 IVMEYASG 101 (280)
Q Consensus 94 lv~e~~~~ 101 (280)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 78999966
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0038 Score=52.63 Aligned_cols=79 Identities=15% Similarity=0.199 Sum_probs=47.8
Q ss_pred CCeeeecccccCCceEEEEEEecCC---CcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCee-eeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~ 96 (280)
+..++.. |..|-...+|++...+. +..|++|+........-.-.+|..+++.+..-++. ++++++. + .+|.
T Consensus 15 ~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~--G~i~ 89 (330)
T PLN02421 15 SDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG--N--GMIQ 89 (330)
T ss_pred CceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC--C--cEee
Confidence 3444444 44477788999875432 33789998766443332345788888888554443 4555542 2 2478
Q ss_pred eccCCCch
Q 023591 97 EYASGGEL 104 (280)
Q Consensus 97 e~~~~~~L 104 (280)
+|+++.++
T Consensus 90 ~fi~g~~l 97 (330)
T PLN02421 90 SFINARTL 97 (330)
T ss_pred hhhcCCCC
Confidence 88877554
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0036 Score=51.50 Aligned_cols=75 Identities=11% Similarity=0.073 Sum_probs=48.3
Q ss_pred eeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC---CCCeeeeceEEecCCeEEEEEeccC
Q 023591 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYAS 100 (280)
Q Consensus 24 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (280)
+-.+.++.|....+|++. .++..+.+|.-. ......+..|..-|+.|. .-.++++++++..++..++++||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 446678889999999988 467789999766 334456778888888773 3457788888887777799999987
Q ss_pred CC
Q 023591 101 GG 102 (280)
Q Consensus 101 ~~ 102 (280)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 65
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0028 Score=51.99 Aligned_cols=30 Identities=23% Similarity=0.325 Sum_probs=23.8
Q ss_pred CceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 137 ~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
.++|+|+++.||+++.++. ..-++||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC-EEEEECcHhcc
Confidence 4899999999999986432 24699998765
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0044 Score=52.90 Aligned_cols=74 Identities=19% Similarity=0.160 Sum_probs=49.8
Q ss_pred ecccccCCceEEEEEEecCCCcEEEEEEeee----C---CcccHHHHHHHHHhhhCC--CCC-eeeeceEEecCCeEEEE
Q 023591 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIER----G---DKIDENVQREIINHRSLR--HPN-IVRFKEVILTPTHLAIV 95 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~----~---~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~lv 95 (280)
++.||.|...-||++.+...++.|+||.-.. . +...++..-|.+.|+... .|. +++++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 7788999999999999853355689997532 1 233355666777777663 344 4445443 45667888
Q ss_pred EeccCC
Q 023591 96 MEYASG 101 (280)
Q Consensus 96 ~e~~~~ 101 (280)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 988854
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.013 Score=50.25 Aligned_cols=75 Identities=9% Similarity=0.046 Sum_probs=44.2
Q ss_pred ecccccCCceEEEEEEecCC-CcE-----EEEEEeeeCCcccHHHHHHHHHhhhCCCCCee-eeceEEecCCeEEEEEec
Q 023591 26 VRDIGSGNFGVARLMRDKKT-EEL-----VAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~~-~~~-----vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~ 98 (280)
++.|..|-...+|++..... +.. |.++.........-+-.+|+.+++.+...++. ++++.+. -+++.||
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef 130 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW 130 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence 34555588889999975432 122 44443322222222335688888888655544 4555553 2689999
Q ss_pred cCCCch
Q 023591 99 ASGGEL 104 (280)
Q Consensus 99 ~~~~~L 104 (280)
++|.+|
T Consensus 131 IeGr~l 136 (383)
T PTZ00384 131 VEGNTM 136 (383)
T ss_pred eccccC
Confidence 988665
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0047 Score=48.47 Aligned_cols=55 Identities=16% Similarity=0.113 Sum_probs=32.6
Q ss_pred CcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCe-eeeceEEecCCeEEEEEeccCCCch
Q 023591 46 EELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL 104 (280)
Q Consensus 46 ~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L 104 (280)
++.|++++........-....|..+++.+...++ .++++.+.. ..|.+|+++.+|
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE-
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEeccccc
Confidence 4568999888775555566778888888754444 445555422 246688866553
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.078 Score=44.19 Aligned_cols=29 Identities=31% Similarity=0.615 Sum_probs=24.5
Q ss_pred cCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 136 ~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
.+++|||+.+.||+++. +. +.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~--i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NE--VYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-Cc--EEEEECcccc
Confidence 57899999999999986 33 8999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.07 Score=44.56 Aligned_cols=29 Identities=21% Similarity=0.266 Sum_probs=25.8
Q ss_pred CceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 137 ~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
+++|+|+.++|++++.++. +.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG--GYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence 6999999999999987776 8999998766
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.11 Score=43.68 Aligned_cols=70 Identities=11% Similarity=0.005 Sum_probs=42.9
Q ss_pred CceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCC--eeeec---e--EEecCCeEEEEEeccCCCc
Q 023591 33 NFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFK---E--VILTPTHLAIVMEYASGGE 103 (280)
Q Consensus 33 ~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~---~--~~~~~~~~~lv~e~~~~~~ 103 (280)
.-..||.+... ++..+++|+..........+..|+..+..|.... ++... + +...++..+.++++.+|..
T Consensus 37 ~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 34578888753 4566899987655555667778888887663211 22211 1 1223456788899887653
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.027 Score=47.27 Aligned_cols=131 Identities=15% Similarity=0.128 Sum_probs=77.1
Q ss_pred CceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCC---eee---eceE--EecCC--eEEEEEeccCCC
Q 023591 33 NFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN---IVR---FKEV--ILTPT--HLAIVMEYASGG 102 (280)
Q Consensus 33 ~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~---iv~---~~~~--~~~~~--~~~lv~e~~~~~ 102 (280)
.-..+|++...+ |+ +++|+.... ....++..|+..++.|.-.. .++ .-|- ..... ..+.+++|++|.
T Consensus 37 ~eN~~f~~~~~~-g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTED-GR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecC-CC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 455788888754 33 499998887 67778888888888873222 222 1111 01123 778899999887
Q ss_pred chHH------------HHH------hcCC------C---CHH----H---------HHHHHHHHHHHHHHHH--------
Q 023591 103 ELFE------------RIC------NAGR------F---SED----E---------ARFFFQQLISGVSYCH-------- 134 (280)
Q Consensus 103 ~L~~------------~~~------~~~~------l---~~~----~---------~~~~~~~i~~~l~~Lh-------- 134 (280)
.+.. .+. +..+ + ... . -.....++...+..+.
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 6651 110 0000 0 000 0 0002223333344333
Q ss_pred hcC--ceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 135 SMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 135 ~~~--i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
..+ ++|+|+.|.||+++.+.. -+.+.||+-+.
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 233 999999999999987763 36899999665
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.00059 Score=66.52 Aligned_cols=148 Identities=16% Similarity=0.143 Sum_probs=101.7
Q ss_pred HhhhCCCCCeeeeceEEec--CCeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC-----c
Q 023591 70 NHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ-----V 138 (280)
Q Consensus 70 ~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~~-----i 138 (280)
.++...|+++.....-... ....+..++++.+|.+.+.+-++ .++++.-+.....+.+....-+|... -
T Consensus 1282 e~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~ 1361 (2724)
T KOG1826|consen 1282 ELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTN 1361 (2724)
T ss_pred hhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccc
Confidence 3444578877765544332 23457888888899998887543 34555555555555466666655432 6
Q ss_pred eecCCCCCcEEEeCCCCCcEEEeecCCcc-ccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCC
Q 023591 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217 (280)
Q Consensus 139 ~h~dl~~~ni~i~~~~~~~~~l~df~~~~-~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~ 217 (280)
+|.++++-|.++..+.+ ++++++|+.+ ............+++.|..|++...-..+.+ +|+|..|+.+|.+-.|..
T Consensus 1362 v~~~Lkf~lpmIVtny~--v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs~~n~ 1438 (2724)
T KOG1826|consen 1362 VSKSLKFTLPMIVTNYN--VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRSDGNA 1438 (2724)
T ss_pred hhhhhhhhccceecCCc--ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHhcccH
Confidence 79999999999986666 9999999988 3333333345567777888887665566555 999999999999888776
Q ss_pred CCC
Q 023591 218 PFE 220 (280)
Q Consensus 218 p~~ 220 (280)
+|.
T Consensus 1439 ~fi 1441 (2724)
T KOG1826|consen 1439 YFI 1441 (2724)
T ss_pred HHH
Confidence 663
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.01 Score=52.05 Aligned_cols=151 Identities=15% Similarity=0.227 Sum_probs=86.3
Q ss_pred HHHHHHHHhhhCCCCCeeeeceEEecC-CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceec
Q 023591 63 NVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141 (280)
Q Consensus 63 ~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~ 141 (280)
.+.-...+++.+.|+|....+++-... ....+|+|++ +.+|.+.+..+. +-..... +|+
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~~~ 87 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------AHG 87 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------ccc
Confidence 455667888899999999999887543 3588999999 568988875543 2111111 222
Q ss_pred CCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCC
Q 023591 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (280)
Q Consensus 142 dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (280)
+.+.|+ ++.+|- ++.. .... . .+++||||+|.++.++.-|...+..
T Consensus 88 -~~~~~~---------~~~td~-~~t~------~~~~-----------~------~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 88 -VLHLNI---------IYITDH-FLTK------YPSP-----------I------GPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred -cceehh---------hhcccc-cccc------CCCC-----------C------CcchhhhhHHHHHHHHHHhhHHHHH
Confidence 111222 233330 0000 0000 0 1259999999999999988877654
Q ss_pred CCCcchHHHHHhhHhcccccCCC-------CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 222 PEEPKNFRKTIHRILSVQYSIPD-------YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....+...... ........... ....+..+.++...|+-..|..||
T Consensus 134 ~~~s~~l~~i~-k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~ 186 (725)
T KOG1093|consen 134 LTESEYLEILL-KYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP 186 (725)
T ss_pred HHHHHHHHHHH-HhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc
Confidence 43322211111 11000000000 013566788999999999999999
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.035 Score=46.78 Aligned_cols=71 Identities=24% Similarity=0.273 Sum_probs=54.3
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
...|++|++. |+++... ..-..+++..++++.+..++-+.. ..+-|+|+.-.||+++ .|+ |.|+||-+++.
T Consensus 299 ~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn--vtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGN--VTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCc--eEEEEeeeeec
Confidence 3567888887 4455322 113457888899998888877764 4588999999999999 776 99999999883
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.11 Score=45.62 Aligned_cols=76 Identities=16% Similarity=0.039 Sum_probs=47.3
Q ss_pred eecccccCCceEEEEEEecCC--------CcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCee-eeceEEecCCeEEEE
Q 023591 25 LVRDIGSGNFGVARLMRDKKT--------EELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIV 95 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv 95 (280)
-++.|..|-.-.+|++..... ++.|++++........-.-.+|..+++.+...++- ++++.+. -+.|
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 556666677788999875421 46789998766543333445677777777544444 3445442 2457
Q ss_pred EeccCCCch
Q 023591 96 MEYASGGEL 104 (280)
Q Consensus 96 ~e~~~~~~L 104 (280)
.+|++|.+|
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 888877644
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.057 Score=42.34 Aligned_cols=98 Identities=17% Similarity=0.098 Sum_probs=59.8
Q ss_pred EEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHH
Q 023591 49 VAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 126 (280)
Q Consensus 49 vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i 126 (280)
..+|++...+- ....+.++..++.++. .|+++..- +...+.++.|.|...... .... +..=
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~---------~~N~----i~ag 150 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN---------FSNF----ITAG 150 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc---------hhHH----HHHh
Confidence 44555543222 2344566777666553 35555421 334678999988543211 1111 1112
Q ss_pred HHHHHHHHh--cCceecCCCCCcEEEeCCCCCcEEEeecCC
Q 023591 127 ISGVSYCHS--MQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (280)
Q Consensus 127 ~~~l~~Lh~--~~i~h~dl~~~ni~i~~~~~~~~~l~df~~ 165 (280)
+.+|...|+ .+.+|||..|+|||-|..|. +||.|-+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~--lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGY--LKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCC--EEecChhh
Confidence 456777883 56999999999999999998 99999654
|
The function of this family is unknown. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.43 Score=46.62 Aligned_cols=32 Identities=34% Similarity=0.484 Sum_probs=25.9
Q ss_pred cCceecCCCCCcEEEeCCCCCcEE-EeecCCcc
Q 023591 136 MQVCHRDLKLENTLLDGSPAPRLK-ICDFGYSK 167 (280)
Q Consensus 136 ~~i~h~dl~~~ni~i~~~~~~~~~-l~df~~~~ 167 (280)
.+++|+|+++.||+++.++..++. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 569999999999999877532355 99999765
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.13 Score=44.12 Aligned_cols=62 Identities=16% Similarity=0.105 Sum_probs=43.0
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhcCceecCCCCCcEEEeCCC
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY-CHSMQVCHRDLKLENTLLDGSP 154 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~-Lh~~~i~h~dl~~~ni~i~~~~ 154 (280)
..++=+|..|.++..++...+ .++....+++.-..+|+-. |---+++|.|+.|.||++....
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred ceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 345556788888888886543 4555666666666666543 3356799999999999996433
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 280 | ||||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-148 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-147 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-147 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-147 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-145 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-142 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-49 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-47 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-47 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-47 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-47 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-47 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-47 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-47 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-46 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-46 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-44 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-44 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-44 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-43 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-43 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-43 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-43 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-43 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-38 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-38 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-38 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-38 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-38 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-37 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-37 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-37 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-37 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-37 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-37 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-37 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-37 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-37 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-37 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-37 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-37 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-37 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-37 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-37 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-36 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-36 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-36 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-35 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-35 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-35 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-35 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-35 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-35 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-35 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-35 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-35 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-35 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-35 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-35 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-35 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-34 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-34 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-34 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-34 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-34 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-34 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-34 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-34 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-34 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-34 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-34 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-34 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-34 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-34 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-34 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-34 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-34 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-34 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-34 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-34 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-34 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-34 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-34 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-34 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-34 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-34 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-34 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-34 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-34 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-34 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-34 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-34 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-34 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-34 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-34 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-34 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-34 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-34 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-34 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-34 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-34 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-34 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-34 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-34 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-34 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-34 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-34 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-34 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-34 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-34 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-34 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-34 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-34 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-34 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-34 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-34 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-34 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-34 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-34 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-34 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-34 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-34 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-33 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-33 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-33 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-32 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-32 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-32 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-32 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-32 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-32 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-32 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-32 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-32 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-32 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-32 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-32 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-32 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-32 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-32 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-32 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-32 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-32 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-32 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-32 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-31 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-31 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-31 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-31 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-31 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-31 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-30 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-30 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-30 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-30 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-30 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-30 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-30 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-30 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-30 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-30 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-30 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-29 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-29 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-29 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-29 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-29 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-29 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-29 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-29 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-29 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-29 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-29 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-29 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-29 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-29 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-29 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-29 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-29 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-29 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-29 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-29 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-29 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-29 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-29 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-29 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-29 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-29 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-29 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-29 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-28 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-28 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-28 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-28 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-28 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-28 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-28 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-28 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-28 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-28 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-28 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-28 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-28 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-28 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-28 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-28 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-28 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-28 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-28 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-28 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-28 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-28 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-28 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-28 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-28 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-28 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-28 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-28 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-28 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-28 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-28 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-28 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-28 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-28 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-28 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-28 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-28 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-28 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-28 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-28 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-28 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-27 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-27 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-27 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-27 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-27 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-27 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-27 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-27 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-27 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-27 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-27 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-27 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-27 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-27 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-26 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-26 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-26 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-26 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-26 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-26 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-26 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-26 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-26 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-26 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-26 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-25 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-25 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-25 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-25 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-25 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-25 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-25 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-25 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-25 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-25 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-25 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-25 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-25 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-25 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-25 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-25 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-25 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-25 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-25 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-25 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-25 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-25 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-25 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-25 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-25 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-25 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-25 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-25 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-24 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-24 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-24 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-24 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-24 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-24 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-24 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-24 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-24 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-24 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-24 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-24 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-23 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-22 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-21 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-21 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-21 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-21 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-20 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-20 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-20 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-20 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-20 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-20 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-20 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-20 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-20 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-20 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-20 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-20 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-20 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-20 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-20 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-20 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-20 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-20 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-20 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-20 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-19 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-19 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-19 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-19 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-19 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-19 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-19 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-19 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-19 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-19 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-19 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-19 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-19 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-19 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-19 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-19 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-19 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-19 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-19 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-19 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-19 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-19 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-19 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-19 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-19 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-19 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-19 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-19 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-19 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-19 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-19 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-19 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-19 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-19 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-19 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-19 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-19 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-18 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-18 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-18 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-18 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-18 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-18 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-18 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-18 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-18 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-18 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-17 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-17 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-17 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-17 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-17 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-17 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-17 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-17 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-17 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-17 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-17 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-15 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-15 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-14 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-13 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-13 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-13 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-13 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 9e-13 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-11 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 8e-11 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 8e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 8e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 9e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 5e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-08 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-08 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-08 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-08 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-08 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 6e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-08 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-08 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-08 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-08 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 8e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-07 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 6e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-06 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-06 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-06 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-05 |
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 483 bits (1244), Expect = e-174
Identities = 237/266 (89%), Positives = 254/266 (95%), Gaps = 1/266 (0%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERG I
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RILSV+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 241 SIPDYVHISPECRHLISRIFVADPAK 266
SIPD + ISPEC HLISRIFVADPA
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPAT 265
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 387 bits (995), Expect = e-136
Identities = 85/261 (32%), Positives = 139/261 (53%), Gaps = 15/261 (5%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
M +P + + ++LV+ +G G +G +L ++ TEE VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 186
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPDY 245
PE+L ++E+ + DVWSCG+ L ML G P++ P + + + + + +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKKTYLNPW 231
Query: 246 VHISPECRHLISRIFVADPAK 266
I L+ +I V +P+
Sbjct: 232 KKIDSAPLALLHKILVENPSA 252
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 383 bits (985), Expect = e-135
Identities = 85/261 (32%), Positives = 139/261 (53%), Gaps = 15/261 (5%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
M +P + + ++LV+ +G G +G +L ++ TEE VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 186
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPDY 245
PE+L ++E+ + DVWSCG+ L ML G P++ P + + + + + +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKKTYLNPW 231
Query: 246 VHISPECRHLISRIFVADPAK 266
I L+ +I V +P+
Sbjct: 232 KKIDSAPLALLHKILVENPSA 252
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 306 bits (786), Expect = e-105
Identities = 102/250 (40%), Positives = 135/250 (54%), Gaps = 14/250 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y L +G G FG ++ + T VAVK + R KI ++REI N + RH
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TPT +VMEY SGGELF+ IC GR E EAR FQQ++S V YCH
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ + Y
Sbjct: 131 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
G D+WSCGV LY +L G PF+D P F+K I + IP+ +++ L+
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPE--YLNRSVATLL 242
Query: 257 SRIFVADPAK 266
+ DP K
Sbjct: 243 MHMLQVDPLK 252
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-103
Identities = 98/249 (39%), Positives = 142/249 (57%), Gaps = 13/249 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
Y L++ IG GNF +L R T VA+K I++ +++ + + RE+ + L HP
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHP 74
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV+ EVI T L ++MEYASGGE+F+ + GR E EAR F+Q++S V YCH +
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRDLK EN LLD +KI DFG+S + + + G P Y APE+ K+YDG
Sbjct: 135 IVHRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
DVWS GV LY ++ G+ PF+ + + +L +Y IP Y+ S +C +L+
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VLRGKYRIPFYM--STDCENLLK 246
Query: 258 RIFVADPAK 266
R V +P K
Sbjct: 247 RFLVLNPIK 255
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = e-103
Identities = 86/251 (34%), Positives = 120/251 (47%), Gaps = 14/251 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
RY R +G G F + D T+E+ A K + + E + EI HRSL H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 195
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL KK +
Sbjct: 135 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
+ DVWS G +Y +LVG PFE ++T RI +YSIP HI+P L
Sbjct: 193 SFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAASL 245
Query: 256 ISRIFVADPAK 266
I ++ DP
Sbjct: 246 IQKMLQTDPTA 256
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = e-102
Identities = 100/250 (40%), Positives = 136/250 (54%), Gaps = 14/250 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y L +G G FG ++ + + T VAVK + R KI ++REI N + RH
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRH 75
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TP+ + +VMEY SGGELF+ IC GR E E+R FQQ++SGV YCH
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ + Y
Sbjct: 136 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
G D+WS GV LY +L G PF+D P F+K I + P +++P L+
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICDGIFYTPQ--YLNPSVISLL 247
Query: 257 SRIFVADPAK 266
+ DP K
Sbjct: 248 KHMLQVDPMK 257
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = e-102
Identities = 86/251 (34%), Positives = 120/251 (47%), Gaps = 14/251 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
RY R +G G F + D T+E+ A K + + E + EI HRSL H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 195
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL KK +
Sbjct: 161 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
+ DVWS G +Y +LVG PFE ++T RI +YSIP HI+P L
Sbjct: 219 SFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAASL 271
Query: 256 ISRIFVADPAK 266
I ++ DP
Sbjct: 272 IQKMLQTDPTA 282
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = e-101
Identities = 109/250 (43%), Positives = 149/250 (59%), Gaps = 15/250 (6%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y + +G G+FG +L KT++ VA+K+I R + V+REI + LRH
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISR-QLLKKSDMHMRVEREISYLKLLRH 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TPT + +V+EYA GGELF+ I R +EDE R FFQQ+I + YCH
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
++ HRDLK EN LLD + +KI DFG S + K++ G+P Y APEV+ K Y
Sbjct: 128 KIVHRDLKPENLLLDDN--LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
G DVWSCG+ LYVMLVG PF+D P F+K + S Y +PD +SP + LI
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPD--FLSPGAQSLI 239
Query: 257 SRIFVADPAK 266
R+ VADP +
Sbjct: 240 RRMIVADPMQ 249
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = e-100
Identities = 77/259 (29%), Positives = 125/259 (48%), Gaps = 24/259 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLR 75
+Y + +G G++G + + D +T AVK +++ K+ + NV++EI R LR
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEANVKKEIQLLRRLR 64
Query: 76 HPNIVRFKEVIL--TPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVS 131
H N+++ +V+ + +VMEY G E+ + + RF +A +F QLI G+
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLE 123
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPE 188
Y HS + H+D+K N LL LKI G +++ + +++ G+PA+ PE
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTG--GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 189 VLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
+ + G D+WS GVTLY + G YPFE N K I Y+IP
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYKLFENIGKGSYAIPGD-- 235
Query: 248 ISPECRHLISRIFVADPAK 266
P L+ + +PAK
Sbjct: 236 CGPPLSDLLKGMLEYEPAK 254
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 290 bits (746), Expect = 3e-99
Identities = 74/252 (29%), Positives = 127/252 (50%), Gaps = 15/252 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
+ +++ +G G+F T VA+K I++ + + VQ E+ H L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS 135
P+I+ ++ +V+E GE+ + N FSE+EAR F Q+I+G+ Y HS
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 194
+ HRDL L N LL + +KI DFG + + + T+ GTP YI+PE+ +
Sbjct: 131 HGILHRDLTLSNLLLTRN--MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
+ + +DVWS G Y +L+G PF+ + T+++++ Y +P +S E +
Sbjct: 189 HGLE-SDVWSLGCMFYTLLIGRPPFDT----DTVKNTLNKVVLADYEMPS--FLSIEAKD 241
Query: 255 LISRIFVADPAK 266
LI ++ +PA
Sbjct: 242 LIHQLLRRNPAD 253
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 1e-98
Identities = 92/293 (31%), Positives = 135/293 (46%), Gaps = 53/293 (18%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER------------------------- 56
+Y L +IG G++GV +L ++ A+K + +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 57 --GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAG 112
E V +EI + L HPN+V+ EV+ P HL +V E + G + E +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-----K 167
SED+ARF+FQ LI G+ Y H ++ HRD+K N L+ +KI DFG S
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED--GHIKIADFGVSNEFKGS 190
Query: 168 SSVLHSQPKSTVGTPAYIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
++L +TVGTPA++APE L +K + GK DVW+ GVTLY + G PF D
Sbjct: 191 DALLS----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
Query: 226 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK----SEM--HDW 272
K I S PD I+ + + LI+R+ +P E+ H W
Sbjct: 247 CLHSK----IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 2e-97
Identities = 78/250 (31%), Positives = 131/250 (52%), Gaps = 14/250 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH 76
D +++ R +G G FG L R+K+ + ++A+K + + ++ ++REI LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R + +++E+A GEL++ + GRF E + F ++L + YCH
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN L+ LKI DFG+S + + ++ GT Y+ PE++ K +D
Sbjct: 134 KVIHRDIKPENLLMGYK--GELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTHD 190
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
K D+W GV Y LVG PF+ P + R+ I++V P ++ S + LI
Sbjct: 191 EK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----IVNVDLKFPPFL--SDGSKDLI 243
Query: 257 SRIFVADPAK 266
S++ P +
Sbjct: 244 SKLLRYHPPQ 253
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 1e-96
Identities = 81/250 (32%), Positives = 135/250 (54%), Gaps = 14/250 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH 76
+ +E+ R +G G FG L R+K+++ ++A+K + + ++ ++RE+ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R T + +++EYA G ++ + +F E + +L + +SYCHS
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN LL + LKI DFG+S S+ GT Y+ PE++ + +D
Sbjct: 129 RVIHRDIKPENLLLGSA--GELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
K D+WS GV Y LVG PFE +++T RI V+++ PD ++ R LI
Sbjct: 186 EK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPD--FVTEGARDLI 238
Query: 257 SRIFVADPAK 266
SR+ +P++
Sbjct: 239 SRLLKHNPSQ 248
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 2e-95
Identities = 75/260 (28%), Positives = 115/260 (44%), Gaps = 32/260 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--------VQREIINHR 72
+Y++ +GSG FG VA+K++E+ D+I + V E++ +
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLK 101
Query: 73 SLRH--PNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISG 129
+ ++R + P +++E +LF+ I G E+ AR FF Q++
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 161
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIA 186
V +CH+ V HRD+K EN L+D + LK+ DFG K +V GT Y
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSP 216
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
PE + Y G+ A VWS G+ LY M+ G PFE E I+ Q
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQ-- 264
Query: 247 HISPECRHLISRIFVADPAK 266
+S EC+HLI P+
Sbjct: 265 RVSSECQHLIRWCLALRPSD 284
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 3e-95
Identities = 74/255 (29%), Positives = 111/255 (43%), Gaps = 24/255 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIINHR 72
+Y + +GSG FG DK+ + V VK+I++ D V EI
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 73 SLRHPNIVRFKEVILTPTHLAIVME-YASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ H NI++ ++ +VME + SG +LF I R E A + F+QL+S V
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y + HRD+K EN ++ +K+ DFG + + GT Y APEVL+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAED--FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
Y G ++WS GVTLY ++ PF + EE + P V S E
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAIHPPYLV--SKE 250
Query: 252 CRHLISRIFVADPAK 266
L+S + P +
Sbjct: 251 LMSLVSGLLQPVPER 265
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 8e-95
Identities = 72/262 (27%), Positives = 104/262 (39%), Gaps = 34/262 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHR 72
Y L +G G FG VA+K I R +++ E+
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR-NRVLGWSPLSDSVTCPLEVALLW 89
Query: 73 SLR----HPNIVRFKEVILTPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLI 127
+ HP ++R + T +V+E +LF+ I G E +R FF Q++
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAY 184
+ + +CHS V HRD+K EN L+D K+ DFG GT Y
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVY 204
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
PE + + +Y A VWS G+ LY M+ G PFE IL + P
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER----------DQEILEAELHFPA 254
Query: 245 YVHISPECRHLISRIFVADPAK 266
H+SP+C LI R P+
Sbjct: 255 --HVSPDCCALIRRCLAPKPSS 274
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 4e-88
Identities = 87/252 (34%), Positives = 132/252 (52%), Gaps = 12/252 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHP 77
+ Y L IG G++G ++ K T A K I + ++ + ++EI +SL HP
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHP 66
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NI+R E T + +VME +GGELFER+ + F E +A + ++S V+YCH +
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 138 VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN L SP LK+ DFG + ++ VGTP Y++P+V L+ Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV-LEGLY- 184
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRH 254
G D WS GV +YV+L G PF P + + K I ++ D++++SP+
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAES 240
Query: 255 LISRIFVADPAK 266
LI R+ P +
Sbjct: 241 LIRRLLTKSPKQ 252
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 265 bits (678), Expect = 5e-88
Identities = 53/294 (18%), Positives = 103/294 (35%), Gaps = 59/294 (20%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER------------------GDKIDE 62
+ Y ++R + G F L K + A+K E+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 63 NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------RF 114
+ + E+ +++ + + +I + I+ EY + +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 115 SEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 170
+ + +++ SY H+ +CHRD+K N L+D + R+K+ DFG S+
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN--GRVKLSDFGESEYMVDKK 206
Query: 171 LHSQPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
+ + GT ++ PE + Y+G D+WS G+ LYVM PF +
Sbjct: 207 IK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI---SLV 259
Query: 230 KTIHRILSVQYSIPDYV-----------------HISPECRHLISRIFVADPAK 266
+ + I + P +S E + +PA+
Sbjct: 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 6e-87
Identities = 86/253 (33%), Positives = 131/253 (51%), Gaps = 11/253 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
SD Y++ ++G G F V R K T A K I + + ++RE R L+H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCHS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL K Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
K D+W+CGV LY++LVG PF D ++ + + + I + Y P++ ++PE +
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAK 239
Query: 254 HLISRIFVADPAK 266
LI + +P K
Sbjct: 240 SLIDSMLTVNPKK 252
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 2e-86
Identities = 82/262 (31%), Positives = 124/262 (47%), Gaps = 20/262 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIIN 70
D Y + + +GSG G +L ++KT + VA+K I + NV+ EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 131 SYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 190 LLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQYSIPDYV 246
L+ + D WS GV L++ L G PF + + + I S +Y+ V
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----ITSGKYNFIPEV 243
Query: 247 --HISPECRHLISRIFVADPAK 266
+S + L+ ++ V DP
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKA 265
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 9e-86
Identities = 64/287 (22%), Positives = 115/287 (40%), Gaps = 41/287 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ + L +G G R KKT +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 78 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 132
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 191 --------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS- 241
+K+Y D+WS GVT Y G+ PF E P+ ++ +++I++ + S
Sbjct: 188 ERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 242 ------------------IPDYVHISPECR----HLISRIFVADPAK 266
+P +S + +++ I AD K
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 2e-85
Identities = 77/255 (30%), Positives = 122/255 (47%), Gaps = 14/255 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKID-ENVQREIINHRSLRHP 77
D + R +GSG FG L+ ++ + +K I ++ E ++ EI +SL HP
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYC 133
NI++ EV ++ IVME GGEL ERI SE +Q+++ ++Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 134 HSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
HS V H+DLK EN L SP +KI DFG ++ + GT Y+APEV K
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV-FK 199
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPE 251
++ K D+WS GV +Y +L G PF + +K + + + ++P+
Sbjct: 200 RDVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQ 254
Query: 252 CRHLISRIFVADPAK 266
L+ ++ DP +
Sbjct: 255 AVDLLKQMLTKDPER 269
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 5e-85
Identities = 80/261 (30%), Positives = 125/261 (47%), Gaps = 18/261 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIIN 70
D Y + + +GSG G +L ++KT + VA++ I + NV+ EI
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 131 SYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312
Query: 190 LLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDY 245
L+ + D WS GV L++ L G PF + + + +I S +Y+ +
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD---QITSGKYNFIPEVW 369
Query: 246 VHISPECRHLISRIFVADPAK 266
+S + L+ ++ V DP
Sbjct: 370 AEVSEKALDLVKKLLVVDPKA 390
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 255 bits (655), Expect = 5e-85
Identities = 85/252 (33%), Positives = 129/252 (51%), Gaps = 12/252 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-NVQREIINHRSLRHPN 78
+ + +GSG F L++ + T +L A+K I++ + +++ EI + ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV +++ + TH +VM+ SGGELF+RI G ++E +A QQ++S V Y H +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 139 CHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYD 196
HRDLK EN L ++ I DFG SK + + + GTP Y+APEVL +K Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY- 184
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRH 254
K D WS GV Y++L G PF + E K F K I Y P + IS +
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKD 240
Query: 255 LISRIFVADPAK 266
I + DP +
Sbjct: 241 FICHLLEKDPNE 252
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 6e-85
Identities = 64/287 (22%), Positives = 114/287 (39%), Gaps = 41/287 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ + L +G G R KKT +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 78 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 132
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 191 --------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS- 241
+K+Y D+WS GVT Y G+ PF E P+ ++ +++I++ + S
Sbjct: 188 ERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 242 ------------------IPDYVHISP----ECRHLISRIFVADPAK 266
+P +S +++ I AD K
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 3e-84
Identities = 86/258 (33%), Positives = 135/258 (52%), Gaps = 16/258 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D YE+ ++GSG F + R R K T + A K+I R E ++RE+ R
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+RHPNI+ ++ T + +++E SGGELF+ + +EDEA F +Q++ GV Y
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS ++ H DLK EN +L P PR+K+ DFG + ++ K+ GTP ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248
+ G AD+WS GV Y++L GA PF + + I +V Y + + +
Sbjct: 184 NYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTN----ISAVNYDFDEEYFSNT 238
Query: 249 SPECRHLISRIFVADPAK 266
S + I R+ V DP +
Sbjct: 239 SELAKDFIRRLLVKDPKR 256
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 9e-84
Identities = 89/253 (35%), Positives = 138/253 (54%), Gaps = 12/253 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
++RY +V +G G+FG +D+ T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEV L+ Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
D K DVWS GV LY++L G PF E ++ + + +Y+ +P + IS + +
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAK 254
Query: 254 HLISRIFVADPAK 266
LI ++ P+
Sbjct: 255 DLIRKMLTFHPSL 267
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 1e-83
Identities = 87/253 (34%), Positives = 132/253 (52%), Gaps = 11/253 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKID-ENVQREIINHRSLRH 76
SD Y++ ++G G F V R K T A K I + D + ++RE R L+H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCHS
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL K Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
K D+W+CGV LY++LVG PF D ++ + + + I + Y P++ ++PE +
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAK 262
Query: 254 HLISRIFVADPAK 266
LI + +P K
Sbjct: 263 SLIDSMLTVNPKK 275
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 3e-83
Identities = 85/253 (33%), Positives = 122/253 (48%), Gaps = 11/253 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPN 78
+D YE+ DIG G++ V + K T AVK I DK + EI I R +HPN
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPTEEIEILLRYGQHPN 77
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
I+ K+V ++ +V E GGEL ++I FSE EA + V Y H+ V
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 139 CHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
HRDLK N L ++ICDFG++K + T T ++APEVL ++ Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--HISPECR 253
D D+WS GV LY ML G PF + + RI S ++S+ +S +
Sbjct: 198 D-AACDIWSLGVLLYTMLTGYTPF-ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255
Query: 254 HLISRIFVADPAK 266
L+S++ DP +
Sbjct: 256 DLVSKMLHVDPHQ 268
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 3e-83
Identities = 81/265 (30%), Positives = 121/265 (45%), Gaps = 24/265 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREI- 68
+ YE +G G V R K T + AVK I E ++ E +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 69 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
I + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 189 VLLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI- 242
++ D GK D+WS GV +Y +L G+ PF ++ R I+S Y
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQFG 249
Query: 243 -PDYVHISPECRHLISRIFVADPAK 266
P++ S + L+SR V P K
Sbjct: 250 SPEWDDYSDTVKDLVSRFLVVQPQK 274
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 7e-83
Identities = 76/264 (28%), Positives = 119/264 (45%), Gaps = 23/264 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREI-I 69
+Y+ IG G V R + T AVK +E +++ E +RE I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
+ HP+I+ + + + + +V + GELF+ + SE E R + L+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
VS+ H+ + HRDLK EN LLD + +++ DFG+S + + GTP Y+APE+
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 190 LLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
L + GK D+W+CGV L+ +L G+ PF + R I+ QY
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSS 326
Query: 245 YV--HISPECRHLISRIFVADPAK 266
S + LISR+ DP
Sbjct: 327 PEWDDRSSTVKDLISRLLQVDPEA 350
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 7e-83
Identities = 85/258 (32%), Positives = 137/258 (53%), Gaps = 16/258 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y+ ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 133 CHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS+Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248
+ G AD+WS GV Y++L GA PF + + + +V Y D + +
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----VSAVNYEFEDEYFSNT 244
Query: 249 SPECRHLISRIFVADPAK 266
S + I R+ V DP K
Sbjct: 245 SALAKDFIRRLLVKDPKK 262
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 1e-82
Identities = 57/263 (21%), Positives = 104/263 (39%), Gaps = 26/263 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++K + + A+KY+ + + ++ + EI L+ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 147 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
+DVWS G LY M G PF+ N +H I+ + I
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---IINQISKLHAIIDPNHEIE 260
Query: 244 DYVHISPECRHLISRIFVADPAK 266
+ + ++ DP +
Sbjct: 261 FPDIPEKDLQDVLKCCLKRDPKQ 283
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 1e-82
Identities = 90/253 (35%), Positives = 137/253 (54%), Gaps = 12/253 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
++RY +V +G G+FG +D+ T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEV L+ Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECR 253
D K DVWS GV LY++L G PF KN + R+ + + +P + IS + +
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYG----KNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 254 HLISRIFVADPAK 266
LI ++ P+
Sbjct: 255 DLIRKMLTFHPSL 267
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 3e-82
Identities = 80/258 (31%), Positives = 131/258 (50%), Gaps = 16/258 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y++ ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ HPNI+ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
H+ ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248
+ G AD+WS GV Y++L GA PF + + I +V Y + +
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITAVSYDFDEEFFSQT 245
Query: 249 SPECRHLISRIFVADPAK 266
S + I ++ V + K
Sbjct: 246 SELAKDFIRKLLVKETRK 263
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 3e-82
Identities = 80/258 (31%), Positives = 131/258 (50%), Gaps = 16/258 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y++ ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ H N++ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
H+ ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248
+ G AD+WS GV Y++L GA PF + + I SV Y + + H
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITSVSYDFDEEFFSHT 245
Query: 249 SPECRHLISRIFVADPAK 266
S + I ++ V + K
Sbjct: 246 SELAKDFIRKLLVKETRK 263
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 3e-82
Identities = 95/273 (34%), Positives = 139/273 (50%), Gaps = 15/273 (5%)
Query: 3 RSAMTVGPGM--DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---G 57
+ PGM SDRY+ R +G G+FG L +DK T + AVK I +
Sbjct: 6 MDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK 65
Query: 58 DKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 116
K D E++ RE+ + L HPNI++ E + +V E +GGELF+ I + RFSE
Sbjct: 66 QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP 175
+A +Q++SG++Y H ++ HRDLK EN LL+ S ++I DFG S +
Sbjct: 126 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
K +GT YIAPEV L YD K DVWS GV LY++L G PF N + ++
Sbjct: 186 KDKIGTAYYIAPEV-LHGTYDEK-CDVWSTGVILYILLSGCPPFNG----ANEYDILKKV 239
Query: 236 LS--VQYSIPDYVHISPECRHLISRIFVADPAK 266
+ +P + +S + LI ++ P+
Sbjct: 240 EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSM 272
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 6e-82
Identities = 85/253 (33%), Positives = 135/253 (53%), Gaps = 12/253 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
S+ Y+ V+ +GSG +G L RDK T A+K I + + + E+ + L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ + + +VME GGELF+ I + +F+E +A +Q++SGV+Y H
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL +KI DFG S + K +GT YIAPEV L+K+Y
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-LRKKY 214
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
D K DVWS GV L+++L G PF + ++ + ++ +Y+ P++ ++S +
Sbjct: 215 DEK-CDVWSIGVILFILLAGYPPFGG----QTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269
Query: 254 HLISRIFVADPAK 266
LI ++ D +
Sbjct: 270 DLIKQMLQFDSQR 282
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 258 bits (659), Expect = 1e-81
Identities = 72/276 (26%), Positives = 107/276 (38%), Gaps = 31/276 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
+E+ +G+G FG + T E VA+K + K E EI + L HPN
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 79 IVRFKEVILTPTHLA------IVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISG 129
+V +EV LA + MEY GG+L + + N E R + S
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 130 VSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
+ Y H ++ HRDLK EN +L G KI D GY+K VGT Y+APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-------------- 234
+L +K+Y D WS G + + G PF +P + +
Sbjct: 194 LLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252
Query: 235 ILSVQYSIPDYVHISPECRHLISRIF----VADPAK 266
+ +P H+S + R + +
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQ 288
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 1e-81
Identities = 56/263 (21%), Positives = 104/263 (39%), Gaps = 26/263 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++K + + A+KY+ + + ++ + EI L+ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 128 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
+DVWS G LY M G PF+ + +H I+ + I
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIE 241
Query: 244 DYVHISPECRHLISRIFVADPAK 266
+ + ++ DP +
Sbjct: 242 FPDIPEKDLQDVLKCCLKRDPKQ 264
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 1e-81
Identities = 59/250 (23%), Positives = 109/250 (43%), Gaps = 8/250 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
++Y + D+G G FG+ + +++ K+++ V++EI RH NI
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQV 138
+ E + L ++ E+ SG ++FERI + +E E + Q+ + + HS +
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-ST 182
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLI 256
D+WS G +YV+L G PF + I++ +Y+ + + IS E +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNAEYTFDEEAFKEISIEAMDFV 238
Query: 257 SRIFVADPAK 266
R+ V +
Sbjct: 239 DRLLVKERKS 248
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 1e-81
Identities = 71/278 (25%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ +E + +G G FG R+ A+K I ++ + E++ SL H +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 80 VRFKEVIL-------------TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQ 125
VR+ L + L I MEY G L++ I + DE F+Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---------------SV 170
++ +SY HS + HRDLK N +D S +KI DFG +K+
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
S +GT Y+A EVL + + D++S G+ + M+ YPF E N K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILK 239
Query: 231 TIHRILSVQYSIPDYV--HISPECRHLISRIFVADPAK 266
++ SV P + + +I + DP K
Sbjct: 240 ---KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNK 274
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 2e-81
Identities = 88/250 (35%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
SD +E+ ++G G + + K T++ A+K +++ + V+ EI L HPNI
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRLSHPNI 110
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
++ KE+ TPT +++V+E +GGELF+RI G +SE +A +Q++ V+Y H +
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 140 HRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRDLK EN L +P LKI DFG SK K+ GTP Y APE+L Y G
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GP 229
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLI 256
D+WS G+ Y++L G PF D + + RIL+ +Y P + +S + L+
Sbjct: 230 EVDMWSVGIITYILLCGFEPFYD---ERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV 286
Query: 257 SRIFVADPAK 266
++ V DP K
Sbjct: 287 RKLIVLDPKK 296
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 2e-81
Identities = 75/301 (24%), Positives = 125/301 (41%), Gaps = 58/301 (19%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKID-ENVQREIINHRS 73
+Y L IG G++GV R+ + +T + A+K + + + D E ++ E+ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 113
L HPNI R EV ++ +VME GG L +++
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 114 --------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153
E +Q+ S + Y H+ +CHRD+K EN L +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 154 PAPRLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYD-GKIADVWSCGV 207
+ +K+ DFG SK + + GTP ++APEVL G D WS GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 208 TLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIFVADPA 265
L+++L+GA PF + + +L+ + P+Y +SP R L+S + +
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQ----VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320
Query: 266 K 266
+
Sbjct: 321 E 321
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 253 bits (647), Expect = 2e-81
Identities = 90/264 (34%), Positives = 136/264 (51%), Gaps = 23/264 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--------------GDKIDENVQ 65
+ Y VR +GSG +G L ++K A+K I++ +K E +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 125
EI +SL HPNI++ +V + +V E+ GGELFE+I N +F E +A +Q
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 126 LISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
++SG+ Y H + HRD+K EN LL + + +KI DFG S + + +GT Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSI 242
IAPEV LKK+Y+ K DVWSCGV +Y++L G PF +N + I ++ +
Sbjct: 215 IAPEV-LKKKYNEK-CDVWSCGVIMYILLCGYPPFGG----QNDQDIIKKVEKGKYYFDF 268
Query: 243 PDYVHISPECRHLISRIFVADPAK 266
D+ +IS E + LI + D K
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNK 292
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 3e-81
Identities = 87/257 (33%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
++ Y+L ++G G F V R + A I D + ++RE R L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I H ++ + +GGELFE I +SE +A QQ++ V +CH M
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 137 QVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 191
V HR+LK EN LL G+ +K+ DFG + Q GTP Y++PEVL
Sbjct: 130 GVVHRNLKPENLLLASKLKGAA---VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHIS 249
K Y GK D+W+CGV LY++LVG PF D ++ + +++ I + Y P++ ++
Sbjct: 187 KDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVT 241
Query: 250 PECRHLISRIFVADPAK 266
PE + LI+++ +P+K
Sbjct: 242 PEAKDLINKMLTINPSK 258
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 4e-81
Identities = 92/258 (35%), Positives = 133/258 (51%), Gaps = 14/258 (5%)
Query: 20 SDRYEL---VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLR 75
Y+L + +G G+F + R KK+ + AVK I + +++ N Q+EI
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEG 64
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HPNIV+ EV H +VME +GGELFERI FSE EA + ++L+S VS+ H
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 136 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKK 193
+ V HRDLK EN L D + +KI DFG+++ +QP T T Y APE+L +
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---HRILSVQYS--IPDYVHI 248
YD + D+WS GV LY ML G PF+ + + +I +S + ++
Sbjct: 185 GYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243
Query: 249 SPECRHLISRIFVADPAK 266
S E + LI + DP K
Sbjct: 244 SQEAKDLIQGLLTVDPNK 261
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 2e-80
Identities = 69/251 (27%), Positives = 118/251 (47%), Gaps = 9/251 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D Y+++ ++GSG FGV +K T + K+I +D V+ EI L HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQ 137
++ + + +++E+ SGGELF+RI + SE E + +Q G+ + H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ H D+K EN + + A +KI DFG + K T T + APE++ ++ G
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-G 228
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHL 255
D+W+ GV YV+L G PF ++ +T+ + + + +SPE +
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAG----EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 256 ISRIFVADPAK 266
I + +P K
Sbjct: 285 IKNLLQKEPRK 295
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 3e-80
Identities = 54/263 (20%), Positives = 104/263 (39%), Gaps = 26/263 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++ +++ A+KY+ + + ++ + EI L+ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + + S VG Y+ PE +
Sbjct: 175 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
+DVWS G LY M G PF+ + +H I+ + I
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIE 288
Query: 244 DYVHISPECRHLISRIFVADPAK 266
+ + ++ DP +
Sbjct: 289 FPDIPEKDLQDVLKCCLKRDPKQ 311
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 2e-79
Identities = 69/257 (26%), Positives = 117/257 (45%), Gaps = 15/257 (5%)
Query: 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREI-INHRSL 74
++ Y L +++G G F V R K T + A K+++ RG + EI + +
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSY 132
P ++ EV + + +++EYA+GGE+F A SE++ +Q++ GV Y
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 133 CHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
H + H DLK +N LL P +KI DFG S+ + + +GTP Y+APE+L
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
D+W+ G+ Y++L PF + + + I V + + +S
Sbjct: 207 YDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----ISQVNVDYSEETFSSVS 261
Query: 250 PECRHLISRIFVADPAK 266
I + V +P K
Sbjct: 262 QLATDFIQSLLVKNPEK 278
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 2e-78
Identities = 78/261 (29%), Positives = 123/261 (47%), Gaps = 20/261 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE------RGDKIDENVQREIINHRS 73
D YEL IG G F V R +++T + AVK ++ E+++RE
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISG 129
L+HP+IV E + L +V E+ G +L I +SE A + +Q++
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 130 VSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAP 187
+ YCH + HRD+K LL + +K+ FG + VGTP ++AP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDY 245
EV+ ++ Y GK DVW CGV L+++L G PF +E + I+ +Y +
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQW 256
Query: 246 VHISPECRHLISRIFVADPAK 266
HIS + L+ R+ + DPA+
Sbjct: 257 SHISESAKDLVRRMLMLDPAE 277
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 2e-78
Identities = 77/251 (30%), Positives = 126/251 (50%), Gaps = 9/251 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D Y++ ++G+G FGV + ++ T A K++ + D E V++EI LRHP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQ 137
+V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G+ + H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
H DLK EN + + LK+ DFG + K T GT + APEV K G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHL 255
D+WS GV Y++L G PF +N +T+ + S +++ D + IS + +
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 256 ISRIFVADPAK 266
I ++ +ADP
Sbjct: 391 IRKLLLADPNT 401
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 2e-78
Identities = 74/253 (29%), Positives = 124/253 (49%), Gaps = 11/253 (4%)
Query: 20 SDRYELVR--DIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRH 76
+ Y + + +G G FG + T +A K I+ RG K E V+ EI L H
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHS 135
N+++ + + + +VMEY GGELF+RI + +E + F +Q+ G+ + H
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
M + H DLK EN L A ++KI DFG ++ + K GTP ++APEV + ++
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV-VNYDF 264
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
D+WS GV Y++L G PF + + IL+ ++ ++ IS E +
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN----ILACRWDLEDEEFQDISEEAK 320
Query: 254 HLISRIFVADPAK 266
IS++ + + +
Sbjct: 321 EFISKLLIKEKSW 333
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 9e-78
Identities = 86/275 (31%), Positives = 134/275 (48%), Gaps = 16/275 (5%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
V G+ + D Y++ + +G G G + +K+T+E A+K ++
Sbjct: 43 FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----C 98
Query: 62 ENVQREI-INHRSLRHPNIVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RF 114
+RE+ ++ R+ + P+IVR +V L IVME GGELF RI + G F
Sbjct: 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS 173
+E EA + + + Y HS+ + HRD+K EN L P LK+ DFG++K + H+
Sbjct: 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+ TP Y+APEVL ++YD K D+WS GV +Y++L G PF
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277
Query: 234 RILSVQYSIPDYV--HISPECRHLISRIFVADPAK 266
RI QY P+ +S E + LI + +P +
Sbjct: 278 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 312
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 9e-77
Identities = 76/259 (29%), Positives = 120/259 (46%), Gaps = 19/259 (7%)
Query: 20 SDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHP 77
+D Y+L + +G G G ++T + A+K + ++E+ + ++ P
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGP 82
Query: 78 NIVRFKEVILTPTHLA----IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVS 131
+IV +V H I+ME GGELF RI G F+E EA + + + +
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 132 YCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV 189
+ HS + HRD+K EN L LK+ DFG++K ++ TP Y+APEV
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEV 200
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--H 247
L ++YD K D+WS GV +Y++L G PF RI QY P+
Sbjct: 201 LGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259
Query: 248 ISPECRHLISRIFVADPAK 266
+S + + LI + DP +
Sbjct: 260 VSEDAKQLIRLLLKTDPTE 278
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 6e-76
Identities = 80/294 (27%), Positives = 123/294 (41%), Gaps = 37/294 (12%)
Query: 20 SDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREI-INHRSLRH 76
D Y+L D +G G + + T + AVK IE + I V RE+ + ++ H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
N++ E +V E GG + I F+E EA Q + S + + H+
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 137 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIA 186
+ HRDLK EN L + +P +KICDF S + + + G+ Y+A
Sbjct: 131 GIAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 187 PEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPF-----------EDPEEPKNFRKT 231
PEV+ + K D+WS GV LY++L G PF P
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 232 IHRILSVQYS--IPDYVHISPECRHLISRIFVADPAK----SE--MHDWRRGCS 277
I +Y D+ HIS + LIS++ V D + ++ H W +GC+
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 2e-75
Identities = 70/253 (27%), Positives = 129/253 (50%), Gaps = 16/253 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHP 77
++Y ++ IG G+FG A L++ + +K I E +RE+ +++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV+++E L IVM+Y GG+LF+RI F ED+ +F Q+ + + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ HRD+K +N L +++ DFG ++ + ++ +GTP Y++PE+ K
Sbjct: 144 RKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECR 253
Y+ K +D+W+ G LY + + FE + + + +I+S + + H S + R
Sbjct: 202 YNNK-SDIWALGCVLYELCTLKHAFEA----GSMKNLVLKIISGSFPPVSL--HYSYDLR 254
Query: 254 HLISRIFVADPAK 266
L+S++F +P
Sbjct: 255 SLVSQLFKRNPRD 267
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 3e-75
Identities = 63/269 (23%), Positives = 105/269 (39%), Gaps = 26/269 (9%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHP 77
D+ Y ++ +G G F L+ A+K I ++ D E QRE HR HP
Sbjct: 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86
Query: 78 NIVRFKEVILTPT----HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISG 129
NI+R L +++ + G L+ I +ED+ + + G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----------V 179
+ H+ HRDLK N LL + + D G + +H +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDE--GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 180 GTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237
T +Y APE+ + + + DVWS G LY M+ G P++ + + ++ +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALAVQ 261
Query: 238 VQYSIPDYVHISPECRHLISRIFVADPAK 266
Q SIP S L++ + DP +
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQ 290
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-74
Identities = 76/262 (29%), Positives = 124/262 (47%), Gaps = 25/262 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHP 77
+ YE++ IG+G++G + +R K +++ K ++ G + + + E+ R L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 78 NIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
NIVR+ + I+ T L IVMEY GG+L I + E+ QL +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 132 YCHSM-----QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYI 185
CH V HRDLK N LDG +K+ DFG ++ + S K+ VGTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPD 244
+PE + + Y+ K +D+WS G LY + PF + ++ +I ++ IP
Sbjct: 184 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY 238
Query: 245 YVHISPECRHLISRIFVADPAK 266
S E +I+R+
Sbjct: 239 --RYSDELNEIITRMLNLKDYH 258
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 9e-73
Identities = 58/264 (21%), Positives = 102/264 (38%), Gaps = 34/264 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++ + IGSG FG + + + +K + +E +RE+ L H NIV
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIV 67
Query: 81 RFKEVILTPTH----------------LAIVMEYASGGELFERI--CNAGRFSEDEARFF 122
+ + L I ME+ G L + I + + A
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182
F+Q+ GV Y HS ++ +RDLK N L + ++KI DFG S + + GT
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDT--KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242
Y++PE + ++Y + D+++ G+ L +L E F + I
Sbjct: 186 RYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDT---AFETSKFFTDLRDG-----II 236
Query: 243 PDYVHISPECRHLISRIFVADPAK 266
D + + L+ ++ P
Sbjct: 237 SD--IFDKKEKTLLQKLLSKKPED 258
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-70
Identities = 71/256 (27%), Positives = 113/256 (44%), Gaps = 16/256 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
+ + + IG G F VA+K ++ D +D + +EI + L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 132
PN++++ + L IV+E A G+L I + + E +F QL S + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL 191
HS +V HRD+K N + + +K+ D G + S + S VGTP Y++PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISP 250
+ Y+ K +D+WS G LY M PF + N +I Y +P H S
Sbjct: 210 ENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPS-DHYSE 265
Query: 251 ECRHLISRIFVADPAK 266
E R L++ DP K
Sbjct: 266 ELRQLVNMCINPDPEK 281
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 3e-70
Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 39/274 (14%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSLR-HPNI 79
R + R + G F +D + A+K + ++ + +E+ + L HPNI
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 80 VRF-------KEVILTPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISG 129
V+F KE T +++ G+L E + G S D F Q
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 130 VSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------- 178
V + H + + HRDLK+EN LL +K+CDFG + + + +
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 179 ----VGTPAYIAPEV--LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
TP Y PE+ L G+ D+W+ G LY++ +PFED
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG--------AK 258
Query: 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
RI++ +YSIP + LI + +P +
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEE 292
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-68
Identities = 75/257 (29%), Positives = 113/257 (43%), Gaps = 36/257 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPN 78
D + +G G G + +K+T+E A+K ++ +RE+ ++ R+ + P+
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPH 72
Query: 79 IVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSY 132
IVR +V L IVME GGELF RI + G F+E EA + + + Y
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 133 CHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
HS+ + HRD+K EN L P LK+ DFG A E
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKET-T 171
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--HIS 249
++YD K D+WS GV +Y++L G PF RI QY P+ +S
Sbjct: 172 GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 230
Query: 250 PECRHLISRIFVADPAK 266
E + LI + +P +
Sbjct: 231 EEVKMLIRNLLKTEPTQ 247
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-68
Identities = 58/251 (23%), Positives = 101/251 (40%), Gaps = 17/251 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSL-RH 76
++ + +G G++G +R K+ L AVK RG K E+ +H + +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHS 135
P VR ++ L + E G L + G E + + + + +++ HS
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ H D+K N L P R K+ DFG + G P Y+APE+ L+ Y
Sbjct: 176 QGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-LQGSY 232
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
ADV+S G+T+ + P + +++ L + +S E R +
Sbjct: 233 GTA-ADVFSLGLTILEVACNMEL---PHGGEGWQQLRQGYLPPE--FTA--GLSSELRSV 284
Query: 256 ISRIFVADPAK 266
+ + DP
Sbjct: 285 LVMMLEPDPKL 295
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-66
Identities = 73/253 (28%), Positives = 122/253 (48%), Gaps = 20/253 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 76
++ + +G G+F L R+ T A+K +I + +K+ +R++++ L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS--RLDH 89
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 193
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L +K
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
K +D+W+ G +Y ++ G PF E F+K I+ ++Y P+ P+ R
Sbjct: 208 SA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 260
Query: 254 HLISRIFVADPAK 266
L+ ++ V D K
Sbjct: 261 DLVEKLLVLDATK 273
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-65
Identities = 62/276 (22%), Positives = 105/276 (38%), Gaps = 40/276 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+E ++ +G G FGV ++K + A+K I + E V RE+ L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 79 IVRFKEVILT------------PTHLAIVMEYASGGELFERI---CNAGRFSEDEARFFF 123
IVR+ L +L I M+ L + + C F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------------SSV 170
Q+ V + HS + HRDLK N +K+ DFG
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+++ VGT Y++PE + Y K D++S G+ L+ +L YPF E +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMERV---R 235
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
T+ + ++++ P + P ++ + P +
Sbjct: 236 TLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPME 270
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 5e-65
Identities = 64/282 (22%), Positives = 106/282 (37%), Gaps = 46/282 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNI 79
+ + +G G+ G + VAVK + + EI + S HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-------EARFFFQQLISGVSY 132
+R+ T L I +E L + + + E+ +Q+ SGV++
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 133 CHSMQVCHRDLKLENTLLDGSPAP-----------RLKICDFGYSK-----SSVLHSQPK 176
HS+++ HRDLK +N L+ S R+ I DFG K S +
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 177 STVGTPAYIAPEVLLKKEYD------GKIADVWSCGVTLYVMLVGAY-PFEDPEEPKNFR 229
+ GT + APE+L + + D++S G Y +L PF D
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS----- 245
Query: 230 KTIHRILSVQYSIPDYV-----HISPECRHLISRIFVADPAK 266
I+ +S+ + + E LIS++ DP K
Sbjct: 246 -RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK 286
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 3e-62
Identities = 62/259 (23%), Positives = 94/259 (36%), Gaps = 23/259 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNIV 80
+ +G G G R VAVK I + RE+ + S HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVI 81
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVC 139
R+ I +E L E + E QQ SG+++ HS+ +
Sbjct: 82 RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140
Query: 140 HRDLKLENTLL---DGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL-- 190
HRDLK N L+ + + I DFG K S+ GT +IAPE+L
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 191 -LKKEYDGKIADVWSCGVTLYVMLVGAY-PFEDPEEPKNFRKTIHRILSVQYSIPDY-VH 247
K+ D++S G Y ++ PF + R+ + + H
Sbjct: 201 DCKENPTYT-VDIFSAGCVFYYVISEGSHPFGKSLQ----RQANILLGACSLDCLHPEKH 255
Query: 248 ISPECRHLISRIFVADPAK 266
R LI ++ DP K
Sbjct: 256 EDVIARELIEKMIAMDPQK 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 5e-61
Identities = 49/279 (17%), Positives = 94/279 (33%), Gaps = 40/279 (14%)
Query: 19 DSDRYELVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERGDKIDENVQREIIN-HR 72
S + +G G F + D K ++ +K + + + + +++ +
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-----NAGRFSEDEARFFFQQLI 127
++F L +V E S G L I + F +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPR---------LKICDFGYSKSSVLHSQPKST 178
+ H ++ H D+K +N +L + L + D G S + PK T
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGT 240
Query: 179 V-----GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPKNFRKTI 232
+ T + E+L K ++ +I D + T+Y ML G Y ++
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 233 HR---------ILSVQYSIPDYVHIS--PECRHLISRIF 260
R V +IPD H+ R + ++F
Sbjct: 300 RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 7e-61
Identities = 75/256 (29%), Positives = 136/256 (53%), Gaps = 22/256 (8%)
Query: 21 DRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----S 73
++EL++ +G G+FG + + + +L A+K + + + + R
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVE 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
+ HP IV+ T L +++++ GG+LF R+ F+E++ +F+ +L + +
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 134 HSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVL 190
HS+ + +RDLK EN LLD G +K+ DFG SK S+ H + + GT Y+APEV+
Sbjct: 143 HSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
++ + + AD WS GV ++ ML G PF+ K+ ++T+ IL + +P + +SP
Sbjct: 199 NRRGH-TQSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSP 251
Query: 251 ECRHLISRIFVADPAK 266
E + L+ +F +PA
Sbjct: 252 EAQSLLRMLFKRNPAN 267
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 3e-60
Identities = 78/254 (30%), Positives = 126/254 (49%), Gaps = 27/254 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
++++R +G+G+FG L+R + A+K + K + V+ + + H +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLMLSIV 63
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
HP I+R + ++M+Y GGELF + + RF A+F+ ++ + Y H
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 135 SMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
S + +RDLK EN LLD G +KI DFG++K + + GTP YIAPEV+
Sbjct: 124 SKDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVST 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
K Y K D WS G+ +Y ML G PF D K + K IL+ + P + +
Sbjct: 178 KPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK----ILNAELRFPP--FFNEDV 230
Query: 253 RHLISRIFVADPAK 266
+ L+SR+ D ++
Sbjct: 231 KDLLSRLITRDLSQ 244
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 6e-60
Identities = 62/251 (24%), Positives = 115/251 (45%), Gaps = 15/251 (5%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPNI 79
E++R IG G+FG +++ T+++ A+KY+ + ++ N R + L HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
V + +V++ GG+L + F E+ + F +L+ + Y + ++
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 140 HRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
HRD+K +N LLD G + I DF + +Q + GT Y+APE+ ++ G
Sbjct: 138 HRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 198 --KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
D WS GVT Y +L G P+ + ++ +H + + P S E L
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFETTVVTYPSA--WSQEMVSL 250
Query: 256 ISRIFVADPAK 266
+ ++ +P +
Sbjct: 251 LKKLLEPNPDQ 261
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 7e-60
Identities = 74/252 (29%), Positives = 133/252 (52%), Gaps = 19/252 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
D+++ ++ +G+G+FG L++ K++ A+K +++ + +N + ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ +RDLK EN L+D G +++ DFG++K + + + GTP +APE++L K
Sbjct: 161 DLIYRDLKPENLLIDQQG----YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKG 214
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
Y K D W+ GV +Y M G PF + + + K I+S + P H S + +
Sbjct: 215 Y-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKD 267
Query: 255 LISRIFVADPAK 266
L+ + D K
Sbjct: 268 LLRNLLQVDLTK 279
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 1e-59
Identities = 64/274 (23%), Positives = 105/274 (38%), Gaps = 40/274 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSL-R 75
+ + + IGSG FG + + A+K + G ++N RE+ H L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
H ++VR+ H+ I EY +GG L + I R F E E + Q+ G+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 132 YCHSMQVCHRDLKLENTLLD-----------------GSPAPRLKICDFGYSKSSVLHSQ 174
Y HSM + H D+K N + S KI D G+ S
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISS 186
Query: 175 PKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
P+ G ++A EVL + K AD+++ +T+ + ++ H
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQ-------WH 238
Query: 234 RILSVQYS-IPDYVHISPECRHLISRIFVADPAK 266
I + IP +S E L+ + DP +
Sbjct: 239 EIRQGRLPRIPQ--VLSQEFTELLKVMIHPDPER 270
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-58
Identities = 77/257 (29%), Positives = 128/257 (49%), Gaps = 22/257 (8%)
Query: 21 DRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQRE-IINHR---- 72
+ +EL+R +G G +G R + T ++ A+K +++ + R
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HP IV T L +++EY SGGELF ++ G F ED A F+ ++ + +
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 189
H + +RDLK EN +L+ G +K+ DFG K S+ T GT Y+APE+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
L++ + + D WS G +Y ML GA PF +N +KTI +IL + ++P Y ++
Sbjct: 193 LMRSGH-NRAVDWWSLGALMYDMLTGAPPFTG----ENRKKTIDKILKCKLNLPPY--LT 245
Query: 250 PECRHLISRIFVADPAK 266
E R L+ ++ + A
Sbjct: 246 QEARDLLKKLLKRNAAS 262
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-58
Identities = 85/257 (33%), Positives = 132/257 (51%), Gaps = 26/257 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------R 72
+ ++ ++ +G G FG L+R+K T A+K + R + I + ++ + H +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL-RKEVI---IAKDEVAHTVTESRVLQ 60
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ RHP + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 189
HS V +RD+KLEN +LD G +KI DFG K + T GTP Y+APEV
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
L +Y G+ D W GV +Y M+ G PF + + + F IL + P +S
Sbjct: 177 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPRT--LS 229
Query: 250 PECRHLISRIFVADPAK 266
PE + L++ + DP +
Sbjct: 230 PEAKSLLAGLLKKDPKQ 246
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 3e-58
Identities = 83/256 (32%), Positives = 123/256 (48%), Gaps = 23/256 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
D +E +R +G G+FG L R K+T +L AVK + + D I +Q + +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL-KKDVI---LQDDDVECTMTEKRILS 78
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ HP + + TP L VME+ +GG+L I + RF E ARF+ ++IS +
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
+ H + +RDLKL+N LLD K+ DFG K + + +T GTP YIAPE+L
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
+ Y G D W+ GV LY ML G PFE E F IL+ + P +
Sbjct: 197 QEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPT--WLHE 249
Query: 251 ECRHLISRIFVADPAK 266
+ ++ +P
Sbjct: 250 DATGILKSFMTKNPTM 265
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 5e-58
Identities = 82/258 (31%), Positives = 124/258 (48%), Gaps = 27/258 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ ++ IG G+FG L R K E AVK + + I ++++ H
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL-QKKAI---LKKKEEKHIMSERNVLL 93
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++++HP +V T L V++Y +GGELF + F E ARF+ ++ S +
Sbjct: 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y HS+ + +RDLK EN LLD G + + DFG K ++ H+ ST GTP Y+APE
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
VL K+ Y + D W G LY ML G PF +N + IL+ + +I
Sbjct: 210 VLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYS----RNTAEMYDNILNKPLQLKP--NI 262
Query: 249 SPECRHLISRIFVADPAK 266
+ RHL+ + D K
Sbjct: 263 TNSARHLLEGLLQKDRTK 280
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 5e-58
Identities = 83/258 (32%), Positives = 126/258 (48%), Gaps = 27/258 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ + L + +G G+FG L KKT + A+K + K D + + +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVECTMVEKRVLS 72
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ HP + T +L VMEY +GG+L I + +F A F+ ++I G+
Sbjct: 73 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
+ HS + +RDLKL+N LLD G +KI DFG K ++L +T GTP YIAPE
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
+LL ++Y D WS GV LY ML+G PF +E + F I P + +
Sbjct: 189 ILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMDNPFYPRW--L 241
Query: 249 SPECRHLISRIFVADPAK 266
E + L+ ++FV +P K
Sbjct: 242 EKEAKDLLVKLFVREPEK 259
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-57
Identities = 76/261 (29%), Positives = 125/261 (47%), Gaps = 28/261 (10%)
Query: 24 ELVRDIGSGNFG---VARLMRDKKTEELVAVK-----YIERGDKIDENVQRE-----IIN 70
EL++ +G+G +G + R + T +L A+K I + K E+ + E I
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 117 Q----SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 131 SYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 186
+ H + + +RD+KLEN LLD G + + DFG SK V ++ GT Y+A
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 187 PEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
P+++ + K D WS GV +Y +L GA PF E + + RIL + P
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288
Query: 246 VHISPECRHLISRIFVADPAK 266
+S + LI R+ + DP K
Sbjct: 289 --MSALAKDLIQRLLMKDPKK 307
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-57
Identities = 80/258 (31%), Positives = 120/258 (46%), Gaps = 27/258 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ + +G G+FG L K T+EL AVK + + D + +Q + +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL-KKDVV---IQDDDVECTMVEKRVLA 75
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+
Sbjct: 76 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
+ S + +RDLKL+N +LD G +KI DFG K ++ T GTP YIAPE
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
++ + Y GK D W+ GV LY ML G PFE +E + F+ I+ + P +
Sbjct: 192 IIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPKS--M 244
Query: 249 SPECRHLISRIFVADPAK 266
S E + + P K
Sbjct: 245 SKEAVAICKGLMTKHPGK 262
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 187 bits (475), Expect = 3e-57
Identities = 33/292 (11%), Positives = 69/292 (23%), Gaps = 62/292 (21%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR-- 75
+G + D++T E V ++ + ++ E++ R LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 76 -----------------------HPNIVRFKEVILTPTHLAIVMEY--------ASGGEL 104
++R + L+ Y G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
Q+I ++ H + H L+ + +LD + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFLTGFE 251
Query: 165 YSKSSVLHSQPKSTVGTPAYIAPEVL----------LKKEYDGKIADVWSCGVTLYVMLV 214
V + + + PE+ ++ D W+ G+ +Y +
Sbjct: 252 ---HLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 215 GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
P +I R L+
Sbjct: 309 ADLPITKDAALGGSEWIFRSCK----------NIPQPVRALLEGFLRYPKED 350
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 3e-57
Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 28/263 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
++L+R IG G++ L+R KKT+ + A+K + + + + E I+
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV-KKELV---NDDEDIDWVQTEKHVFE 64
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----KNFRKTIHRILSVQYSIP 243
+L ++Y G D W+ GV ++ M+ G PF+ IL Q IP
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239
Query: 244 DYVHISPECRHLISRIFVADPAK 266
+S + ++ DP +
Sbjct: 240 RS--LSVKAASVLKSFLNKDPKE 260
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-56
Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 28/263 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
++L+R IG G++ L+R KKT+ + A++ + + + + E I+
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV-KKELV---NDDEDIDWVQTEKHVFE 107
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR-----KTIHRILSVQYSIP 243
+L ++Y G D W+ GV ++ M+ G PF+ N IL Q IP
Sbjct: 224 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282
Query: 244 DYVHISPECRHLISRIFVADPAK 266
+S + ++ DP +
Sbjct: 283 R--SLSVKAASVLKSFLNKDPKE 303
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 5e-56
Identities = 85/252 (33%), Positives = 128/252 (50%), Gaps = 15/252 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
+ +E ++ +G G FG L+++K T A+K +++ + ++ + + RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + K T L VMEYA+GGELF + FSED ARF+ +++S + Y HS
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 137 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 194
+ V +RDLKLEN +LD +KI DFG K + T GTP Y+APEVL +
Sbjct: 268 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
Y G+ D W GV +Y M+ G PF + + K F IL + P + PE +
Sbjct: 326 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILMEEIRFPRT--LGPEAKS 378
Query: 255 LISRIFVADPAK 266
L+S + DP +
Sbjct: 379 LLSGLLKKDPKQ 390
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-55
Identities = 65/254 (25%), Positives = 100/254 (39%), Gaps = 15/254 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +G G+FG M+DK+T AVK + ++ E++ L P
Sbjct: 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPR 111
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + I ME GG L + I G ED A ++ Q + G+ Y H+ ++
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLK 192
H D+K +N LL R +CDFG++ GT ++APEV++
Sbjct: 172 LHGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
K D K D+WS + ML G +P+ K I IP +P
Sbjct: 231 KPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK-IASEPPPIREIPP--SCAPLT 286
Query: 253 RHLISRIFVADPAK 266
I +P
Sbjct: 287 AQAIQEGLRKEPVH 300
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-55
Identities = 83/259 (32%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
YE+V+ IG G FG +L+R K T ++ A+K + E ++R
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIMAFA 126
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P +V+ +L +VMEY GG+L + + E ARF+ +++ + H
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK 192
SM HRD+K +N LLD S LK+ DFG + VGTP YI+PEVL
Sbjct: 186 SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 193 KEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVH 247
+ D G+ D WS GV LY MLVG PF + T +I++ + PD
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA----DSLVGTYSKIMNHKNSLTFPDDND 299
Query: 248 ISPECRHLISRIFVADPAK 266
IS E ++LI F+ D
Sbjct: 300 ISKEAKNLICA-FLTDREV 317
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 3e-55
Identities = 41/286 (14%), Positives = 74/286 (25%), Gaps = 46/286 (16%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
+ +LV + G+ V L+RD + E A+K G + E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 78 NIVRFKEVI--------------------------LTPTHLAIVMEYASG------GELF 105
+ ++ + ++M AS L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 106 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165
G QLI + S + H +N + RL + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD--GRLMLGDVS- 239
Query: 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ P AP L + W G+++Y + PF
Sbjct: 240 --ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 224 EPKNF---RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
R ++ + + + + LI R D +
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRR 343
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 8e-55
Identities = 75/260 (28%), Positives = 120/260 (46%), Gaps = 19/260 (7%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-------SLRH 76
+ R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ + H+
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL K
Sbjct: 312 FVVYRDLKPANILLDEH--GHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
AD +S G L+ +L G PF + K+ + L++ +PD SPE R L+
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRSLL 425
Query: 257 SRIFVADPAKSEMHDWRRGC 276
+ D + R GC
Sbjct: 426 EGLLQRDVNR------RLGC 439
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-53
Identities = 79/253 (31%), Positives = 122/253 (48%), Gaps = 17/253 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
+ + +G G+FG L K T+EL AVK +++ I ++ V++ ++
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LPG 399
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+ +
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKK 193
S + +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE++ +
Sbjct: 460 SKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
Y GK D W+ GV LY ML G PFE +E + F+ I+ + P +S E
Sbjct: 518 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPKS--MSKEAV 570
Query: 254 HLISRIFVADPAK 266
+ + P K
Sbjct: 571 AICKGLMTKHPGK 583
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-53
Identities = 68/262 (25%), Positives = 113/262 (43%), Gaps = 17/262 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRH 76
+ + R +G G FG + + T ++ A K +E+ + +N + +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH 134
+V T L +V+ +GG+L I + G+ F E A F+ ++ G+ H
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ +RDLK EN LLD ++I D G + K VGT Y+APEV+ +
Sbjct: 304 RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
Y D W+ G LY M+ G PF+ ++ + + V + SP+ R
Sbjct: 362 Y-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQARS 418
Query: 255 LISRIFVADPAKSEMHDWRRGC 276
L S++ DPA+ R GC
Sbjct: 419 LCSQLLCKDPAE------RLGC 434
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 4e-53
Identities = 66/260 (25%), Positives = 118/260 (45%), Gaps = 28/260 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
+E+++ IG G FG +++ K +++ A+K + E ++R +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL----NKWEMLKRAETACFREERDVLVNG 131
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYC 133
I +L +VM+Y GG+L + R E+ ARF+ +++ +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 191
H + HRD+K +N L+D + +++ DFG + +S+ VGTP YI+PE+L
Sbjct: 192 HQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 192 KKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDY 245
E G D WS GV +Y ML G PF ++ +T +I++ ++ P
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA----ESLVETYGKIMNHKERFQFPTQ 305
Query: 246 V-HISPECRHLISRIFVADP 264
V +S + LI R+ +
Sbjct: 306 VTDVSENAKDLIRRLICSRE 325
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 4e-53
Identities = 65/266 (24%), Positives = 112/266 (42%), Gaps = 31/266 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------R 72
D +E+++ IG G F +++ K+T ++ A+K + + ++R ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM----NKWDMLKRGEVSCFREERDVLV 116
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVS 131
+ I + +L +VMEY GG+L + G R + ARF+ +++ +
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 189
H + HRD+K +N LLD +++ DFG +S VGTP Y++PE+
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 190 LLKKEYD------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYS 241
L G D W+ GV Y M G PF + +T +I+ S
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA----DSTAETYGKIVHYKEHLS 290
Query: 242 IPDY-VHISPECRHLISRIFVADPAK 266
+P + E R I R + P
Sbjct: 291 LPLVDEGVPEEARDFIQR-LLCPPET 315
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-53
Identities = 74/267 (27%), Positives = 111/267 (41%), Gaps = 24/267 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
D + R +G G FG + K T +L A K + + + + + +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSY 132
IV T T L +VM +GG++ I N F E A F+ Q++SG+ +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 189
H + +RDLK EN LLD G ++I D G + GTP ++APE+
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDG----NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
LL +EY D ++ GVTLY M+ PF E ++ R+L + PD S
Sbjct: 361 LLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FS 417
Query: 250 PECRHLISRIFVADPAKSEMHDWRRGC 276
P + + DP K R G
Sbjct: 418 PASKDFCEALLQKDPEK------RLGF 438
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-52
Identities = 73/247 (29%), Positives = 120/247 (48%), Gaps = 16/247 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVIL 87
+G G +G+ RD + +A+K I D + + EI H+ L+H NIV++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 88 TPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+ I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 145 LENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKE--YDGKIAD 201
+N L++ + + LKI DFG SK + ++ ++ GT Y+APE++ K Y AD
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-AD 207
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRI 259
+WS G T+ M G PF + EP+ + ++ + IP+ +S E + I +
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVGMFKVHPEIPE--SMSAEAKAFILKC 262
Query: 260 FVADPAK 266
F DP K
Sbjct: 263 FEPDPDK 269
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-49
Identities = 35/288 (12%), Positives = 72/288 (25%), Gaps = 55/288 (19%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR-- 75
+G + D++T E V ++ + ++ E++ R LR
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 76 --------------------HPNIVRFKEVILTPTHLAIVMEYAS-----------GGEL 104
P + V L + ++ + G L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
Q+I ++ H + H L+ + +LD + + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFE 256
Query: 165 YSKS--SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI----ADVWSCGVTLYVMLVGAYP 218
+ + S P A +L ++ + D W+ G+ +Y + P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 219 FEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
D +I R L+
Sbjct: 317 NTDDAALGGSEWIFRSC----------KNIPQPVRALLEGFLRYPKED 354
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-47
Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 7/223 (3%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDK 59
+ PGM + + + IG G+FG D +T+++VA+K I E +
Sbjct: 3 HSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED 62
Query: 60 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
E++Q+EI P + ++ L T L I+MEY GG + + G E +
Sbjct: 63 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQI 121
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 178
++++ G+ Y HS + HRD+K N LL +K+ DFG + ++T
Sbjct: 122 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEH--GEVKLADFGVAGQLTDTQIKRNTF 179
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
VGTP ++APEV+ + YD K AD+WS G+T + G P +
Sbjct: 180 VGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSE 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-46
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 10/206 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ ++++ +G G++G K+T ++VA+K + + E + +EI + P++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHV 86
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
V++ T L IVMEY G + + I +EDE Q + G+ Y H M+
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K N LL +G K+ DFG + + + ++ + +GTP ++APEV+ + Y
Sbjct: 147 IHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFED 221
+ AD+WS G+T M G P+ D
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYAD 227
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 8e-46
Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 9/230 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREI-INHRSLR 75
D +E + ++G+GN GV + K + ++A K I K + RE+ + H
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-N 89
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ HRD+K N L++ +K+CDFG S + S S VGT +Y++PE L
Sbjct: 150 KHKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 206
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
Y + +D+WS G++L M VG YP P+ + ++ P
Sbjct: 207 YSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-45
Identities = 73/260 (28%), Positives = 119/260 (45%), Gaps = 31/260 (11%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHP 77
+Y IG G G D T + VA++ + ++ K + + EI+ R ++P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV + + L L +VMEY +GG L + + E + ++ + + + HS Q
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
V HRD+K +N LL DG +K+ DFG+ + + S+ + VGTP ++APEV+ +K
Sbjct: 137 VIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--------DYV 246
Y K D+WS G+ M+ G P+ + E P L Y I +
Sbjct: 193 YGPK-VDIWSLGIMAIEMIEGEPPYLN-ENP----------LRALYLIATNGTPELQNPE 240
Query: 247 HISPECRHLISRIFVADPAK 266
+S R ++R D K
Sbjct: 241 KLSAIFRDFLNRCLEMDVEK 260
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-45
Identities = 73/263 (27%), Positives = 112/263 (42%), Gaps = 36/263 (13%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D E+ +G G FGV + + K + VA+K I + + E+ + HPN
Sbjct: 6 DYKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQI-ESESERKAFIVELRQLSRVNHPN 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI---SGVSYCHS 135
IV+ L P + +VMEYA GG L+ + A A + GV+Y HS
Sbjct: 63 IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 136 MQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
MQ + HRDLK N LL LKICDFG + + + + G+ A++APEV
Sbjct: 121 MQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKTIHRILSVQYSIP 243
Y K DV+S G+ L+ ++ PF++ P R +
Sbjct: 178 SNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP----------LI 226
Query: 244 DYVHISPECRHLISRIFVADPAK 266
+ L++R + DP++
Sbjct: 227 KNLP--KPIESLMTRCWSKDPSQ 247
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-45
Identities = 71/259 (27%), Positives = 125/259 (48%), Gaps = 29/259 (11%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPN 78
+ IG G+ G+ L R+K + VAVK ++ R + E + E++ R +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V + L L ++ME+ GG L + I + R +E++ + ++ ++Y H+ V
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K ++ LL DG R+K+ DFG+ + S + KS VGTP ++APEV+ + Y
Sbjct: 163 IHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--------DYVH 247
+ D+WS G+ + M+ G P+ + P + + +
Sbjct: 219 ATE-VDIWSLGIMVIEMVDGEPPYFS-DSP----------VQAMKRLRDSPPPKLKNSHK 266
Query: 248 ISPECRHLISRIFVADPAK 266
+SP R + R+ V DP +
Sbjct: 267 VSPVLRDFLERMLVRDPQE 285
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 8e-45
Identities = 65/270 (24%), Positives = 120/270 (44%), Gaps = 22/270 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREI-INHRSLR 75
+ + E + ++GSG G MR +KT ++AVK + + ++ + ++ + +S
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P IV+ +T T + I ME + G E ++ + Y
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL---- 190
V HRD+K N LLD ++K+CDFG S V + G AY+APE +
Sbjct: 143 KHGVIHRDVKPSNILLDER--GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 191 -LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHI 248
K +YD + ADVWS G++L + G +P+++ K + + ++L + +P ++
Sbjct: 201 PTKPDYDIR-ADVWSLGISLVELATGQFPYKN---CKTDFEVLTKVLQEEPPLLPGHMGF 256
Query: 249 SPECRHLISRIFVADPAK----SEM--HDW 272
S + + + D K +++ H +
Sbjct: 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSF 286
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-44
Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 18/248 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPNIVRF--- 82
IG G+F D +T VA ++ QR E + L+HPNIVRF
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 83 -KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VC 139
+ + + +V E + G L + R + +Q++ G+ + H+ +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
HRDLK +N + G P +KI D G + S K+ +GTP ++APE+ +++YD
Sbjct: 154 HRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEM-YEEKYDES- 209
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQYSIPDYVHISPECRHLISR 258
DV++ G+ + M YP+ + + +R+ + S PE + +I
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDK--VAIPEVKEIIEG 265
Query: 259 IFVADPAK 266
+ +
Sbjct: 266 CIRQNKDE 273
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-44
Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREI-INHRSLR 75
+D E + ++G G +GV MR + +++AVK I E + ++ I+ R++
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICN-AGRFSEDEARFFFQQLISGVSY 132
P V F + + I ME + ++++ + ED ++ + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 133 CHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
HS + V HRD+K N L++ ++K+CDFG S V K G Y+APE +
Sbjct: 125 LHSKLSVIHRDVKPSNVLINAL--GQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERI 181
Query: 191 L----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
+K Y K +D+WS G+T+ + + +P++ P
Sbjct: 182 NPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP 219
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-43
Identities = 74/272 (27%), Positives = 116/272 (42%), Gaps = 30/272 (11%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRH 76
+ D YEL IGSG V + +E VA+K I E+ + + +EI H
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELF--------ERICNAGRFSEDEARFFFQQLIS 128
PNIV + + L +VM+ SGG + + +G E ++++
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTP 182
G+ Y H HRD+K N LL + ++I DFG S + K+ VGTP
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHR 234
++APEV+ + + YD K AD+WS G+T + GA P+ +N ++
Sbjct: 191 CWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 235 ILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
+ + + Y R +IS DP K
Sbjct: 250 GVQDKEMLKKY---GKSFRKMISLCLQKDPEK 278
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-43
Identities = 60/213 (28%), Positives = 108/213 (50%), Gaps = 17/213 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHP 77
++ +E+V ++G G FG ++K+T L A K I + +++++ EI + HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSM 136
IV+ L I++E+ GG + + +E + + +Q++ +++ HS
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLL-- 191
++ HRDLK N L+ +G +++ DFG S K+ + S +GTP ++APEV++
Sbjct: 137 RIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 192 ---KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
YD K AD+WS G+TL M P +
Sbjct: 193 TMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHE 224
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 9e-43
Identities = 76/256 (29%), Positives = 120/256 (46%), Gaps = 26/256 (10%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIV 80
+ IG+G+FG + R + VAVK + D E V RE+ + LRHPNIV
Sbjct: 40 NIKEKIGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSM- 136
F + P +L+IV EY S G L+ + +G E + G++Y H+
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLK 192
+ HR+LK N L+D +K+CDFG S+ + S KS GTP ++APEVL
Sbjct: 158 PPIVHRNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISP 250
+ + K +DV+S GV L+ + P+ + N + + + IP ++ P
Sbjct: 214 EPSNEK-SDVYSFGVILWELATLQQPWGN----LNPAQVVAAVGFKCKRLEIPRNLN--P 266
Query: 251 ECRHLISRIFVADPAK 266
+ +I + +P K
Sbjct: 267 QVAAIIEGCWTNEPWK 282
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 1e-42
Identities = 42/225 (18%), Positives = 79/225 (35%), Gaps = 26/225 (11%)
Query: 58 DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---CNAGRF 114
+ +I N V + +L I M+ L + + C+
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
F Q+ V + HS + HRDLK N +K+ DFG + +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEE 219
Query: 175 PKST-------------VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
++ VGT Y++PE + Y K D++S G+ L+ +L Y F
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFST 275
Query: 222 PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
E + I + ++++ + P+ ++ + P +
Sbjct: 276 QMERV---RIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTE 316
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-09
Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 2/66 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPN 78
+E ++ +G G FGV ++K + A+K I ++ E V RE+ L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 79 IVRFKE 84
IVR+
Sbjct: 66 IVRYFN 71
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-42
Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 17/232 (7%)
Query: 6 MTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDEN 63
+ + P ++ + + +IG G +G M K + +++AVK I +K +
Sbjct: 9 LKISPEQHWDF--TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66
Query: 64 VQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICNA--GRFSEDE 118
+ ++ + RS P IV+F + I ME S + ++ + + E+
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126
Query: 119 ARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ +++ +++ HRD+K N LLD S +K+CDFG S V
Sbjct: 127 LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS--GNIKLCDFGISGQLVDSIAKTR 184
Query: 178 TVGTPAYIAPEVL----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
G Y+APE + ++ YD + +DVWS G+TLY + G +P+
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSV 235
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 3e-42
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 20/220 (9%)
Query: 19 DSDRYELVRDIGSG--NFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRS 73
+ YEL+ IG G + L R K T E V V+ I +++ +Q E+ +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVS 131
HPNIV ++ + L +V + + G + IC +E + Q ++ +
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPA 183
Y H M HR +K + L+ + + + + V+H PK +V
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 184 YIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+++PEVL + YD K +D++S G+T + G PF+D
Sbjct: 201 WLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 239
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-42
Identities = 73/259 (28%), Positives = 107/259 (41%), Gaps = 27/259 (10%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRHPN 78
L IG G FG ++ R + VAVK D ENV++E L+HPN
Sbjct: 10 TLEEIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-- 136
I+ + V L +L +VME+A GG L + R D + Q+ G++Y H
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 137 -QVCHRDLKLENTLLDGSPAPR------LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ HRDLK N L+ LKI DFG ++ + S G A++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEV 185
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVH 247
+ + +DVWS GV L+ +L G PF + + + + IP
Sbjct: 186 IRASMFSKG-SDVWSYGVLLWELLTGEVPFRG----IDGLAVAYGVAMNKLALPIPSTCP 240
Query: 248 ISPECRHLISRIFVADPAK 266
L+ + DP
Sbjct: 241 --EPFAKLMEDCWNPDPHS 257
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-42
Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 22/219 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPN 78
+ +ELV +G+G +G R KT +L A+K ++ +E +++EI + H N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 79 IVRF------KEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGV 130
I + K L +VME+ G + + + E+ + ++++ G+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 131 SYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAP 187
S+ H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++AP
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 188 EVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
EV+ E YD K +D+WS G+T M GA P D
Sbjct: 199 EVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-41
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSL 74
+ +R+IG G+FG RD + E+VA+K + + +K + + +E+ + L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKL 111
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
RHPN ++++ L +VMEY G + E E + G++Y H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 135 SMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL- 191
S + HRD+K N LL G +K+ DFG + + S VGTP ++APEV+L
Sbjct: 172 SHNMIHRDVKAGNILLSEPG----LVKLGDFGSASI---MAPANSFVGTPYWMAPEVILA 224
Query: 192 --KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ +YDGK DVWS G+T + P +
Sbjct: 225 MDEGQYDGK-VDVWSLGITCIELAERKPPLFN 255
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-41
Identities = 69/264 (26%), Positives = 112/264 (42%), Gaps = 33/264 (12%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV--------QREIINHRSLR 75
E + IG G FG+ R K + +VA+K + GD E QRE+ +L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 134
HPNIV+ ++ P +VME+ G+L+ R+ + + G+ Y
Sbjct: 82 HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 135 SM--QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HRDL+ N L + K+ DFG S+ +G ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPET 197
Query: 190 LL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-----SI 242
+ ++ Y K AD +S + LY +L G PF++ K I I ++ +I
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGLRPTI 251
Query: 243 PDYVHISPECRHLISRIFVADPAK 266
P+ P R++I + DP K
Sbjct: 252 PEDCP--PRLRNVIELCWSGDPKK 273
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-41
Identities = 52/256 (20%), Positives = 98/256 (38%), Gaps = 27/256 (10%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIV 80
+ + + G R + + + VK ++ D + + E R HPN++
Sbjct: 13 NFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 81 RFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 136
+P H ++ + G L+ + F D+++ F + G+++ H++
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 137 Q--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ + L + ++D +I S Q + PA++APE L KK
Sbjct: 131 EPLIPRHALNSRSVMIDEDM--TARISMADVKFSF----QSPGRMYAPAWVAPEALQKKP 184
Query: 195 YDGKI--ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISP 250
D AD+WS V L+ ++ PF D + + ++ +IP ISP
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFAD----LSNMEIGMKVALEGLRPTIPP--GISP 238
Query: 251 ECRHLISRIFVADPAK 266
L+ DPAK
Sbjct: 239 HVSKLMKICMNEDPAK 254
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-39
Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 12/204 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
DRY + +G G +G D T E VA+K I R + +E V RE+ + L+H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
NI+ K VI L ++ EYA +L + + S + F QLI+GV++CHS
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 137 QVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 191
+ HRDLK +N LL S A LKI DFG +++ + + + + T Y PE+LL
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
+ Y + D+WS ML+
Sbjct: 212 SRHYSTSV-DIWSIACIWAEMLMK 234
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-39
Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
E+ IG G FG R + VA++ I+ ++ ++ RE++ +R RH
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
N+V F ++P HLAI+ G L+ + +A ++ R Q+++ G+ Y H+
Sbjct: 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL 190
+ H+DLK +N D ++ I DFG + + + G ++APE++
Sbjct: 150 GILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 191 ---------LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
K + +DV++ G Y + +PF+
Sbjct: 207 RQLSPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKT 245
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-39
Identities = 80/297 (26%), Positives = 120/297 (40%), Gaps = 49/297 (16%)
Query: 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
T G G D P Y + IG+G+FGV + + ELVA+K + DK +N R
Sbjct: 43 TPGQGPDRPQ---EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--R 96
Query: 67 EIINHRSLRHPNIVRFKEVILTPT------HLAIVMEYASG---GELFERICNAGRFSED 117
E+ R L H NIVR + + +L +V++Y
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ + QL ++Y HS +CHRD+K +N LLD A LK+CDFG +K L +
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEPN 213
Query: 178 T--VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEE-------- 224
+ + Y APE++ +Y I DVWS G L +L+G +P + +
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 225 ---PKNFRKTIHRILS--VQYSIPDYV----------HISPECRHLISRIFVADPAK 266
P R+ I + ++ P PE L SR+ P
Sbjct: 273 LGTPT--REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-38
Identities = 67/287 (23%), Positives = 116/287 (40%), Gaps = 40/287 (13%)
Query: 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSL 74
M S +++ + +G+G + +K T VA+K + + + REI + L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISG 129
+H NIVR +VI T L +V E+ + + ++F QL+ G
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 188
+++CH ++ HRDLK +N L++ +LK+ DFG +++ + S+ V T Y AP+
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 189 VLL-KKEYDGKIADVWSCGVTLYVMLVGA--------------------YPFED------ 221
VL+ + Y I D+WSCG L M+ G P E
Sbjct: 179 VLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237
Query: 222 --PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
P+ N ++ R L + + + +P
Sbjct: 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDM 284
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-38
Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 29/259 (11%)
Query: 24 ELVRDIGSGNFG-VAR-LMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPN 78
+ + IGSG+FG V + VAVK + + +Q E+ R RH N
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
I+ F T LAIV ++ G L+ + + +F + +Q G+ Y H+
Sbjct: 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ HRDLK N L +KI DFG + Q + G+ ++APEV+ ++
Sbjct: 141 IIHRDLKSNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 195 ---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
Y + +DV++ G+ LY ++ G P+ + N R I ++ PD +
Sbjct: 199 SNPYSFQ-SDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVGRGSLSPDLSKVRSN 253
Query: 252 C----RHLISRIFVADPAK 266
C + L++ +
Sbjct: 254 CPKRMKRLMAECLKKKRDE 272
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-38
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
+YE + IG G +G ++++T E+VA+K + R D DE V REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
NIVR +V+ + L +V E+ + F+ G + + F QL+ G+ +CH
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-K 192
S V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPF 219
K Y I D+WS G + P
Sbjct: 177 KLYSTSI-DMWSAGCIFAELANAGRPL 202
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-38
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE 62
+ V G + ++YE + +G G++G+ R+K T +VA+K D+
Sbjct: 7 HHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDK 65
Query: 63 NV----QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSE 116
V REI + LRH N+V EV +V E+ + E N
Sbjct: 66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDY 123
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176
+ + Q+I+G+ +CHS + HRD+K EN L+ S +K+CDFG++++ +
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVY 181
Query: 177 ST-VGTPAYIAPEVLL-KKEYDGKIADVWSCG 206
V T Y APE+L+ +Y + DVW+ G
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAV-DVWAIG 212
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-38
Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 18/196 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
++YE + IG G++GV R++ T ++VA+K + D ++ REI + L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
PN+V EV L +V EY +R E + Q + V++CH
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-T--VGTPAYIAPEVLL 191
HRD+K EN L+ +K+CDFG+++ L V T Y +PE+L+
Sbjct: 120 KHNCIHRDVKPENILITKH--SVIKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELLV 175
Query: 192 K-KEYDGKIADVWSCG 206
+Y + DVW+ G
Sbjct: 176 GDTQYGPPV-DVWAIG 190
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-37
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------ 65
M + + + RYE + +G G F RDK T ++VA+K I + E
Sbjct: 1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTA 59
Query: 66 -REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFF 122
REI + L HPNI+ + +++++V ++ + + N+ + + +
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAY 117
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-V 179
+ G+ Y H + HRDLK N LLD G LK+ DFG +KS ++ + V
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQV 173
Query: 180 GTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
T Y APE+L + Y + D+W+ G L +L+
Sbjct: 174 VTRWYRAPELLFGARMYGVGV-DMWAVGCILAELLLR 209
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 70/284 (24%), Positives = 119/284 (41%), Gaps = 47/284 (16%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
Y + IG+G+FGV + +++E VA+K + DK +N RE+ R ++HPN+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV-LQDKRFKN--RELQIMRIVKHPNV 94
Query: 80 VRFKEVILTPTH------LAIVMEYASG---GELFERICNAGRFSEDEARFFFQQLISGV 130
V K + L +V+EY + + QL+ +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
+Y HS+ +CHRD+K +N LLD LK+ DFG +K +L + + + + Y APE
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEPNVSYICSRYYRAPE 211
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEE-----------PKNFRKTIHR 234
++ Y I D+WS G + ++ G +P E + P R+ I
Sbjct: 212 LIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS--REQIKT 268
Query: 235 ILS--VQYSIPDYV----------HISPECRHLISRIFVADPAK 266
+ +++ P P+ LISR+ P+
Sbjct: 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSA 312
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ Y + +G G + + K T+ LVA+K I E + RE+ + L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 79 IVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++I T L +V EY + + + + F QL+ G++YCH
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKE 194
+V HRDLK +N L++ LK+ DFG +++ + ++ V T Y P++LL +
Sbjct: 120 KVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 195 YDGKIADVWSCGVTLYVMLVG 215
Y +I D+W G Y M G
Sbjct: 178 YSTQI-DMWGVGCIFYEMATG 197
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-36
Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
++Y + IG G +GV ++ E A+K I R +K DE + REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
NIV+ +VI T L +V E+ +L + G A+ F QL++G++YCH
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-K 192
+V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 193 KEYDGKIADVWSCGVTLYVMLVG 215
K+Y I D+WS G M+ G
Sbjct: 176 KKYSTTI-DIWSVGCIFAEMVNG 197
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-36
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN 78
D Y+LVR +G G + + E V VK ++ K + ++REI +LR PN
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPN 92
Query: 79 IVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+ +++ P A+V E+ + + + ++ + RF+ +++ + YCHSM
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK-K 193
+ HRD+K N ++D +L++ D+G ++ H + V + + PE+L+ +
Sbjct: 150 GIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPF 219
YD + D+WS G L M+ PF
Sbjct: 207 MYDYSL-DMWSLGCMLASMIFRKEPF 231
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-36
Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 15/223 (6%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
M ++ ++Y+ + +G G +GV +D +VA+K I R D
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAE 58
Query: 61 DENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRF 114
DE + REI + L HPNIV +VI + L +V E+ ++ + N
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGL 116
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
+ + + + QL+ GV++CH ++ HRDLK +N L++ LK+ DFG +++ + +
Sbjct: 117 QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVR 174
Query: 175 PKST-VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
+ V T Y AP+VL+ K+Y + D+WS G M+ G
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITG 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----Q 65
++ P + +YE + IG G FG R +KT + VA+K + + E
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITAL 64
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLA--------IVMEYASG--GELFERICNAGRFS 115
REI + L+H N+V E+ T +V ++ L + +F+
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFT 122
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVL 171
E + Q L++G+ Y H ++ HRD+K N L+ LK+ DFG +S +
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNS 180
Query: 172 HSQP-KSTVGTPAYIAPEVLL-KKEYDGKIADVWSCG 206
+ V T Y PE+LL +++Y I D+W G
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPI-DLWGAG 216
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
+G G FG A + ++T E++ +K + R ++ +E+ R L HPN+++F V+
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 88 TPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L + EY GG L I + + + F + + SG++Y HSM + HRDL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 147 NTLLDGSPAPRLKICDFGYSK---------------SSVLHSQPKSTVGTPAYIAPEVLL 191
N L+ + + + DFG ++ + + VG P ++APE++
Sbjct: 138 NCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222
+ YD K DV+S G+ L ++ D
Sbjct: 196 GRSYDEK-VDVFSFGIVLCEIIGRVNADPDY 225
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-35
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 21 DRYELVRD-IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH 76
D +E +G G +G A+ +D K ++ A+K IE I + REI R L+H
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAK-RKDGKDDKDYALKQIEG-TGISMSACREIALLRELKH 77
Query: 77 PNIVRFKEVILTPTHLAI--VMEYAS--------GGELFERICNAGRFSEDEARFFFQQL 126
PN++ ++V L+ + + +YA + + + Q+
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPR--LKICDFG----YSKSSVLHSQPKSTVG 180
+ G+ Y H+ V HRDLK N L+ G R +KI D G ++ + V
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 181 TPAYIAPEVLL-KKEYDGKIADVWSCG 206
T Y APE+LL + Y I D+W+ G
Sbjct: 198 TFWYRAPELLLGARHYTKAI-DIWAIG 223
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-35
Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 29/226 (12%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF- 82
L+ +G G +G + R E VAVK D+ + E+ N LRH NI+ F
Sbjct: 11 TLLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 83 ---KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-- 137
+ T L ++ Y G L++ + + SG+++ H
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 138 ------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIA 186
+ HRDLK +N L+ + + I D G + ++ L VGT Y+A
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 187 PEVL------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
PEVL + + D+W+ G+ L+ + E+ K
Sbjct: 186 PEVLDETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-35
Identities = 71/207 (34%), Positives = 100/207 (48%), Gaps = 9/207 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLR 75
++RY++V +G G L D VA+K I + E +RE+ N L
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
H NIV +V +VMEY G L E I + G S D A F Q++ G+ + H
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKK 193
M++ HRD+K +N L+D LKI DFG +K S +Q +GT Y +PE +
Sbjct: 130 MRIVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFE 220
D D++S G+ LY MLVG PF
Sbjct: 188 ATDEC-TDIYSIGIVLYEMLVGEPPFN 213
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 19/228 (8%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE 62
++ D + DR+++ R G G FG +L ++K T VA+K + D
Sbjct: 5 MMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFR 63
Query: 63 N-VQREIINHRSLRHPNIVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGR- 113
N + + + L HPNIV+ + T L +VMEY L N R
Sbjct: 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRR 122
Query: 114 ---FSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168
+ F QLI + H S+ VCHRD+K N L++ + LK+CDFG +K
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKK 181
Query: 169 SVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
+ + + Y APE++ + Y + D+WS G M++G
Sbjct: 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLG 228
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 3e-34
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 28/206 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ-------REIINHRS 73
RYE V +IG G +G RD + VA+K + R RE+ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRR 67
Query: 74 LR---HPNIVRFKEVILTPTH-----LAIVMEYASG--GELFERICNAGRFSEDEARFFF 123
L HPN+VR +V T + +V E+ ++ + +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVG 180
+Q + G+ + H+ + HRDLK EN L+ +K+ DFG ++ +S V
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSG--GTVKLADFGLARI---YSYQMALTPVVV 181
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCG 206
T Y APEVLL+ Y + D+WS G
Sbjct: 182 TLWYRAPEVLLQSTYATPV-DMWSVG 206
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-34
Identities = 55/246 (22%), Positives = 101/246 (41%), Gaps = 32/246 (13%)
Query: 7 TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
+ G G +P++ + + ++V+ IG G +G + K E VAVK ++
Sbjct: 20 SSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWF 77
Query: 64 VQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
+ EI +RH NI+ F + + T L ++ +Y G L++ + +
Sbjct: 78 RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSM 136
Query: 120 RFFFQQLISGVSYCHSMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSK---- 167
+SG+ + H+ + HRDLK +N L+ + I D G +
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVKFIS 194
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVL------LKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
++ + P + VGT Y+ PEVL + AD++S G+ L+ +
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM-ADMYSFGLILWEVARRCVSGG 253
Query: 221 DPEEPK 226
EE +
Sbjct: 254 IVEEYQ 259
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-33
Identities = 62/246 (25%), Positives = 98/246 (39%), Gaps = 32/246 (13%)
Query: 7 TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
T G G +P++ + L IG G FG + R K E VAVK ++
Sbjct: 25 TSGSGSGLPLLVQRTIARTIVLQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWF 82
Query: 64 VQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
+ EI LRH NI+ F + T T L +V +Y G LF+ + N + +
Sbjct: 83 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGM 141
Query: 120 RFFFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---- 167
SG+++ H + HRDLK +N L+ + I D G +
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDS 199
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ + P VGT Y+APEVL E + AD+++ G+ + +
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGG 258
Query: 221 DPEEPK 226
E+ +
Sbjct: 259 IHEDYQ 264
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-33
Identities = 73/293 (24%), Positives = 106/293 (36%), Gaps = 52/293 (17%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
RY ++ +G G G+ D ++ VA+K I D ++ REI R L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--------ELFE----RICNAGRFSEDEARFFFQQL 126
IV+ E++ + E E + G E+ AR F QL
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL 129
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 182
+ G+ Y HS V HRDLK N ++ + LKI DFG ++ H K + T
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--- 238
Y +P +LL Y I D+W+ G ML G F + + + IL
Sbjct: 189 WYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKTLFAG----AHELEQMQLILESIPV 243
Query: 239 ---------QYSIPDYV----------------HISPECRHLISRIFVADPAK 266
IP Y+ IS E + +I P
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-33
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 9/205 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLRHP 77
Y L R +G G G D E +VA+K + D QRE L+ P
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
++V + L + M +G +L + G + A +Q+ S + H+
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K EN L+ S + DFG + + +Q +TVGT Y+APE +
Sbjct: 155 ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFE 220
+ AD+++ LY L G+ P++
Sbjct: 213 TYR-ADIYALTCVLYECLTGSPPYQ 236
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-32
Identities = 68/250 (27%), Positives = 99/250 (39%), Gaps = 30/250 (12%)
Query: 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV---- 64
G M P DRYEL +G G L RD + VAVK + D +
Sbjct: 1 GSHMTTPSHLS-DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF 59
Query: 65 QREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
+RE N +L HP IV + IVMEY G L + + G + A
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPK 176
+++ H + HRD+K N ++ S +K+ DFG + S +Q
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--------------EDP 222
+ +GT Y++PE D + +DV+S G LY +L G PF EDP
Sbjct: 178 AVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236
Query: 223 EEPKNFRKTI 232
P + +
Sbjct: 237 IPPSARHEGL 246
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-32
Identities = 51/226 (22%), Positives = 84/226 (37%), Gaps = 28/226 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEE-LVAVKYIERGDKIDENVQ----REIINHRSL 74
+ +YE+ I G G L D+ V +K + D Q E +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEV 136
Query: 75 RHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
HP+IV+ + IVMEY G L + EA + +++
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPA 194
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+SY HS+ + + DLK EN +L +LK+ D G + GTP + APE+
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAPEI 248
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFED------PEEPKNFR 229
+ D+++ G TL + + PE+ +
Sbjct: 249 VRTGPTVA--TDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK 292
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRD-KKTEELVAVKYIERGDKIDENVQ----REI---INHR 72
+YE V +IG G +G RD K VA+K + R +E + RE+ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 73 SLRHPNIVRFKEVILTP-----THLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQ 125
+ HPN+VR +V T L +V E+ ++ + + Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQ 128
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 183
L+ G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ Q T V T
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARI--YSFQMALTSVVVTLW 184
Query: 184 YIAPEVLLKKEYDGKIADVWSCG 206
Y APEVLL+ Y + D+WS G
Sbjct: 185 YRAPEVLLQSSYATPV-DLWSVG 206
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-31
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
+RY+ + +GSG +G D KT VAVK + R I + RE+ + ++H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V L +V G +L I + ++D +F Q++ G+
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y HS + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNED--CELKILDFGLARH----TADEMTGYVATRWYRAPE 199
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVG 215
++L Y+ + D+WS G + +L G
Sbjct: 200 IMLNWMHYNQTV-DIWSVGCIMAELLTG 226
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 59/251 (23%), Positives = 100/251 (39%), Gaps = 21/251 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
RY+ ++ IGSG G+ D E VA+K + R ++ + RE++ + + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
NI+ V L IVME L ++ + + Q++ G+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGI 140
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HS + HRDLK N ++ LKI DFG ++++ V T Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIPDYVHI 248
L Y + D+WS G + M+ G F + ++++ +
Sbjct: 199 LGMGYKENV-DIWSVGCIMGEMIKGGVLFPG----TDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 249 SPECRHLISRI 259
P R +
Sbjct: 254 QPTVRTYVENR 264
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 73/289 (25%), Positives = 124/289 (42%), Gaps = 57/289 (19%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
Y +GSG +G DK++ E VA+K + R +I + RE++ + ++H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V + L +VM + +L + + +FSE++ ++ Q++ G+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGL 139
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y HS V HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNED--CELKILDFGLARH----ADAEMTGYVVTRWYRAPE 193
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV-------- 238
V+L Y+ + D+WS G + ML G F K++ + +IL V
Sbjct: 194 VILSWMHYNQTV-DIWSVGCIMAEMLTGKTLF-----KGKDYLDQLTQILKVTGVPGTEF 247
Query: 239 ----------QY--SIPD---------YVHISPECRHLISRIFVADPAK 266
Y S+P + SP+ L+ ++ D K
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDK 296
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 67/289 (23%), Positives = 117/289 (40%), Gaps = 56/289 (19%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
Y ++ +GSG +G D +T VA+K + R ++ + RE+ + +RH
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V L +VM + G +L ++ + ED +F Q++ G+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y H+ + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ----ADSEMTGYVVTRWYRAPE 195
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV-------- 238
V+L Y + D+WS G + M+ G F + + I+ V
Sbjct: 196 VILNWMRYTQTV-DIWSVGCIMAEMITGKTLF-----KGSDHLDQLKEIMKVTGTPPAEF 249
Query: 239 ----------QY--SIPD---------YVHISPECRHLISRIFVADPAK 266
Y +P+ + SP +L+ ++ V D +
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 298
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 47/238 (19%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
S +Y L + +G+G+FG+ + D ++ + A+K + + D +N RE+ + L H NI
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-DPRYKN--RELDIMKVLDHVNI 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG--------------------------- 112
++ + T N G
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 113 --------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158
+ + QL V + HS+ +CHRD+K +N L++ L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TL 181
Query: 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
K+CDFG +K + + + + Y APE++L EY I D+WS G +++G
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILG 238
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 67/214 (31%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQ------REIINH 71
RY + IG G +G+ D + VA+K KI E+ REI
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKIL 79
Query: 72 RSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 126
RH NI+ ++I PT + IV + +L ++ S D +F Q+
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQI 137
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 182
+ G+ Y HS V HRDLK N LL+ + LKICDFG ++ + V T
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
Y APE++L K Y I D+WS G L ML
Sbjct: 196 WYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSN 228
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 58/253 (22%), Positives = 103/253 (40%), Gaps = 25/253 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
RY+ ++ IGSG G+ D + VA+K + R ++ + RE++ + + H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
NI+ V L +VME L + I + + Q++ G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGI 177
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
+ HS + HRDLK N ++ LKI DFG +++ + T V T Y APE
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 233
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIPDYV 246
V+L Y + D+WS G + M+ F +++ ++++
Sbjct: 234 VILGMGYKENV-DIWSVGCIMGEMVRHKILFPG----RDYIDQWNKVIEQLGTPCPEFMK 288
Query: 247 HISPECRHLISRI 259
+ P R+ +
Sbjct: 289 KLQPTVRNYVENR 301
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 36/223 (16%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQ------REII 69
+ S ++L +G G +GV K T E+VA+K KI+ + REI
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIK 61
Query: 70 NHRSLRHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQ 124
+ +H NI+ + + I+ E +L R+ + S+D ++F
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIY 119
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKST-- 178
Q + V H V HRDLK N L++ + LK+CDFG +S+ +S+P
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSN--CDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 179 -----VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
V T Y APEV+L +Y + DVWSCG L + +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLR 219
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-30
Identities = 53/240 (22%), Positives = 95/240 (39%), Gaps = 29/240 (12%)
Query: 9 GPGMDMP-IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE 67
G + + S +L+ G FG + + + E VAVK DK + E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGC--VWKAQLLNEYVAVKIFPIQDKQSWQNEYE 68
Query: 68 IINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 123
+ + ++H NI++F K L ++ + G L + + A S +E
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIA 127
Query: 124 QQLISGVSYCHSMQ----------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
+ + G++Y H + HRD+K +N LL + I DFG +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGK 185
Query: 174 QPKST---VGTPAYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
T VGT Y+APEVL +++ + D+++ G+ L+ + + P +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDE 244
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 61/294 (20%), Positives = 102/294 (34%), Gaps = 50/294 (17%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------------ 65
Y + R I SG++G D + VA+K + V
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 66 REIINHRSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERI-CNAGRFSEDEA 119
REI HPNI+ +++ + L +V E +L + I S
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHI 136
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
++F ++ G+ H V HRDL N LL + + ICDF ++ + V
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN--NDITICDFNLAREDTADANKTHYV 194
Query: 180 GTPAYIAPEVLLK-KEYDGKIADVWSCG---------------------VTLYVMLVGAY 217
Y APE++++ K + + D+WS G + V +VG
Sbjct: 195 THRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 218 PFEDPEEPKNF--RKTIHRILSVQYSIP---DYVHISPECRHLISRIFVADPAK 266
ED + R + LS + P LI+++ +P +
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 55/238 (23%), Positives = 87/238 (36%), Gaps = 37/238 (15%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D D +L+ IG G +G + + E VAVK ++ + ++ I + H N
Sbjct: 11 DLDNLKLLELIGRGRYG--AVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDN 68
Query: 79 IVRF-----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
I RF + +VMEY G L + + + + + G++Y
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 134 HSM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVLHSQP 175
H+ + HRDL N L+ I DFG S +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKND--GTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 176 KSTVGTPAYIAPEVL------LKKEYDGKIADVWSCGVTLYVML---VGAYPFEDPEE 224
S VGT Y+APEVL E K D+++ G+ + + +P E E
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-29
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 41/226 (18%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSL 74
DRYE+ IG+G++G DK + +VA+K I R D ID + + REI L
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 75 RHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
H ++V+ ++++ L +V+E A + + +E + L+ G
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
V Y HS + HRDLK N L++ +K+CDFG +++ S +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQD--CSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 184 ----------------------YIAPEVLL-KKEYDGKIADVWSCG 206
Y APE++L ++ Y I DVWS G
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIG 271
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-28
Identities = 54/238 (22%), Positives = 92/238 (38%), Gaps = 26/238 (10%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHR 72
+ RY LVR +G G+F L +D VA+K + E + EI +N
Sbjct: 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDA 75
Query: 73 SLRHP------NIVRFKEV----ILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEAR 120
+I++ + H+ +V E G L + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK 134
Query: 121 FFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPR----LKICDFGYSKSSVLHSQP 175
+QL+ G+ Y H + H D+K EN L++ +P +KI D G +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHY 192
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+++ T Y +PEVLL + D+WS ++ ++ G + FE E + H
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-28
Identities = 60/239 (25%), Positives = 96/239 (40%), Gaps = 36/239 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
D Y + IG G++G L DK TE+ VA+K + R D ID + + REI L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 77 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
I+R ++I+ L IV+E A +L + +E+ + L+ G +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-------- 183
+ H + HRDLK N LL+ +K+CDFG +++
Sbjct: 144 FIHESGIIHRDLKPANCLLNQD--CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 184 ---------------YIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
Y APE++L + Y I D+WS G +L + +
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTNR 259
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 66/225 (29%), Positives = 98/225 (43%), Gaps = 34/225 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLR- 75
+YELV+ +G G +G+ D++T E+VAVK I + D + REI+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 76 HPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
H NIV V+ + +V +Y +L + A ++ QLI + Y
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------------- 178
HS + HRD+K N LL+ +K+ DFG S+S V + +
Sbjct: 126 HSGGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 179 -------VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
V T Y APE+LL +Y I D+WS G L +L G
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCG 227
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 64/211 (30%), Positives = 91/211 (43%), Gaps = 22/211 (10%)
Query: 18 HDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH 76
H + RYE+++ IG G+FG V + D K + VA+K + + EI R L H
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEH 149
Query: 77 ---------PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQ 125
N++ E H+ + E S L+E I FS R F
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAY 184
++ + H ++ H DLK EN LL +K+ DFG SS Q T + + Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFY 265
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
APEV+L Y I D+WS G L +L G
Sbjct: 266 RAPEVILGARYGMPI-DMWSLGCILAELLTG 295
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 64/206 (31%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP--- 77
DRYE+ IG G+FG D+ +E VA+K I+ Q E+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 78 ---NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 132
IV K + HL +V E S L++ + N S + R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 133 CHS--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 189
+ + + H DLK EN LL +KI DFG SS Q + + Y +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEV 229
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVG 215
LL YD I D+WS G L M G
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTG 254
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-26
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + ++ +G GNFG + T E+VAVK + ++ + +REI +S
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 67
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L+H NIV++K V + L ++MEY G L + + + R + + Q+ G+
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
Y + + HRDL N L+ + R+KI DFG +K + + V P
Sbjct: 128 EYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWY 184
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY 210
APE L + ++ +DVWS GV LY
Sbjct: 185 APESLTESKFSVA-SDVWSFGVVLY 208
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + ++ +G GNFG + T E+VAVK + ++ + +REI +S
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 98
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L+H NIV++K V + L ++MEY G L + + + R + + Q+ G+
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
Y + + HRDL N L+ + R+KI DFG +K + + V P
Sbjct: 159 EYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWY 215
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY 210
APE L + ++ +DVWS GV LY
Sbjct: 216 APESLTESKFSVA-SDVWSFGVVLY 239
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 60/207 (28%), Positives = 80/207 (38%), Gaps = 14/207 (6%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
L IG GNFG R + LVAVK D + +E + HPNIVR
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 82 FKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V + IVME GG+ + R +G+ Y S H
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEY 195
RDL N L+ LKI DFG S+ + G + APE L Y
Sbjct: 237 RDLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVWS G+ L+ +GA P+ +
Sbjct: 293 SSE-SDVWSFGILLWETFSLGASPYPN 318
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-25
Identities = 39/251 (15%), Positives = 70/251 (27%), Gaps = 38/251 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRH 76
RY L+ G D + VA+ +++ + ++ + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + R +V+ T +V E+ GG L E S A Q L + H
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V + S + + PA +
Sbjct: 149 GVALSIDHPSRVRV--SIDGDVV-------------------LAYPATMPDA-------- 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH--ISPECRH 254
D+ G +LY +LV +P + R + Q P + I +
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-PAERDTAGQPIEPADIDRDIPFQISA 238
Query: 255 LISRIFVADPA 265
+ +R D
Sbjct: 239 VAARSVQGDGG 249
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 63/235 (26%), Positives = 94/235 (40%), Gaps = 18/235 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + + +G GNFG L T LVAVK + G + QREI ++
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA 80
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L IV+++ V P L +VMEY G L + + + R + Q+ G+
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
Y S + HRDL N L+ S A +KI DFG +K + + V P
Sbjct: 141 EYLGSRRCVHRDLAARNILV-ESEA-HVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWY 197
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
APE L + + +DVWS GV LY + E + ++
Sbjct: 198 APESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 8e-25
Identities = 57/213 (26%), Positives = 84/213 (39%), Gaps = 21/213 (9%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRH 76
L+ +G G+FGV VAVK ++ + I SL H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
N++R V+LTP + +V E A G L +R+ + G F + Q+ G+ Y S
Sbjct: 81 RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEV 189
+ HRDL N LL + +KI DFG + L APE
Sbjct: 140 KRFIHRDLAARNLLL-ATRD-LVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 190 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
L + + +D W GVTL+ + G P+
Sbjct: 196 LKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-24
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 19 DSDRYELVRDIGSGNFGV---ARL-MRDKKTEELVAVKYI--ERGDKIDENVQREIINHR 72
+ + +RD+G G+FG R T E VAVK + E G ++++EI R
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78
Query: 73 SLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISG 129
+L H NIV++K + + ++ME+ G L E + N + + + + Q+ G
Sbjct: 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYI--- 185
+ Y S Q HRDL N L+ S ++KI DFG +K + + + TV
Sbjct: 139 MDYLGSRQYVHRDLAARNVLV-ESEH-QVKIGDFGLTK--AIETDKEYYTVKDDRDSPVF 194
Query: 186 --APEVLLKKEYDGKIADVWSCGVTLY 210
APE L++ ++ +DVWS GVTL+
Sbjct: 195 WYAPECLMQSKFYIA-SDVWSFGVTLH 220
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 6e-24
Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 8/208 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + R CN S + Q+ S + Y
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
HR+L N L+ + +K+ DFG S+ + APE L +
Sbjct: 338 NFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVW+ GV L+ + G P+
Sbjct: 396 FSIK-SDVWAFGVLLWEIATYGMSPYPG 422
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-23
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 10/209 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + R CN S + Q+ S + Y
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLLKK 193
HRDL N L+ + +K+ DFG S+ + + G P + APE L
Sbjct: 131 NFIHRDLAARNCLVGENHL--VKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
++ K +DVW+ GV L+ + G P+
Sbjct: 188 KFSIK-SDVWAFGVLLWEIATYGMSPYPG 215
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-23
Identities = 50/211 (23%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINH----RSLR 75
+ ++ +GSG FG + + + ++ VA+K + +EI++ S+
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD 75
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
+P++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 76 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLL 191
++ HRDL N L+ +P +KI DFG +K + G P ++A E +L
Sbjct: 135 DRRLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ Y + +DVWS GVT++ +M G+ P++
Sbjct: 193 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-23
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 21 DRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSL 74
+ +RD+G G+FG L + T E+VAVK + + G + ++EI R+L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 75 RHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
H +I+++K L +VMEY G L + + + F QQ+ G++Y
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAY 149
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----AP 187
H+ HRDL N LL + +KI DFG +K +V V AP
Sbjct: 150 LHAQHYIHRDLAARNVLL-DNDR-LVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAP 206
Query: 188 EVLLKKEYDGKIADVWSCGVTLY 210
E L + ++ +DVWS GVTLY
Sbjct: 207 ECLKEYKFYYA-SDVWSFGVTLY 228
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-23
Identities = 56/222 (25%), Positives = 85/222 (38%), Gaps = 32/222 (14%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP-- 77
+RYE+V ++G G FG V + + + VA+K I K E + EI + ++
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 78 ----NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVS 131
V + H+ I E G FE + + R QL +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 132 YCHSMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHSQ 174
+ H Q+ H DLK EN L S +++ DFG S+ +
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHE 194
Query: 175 PKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+T V T Y PEV+L+ + DVWS G L+ G
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 7e-23
Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 38/227 (16%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSL 74
+ + ++R +G G FG V + ++ AVK + K + + E I + +
Sbjct: 35 NAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 132
+ NIV++ + H+ ++ E G L+E I F ++ + + +++ ++Y
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 133 CHSMQVCHRDLKLENTLLDGSPA-----------------------PRLKICDFGYSKSS 169
M + H DLK EN LLD +K+ DFG +
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA 209
Query: 170 VLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
S + + T Y APEV+L +D D+WS G L + G
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTG 255
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 4e-22
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 10/208 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 241 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
HRDL+ N L+ + K+ DFG ++ + APE L
Sbjct: 300 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L + G P+
Sbjct: 358 FTIK-SDVWSFGILLTELTTKGRVPYPG 384
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 6e-22
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D V++IGSG FG+ L ++ VA+K I G +E+ E L HP
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPK 64
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V L + +V E+ G L + R G F+ + + G++Y
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV
Sbjct: 124 CVIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
Y K +DVWS GV ++ V G P+E+
Sbjct: 181 RYSSK-SDVWSFGVLMWEVFSEGKIPYEN 208
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-22
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
++ R + + IGSG+ G RL + + VA+K ++ G ++ + E
Sbjct: 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HPNI+R + V+ IV EY G L F R + G+F+ + + + +G+
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMR 165
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---AP 187
Y + HRDL N L+D + K+ DFG S+ +T G I AP
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
Query: 188 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
E + + + +DVWS GV ++ V+ G P+ +
Sbjct: 224 EAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWN 257
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 8e-22
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 10/208 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 324 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
HRDL+ N L+ + K+ DFG ++ + APE L
Sbjct: 383 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L + G P+
Sbjct: 441 FTIK-SDVWSFGILLTELTTKGRVPYPG 467
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-21
Identities = 66/223 (29%), Positives = 91/223 (40%), Gaps = 34/223 (15%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHR-- 72
RYE+V +G G FG V + K VAVK ++ D+ E + EI +N
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGV 130
+ V+ E H+ IV E G ++ I G F D R Q+ V
Sbjct: 74 NSTF-RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHS 173
++ HS ++ H DLK EN L S P +K+ DFG S+
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188
Query: 174 QPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+ ST V T Y APEV+L + DVWS G L +G
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLG 230
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-21
Identities = 61/222 (27%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 21 DRYELVRD--------IGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQRE 67
+ L RD +G GNFG KK + VA+K +++G E + RE
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMRE 60
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
L +P IVR V + +VME A GG L + + Q+
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT-- 181
G+ Y HRDL N LL + KI DFG SK L + +
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKW 175
Query: 182 P-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
P + APE + +++ + +DVWS GVT++ + G P++
Sbjct: 176 PLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 216
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 1e-21
Identities = 57/275 (20%), Positives = 98/275 (35%), Gaps = 66/275 (24%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLR 75
RY ++R +G G+F L D + ++ VA+K ++ + E EI + +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 76 HPN---IVR----FKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQL 126
PN +V+ FK + TH+ +V E + + N + QQ+
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK-SNYQGLPLPCVKKIIQQV 155
Query: 127 ISGVSYCHS-MQVCHRDLKLENTLLD---------------------------------- 151
+ G+ Y H+ ++ H D+K EN LL
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 152 -------------GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
+ ++KI D G + +H + T Y + EVL+ Y+
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
AD+WS + + G Y FE + R H
Sbjct: 274 -ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-21
Identities = 50/209 (23%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ ++ +GSG FG + + + ++ VA+K + K ++ + E S+ +P
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSM 136
++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 78 HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLLKK 193
++ HRDL N L+ +P +KI DFG +K + G P ++A E +L +
Sbjct: 137 RLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
Y + +DVWS GVT++ +M G+ P++
Sbjct: 195 IYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-21
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 20/217 (9%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D+ + + +G+G FG RL K E VA+K ++ G +K + E
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HPNI+R + V+ + IV EY G L F R + +F+ + + + SG+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMK 161
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI--- 185
Y M HRDL N L++ + K+ DFG + VL P +T G I
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWT 217
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+PE + +++ +DVWS G+ L+ VM G P+ +
Sbjct: 218 SPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-21
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 21 DRYELV---RDIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINH---- 71
DR L +++GSGNFG + + KK + VAVK + + + D ++ E++
Sbjct: 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVM 72
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ L +P IVR + + + +VME A G L + + + Q+ G+
Sbjct: 73 QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYI 185
Y HRDL N LL + KI DFG SK L + K+ P +
Sbjct: 132 YLEESNFVHRDLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWY 187
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
APE + ++ K +DVWS GV ++ G P+
Sbjct: 188 APECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 223
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-21
Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYI--ERGDKIDENVQREIINHR 72
++ +GSG FG + + ++ ++ V +K I + G + + V ++
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 131
SL H +IVR + + L +V +Y G L + + + G + Q+ G+
Sbjct: 71 SLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----A 186
Y + HR+L N LL SP+ ++++ DFG + +L K + + A A
Sbjct: 130 YLEEHGMVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMA 185
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
E + +Y + +DVWS GVT++ +M GA P+
Sbjct: 186 LESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 12/209 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L + +G+G FG + K + VAVK ++ G E E ++L+H
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDK 244
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ T + I+ E+ + G L F + + + F Q+ G+++
Sbjct: 245 LVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
HRDL+ N L+ S KI DFG ++ + ++ + G I APE +
Sbjct: 304 NYIHRDLRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFG 360
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L ++ G P+
Sbjct: 361 SFTIK-SDVWSFGILLMEIVTYGRIPYPG 388
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 1e-20
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
+ L++++GSG FGV + K + VAVK I+ G ++ +E L
Sbjct: 6 KREEITLLKELGSGQFGVVKLGKW----KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
HP +V+F V + IV EY S G L + R + + + G+++
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVL 190
S Q HRDL N L+D +K+ DFG ++ VL Q S+VGT + APEV
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVF 177
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+Y K +DVW+ G+ ++ V +G P++
Sbjct: 178 HYFKYSSK-SDVWAFGILMWEVFSLGKMPYDL 208
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-20
Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +LV +G+G FG + + VAVK +++G + E + L+H
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR V+ T + I+ EY G L F + + + + ++ Q+ G+++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
HRDL+ N L+ + + KI DFG ++ + ++ + G I APE +
Sbjct: 129 NYIHRDLRAANILVSDTLS--CKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L ++ G P+
Sbjct: 186 TFTIK-SDVWSFGILLTEIVTHGRIPYPG 213
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-20
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
D ++++G+G FGV + + + VA+K I+ G ++ E +L
Sbjct: 22 DPKDLTFLKELGTGQFGVVKYGKW----RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS 77
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H +V+ V + I+ EY + G L + R RF + + + + Y
Sbjct: 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVL 190
S Q HRDL N L++ +K+ DFG S+ VL + S+VG+ + PEVL
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVL 193
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ ++ K +D+W+ GV ++ + +G P+E
Sbjct: 194 MYSKFSSK-SDIWAFGVLMWEIYSLGKMPYER 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-20
Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 18/210 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 75
Query: 79 IVRFKEVILTPT-HLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + R D F + + Y
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLK 192
HRDL N L+ S K+ DFG +K + + + APE L +
Sbjct: 136 NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 188
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
K++ K +DVWS G+ L+ + G P+
Sbjct: 189 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 217
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-20
Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 18/210 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 247
Query: 79 IVRFKEVILT-PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + R D F + + Y
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLK 192
HRDL N L+ K+ DFG +K + + + APE L +
Sbjct: 308 NNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 360
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
K++ K +DVWS G+ L+ + G P+
Sbjct: 361 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 389
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 4e-20
Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 20/206 (9%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 83
+G GNFG KK + VA+K +++G E + RE L +P IVR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 84 EVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
V + +VME A GG L + + Q+ G+ Y HR+
Sbjct: 403 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLLKKEYD 196
L N LL + KI DFG SK L + + + APE + +++
Sbjct: 462 LAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 197 GKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVWS GVT++ + G P++
Sbjct: 518 SR-SDVWSYGVTMWEALSYGQKPYKK 542
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 7e-20
Identities = 51/219 (23%), Positives = 85/219 (38%), Gaps = 22/219 (10%)
Query: 20 SDRYE-------LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQRE 67
+Y L R +G G FG K + VAVK ++ E E
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
+ ++L HP+IV+ +I I+ME GEL + N + Q+
Sbjct: 64 AVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 122
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI- 185
++Y S+ HRD+ + N L+ +K+ DFG S+ + T I
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSR-YIEDEDYYKASVTRLPIK 179
Query: 186 --APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+PE + + + +DVW V ++ ++ G PF
Sbjct: 180 WMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFW 217
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 9e-20
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 17/214 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+R EL R IG G FG M + VA+K + D + E +E + R
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 72
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HP+IV+ VI I+ME + GEL F + + QL + ++
Sbjct: 73 FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALA 130
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPE 188
Y S + HRD+ N L+ + +K+ DFG S+ + S P ++APE
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPE 187
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ + + +DVW GV ++ +++ G PF+
Sbjct: 188 SINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 220
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-19
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 17/216 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERG--DKIDENVQREIINHR 72
+ IG+G FG L +E+ VA+K ++ G +K + E
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 101
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGV 130
H NI+R + VI + I+ EY G L F R G FS + + + +G+
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGM 160
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---A 186
Y +M HRDL N L++ + K+ DFG S+ + +T G I A
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
PE + +++ +DVWS G+ ++ VM G P+ +
Sbjct: 219 PEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 52/228 (22%), Positives = 90/228 (39%), Gaps = 35/228 (15%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHR 72
++ L R +G G FG A+L ++ + VAVK ++ +++ RE +
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 73 SLRHPNIVRF------KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
HP++ + +++ + G+L F A R E+ Q
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQ 137
Query: 125 QLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
L+ G+ Y S HRDL N +L + + DFG S+ ++S
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYY 193
Query: 178 TVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
G + + A E L Y +DVW+ GVT++ +M G P+
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPY 240
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 53/220 (24%), Positives = 81/220 (36%), Gaps = 24/220 (10%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
L+R +G G FG M + + VAVK + + + E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------ 127
H NIVR V L I+ME +GG+L + + L+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 128 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI 185
G Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAML 207
Query: 186 -----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
PE ++ + K D WS GV L+ + +G P+
Sbjct: 208 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-19
Identities = 53/250 (21%), Positives = 90/250 (36%), Gaps = 43/250 (17%)
Query: 10 PGMDMPIMHDSDRYE-------LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDK 59
P + + + L + +G G FG L ++ T VAVK ++ +
Sbjct: 16 PRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS 75
Query: 60 IDENVQ---REIINHRSLRHPNIVR-----FKEVILTPTHLAIVMEYASGGEL--FERIC 109
++ E + HPN++R + +++ + G+L +
Sbjct: 76 SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135
Query: 110 NAGRFSEDEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162
R Q L+ G+ Y + HRDL N +L + + D
Sbjct: 136 ---RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVAD 190
Query: 163 FGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA 216
FG SK ++S G A + A E L + Y K +DVW+ GVT++ + G
Sbjct: 191 FGLSK--KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGM 247
Query: 217 --YPFEDPEE 224
YP E
Sbjct: 248 TPYPGVQNHE 257
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-19
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPN 78
EL R IG G FG M + VA+K + D + E +E + R HP+
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ VI I+ME + GEL + + QL + ++Y S +
Sbjct: 453 IVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVG-TPA-YIAPEVLLKK 193
HRD+ N L+ + +K+ DFG S+ + K++ G P ++APE + +
Sbjct: 512 FVHRDIAARNVLVSSNDC--VKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVW GV ++ +++ G PF+
Sbjct: 568 RFTSA-SDVWMFGVCMWEILMHGVKPFQG 595
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 6e-19
Identities = 52/220 (23%), Positives = 81/220 (36%), Gaps = 24/220 (10%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
L+R +G G FG M + + VAVK + + + E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------ 127
H NIVR V L I++E +GG+L + + L+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 128 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI 185
G Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAML 248
Query: 186 -----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
PE ++ + K D WS GV L+ + +G P+
Sbjct: 249 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 287
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
+ I S IG G+FG L+ + + AVK + R I E Q E
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76
Query: 68 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 135
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 183
Q+ G+ Y S + HRDL N +LD +K+ DFG ++ + + S
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR-DMYDKEYYSVHNKTGA 192
Query: 184 -----YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L +++ K +DVWS GV L+ +M GA P+
Sbjct: 193 KLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 233
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-18
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL 74
L R++G G FG + K + LVAVK ++ QRE +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE---------RICNAGRFSEDEARFFFQQ 125
+H +IV+F V L +V EY G+L + I G+ + + Q
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 126 LI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
++ SG+ Y S HRDL N L+ +KI DFG S+ ++S
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYR 190
Query: 179 VGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
VG + PE ++ +++ + +DVWS GV L+
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILW 226
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 5e-18
Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 18/221 (8%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
+ I S IG G+FG L+ + + AVK + R I E Q E
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 68 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 199
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
Q+ G+ + S + HRDL N +LD +K+ DFG ++ T A
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 185 I-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ A E L +++ K +DVWS GV L+ +M GA P+
Sbjct: 258 LPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 297
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-18
Identities = 37/219 (16%), Positives = 72/219 (32%), Gaps = 29/219 (13%)
Query: 24 ELVRDIGSGNFGV-------ARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR 75
+G G F + E V +K +++ E+ L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H ++V V + +V E+ G L + + N + +QL + + +
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL 129
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRL------KICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
+ H ++ +N LL + K+ D G S + + + + ++ P
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI---PWVPP 186
Query: 188 EVLLKKEYDGKI----ADVWSCGVTLY-VMLVGAYPFED 221
E + + K D WS G TL+ + G P
Sbjct: 187 ECIE----NPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 32/226 (14%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL 74
L ++G G FG + ++ + LVAVK ++ + QRE L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------RICNAGRFSEDEARFFFQQL 126
+H +IVRF V L +V EY G+L AG QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 127 I-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
+ +G+ Y + HRDL N L+ +KI DFG S+ ++S V
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSR--DIYSTDYYRV 216
Query: 180 GTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
G + PE +L +++ + +DVWS GV L+ + G P+
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 22/229 (9%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
D+ I H+ R IG G+FGV + + A+K + R ++ + RE
Sbjct: 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE 72
Query: 68 IINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFF 123
+ R L HPN++ ++L +++ Y G+L F R + + F
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIR-SPQRNPTVKDLISFG 130
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVG 180
Q+ G+ Y + HRDL N +LD S +K+ DFG ++ +S +
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHA 188
Query: 181 T-PA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEE 224
P + A E L + K +DVWS GV L+ ++ GA Y DP +
Sbjct: 189 RLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFD 236
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-17
Identities = 45/222 (20%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
++ + R++G G+FG VA+ + + E VA+K + + E + E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEAR--------FFF 123
++VR V+ ++ME + G+L + R +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
++ G++Y ++ + HRDL N ++ + +KI DFG ++ ++ G
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKG 200
Query: 184 YI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ +PE L + +DVWS GV L+ + + P+
Sbjct: 201 LLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY 241
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 5e-17
Identities = 44/230 (19%), Positives = 87/230 (37%), Gaps = 34/230 (14%)
Query: 19 DSDRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINH 71
+ ++G FG + + VA+K ++ + E + E +
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR 66
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFF 122
L+HPN+V V+ L+++ Y S G+L + + ++
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 123 FQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175
+ +G+ Y S V H+DL N L+ +KI D G + +++
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR--EVYAAD 182
Query: 176 KSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ + + APE ++ ++ +D+WS GV L+ V G P+
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 55/235 (23%), Positives = 86/235 (36%), Gaps = 47/235 (20%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
+R + +G+G FG A + VAVK + ER + E V
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------FERICNAGRFSE 116
+ H NIV ++ EY G+L + +
Sbjct: 83 L-----GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
DE + L+S G+++ S HRDL N LL KICDFG ++
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLAR-- 193
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
+ + V A + APE + Y + +DVWS G+ L+ + +G+ P
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 8e-16
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 79
+++ L R IGSG+FG L + +T E VA+K E + E +R L+ I
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ + + +VM+ S +LF C+ + S Q+I+ V + HS
Sbjct: 66 PNVRWFGVEGDYNVLVMDLLGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 138 VCHRDLKLENTLLD-GSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 188
HRD+K +N L+ G A ++ I DFG +K S+ H + K+ GT Y +
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183
Query: 189 VLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L E D D+ S G L L G+ P
Sbjct: 184 THLGIEQSRRD----DLESLGYVLMYFLRGSLP 212
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 55/236 (23%), Positives = 90/236 (38%), Gaps = 42/236 (17%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+ E VRDIG G FG A + + +VAVK ++ + + QRE
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSE 116
+PNIV+ V + ++ EY + G+L + A S
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 117 DEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
+ + +G++Y + HRDL N L+ +KI DFG S++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN- 223
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++S I PE + Y + +DVW+ GV L+ + G P+
Sbjct: 224 -IYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-15
Identities = 58/233 (24%), Positives = 87/233 (37%), Gaps = 47/233 (20%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
D + + IG GNFG AR+ +D + A+K + + D E V +
Sbjct: 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCK 81
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDE 118
+ HPNI+ +L + +EYA G L E +
Sbjct: 82 L-----GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 119 ARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171
+ QQL+ G+ Y Q HRDL N L+ + KI DFG S+ +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEV 194
Query: 172 HSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
+ T + A E L Y +DVWS GV L+ ++ +G P
Sbjct: 195 Y-----VKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-15
Identities = 48/215 (22%), Positives = 86/215 (40%), Gaps = 24/215 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
Y++ R IG G+FGV + + VA+K+ E ++ E ++ L I
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
H +V++ S +L +C +FS +Q+++ V H
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 138 VCHRDLKLENTLL---DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIA 186
+ +RD+K +N L+ + A + + DFG K + H + K+ GT Y++
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 187 PEVLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L +E D D+ + G L G+ P
Sbjct: 187 INTHLGREQSRRD----DLEALGHVFMYFLRGSLP 217
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-15
Identities = 53/236 (22%), Positives = 90/236 (38%), Gaps = 42/236 (17%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
L + +G G FG A ++ + VAVK ++ ++ E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSE 116
+ HP++++ L +++EYA G L ++
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
DE LIS G+ Y M++ HRDL N L+ +KI DFG S+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRD- 199
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ + + I A E L Y + +DVWS GV L+ ++ +G P+
Sbjct: 200 -VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 46/222 (20%), Positives = 82/222 (36%), Gaps = 42/222 (18%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVK-------YIERGDKIDE-NVQRE 67
+ + + +G+G FG A + + VAVK E+ + E +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEAR 120
+ +H NIV + ++ EY G+L + F+ +
Sbjct: 106 L-----GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 121 FFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
+ L+ G+++ S HRD+ N LL + KI DFG ++ + +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLARD--IMN 216
Query: 174 QPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
V A + APE + Y + +DVWS G+ L+
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLW 257
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-15
Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIV 80
+ + + IG GNFG RL ++ T E VA+K +E + E ++ L I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 81 RFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+ + A+V+E S +LF +C+ FS QLIS + Y HS +
Sbjct: 69 QVYYFGPCGKYNAMVLELLGPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 139 CHRDLKLENTLLDGSPAPRLKIC---DFGYSK-----SSVLH---SQPKSTVGTPAYIAP 187
+RD+K EN L+ ++ DF +K + H + KS GT Y++
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 188 EVLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L KE D D+ + G L G+ P
Sbjct: 187 NTHLGKEQSRRD----DLEALGHMFMYFLRGSLP 216
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-15
Identities = 57/249 (22%), Positives = 92/249 (36%), Gaps = 53/249 (21%)
Query: 14 MPIMHDSDRYE-------LVRDIGSGNFG-----VARLMRDKKTEELVAVKYI------- 54
+ +D+ ++E L + +G G FG A + T VAVK +
Sbjct: 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 55 ERGDKIDE-NVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGEL-------- 104
E + E + I H N+V P L +++E+ G L
Sbjct: 73 EHRALMSELKILIHI-----GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 127
Query: 105 -FERICNAGRFSEDEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAP 156
+ + LI G+ + S + HRDL N LL
Sbjct: 128 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV- 186
Query: 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY- 210
+KICDFG ++ ++ P A + APE + + Y + +DVWS GV L+
Sbjct: 187 -VKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWE 242
Query: 211 VMLVGAYPF 219
+ +GA P+
Sbjct: 243 IFSLGASPY 251
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-15
Identities = 60/213 (28%), Positives = 88/213 (41%), Gaps = 22/213 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
+RY L R IGSG+FG L D E VA+K E + E ++ ++ I
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ + +VME S +LF C+ +FS Q+IS + Y HS
Sbjct: 68 PTIRWCGAEGDYNVMVMELLGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 138 VCHRDLKLENTLL-DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 188
HRD+K +N L+ G + I DFG +K + H + K+ GT Y +
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185
Query: 189 VLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L E D D+ S G L +G+ P
Sbjct: 186 THLGIEQSRRD----DLESLGYVLMYFNLGSLP 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-14
Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 37/230 (16%)
Query: 21 DRYELVRDIGSGNFG------VARLMRDKKTEEL-VAVKYIERGDKIDENV--QREIINH 71
D+ L + +G G FG + +DK E + VAVK ++ + E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARF 121
+ + +H NI+ L +++EYAS G L + E +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 122 FFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
F+ L+S G+ Y S + HRDL N L+ + +KI DFG ++ +++
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINNI 210
Query: 175 PKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
T + APE L + Y + +DVWS GV ++ + +G P
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSP 259
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-14
Identities = 54/231 (23%), Positives = 81/231 (35%), Gaps = 51/231 (22%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
+ E + +GSG FG A + VAVK + ER + E + +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL----------------FERICNA 111
+ H NIV + ++ EY G+L
Sbjct: 105 L-----GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 112 GRFSEDEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
ED F+ L+ G+ + HRDL N L+ +KICDFG
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFG 217
Query: 165 YSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
++ + S V A + APE L + Y K +DVWS G+ L+
Sbjct: 218 LARD--IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLW 265
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-14
Identities = 58/226 (25%), Positives = 87/226 (38%), Gaps = 46/226 (20%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEE--LVAVKYI-------ERGDKIDE-NVQ 65
DR L + +G G FG A + K VAVK + + D I E +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSE 116
+ I +H NI+ L +++EYAS G L +
Sbjct: 129 KMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
E + + L+S G+ Y S + HRDL N L+ + +KI DFG ++
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLAR-- 239
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
+H T + APE L + Y + +DVWS GV L+
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLW 284
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-14
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 37/231 (16%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEE--LVAVKYIERGDKIDENV--QREIINH 71
D+ L + +G G FG A + K +E VAVK ++ + E+
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARF 121
+ + +H NI+ L +++EYAS G L + E +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 122 FFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
F+ L+S G+ Y S + HRDL N L+ + +KI DFG ++ +++
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNI 256
Query: 175 PKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
T + APE L + Y + +DVWS GV ++ + +G P+
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 306
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 8e-12
Identities = 39/196 (19%), Positives = 59/196 (30%), Gaps = 52/196 (26%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---------VQREIIN 70
+++ + IG G FG T VA+K I N + EII
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 71 HRSL---------RHPNIVRFKEVIL------------------------------TPTH 91
+ L R + V
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLL 150
L IV+E+ GG E++ S A+ QL + ++ S++ HRDL N LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 151 DGSPAPRLKICDFGYS 166
+ +L G S
Sbjct: 196 KKTSLKKLHYTLNGKS 211
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 2e-09
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 15/106 (14%)
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST--VGTPAYI 185
G+++ H HRD+K N LLD + KI DFG ++ S ++ VGT AY+
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYM 202
Query: 186 APEVLLKKEY-DGKI---ADVWSCGVTLYVMLVGAYPFEDPEEPKN 227
AP E G+I +D++S GV L ++ G ++ EP+
Sbjct: 203 AP------EALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 63/215 (29%), Positives = 88/215 (40%), Gaps = 52/215 (24%)
Query: 29 IGSGNFG-VAR-LMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRF-- 82
IG G FG V + ++RD VA+K I+E + EI RHP++V
Sbjct: 47 IGHGVFGKVYKGVLRDGAK---VALKRRTPESSQGIEE-FETEIETLSFCRHPHLVSLIG 102
Query: 83 --KEVILTPTHLAIVMEYASGGELFERICNAGRFSE------------DEARFFFQQLIS 128
E + ++ +Y G L + + + AR
Sbjct: 103 FCDE----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR-------- 150
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STV--GTPAYI 185
G+ Y H+ + HRD+K N LLD + P KI DFG SK Q STV GT YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYI 208
Query: 186 APE-----VLLKKEYDGKIADVWSCGVTLYVMLVG 215
PE L +K +DV+S GV L+ +L
Sbjct: 209 DPEYFIKGRLTEK------SDVYSFGVVLFEVLCA 237
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 30/167 (17%), Positives = 60/167 (35%), Gaps = 24/167 (14%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 81
++ L + IGSG FG+ L E A ++ + + + E+ ++ + + ++
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 82 FKEVILTPTHLAI-------------------VMEY--ASGGELFERICNAGRFSEDEAR 120
+L I VME ++ N G F +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG--QN-GTFKKSTVL 154
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+++ + Y H + H D+K N LL ++ + D+G S
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-09
Identities = 22/171 (12%), Positives = 57/171 (33%), Gaps = 29/171 (16%)
Query: 22 RYELVRDIGSGNFGV--------ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
+++L N G+ ++ ++K ++ D N Q R+
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQN--FFQRA 99
Query: 74 LRHPNIVRFKEVILTPT---------------HLAIVMEY--ASGGELFERICNAGRFSE 116
+ + ++K++ TP + +V+ S + SE
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV-SPKHVLSE 158
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+L+ + + H + H ++ EN +D ++ + +G++
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 6e-08
Identities = 27/169 (15%), Positives = 54/169 (31%), Gaps = 25/169 (14%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEEL-----VAVK---------------YIERGDKID 61
+++ IG G FG L +E + VK Y
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 62 ENVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE 118
+ L P ++ ++M+ + +++E RFS
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-NA-KRFSRKT 153
Query: 119 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+++ + Y H + H D+K N LL+ ++ + D+G +
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 8e-08
Identities = 56/215 (26%), Positives = 82/215 (38%), Gaps = 61/215 (28%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQRE------IINHRSLRHPNI 79
+G G FG RL D LVAVK ++ + + + +I+ H N+
Sbjct: 38 LGRGGFGKVYKGRL-ADGT---LVAVKRLKEERT--QGGELQFQTEVEMISM--AVHRNL 89
Query: 80 VRFKEVILTPTHLAIVMEYASGG----ELFERICNAGRFS--------EDEARFFFQQLI 127
+R + +TPT +V Y + G L ER + AR
Sbjct: 90 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR------- 142
Query: 128 SGVSYCH---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----- 179
G++Y H ++ HRD+K N LLD + DFG +K L + V
Sbjct: 143 -GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVR 196
Query: 180 GTPAYIAPE-----VLLKKEYDGKIADVWSCGVTL 209
GT +IAPE +K DV+ GV L
Sbjct: 197 GTIGHIAPEYLSTGKSSEK------TDVFGYGVML 225
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-07
Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 11/119 (9%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
+ Q+ G+ + S + HRDL N LL +KICDFG ++ ++ P
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKG 253
Query: 182 PAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHR 234
A + APE + + Y + +DVWS GV L+ + +GA P+ + + F + +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 6e-04
Identities = 31/153 (20%), Positives = 55/153 (35%), Gaps = 22/153 (14%)
Query: 18 HDSDRYE-------LVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG----DKID 61
+D+ ++E L + +G G FG A + T VAVK ++ G +
Sbjct: 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 71
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFERICNAGRFSEDEAR 120
+ +I+ H H N+V P L +++E+ G L + + R +
Sbjct: 72 LMSELKILIHIG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYK 129
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153
+ G Y + DLK + S
Sbjct: 130 TKGARFRQGKDYVGA---IPVDLKRRLDSITSS 159
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 8e-06
Identities = 40/301 (13%), Positives = 98/301 (32%), Gaps = 80/301 (26%)
Query: 23 YELVRDIGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+ V ++ N+ ++ + +++ ++ YIE+ D++ + Q + S R +
Sbjct: 80 QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPYL 138
Query: 81 RFKEVI--LTPTHLAIV--MEYASGGE----LFERICNAGRFSEDEARFFFQQL-ISGVS 131
+ ++ + L P ++ + G + +C + + + + F+ ++ +
Sbjct: 139 KLRQALLELRPAKNVLIDGV----LGSGKTWVALDVCLSYKV---QCKMDFKIFWLN-LK 190
Query: 132 YCHS-------MQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
C+S +Q + ++ + D S +L+I +L S+P
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP-------- 242
Query: 184 YIAPEVLLKKEYDGKI-ADVWS----------C---------GVTLYVMLVGAY------ 217
Y LL + +V + C VT ++
Sbjct: 243 Y--ENCLL-------VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDH 293
Query: 218 ---PFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHLISRIFVADPAKSEMHDWR 273
E K + Q +P V +P +I+ A + +W+
Sbjct: 294 HSMTLTPDEVKSLLLKYLD--CRPQ-DLPREVLTTNPRRLSIIAESIRDGLATWD--NWK 348
Query: 274 R 274
Sbjct: 349 H 349
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 280 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.53 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.3 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.09 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.95 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.81 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.8 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.63 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.45 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.38 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.25 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.17 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.05 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.98 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.88 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.72 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.7 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.69 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.64 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.62 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.58 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.47 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.33 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.04 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.03 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.82 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.52 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.2 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.98 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-64 Score=413.04 Aligned_cols=250 Identities=29% Similarity=0.512 Sum_probs=221.9
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
...++|++++.||+|+||+||+|++..+++.||+|++.+. ....+.+.+|+.++++++|||||++++++.+++.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3457899999999999999999999999999999999753 344567899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~- 172 (280)
+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+|+.....
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPES 186 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTT
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCC
Confidence 99999999999999999899999999999999999999999999999999999999998887 999999999855432
Q ss_pred --CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCH
Q 023591 173 --SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (280)
Q Consensus 173 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (280)
......+||+.|+|||++.+..++.. +|||||||++|+|++|..||...+. ......+....+.++. .+|+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~~~~~~~p~--~~s~ 259 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNE----GLIFAKIIKLEYDFPE--KFFP 259 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCT--TCCH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCc--ccCH
Confidence 22345679999999999988888655 9999999999999999999986543 3445556666677776 6999
Q ss_pred HHHHHHHHhcccCCCCcC------------CCcccccc
Q 023591 251 ECRHLISRIFVADPAKSE------------MHDWRRGC 276 (280)
Q Consensus 251 ~l~~li~~~l~~dp~~Rp------------~h~~~~~~ 276 (280)
++++||.+||+.||++|| .||||++.
T Consensus 260 ~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 999999999999999999 69999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-64 Score=406.74 Aligned_cols=256 Identities=39% Similarity=0.671 Sum_probs=206.2
Q ss_pred CCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEec
Q 023591 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILT 88 (280)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 88 (280)
.++.+...++|++.+.||+|+||+||+|++..+++.||+|++.+.. ...+.+.+|+.++++++|||||++++++.+
T Consensus 5 ~l~~G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 84 (275)
T 3hyh_A 5 SLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS 84 (275)
T ss_dssp ---------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCCCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 3334445589999999999999999999999999999999997642 334568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
++.+++||||+ +|+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+|+.
T Consensus 85 ~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~ 161 (275)
T 3hyh_A 85 KDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNI 161 (275)
T ss_dssp SSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC--
T ss_pred CCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCee
Confidence 99999999999 6799999998899999999999999999999999999999999999999998887 99999999986
Q ss_pred cccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCC
Q 023591 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (280)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (280)
...........||+.|+|||++.+..++..++||||+||++|+|++|..||...+ .......+....+.++. .+
T Consensus 162 ~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~----~~~~~~~i~~~~~~~p~--~~ 235 (275)
T 3hyh_A 162 MTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES----IPVLFKNISNGVYTLPK--FL 235 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHTCCCCCT--TS
T ss_pred cCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHcCCCCCCC--CC
Confidence 6655555667899999999999988887666999999999999999999997643 33444555556666665 68
Q ss_pred CHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 249 SPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
|+++++||.+||+.||++|| +||||+...
T Consensus 236 s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 236 SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHcCcccccCC
Confidence 99999999999999999999 999998643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-62 Score=404.46 Aligned_cols=250 Identities=26% Similarity=0.453 Sum_probs=215.3
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
+.|++.++||+|+||+||+|++..+|+.||||++.... ...+.+.+|+.++++++|||||++++++.+++.+|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999997643 33456889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCCC
Q 023591 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (280)
Q Consensus 100 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~ 178 (280)
++|+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|...... ......
T Consensus 154 ~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 154 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCC
T ss_pred CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCccccc
Confidence 99999998865 56999999999999999999999999999999999999998887 999999999855433 334567
Q ss_pred cCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHH
Q 023591 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258 (280)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 258 (280)
.||+.|+|||++.+..++.. +|||||||++|+|++|..||...+.......+.. .....++.+..+|+++++||.+
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SSCCCCSCGGGSCHHHHHHHHH
T ss_pred ccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCCccccCCHHHHHHHHH
Confidence 89999999999988888665 9999999999999999999987554333322221 1222334444689999999999
Q ss_pred hcccCCCCcC------CCccccccc
Q 023591 259 IFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 259 ~l~~dp~~Rp------~h~~~~~~~ 277 (280)
||+.||++|| .||||++..
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HcCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999 999998654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-62 Score=400.27 Aligned_cols=249 Identities=31% Similarity=0.559 Sum_probs=211.1
Q ss_pred CCCCeeeecccccCCceEEEEEEec---CCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
++++|++++.||+|+||+||+|++. .+++.||+|++.+.. .....+.+|+.++++++|||||++++++.+++.+
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 4578999999999999999999874 467899999987532 2334678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~- 171 (280)
|+||||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC----
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCC
Confidence 999999999999999999899999999999999999999999999999999999999998887 99999999975433
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
........||+.|+|||++.+..++.. +|||||||++|+|++|..||...+. ......+....+.++. .+|++
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~----~~~~~~i~~~~~~~p~--~~s~~ 252 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDR----KETMTMILKAKLGMPQ--FLSPE 252 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHH
T ss_pred CccccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCH----HHHHHHHHcCCCCCCC--cCCHH
Confidence 333456789999999999988888766 9999999999999999999987543 3344455555666665 68999
Q ss_pred HHHHHHHhcccCCCCcC-----------CCcccccc
Q 023591 252 CRHLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+++||.+||+.||++|| .||||++.
T Consensus 253 ~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 99999999999999998 69999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-61 Score=402.00 Aligned_cols=250 Identities=28% Similarity=0.508 Sum_probs=207.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
.-++|++++.||+|+||+||+|++..+|+.||||++.+... ..+.+.+|+.++++++|||||++++++.+++.+|+|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 44799999999999999999999999999999999986532 335688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 96 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
|||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTV 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCHHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecCCc
Confidence 9999999999999654 35799999999999999999999999999999999999998887 9999999997543321
Q ss_pred -CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
......||+.|+|||++.+..++.. +|||||||++|+|++|..||...+.. .....+....+. +....+|+++
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i~~~~~~-~~~~~~s~~~ 253 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMK----NLVLKIISGSFP-PVSLHYSYDL 253 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHTCCC-CCCTTSCHHH
T ss_pred ccccccCCCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHHHcCCCC-CCCccCCHHH
Confidence 1234569999999999988888655 99999999999999999999875443 333344433332 2233689999
Q ss_pred HHHHHHhcccCCCCcC------CCcccccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
++||.+||+.||++|| .||||++.
T Consensus 254 ~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 9999999999999999 99999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-60 Score=405.02 Aligned_cols=250 Identities=26% Similarity=0.453 Sum_probs=215.5
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
+.|++++.||+|+||.||+|++..+|+.||||++.... ...+.+.+|+.++++++|||||++++++.+++.+|+||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 57999999999999999999999999999999997653 33456889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCCC
Q 023591 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (280)
Q Consensus 100 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~~ 178 (280)
+||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|...... ......
T Consensus 231 ~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 231 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCCC
T ss_pred CCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCcccccc
Confidence 99999998865 56999999999999999999999999999999999999998887 999999999855433 334566
Q ss_pred cCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHH
Q 023591 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258 (280)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 258 (280)
.||+.|+|||++.+..++.. +|||||||++|+|++|..||...+....+..+.. .....++....+|+++++||.+
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSCTTSSCHHHHHHHHH
T ss_pred ccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCcccccCCHHHHHHHHH
Confidence 79999999999988888665 9999999999999999999987554333322221 1222344445789999999999
Q ss_pred hcccCCCCcC------CCccccccc
Q 023591 259 IFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 259 ~l~~dp~~Rp------~h~~~~~~~ 277 (280)
||+.||++|| .||||++..
T Consensus 384 ~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HcCCChhHCcCHHHHhcCHHhcCCC
Confidence 9999999999 999998653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-60 Score=387.05 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=205.4
Q ss_pred CCe-eeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEec----CCeE
Q 023591 21 DRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHL 92 (280)
Q Consensus 21 ~~y-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 92 (280)
++| ++.++||+|+||+||+|.+..++..||+|.+.... ...+.+.+|+.++++++|||||++++++.+ +..+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 466 78889999999999999999999999999997643 233568899999999999999999999865 3568
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEeC-CCCCcEEEeecCCcccc
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 169 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~ni~i~~-~~~~~~~l~df~~~~~~ 169 (280)
++||||+++|+|.+++.+.+.+++..+..++.||+.||+|||++| |+||||||+|||++. ++. +||+|||+|+..
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~--vKl~DFGla~~~ 182 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLK 182 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC--EEECCTTGGGGC
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC--EEEEeCcCCEeC
Confidence 999999999999999998889999999999999999999999999 999999999999974 565 999999999743
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
. ........||+.|+|||++.+ .++.. +|||||||++|+|++|..||........ ....+.............+
T Consensus 183 ~-~~~~~~~~GTp~YmAPE~~~~-~y~~~-~DiwSlGvilyelltg~~Pf~~~~~~~~---~~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 183 R-ASFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQ---IYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp C-TTSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHH---HHHHHTTTCCCGGGGGCCC
T ss_pred C-CCccCCcccCccccCHHHcCC-CCCcH-HHHHHHHHHHHHHHHCCCCCCCCCcHHH---HHHHHHcCCCCCCCCccCC
Confidence 2 233445679999999998864 56555 9999999999999999999976544332 2233333222222223578
Q ss_pred HHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 250 PECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+++++||.+||+.||++|| +||||++.
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 9999999999999999999 99999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-60 Score=391.78 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=212.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
..+.|++.+.||+|+||+||+|++..+|+.||||++...... .+|+.++++++|||||++++++.+++.+|+||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 346789999999999999999999999999999999865432 4699999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC----
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---- 174 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~---- 174 (280)
++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++. ++||+|||+|+.......
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC---------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccce
Confidence 999999999998889999999999999999999999999999999999999988763 399999999975443221
Q ss_pred --CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 175 --PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 175 --~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
.....||+.|+|||++.+..++.. +|||||||++|+|++|..||...........+...... ...++. .+|+++
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~--~~s~~~ 286 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP-IREIPP--SCAPLT 286 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG-GGGSCT--TSCHHH
T ss_pred ecCCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC-chhcCc--cCCHHH
Confidence 233569999999999998888766 99999999999999999999887665555544432111 112333 689999
Q ss_pred HHHHHHhcccCCCCcC-------------------CCccccccc
Q 023591 253 RHLISRIFVADPAKSE-------------------MHDWRRGCS 277 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp-------------------~h~~~~~~~ 277 (280)
.+||.+||+.||.+|| .|||+.+..
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 9999999999999999 599998654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-57 Score=384.26 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=211.3
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---cHHHHHHHHHhhhCCCCCeeeeceEEec------CC
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT------PT 90 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 90 (280)
.++|++++.||+|+||+||+|++..+|+.||||++.+.... .+.+.+|+.++++++|||||++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36899999999999999999999999999999999764332 3457789999999999999999998764 35
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
.+|+||||++ |+|.+++.+.+++++..++.+++||+.||+|||++||+||||||+||+++.++. +||+|||+|+...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC-
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecc
Confidence 7899999996 689999988889999999999999999999999999999999999999998887 9999999997543
Q ss_pred c-----CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccccc----
Q 023591 171 L-----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS---- 241 (280)
Q Consensus 171 ~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 241 (280)
. ........||+.|+|||++.+..+...++||||+||++|+|++|..||...+..+.+..+..........
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 2 2223456799999999998887766666999999999999999999998876555444444332211110
Q ss_pred ------------CCC---------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 242 ------------IPD---------YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 242 ------------~~~---------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
++. .+.+|+++.+||.+||+.||++|| .||||++.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 010 135789999999999999999999 99999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-56 Score=396.95 Aligned_cols=252 Identities=28% Similarity=0.422 Sum_probs=215.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHH---HHHHhhhCCCCCeeeeceEEecCCe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQR---EIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
..++|++++.||+|+||+||+|++..+|+.||+|++.+.. .....+.+ ++.+++.++|||||++++++.+++.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 4588999999999999999999999999999999997532 22222333 4566677899999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+|.....
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK 344 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeecCC
Confidence 9999999999999999999899999999999999999999999999999999999999998887 99999999975433
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
......+||+.|+|||++.++..+..++|+|||||++|+|++|..||....... .......+......++. .+|++
T Consensus 345 -~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~~~~~p~--~~S~~ 420 (689)
T 3v5w_A 345 -KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPD--SFSPE 420 (689)
T ss_dssp -CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHCCCCCCT--TSCHH
T ss_pred -CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCCCCCc--cCCHH
Confidence 334567899999999999755433445999999999999999999997654322 33455556666666666 69999
Q ss_pred HHHHHHHhcccCCCCcC-----------CCcccccc
Q 023591 252 CRHLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+++||.+||+.||.+|+ .||||++.
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 99999999999999998 89999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-56 Score=375.82 Aligned_cols=275 Identities=87% Similarity=1.394 Sum_probs=228.8
Q ss_pred CCCcccccCCCCCCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCee
Q 023591 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80 (280)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv 80 (280)
|++...+.+| ..++.....++|++++.||+|+||.||++++..+++.||+|++.......+.+.+|+.++++++||||+
T Consensus 1 m~~~~~~~~p-~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv 79 (361)
T 3uc3_A 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79 (361)
T ss_dssp -----------CCCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCCCCC-CCccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCC
Confidence 6666666555 566788888999999999999999999999999999999999998777778899999999999999999
Q ss_pred eeceEEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEE
Q 023591 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (280)
Q Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l 160 (280)
++++++.++...++||||+++++|.+++...+.+++..++.++.|++.||+|||+.|++||||||+||+++.++..++||
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred cEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEE
Confidence 99999999999999999999999999998888899999999999999999999999999999999999998877777999
Q ss_pred eecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc
Q 023591 161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240 (280)
Q Consensus 161 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
+|||++.............+++.|+|||.+.+..++..++||||||+++|+|++|..||...............+.....
T Consensus 160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 239 (361)
T 3uc3_A 160 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239 (361)
T ss_dssp CCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC
T ss_pred eecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC
Confidence 99999875555555566679999999999988888767689999999999999999999988777777777778777777
Q ss_pred cCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 241 SIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.++....+++++.+||.+||+.||++|| .||||.+.
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 7777777899999999999999999999 99999654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=372.23 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=205.6
Q ss_pred CCCCCeeeecccccCCceEEEEEEec-----CCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
+..++|.+.+.||+|+||+||++++. .++..||||.++... ...+++.+|+.++++++|||||++++++.+++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 45578999999999999999999865 357889999997643 334578899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcE
Q 023591 92 LAIVMEYASGGELFERICNA-------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~ 158 (280)
+++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||+++.++. +
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~ 167 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--V 167 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--E
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--E
Confidence 99999999999999999653 36999999999999999999999999999999999999998887 9
Q ss_pred EEeecCCccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhh
Q 023591 159 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHR 234 (280)
Q Consensus 159 ~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (280)
||+|||+|+...... ......+++.|+|||.+.+..++.+ +||||||+++|||+| |..||...+..+. ...
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~----~~~ 242 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEV----IEC 242 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHH----HHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHH
Confidence 999999997443322 2233458899999999998888655 999999999999998 8999987654332 333
Q ss_pred Hhccc-ccCCCCCCCCHHHHHHHHHhcccCCCCcC----CCccccc
Q 023591 235 ILSVQ-YSIPDYVHISPECRHLISRIFVADPAKSE----MHDWRRG 275 (280)
Q Consensus 235 ~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rp----~h~~~~~ 275 (280)
+.... ...|. .+|+++.+|+.+||+.||++|| -|+||++
T Consensus 243 i~~~~~~~~p~--~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 243 ITQGRVLQRPR--TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp HHHTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHcCCCCCCCc--cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 33322 23333 6899999999999999999999 6667654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=371.59 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=201.7
Q ss_pred CCCeeeecccccCCceEEEEEEec---CCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 95 (280)
.++|++.+.||+|+||+||+|+++ .+++.||+|.+.+.. ...++.+|+++++.+ +||||+++++++.+++.+++|
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 378999999999999999999875 467889999887643 345678999999988 699999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC--
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-- 173 (280)
|||+++++|.+++. .+++..++.+++||+.||+|||++||+||||||+||+++.+. +.+||+|||+|+......
T Consensus 99 mE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 99 MPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp EECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSCG
T ss_pred EeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCcccc
Confidence 99999999999884 499999999999999999999999999999999999998662 249999999996433211
Q ss_pred ---------------------------CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcc
Q 023591 174 ---------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (280)
Q Consensus 174 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (280)
......||+.|+|||++.+......++||||+||++|+|++|..||....+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~ 254 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL 254 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 11234689999999999877655555999999999999999999997655432
Q ss_pred hH-HHHHh----------------------------------hHhcc--------------cccCCCCCCCCHHHHHHHH
Q 023591 227 NF-RKTIH----------------------------------RILSV--------------QYSIPDYVHISPECRHLIS 257 (280)
Q Consensus 227 ~~-~~~~~----------------------------------~~~~~--------------~~~~~~~~~~~~~l~~li~ 257 (280)
.. ..+.. .+... ....+.+..+|+++.+||+
T Consensus 255 ~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~ 334 (361)
T 4f9c_A 255 TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLD 334 (361)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHH
T ss_pred HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHH
Confidence 21 11111 00000 0011223468999999999
Q ss_pred HhcccCCCCcC------CCccccccc
Q 023591 258 RIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 258 ~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
+||+.||++|| .||||++.+
T Consensus 335 ~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 335 KLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHCcCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999 999999865
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=369.09 Aligned_cols=247 Identities=24% Similarity=0.385 Sum_probs=191.9
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCC--------
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 90 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------- 90 (280)
++|++++.||+|+||+||+|++..+++.||||++..... ..+.+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 469999999999999999999999999999999976543 2356889999999999999999999987543
Q ss_pred ----eEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeec
Q 023591 91 ----HLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (280)
Q Consensus 91 ----~~~lv~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df 163 (280)
.+|+||||+++++|.+++..... .+...++.++.||+.||+|||++||+||||||+||+++.++. +||+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DF 162 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDF 162 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccC
Confidence 37999999999999999987654 455678999999999999999999999999999999998887 999999
Q ss_pred CCccccccCCCC-------------CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHH
Q 023591 164 GYSKSSVLHSQP-------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (280)
Q Consensus 164 ~~~~~~~~~~~~-------------~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (280)
|+|+........ ....||+.|+|||++.+..++.. +|||||||++|+|++ ||.... ....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyell~---Pf~~~~---~~~~ 235 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQM---ERVR 235 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHS---CCSSHH---HHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHHHHHHHHHcc---CCCCcc---HHHH
Confidence 999754332211 23469999999999988888665 999999999999995 775421 1222
Q ss_pred HHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
....+....+. +.....++.+.+||.+||+.||++|| +||||++..
T Consensus 236 ~~~~~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 236 TLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHHHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHHHhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 22222222211 11113467789999999999999999 999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=361.39 Aligned_cols=244 Identities=24% Similarity=0.348 Sum_probs=194.1
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
...+++++.+.||+|+||+||+++... .||||+++... ...+.+.+|+.++++++|||||++++++. ++.+++
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~i 108 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAI 108 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEE
Confidence 456789999999999999999998753 48999987543 23356889999999999999999999875 456899
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-
Q 023591 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~- 172 (280)
||||+++|+|.+++... .++++..+..++.||+.||+|||+++|+||||||+|||++.++. +||+|||+|+.....
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRWS 186 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC-----
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceecccCC
Confidence 99999999999999654 57999999999999999999999999999999999999998887 999999999754322
Q ss_pred --CCCCCCcCCCcccCcccccCCc--CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC-CCCCC
Q 023591 173 --SQPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI-PDYVH 247 (280)
Q Consensus 173 --~~~~~~~~~~~~~aPE~~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 247 (280)
.......||+.|+|||++.+.. ..+.++|||||||++|||++|..||...+...........-.. .... .....
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~-~p~~~~~~~~ 265 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA-SPDLSKLYKN 265 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC-CCCSTTSCTT
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC-CCCccccccc
Confidence 2234557999999999986432 2344599999999999999999999876654333333222111 1111 11236
Q ss_pred CCHHHHHHHHHhcccCCCCcC
Q 023591 248 ISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp 268 (280)
+|+++.+|+.+||+.||++||
T Consensus 266 ~~~~l~~li~~cl~~dP~~RP 286 (307)
T 3omv_A 266 CPKAMKRLVADCVKKVKEERP 286 (307)
T ss_dssp SCHHHHHHHHHHTCSSSTTSC
T ss_pred chHHHHHHHHHHcCCCHhHCc
Confidence 899999999999999999999
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=365.16 Aligned_cols=241 Identities=25% Similarity=0.396 Sum_probs=196.0
Q ss_pred CCCCeeeecccccCCceEEEEEEec-----CCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
..++|.+.++||+|+||+||+++.. .++..||||.++... ...+++.+|+.++++++|||||++++++.++..+
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3467899999999999999999864 367899999997643 3346788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCc
Q 023591 93 AIVMEYASGGELFERICNA---------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~ 157 (280)
++||||+++|+|.+++... .++++..+..++.||+.||+|||+.+|+||||||+||+++.++.
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~-- 196 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV-- 196 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--
Confidence 9999999999999998653 35899999999999999999999999999999999999998887
Q ss_pred EEEeecCCccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHh
Q 023591 158 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (280)
Q Consensus 158 ~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 233 (280)
+||+|||+++...... ......+++.|+|||.+.+..++.+ +||||||+++|||+| |..||...+..+...
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~---- 271 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAID---- 271 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH----
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCCHHHHHH----
Confidence 9999999997543322 2234568999999999988888655 999999999999999 899998765433332
Q ss_pred hHhcc-cccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 234 RILSV-QYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 234 ~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+... ....|. .+|+++.+|+.+||+.||++||
T Consensus 272 ~i~~g~~~~~p~--~~~~~~~~li~~cl~~dP~~RP 305 (329)
T 4aoj_A 272 CITQGRELERPR--ACPPEVYAIMRGCWQREPQQRH 305 (329)
T ss_dssp HHHHTCCCCCCT--TCCHHHHHHHHHHCCSSTTTSC
T ss_pred HHHcCCCCCCcc--cccHHHHHHHHHHcCcChhHCc
Confidence 22222 233343 7899999999999999999999
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=393.31 Aligned_cols=253 Identities=30% Similarity=0.545 Sum_probs=218.8
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
.++|++.+.||+|+||.||+|+++.+|+.||+|++..... ..+.+.+|+.+|+.++|||||++++++.++..+++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 4789999999999999999999999999999999976542 345688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCC
Q 023591 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (280)
Q Consensus 99 ~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (280)
++||+|.+++.. ...+++..+..+++||+.||+|||++||+||||||+||+++.+..+.+||+|||+++..........
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~ 315 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 315 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceee
Confidence 999999998864 4579999999999999999999999999999999999999876555699999999987665555556
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC--CCCCCCHHHHHH
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHL 255 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 255 (280)
..||+.|+|||++.+..++.. +|||||||++|+|++|..||...+... ....+....+.++ .+..+|+++++|
T Consensus 316 ~~GT~~y~APEv~~~~~y~~~-~DiWSlGvilyeml~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 316 TTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDE----TLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp ECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred eEECccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 679999999999998888655 999999999999999999998755433 3344444444333 234789999999
Q ss_pred HHHhcccCCCCcC------CCccccccc
Q 023591 256 ISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 256 i~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
|.+||+.||.+|| .||||+...
T Consensus 391 i~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 391 IRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred HHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 9999999999999 999998643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-55 Score=360.32 Aligned_cols=242 Identities=21% Similarity=0.347 Sum_probs=201.4
Q ss_pred CCCCeeeecccccCCceEEEEEEec-----CCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
..+++++.++||+|+||+||+++.. .+++.||||.+.... ...+++.+|+.++++++|||||++++++.++..
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 4578999999999999999999853 457889999986532 334679999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC
Q 023591 92 LAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~ 155 (280)
+++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC
Confidence 99999999999999999643 35899999999999999999999999999999999999998887
Q ss_pred CcEEEeecCCccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHH
Q 023591 156 PRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (280)
Q Consensus 156 ~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~ 231 (280)
+||+|||+++...... ......+++.|+|||.+.++.++.+ +||||||+++|||+| |..||...+..+ .
T Consensus 184 --~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~~~~~----~ 256 (308)
T 4gt4_A 184 --VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQD----V 256 (308)
T ss_dssp --EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTCCHHH----H
T ss_pred --EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCHHH----H
Confidence 9999999997543322 2344568999999999998888655 999999999999998 899998765433 2
Q ss_pred HhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
...+.... ..+....+|+++.+|+.+||+.||++||
T Consensus 257 ~~~i~~~~-~~~~p~~~~~~~~~li~~C~~~dP~~RP 292 (308)
T 4gt4_A 257 VEMIRNRQ-VLPCPDDCPAWVYALMIECWNEFPSRRP 292 (308)
T ss_dssp HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHcCC-CCCCcccchHHHHHHHHHHcCCChhHCc
Confidence 33333322 2222337899999999999999999999
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=354.87 Aligned_cols=250 Identities=40% Similarity=0.694 Sum_probs=221.5
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
..++|++.+.||+|+||.||++++..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 45789999999999999999999999999999999976432 335677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
|||+++++|.+++...+.+++..++.++.|++.||+|||+.|++||||||+||+++.++. +||+|||++.........
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGG
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCcc
Confidence 999999999999988889999999999999999999999999999999999999998887 999999999866555555
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....+++.|+|||.+.+..++..++||||||+++|+|++|..||...+. ......+....+.++. .+++++.+|
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~l 244 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL----KELRERVLRGKYRIPF--YMSTDCENL 244 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCC--CCCHHHHHH
Confidence 6677999999999999888876679999999999999999999987543 3444455555666665 689999999
Q ss_pred HHHhcccCCCCcC------CCcccccc
Q 023591 256 ISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 256 i~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
|++||+.||.+|| .||||+..
T Consensus 245 i~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 9999999999999 99999854
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=351.35 Aligned_cols=254 Identities=31% Similarity=0.576 Sum_probs=218.6
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-------ccHHHHHHHHHhhhCCCCCeeeeceEEecCC
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 90 (280)
...++|++.+.||+|+||.||++++..+++.||+|++.+... ..+.+.+|+.++++++||||+++++++.++.
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 345789999999999999999999999999999999986532 2367889999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC--CcEEEeecCCccc
Q 023591 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKS 168 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~--~~~~l~df~~~~~ 168 (280)
.+++||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++. ..++|+|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999999999988888999999999999999999999999999999999999986662 2499999999986
Q ss_pred cccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC--CC
Q 023591 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YV 246 (280)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 246 (280)
...........+++.|+|||.+.+..++.. +||||||+++|+|++|..||...+... ....+....+.++. +.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~~ll~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQE----TLANITAVSYDFDEEFFS 243 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHTTCCCCCHHHHT
T ss_pred cCCCCccccCCCCccEECchHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCCCchhcc
Confidence 655555566779999999999988777655 999999999999999999998754433 33344444443332 24
Q ss_pred CCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 247 HISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.+++++++||.+||+.||.+|| .||||+..
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 6899999999999999999999 99999853
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=345.72 Aligned_cols=249 Identities=33% Similarity=0.571 Sum_probs=217.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++++.||+|+||.||++++..+++.||+|++.+. ......+.+|+.+++.++||||+++++++...+.+++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 347899999999999999999999999999999999763 3345678889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-CC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~-~~ 173 (280)
||||+++++|.+++.+...+++..++.++.||+.||+|||++||+||||||+||+++.++. ++|+|||++..... ..
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCC
Confidence 9999999999999988888999999999999999999999999999999999999998887 99999999875332 23
Q ss_pred CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
......+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+. ......+......++. .+++++.
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~ 233 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFPR--TLSPEAK 233 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred cccccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCCCCC--CCCHHHH
Confidence 3445678999999999988877665 9999999999999999999986543 3334444445555665 6899999
Q ss_pred HHHHHhcccCCCCcC-----------CCcccccc
Q 023591 254 HLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+||.+||+.||++|| .||||++.
T Consensus 234 ~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 999999999999997 89999754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=354.27 Aligned_cols=243 Identities=23% Similarity=0.401 Sum_probs=199.9
Q ss_pred CCCCeeeecccccCCceEEEEEEecCC-----CcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCC-CCeeeeceEEecC-
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLRH-PNIVRFKEVILTP- 89 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~- 89 (280)
..++|++.+.||+|+||+||+|.+..+ ++.||+|.+..... ..+.+.+|+.++++++| ||||++++++..+
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 357899999999999999999997654 36799999876432 23568899999999966 8999999998664
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC
Q 023591 90 THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~ 153 (280)
..+++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||+++.+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence 5689999999999999999653 348999999999999999999999999999999999999988
Q ss_pred CCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHH
Q 023591 154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (280)
Q Consensus 154 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~ 229 (280)
+. +||+|||+|+....... .....+++.|+|||.+.+..++.+ +|||||||++|||+| |..||........+.
T Consensus 222 ~~--vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 222 NV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp GC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CC--EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 87 99999999975433222 234457899999999998888655 999999999999998 899998766544333
Q ss_pred HHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 230 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..... ......|. .+++++.+|+.+||+.||++||
T Consensus 299 ~~i~~--g~~~~~p~--~~~~~~~~li~~c~~~dP~~RP 333 (353)
T 4ase_A 299 RRLKE--GTRMRAPD--YTTPEMYQTMLDCWHGEPSQRP 333 (353)
T ss_dssp HHHHH--TCCCCCCT--TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHc--CCCCCCCc--cCCHHHHHHHHHHcCcChhHCc
Confidence 33222 12233343 6899999999999999999999
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-52 Score=353.17 Aligned_cols=256 Identities=28% Similarity=0.469 Sum_probs=217.6
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhC-CCCCeeeeceEEecCC
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 90 (280)
.....++|++++.||+|+||+||++++..+++.||+|++.+.. ...+.+.+|..++.++ +||||+++++++.++.
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 3445689999999999999999999999999999999998642 2334577888888776 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc-
Q 023591 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS- 169 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~- 169 (280)
.+++||||+++++|..++.+...+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++...
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~ 204 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCC
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecc
Confidence 99999999999999999988889999999999999999999999999999999999999998887 999999999752
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc-----chHHHHHhhHhcccccCCC
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----KNFRKTIHRILSVQYSIPD 244 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 244 (280)
..........+++.|+|||++.+..++.. +|+||||+++|+|++|..||...... .........+......++.
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~-~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~ 283 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 283 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT
T ss_pred cCCCccccccCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC
Confidence 23334456679999999999988888665 99999999999999999999643221 1223344555556666666
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC------------CCcccccc
Q 023591 245 YVHISPECRHLISRIFVADPAKSE------------MHDWRRGC 276 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp------------~h~~~~~~ 276 (280)
.+++++.+||++||+.||.+|| .||||++.
T Consensus 284 --~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 284 --SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp --TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred --cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 6899999999999999999997 69999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=349.81 Aligned_cols=250 Identities=32% Similarity=0.525 Sum_probs=212.4
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 92 (280)
...++|++++.||+|+||.||++++..+++.||+|++.+. ....+.+.+|..+++.+ +||||+++++++.++..+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4558999999999999999999999999999999999763 23445677899999888 799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~- 171 (280)
++||||+++++|.+++.+...+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++.....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC-
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecccC
Confidence 999999999999999988889999999999999999999999999999999999999998887 99999999875332
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
........+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+. ......+......++. .++++
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~~~~ 250 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENE----DDLFEAILNDEVVYPT--WLHED 250 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHH
T ss_pred CccccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCC--CCCHH
Confidence 233445678999999999988777665 9999999999999999999987544 3344455555666665 58999
Q ss_pred HHHHHHHhcccCCCCcC------------CCcccccc
Q 023591 252 CRHLISRIFVADPAKSE------------MHDWRRGC 276 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp------------~h~~~~~~ 276 (280)
+.+||++||+.||.+|| .||||++.
T Consensus 251 ~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 99999999999999998 69999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=348.16 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=220.2
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
.....++|++.+.||+|+||.||++++..+++.||+|++.+. ......+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 334568999999999999999999999999999999998753 2344678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
+++||||+.+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++.....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPR 167 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccC
Confidence 9999999999999999998889999999999999999999999999999999999999998887 99999999986655
Q ss_pred CCCCCCCcCCCcccCcccccCC---cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCC
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (280)
........+++.|+|||++.+. .++.. +||||||+++|+|++|..||...... ........+......++. .+
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~-~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~p~--~~ 243 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRRPYHIRSST-SSKEIVHTFETTVVTYPS--AW 243 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBCTT-HHHHHHHHHHHHHHHSSCSSCCCTTS-CHHHHHHHHHHCCCCCCT--TS
T ss_pred CCceeccCCCccccCCeeeccCCCCCCCcc-ceeechHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhhcccCCCC--cC
Confidence 5555667899999999998643 35444 99999999999999999999765442 233344444444555555 68
Q ss_pred CHHHHHHHHHhcccCCCCcC-------CCcccccc
Q 023591 249 SPECRHLISRIFVADPAKSE-------MHDWRRGC 276 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp-------~h~~~~~~ 276 (280)
++++.+||.+||+.||.+|| .||||++.
T Consensus 244 s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 99999999999999999999 89999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=344.74 Aligned_cols=256 Identities=33% Similarity=0.602 Sum_probs=217.2
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-------ccHHHHHHHHHhhhCCCCCeeeeceEEec
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILT 88 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 88 (280)
.....++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85 (326)
T ss_dssp CSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 33445789999999999999999999999999999999976432 24678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC--CCcEEEeecCCc
Q 023591 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYS 166 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~--~~~~~l~df~~~ 166 (280)
+...++||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ ..+++|+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999999998888899999999999999999999999999999999999998766 224999999999
Q ss_pred cccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC--
Q 023591 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-- 244 (280)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 244 (280)
.............+++.|+|||.+.+..++.. +||||||+++|+|++|..||.......... .+......++.
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~ 240 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLA----NVSAVNYEFEDEY 240 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHH----HHHHTCCCCCHHH
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHH----HHHhcCCCcCccc
Confidence 86655555556678999999999987777655 999999999999999999998754332222 22222222221
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 245 YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
...+++.+.+||.+||+.||++|| .||||++.
T Consensus 241 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 236789999999999999999999 99999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=347.87 Aligned_cols=249 Identities=43% Similarity=0.753 Sum_probs=216.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||.||++.+..+++.||+|++.+. ......+.+|+.+++.++||||+++++++..+...++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 448999999999999999999999999999999998753 2344678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
||||+ +++|.+++...+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++. +||+|||++........
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNF 163 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBT
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCcc
Confidence 99999 6799999988889999999999999999999999999999999999999998877 99999999986666655
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
.....+++.|+|||.+.+..+...++||||||+++|+|++|..||........ ...+....+..+. .+|+++.+
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~ 237 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----FKKVNSCVYVMPD--FLSPGAQS 237 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----BCCCCSSCCCCCT--TSCHHHHH
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----HHHHHcCCCCCcc--cCCHHHHH
Confidence 66778999999999998888766669999999999999999999976543221 2222333334444 68999999
Q ss_pred HHHHhcccCCCCcC------CCcccccc
Q 023591 255 LISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
||++||+.||.+|| .||||+..
T Consensus 238 li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 238 LIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 99999999999999 99999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=339.42 Aligned_cols=247 Identities=32% Similarity=0.572 Sum_probs=216.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||.||++++..+++.||+|++.+. ....+.+.+|..+++.++||||+++++++.+...+++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 457899999999999999999999999999999999764 2344667889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
||||+++++|.+++.....+++..++.++.||+.||.|||++|++||||+|+||+++.++. +||+|||++..... .
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~~--~ 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--V 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--C
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceecCC--c
Confidence 9999999999999998889999999999999999999999999999999999999998887 99999999875432 2
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
.....+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+. ......+......++. .+++++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~p~--~~~~~~~~ 232 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNT----MKTYEKILNAELRFPP--FFNEDVKD 232 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHCCCCCCT--TSCHHHHH
T ss_pred cccccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCC--CCCHHHHH
Confidence 345678999999999988887665 9999999999999999999987543 3334444455555655 68999999
Q ss_pred HHHHhcccCCCCcC-----------CCcccccc
Q 023591 255 LISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 255 li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
||.+||+.||.+|| .||||++.
T Consensus 233 li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 233 LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 99999999999998 89999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=348.23 Aligned_cols=252 Identities=25% Similarity=0.468 Sum_probs=216.0
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
.++|++.+.||+|+||.||++.+..+++.+|+|.+.........+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 47999999999999999999999999999999999876666667889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCC
Q 023591 100 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (280)
Q Consensus 100 ~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~ 178 (280)
++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.+....++|+|||++............
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 163 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence 9999999997654 799999999999999999999999999999999999998744455999999999865544444455
Q ss_pred cCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC--CCCCCHHHHHHH
Q 023591 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLI 256 (280)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li 256 (280)
.+++.|+|||.+.+..++.. +||||||+++|+|++|..||....... ....+....+.++. +..+|+++.+||
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T 1tki_A 164 FTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQ----IIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred cCChhhcCcHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcCCCHHH----HHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence 68999999999987766554 999999999999999999998755433 33333333333321 236899999999
Q ss_pred HHhcccCCCCcC------CCcccccc
Q 023591 257 SRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 257 ~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.+||+.||.+|| .||||++.
T Consensus 239 ~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 239 DRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHcCCChhHCcCHHHHhcChhhccC
Confidence 999999999999 99999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=343.38 Aligned_cols=251 Identities=33% Similarity=0.541 Sum_probs=215.5
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCe
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 91 (280)
....++|++.+.||+|+||.||++++..+++.||+|++.+. ....+.+.+|..++..+ +||||+++++++.++..
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34568999999999999999999999999999999999764 33445677888888876 99999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
+++||||+++++|.+++.....+++..++.++.||+.||+|||++|++||||||+||+++.++. ++|+|||++.....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENML 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhccc
Confidence 9999999999999999988888999999999999999999999999999999999999998887 99999999875332
Q ss_pred -CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCH
Q 023591 172 -HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (280)
Q Consensus 172 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (280)
........+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+. ......+......++. .+++
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~ 243 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIRMDNPFYPR--WLEK 243 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCCCh-hhhHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHhCCCCCCc--ccCH
Confidence 223445678999999999988877655 9999999999999999999987543 2333444444555555 5899
Q ss_pred HHHHHHHHhcccCCCCcC-------CCcccccc
Q 023591 251 ECRHLISRIFVADPAKSE-------MHDWRRGC 276 (280)
Q Consensus 251 ~l~~li~~~l~~dp~~Rp-------~h~~~~~~ 276 (280)
++.+||.+||+.||++|| .||||++.
T Consensus 244 ~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 244 EAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 999999999999999999 79999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=343.07 Aligned_cols=250 Identities=32% Similarity=0.512 Sum_probs=216.5
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 92 (280)
...++|++.+.||+|+||.||++++..+++.||+|++.+. ....+.+.+|..++..+ +||+|+++++++.+.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 3558999999999999999999999999999999999764 23445677899999887 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~- 171 (280)
++||||+++++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++.....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCcccccccC
Confidence 999999999999999988888999999999999999999999999999999999999998887 99999999875332
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
........+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+. ......+......++. .++++
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~ 247 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYPK--SMSKE 247 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHH
T ss_pred CcccccccCCccccChhhhcCCCcCCc-ccccchHHHHHHHHcCCCCCCCCCH----HHHHHHHHhCCCCCCC--CCCHH
Confidence 233455678999999999988887655 9999999999999999999986543 3344455555556665 68999
Q ss_pred HHHHHHHhcccCCCCcC-----------CCcccccc
Q 023591 252 CRHLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+.+||.+||+.||.+|| .||||++.
T Consensus 248 ~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp HHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 99999999999999999 89999854
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-51 Score=335.40 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=214.0
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
....++|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 345589999999999999999999999999999999987643 3345678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 174 (280)
|||+++++|.+++... .+++..++.++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++........
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCC
T ss_pred EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCcccc
Confidence 9999999999998664 6999999999999999999999999999999999999998887 99999999875443332
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
.....+++.|+|||.+.+..++.. +||||||+++|+|++|..||............. ............+++.+.+
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 248 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFRD 248 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HHCSCCCSCGGGSCHHHHH
T ss_pred cCCccCCcCccChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCCCCCCCCccccCHHHHH
Confidence 344568999999999988888665 999999999999999999998755432222222 1222222233368999999
Q ss_pred HHHHhcccCCCCcC------CCccccccc
Q 023591 255 LISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
||.+||+.||++|| .||||+...
T Consensus 249 li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 249 FLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 99999999999999 999998643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=340.16 Aligned_cols=253 Identities=29% Similarity=0.485 Sum_probs=215.3
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc----cHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 93 (280)
..++|++.+.||+|+||.||++++..+++.||+|++.+.... .+.+.+|..+++++ +||||+++++++.++..++
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 357899999999999999999999999999999999865322 34567899999887 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc-cC
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~-~~ 172 (280)
+||||+++++|.+++.+...+++..++.++.||+.||+|||++||+||||||+||+++.++. ++|+|||++.... ..
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCTT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCCC
Confidence 99999999999999988888999999999999999999999999999999999999998887 9999999987532 22
Q ss_pred CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc-----chHHHHHhhHhcccccCCCCCC
Q 023591 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----KNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
.......+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...... .........+......++. .
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~ 241 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--S 241 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--T
T ss_pred CcccccCCCccccCccccCCCCCChH-HhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--C
Confidence 33445678999999999988877655 99999999999999999999753221 1223334445555556665 6
Q ss_pred CCHHHHHHHHHhcccCCCCcC------------CCcccccc
Q 023591 248 ISPECRHLISRIFVADPAKSE------------MHDWRRGC 276 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp------------~h~~~~~~ 276 (280)
+++++.+||.+||+.||.+|| .||||++.
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 899999999999999999997 69999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=340.92 Aligned_cols=248 Identities=30% Similarity=0.545 Sum_probs=217.3
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
...++|++.+.||+|+||.||++++..+++.||+|++.+.. ...+.+.+|+.+++.++||||+++++++.++..++
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 35589999999999999999999999999999999987642 34467888999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
+||||+++++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++. ++|+|||++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceeccC--
Confidence 99999999999999988888999999999999999999999999999999999999998887 99999999875432
Q ss_pred CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
......+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+. ......+......++. .+++++.
T Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~~~~~~ 266 (350)
T 1rdq_E 194 RTWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQP----IQIYEKIVSGKVRFPS--HFSSDLK 266 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TCCHHHH
T ss_pred CcccccCCccccCHHHhcCCCCCCc-CCEecccHhHhHHhhCCCCCCCCCH----HHHHHHHHcCCCCCCC--CCCHHHH
Confidence 2345578999999999988877655 9999999999999999999986543 3344445555555655 6899999
Q ss_pred HHHHHhcccCCCCcC-----------CCcccccc
Q 023591 254 HLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+||.+||+.||.+|| .||||++.
T Consensus 267 ~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 999999999999997 89999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=342.07 Aligned_cols=250 Identities=32% Similarity=0.527 Sum_probs=209.1
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHH-hhhCCCCCeeeeceEEecCCeE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIIN-HRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
...++|++++.||+|+||.||++++..+++.||+|++.+... ....+.+|..+ ++.++||||+++++++.+++.+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 355899999999999999999999999999999999976532 22345556665 4668999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc-c
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-L 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~-~ 171 (280)
++||||+++++|.+++.+...+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++.... .
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCccccccccC
Confidence 999999999999999988888999999999999999999999999999999999999998887 9999999987533 2
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
........+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+. ......+......++. .++++
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~~~~~~~--~~~~~ 265 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNT----AEMYDNILNKPLQLKP--NITNS 265 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSBH----HHHHHHHHHSCCCCCS--SSCHH
T ss_pred CCccccccCCccccCHHHhCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHhcccCCCC--CCCHH
Confidence 334456679999999999988877655 9999999999999999999987543 3344444445555554 68999
Q ss_pred HHHHHHHhcccCCCCcC----------CCcccccc
Q 023591 252 CRHLISRIFVADPAKSE----------MHDWRRGC 276 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp----------~h~~~~~~ 276 (280)
+++||.+||+.||.+|| .||||++.
T Consensus 266 ~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 266 ARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 99999999999999999 89999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=345.71 Aligned_cols=258 Identities=27% Similarity=0.495 Sum_probs=216.8
Q ss_pred CCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
.......++|++.+.||+|+||.||++.+..+++.||+|++..... ....+.+|+.++++++||||+++++++.++...
T Consensus 44 ~~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 44 VKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp CBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred ccCCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 3344456799999999999999999999999999999999876532 334678999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
++||||+++++|.+++.... .+++..++.++.||+.||+|||+.|++|+||+|+||+++.++...++|+|||++.....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999999999886543 79999999999999999999999999999999999999866555699999999986554
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC--CCCCCCC
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHIS 249 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 249 (280)
........+++.|+|||.+.+..++.. +||||||+++|+|++|..||......... ..+....+.+ .....++
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s 278 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETL----QNVKRCDWEFDEDAFSSVS 278 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHHCCCCCCSSTTTTSC
T ss_pred CcceeeeccCCCccCchhccCCCCCCc-ccEeeHhHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCccccccCC
Confidence 444445568999999999988777555 99999999999999999999875443222 2333333222 2234689
Q ss_pred HHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 250 PECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+++.+||.+||+.||++|| .||||++.
T Consensus 279 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 9999999999999999999 99999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=329.96 Aligned_cols=255 Identities=24% Similarity=0.433 Sum_probs=205.3
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|++.+.||+|+||+||++++..+++.||+|++...... ...+.+|+.++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 6899999999999999999999999999999999764332 3567889999999999999999999999999999999
Q ss_pred ccCCCchHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCC
Q 023591 98 YASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (280)
Q Consensus 98 ~~~~~~L~~~~-~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (280)
|+++ ++.+.+ .....+++..++.++.|++.||++||+.|++|+||||+||+++.++. ++|+|||++...... ...
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCccccc
Confidence 9976 555555 44678999999999999999999999999999999999999998887 999999999754322 233
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcch-HHHHHhhHhcccc-c------------
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQY-S------------ 241 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~-~------------ 241 (280)
....+++.|+|||.+.+....+.++||||||+++|+|++|..||........ ............. .
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 4456789999999998777545559999999999999998888654443322 2222221111100 0
Q ss_pred ----------CCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 242 ----------IPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 242 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
......+++++++||.+||+.||++|| +||||++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p 291 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence 001124789999999999999999999 9999997643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=343.55 Aligned_cols=251 Identities=34% Similarity=0.600 Sum_probs=215.2
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++.++...++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3589999999999999999999999999999999976543 2356778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC-CcEEEeecCCccccccCCCC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~-~~~~l~df~~~~~~~~~~~~ 175 (280)
||+++++|.+.+.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++. ..+||+|||++.........
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 99999999999988888999999999999999999999999999999999999986542 45999999999866554444
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC--CCCCCCHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECR 253 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~ 253 (280)
....+++.|+|||.+.+..++.. +||||||+++|+|++|..||...+.. .....+....+.++ .+..+++++.
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQH----RLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp CCSCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred ccCCCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhCCCCCCcccccCCCHHHH
Confidence 55678999999999988777665 99999999999999999999875432 23333333333333 2346899999
Q ss_pred HHHHHhcccCCCCcC------CCccccc
Q 023591 254 HLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
+||.+||+.||++|| .||||++
T Consensus 263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 999999999999999 9999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=353.31 Aligned_cols=252 Identities=39% Similarity=0.697 Sum_probs=220.9
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
....++|++.+.||+|+||.||++++..+|+.||+|++.+.. ...+.+.+|+.+++.++||||+++++++..+...
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 345689999999999999999999999999999999997542 3346788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
++||||+++++|.+++...+.+++..++.++.||+.||+|||+.|++||||||+||+++.++. +||+|||++......
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhcccc
Confidence 999999999999999988888999999999999999999999999999999999999998887 999999999866555
Q ss_pred CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
.......+++.|+|||.+.+..+...++||||||+++|+|++|..||....... ....+....+..+. .+++++
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~ 243 (476)
T 2y94_A 170 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT----LFKKICDGIFYTPQ--YLNPSV 243 (476)
T ss_dssp CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH----HHHHHHTTCCCCCT--TCCHHH
T ss_pred ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH----HHHHHhcCCcCCCc--cCCHHH
Confidence 555566799999999999888776667999999999999999999998755433 33344444444444 689999
Q ss_pred HHHHHHhcccCCCCcC------CCcccccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.+||.+||+.||.+|| .||||++.
T Consensus 244 ~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 9999999999999999 99999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=337.58 Aligned_cols=243 Identities=23% Similarity=0.273 Sum_probs=185.4
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCC----eEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~ 96 (280)
.+|.+.+.||+|+||+||++++ +|+.||||++............|+..+.+++|||||++++++..++ .+++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 5799999999999999999988 4889999998765443333445666677889999999999997653 589999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~--------~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
||+++|+|.+++.. .+++++.+.+++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++.
T Consensus 81 Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred cCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCcc
Confidence 99999999999965 4689999999999999999999987 9999999999999998887 99999999975
Q ss_pred cccCCC-----CCCCcCCCcccCcccccCCcC-----CCccchhhHHHHHHHHHHhCCCCCCCCCC----------cc-h
Q 023591 169 SVLHSQ-----PKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEE----------PK-N 227 (280)
Q Consensus 169 ~~~~~~-----~~~~~~~~~~~aPE~~~~~~~-----~~~~~DiwslG~~l~~l~~g~~p~~~~~~----------~~-~ 227 (280)
...... .....+|+.|+|||++.+... .+.++|||||||++|||++|..||..... .. .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 443322 233569999999999875421 23459999999999999999776643221 11 1
Q ss_pred HHHHHhhHhcccc--cCCCC---CCCCHHHHHHHHHhcccCCCCcC
Q 023591 228 FRKTIHRILSVQY--SIPDY---VHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 228 ~~~~~~~~~~~~~--~~~~~---~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.......+..... .++.. ...++.+.+|+.+||+.||++||
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RP 283 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSC
T ss_pred HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCc
Confidence 2223333333222 22211 11235789999999999999999
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=338.34 Aligned_cols=253 Identities=33% Similarity=0.562 Sum_probs=212.7
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
..++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3489999999999999999999999999999999986543 23356889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC---C
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---S 173 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~---~ 173 (280)
||+++++|.+++.....+++..++.++.||+.||+|||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRER 162 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEEC
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCccc
Confidence 99999999999988778999999999999999999999999999999999999998887 999999998743322 2
Q ss_pred CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
......+++.|+|||.+.+..+...++||||||+++|+|++|..||............. .......+....+++++.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---KEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH---HTTCTTSTTGGGSCHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hcccccCCccccCCHHHH
Confidence 22355789999999999888776666999999999999999999998765543322222 222223333346899999
Q ss_pred HHHHHhcccCCCCcC------CCcccccc
Q 023591 254 HLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+||.+||+.||++|| .||||++.
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 999999999999999 99999753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=349.55 Aligned_cols=253 Identities=34% Similarity=0.592 Sum_probs=213.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
-.++|++.+.||+|+||.||++.+..+++.+|+|++..... ..+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 34789999999999999999999999999999999976542 234578999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC-CCCcEEEeecCCccccccCCC
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~-~~~~~~l~df~~~~~~~~~~~ 174 (280)
|||+++++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.+ ....+||+|||++........
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 9999999999999888899999999999999999999999999999999999999853 234599999999975443322
Q ss_pred -CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC--CCCCCCCHH
Q 023591 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPE 251 (280)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 251 (280)
.....+++.|+|||.+.+..++.. +||||||+++|+|++|..||...... .....+....+.+ +.+..++++
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQH----RLYQQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred eeecccCCcccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCccHH----HHHHHHHhCCCCCCccccccCCHH
Confidence 234578999999999988877665 99999999999999999999875443 2333333333333 334578999
Q ss_pred HHHHHHHhcccCCCCcC------CCcccccc
Q 023591 252 CRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+.+||.+||+.||++|| .||||++.
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 99999999999999999 99999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=332.11 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=208.7
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
..-.++|++++.||+|+||+||++++. +++.||+|++..... ....+.+|+.++++++||||+++++++.++...+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEE
Confidence 335589999999999999999999985 588999999875432 2356789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
+||||+++ +|.+.+... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 96 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 96 LVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIP 172 (311)
T ss_dssp EEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSC
T ss_pred EEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecCCC
Confidence 99999975 888777654 45999999999999999999999999999999999999998887 999999999754322
Q ss_pred -CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccccc-C--------
Q 023591 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-I-------- 242 (280)
Q Consensus 173 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~-------- 242 (280)
.......+++.|+|||.+.+......++||||||+++|+|++|..||...................... +
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 223345679999999998775544555999999999999999999998877766655554432221110 0
Q ss_pred ---------C------CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 243 ---------P------DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 243 ---------~------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
. ....+++++.+||.+||+.||++|| .||||++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 0 0124788999999999999999999 9999997653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=345.11 Aligned_cols=252 Identities=32% Similarity=0.470 Sum_probs=213.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||+||++++..+++.||+|++.+. ....+.+.+|+.+++.++||||+++++++.++..+++
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 457999999999999999999999999999999999762 2334567899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~- 173 (280)
||||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSE
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCCc
Confidence 9999999999998865 46999999999999999999999999999999999999998887 9999999997543332
Q ss_pred -CCCCCcCCCcccCcccccCCc----CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCC
Q 023591 174 -QPKSTVGTPAYIAPEVLLKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (280)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~~~----~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (280)
......+++.|+|||++.+.. ++ .++|+||||+++|+|++|..||...+......++..... ...++....+
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~ 300 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYG-RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN--SLTFPDDNDI 300 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEE-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCCCCTTCCC
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCC-CcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc--cccCCCcccc
Confidence 234567999999999997654 43 449999999999999999999987654443443333221 2345555579
Q ss_pred CHHHHHHHHHhcccCCCC--cC------CCcccccc
Q 023591 249 SPECRHLISRIFVADPAK--SE------MHDWRRGC 276 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~--Rp------~h~~~~~~ 276 (280)
|+++++||.+||+.+|.+ || .||||++.
T Consensus 301 s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 301 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred cHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 999999999999988888 88 99999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=330.33 Aligned_cols=262 Identities=29% Similarity=0.496 Sum_probs=207.9
Q ss_pred cCCCCCCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceE
Q 023591 8 VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEV 85 (280)
Q Consensus 8 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~ 85 (280)
.+|.+.-..+...++|++.+.||+|+||.||++.+..++..+|+|++.... ...+.+.+|+.++++++||||++++++
T Consensus 9 ~~~~~~~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 88 (285)
T 3is5_A 9 SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88 (285)
T ss_dssp ----CCEESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cccccCCCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHh
Confidence 455555566667799999999999999999999999999999999987653 334678899999999999999999999
Q ss_pred EecCCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC-CCCcEEE
Q 023591 86 ILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKI 160 (280)
Q Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~-~~~~~~l 160 (280)
+.+....++||||+++++|.+.+.. ...+++..++.++.|++.||++||+.|++|+||+|+||+++.+ ....++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl 168 (285)
T 3is5_A 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKI 168 (285)
T ss_dssp EECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred eecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEE
Confidence 9999999999999999999988743 3679999999999999999999999999999999999999542 2345999
Q ss_pred eecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc
Q 023591 161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240 (280)
Q Consensus 161 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
+|||++.............+++.|+|||.+. ..++ .++||||||+++|+|++|..||........ .........
T Consensus 169 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~-~~~Di~slG~il~~ll~g~~pf~~~~~~~~----~~~~~~~~~ 242 (285)
T 3is5_A 169 IDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVT-FKCDIWSAGVVMYFLLTGCLPFTGTSLEEV----QQKATYKEP 242 (285)
T ss_dssp CCCCCCCC----------CTTGGGCCHHHHT-TCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCC
T ss_pred EeeecceecCCcccCcCcccccCcCChHHhc-cCCC-cccCeehHHHHHHHHHhCCCCCCCCCHHHH----HhhhccCCc
Confidence 9999997655555555667899999999875 3444 459999999999999999999987543222 222222222
Q ss_pred cCC-CCCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 241 SIP-DYVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 241 ~~~-~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
... ....+++++.+||.+||+.||++|| .||||++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 243 NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 111 1224789999999999999999999 9999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=334.51 Aligned_cols=252 Identities=30% Similarity=0.504 Sum_probs=206.7
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEec---CCCcEEEEEEeeeCC-----cccHHHHHHHHHhhhCCCCCeeeeceEEe
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVIL 87 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 87 (280)
.....++|++.+.||+|+||.||++++. .+++.||+|++.+.. .....+.+|+.++++++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3445689999999999999999999985 678999999987642 23345778999999999999999999999
Q ss_pred cCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
.++.+++||||+++++|.+++.....+++..++.++.||+.||.|||++|++||||+|+||+++.++. +||+|||++.
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~ 169 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCK 169 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC-
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCccc
Confidence 99999999999999999999988888999999999999999999999999999999999999998887 9999999987
Q ss_pred ccccC-CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCC
Q 023591 168 SSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (280)
Q Consensus 168 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (280)
..... .......+++.|+|||.+.+..++.. +||||||+++|+|++|..||...... .....+......++.
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~~~~~~~p~-- 242 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRK----KTIDKILKCKLNLPP-- 242 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHTCCCCCT--
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCc-ccchhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhCCCCCCC--
Confidence 43322 23345568999999999988777655 99999999999999999999875443 233344444445554
Q ss_pred CCCHHHHHHHHHhcccCCCCcC-----------CCcccccc
Q 023591 247 HISPECRHLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
.+++++.+||.+||+.||.+|| .||||++.
T Consensus 243 ~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 6899999999999999999998 89999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=331.61 Aligned_cols=250 Identities=35% Similarity=0.580 Sum_probs=206.0
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---------------------------ccHHHHHHHHHh
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------------------------IDENVQREIINH 71 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---------------------------~~~~~~~e~~~l 71 (280)
..++|++.+.||+|+||.||++++..+++.||+|++..... ..+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 45899999999999999999999999999999999875431 124678999999
Q ss_pred hhCCCCCeeeeceEEec--CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEE
Q 023591 72 RSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (280)
Q Consensus 72 ~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~ 149 (280)
++++||||+++++++.. ....++||||+++++|.+++ ...++++..++.++.|++.||+|||+.|++|+||+|+||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99999999999999986 56899999999999998754 3457999999999999999999999999999999999999
Q ss_pred EeCCCCCcEEEeecCCccccccCC-CCCCCcCCCcccCcccccCCcC--CCccchhhHHHHHHHHHHhCCCCCCCCCCcc
Q 023591 150 LDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (280)
Q Consensus 150 i~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (280)
++.++. ++|+|||++....... ......+++.|+|||.+.+... ...++||||||+++|+|++|..||.....
T Consensus 170 ~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-- 245 (298)
T 2zv2_A 170 VGEDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI-- 245 (298)
T ss_dssp ECTTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred ECCCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH--
Confidence 998887 9999999987543322 1234568999999999876543 34558999999999999999999976432
Q ss_pred hHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
......+......++....+++++.+||.+||+.||++|| .||||++
T Consensus 246 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 246 --MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp --HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred --HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 2233344444455555557899999999999999999999 9999964
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=335.04 Aligned_cols=253 Identities=31% Similarity=0.569 Sum_probs=215.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-------ccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
..++|++.+.||+|+||.||++++..+++.||+|++..... ..+.+.+|+.++++++||||+++++++..+..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 34789999999999999999999999999999999976432 24568899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC--CcEEEeecCCcccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSS 169 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~--~~~~l~df~~~~~~ 169 (280)
.++||||+++++|.+++.....+++..++.++.|++.||++||+.|++|+||+|+||+++.++. .+++|+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 9999999999999999988888999999999999999999999999999999999999987762 14999999999866
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC--CCC
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVH 247 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 247 (280)
..........+++.|+|||.+.+..++.. +||||||+++|+|++|..||........ ...+......++. ...
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~ 244 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQET----LANITSVSYDFDEEFFSH 244 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHTTCCCCCHHHHTT
T ss_pred CccccccccCCCCCccCcccccCCCCCCc-cccHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhcccccChhhhcc
Confidence 55544556678999999999988777655 9999999999999999999987544322 2233333332221 136
Q ss_pred CCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 248 ISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+++.+.+||.+||+.||++|| .||||+..
T Consensus 245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp CCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 889999999999999999999 99999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=337.99 Aligned_cols=253 Identities=36% Similarity=0.599 Sum_probs=198.8
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
.++|++.+.||+|+||.||++++..+++.||+|++.... ..+.+.+|+.++++++||||+++++++......++||||+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 367999999999999999999999999999999987653 3456788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC-CCCCcEEEeecCCccccccCCCCCCC
Q 023591 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKST 178 (280)
Q Consensus 100 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~-~~~~~~~l~df~~~~~~~~~~~~~~~ 178 (280)
++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++. +....++|+|||++............
T Consensus 131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 210 (349)
T 2w4o_A 131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210 (349)
T ss_dssp CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccc
Confidence 99999999988888999999999999999999999999999999999999975 22344999999998865544444556
Q ss_pred cCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC--CCCCCCCHHHHHHH
Q 023591 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLI 256 (280)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li 256 (280)
.+++.|+|||.+.+..++.. +||||||+++|+|++|..||......... ...+......+ +.+..++.++.+||
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~li 286 (349)
T 2w4o_A 211 CGTPGYCAPEILRGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQFM---FRRILNCEYYFISPWWDEVSLNAKDLV 286 (349)
T ss_dssp --CGGGSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCTTCHHHH---HHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred cCCCCccCHHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCcccHHH---HHHHHhCCCccCCchhhhCCHHHHHHH
Confidence 78999999999988777655 99999999999999999999776543322 22333333322 22346899999999
Q ss_pred HHhcccCCCCcC------CCccccccc
Q 023591 257 SRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 257 ~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.+||+.||++|| .||||++..
T Consensus 287 ~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 287 RKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999999999999 999998654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=326.99 Aligned_cols=255 Identities=39% Similarity=0.658 Sum_probs=209.5
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
.....++|++.+.||+|++|.||++.+..+++.||+|.+... ....+.+.+|+..+++++||||+++++++..+..
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 344568999999999999999999999999999999998753 2334578899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
.++||||+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCC
Confidence 9999999999999999988888999999999999999999999999999999999999998877 99999999876554
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
........+++.|+|||.+.+..+.+.++||||||+++|+|++|..||..... ......+.......+. .++..
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~--~~~~~ 237 (276)
T 2h6d_A 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV----PTLFKKIRGGVFYIPE--YLNRS 237 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHH
T ss_pred CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHhhcCcccCch--hcCHH
Confidence 44445566889999999998777655669999999999999999999976433 2233333333444444 57899
Q ss_pred HHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 252 CRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
+.++|.+||+.||++|| .||||++...
T Consensus 238 l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence 99999999999999999 9999987643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=353.18 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=220.0
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||.||++++..+++.||+|++.+. ......+.+|+.++++++||||+++++++.++..+++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 457899999999999999999999999999999999753 2334567889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 95 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
||||+++++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||++......
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEG 339 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceecccC
Confidence 999999999999987654 4999999999999999999999999999999999999998887 999999999865544
Q ss_pred CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
.......+++.|+|||++.+..++.. +|+||||+++|+|++|..||...............+......++. .+|+++
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~--~~s~~~ 416 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE--RFSPQA 416 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCT--TSCHHH
T ss_pred ccccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCc--cCCHHH
Confidence 44445679999999999988877655 999999999999999999998765544445555555555555554 689999
Q ss_pred HHHHHHhcccCCCCcC-----------CCcccccc
Q 023591 253 RHLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
++||.+||+.||.+|| .||||++.
T Consensus 417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp HHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred HHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 9999999999999998 89999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=331.49 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=195.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
..++|++++.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 4578999999999999999999999999999999987643 34467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 97 EYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 97 e~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
||++ ++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++. +||+|||++....
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFG 159 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETT
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecC
Confidence 9997 5999888643 35899999999999999999999999999999999999998887 9999999987543
Q ss_pred cC-CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc---------
Q 023591 171 LH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------- 240 (280)
Q Consensus 171 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------- 240 (280)
.. .......+++.|+|||.+.+......++||||||+++|+|++|..||...........+.........
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 22 22344568999999999977544445599999999999999999999876654444433332211000
Q ss_pred -------------------cCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 241 -------------------SIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 241 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.......+++++.+||.+||+.||++|| .||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence 0001125788999999999999999999 99999865
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=350.27 Aligned_cols=253 Identities=30% Similarity=0.430 Sum_probs=220.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||.||++++..+++.||+|++.+.. .....+.+|+.++++++||||+++++++.....+++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 4589999999999999999999999999999999997642 334567889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 95 VMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||++....
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~~ 340 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELK 340 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeecc
Confidence 99999999999998653 36999999999999999999999999999999999999998887 9999999997554
Q ss_pred cCCC-CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 171 LHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 171 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
.... .....+++.|+|||++.+..++.. +|+||||+++|+|++|..||...............+......++. .+|
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~--~~s 417 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFS 417 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT--TSC
T ss_pred CCCcccccccCCccccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc--ccC
Confidence 4332 234579999999999988877665 999999999999999999998765544455556666666666665 689
Q ss_pred HHHHHHHHHhcccCCCCcC-----------CCcccccc
Q 023591 250 PECRHLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+++.+||.+||+.||.+|| .||||++.
T Consensus 418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 9999999999999999999 79999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=325.72 Aligned_cols=252 Identities=34% Similarity=0.599 Sum_probs=215.5
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++..+...+++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999999876442 2355778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC-CcEEEeecCCccccccCCCC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~-~~~~l~df~~~~~~~~~~~~ 175 (280)
||+++++|.+.+.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ..++|+|||++.........
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence 99999999999988888999999999999999999999999999999999999976543 45999999999766555555
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc--cCCCCCCCCHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECR 253 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~ 253 (280)
....+++.|+|||.+.+..++.. +||||||+++|+|++|..||.......... .+..... ..+....+++++.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYA----QIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp CCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCCCTTTTTTSCHHHH
T ss_pred cCCCCCcCCcCchhhcCCCCCcc-cchHHHHHHHHHHHHCCCCCCCCchhHHHH----HHHhccccCCchhhcccCHHHH
Confidence 56678999999999988877665 999999999999999999998755432222 2222222 2333346899999
Q ss_pred HHHHHhcccCCCCcC------CCcccccc
Q 023591 254 HLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+||.+||+.||++|| .||||++.
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred HHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 999999999999999 99999764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=327.17 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=203.4
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|++.+.||+|+||.||++++ .+++.||+|++.... ...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 6899999999999999999998 678899999986543 234678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCC
Q 023591 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (280)
Q Consensus 98 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (280)
|+++ +|.+++... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++. +||+|||++...... ...
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCcccccc
Confidence 9975 898888764 57999999999999999999999999999999999999998887 999999998744322 222
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc--------------c
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------------S 241 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------~ 241 (280)
....+++.|+|||.+.+....+.++||||||+++|+|++|..||..................... .
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 34467899999999876554455599999999999999999999876554444443332211100 0
Q ss_pred CC---------CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 242 IP---------DYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 242 ~~---------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+. ....+++++.+||.+||+.||++|| .||||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 00 0125789999999999999999999 99999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=352.59 Aligned_cols=253 Identities=36% Similarity=0.607 Sum_probs=213.7
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--------------cccHHHHHHHHHhhhCCCCCeeeec
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNIVRFK 83 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~ 83 (280)
...++|++++.||+|+||+||+|++..+++.||+|++.+.. ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 34589999999999999999999999999999999987643 2345688999999999999999999
Q ss_pred eEEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC-CcEEEee
Q 023591 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICD 162 (280)
Q Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~-~~~~l~d 162 (280)
+++.++...++||||+++++|.+.+.....+++..++.++.||+.||+|||+.|++||||+|+||+++.++. ..++|+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999999999988888999999999999999999999999999999999999987653 3599999
Q ss_pred cCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC
Q 023591 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242 (280)
Q Consensus 163 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
||++.............+++.|+|||.+.+ .++.. +||||+|+++|+|++|..||....... ....+....+.+
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~ 266 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEK-CDVWSCGVIMYILLCGYPPFGGQNDQD----IIKKVEKGKYYF 266 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCC
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCC
Confidence 999986665555566779999999999864 45554 999999999999999999998755433 333333333322
Q ss_pred C--CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 243 P--DYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 243 ~--~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+ .+..+|+++++||.+||+.||.+|| .||||++.
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 2 2346899999999999999999999 99999754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=337.80 Aligned_cols=263 Identities=24% Similarity=0.395 Sum_probs=210.7
Q ss_pred CCCCCCCCCCCeeeecccccC--CceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEE
Q 023591 12 MDMPIMHDSDRYELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVI 86 (280)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~G--~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~ 86 (280)
...+.....++|++.+.||+| +||.||++++..+++.||+|++..... ..+.+.+|+.++++++||||+++++++
T Consensus 16 ~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp --CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 344566677999999999999 999999999999999999999986532 234577899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 87 LTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
..++.+++||||+++++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl~dfg 173 (389)
T 3gni_B 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLR 173 (389)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCGG
T ss_pred EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccc
Confidence 9999999999999999999999765 67999999999999999999999999999999999999998887 9999999
Q ss_pred Ccccccc--------CCCCCCCcCCCcccCcccccC--CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhh
Q 023591 165 YSKSSVL--------HSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (280)
Q Consensus 165 ~~~~~~~--------~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (280)
.+..... ........+++.|+|||.+.+ ..++.. +|||||||++|+|++|..||...............
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 252 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 8753221 122233467888999999987 455554 99999999999999999999876554443332221
Q ss_pred Hhcc----------------------------------------cccCCCCCCCCHHHHHHHHHhcccCCCCcC------
Q 023591 235 ILSV----------------------------------------QYSIPDYVHISPECRHLISRIFVADPAKSE------ 268 (280)
Q Consensus 235 ~~~~----------------------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------ 268 (280)
.... ....+....+++++.+||.+||+.||++||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 1100 000011235789999999999999999999
Q ss_pred CCccccccc
Q 023591 269 MHDWRRGCS 277 (280)
Q Consensus 269 ~h~~~~~~~ 277 (280)
.||||++..
T Consensus 333 ~hp~f~~~~ 341 (389)
T 3gni_B 333 NHSFFKQIK 341 (389)
T ss_dssp TSGGGGGC-
T ss_pred cCHHHHHHh
Confidence 999998653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=346.80 Aligned_cols=249 Identities=35% Similarity=0.585 Sum_probs=207.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||.||++++..+++.||+|++.+. ......+.+|+.++++++||||+++++++...+.+++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 447899999999999999999999999999999999753 2333556789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-C
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-H 172 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~-~ 172 (280)
||||+++++|.+++.....+++..+..++.||+.||+|||+ .||+||||||+||+++.++. ++|+|||++..... .
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDG 303 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC--
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCCC
Confidence 99999999999999888899999999999999999999998 99999999999999998887 99999999875322 2
Q ss_pred CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
.......+++.|+|||.+.+..++.. +||||||+++|+|++|..||..... ......+......++. .+++++
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~~~~~ 376 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILMEEIRFPR--TLGPEA 376 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHH
T ss_pred cccccccCCccccCHhhcCCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCH----HHHHHHHHhCCCCCCc--cCCHHH
Confidence 33445678999999999988887665 9999999999999999999987543 3333444445555555 689999
Q ss_pred HHHHHHhcccCCCCcC-----------CCcccccc
Q 023591 253 RHLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
.+||.+||+.||.+|| +||||++.
T Consensus 377 ~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 9999999999999997 89999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=325.66 Aligned_cols=250 Identities=34% Similarity=0.600 Sum_probs=213.5
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
..++|++.+.||+|+||.||++.+..++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3578999999999999999999999999999999987643 345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEE---eCCCCCcEEEeecCCccccccCCC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i---~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
|+++++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||++ +.++. ++|+|||++........
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~--~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP--LKLIDFGLAARFKPGKM 164 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCC--EEECCCTTCEECCTTSC
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCc--EEEEecccceeccCccc
Confidence 99999999999888889999999999999999999999999999999999999 54554 99999999986665555
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC--CCCCCHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPEC 252 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l 252 (280)
.....+++.|+|||.+.+. ++.. +||||||+++|+|++|..||......... ..+......++. +..+++++
T Consensus 165 ~~~~~~t~~y~aPE~~~~~-~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL-YGPE-CDEWSAGVMMYVLLCGYPPFSAPTDSEVM----LKIREGTFTFPEKDWLNVSPQA 238 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC-BCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCHHHHTTSCHHH
T ss_pred hhccCCCCCccChHHhccc-CCch-hhehhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhCCCCCCchhhhcCCHHH
Confidence 5667799999999988654 5444 99999999999999999999875543322 233333333322 23578999
Q ss_pred HHHHHHhcccCCCCcC------CCcccccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.+||.+||+.||++|| .||||++.
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 9999999999999999 99999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=331.66 Aligned_cols=254 Identities=36% Similarity=0.607 Sum_probs=195.2
Q ss_pred CCeeee---cccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC-CCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELV---RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~---~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++. +.||+|+||.||++.+..+++.||+|++.+. ......+|+.+++++. ||||+++++++.++...++||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 567776 7899999999999999999999999998753 3456788999999996 999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-CCcEEEeecCCccccccC-CC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH-SQ 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~~~~~l~df~~~~~~~~~-~~ 174 (280)
||+++++|.+++.....+++..++.++.|++.||+|||++|++||||+|+||+++.++ ...++|+|||++...... ..
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 9999999999999888999999999999999999999999999999999999998655 225999999998744332 22
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc---chHHHHHhhHhcccccCCC--CCCCC
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQYSIPD--YVHIS 249 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~~ 249 (280)
.....+++.|+|||.+.+..++.. +||||||+++|+|++|..||...... .........+....+.++. +..++
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp ------------------CCCCHH-HHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred ccccCCCcCccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence 344567899999999988777655 99999999999999999999865432 2234455555555544432 23589
Q ss_pred HHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 250 PECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
+++.+||.+||+.||.+|| .||||++..
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 9999999999999999999 999998653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=327.31 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=206.5
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC------cccHHHHHHHHHhhhC---CCCCeeeeceEEecCC
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSL---RHPNIVRFKEVILTPT 90 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~ 90 (280)
.++|++.+.||+|+||+||++++..+++.||+|++.... .......+|+.+++++ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 579999999999999999999999999999999987532 2234677788877766 4999999999998754
Q ss_pred -----eEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeec
Q 023591 91 -----HLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (280)
Q Consensus 91 -----~~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df 163 (280)
..+++||+++ ++|.+++..... +++..++.++.|++.||+|||+.|++|+||||+||+++.++. ++|+||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Df 164 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADF 164 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECSC
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEeeC
Confidence 5899999996 599999977654 999999999999999999999999999999999999998887 999999
Q ss_pred CCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-cC
Q 023591 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SI 242 (280)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 242 (280)
|++.............+++.|+|||.+.+..++.. +||||||+++|+|++|..||...........+......... .+
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 99986655555556678999999999988887665 99999999999999999999886655544444433221110 00
Q ss_pred CC--------------------CCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 243 PD--------------------YVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 243 ~~--------------------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
+. .+.+++++.+||.+||+.||++|| .||||++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 00 135789999999999999999999 999998654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=334.15 Aligned_cols=254 Identities=32% Similarity=0.515 Sum_probs=213.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
..++|++.+.||+|+||.||++.+..+++.||+|++.+.... ..+|++++.++ +||||+++++++.++...++|||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 357899999999999999999999999999999999875433 34678888777 89999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-C-CcEEEeecCCccccccC-CC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-A-PRLKICDFGYSKSSVLH-SQ 174 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~-~~~~l~df~~~~~~~~~-~~ 174 (280)
|+++++|.+.+...+.+++..+..++.||+.||+|||+.|++||||||+||++..+. . ..++|+|||++...... ..
T Consensus 97 ~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 176 (342)
T 2qr7_A 97 LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176 (342)
T ss_dssp CCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc
Confidence 999999999998888899999999999999999999999999999999999985432 2 34999999998754332 23
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC--CCCCCCHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPEC 252 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 252 (280)
.....+++.|+|||.+.+..++.. +||||||+++|+|++|..||..... .........+....+.++ .+..+|+++
T Consensus 177 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 254 (342)
T 2qr7_A 177 LMTPCYTANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTA 254 (342)
T ss_dssp BCCSSCCSSCCCHHHHHHHHHHHH-HHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTTTTSCHHH
T ss_pred eeccCCCccccCHHHhcCCCCCCc-cCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcccCccccccCCHHH
Confidence 345678999999999987766555 9999999999999999999986433 233444555555555443 234689999
Q ss_pred HHHHHHhcccCCCCcC------CCccccccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.+||.+||+.||++|| .||||.++.
T Consensus 255 ~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 9999999999999999 999997654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=348.50 Aligned_cols=265 Identities=34% Similarity=0.591 Sum_probs=216.8
Q ss_pred ccccCCCCCCCCC--CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCe
Q 023591 5 AMTVGPGMDMPIM--HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNI 79 (280)
Q Consensus 5 ~~~~~~~~~~~~~--~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~i 79 (280)
.+...|++..... ...++|++++.||+|+||+||++++..++..||+|++.+. ......+.+|+.++++++||||
T Consensus 19 ~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 98 (494)
T 3lij_A 19 DLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98 (494)
T ss_dssp GCCCCGGGGCCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTB
T ss_pred eeccchhheeecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCC
Confidence 3444454443322 2335899999999999999999999999999999998764 3345678899999999999999
Q ss_pred eeeceEEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-CCcE
Q 023591 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRL 158 (280)
Q Consensus 80 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~~~~ 158 (280)
+++++++.+....++||||+++++|.+.+.....+++..++.++.||+.||.|||++|++||||||+||+++..+ ...+
T Consensus 99 v~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 178 (494)
T 3lij_A 99 MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALI 178 (494)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCE
T ss_pred CeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcE
Confidence 999999999999999999999999999998888899999999999999999999999999999999999997643 3459
Q ss_pred EEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc
Q 023591 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238 (280)
Q Consensus 159 ~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 238 (280)
||+|||++.............+++.|+|||.+. ..++.. +||||+|+++|+|++|..||....... ....+...
T Consensus 179 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~ 252 (494)
T 3lij_A 179 KIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEK-CDVWSIGVILFILLAGYPPFGGQTDQE----ILRKVEKG 252 (494)
T ss_dssp EECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHT
T ss_pred EEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCc-hhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhC
Confidence 999999998666555556677999999999885 456554 999999999999999999998765433 33333333
Q ss_pred ccc--CCCCCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 239 QYS--IPDYVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 239 ~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
.+. .+.+..+|+++.+||.+||+.||.+|| .||||++
T Consensus 253 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 253 KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp CCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred CCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 332 233457899999999999999999999 9999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=342.88 Aligned_cols=253 Identities=25% Similarity=0.486 Sum_probs=211.5
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||+||++++..+++.||+|++.+. ......+.+|..++..++||||+++++++.++..+++
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 457899999999999999999999999999999999753 2233447889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
||||+++++|.+++.+ ...+++..++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||++.......
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDG 229 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccCC
Confidence 9999999999999977 468999999999999999999999999999999999999998887 9999999987543332
Q ss_pred C--CCCCcCCCcccCccccc-----CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCC-
Q 023591 174 Q--PKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY- 245 (280)
Q Consensus 174 ~--~~~~~~~~~~~aPE~~~-----~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 245 (280)
. .....+++.|+|||++. ...++.. +||||||+++|+|++|..||...+..+...++..... .+.++..
T Consensus 230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~-~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~ 306 (437)
T 4aw2_A 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--RFQFPTQV 306 (437)
T ss_dssp CEECCSCCSCGGGCCHHHHHHHHTSCCEECTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCCCCSSC
T ss_pred CcccccccCCcCeeChHHHhhcccCCCCCCCc-CeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc--cccCCccc
Confidence 2 23457899999999986 3445444 9999999999999999999987654444444333221 2233332
Q ss_pred CCCCHHHHHHHHHhcccCCCC--cC------CCcccccc
Q 023591 246 VHISPECRHLISRIFVADPAK--SE------MHDWRRGC 276 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~--Rp------~h~~~~~~ 276 (280)
..+|+++++||++||..+|++ || .||||++.
T Consensus 307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 358999999999999988888 88 99999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=324.17 Aligned_cols=249 Identities=34% Similarity=0.622 Sum_probs=211.5
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||.||++.+..++..||+|++.... .....+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4589999999999999999999999999999999987532 234568889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
||||+++++|.+.+.....+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++..... ..
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~-~~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SR 163 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC-----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCc-cc
Confidence 9999999999999988888999999999999999999999999999999999999998887 99999998754332 22
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
.....+++.|+|||.+.+..++.. +||||||+++|+|++|..||..... ......+......++. .+++++.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTY----QETYKRISRVEFTFPD--FVTEGARD 236 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHTCCCCCT--TSCHHHHH
T ss_pred ccccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCcH----HHHHHHHHhCCCCCCC--cCCHHHHH
Confidence 344568899999999988777655 9999999999999999999986443 3333344444445554 68999999
Q ss_pred HHHHhcccCCCCcC------CCccccccc
Q 023591 255 LISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
||.+||+.||.+|| .||||++.+
T Consensus 237 li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 237 LISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 99999999999999 999998654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=350.74 Aligned_cols=257 Identities=36% Similarity=0.592 Sum_probs=215.4
Q ss_pred CCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
..+...++|++.+.||+|+||+||++++..+++.||+|++.+. ......+.+|+.++++++||||+++++++.....
T Consensus 16 ~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp TCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 3344568999999999999999999999999999999998653 3345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-CCcEEEeecCCccccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV 170 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~~~~~l~df~~~~~~~ 170 (280)
.++||||+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++..+ ...+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999999999998888999999999999999999999999999999999999996432 3359999999998665
Q ss_pred cCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc--cCCCCCCC
Q 023591 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHI 248 (280)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 248 (280)
.........+++.|+|||.+.+ .++ .++||||||+++|+|++|..||......... ..+....+ ..+.+..+
T Consensus 176 ~~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~ 249 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAPEVLRG-TYD-EKCDVWSAGVILYILLSGTPPFYGKNEYDIL----KRVETGKYAFDLPQWRTI 249 (486)
T ss_dssp CC----CCTTGGGGCCGGGGGS-CCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCSCSGGGGGS
T ss_pred CCCccCCCcCCCCCCCHHHhCC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCCcccCCC
Confidence 5555566679999999999865 354 4599999999999999999999875543333 33333332 33444568
Q ss_pred CHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 249 SPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
|+++++||.+||+.||.+|| .||||++..
T Consensus 250 s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 99999999999999999999 999998643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=334.15 Aligned_cols=243 Identities=30% Similarity=0.468 Sum_probs=210.6
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---------ccHHHHHHHHHhhhCCCCCeeeeceEEecC
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 89 (280)
..++|++.+.||+|+||.||++++..+++.||+|++..... ....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 34789999999999999999999999999999999986532 233567899999999999999999999999
Q ss_pred CeEEEEEeccCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 90 THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 90 ~~~~lv~e~~~~~-~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
...++||||+.++ +|.+++.....+++..++.++.||+.||+|||+.|++|+||||+||+++.++. ++|+|||++..
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~ 179 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAY 179 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceE
Confidence 9999999998665 99999988889999999999999999999999999999999999999998877 99999999986
Q ss_pred cccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCC
Q 023591 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (280)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (280)
...........+++.|+|||.+.+..+...++||||||+++|+|++|..||..... ........+. .+
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~~~~~~~--~~ 247 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAIHPPY--LV 247 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTTCCCCSS--CC
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhhccCCCc--cc
Confidence 55554445567899999999998888766669999999999999999999975221 1122222222 58
Q ss_pred CHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 249 SPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
++++.+||.+||+.||++|| .||||++
T Consensus 248 ~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 99999999999999999999 9999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=340.53 Aligned_cols=252 Identities=26% Similarity=0.446 Sum_probs=209.3
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||.||++++..+++.||+|++.+.. ...+.+.+|..++..++|+||+++++++.+++.+++
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 4589999999999999999999999999999999997632 233457889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
||||+++++|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADG 216 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCCC
Confidence 99999999999999765 47999999999999999999999999999999999999998887 9999999997544333
Q ss_pred C--CCCCcCCCcccCcccccC-------CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC
Q 023591 174 Q--PKSTVGTPAYIAPEVLLK-------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (280)
Q Consensus 174 ~--~~~~~~~~~~~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (280)
. .....+++.|+|||++.. ..++.. +|+||||+++|+|++|..||...+......++..... ...++.
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~ 293 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE-CDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE--HLSLPL 293 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCCCC-
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChH-HhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--CcCCCc
Confidence 2 234578999999999873 345444 9999999999999999999987654443333332211 122221
Q ss_pred -CCCCCHHHHHHHHHhcccCCCCcC---------CCcccccc
Q 023591 245 -YVHISPECRHLISRIFVADPAKSE---------MHDWRRGC 276 (280)
Q Consensus 245 -~~~~~~~l~~li~~~l~~dp~~Rp---------~h~~~~~~ 276 (280)
...+|+++++||++||. +|.+|+ .||||++.
T Consensus 294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 23689999999999999 999994 99999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=326.08 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=206.0
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|++++.||+|+||.||++++..+++.||+|++...... .+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 7899999999999999999999999999999998665432 3456789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~ 176 (280)
|+++++|.+++.....+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC-------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCcccccC
Confidence 9999999998888888999999999999999999999999999999999999998877 999999998754422 2234
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc---------------ccc
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QYS 241 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------~~~ 241 (280)
...+++.|+|||.+.+....+.++||||||+++|+|++|..||................... ...
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence 45688999999999775544555999999999999999999998766544333322221110 001
Q ss_pred CCC----------CCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 242 IPD----------YVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 242 ~~~----------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.+. ...+++++.+||.+||+.||++|| .||||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 110 135788999999999999999999 999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=336.06 Aligned_cols=251 Identities=31% Similarity=0.565 Sum_probs=209.3
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC------cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++..+..++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 368999999999999999999999999999999986421 23467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC-CcEEEeecCCccc
Q 023591 94 IVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKS 168 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~-~~~~l~df~~~~~ 168 (280)
+||||+++++|.+.+... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++. ..++|+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998877432 35899999999999999999999999999999999999986543 4599999999875
Q ss_pred cccCCC-CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC--CC
Q 023591 169 SVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DY 245 (280)
Q Consensus 169 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 245 (280)
...... .....+++.|+|||.+.+..++.. +||||||+++|+|++|..||.... ......+....+..+ .+
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~i~~~~~~~~~~~~ 256 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTK-----ERLFEGIIKGKYKMNPRQW 256 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCSSH-----HHHHHHHHHTCCCCCHHHH
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCch-HhhHHHHHHHHHHHHCCCCCCCcH-----HHHHHHHHcCCCCCCcccc
Confidence 543322 344568999999999988877655 999999999999999999997642 122333333333222 12
Q ss_pred CCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 246 VHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
..+++++.+||.+||+.||++|| .||||++.
T Consensus 257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 36899999999999999999999 99999753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=332.92 Aligned_cols=262 Identities=29% Similarity=0.398 Sum_probs=204.4
Q ss_pred CCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
+.....++|++.+.||+|+||.||++++..+++.||+|++..... ....+.+|+.++++++||||+++++++.++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 344466899999999999999999999999999999999875432 23456789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC---CCcEEEeecCCccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKS 168 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~---~~~~~l~df~~~~~ 168 (280)
.++||||+++ +|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++ ...++|+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999975 9999999888999999999999999999999999999999999999996432 23499999999875
Q ss_pred cccC-CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-cC----
Q 023591 169 SVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SI---- 242 (280)
Q Consensus 169 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~---- 242 (280)
.... .......+++.|+|||.+.+......++||||||+++|+|++|..||..................... .+
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 4322 22334567899999999987664455599999999999999999999876654444444333211110 00
Q ss_pred ---------CC----------CCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 243 ---------PD----------YVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 243 ---------~~----------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
+. ...+++++.+||.+||+.||++|| .||||++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 00 011678999999999999999999 999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=353.28 Aligned_cols=254 Identities=36% Similarity=0.583 Sum_probs=214.6
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
....++|++.+.||+|+||.||++++..+++.||+|++.+. ....+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34457899999999999999999999999999999998754 23446788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC-CCCcEEEeecCCcccccc
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~-~~~~~~l~df~~~~~~~~ 171 (280)
++||||+.+++|.+.+.....+++..++.++.||+.||.|||++|++||||||+||+++.. ....++|+|||++.....
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999999999888899999999999999999999999999999999999999532 233499999999876554
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc--cCCCCCCCC
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHIS 249 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 249 (280)
........+++.|+|||.+.+ .++. ++||||||+++|+|++|..||......... ..+....+ ..+.+..+|
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s 255 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TYDE-KCDVWSTGVILYILLSGCPPFNGANEYDIL----KKVEKGKYTFELPQWKKVS 255 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCSGGGGGSC
T ss_pred ccccccCCCCccccCceeecC-CCCC-cceeHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHcCCCCCCCcccccCC
Confidence 444445568999999999866 4554 499999999999999999999876543333 33333332 333445689
Q ss_pred HHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 250 PECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+++++||.+||+.||.+|| .||||++.
T Consensus 256 ~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 256 ESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 9999999999999999999 99999754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=325.05 Aligned_cols=251 Identities=34% Similarity=0.629 Sum_probs=209.1
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-------ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
++|++.+.||+|+||.||++++..+++.||+|++..... ..+.+.+|+.++++++||||+++++++..+...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 689999999999999999999999999999999876432 2467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC--CCcEEEeecCCcccccc
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVL 171 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~--~~~~~l~df~~~~~~~~ 171 (280)
+||||+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ ..+++|+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888899999999999999999999999999999999999998765 23599999999876554
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC--CCCCCC
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHIS 249 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 249 (280)
........+++.|+|||.+.+..++.. +||||||+++|+|++|..||........ ...+......++ ....++
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 165 GNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQET----LTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCCCHHHHTTCC
T ss_pred CCcccccCCCcCccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCCCCcchHHH----HHHhHhcccCCcchhcccCC
Confidence 444455668999999999987777655 9999999999999999999987543322 222222222222 123578
Q ss_pred HHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 250 PECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+.+.+||.+||+.||++|| .||||++.
T Consensus 240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 9999999999999999999 99999753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=337.27 Aligned_cols=251 Identities=29% Similarity=0.515 Sum_probs=205.7
Q ss_pred CCeee--ecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYEL--VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~--~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
+.|++ .+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34555 678999999999999999999999999998654 344678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
|+++++|.+++... ..+++..++.++.||+.||+|||+.|++|+||+|+||++..+...+++|+|||++..........
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 99999998888654 46999999999999999999999999999999999999965554569999999998665555555
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC--CCCCCCHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRH 254 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 254 (280)
...+++.|+|||.+.+..++.. +||||||+++|+|++|..||...........+ ....+.++ ....+++++.+
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~~~~~~~ 321 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI----LACRWDLEDEEFQDISEEAKE 321 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HHTCCCSCSGGGTTSCHHHHH
T ss_pred cccCCCcEeChhhccCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhccCCCChhhhccCCHHHHH
Confidence 6678999999999977766555 99999999999999999999876543333333 33332222 22468999999
Q ss_pred HHHHhcccCCCCcC------CCcccccc
Q 023591 255 LISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
||.+||+.||.+|| .||||++.
T Consensus 322 li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 322 FISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 99999999999999 99999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=323.31 Aligned_cols=252 Identities=31% Similarity=0.409 Sum_probs=203.8
Q ss_pred CCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc----HHHHHHHHHhhhCCCCCeeeeceEEec
Q 023591 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILT 88 (280)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~ 88 (280)
.+......++|++.+.||+|+||.||++++..+++.||+|.+....... +.+.+|+.++++++||||+++++++..
T Consensus 3 ~~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 82 (294)
T 4eqm_A 3 HMIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE 82 (294)
T ss_dssp -CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred cchhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence 3334445689999999999999999999999999999999986643332 467789999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
++..++||||+++++|.+++...+++++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~ 160 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKA 160 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTT
T ss_pred CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCccc
Confidence 9999999999999999999988889999999999999999999999999999999999999998887 99999999875
Q ss_pred cccCC--CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCC
Q 023591 169 SVLHS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (280)
Q Consensus 169 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (280)
..... ......+++.|+|||.+.+..++.. +||||||+++|+|++|..||..........+....... ........
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~ 238 (294)
T 4eqm_A 161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVP-NVTTDVRK 238 (294)
T ss_dssp C-------------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCC-CHHHHSCT
T ss_pred cccccccccCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCC-Ccchhccc
Confidence 43322 2233468999999999988877655 99999999999999999999875543322222211110 00011123
Q ss_pred CCCHHHHHHHHHhcccCCCCcC
Q 023591 247 HISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+++.+.++|.+||+.||.+||
T Consensus 239 ~~~~~l~~li~~~l~~dp~~R~ 260 (294)
T 4eqm_A 239 DIPQSLSNVILRATEKDKANRY 260 (294)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSC
T ss_pred CCCHHHHHHHHHHhcCCHhHcc
Confidence 6899999999999999999999
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=320.76 Aligned_cols=249 Identities=33% Similarity=0.629 Sum_probs=214.7
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||.||++++..+++.||+|++... ......+.+|+.++++++||||+++++++.+....++
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 91 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL 91 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence 458999999999999999999999999999999998753 2334578899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
+|||+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..... ..
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~-~~ 168 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS-LR 168 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-SC
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-cc
Confidence 9999999999999988888999999999999999999999999999999999999998887 99999998864432 22
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
.....+++.|+|||.+.+..++.. +||||||+++|+|++|..||....... ....+......++. .+++++.+
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~ 241 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTE----THRRIVNVDLKFPP--FLSDGSKD 241 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTTCCCCCT--TSCHHHHH
T ss_pred cccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHhH----HHHHHhccccCCCC--cCCHHHHH
Confidence 344568899999999988877665 999999999999999999998654322 23334444444544 68999999
Q ss_pred HHHHhcccCCCCcC------CCccccccc
Q 023591 255 LISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
||.+||+.||.+|| .||||++..
T Consensus 242 li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 99999999999999 999998643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=353.50 Aligned_cols=249 Identities=32% Similarity=0.512 Sum_probs=218.3
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 93 (280)
..++|++++.||+|+||.||++++..+++.||||++.+. ....+.+..|..++..+ +|++|+.+++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 457899999999999999999999999999999999753 34456677889998887 7999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc-cC
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~-~~ 172 (280)
+||||+++++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||++.... ..
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCC
Confidence 99999999999999988889999999999999999999999999999999999999998887 9999999997532 23
Q ss_pred CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
.......+++.|+|||++.+..++.. +|+||||+++|+|++|..||...+. ......+......++. .+++++
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~ 569 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYPK--SMSKEA 569 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHSSCCCCCT--TSCHHH
T ss_pred cccccccCCCcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCCH----HHHHHHHHhCCCCCCc--cCCHHH
Confidence 33455679999999999988888665 9999999999999999999987543 3445556666666766 689999
Q ss_pred HHHHHHhcccCCCCcC-----------CCcccccc
Q 023591 253 RHLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
.+||++||+.||++|| .||||++.
T Consensus 570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 570 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 9999999999999998 79999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=324.42 Aligned_cols=258 Identities=31% Similarity=0.501 Sum_probs=206.6
Q ss_pred CCCCeeee-cccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEE
Q 023591 19 DSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 19 ~~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 95 (280)
-.++|++. +.||+|+||.||++++..+++.||+|++.... ...+.+.+|+.++.++ +||||+++++++.+++..++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 45789996 78999999999999999999999999997654 3346788999999885 799999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC-CcEEEeecCCccccccCC-
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHS- 173 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~-~~~~l~df~~~~~~~~~~- 173 (280)
|||+++++|.+++.....+++..++.++.||+.||++||+.|++|+||+|+||+++.++. ..++|+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 999999999999988888999999999999999999999999999999999999986653 348999999986443221
Q ss_pred -------CCCCCcCCCcccCcccccC-----CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcc-----------hHHH
Q 023591 174 -------QPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-----------NFRK 230 (280)
Q Consensus 174 -------~~~~~~~~~~~~aPE~~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-----------~~~~ 230 (280)
......+++.|+|||.+.+ ..++.. +||||||+++|+|++|..||....... ....
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTT-HHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcc-cccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 1123458899999999865 345444 999999999999999999998754321 0122
Q ss_pred HHhhHhcccccCCC--CCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 231 TIHRILSVQYSIPD--YVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 231 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
....+......++. ...+++++.+||.+||+.||++|| +||||++..
T Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 33334444444332 235889999999999999999999 999998753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=337.71 Aligned_cols=255 Identities=33% Similarity=0.531 Sum_probs=201.0
Q ss_pred CCCCCCeeee-cccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhh-hCCCCCeeeeceEEec----CC
Q 023591 17 MHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-SLRHPNIVRFKEVILT----PT 90 (280)
Q Consensus 17 ~~~~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~----~~ 90 (280)
....++|.+. +.||+|+||+||++.+..+++.||+|++... ..+.+|+.++. ..+||||+++++++.. ..
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 3345788887 6899999999999999999999999998643 45678888774 4589999999999875 56
Q ss_pred eEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-CCcEEEeecCCcc
Q 023591 91 HLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK 167 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~~~~~l~df~~~~ 167 (280)
.+++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++.++ ...+||+|||++.
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 7899999999999999997653 599999999999999999999999999999999999998732 3349999999998
Q ss_pred ccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC--CCC
Q 023591 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDY 245 (280)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 245 (280)
............+++.|+|||++.+..++.. +||||||+++|+|++|..||...............+....+.+ +.+
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 291 (400)
T 1nxk_A 213 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291 (400)
T ss_dssp ECC-----------CTTCCGGGSCCCCSSSH-HHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTT
T ss_pred ccCCCCccccCCCCCCccCHhhcCCCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccc
Confidence 6554444456678999999999988777655 9999999999999999999987654322111222233333333 334
Q ss_pred CCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 246 VHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
..+++++.+||.+||+.||++|| .||||.+.
T Consensus 292 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 57899999999999999999999 99999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=322.44 Aligned_cols=251 Identities=29% Similarity=0.515 Sum_probs=191.1
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
...++|++.+.||+|+||.||++++..+++.||+|.+.... ...+.+.+|+.++++++||||+++++++......+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 34578999999999999999999999999999999987532 23467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
+||||+++++|.+++... .++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMP 165 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC--
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCC
Confidence 999999999999998765 57999999999999999999999999999999999999998877 999999998754322
Q ss_pred -CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 173 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
.......+++.|+|||.+.+..++.. +||||||+++|+|++|..||......... ..+.......+. .++.+
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~--~~~~~ 238 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTL----NKVVLADYEMPS--FLSIE 238 (278)
T ss_dssp --------------------------C-THHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCCCCT--TSCHH
T ss_pred CCcceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHHHHH----HHHhhcccCCcc--ccCHH
Confidence 22234568899999999987777555 99999999999999999999875543222 222223333333 68999
Q ss_pred HHHHHHHhcccCCCCcC------CCccccccc
Q 023591 252 CRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
+.+||.+||+.||++|| .||||.+.+
T Consensus 239 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 99999999999999999 999998654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=320.23 Aligned_cols=252 Identities=33% Similarity=0.573 Sum_probs=213.0
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
.++|++.+.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 478999999999999999999999999999999987543 334678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC---CC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQ 174 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~---~~ 174 (280)
|+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchhc
Confidence 9999999999887778999999999999999999999999999999999999998877 999999998744322 22
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
.....+++.|+|||.+.+..+...++||||||+++|+|++|..||.............. ......+....+++.+.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK---EKKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH---TTCTTSTTGGGSCHHHHH
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh---hcccccCchhhcCHHHHH
Confidence 34456889999999998877655669999999999999999999987655433222221 122222333468999999
Q ss_pred HHHHhcccCCCCcC------CCcccccc
Q 023591 255 LISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
||.+||+.||++|| .||||++.
T Consensus 241 li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 99999999999999 99999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=320.57 Aligned_cols=250 Identities=34% Similarity=0.523 Sum_probs=214.6
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||.||++.+..+++.+|+|++.... ...+.+.+|+.++++++|+||+++++++.+++..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 4589999999999999999999999999999999987643 233567789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-C
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~ 173 (280)
+|||+++++|.+++.....+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTTC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCcc
Confidence 9999999999999988888999999999999999999999999999999999999998877 999999998754422 2
Q ss_pred CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
......+++.|+|||.+.+..++.. +||||||+++|+|++|..||...... .....+......++. .+++.+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~ 243 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRIKKNEYSIPK--HINPVAA 243 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHTTCCCCCT--TSCHHHH
T ss_pred ccccccCCCCcCCcchhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhhccCCCcc--ccCHHHH
Confidence 2344568899999999987777555 99999999999999999999765432 223333444444444 6889999
Q ss_pred HHHHHhcccCCCCcC------CCccccccc
Q 023591 254 HLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
++|.+||+.||++|| .||||+...
T Consensus 244 ~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 244 SLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 999999999999999 999997653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=328.28 Aligned_cols=263 Identities=26% Similarity=0.396 Sum_probs=208.6
Q ss_pred CCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEec--
Q 023591 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-- 88 (280)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 88 (280)
.+.....++|++.+.||+|+||.||++++..+++.||+|++.... .....+.+|+.++++++||||+++++++..
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 10 CPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp CTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred ccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 344456789999999999999999999999999999999986543 234567899999999999999999999876
Q ss_pred ------CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEe
Q 023591 89 ------PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (280)
Q Consensus 89 ------~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~ 161 (280)
.+..++||||+++ +|.+.+... ..+++..++.++.|++.||++||+.|++||||||+||+++.++. ++|+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~ 166 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLA 166 (351)
T ss_dssp -------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEEC
T ss_pred cccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEc
Confidence 3468999999975 777766543 57999999999999999999999999999999999999998887 9999
Q ss_pred ecCCccccccC-----CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHh
Q 023591 162 DFGYSKSSVLH-----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 236 (280)
Q Consensus 162 df~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 236 (280)
|||++...... .......+++.|+|||.+.+....+.++||||||+++|+|++|..||...........+.....
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99998754322 1223446789999999987755445559999999999999999999987655443333333222
Q ss_pred cccccC-CCCC-------------------------CCCHHHHHHHHHhcccCCCCcC------CCcccccccCC
Q 023591 237 SVQYSI-PDYV-------------------------HISPECRHLISRIFVADPAKSE------MHDWRRGCSVS 279 (280)
Q Consensus 237 ~~~~~~-~~~~-------------------------~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~~ 279 (280)
...... +... ..++.+.+||.+||+.||++|| .||||+....+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 111111 0000 0267899999999999999999 99999876543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=325.18 Aligned_cols=251 Identities=34% Similarity=0.595 Sum_probs=208.9
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
..++|++.+.||+|+||.||++++..+++.||+|.+..... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 34789999999999999999999999999999999986543 33568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEE---eCCCCCcEEEeecCCccccccCCC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i---~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
|+++++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||++ +.++. ++|+|||++..... ..
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~-~~ 163 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSK--IMITDFGLSKMEQN-GI 163 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCC--EEBCSCSTTCCCCC-BT
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCC--EEEccCCcceecCC-Cc
Confidence 99999999999888889999999999999999999999999999999999999 44444 99999998864322 22
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC--CCCCCCCHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPEC 252 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 252 (280)
.....+++.|+|||.+.+..++.. +||||||+++|+|++|..||........ ...+......+ +....+++++
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~ 238 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVITYILLCGYPPFYEETESKL----FEKIKEGYYEFESPFWDDISESA 238 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHH-HHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHCCCCCCTTTTTTSCHHH
T ss_pred cccccCCCCccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHcCCCCCCccccccCCHHH
Confidence 233458899999999987777554 9999999999999999999987554322 22333332222 2234689999
Q ss_pred HHHHHHhcccCCCCcC------CCccccccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.+||.+||+.||++|| .||||++..
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 239 KDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 9999999999999999 999998654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=343.76 Aligned_cols=251 Identities=27% Similarity=0.414 Sum_probs=199.5
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecC------C
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 90 (280)
.++|++++.||+|+||.||++.+..+++.||+|++... ......+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999999999999999999764 23345677899999999999999999999654 3
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
.+++||||+++ +|.+.+.. .+++..++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||+++...
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 215 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC----
T ss_pred eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecC
Confidence 57999999976 56666643 4899999999999999999999999999999999999998887 9999999998665
Q ss_pred cCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc----------
Q 023591 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY---------- 240 (280)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 240 (280)
.........+++.|+|||.+.+..++.. +|||||||++|+|++|..||...+..+.+..+.........
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred CCcccCCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 5555556778999999999998887665 99999999999999999999876654444443332211100
Q ss_pred -----cCCCCC---------------------CCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 241 -----SIPDYV---------------------HISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 241 -----~~~~~~---------------------~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
..+... ..++++.+||.+||+.||++|| .||||+.+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 000000 0156799999999999999999 99999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=321.42 Aligned_cols=254 Identities=31% Similarity=0.502 Sum_probs=212.8
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----------cccHHHHHHHHHhhhCC-CCCeeeeceE
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----------KIDENVQREIINHRSLR-HPNIVRFKEV 85 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~e~~~l~~l~-h~~iv~~~~~ 85 (280)
....++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|+.+++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 345689999999999999999999999999999999997643 12245678999999995 9999999999
Q ss_pred EecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCC
Q 023591 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (280)
Q Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~ 165 (280)
+..+...++||||+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~ 170 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGF 170 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTT
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccc
Confidence 9999999999999999999999988888999999999999999999999999999999999999998887 99999999
Q ss_pred ccccccCCCCCCCcCCCcccCccccc------CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc
Q 023591 166 SKSSVLHSQPKSTVGTPAYIAPEVLL------KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239 (280)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 239 (280)
+.............+++.|+|||.+. ...+ +.++||||||+++|+|++|..||........ ...+....
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~ 245 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM----LRMIMSGN 245 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTC
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccC-CcccccHhHHHHHHHHHHCCCCCcCccHHHH----HHHHhcCC
Confidence 87665555555667899999999885 2334 3449999999999999999999977543222 22222223
Q ss_pred ccC--CCCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 240 YSI--PDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 240 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
..+ +....+++.+.+||.+||+.||++|| .||||++..
T Consensus 246 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 222 22346889999999999999999999 999998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=325.68 Aligned_cols=249 Identities=35% Similarity=0.528 Sum_probs=214.3
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||.||++.+..+++.+|+|++.... ...+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4578999999999999999999999999999999987643 233567889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-C
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~ 173 (280)
||||+++++|.+++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGE 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTTC
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCcc
Confidence 9999999999999988888999999999999999999999999999999999999998877 999999998754422 2
Q ss_pred CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
......+++.|+|||.+.+..++.. +||||||+++|+|++|..||...... .....+......++. .+++.+.
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~ 269 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRIKKNEYSIPK--HINPVAA 269 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHTCCCCCT--TSCHHHH
T ss_pred cccccCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHHHCcCCCCCCCHH----HHHHHHhcCCCCCCc--cCCHHHH
Confidence 2344568899999999988777655 99999999999999999999765432 233333344444554 6889999
Q ss_pred HHHHHhcccCCCCcC------CCcccccc
Q 023591 254 HLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+||.+||+.||++|| .||||...
T Consensus 270 ~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 270 SLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 999999999999999 99999754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=334.24 Aligned_cols=257 Identities=30% Similarity=0.526 Sum_probs=207.6
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC------CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
..++|++.+.||+|+||.||++.+..+++.||+|++... ....+.+.+|+.++++++||||+++++++.++...
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 103 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYI 103 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeE
Confidence 347899999999999999999999999999999998753 33446788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHH
Q 023591 93 AIVMEYASGGELFERICN----------------------------------------AGRFSEDEARFFFQQLISGVSY 132 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~----------------------------------------~~~l~~~~~~~~~~~i~~~l~~ 132 (280)
++||||+++++|.+++.. ...+++..++.++.||+.||++
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 999999999999998742 1124678899999999999999
Q ss_pred HHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-----CCCCcCCCcccCcccccC--CcCCCccchhhHH
Q 023591 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLK--KEYDGKIADVWSC 205 (280)
Q Consensus 133 Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~--~~~~~~~~Diwsl 205 (280)
||+.|++|+||+|+||+++.++...++|+|||++........ .....+++.|+|||.+.+ ..++ .++|||||
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~Diwsl 262 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG-PKCDAWSA 262 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC-THHHHHHH
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC-cHHHHHHH
Confidence 999999999999999999877755699999999875433221 234568999999999865 4444 45999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 206 GVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 206 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
|+++|+|++|..||................ ..+..+....+++++.+||.+||+.||.+|| .||||++.+.
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKK--LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcc--cccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 999999999999998765544333333221 1112222335789999999999999999999 9999987653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=339.35 Aligned_cols=253 Identities=32% Similarity=0.543 Sum_probs=200.6
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---------cccHHHHHHHHHhhhCCCCCeeeeceEEecCC
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 90 (280)
.++|++.+.||+|+||.||++.+..+++.||+|++.+.. .....+.+|+.++++++||||+++++++. ..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 478999999999999999999999999999999987632 11234788999999999999999999975 45
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-CCcEEEeecCCcccc
Q 023591 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 169 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~~~~~l~df~~~~~~ 169 (280)
..++||||+++++|.+++.....+++..++.++.|++.||+|||++|++||||||+||+++.++ ...+||+|||++...
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 6899999999999999988888899999999999999999999999999999999999997543 335999999999866
Q ss_pred ccCCCCCCCcCCCcccCcccccC--CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC--CC
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DY 245 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 245 (280)
..........+++.|+|||.+.+ ....+.++||||||+++|+|++|..||............... ....+. .+
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~---~~~~~~~~~~ 369 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---GKYNFIPEVW 369 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT---TCCCCCHHHH
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc---CCCCCCchhh
Confidence 55444556678999999999864 222244599999999999999999999876554444333222 222211 12
Q ss_pred CCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 246 VHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
..+++.+.+||.+||+.||++|| .||||++.
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 35899999999999999999999 99999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=328.82 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=204.5
Q ss_pred CCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc------ccHHHHHHHHHhhhCCCCCeeeeceEEec
Q 023591 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILT 88 (280)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 88 (280)
......++|++.+.||+|+||.||++++..+++.||+|.+..... ....+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ---------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 344556899999999999999999999999999999999875321 23467899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 89 PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
....++||||+++ +|.+.+... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~ 160 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAK 160 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGS
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccce
Confidence 9999999999976 888888654 36899999999999999999999999999999999999998887 9999999987
Q ss_pred ccccC-CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-cCCC-
Q 023591 168 SSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPD- 244 (280)
Q Consensus 168 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~- 244 (280)
..... .......+++.|+|||.+.+......++||||||+++|+|++|..||...........+......... .++.
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 54332 23344568999999999977654455699999999999999999999876655444444433221110 0100
Q ss_pred --------------------CCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 245 --------------------YVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 245 --------------------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
...+++++.+||.+||+.||++|| .||||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 135678999999999999999999 999998654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=327.77 Aligned_cols=254 Identities=24% Similarity=0.403 Sum_probs=201.0
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc--cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
++|++++.||+|+||.||++++..+++.||+|++...... ...+.+|+.++++++||||+++++++..+...++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 6899999999999999999999999999999998654322 12345799999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCC
Q 023591 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (280)
Q Consensus 99 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~ 176 (280)
+++ +|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC--------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCccccc
Confidence 975 888888664 45999999999999999999999999999999999999998887 999999998744322 2223
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc---------------c
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY---------------S 241 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------~ 241 (280)
...+++.|+|||.+.+....+.++||||||+++|+|++|..||......+....+......... .
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence 4467899999999877554455599999999999999999999876654444433332211100 0
Q ss_pred CC---------CCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 242 IP---------DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 242 ~~---------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
++ ....+++++.+||.+||+.||++|| .||||.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 00 0125789999999999999999999 999998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=331.74 Aligned_cols=252 Identities=23% Similarity=0.393 Sum_probs=203.7
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEec----------
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT---------- 88 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------- 88 (280)
..++|++.+.||+|+||.||+|++..+++.||+|++...... ..+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 457999999999999999999999999999999998765433 2379999999999999999999843
Q ss_pred ----------------------------CCeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhc
Q 023591 89 ----------------------------PTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSM 136 (280)
Q Consensus 89 ----------------------------~~~~~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~Lh~~ 136 (280)
...+++||||+++ +|.+.+. ....+++..++.++.||+.||+|||+.
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp ----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3348899999975 7766653 456799999999999999999999999
Q ss_pred CceecCCCCCcEEEe-CCCCCcEEEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhC
Q 023591 137 QVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215 (280)
Q Consensus 137 ~i~h~dl~~~ni~i~-~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g 215 (280)
|++||||||+||+++ .++. ++|+|||++.............+++.|+|||.+.+....+.++||||+||++|+|++|
T Consensus 161 gi~H~Dikp~Nil~~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 238 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238 (383)
T ss_dssp TEECSCCCGGGEEEETTTTE--EEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred cCccCccCHHHEEEcCCCCc--EEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC
Confidence 999999999999997 4555 9999999998666666666677899999999988766445559999999999999999
Q ss_pred CCCCCCCCCcchHHHHHhhHhcc-------------cccCC----------CCCCCCHHHHHHHHHhcccCCCCcC----
Q 023591 216 AYPFEDPEEPKNFRKTIHRILSV-------------QYSIP----------DYVHISPECRHLISRIFVADPAKSE---- 268 (280)
Q Consensus 216 ~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rp---- 268 (280)
..||......+....+....... ...++ ....+++++.+||.+||+.||++||
T Consensus 239 ~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (383)
T 3eb0_A 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318 (383)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 99998866544444443321110 00111 0125789999999999999999999
Q ss_pred --CCcccccc
Q 023591 269 --MHDWRRGC 276 (280)
Q Consensus 269 --~h~~~~~~ 276 (280)
.||||++.
T Consensus 319 ~l~hp~f~~~ 328 (383)
T 3eb0_A 319 AMAHPFFDHL 328 (383)
T ss_dssp HHTSGGGHHH
T ss_pred HhcCHHHHHH
Confidence 99999753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=329.98 Aligned_cols=248 Identities=31% Similarity=0.525 Sum_probs=209.8
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---------cHHHHHHHHHhhhC-CCCCeeeeceEEecCC
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------DENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 90 (280)
++|++.+.||+|++|.||++.+..+|+.||||++...... .+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999999989999999998765321 24567899999998 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
..++||||+++++|.+++.....+++..+..++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccC
Confidence 99999999999999999988888999999999999999999999999999999999999998877 9999999988665
Q ss_pred cCCCCCCCcCCCcccCcccccCC------cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC--
Q 023591 171 LHSQPKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI-- 242 (280)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 242 (280)
.........+++.|+|||.+.+. .++ .++||||||+++|+|++|..||....... ....+......+
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYG-KEVDLWACGVILFTLLAGSPPFWHRRQIL----MLRMIMEGQYQFSS 326 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCCH
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCC-chhhHHhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhCCCCCCC
Confidence 55555567789999999998632 343 44999999999999999999997654322 222233222222
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 243 PDYVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
+.+..+++.+.+||.+||+.||++|| .||||++
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 22346789999999999999999999 9999974
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=321.62 Aligned_cols=249 Identities=27% Similarity=0.455 Sum_probs=208.5
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEeccC
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (280)
.|+..+.||+|+||.||++++..+|+.||+|++..... ..+.+.+|+.++++++||||+++++++......++||||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 48888999999999999999998999999999976543 34568899999999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCCCCc
Q 023591 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 179 (280)
Q Consensus 101 ~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~~~ 179 (280)
+++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... ......
T Consensus 126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCcccccccc
Confidence 9999998754 56999999999999999999999999999999999999998877 9999999987544332 234456
Q ss_pred CCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHh
Q 023591 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259 (280)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 259 (280)
+++.|+|||.+.+..++.. +||||||+++|+|++|..||.............. ...........+++.+.+||.+|
T Consensus 203 gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 203 GTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPPPKLKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp SCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SSCCCCTTGGGSCHHHHHHHHHH
T ss_pred CCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCCCcCccccCCHHHHHHHHHH
Confidence 8999999999988777665 9999999999999999999986543222222111 11112222335789999999999
Q ss_pred cccCCCCcC------CCccccccc
Q 023591 260 FVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 260 l~~dp~~Rp------~h~~~~~~~ 277 (280)
|+.||++|| .||||.+..
T Consensus 279 l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 279 LVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred ccCChhhCcCHHHHhcChhhccCC
Confidence 999999999 999998653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=332.20 Aligned_cols=253 Identities=29% Similarity=0.375 Sum_probs=194.7
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCC-CCCeeeeceEEecCC--eEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPT--HLA 93 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~~~ 93 (280)
.++|++++.||+|+||.||++.+..+++.||+|++.... .......+|+.+++++. ||||+++++++..++ .++
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 478999999999999999999999999999999986532 23345678999999996 999999999997544 789
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~- 172 (280)
+||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.|++||||||+||+++.++. +||+|||+++.....
T Consensus 88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCC
T ss_pred EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCcccccccccc
Confidence 9999997 589888865 57999999999999999999999999999999999999998887 999999999743221
Q ss_pred ---------------------CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHH
Q 023591 173 ---------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (280)
Q Consensus 173 ---------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (280)
.......+++.|+|||.+.+....+.++|||||||++|+|++|..||...+.......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 11223468899999999987544455599999999999999999999876554444333
Q ss_pred HhhHhcccc-----------------------------------------cCCCCCCCCHHHHHHHHHhcccCCCCcC--
Q 023591 232 IHRILSVQY-----------------------------------------SIPDYVHISPECRHLISRIFVADPAKSE-- 268 (280)
Q Consensus 232 ~~~~~~~~~-----------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rp-- 268 (280)
......... .......+++++.+||.+||+.||++||
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 321110000 0011125789999999999999999999
Q ss_pred ----CCcccccc
Q 023591 269 ----MHDWRRGC 276 (280)
Q Consensus 269 ----~h~~~~~~ 276 (280)
.||||+..
T Consensus 324 ~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 324 NDALKHPFVSIF 335 (388)
T ss_dssp HHHTTSTTTTTT
T ss_pred HHHhCCHHHHHh
Confidence 99999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=335.02 Aligned_cols=263 Identities=27% Similarity=0.367 Sum_probs=203.5
Q ss_pred CCCCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEe
Q 023591 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVIL 87 (280)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 87 (280)
++.+......++|++.+.||+|+||.||++++..+++.||||++..... ..+.+.+|+.++++++|+||+++++++.
T Consensus 16 ~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 16 FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp TTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred hcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 4445556667999999999999999999999999999999999976422 2356789999999999999999999987
Q ss_pred cC-----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEee
Q 023591 88 TP-----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (280)
Q Consensus 88 ~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~d 162 (280)
.. ..+++||||++ ++|.+++.....+++..++.++.||+.||+|||+.|++||||||+||+++.++. +||+|
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~D 172 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCD 172 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECC
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEcc
Confidence 65 57999999996 599999988888999999999999999999999999999999999999998877 99999
Q ss_pred cCCccccccCCC-----------------------CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCC
Q 023591 163 FGYSKSSVLHSQ-----------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219 (280)
Q Consensus 163 f~~~~~~~~~~~-----------------------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~ 219 (280)
||+++....... .....+++.|+|||.+......+.++|||||||++|+|++|..||
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 999975433221 244568999999998755544455599999999999999854443
Q ss_pred -----------CCCCC-----------------cchHHHHHh--------------------hHhcccccCC-----CCC
Q 023591 220 -----------EDPEE-----------------PKNFRKTIH--------------------RILSVQYSIP-----DYV 246 (280)
Q Consensus 220 -----------~~~~~-----------------~~~~~~~~~--------------------~~~~~~~~~~-----~~~ 246 (280)
..... ...+..+.. .+.......+ ..+
T Consensus 253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (432)
T 3n9x_A 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP 332 (432)
T ss_dssp CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence 22210 000000100 0000000000 013
Q ss_pred CCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 247 HISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.+++++.+||.+||+.||.+|| .||||++.
T Consensus 333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 5899999999999999999999 99999865
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=328.17 Aligned_cols=253 Identities=30% Similarity=0.518 Sum_probs=213.0
Q ss_pred CCCeeeecccccCCceEEEEEEec---CCCcEEEEEEeeeCC-----cccHHHHHHHHHhhhC-CCCCeeeeceEEecCC
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 90 (280)
.++|++.+.||+|+||.||++++. .+++.||+|++.+.. ...+.+.+|+.+++++ +|+||+++++++..+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 379999999999999999999984 578999999986532 3345567899999999 7999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
..++||||+++++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||++....
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeecc
Confidence 99999999999999999988888999999999999999999999999999999999999998877 9999999987443
Q ss_pred cC--CCCCCCcCCCcccCcccccCCc-CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 171 LH--SQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 171 ~~--~~~~~~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
.. .......+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||...............+......++. .
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~ 288 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--E 288 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--T
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc--c
Confidence 22 1223456899999999997633 23445999999999999999999998766555555555555555555554 6
Q ss_pred CCHHHHHHHHHhcccCCCCcC-----------CCcccccc
Q 023591 248 ISPECRHLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+++.+.+||.+||+.||.+|| .||||++.
T Consensus 289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 899999999999999999997 89999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=325.30 Aligned_cols=258 Identities=27% Similarity=0.430 Sum_probs=208.3
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
...++|++.+.||+|+||.||++++..+++.||+|++...... .+.+.+|+.++++++||||+++++++......++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 3558999999999999999999999999999999998765432 2446789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-C
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~ 173 (280)
||||+++++|.++......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC--------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCceeecCCcc
Confidence 9999999888888877788999999999999999999999999999999999999998886 999999998744332 2
Q ss_pred CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc---------------c
Q 023591 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------V 238 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------~ 238 (280)
......+++.|+|||.+.+....+.++||||||+++|+|++|..||.................. .
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 2344568899999999987644455599999999999999999999876654443333221111 0
Q ss_pred cccCCC----------CCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 239 QYSIPD----------YVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 239 ~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
....+. .+.+++++.+||.+||+.||++|| .||||+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 001111 125789999999999999999999 999998653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=326.22 Aligned_cols=254 Identities=24% Similarity=0.411 Sum_probs=206.5
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC-----CCCeeeeceEEecCCe
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFKEVILTPTH 91 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~ 91 (280)
....++|++.+.||+|+||.||++++..+++.||+|++............|+.+++.+. ||||+++++++...+.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 34468999999999999999999999999999999999866655667788999999886 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC----------------
Q 023591 92 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS---------------- 153 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~---------------- 153 (280)
.++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.|++||||||+||+++..
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 99999999 889999997654 59999999999999999999999999999999999999751
Q ss_pred -------CCCcEEEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcc
Q 023591 154 -------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (280)
Q Consensus 154 -------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (280)
....++|+|||++.... .......+++.|+|||.+.+..++.. +||||||+++|+|++|..||.......
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~ 266 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHME 266 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHCCCCCCCCcHHH
Confidence 13349999999987433 23345678999999999988887666 999999999999999999998765433
Q ss_pred hHHHHHhhHhccc----------------------ccCCCC------------------CCCCHHHHHHHHHhcccCCCC
Q 023591 227 NFRKTIHRILSVQ----------------------YSIPDY------------------VHISPECRHLISRIFVADPAK 266 (280)
Q Consensus 227 ~~~~~~~~~~~~~----------------------~~~~~~------------------~~~~~~l~~li~~~l~~dp~~ 266 (280)
............. ..++.. ...++.+.+||.+||+.||++
T Consensus 267 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 346 (360)
T 3llt_A 267 HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTL 346 (360)
T ss_dssp HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhh
Confidence 3222221111000 001110 012477889999999999999
Q ss_pred cC------CCcccc
Q 023591 267 SE------MHDWRR 274 (280)
Q Consensus 267 Rp------~h~~~~ 274 (280)
|| .||||+
T Consensus 347 Rpta~elL~hp~f~ 360 (360)
T 3llt_A 347 RPSPAELLKHKFLE 360 (360)
T ss_dssp SCCHHHHTTSGGGC
T ss_pred CCCHHHHhcCcccC
Confidence 99 999996
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=328.61 Aligned_cols=251 Identities=26% Similarity=0.364 Sum_probs=200.7
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc----HHHHHHHHHhhhCCCCCeeeeceEEecCC----
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPT---- 90 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 90 (280)
..++|++.+.||+|+||.||++++..+++.||+|++....... ..+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4589999999999999999999999999999999997653322 45778999999999999999999987643
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
..++||||+++++|.+++...+++++..++.++.|++.||+|||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC----
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCccccc
Confidence 35999999999999999988889999999999999999999999999999999999999998887 9999999987443
Q ss_pred cCCC----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCC
Q 023591 171 LHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (280)
Q Consensus 171 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (280)
.... .....+++.|+|||.+.+..++.. +||||||+++|+|++|..||.................. .......
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~ 244 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI--PPSARHE 244 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC--CHHHHST
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC--CcccccC
Confidence 3221 223457999999999988777555 99999999999999999999875543322222221111 1111123
Q ss_pred CCCHHHHHHHHHhcccCCCCcC------CCcccc
Q 023591 247 HISPECRHLISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp------~h~~~~ 274 (280)
.+++++.+||.+||+.||++|| .|+|++
T Consensus 245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 5899999999999999999999 788875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=324.77 Aligned_cols=255 Identities=27% Similarity=0.498 Sum_probs=206.9
Q ss_pred CCCeeee-cccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEE
Q 023591 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 20 ~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 94 (280)
.++|.+. +.||+|+||.||++++..+++.||+|++.... .....+.+|+.+++++ .||||+++++++......++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 4678887 89999999999999999999999999987532 2346788899999998 56999999999999999999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-CCcEEEeecCCcccccc
Q 023591 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVL 171 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~~~~~l~df~~~~~~~~ 171 (280)
||||+++++|.+++... ..+++..++.++.|++.||++||+.|++||||+|+||+++... .+.++|+|||++.....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999999999988543 5799999999999999999999999999999999999998621 23499999999986655
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
........+++.|+|||.+.+..++.. +||||||+++|+|++|..||............... ...+..+....+++.
T Consensus 187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~ 263 (327)
T 3lm5_A 187 ACELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV--NVDYSEETFSSVSQL 263 (327)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTTTTSCHH
T ss_pred ccccccccCCcCccCCeeecCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc--ccccCchhhcccCHH
Confidence 544555678999999999988877655 99999999999999999999876543333322221 122222333468999
Q ss_pred HHHHHHHhcccCCCCcC------CCccccccc
Q 023591 252 CRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
+.+||.+||+.||++|| .||||++..
T Consensus 264 ~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 99999999999999999 999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=329.04 Aligned_cols=254 Identities=27% Similarity=0.445 Sum_probs=209.7
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
..++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 4589999999999999999999999999999999987653 23356789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
||+++++|.+++.....+++..+..++.|++.+|.+||+. |++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~-~~ 187 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-MA 187 (360)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH-C-
T ss_pred ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCcccccc-cc
Confidence 9999999999998888899999999999999999999996 9999999999999998887 999999998644322 23
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcch----------------------------
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN---------------------------- 227 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---------------------------- 227 (280)
....+++.|+|||.+.+..++.. +||||||+++|+|++|..||........
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3eqc_A 188 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266 (360)
T ss_dssp ---CCCCTTCCHHHHTTCCCSHH-HHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred cCCCCCCCeECHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence 34568999999999988777655 9999999999999999999976443211
Q ss_pred ----------HHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 228 ----------FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 228 ----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.......+............+++++.+||.+||+.||++|| .||||++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 01111222222222222235789999999999999999999 99999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=331.93 Aligned_cols=257 Identities=26% Similarity=0.334 Sum_probs=209.1
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC------CCCCeeeeceEEecC
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL------RHPNIVRFKEVILTP 89 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~ 89 (280)
.....++|++.+.||+|+||.||++.+..+++.||+|++.........+.+|+.+++.+ +|+||+++++++...
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 33455789999999999999999999999999999999987665556777888888776 577999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 90 THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
...++||||+. ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+||+++.++...+||+|||++.
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999999996 58999887654 4999999999999999999999999999999999999998876669999999986
Q ss_pred ccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccccc------
Q 023591 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS------ 241 (280)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 241 (280)
... .......+++.|+|||.+.+..++.. +|||||||++|+|++|..||......+....+..........
T Consensus 251 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~ 327 (429)
T 3kvw_A 251 YEH--QRVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327 (429)
T ss_dssp ETT--CCCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred ecC--CcccccCCCCCccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence 432 23345678999999999988888665 999999999999999999998766544433333221100000
Q ss_pred --------------------------------------CCC---------CCCCCHHHHHHHHHhcccCCCCcC------
Q 023591 242 --------------------------------------IPD---------YVHISPECRHLISRIFVADPAKSE------ 268 (280)
Q Consensus 242 --------------------------------------~~~---------~~~~~~~l~~li~~~l~~dp~~Rp------ 268 (280)
.+. ....++++.+||.+||+.||++||
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407 (429)
T ss_dssp THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence 000 013478899999999999999999
Q ss_pred CCcccccc
Q 023591 269 MHDWRRGC 276 (280)
Q Consensus 269 ~h~~~~~~ 276 (280)
.||||++.
T Consensus 408 ~Hpw~~~~ 415 (429)
T 3kvw_A 408 RHPWLRRR 415 (429)
T ss_dssp TSTTTC--
T ss_pred CChhhccC
Confidence 99999865
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=324.68 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=207.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecC-----Ce
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 91 (280)
..++|++++.||+|+||.||++.+..+++.||+|++..... ....+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 34799999999999999999999999999999999875432 235678999999999999999999998754 36
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
.++|||++++ +|.+++.. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADP 180 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCG
T ss_pred EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCC
Confidence 8999999974 99988865 46999999999999999999999999999999999999998887 99999999875443
Q ss_pred CCC----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-------
Q 023591 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY------- 240 (280)
Q Consensus 172 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 240 (280)
... .....+++.|+|||.+.+....+.++||||||+++|+|++|..||......+....+.........
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 222 234578999999998776654455599999999999999999999887665554444322111100
Q ss_pred ---------cCCC---------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 241 ---------SIPD---------YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 241 ---------~~~~---------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
..+. ...+++++.+||.+||+.||++|| .||||++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 0000 135789999999999999999999 99999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=336.73 Aligned_cols=255 Identities=27% Similarity=0.388 Sum_probs=188.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecC-----C
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP-----T 90 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 90 (280)
..++|++.+.||+|+||.||++++..+++.||||++.... ...+.+.+|+.++++++||||+++++++... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 4589999999999999999999999999999999987542 2235678899999999999999999998533 5
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
.+++||||+ +++|.+++.....+++..++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||+++...
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTT
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--Eeecccccchhcc
Confidence 799999998 4699999988888999999999999999999999999999999999999998887 9999999997543
Q ss_pred cCC----------------------------CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh--------
Q 023591 171 LHS----------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-------- 214 (280)
Q Consensus 171 ~~~----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-------- 214 (280)
... ......+|+.|+|||++......+.++|||||||++|+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 221 11233568999999987554433455999999999999998
Q ss_pred ---CCCCCCCCCC--------------------cchHHHHHhhHhc----------------------cc--cc-CCCCC
Q 023591 215 ---GAYPFEDPEE--------------------PKNFRKTIHRILS----------------------VQ--YS-IPDYV 246 (280)
Q Consensus 215 ---g~~p~~~~~~--------------------~~~~~~~~~~~~~----------------------~~--~~-~~~~~ 246 (280)
|.++|.+... ...+..+...... .. .. ....+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 6666654321 0001111100000 00 00 00123
Q ss_pred CCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 247 HISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
..++++.+||.+||+.||++|| .||||++.
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 5689999999999999999999 99999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=318.80 Aligned_cols=254 Identities=36% Similarity=0.610 Sum_probs=213.6
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
..++|++.+.||+|++|.||++++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++......+++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3479999999999999999999999999999999987542 3456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-CCcEEEeecCCccccccCCC
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~~~~~l~df~~~~~~~~~~~ 174 (280)
||++++++|.+.+.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++ ...++|+|||++........
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 99999999999998888899999999999999999999999999999999999997644 34599999999876554444
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc--cCCCCCCCCHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPEC 252 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 252 (280)
.....+++.|+|||.+.+. ++. ++||||||+++|+|++|..||....... ....+..... ..+....+++++
T Consensus 180 ~~~~~~~~~y~aPE~~~~~-~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRGT-YDE-KCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVETGKYAFDLPQWRTISDDA 253 (287)
T ss_dssp CSCHHHHHTTCCHHHHTTC-CCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred cccccCcccccChHHhcCC-CCC-chhhHhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCchhhhhcCHHH
Confidence 4455678899999988654 544 4999999999999999999998754332 2223333322 233334689999
Q ss_pred HHHHHHhcccCCCCcC------CCcccccccC
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
.+||.+||+.||++|| .||||++...
T Consensus 254 ~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred HHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 9999999999999999 9999987653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=320.16 Aligned_cols=253 Identities=23% Similarity=0.397 Sum_probs=206.5
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC-CCCeeeeceEEec--CCeEEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILT--PTHLAI 94 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~l 94 (280)
...++|++.+.||+|+||.||++++..+++.||+|++... ..+.+.+|+.++++++ ||||+++++++.. ....++
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 3568999999999999999999999999999999998743 3467889999999996 9999999999987 567899
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
+|||+++++|.+++.. +++..++.++.|++.||++||+.|++|+||+|+||+++.++. .++|+|||++........
T Consensus 111 v~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp EEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCC
T ss_pred EEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCc
Confidence 9999999999988754 899999999999999999999999999999999999986662 399999999986665555
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHh----------ccccc---
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL----------SVQYS--- 241 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------~~~~~--- 241 (280)
.....+++.|+|||.+.+....+.++||||||+++|+|++|..||................. .....
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266 (330)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCT
T ss_pred cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccccc
Confidence 66677899999999998744445559999999999999999999965543221111111100 00000
Q ss_pred -------------------CCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 242 -------------------IPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 242 -------------------~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
......+++++.+||.+||+.||++|| .||||++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 001112789999999999999999999 99999865
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=314.05 Aligned_cols=250 Identities=23% Similarity=0.354 Sum_probs=204.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEec----CCe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTH 91 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~ 91 (280)
....|++.+.||+|+||.||++.+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 4467899999999999999999999999999999987643 233567889999999999999999998865 356
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEe-CCCCCcEEEeecCCccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLD-GSPAPRLKICDFGYSKS 168 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~ni~i~-~~~~~~~~l~df~~~~~ 168 (280)
.++||||+++++|.+++.....+++..++.++.|++.||.+||+.| ++|+||+|+||+++ .++. ++|+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~--~kl~Dfg~~~~ 181 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGG
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC--EEEeeCCCccc
Confidence 8999999999999999988888999999999999999999999999 99999999999997 5565 99999999863
Q ss_pred cccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCC
Q 023591 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (280)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (280)
... .......+++.|+|||.+.+ .++. ++||||||+++|+|++|..||........... .+.............
T Consensus 182 ~~~-~~~~~~~~t~~y~aPE~~~~-~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~ 255 (290)
T 1t4h_A 182 KRA-SFAKAVIGTPEFMAPEMYEE-KYDE-SVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVA 255 (290)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGT-CCCT-HHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HHTTTCCCGGGGGCC
T ss_pred ccc-cccccccCCcCcCCHHHHhc-cCCC-cchHHHHHHHHHHHHhCCCCCCCcCcHHHHHH---HHhccCCccccCCCC
Confidence 322 22334568899999998764 4544 49999999999999999999987554333322 222221111112257
Q ss_pred CHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 249 SPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
++++.+||.+||+.||.+|| .||||++.
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 256 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 78999999999999999999 99999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=318.85 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=205.1
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEec------CC
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT------PT 90 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------~~ 90 (280)
...++|++.+.||+|+||.||++++..+++.||+|++.......+.+.+|+.+++++ +||||+++++++.. ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 356899999999999999999999999999999999988777778899999999998 89999999999976 46
Q ss_pred eEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 91 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
..++||||+++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~ 178 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQ 178 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTTC-
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCcee
Confidence 799999999999999999764 47999999999999999999999999999999999999998877 99999999875
Q ss_pred cccC-CCCCCCcCCCcccCccccc-----CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC
Q 023591 169 SVLH-SQPKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242 (280)
Q Consensus 169 ~~~~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
.... .......+++.|+|||.+. +..++. ++||||||+++|+|++|..||.......... .+.......
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~ 253 (326)
T 2x7f_A 179 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMHPMRALF----LIPRNPAPR 253 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCT-THHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSCCCC
T ss_pred cCcCccccccccCCccccChhhhccccccCcCCCc-cchHHHHHHHHHHHHhCCCCCCCCcHHHHHH----HhhcCcccc
Confidence 4322 2233456889999999986 344444 4999999999999999999997654322222 222222222
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 243 PDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.....+++.+.+||.+||+.||.+|| .||||++..
T Consensus 254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 22336899999999999999999999 999998654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=324.81 Aligned_cols=253 Identities=33% Similarity=0.556 Sum_probs=204.5
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---------cccHHHHHHHHHhhhCCCCCeeeeceEEecC
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 89 (280)
..++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3478999999999999999999999999999999986532 1223578899999999999999999998765
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-CCcEEEeecCCccc
Q 023591 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKS 168 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~~~~~l~df~~~~~ 168 (280)
. .++||||+++++|.+++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++ ...++|+|||++..
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 5 899999999999999998888899999999999999999999999999999999999998654 33599999999875
Q ss_pred cccCCCCCCCcCCCcccCccccc---CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC--
Q 023591 169 SVLHSQPKSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP-- 243 (280)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 243 (280)
...........+++.|+|||.+. ...+ ..++||||||+++|+|++|..||............... ....+.
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~ 242 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---GKYNFIPE 242 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHTTTTTC-TTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH---TCCCCCHH
T ss_pred cccccccccccCCcCccCchhhccCCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh---CccccCch
Confidence 43322222345789999999974 3344 44599999999999999999999876554443333222 111111
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 244 DYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
....+++++.+||.+||+.||++|| .||||++.
T Consensus 243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 1135789999999999999999999 99999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=326.79 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=199.5
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCC-----
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 90 (280)
..++|++.+.||+|+||.||++.+..+|+.||+|++..... ..+.+.+|+.++++++||||+++++++..+.
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 45789999999999999999999999999999999865432 2356778999999999999999999997653
Q ss_pred -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 91 -~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
.+++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.|++||||||+||+++.++. +||+|||++...
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeeccccc
Confidence 469999999 7799998865 57999999999999999999999999999999999999998877 999999999754
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc----------
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------- 239 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 239 (280)
.. ......+++.|+|||.+.+....+.++||||+||++|+|++|..||...+.......+........
T Consensus 179 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 179 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred cc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 32 233456789999999988743334559999999999999999999987654443333322111100
Q ss_pred --------------ccC-CCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 240 --------------YSI-PDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 240 --------------~~~-~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
..+ ......++++.+||.+||+.||++|| .||||++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 000 01135789999999999999999999 99999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=325.19 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=198.6
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCC-------
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT------- 90 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------- 90 (280)
...++|++.+.||+|+||.||++++..+++.||+|++...........+++..+..++||||+++++++....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 3557999999999999999999999999999999999877666677788888889999999999999986533
Q ss_pred eEEEEEeccCCCchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--hcCceecCCCCCcEEEeC-CCCCcEEEeec
Q 023591 91 HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDG-SPAPRLKICDF 163 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~----~~~~~l~~~~~~~~~~~i~~~l~~Lh--~~~i~h~dl~~~ni~i~~-~~~~~~~l~df 163 (280)
..++||||+++ +|.+.+ .....+++..++.++.|++.||.+|| +.|++|+||||+||+++. ++. ++|+||
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~--~kl~Df 176 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKLCDF 176 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE--EEECCC
T ss_pred eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc--EEEeeC
Confidence 38899999976 554443 34567999999999999999999999 999999999999999986 565 999999
Q ss_pred CCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc----
Q 023591 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---- 239 (280)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 239 (280)
|++.............+++.|+|||.+.+....+.++||||||+++|+|++|..||....................
T Consensus 177 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 177 GSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp TTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 9998666555556667899999999987766445559999999999999999999988665444444333211100
Q ss_pred ---------ccC-------------CCCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 240 ---------YSI-------------PDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 240 ---------~~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
..+ ......++++.+||.+||+.||.+|| .||||++..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 000 00112568899999999999999999 999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=318.08 Aligned_cols=243 Identities=21% Similarity=0.253 Sum_probs=193.5
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc---HHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|+||+||++++..+++.||+|++....... .....|+..+.++ +|+||+++++++.++...++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 68999999999999999999999999999999886543222 2334455444444 9999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
||+ +++|.+.+... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++. +||+|||++.........
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCC
Confidence 999 56888887654 46999999999999999999999999999999999999988887 999999998766555555
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....+++.|+|||.+.+ .++. ++||||||+++|+|++|..|+... ...... ............+++++.+|
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~-~~DiwslG~il~el~~g~~~~~~~---~~~~~~----~~~~~~~~~~~~~~~~l~~l 284 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGT-AADVFSLGLTILEVACNMELPHGG---EGWQQL----RQGYLPPEFTAGLSSELRSV 284 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCST-HHHHHHHHHHHHHHHHTCCCCSSH---HHHHHH----TTTCCCHHHHTTSCHHHHHH
T ss_pred cccCCCccccCHhHhcC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCc---cHHHHH----hccCCCcccccCCCHHHHHH
Confidence 56678999999998875 5544 499999999999999997666542 112211 11111111122588999999
Q ss_pred HHHhcccCCCCcC------CCccccc
Q 023591 256 ISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 256 i~~~l~~dp~~Rp------~h~~~~~ 275 (280)
|.+||+.||++|| .||||++
T Consensus 285 i~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 285 LVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHcCCChhhCcCHHHHHhCccccC
Confidence 9999999999999 9999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=323.17 Aligned_cols=246 Identities=23% Similarity=0.355 Sum_probs=197.5
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCC--------
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 90 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------- 90 (280)
++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 68999999999999999999999999999999997543 33467889999999999999999999885432
Q ss_pred -------------------------------------------------eEEEEEeccCCCchHHHHHhcCC---CCHHH
Q 023591 91 -------------------------------------------------HLAIVMEYASGGELFERICNAGR---FSEDE 118 (280)
Q Consensus 91 -------------------------------------------------~~~lv~e~~~~~~L~~~~~~~~~---l~~~~ 118 (280)
..+++|||+++++|.+++..... .+...
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 38999999999999999977543 56667
Q ss_pred HHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-------------CCCCCcCCCccc
Q 023591 119 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------------QPKSTVGTPAYI 185 (280)
Q Consensus 119 ~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-------------~~~~~~~~~~~~ 185 (280)
++.++.||+.||+|||+.|++|+||||+||+++.++. ++|+|||++....... ......+++.|+
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 9999999999999999999999999999999998876 9999999987544332 223346899999
Q ss_pred CcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCC
Q 023591 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 265 (280)
Q Consensus 186 aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 265 (280)
|||.+.+..++.. +||||||+++|+|++|..|+.. ............... .....++++.+||.+||+.||+
T Consensus 244 aPE~~~~~~~~~~-~Di~slG~il~el~~~~~~~~~------~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~ 315 (332)
T 3qd2_B 244 SPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQME------RVRIITDVRNLKFPL-LFTQKYPQEHMMVQDMLSPSPT 315 (332)
T ss_dssp CHHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCHHH------HHHHHHHHHTTCCCH-HHHHHCHHHHHHHHHHHCSSGG
T ss_pred ChHHhcCCCCcch-hhHHHHHHHHHHHHHcCCChhH------HHHHHHHhhccCCCc-ccccCChhHHHHHHHHccCCCC
Confidence 9999988877655 9999999999999998766421 122222222221111 0113567899999999999999
Q ss_pred CcC------CCcccccc
Q 023591 266 KSE------MHDWRRGC 276 (280)
Q Consensus 266 ~Rp------~h~~~~~~ 276 (280)
+|| .||||++.
T Consensus 316 ~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 316 ERPEATDIIENAIFENL 332 (332)
T ss_dssp GSCCHHHHHHSTTCCCC
T ss_pred cCCCHHHHhhchhhhcC
Confidence 999 99999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=329.19 Aligned_cols=253 Identities=28% Similarity=0.440 Sum_probs=202.6
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecC------CeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP------THL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~ 92 (280)
...+|++.+.||+|+||.||++++..+++.||||++...... ..+|++++++++|+||+++++++... ..+
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh---HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 345799999999999999999999999999999998765432 34799999999999999999988531 247
Q ss_pred EEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 93 AIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
++||||+++ ++.+.+. ....+++..++.++.||+.||+|||+.||+||||||+||+++.++. .+||+|||+++.
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~ 206 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEE
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhh
Confidence 799999976 6665553 3567999999999999999999999999999999999999986543 389999999986
Q ss_pred cccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc-----------
Q 023591 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS----------- 237 (280)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------- 237 (280)
...........+++.|+|||.+.+......++|||||||++|+|++|..||......+.+.++......
T Consensus 207 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp CCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred cccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 555555556678999999999877644445599999999999999999999886654444444332111
Q ss_pred --ccccCCC----------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 238 --VQYSIPD----------YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 238 --~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
..+.++. ....++++.+||.+||+.||.+|| .||||++.
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 0111111 125689999999999999999999 99999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=321.36 Aligned_cols=246 Identities=28% Similarity=0.427 Sum_probs=204.4
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc----cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
++|++.+.||+|+||.||++++..+++.||+|++...... .+.+.+|+.++++++||||+++++++..+...++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 5699999999999999999999999999999999764322 245778999999999999999999999999999999
Q ss_pred eccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 97 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~-~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
||+. ++|.+.+. ...++++..++.++.|++.||.+||+.|++||||+|+||+++.++. +||+|||++..... .
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~---~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---A 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---B
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEeeccCceecCC---C
Confidence 9997 57877774 4567999999999999999999999999999999999999998876 99999999875432 2
Q ss_pred CCCcCCCcccCccccc---CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 176 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~---~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
....+++.|+|||.+. +..++.. +||||||+++|+|++|..||........... +............+++.+
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~-~DiwslG~il~ell~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l 282 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHWSEYF 282 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCCCTTSCHHH
T ss_pred CcccCCcceeCHhhhccccCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhcCCCCCCCCCCCHHH
Confidence 3456899999999985 3455444 9999999999999999999977554332222 222222222233689999
Q ss_pred HHHHHHhcccCCCCcC------CCccccccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.+||.+||+.||++|| .||||....
T Consensus 283 ~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 9999999999999999 999997643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=315.61 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=190.8
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc---HHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
...++|++.+.||+|+||.||++++..+++.||+|.+....... +.+.++...++.++||||+++++++..++..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 35689999999999999999999999999999999987643222 223344455777899999999999999999999
Q ss_pred EEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 95 VMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 95 v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
||||+++ +|.+++. ....+++..++.++.|++.||++||+. |++|+||+|+||+++.++. ++|+|||++...
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDFGISGYL 160 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC--EEBCCC------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecCCcccc
Confidence 9999975 8877664 356799999999999999999999998 9999999999999998776 999999998766
Q ss_pred ccCCCCCCCcCCCcccCcccc----cCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCC
Q 023591 170 VLHSQPKSTVGTPAYIAPEVL----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (280)
..........+++.|+|||.+ .+..+ +.++||||||+++|+|++|..||........ ............. ..
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~-~~ 236 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQ--QLKQVVEEPSPQL-PA 236 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH--HHHHHHHSCCCCC-CT
T ss_pred cccccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCccccCchHH--HHHHHhccCCCCc-cc
Confidence 555555556789999999996 33344 4559999999999999999999976443221 1222222222222 22
Q ss_pred CCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 246 VHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
..+++++.+||.+||+.||++|| .||||+..
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 36899999999999999999999 99999753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=321.29 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=202.5
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCC--eEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLA 93 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 93 (280)
...++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.... ..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 34689999999999999999999999999999999987643 33466789999999999999999999988655 789
Q ss_pred EEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEE----eCCCCCcEEEeecCCc
Q 023591 94 IVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL----DGSPAPRLKICDFGYS 166 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i----~~~~~~~~~l~df~~~ 166 (280)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||||+||++ +.++ .+||+|||++
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~Dfg~a 163 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAA 163 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE--EEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc--eEEEccCCCc
Confidence 9999999999999997644 39999999999999999999999999999999999998 4343 4999999999
Q ss_pred cccccCCCCCCCcCCCcccCccccc--------CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc
Q 023591 167 KSSVLHSQPKSTVGTPAYIAPEVLL--------KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238 (280)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 238 (280)
.............+++.|+|||.+. +..++.. +||||||+++|+|++|..||...............+...
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTT-HHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 8665555555667899999999986 3455444 999999999999999999998665544444444444332
Q ss_pred cc-------------------cCCCC----CCCCHHHHHHHHHhcccCCCCcC
Q 023591 239 QY-------------------SIPDY----VHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 239 ~~-------------------~~~~~----~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.. .++.. ..+++.+.+||++||+.||++||
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~ 295 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhc
Confidence 21 11111 12356789999999999999999
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=315.44 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=206.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
..++|++.+.||+|+||.||++.+..+++.||+|.+.... ..+.+.+|+.++++++||||+++++++......++||||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 3478999999999999999999999999999999987643 457788999999999999999999999999999999999
Q ss_pred cCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCC
Q 023591 99 ASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (280)
Q Consensus 99 ~~~~~L~~~~~-~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (280)
+++++|.+++. ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~ 183 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKRN 183 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCBC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhccccC
Confidence 99999999986 4567999999999999999999999999999999999999998877 9999999987543322 233
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (280)
...+++.|+|||.+.+..++.. +||||||+++|+|++|..||............ .......+.....+++.+.+||
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li 259 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---PTNPPPTFRKPELWSDNFTDFV 259 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCCCCSSGGGSCHHHHHHH
T ss_pred ccCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hcCCCcccCCcccCCHHHHHHH
Confidence 4568899999999988877666 99999999999999999999865432222211 1111122222235789999999
Q ss_pred HHhcccCCCCcC------CCccccccc
Q 023591 257 SRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 257 ~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.+||+.||.+|| .||||++..
T Consensus 260 ~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 260 KQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 999999999999 999998653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=315.47 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=213.4
Q ss_pred CCCCCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEe
Q 023591 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVIL 87 (280)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 87 (280)
|++........++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.
T Consensus 11 p~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 90 (303)
T 3a7i_A 11 PGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL 90 (303)
T ss_dssp --CTTCEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CchhcCCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 3444444455678999999999999999999999999999999997653 34467889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
.+...++||||+++++|.+++.. .++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~ 167 (303)
T 3a7i_A 91 KDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAG 167 (303)
T ss_dssp ETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCE
T ss_pred cCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccce
Confidence 99999999999999999998854 57999999999999999999999999999999999999988877 9999999987
Q ss_pred ccccCC-CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-cccCCCC
Q 023591 168 SSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDY 245 (280)
Q Consensus 168 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 245 (280)
...... ......+++.|+|||.+.+..++.. +||||||+++|+|++|..||.......... .+... ...++
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~-- 240 (303)
T 3a7i_A 168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLF----LIPKNNPPTLE-- 240 (303)
T ss_dssp ECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSCCCCCC--
T ss_pred ecCccccccCccCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcCHHHHHH----HhhcCCCCCCc--
Confidence 544332 2344568899999999988877665 999999999999999999997654322221 11111 11222
Q ss_pred CCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 246 VHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
..++..+.+||.+||+.||.+|| .||||.+.
T Consensus 241 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 241 GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 36899999999999999999999 99999654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=321.20 Aligned_cols=264 Identities=28% Similarity=0.386 Sum_probs=188.2
Q ss_pred CCCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC--CcccHHHHHHHHHhhhCCCCCeeeeceEEecC
Q 023591 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (280)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 89 (280)
...+.....++|++.+.||+|+||.||++.+..+++.||+|.+... ....+.+.+|+..+++++||||+++++++..+
T Consensus 6 ~~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 6 SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp -------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS
T ss_pred cccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 3456666779999999999999999999999989999999988654 23445678899999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEe
Q 023591 90 THLAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~--------~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~ 161 (280)
+..++||||+++++|.+++.. ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~ 163 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIA 163 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEEC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEE
Confidence 999999999999999998863 356999999999999999999999999999999999999998877 9999
Q ss_pred ecCCccccccCC------CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhH
Q 023591 162 DFGYSKSSVLHS------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235 (280)
Q Consensus 162 df~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (280)
|||++....... ......+++.|+|||.+.+......++||||||+++|+|++|..||................
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence 999876433221 12334688999999998763333445999999999999999999998765544333222211
Q ss_pred hccc----ccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 236 LSVQ----YSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 236 ~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.... ........+++++.+||.+||+.||.+|| .||||++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 1100 00111236789999999999999999999 999998643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=312.39 Aligned_cols=247 Identities=24% Similarity=0.345 Sum_probs=200.8
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 95 (280)
.++|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+..+.++ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 478999999999999999999999999999999998643 2335677889999888 999999999999999999999
Q ss_pred EeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-----------------
Q 023591 96 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP----------------- 154 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~----------------- 154 (280)
|||+++++|.+++... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999998764 6799999999999999999999999999999999999998543
Q ss_pred CCcEEEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhh
Q 023591 155 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (280)
Q Consensus 155 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (280)
...++|+|||.+..... .....+++.|+|||.+.+......++||||||+++|+|++|..++... ........
T Consensus 170 ~~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~- 242 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWHEIRQ- 242 (289)
T ss_dssp CCCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHHHHHHT-
T ss_pred ceEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHHHHHHc-
Confidence 22499999998875433 233458999999999977655445699999999999999998876542 12222211
Q ss_pred HhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 235 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.....++. .+++++.+||.+||+.||++|| .||||++.+
T Consensus 243 --~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 243 --GRLPRIPQ--VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp --TCCCCCSS--CCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred --CCCCCCCc--ccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 11112333 6899999999999999999999 999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=317.08 Aligned_cols=240 Identities=27% Similarity=0.422 Sum_probs=201.4
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC-CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
...++|++.+.||+|+||.||++.+..+++.||+|.+... ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 3568999999999999999999999999999999988653 334466889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC-----
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceeccccccc
Confidence 99999999999977 567999999999999999999999999999999999999998877 999999998744332221
Q ss_pred ---------------CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcch-----HHHHHhhH
Q 023591 176 ---------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-----FRKTIHRI 235 (280)
Q Consensus 176 ---------------~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~ 235 (280)
....+++.|+|||.+.+..++.. +||||||+++|+|++|..||........ .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 242 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR- 242 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence 14568999999999988777665 9999999999999999999876433211 1111111
Q ss_pred hcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..+. .+++.+.++|.+||+.||++||
T Consensus 243 -----~~~~--~~~~~l~~li~~~l~~dP~~Rp 268 (310)
T 3s95_A 243 -----YCPP--NCPPSFFPITVRCCDLDPEKRP 268 (310)
T ss_dssp -----TCCT--TCCTTHHHHHHHHTCSSGGGSC
T ss_pred -----cCCC--CCCHHHHHHHHHHccCChhhCc
Confidence 1122 5788999999999999999999
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=326.70 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=200.3
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCC------eE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT------HL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~ 92 (280)
...+|++.+.||+|+||.||++++..+++ +|+|++....... .+|+.+++.++||||+++++++.... .+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~---~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK---NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSC---CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchH---HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 34689999999999999999999987666 8888876544322 36999999999999999999986433 38
Q ss_pred EEEEeccCCCchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEe-CCCCCcEEEeecCCcc
Q 023591 93 AIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSK 167 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~----~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~-~~~~~~~~l~df~~~~ 167 (280)
++||||+++ ++.+.+ .....+++..++.++.||+.||+|||+.|++||||||+||+++ .++. +||+|||++.
T Consensus 114 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~--~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV--LKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE--EEECCCTTCE
T ss_pred EEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc--EEEeeCCCcc
Confidence 899999976 443333 2356799999999999999999999999999999999999998 5665 9999999998
Q ss_pred ccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc---------
Q 023591 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------- 238 (280)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 238 (280)
............+++.|+|||.+.+....+.++|||||||++|+|++|..||......+....+.......
T Consensus 191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 66555556667789999999998776544555999999999999999999998866544444443321110
Q ss_pred ----cccCCC----------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 239 ----QYSIPD----------YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 239 ----~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
...++. ...+++++.+||.+||+.||.+|| .||||++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 001111 124789999999999999999999 99999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=322.87 Aligned_cols=251 Identities=22% Similarity=0.400 Sum_probs=210.7
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc------------------HHHHHHHHHhhhCCCCCee
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID------------------ENVQREIINHRSLRHPNIV 80 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------------------~~~~~e~~~l~~l~h~~iv 80 (280)
..++|++.+.||+|+||.||++++ +++.||+|.+....... +.+.+|+.++++++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 457999999999999999999999 79999999987542111 7889999999999999999
Q ss_pred eeceEEecCCeEEEEEeccCCCchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEe
Q 023591 81 RFKEVILTPTHLAIVMEYASGGELFER------ICN--AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLD 151 (280)
Q Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~--~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~ 151 (280)
++++++.+++..++||||+++++|.++ +.. ...+++..++.++.|++.||.+||+ .|++|+||+|+||+++
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999999999999999999999999988 655 5679999999999999999999999 9999999999999999
Q ss_pred CCCCCcEEEeecCCccccccCCCCCCCcCCCcccCcccccCC-cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHH
Q 023591 152 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (280)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (280)
.++. ++|+|||++...... ......+++.|+|||.+.+. .++..++||||||+++|+|++|..||....... .
T Consensus 187 ~~~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~ 260 (348)
T 2pml_X 187 KNGR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV---E 260 (348)
T ss_dssp TTSC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH---H
T ss_pred CCCc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH---H
Confidence 8887 999999998754332 33455688999999999877 454436999999999999999999998765532 2
Q ss_pred HHhhHhcccccCCCC-----------------CCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 231 TIHRILSVQYSIPDY-----------------VHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 231 ~~~~~~~~~~~~~~~-----------------~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
....+......++.. ..+++++.+||.+||+.||.+|| .||||++..
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 233333333333321 46899999999999999999999 999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=327.10 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=194.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCC-----
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 90 (280)
..++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 3479999999999999999999999999999999997643 22345778999999999999999999997654
Q ss_pred -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 91 -~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
..++||||+++ +|.+.+. ..+++..+..++.||+.||.|||++|++||||||+||+++.++. +||+|||++...
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 177 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC----
T ss_pred cceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeeccccc
Confidence 78999999975 7888775 35899999999999999999999999999999999999998877 999999999765
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc------------
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------ 237 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------ 237 (280)
..........+++.|+|||.+.+..++.. +||||||+++|+|++|..||...+....+..+......
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 256 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred ccccccCCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 44444455678999999999988877665 99999999999999999999876543333333221100
Q ss_pred ------ccccC--------------CCC----CCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 238 ------VQYSI--------------PDY----VHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 238 ------~~~~~--------------~~~----~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
....+ +.. ...++++.+||.+||+.||++|| .||||+.+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 00000 000 00156799999999999999999 99999754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=318.19 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=198.9
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---cHHHHHHHHHhhhCCC--CCeeeeceEEecCCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRH--PNIVRFKEVILTPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~ 93 (280)
..++|++.+.||+|+||.||++.+. +++.||+|++...... .+.+.+|+.++++++| +||+++++++..+...+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 4578999999999999999999985 5888999999765432 2567889999999976 99999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
+|||+. +++|.+++.....+++..++.++.||+.||.|||+.|++||||||+||+++ ++. +||+|||++.......
T Consensus 86 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~--~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 86 MVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM--LKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEECCC-SEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTE--EEECCCSSSCCC----
T ss_pred EEEeCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCc--EEEeecccccccCccc
Confidence 999954 779999999988999999999999999999999999999999999999997 344 9999999997544332
Q ss_pred C---CCCCcCCCcccCcccccC-----------CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc
Q 023591 174 Q---PKSTVGTPAYIAPEVLLK-----------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239 (280)
Q Consensus 174 ~---~~~~~~~~~~~aPE~~~~-----------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 239 (280)
. .....+++.|+|||.+.+ ..+ +.++||||||+++|+|++|..||...... ......+....
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~ 237 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHAIIDPN 237 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------C-CHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHHHHHCTT
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCC-CchhhHHHHHHHHHHHHhCCCcchhhhhH---HHHHHHHhcCC
Confidence 2 234568999999999864 334 44599999999999999999999765432 12222222222
Q ss_pred ccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 240 YSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
.........++++.+||.+||+.||.+|| .||||+.
T Consensus 238 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 22222235678999999999999999999 9999974
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=313.07 Aligned_cols=245 Identities=29% Similarity=0.458 Sum_probs=195.1
Q ss_pred CCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---cHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
......++|++.+.||+|+||.||++++ +++.||+|++...... .+.+.+|+.++++++||||+++++++.....
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 3344568999999999999999999987 4778999998765432 2457789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEeCCCCCcEEEeecCCc
Q 023591 92 LAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~ni~i~~~~~~~~~l~df~~~ 166 (280)
.++||||+++++|.+++..... +++..++.++.|++.||++||+.| ++||||||+||+++.++. ++|+|||++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a 186 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLS 186 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC--
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCC
Confidence 9999999999999999976553 999999999999999999999999 999999999999998877 999999998
Q ss_pred cccccC-CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCC
Q 023591 167 KSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245 (280)
Q Consensus 167 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (280)
...... .......+++.|+|||.+.+..++.. +||||||+++|+|++|..||............. ........+.
T Consensus 187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~--~~~~~~~~~~- 262 (309)
T 3p86_A 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAAVG--FKCKRLEIPR- 262 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH--HSCCCCCCCT-
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcCCCCCCCc-
Confidence 743322 22344568999999999988877655 999999999999999999998755432222111 1222233333
Q ss_pred CCCCHHHHHHHHHhcccCCCCcC
Q 023591 246 VHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+++++.+||.+||+.||.+||
T Consensus 263 -~~~~~l~~li~~~l~~dP~~Rp 284 (309)
T 3p86_A 263 -NLNPQVAAIIEGCWTNEPWKRP 284 (309)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSC
T ss_pred -cCCHHHHHHHHHHccCChhhCc
Confidence 6899999999999999999999
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=325.24 Aligned_cols=252 Identities=25% Similarity=0.418 Sum_probs=188.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecC------
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 89 (280)
..++|++++.||+|+||.||++.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 45899999999999999999999999999999999875432 235677899999999999999999998654
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
...+++++++ +++|.+++.. ..+++..++.++.||+.||+|||+.|++||||||+||+++.++. +||+|||+++..
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~ 182 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT 182 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC-------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeeccccccc
Confidence 4679999999 6799888865 57999999999999999999999999999999999999998877 999999998753
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc----------
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------- 239 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 239 (280)
.. ......+++.|+|||.+.+....+.++|||||||++|+|++|..||...+.......+........
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 183 AD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred cc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 32 233456889999999988744444559999999999999999999987665444433332211100
Q ss_pred ---------ccCCC------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 240 ---------YSIPD------YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 240 ---------~~~~~------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
...+. ....++++.+||.+||+.||++|| .||||++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 00000 124688999999999999999999 99999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=321.94 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=200.6
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCC--CCCeeeeceEEecCCeEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR--HPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~l 94 (280)
..+|++.+.||+|+||.||++.+.. ++.||+|++..... ..+.+.+|+.++++++ |+||+++++++..+..+++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 4569999999999999999999865 88999999976532 2356789999999996 5999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
|||+ .+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||+++ ++. +||+|||++........
T Consensus 134 v~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~--~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 134 VMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM--LKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSC--EEECCCSSSCCC-----
T ss_pred EEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCe--EEEEecCccccccCCCc
Confidence 9995 5779999998888999999999999999999999999999999999999996 444 99999999975443321
Q ss_pred ---CCCCcCCCcccCcccccCC----------cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccccc
Q 023591 175 ---PKSTVGTPAYIAPEVLLKK----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241 (280)
Q Consensus 175 ---~~~~~~~~~~~aPE~~~~~----------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
.....+++.|+|||.+.+. .....++||||||+++|+|++|..||...... ......+......
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHAIIDPNHE 286 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHHHHCTTSC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---HHHHHHHhCcccc
Confidence 2345689999999998652 22344599999999999999999999765432 1222233333333
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 242 IPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.+.....++++.+||.+||+.||.+|| .||||+..
T Consensus 287 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 222225688999999999999999999 99999754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=321.90 Aligned_cols=254 Identities=23% Similarity=0.345 Sum_probs=195.3
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc------------cHHHHHHHHHhhhCCCCCeeeeceEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVRFKEVI 86 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv~~~~~~ 86 (280)
..++|++.+.||+|+||.||++.+.. ++.||+|.+...... .+.+.+|+.++++++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 35899999999999999999999865 889999998653221 15688999999999999999999998
Q ss_pred ec-----CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEE
Q 023591 87 LT-----PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (280)
Q Consensus 87 ~~-----~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l 160 (280)
.. ....++||||++ ++|.+.+... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++. ++|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl 175 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITI 175 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEE
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEE
Confidence 53 346899999997 5888877654 47999999999999999999999999999999999999988877 999
Q ss_pred eecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc-
Q 023591 161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ- 239 (280)
Q Consensus 161 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 239 (280)
+|||++.............+++.|+|||.+.+....+.++||||||+++|+|++|..||....................
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 9999997555555555667889999999987744445559999999999999999999987654433333322111100
Q ss_pred -------------------ccCCC------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 240 -------------------YSIPD------YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 240 -------------------~~~~~------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
...+. ....++.+.+||.+||+.||++|| .||||++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 00000 125688999999999999999999 99999865
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=313.29 Aligned_cols=249 Identities=31% Similarity=0.508 Sum_probs=204.1
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC-----CcccHHHHHHHHHhhhCCCCCeeeeceEEe--cCCeE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----DKIDENVQREIINHRSLRHPNIVRFKEVIL--TPTHL 92 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 92 (280)
.++|++.+.||+|+||.||++.+..+++.||+|++... ....+.+.+|+.++++++|+||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999999999999999998753 234467889999999999999999999984 44578
Q ss_pred EEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 93 AIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
++||||++++ |.+++.. ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccC
Confidence 9999999765 7777654 456999999999999999999999999999999999999998877 9999999987543
Q ss_pred cC---CCCCCCcCCCcccCcccccCCcC-CCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCC
Q 023591 171 LH---SQPKSTVGTPAYIAPEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (280)
Q Consensus 171 ~~---~~~~~~~~~~~~~aPE~~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (280)
.. .......+++.|+|||.+.+... ...++||||||+++|+|++|..||..... ......+......++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~i~~~~~~~~~-- 234 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI----YKLFENIGKGSYAIPG-- 234 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHCCCCCCS--
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH----HHHHHHHhcCCCCCCC--
Confidence 22 12234568899999999876432 34459999999999999999999986443 3333444444444444
Q ss_pred CCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 247 HISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.+++.+.+||.+||+.||++|| .||||++..
T Consensus 235 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 6899999999999999999999 999998653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=318.81 Aligned_cols=263 Identities=30% Similarity=0.463 Sum_probs=182.5
Q ss_pred CCCCCCCCCCCCCCeeeec-ccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEe
Q 023591 9 GPGMDMPIMHDSDRYELVR-DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87 (280)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~-~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 87 (280)
.+|.........++|++.+ .||+|+||.||++.+..+++.||+|++..... ...+....++.++|+||+++++++.
T Consensus 16 ~~~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~e~~~~~~~~~h~~i~~~~~~~~ 92 (336)
T 3fhr_A 16 FQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---ARQEVDHHWQASGGPHIVCILDVYE 92 (336)
T ss_dssp ----CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH---HHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccCCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH---HHHHHHHHHHhcCCCChHHHHHHHh
Confidence 3455555556678999966 59999999999999999999999999876432 2222333456679999999999987
Q ss_pred c----CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-CCcEEE
Q 023591 88 T----PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKI 160 (280)
Q Consensus 88 ~----~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~~~~~l 160 (280)
. +...++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ ...++|
T Consensus 93 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl 172 (336)
T 3fhr_A 93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL 172 (336)
T ss_dssp EEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred hccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEE
Confidence 6 446899999999999999997654 699999999999999999999999999999999999997643 345999
Q ss_pred eecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc
Q 023591 161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240 (280)
Q Consensus 161 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
+|||++..... .......+++.|+|||.+.+..++.. +||||||+++|+|++|..||...............+.....
T Consensus 173 ~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (336)
T 3fhr_A 173 TDFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250 (336)
T ss_dssp CCCTTCEEC-----------------------CHHHHH-HHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred eccccceeccc-cccccCCCCcCccChhhhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence 99999874432 22344567899999999977777555 99999999999999999999776543332222222222222
Q ss_pred --cCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 241 --SIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 241 --~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
..+.+..+++++.+||.+||+.||++|| .||||++.
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 2233457899999999999999999999 99999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=316.90 Aligned_cols=256 Identities=28% Similarity=0.356 Sum_probs=205.9
Q ss_pred CCCCeeeecccccCCceEEEEEEe-cCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCC------CeeeeceEEecCCe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRD-KKTEELVAVKYIERGDKIDENVQREIINHRSLRHP------NIVRFKEVILTPTH 91 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~~~~ 91 (280)
-.++|++.+.||+|+||.||++.+ ..+++.||+|++.......+.+.+|+.+++.++|+ +++++++++...+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 357999999999999999999998 56789999999987665567788899999888654 49999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC---------------
Q 023591 92 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--------------- 154 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~--------------- 154 (280)
.++||||+ +++|.+++.... ++++..++.++.|++.||+|||++|++|+||+|+||+++.++
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99999999 779999987665 689999999999999999999999999999999999998743
Q ss_pred --CCcEEEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHH
Q 023591 155 --APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (280)
Q Consensus 155 --~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (280)
...++|+|||++.... .......+++.|+|||.+.+..++.. +||||||+++|+|++|..||...+.........
T Consensus 171 ~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 247 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247 (339)
T ss_dssp ESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHH
T ss_pred ccCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 3459999999987432 23345578999999999988777665 999999999999999999998765433222221
Q ss_pred hhHhccc-----------------cc---------------------CCCCCCCCHHHHHHHHHhcccCCCCcC------
Q 023591 233 HRILSVQ-----------------YS---------------------IPDYVHISPECRHLISRIFVADPAKSE------ 268 (280)
Q Consensus 233 ~~~~~~~-----------------~~---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rp------ 268 (280)
....... .. .......++++.+||.+||+.||.+||
T Consensus 248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 327 (339)
T 1z57_A 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL 327 (339)
T ss_dssp HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHh
Confidence 1111000 00 000112356799999999999999999
Q ss_pred CCcccccccC
Q 023591 269 MHDWRRGCSV 278 (280)
Q Consensus 269 ~h~~~~~~~~ 278 (280)
.||||++...
T Consensus 328 ~hp~f~~~~~ 337 (339)
T 1z57_A 328 KHPFFDLLKK 337 (339)
T ss_dssp TSGGGGGGGC
T ss_pred cCHHHHHHhc
Confidence 9999987653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=313.64 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=204.2
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
...++|++++.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 34589999999999999999999999999999999986543 34467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-CCC
Q 023591 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~-~~~ 174 (280)
||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCccccccccc
Confidence 99999999998865 467999999999999999999999999999999999999998877 99999998653221 122
Q ss_pred CCCCcCCCcccCccccc-----CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 175 PKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~-----~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
.....+++.|+|||.+. +..++ .++||||||+++|+|++|..||.............. ...........++
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 249 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SDPPTLLTPSKWS 249 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTT-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSSGGGSC
T ss_pred cccccCChhhcCCeeeccccCCCCCCc-hhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc---cCCcccCCccccC
Confidence 33456889999999984 34444 459999999999999999999987554332222221 1111222223578
Q ss_pred HHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 250 PECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.++.+||.+||+.||++|| .||||++..
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 9999999999999999999 999998653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=317.02 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=187.9
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCCc---EEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecC
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 89 (280)
.....++|++.+.||+|+||.||++++..++. .||+|.+... ....+.+.+|+.++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 44566899999999999999999999887664 7999998764 33346788999999999999999999999876
Q ss_pred CeE------EEEEeccCCCchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCc
Q 023591 90 THL------AIVMEYASGGELFERICNAG------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (280)
Q Consensus 90 ~~~------~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~ 157 (280)
... +++|||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||||+||+++.++.
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~-- 175 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT-- 175 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC--
Confidence 654 99999999999999885432 5999999999999999999999999999999999999998876
Q ss_pred EEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHh
Q 023591 158 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (280)
Q Consensus 158 ~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 233 (280)
++|+|||++........ .....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||..............
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCc-cchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 99999999875433222 123345678999999988777555 999999999999999 9999987665443333222
Q ss_pred hHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC-------------CCccccccc
Q 023591 234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKSE-------------MHDWRRGCS 277 (280)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-------------~h~~~~~~~ 277 (280)
. ..... ...+++++.+||.+||+.||++|| .|||+...+
T Consensus 255 ~---~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 255 G---NRLKQ--PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp T---CCCCC--CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred C---CCCCC--CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 1 11222 236899999999999999999999 899997654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=311.68 Aligned_cols=256 Identities=28% Similarity=0.402 Sum_probs=206.9
Q ss_pred CCCCCeeeecccccCCceEEEEEEec-CCCcEEEEEEeeeCC---cccHHHHHHHHHhhhC---CCCCeeeeceEEe---
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVIL--- 87 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~--- 87 (280)
...++|++.+.||+|+||.||++++. .+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34589999999999999999999995 678899999987532 2234566777777666 8999999999987
Q ss_pred --cCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeec
Q 023591 88 --TPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (280)
Q Consensus 88 --~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df 163 (280)
.....++||||++ ++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Df 164 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADF 164 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecC
Confidence 4567899999997 59999987654 4999999999999999999999999999999999999998887 999999
Q ss_pred CCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-cccC
Q 023591 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSI 242 (280)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 242 (280)
|++.............+++.|+|||.+.+..++.. +||||||+++|+|++|..||...........+....... ...+
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred cccccccCCCCccccccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 99875554444455678999999999988777655 999999999999999999998766544444443322110 0000
Q ss_pred C--------------------CCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 243 P--------------------DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 243 ~--------------------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
+ ....+++.+.+||.+||+.||++|| .||||++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 0 1135789999999999999999999 999998653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=306.42 Aligned_cols=244 Identities=24% Similarity=0.407 Sum_probs=204.3
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
.....++|++.+.||+|+||.||++.+. +++.||+|++.......+.+.+|+.++++++||||+++++++.++...++|
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 3456689999999999999999999987 467799999988777778899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC--
Q 023591 96 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 172 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-- 172 (280)
|||+++++|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEecccccccccccccc
Confidence 9999999999999654 46899999999999999999999999999999999999988876 999999998744322
Q ss_pred CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
.......+++.|+|||.+.+..++.. +||||||+++|+|++ |..||.......... .+... .........+++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~ 235 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTG-FRLYKPRLASTH 235 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHTT-CCCCCCTTSCHH
T ss_pred ccccCcccccccCCHHHhcCCCCCch-hhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH----HHhcC-ccCCCCCcCCHH
Confidence 12233446778999999987777655 999999999999999 999998755432222 22222 122222367899
Q ss_pred HHHHHHHhcccCCCCcC
Q 023591 252 CRHLISRIFVADPAKSE 268 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp 268 (280)
+.+++.+||+.||++||
T Consensus 236 ~~~li~~~l~~~p~~Rp 252 (269)
T 4hcu_A 236 VYQIMNHCWRERPEDRP 252 (269)
T ss_dssp HHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHccCCcccCc
Confidence 99999999999999999
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=321.24 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=199.5
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE----
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHL---- 92 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---- 92 (280)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4799999999999999999999999999999999976432 235677899999999999999999999876654
Q ss_pred --EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 93 --AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 93 --~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
++||||+. ++|.+.+. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD 195 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC----
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCcccccc
Confidence 99999997 58887763 35999999999999999999999999999999999999998887 9999999987443
Q ss_pred cCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc----------
Q 023591 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY---------- 240 (280)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 240 (280)
. ......+++.|+|||.+.+....+.++||||||+++|+|++|..||...+..+..............
T Consensus 196 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 196 A--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred c--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 2 2334567899999999887443445599999999999999999999876544333333221111000
Q ss_pred ---------cCC------CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 241 ---------SIP------DYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 241 ---------~~~------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
..+ ....+++++.+||.+||+.||++|| .||||+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 000 0125789999999999999999999 99999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=331.80 Aligned_cols=241 Identities=13% Similarity=0.097 Sum_probs=191.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHH---HhhhCCCCCeeeec-------e
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREII---NHRSLRHPNIVRFK-------E 84 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~---~l~~l~h~~iv~~~-------~ 84 (280)
..++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|+. .+++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3578999999999999999999999899999999997532 33466788994 55556899999998 6
Q ss_pred EEecCC-----------------eEEEEEeccCCCchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhcCcee
Q 023591 85 VILTPT-----------------HLAIVMEYASGGELFERICNAGRFSE-------DEARFFFQQLISGVSYCHSMQVCH 140 (280)
Q Consensus 85 ~~~~~~-----------------~~~lv~e~~~~~~L~~~~~~~~~l~~-------~~~~~~~~~i~~~l~~Lh~~~i~h 140 (280)
++..++ ..+++|||+ +++|.+++.....+++ ..++.++.||+.||+|||+.||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 666543 288999999 5799999976555555 888889999999999999999999
Q ss_pred cCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcCCCcccCcccccCC-----------cCCCccchhhHHHHHH
Q 023591 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-----------EYDGKIADVWSCGVTL 209 (280)
Q Consensus 141 ~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~~DiwslG~~l 209 (280)
|||||+||+++.++. +||+|||++..... ......+ +.|+|||.+.+. .++ .++||||||+++
T Consensus 230 rDikp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DvwSlG~il 303 (377)
T 3byv_A 230 TYLRPVDIVLDQRGG--VFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMT-FSFDAWALGLVI 303 (377)
T ss_dssp SCCCGGGEEECTTCC--EEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC-HHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCC--EEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCC-hhhhHHHHHHHH
Confidence 999999999998876 99999999874322 2233456 999999999877 554 459999999999
Q ss_pred HHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 210 YVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 210 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
|+|++|..||........... + ......+++++.+||.+||+.||++|| .||||++.
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~----~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEW----I------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHSSCCC------CCSGG----G------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHHCCCCCcccccccchhh----h------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 999999999976543222111 1 111236899999999999999999999 99999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=315.01 Aligned_cols=263 Identities=28% Similarity=0.381 Sum_probs=200.1
Q ss_pred CCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEe----
Q 023591 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVIL---- 87 (280)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---- 87 (280)
..+.....++|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 3 NIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp ---CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred ccccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence 3445556689999999999999999999999999999999987653 33456789999999999999999999873
Q ss_pred ----------cCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCc
Q 023591 88 ----------TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (280)
Q Consensus 88 ----------~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~ 157 (280)
.....++||||++ ++|.+++.. .++++..++.++.|++.||++||+.|++|+||+|+||+++.++ ..
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~ 159 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LV 159 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TE
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-Ce
Confidence 3467899999997 599998854 5799999999999999999999999999999999999997433 23
Q ss_pred EEEeecCCccccccC----CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHh
Q 023591 158 LKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (280)
Q Consensus 158 ~~l~df~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (280)
++|+|||++...... .......+++.|+|||.+.+......++||||||+++|+|++|..||..............
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999998754322 1223345688899999987644445569999999999999999999987654333332222
Q ss_pred hHhc------------------ccccCC------CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 234 RILS------------------VQYSIP------DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 234 ~~~~------------------~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
.... .....+ ....+++++.+||.+||+.||++|| .||||+..+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 1100 000000 0125899999999999999999999 9999987653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=314.97 Aligned_cols=245 Identities=30% Similarity=0.483 Sum_probs=207.2
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-------ccHHHHHHHHHhhhCC--CCCeeeeceEEec
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLR--HPNIVRFKEVILT 88 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~ 88 (280)
...++|++.+.||+|+||.||++.+..+++.||+|.+..... ....+.+|+.++++++ |+|++++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 345789999999999999999999999999999999976432 2245678999999985 5999999999999
Q ss_pred CCeEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEe-CCCCCcEEEeecCCc
Q 023591 89 PTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYS 166 (280)
Q Consensus 89 ~~~~~lv~e~~~~-~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~-~~~~~~~~l~df~~~ 166 (280)
++..++++|++.+ ++|.+++.....+++..++.++.|++.||++||+.|++|+||+|+||+++ .++. ++|+|||++
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~--~kL~Dfg~~ 197 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSG 197 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE--EEECCCTTC
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC--EEEeeCccc
Confidence 9999999999975 89999998888999999999999999999999999999999999999998 4555 999999998
Q ss_pred cccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCC
Q 023591 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (280)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (280)
..... .......+++.|+|||.+.+..+...++||||||+++|+|++|..||.... . +......++.
T Consensus 198 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~----~~~~~~~~~~-- 264 (320)
T 3a99_A 198 ALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E----IIRGQVFFRQ-- 264 (320)
T ss_dssp EECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHCCCCCSS--
T ss_pred ccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------h----hhcccccccc--
Confidence 75433 223345689999999999877776666899999999999999999996521 1 1122222333
Q ss_pred CCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 247 HISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.+++++.+||.+||+.||++|| .||||++..
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 6899999999999999999999 999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=310.64 Aligned_cols=247 Identities=23% Similarity=0.282 Sum_probs=193.9
Q ss_pred CCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc----cHHHHHHHHHhhhCCCCCeeeeceEEecCC
Q 023591 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPT 90 (280)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 90 (280)
......++|++.+.||+|+||.||++++..+++.||+|++...... .+.+.+|+.++++++||||+++++++..++
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 3444568999999999999999999999999999999998764332 256788999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
..+++|||+++++|.+++....++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATT 185 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC-----
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCcccc
Confidence 99999999999999999988888999999999999999999999999999999999999998876 9999999986443
Q ss_pred cCC--CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-cCCCCCC
Q 023591 171 LHS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVH 247 (280)
Q Consensus 171 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 247 (280)
... ......+++.|+|||.+.+..++.. +||||||+++|+|++|..||...... .....+..... .......
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~ 260 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLS----VMGAHINQAIPRPSTVRPG 260 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHH----HHHHHHHSCCCCGGGTSTT
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHH----HHHHHhccCCCCccccCCC
Confidence 322 2234568899999999988777655 99999999999999999999764322 11111111111 1111236
Q ss_pred CCHHHHHHHHHhcccCCCCcC
Q 023591 248 ISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp 268 (280)
+|+++.++|.+||+.||++||
T Consensus 261 ~~~~l~~li~~~l~~dP~~Rp 281 (309)
T 2h34_A 261 IPVAFDAVIARGMAKNPEDRY 281 (309)
T ss_dssp CCTHHHHHHHHHTCSSGGGSC
T ss_pred CCHHHHHHHHHhccCCHHHHH
Confidence 899999999999999999999
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=314.02 Aligned_cols=255 Identities=29% Similarity=0.411 Sum_probs=202.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecC-----Ce
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 91 (280)
..++|++.+.||+|+||.||++.+..+++.||+|.+..... ....+.+|+.++++++||||+++++++..+ ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 45899999999999999999999999999999999865432 234577899999999999999999987654 67
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
.+++|||+. ++|.+++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDE 164 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC-
T ss_pred EEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEeccccccccc
Confidence 899999996 589988865 56999999999999999999999999999999999999998877 99999999874432
Q ss_pred CCC-----------CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc-
Q 023591 172 HSQ-----------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ- 239 (280)
Q Consensus 172 ~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 239 (280)
... .....+++.|+|||.+.+....+.++||||||+++|+|++|..||....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 211 12245789999999887644445569999999999999999999987653322222221110000
Q ss_pred -------------------ccCC------CCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 240 -------------------YSIP------DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 240 -------------------~~~~------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
...+ ....+++++.+||.+||+.||++|| .||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 0000 0135789999999999999999999 999998654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=314.17 Aligned_cols=244 Identities=23% Similarity=0.358 Sum_probs=199.6
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCc---EEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
....++|++.+.||+|+||.||++++..+++ .||+|.+.... ...+.+.+|+.++++++||||+++++++..+..
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 3456899999999999999999999976554 49999987642 233568899999999999999999999999889
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
.++||||+++++|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLE 202 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEECC
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCcccccc
Confidence 99999999999999999654 57999999999999999999999999999999999999988877 9999999987543
Q ss_pred cCCCC----CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCC
Q 023591 171 LHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245 (280)
Q Consensus 171 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (280)
..... ....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||........... +.. ....+..
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~ 276 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISS----VEE-GYRLPAP 276 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH----HHT-TCCCCCC
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----HHc-CCCCCCC
Confidence 32221 12234667999999987777655 999999999999999 9999987554332222 222 1223333
Q ss_pred CCCCHHHHHHHHHhcccCCCCcC
Q 023591 246 VHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..+++.+.+||.+||+.||.+||
T Consensus 277 ~~~~~~l~~li~~~l~~dp~~Rp 299 (325)
T 3kul_A 277 MGCPHALHQLMLDCWHKDRAQRP 299 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCcCHHHHHHHHHHccCChhhCc
Confidence 47899999999999999999999
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=311.02 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=198.2
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEec-----------
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----------- 88 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------- 88 (280)
.++|++.+.||+|+||.||++++..+++.||+|.+.......+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 468999999999999999999999999999999998766666778899999999999999999998754
Q ss_pred --CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCC
Q 023591 89 --PTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (280)
Q Consensus 89 --~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~ 165 (280)
....++||||+++++|.+++.... .+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~ 162 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGL 162 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcc
Confidence 356899999999999999997544 5889999999999999999999999999999999999988877 99999999
Q ss_pred ccccccC---------------CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHH
Q 023591 166 SKSSVLH---------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (280)
Q Consensus 166 ~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (280)
+...... .......+++.|+|||.+.+......++||||||+++|+|++ ||.... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---~~~~ 236 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---ERVN 236 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---HHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---hHHH
Confidence 8744321 112334578899999999765444455999999999999998 554321 1222
Q ss_pred HHhhHhcccccCCC--CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 231 TIHRILSVQYSIPD--YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 231 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
....+......++. ....++.+.+||.+||+.||++|| .||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 33333333333322 235678899999999999999999 99999754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=304.65 Aligned_cols=242 Identities=25% Similarity=0.383 Sum_probs=202.7
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
...++|++.+.||+|+||.||++.+. ++..||+|.+.......+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 45689999999999999999999876 56679999998877777889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC--
Q 023591 98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-- 174 (280)
|+++++|.+++.... .+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEEE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhhc
Confidence 999999999987654 5999999999999999999999999999999999999998887 99999999874433221
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
.....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||........... +.... ........++.+.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~l~ 235 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----VSQGH-RLYRPHLASDTIY 235 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHTTC-CCCCCTTSCHHHH
T ss_pred ccCCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHH----HHcCC-CCCCCCcChHHHH
Confidence 223345677999999988777666 999999999999999 9999976554322222 22222 1122225789999
Q ss_pred HHHHHhcccCCCCcC
Q 023591 254 HLISRIFVADPAKSE 268 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp 268 (280)
++|.+||+.||++||
T Consensus 236 ~li~~~l~~~p~~Rp 250 (268)
T 3sxs_A 236 QIMYSCWHELPEKRP 250 (268)
T ss_dssp HHHHHTTCSSGGGSC
T ss_pred HHHHHHcCCChhhCc
Confidence 999999999999999
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=306.21 Aligned_cols=245 Identities=20% Similarity=0.351 Sum_probs=202.2
Q ss_pred CCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
......++|++.+.||+|+||.||++.+. ++..||+|++.......+.+.+|+.++++++|+||+++++++..+...++
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 34456789999999999999999999886 56789999998877777889999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-
Q 023591 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~- 172 (280)
||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCHH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEccccccccccccc
Confidence 9999999999999976 457999999999999999999999999999999999999998877 999999998744322
Q ss_pred -CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCH
Q 023591 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (280)
Q Consensus 173 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (280)
.......+++.|+|||.+.+..++.. +||||||+++|+|++ |..||............ ... .........++
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~----~~~-~~~~~~~~~~~ 248 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----AQG-LRLYRPHLASE 248 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HTT-CCCCCCTTCCH
T ss_pred cccccCCccCcccCCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccChhHHHHHH----hcc-cCCCCCCcCCH
Confidence 12233445778999999987777554 999999999999998 99999876543322222 222 11222235789
Q ss_pred HHHHHHHHhcccCCCCcC
Q 023591 251 ECRHLISRIFVADPAKSE 268 (280)
Q Consensus 251 ~l~~li~~~l~~dp~~Rp 268 (280)
.+.++|.+||+.||.+||
T Consensus 249 ~l~~li~~~l~~~p~~Rp 266 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERP 266 (283)
T ss_dssp HHHHHHHHTTCSSGGGSC
T ss_pred HHHHHHHHHccCChhHCc
Confidence 999999999999999999
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=305.57 Aligned_cols=252 Identities=31% Similarity=0.477 Sum_probs=201.0
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
++|.....||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 44445559999999999999999999999999987653 33467889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC-CCCCcEEEeecCCccccccC-CC
Q 023591 100 SGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLH-SQ 174 (280)
Q Consensus 100 ~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~-~~~~~~~l~df~~~~~~~~~-~~ 174 (280)
++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++. ++. ++|+|||++...... ..
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGINPC 179 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC--EEECCTTTCEESCC----
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC--EEEeecccccccCCCCCc
Confidence 9999999987642 4679999999999999999999999999999999999987 555 999999998754332 22
Q ss_pred CCCCcCCCcccCcccccCCc-CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
.....+++.|+|||.+.+.. ....++||||||+++|+|++|..||.......... ...........++. .+++++.
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~ 256 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM-FKVGMFKVHPEIPE--SMSAEAK 256 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH-HHHHHHCCCCCCCT--TSCHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH-Hhhccccccccccc--cCCHHHH
Confidence 34456889999999987643 22445999999999999999999997644322111 11111222223333 6899999
Q ss_pred HHHHHhcccCCCCcC------CCccccccc
Q 023591 254 HLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
+||.+||+.||++|| .||||+...
T Consensus 257 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 257 AFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 999999999999999 999998653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=307.74 Aligned_cols=246 Identities=21% Similarity=0.307 Sum_probs=207.7
Q ss_pred CCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..-...++|++.+.||+|+||.||++.+..++..||+|.+.......+.+.+|+.++++++||||+++++++..+...++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 44456789999999999999999999999999999999998877777889999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGD 164 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCC
Confidence 99999999999999764 45999999999999999999999999999999999999988876 999999998754332
Q ss_pred CC--CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 173 SQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 173 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
.. .....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||.............. .........++
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 238 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-----DYRMERPEGCP 238 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-----TCCCCCCTTCC
T ss_pred ccccccCCccccCcCChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----cCCCCCCCCCC
Confidence 21 122345678999999987777555 999999999999999 9999987654332222211 12222233689
Q ss_pred HHHHHHHHHhcccCCCCcC
Q 023591 250 PECRHLISRIFVADPAKSE 268 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp 268 (280)
+.+.+||.+||+.||.+||
T Consensus 239 ~~l~~li~~~l~~dp~~Rp 257 (288)
T 3kfa_A 239 EKVYELMRACWQWNPSDRP 257 (288)
T ss_dssp HHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHhCCChhhCc
Confidence 9999999999999999999
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=318.56 Aligned_cols=209 Identities=31% Similarity=0.417 Sum_probs=177.3
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC-CC-----CeeeeceEEecCCeEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HP-----NIVRFKEVILTPTHLA 93 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~~ 93 (280)
.++|++.+.||+|+||.||++.+..+++.||+|++.........+.+|+.+++.++ |+ +++++++++......+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 57999999999999999999999999999999999876555566778888888774 44 4999999999999999
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 94 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh--~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
+||||+++ +|.+++... ..+++..++.++.|++.||.+|| +.||+||||||+||+++.+....+||+|||++...
T Consensus 133 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 99999965 999998765 46999999999999999999999 57999999999999997655556999999998754
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHH
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (280)
. .......+++.|+|||.+.+..++.. +||||||+++|+|++|..||...+.......+.
T Consensus 212 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~ 271 (382)
T 2vx3_A 212 G--QRIYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271 (382)
T ss_dssp T--CCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred c--cccccccCCccccChHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 3 23345678999999999988887655 999999999999999999998766544444333
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=321.54 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=185.9
Q ss_pred CCeee-ecccccCCceEEEEEEec--CCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEec--CCeEEEE
Q 023591 21 DRYEL-VRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIV 95 (280)
Q Consensus 21 ~~y~~-~~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 95 (280)
+.|++ .++||+|+||.||++++. .+++.||+|.+... .....+.+|+.++++++||||+++++++.. +..+++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 56777 458999999999999965 56889999998754 344678899999999999999999999954 6789999
Q ss_pred EeccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC--CCCCcEEEeecC
Q 023591 96 MEYASGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG--SPAPRLKICDFG 164 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~---------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~--~~~~~~~l~df~ 164 (280)
|||+.+ +|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||++.. +....+||+|||
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 999965 887777422 24999999999999999999999999999999999999942 122349999999
Q ss_pred CccccccC----CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc---------chHHHH
Q 023591 165 YSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKT 231 (280)
Q Consensus 165 ~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---------~~~~~~ 231 (280)
++...... .......+++.|+|||.+.+....+.++|||||||++|+|++|..||...... ..+..+
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 99754332 22234568999999999987664556699999999999999999999765431 111222
Q ss_pred HhhHhcccc----------------------cC----------CCCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 232 IHRILSVQY----------------------SI----------PDYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 232 ~~~~~~~~~----------------------~~----------~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
......... .+ ......++++.+||.+||+.||.+|| .||||
T Consensus 258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f 337 (405)
T 3rgf_A 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 337 (405)
T ss_dssp HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 111110000 00 00112377899999999999999999 99999
Q ss_pred ccccC
Q 023591 274 RGCSV 278 (280)
Q Consensus 274 ~~~~~ 278 (280)
++...
T Consensus 338 ~~~~~ 342 (405)
T 3rgf_A 338 LEDPL 342 (405)
T ss_dssp TSSSC
T ss_pred ccCCC
Confidence 87654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=308.39 Aligned_cols=251 Identities=30% Similarity=0.490 Sum_probs=204.9
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEe--cCCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVIL--TPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~ 93 (280)
..++|++.+.||+|+||.||++++..+++.||+|.+.... ...+.+.+|+.++++++||||+++++++. .....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4589999999999999999999999999999999997643 23356788999999999999999999875 356899
Q ss_pred EEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC-----ceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 94 IVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~Lh~~~-----i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
+||||+++++|.+++... ..+++..++.++.|++.||++||+.| ++|+||+|+||+++.++. ++|+|||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg 161 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFG 161 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCc
Confidence 999999999999998653 34999999999999999999999999 999999999999998877 9999999
Q ss_pred CccccccCCC-CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-cC
Q 023591 165 YSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SI 242 (280)
Q Consensus 165 ~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 242 (280)
++........ .....+++.|+|||.+.+..++.. +||||||+++|+|++|..||....... ....+..... .+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~i~~~~~~~~ 236 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIREGKFRRI 236 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCC
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCcccCHHH----HHHHHhhcccccC
Confidence 8864332211 122357889999999988777544 999999999999999999998754322 2222222222 23
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 243 PDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
+. .+++++.++|.+||+.||++|| .|+|+.+..+
T Consensus 237 ~~--~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 237 PY--RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp CT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred Cc--ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 33 6899999999999999999999 9999987654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=300.78 Aligned_cols=244 Identities=27% Similarity=0.431 Sum_probs=197.2
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc--------HHHHHHHHHhhhCCCCCeeeeceEEecC
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--------ENVQREIINHRSLRHPNIVRFKEVILTP 89 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 89 (280)
...++|++.+.||+|+||.||++++..+++.||+|.+....... +.+.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 35589999999999999999999999999999999986543221 5688999999999999999999998765
Q ss_pred CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEeCCCC---CcEEEeec
Q 023591 90 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPA---PRLKICDF 163 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~ni~i~~~~~---~~~~l~df 163 (280)
. ++||||+++++|.+.+... ..+++..++.++.|++.||++||+.| ++|+||+|+||+++.++. ..++|+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 5 6999999999998887554 47999999999999999999999999 999999999999976543 23899999
Q ss_pred CCccccccCCCCCCCcCCCcccCcccccC--CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccccc
Q 023591 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241 (280)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
|++..... ......+++.|+|||.+.. ..+ +.++||||||+++|+|++|..||.......... ...+......
T Consensus 174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~ 248 (287)
T 4f0f_A 174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--INMIREEGLR 248 (287)
T ss_dssp TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEE-CHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH--HHHHHHSCCC
T ss_pred Cccccccc--cccccCCCccccCchhhccCCCCc-CchhhHHHHHHHHHHHHcCCCCCccccccHHHH--HHHHhccCCC
Confidence 99873322 2344568899999999843 333 445999999999999999999998765433221 1222222222
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 242 IPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
......+++++.+||.+||+.||++||
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rp 275 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRP 275 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCc
Confidence 222336899999999999999999999
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=325.25 Aligned_cols=251 Identities=16% Similarity=0.143 Sum_probs=184.7
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc----ccHHHHHHHHHhhhC--CCCCeeeec-------eEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL--RHPNIVRFK-------EVI 86 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l--~h~~iv~~~-------~~~ 86 (280)
..+|++.+.||+|+||.||++++..+++.||+|++..... ..+.+.+|+.+++.+ +|||+++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4569999999999999999999999999999999987543 234556774444444 799987754 444
Q ss_pred ecC-----------------CeEEEEEeccCCCchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhcCceecC
Q 023591 87 LTP-----------------THLAIVMEYASGGELFERICNA-GRFSEDEA------RFFFQQLISGVSYCHSMQVCHRD 142 (280)
Q Consensus 87 ~~~-----------------~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~------~~~~~~i~~~l~~Lh~~~i~h~d 142 (280)
..+ ...++||||++ ++|.+++... ..++.... ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 432 34899999998 7999999763 33455555 67779999999999999999999
Q ss_pred CCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcCCCcccCcccccC--CcCCCccchhhHHHHHHHHHHhCCCCCC
Q 023591 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (280)
Q Consensus 143 l~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~ 220 (280)
|||+||+++.++. +||+|||++...... .....+++.|+|||.+.+ ..++ .++||||||+++|+|++|..||.
T Consensus 220 ikp~NIll~~~~~--~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFIMPDGR--LMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFT-HALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEECTTSC--EEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECC-HHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEECCCCC--EEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcC-ccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999998887 999999998744321 114456699999999976 4554 55999999999999999999998
Q ss_pred CCCCcchH--HH-HHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 221 DPEEPKNF--RK-TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 221 ~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
........ .. ...........++....+++.+.+||.+||+.||++|| .||||++.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 76432110 00 00111122334444457899999999999999999999 99999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=315.16 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=199.0
Q ss_pred CCCCeeeecccccCCceEEEEEEec-------CCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhC-CCCCeeeeceEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 88 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 88 (280)
..++|++.+.||+|+||.||++++. .++..||+|.+..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4579999999999999999999874 3456799999876432 335688999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC
Q 023591 89 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~ 152 (280)
++.+++||||+++++|.+++.... .++...++.++.||+.||+|||++|++||||||+||+++.
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 238 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence 999999999999999999997643 4789999999999999999999999999999999999998
Q ss_pred CCCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchH
Q 023591 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (280)
Q Consensus 153 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~ 228 (280)
++. +||+|||++........ .....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||.........
T Consensus 239 ~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 239 NNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp TCC--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCC--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 887 99999999874433221 223345678999999988777655 999999999999999 99999876543333
Q ss_pred HHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
...... .....+ ..+++++.++|.+||+.||++||
T Consensus 316 ~~~~~~---~~~~~~--~~~~~~l~~li~~~l~~dP~~Rp 350 (370)
T 2psq_A 316 KLLKEG---HRMDKP--ANCTNELYMMMRDCWHAVPSQRP 350 (370)
T ss_dssp HHHHTT---CCCCCC--TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhcC---CCCCCC--CCCCHHHHHHHHHHcCCChhhCc
Confidence 222111 112222 36889999999999999999999
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=312.15 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=202.6
Q ss_pred CCCCCCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEE--EEEEeeeC--CcccHHHHHHHHHhhhC-CCCCeeeec
Q 023591 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELV--AVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFK 83 (280)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v--aiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~ 83 (280)
++....-.....++|++.+.||+|+||.||++++..++..+ ++|.+... ....+.+.+|+.+++++ +||||++++
T Consensus 13 ~~~~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 92 (327)
T 1fvr_A 13 NPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92 (327)
T ss_dssp ---CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred CCCCcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhc
Confidence 34334444456689999999999999999999998888755 89988753 33445688999999999 999999999
Q ss_pred eEEecCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCc
Q 023591 84 EVILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147 (280)
Q Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~n 147 (280)
+++.+++..++||||+++++|.+++.... .+++..++.++.||+.||.+||+.|++|+||+|+|
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 172 (327)
T 1fvr_A 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 172 (327)
T ss_dssp EEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred eeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccce
Confidence 99999999999999999999999997654 69999999999999999999999999999999999
Q ss_pred EEEeCCCCCcEEEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcc
Q 023591 148 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (280)
Q Consensus 148 i~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~ 226 (280)
|+++.++. ++|+|||++.............+++.|+|||.+.+..++.. +||||||+++|+|++ |..||.......
T Consensus 173 Il~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~ 249 (327)
T 1fvr_A 173 ILVGENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAE 249 (327)
T ss_dssp EEECGGGC--EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred EEEcCCCe--EEEcccCcCccccccccccCCCCCccccChhhhccccCCch-hcchHHHHHHHHHHcCCCCCCCCCcHHH
Confidence 99988776 99999999875444444445566788999999977776555 999999999999998 999997754322
Q ss_pred hHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....+.. .........+++++.+||.+||+.||.+||
T Consensus 250 ----~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 286 (327)
T 1fvr_A 250 ----LYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERP 286 (327)
T ss_dssp ----HHHHGGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSC
T ss_pred ----HHHHhhc-CCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 2222222 222223336899999999999999999999
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=323.61 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=199.5
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC--------CCCeeeeceEEe----
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--------HPNIVRFKEVIL---- 87 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~---- 87 (280)
.++|++.+.||+|+||.||++++..+++.||+|++.......+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 47999999999999999999999999999999999876666677889999998885 788999999987
Q ss_pred cCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEeCCCC---------
Q 023591 88 TPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPA--------- 155 (280)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~ni~i~~~~~--------- 155 (280)
.....++||||+ +++|.+.+... ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 456899999999 45666666443 4699999999999999999999998 9999999999999986641
Q ss_pred --------------------------------------CcEEEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCC
Q 023591 156 --------------------------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197 (280)
Q Consensus 156 --------------------------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 197 (280)
.+++|+|||++..... ......+++.|+|||.+.+..++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 272 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYNT 272 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCCT
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCCc
Confidence 2499999999875432 234456899999999998888766
Q ss_pred ccchhhHHHHHHHHHHhCCCCCCCCCCcch------HHHHHhhHhcc--------ccc----------------------
Q 023591 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKN------FRKTIHRILSV--------QYS---------------------- 241 (280)
Q Consensus 198 ~~~DiwslG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~--------~~~---------------------- 241 (280)
. +||||||+++|+|++|..||........ ........... .+.
T Consensus 273 ~-~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (397)
T 1wak_A 273 P-ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351 (397)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred H-HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence 5 9999999999999999999986553221 11111100000 000
Q ss_pred ------CCCCCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 242 ------IPDYVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 242 ------~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
+......++++.+||.+||+.||++|| .||||++
T Consensus 352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000012346789999999999999999 9999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=314.62 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=182.8
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc--cHHHHHHHH-HhhhCCCCCeeeeceEEecCCeEE
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREII-NHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
....++|++.+.||+|+||.||++.+..+++.||+|.+...... ...+.+|+. +++.++||||+++++++..++..+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 34568999999999999999999999999999999999765322 234445555 667789999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 94 IVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
+||||+++ +|.+++.. ...+++..++.++.|++.||.+||+. |++|+||+|+||+++.++. +||+|||++.
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~ 174 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGISG 174 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSSSC
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCCce
Confidence 99999975 88877753 56799999999999999999999999 9999999999999998876 9999999987
Q ss_pred ccccCCCCCCCcCCCcccCccccc----CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc-ccC
Q 023591 168 SSVLHSQPKSTVGTPAYIAPEVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSI 242 (280)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 242 (280)
............+++.|+|||.+. +..++. ++||||||+++|+|++|..||...... ......+.... ..+
T Consensus 175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDV-RSDVWSLGITLYELATGRFPYPKWNSV---FDQLTQVVKGDPPQL 250 (327)
T ss_dssp C------------------------------CCS-HHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCC
T ss_pred ecccccccccCCCCccccCceeeccccCcCCCCc-hhhHHHHHHHHHHHHHCCCCCCCcchH---HHHHHHHhcCCCCCC
Confidence 655444444457889999999983 444544 499999999999999999999764321 11111111111 111
Q ss_pred C--CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 243 P--DYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 243 ~--~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+ ....+++++.+||.+||+.||++|| .||||.+.
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 1 1235899999999999999999999 99999753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=310.44 Aligned_cols=245 Identities=23% Similarity=0.255 Sum_probs=200.3
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
..++|++.+.||+|+||.||++++..+++.||+|++.... ..+.+.+|+.+++++ +|+||+++++++..+...++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 3578999999999999999999999999999999987643 345688999999999 99999999999999999999999
Q ss_pred ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC---CcEEEeecCCccccccCC
Q 023591 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 98 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~---~~~~l~df~~~~~~~~~~ 173 (280)
|+ +++|.+++.. ...+++..++.++.|++.||+|||+.|++||||||+||+++.++. ..++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99 8899999876 467999999999999999999999999999999999999986653 239999999997543322
Q ss_pred C--------CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC-
Q 023591 174 Q--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD- 244 (280)
Q Consensus 174 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 244 (280)
. .....+++.|+|||.+.+..++.. +||||||+++|+|++|..||........ ......+.......+.
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRR-DDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIGDTKRATPIE 242 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHHHHHHHSCHH
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCch-hHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHHhhhccCCHH
Confidence 2 235568999999999988777555 9999999999999999999987654322 2222222222211111
Q ss_pred --CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 245 --YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 245 --~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....+ ++.+++.+||+.||.+||
T Consensus 243 ~~~~~~p-~~~~li~~~l~~~p~~RP 267 (330)
T 2izr_A 243 VLCENFP-EMATYLRYVRRLDFFEKP 267 (330)
T ss_dssp HHTTTCH-HHHHHHHHHHHCCTTCCC
T ss_pred HHhccCh-HHHHHHHHHHhCCCCCCC
Confidence 11244 999999999999999999
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=306.70 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=196.5
Q ss_pred CCCCCCCeeeecccccCCceEEEEEE----ecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecC-
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP- 89 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 89 (280)
.....++|++.+.||+|+||.||+++ +..+++.||+|++.... ...+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 34466899999999999999999998 56788999999987643 2335688999999999999999999998653
Q ss_pred -CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 90 -THLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 90 -~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
..+++||||+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~ 162 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTK 162 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCcccc
Confidence 46899999999999999997654 5999999999999999999999999999999999999998876 9999999987
Q ss_pred ccccCCC----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc-----------chHHHHH
Q 023591 168 SSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----------KNFRKTI 232 (280)
Q Consensus 168 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----------~~~~~~~ 232 (280)
....... .....++..|+|||.+.+..++.. +||||||+++|+|++|..||...... .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChH-HHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 5433221 223345667999999988877555 99999999999999999998653210 0011111
Q ss_pred hhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..........+....+++++.+||.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 277 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 277 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCC
Confidence 111222223333347899999999999999999999
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=313.43 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=199.4
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCe-----
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH----- 91 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 91 (280)
.++|++.+.||+|+||.||++.+..+|+.||+|.+..... ..+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 4789999999999999999999999999999999876432 23567789999999999999999999987653
Q ss_pred -EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 92 -LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 92 -~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
.+++|||+. ++|.+++. ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD 177 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC--
T ss_pred eEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCC
Confidence 599999997 58887764 35999999999999999999999999999999999999998877 9999999987433
Q ss_pred cCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc------------
Q 023591 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------ 238 (280)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 238 (280)
. ......+++.|+|||.+.+......++||||||+++|+|++|..||...+...............
T Consensus 178 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 178 A--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred C--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 2 22345678999999998774444455999999999999999999998765433333322211100
Q ss_pred ------------cccCC-CCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 239 ------------QYSIP-DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 239 ------------~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
...+. ....+++++.+||.+||+.||++|| .||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 00111 1235789999999999999999999 999998643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=312.21 Aligned_cols=243 Identities=30% Similarity=0.497 Sum_probs=198.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-------ccHHHHHHHHHhhhC----CCCCeeeeceEEe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSL----RHPNIVRFKEVIL 87 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l----~h~~iv~~~~~~~ 87 (280)
..++|++.+.||+|+||.||++++..+++.||+|++..... ....+.+|+.+++++ +|+||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 35789999999999999999999999999999999876432 123355688888888 8999999999999
Q ss_pred cCCeEEEEEec-cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEe-CCCCCcEEEeecCC
Q 023591 88 TPTHLAIVMEY-ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGY 165 (280)
Q Consensus 88 ~~~~~~lv~e~-~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~-~~~~~~~~l~df~~ 165 (280)
..+..++++|+ +.+++|.+++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++ .++. ++|+|||+
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~--~kl~dfg~ 186 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--AKLIDFGS 186 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE--EEECCCSS
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe--EEEEEcch
Confidence 88899999999 78899999998888899999999999999999999999999999999999998 5665 99999999
Q ss_pred ccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCC
Q 023591 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245 (280)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (280)
+...... ......+++.|+|||.+.+..+...++||||||+++|+|++|..||.... . +......++.
T Consensus 187 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~----~~~~~~~~~~- 254 (312)
T 2iwi_A 187 GALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------E----ILEAELHFPA- 254 (312)
T ss_dssp CEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHTCCCCCT-
T ss_pred hhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------H----HhhhccCCcc-
Confidence 8754432 23345688999999999877776656999999999999999999996421 1 1222333443
Q ss_pred CCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 246 VHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.+++++.+||.+||+.||++|| .||||++.
T Consensus 255 -~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 255 -HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp -TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred -cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 6899999999999999999999 99999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=312.58 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=201.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCC-cEEEEEEeeeCCcccHHHHHHHHHhhhCCCCC------eeeeceEEecCCe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKEVILTPTH 91 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~ 91 (280)
..++|++.+.||+|+||.||++.+..++ +.||+|++.......+.+.+|+.++++++|++ ++.+.+++.....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 3589999999999999999999998776 68999999876656677888999999886655 8899999999999
Q ss_pred EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC----------------
Q 023591 92 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS---------------- 153 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~---------------- 153 (280)
.++||||+ ++++.+.+... ..+++..++.++.||+.||+|||+.|++|+||||+||+++..
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 99999999 55777776554 369999999999999999999999999999999999999432
Q ss_pred -CCCcEEEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHH
Q 023591 154 -PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (280)
Q Consensus 154 -~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (280)
....++|+|||++.... .......+++.|+|||.+.+..++.. +||||||+++|+|++|..||.............
T Consensus 176 ~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252 (355)
T ss_dssp ESCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cCCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 22349999999987432 23345578999999999988887665 999999999999999999998765433332222
Q ss_pred hhHhcccc--------------------------------------cCCCCCCCCHHHHHHHHHhcccCCCCcC------
Q 023591 233 HRILSVQY--------------------------------------SIPDYVHISPECRHLISRIFVADPAKSE------ 268 (280)
Q Consensus 233 ~~~~~~~~--------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rp------ 268 (280)
........ ........+.++.+||.+||+.||++||
T Consensus 253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL 332 (355)
T ss_dssp HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 21110000 0001112245799999999999999999
Q ss_pred CCccccccc
Q 023591 269 MHDWRRGCS 277 (280)
Q Consensus 269 ~h~~~~~~~ 277 (280)
.||||++..
T Consensus 333 ~hp~f~~~~ 341 (355)
T 2eu9_A 333 LHPFFAGLT 341 (355)
T ss_dssp TSGGGGGCC
T ss_pred cChhhcCCC
Confidence 999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=302.12 Aligned_cols=246 Identities=21% Similarity=0.237 Sum_probs=201.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
..++|++.+.||+|+||.||++.+..+++.||+|++.... ..+.+.+|+..++++ +|+|++++++++......++|||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 4578999999999999999999999999999999886543 445688899999999 89999999999999999999999
Q ss_pred ccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC---CcEEEeecCCccccccCC
Q 023591 98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~---~~~~l~df~~~~~~~~~~ 173 (280)
|+ +++|.+++.... ++++..++.++.|++.||++||+.|++|+||+|+||+++.++. ..++|+|||++.......
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99 889999997654 6999999999999999999999999999999999999976542 349999999987544332
Q ss_pred C--------CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC--
Q 023591 174 Q--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP-- 243 (280)
Q Consensus 174 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 243 (280)
. .....+++.|+|||.+.+..++.. +||||||+++|+|++|..||.......... ....+.......+
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYERIGEKKQSTPLR 243 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHHHHHHHHHSCHH
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHcCCCCcchhhccccHH-HHHHHHhhccCccHH
Confidence 2 244568999999999988777554 999999999999999999998765432221 1111111111111
Q ss_pred -CCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 244 -DYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 244 -~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....+++++.++|.+||+.||++||
T Consensus 244 ~~~~~~~~~l~~li~~~l~~dp~~RP 269 (298)
T 1csn_A 244 ELCAGFPEEFYKYMHYARNLAFDATP 269 (298)
T ss_dssp HHTTTSCHHHHHHHHHHHHCCTTCCC
T ss_pred HHHhhCcHHHHHHHHHHhcCCcccCC
Confidence 1125889999999999999999999
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=305.53 Aligned_cols=251 Identities=26% Similarity=0.395 Sum_probs=187.0
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc---HHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
..++|++.+.||+|+||.||++++..+++.||+|++....... +.+.++..+++.++||||+++++++..+...++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 5578999999999999999999999999999999997654322 2233444567778999999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
|||+ ++.+..+... ...+++..++.++.|++.||.+||+. |++|+||+|+||+++.++. ++|+|||++.......
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC-------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccCCc
Confidence 9999 5566655543 56799999999999999999999995 9999999999999998887 9999999987555444
Q ss_pred CCCCCcCCCcccCccccc-----CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHh-cccccCCCCCC
Q 023591 174 QPKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-SVQYSIPDYVH 247 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~-----~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 247 (280)
......+++.|+|||.+. ...++ .++||||||+++|+|++|..||........ ....+. .....++....
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~ 255 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFE---VLTKVLQEEPPLLPGHMG 255 (318)
T ss_dssp -------CCTTCCHHHHC--------CC-THHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHHSCCCCCCSSSC
T ss_pred cccccCCCccccChhhcccccccccCCc-cccchhhHHHHHHHHHhCCCCCCCCCccHH---HHHHHhccCCCCCCccCC
Confidence 445567899999999985 33444 459999999999999999999986543222 222222 22223344446
Q ss_pred CCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 248 ISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+++++.+||.+||+.||.+|| .||||++.
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 899999999999999999999 99999753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=306.30 Aligned_cols=243 Identities=22% Similarity=0.332 Sum_probs=200.3
Q ss_pred CCCCCeeeecccccCCceEEEEEEec-----CCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCC
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 90 (280)
...++|++.+.||+|+||.||++.+. .++..||+|.+.... ...+.+.+|+.++++++||||+++++++..++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 35689999999999999999999873 455889999987543 22356788999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCC
Q 023591 91 HLAIVMEYASGGELFERICNAGR------------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~------------------------l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ 146 (280)
..++||||+++++|.+++..... +++..++.++.||+.||.+||++|++|+||+|+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 179 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence 99999999999999999976543 899999999999999999999999999999999
Q ss_pred cEEEeCCCCCcEEEeecCCccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCC
Q 023591 147 NTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDP 222 (280)
Q Consensus 147 ni~i~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~ 222 (280)
||+++.++. ++|+|||++....... ......+++.|+|||.+.+..++.. +||||||+++|+|++ |..||...
T Consensus 180 NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 180 NILVAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GEEEETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCch-hhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999998876 9999999987443322 1233446778999999987777555 999999999999999 99999876
Q ss_pred CCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 223 EEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
........... . ...+....+++++.++|.+||+.||++||
T Consensus 257 ~~~~~~~~~~~----~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 297 (314)
T 2ivs_A 257 PPERLFNLLKT----G-HRMERPDNCSEEMYRLMLQCWKQEPDKRP 297 (314)
T ss_dssp CGGGHHHHHHT----T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CHHHHHHHhhc----C-CcCCCCccCCHHHHHHHHHHccCChhhCc
Confidence 55333222211 1 11222236899999999999999999999
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=319.25 Aligned_cols=244 Identities=25% Similarity=0.350 Sum_probs=200.5
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
....++|++.+.||+|+||.||++.+..+++.||+|.+..... ..+.+.+|+.++++++||||+++++++..+...++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 3456899999999999999999999998999999999875422 22457789999999999999999999998889999
Q ss_pred EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
||||+++++|.+++...+ .++...+..++.|++.||+|||+.|++||||+|+||+++.++. +||+|||++.......
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGV 267 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTTSE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCCCc
Confidence 999999999999987643 6999999999999999999999999999999999999998877 9999999987432221
Q ss_pred C---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 174 Q---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 174 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
. .....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||.......... .+. .....+....++
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~t~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~ 341 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTRE----FVE-KGGRLPCPELCP 341 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH----HHH-TTCCCCCCTTCC
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHH-cCCCCCCCCCCC
Confidence 1 112234567999999987777555 999999999999998 999998755322211 111 122233333689
Q ss_pred HHHHHHHHHhcccCCCCcC
Q 023591 250 PECRHLISRIFVADPAKSE 268 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp 268 (280)
+++.+||.+||+.||++||
T Consensus 342 ~~l~~li~~cl~~dP~~Rp 360 (377)
T 3cbl_A 342 DAVFRLMEQCWAYEPGQRP 360 (377)
T ss_dssp HHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHcCCCchhCc
Confidence 9999999999999999999
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=299.42 Aligned_cols=242 Identities=24% Similarity=0.408 Sum_probs=202.7
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
...++|++.+.||+|+||.||++.+. +++.||+|.+.......+.+.+|+.++++++||||+++++++..++..+++||
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 45689999999999999999999986 56789999998877667889999999999999999999999999899999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC--CC
Q 023591 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQ 174 (280)
Q Consensus 98 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~--~~ 174 (280)
|+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ..
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHS
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEcccccccccccccccc
Confidence 99999999998765 46899999999999999999999999999999999999988777 999999998744321 12
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
.....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||......... ..+... .........++.+.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~----~~i~~~-~~~~~~~~~~~~l~ 235 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVV----EDISTG-FRLYKPRLASTHVY 235 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHTT-CCCCCCTTSCHHHH
T ss_pred cccccccccccChhhhcCCCccch-hchhhhHHHHHHHhccCCCCCCCCCHHHHH----HHHhcC-CcCCCCccCcHHHH
Confidence 233446778999999987777544 999999999999999 89999875433222 222222 11222236789999
Q ss_pred HHHHHhcccCCCCcC
Q 023591 254 HLISRIFVADPAKSE 268 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp 268 (280)
+++.+||+.||++||
T Consensus 236 ~li~~~l~~~p~~Rp 250 (267)
T 3t9t_A 236 QIMNHCWRERPEDRP 250 (267)
T ss_dssp HHHHHHTCSSGGGSC
T ss_pred HHHHHHccCChhhCc
Confidence 999999999999999
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=298.24 Aligned_cols=242 Identities=29% Similarity=0.406 Sum_probs=189.7
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
...++|++.+.||+|+||.||++.+. ++.||+|++.... ...+.+.+|+.+++.++||||+++++++..+...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 34689999999999999999999985 7889999987542 2236788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---ceecCCCCCcEEEeCC------CCCcEEEeec
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ---VCHRDLKLENTLLDGS------PAPRLKICDF 163 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~---i~h~dl~~~ni~i~~~------~~~~~~l~df 163 (280)
++||||+++++|.+++. ...+++..++.++.|++.||.+||+.| ++|+||+|+||+++.. ....++|+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999998884 457999999999999999999999999 8999999999999862 1334999999
Q ss_pred CCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC
Q 023591 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243 (280)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (280)
|++....... .....+++.|+|||.+.+..++.. +||||||+++|+|++|..||........ ...........+
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~ 234 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAV----AYGVAMNKLALP 234 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCCCSHH-HHHHHHHHHHHHHHHCCCTTTTSCHHHH----HHHHHTSCCCCC
T ss_pred Cccccccccc-ccCCCCccceeCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHhhhcCCCCCC
Confidence 9987443322 234568899999999987776554 9999999999999999999987543222 222223333333
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 244 DYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....+++.+.++|.+||+.||++||
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rp 259 (271)
T 3dtc_A 235 IPSTCPEPFAKLMEDCWNPDPHSRP 259 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCcccCHHHHHHHHHHhcCCcccCc
Confidence 3347899999999999999999999
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=298.55 Aligned_cols=241 Identities=21% Similarity=0.289 Sum_probs=198.7
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecC--C
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--T 90 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~ 90 (280)
.....++|++.+.||+|+||.||++++. ++.||+|++..... ..+.+.+|+.++++++||||+++++++... .
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 4456789999999999999999999985 78899999876532 234678899999999999999999999877 7
Q ss_pred eEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEeCCCCCcEEEeecCCc
Q 023591 91 HLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~ni~i~~~~~~~~~l~df~~~ 166 (280)
..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++. +++.||+++
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~ 160 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVK 160 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSC
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccce
Confidence 8899999999999999998765 4899999999999999999999999 999999999999998887 888887765
Q ss_pred cccccCCCCCCCcCCCcccCcccccCCcCCCc--cchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC
Q 023591 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK--IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (280)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~--~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (280)
.. .......+++.|+|||.+.+...... ++||||||+++|+|++|..||.......... .+.........
T Consensus 161 ~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~ 232 (271)
T 3kmu_A 161 FS----FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM----KVALEGLRPTI 232 (271)
T ss_dssp CT----TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH----HHHHSCCCCCC
T ss_pred ee----ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH----HHHhcCCCCCC
Confidence 43 22234567899999999987655442 5999999999999999999998755432222 22222222222
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 245 YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
...+++++.++|.+||+.||++||
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp 256 (271)
T 3kmu_A 233 PPGISPHVSKLMKICMNEDPAKRP 256 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCCHHHHHHHHHHcCCChhhCc
Confidence 336899999999999999999999
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=300.59 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=198.2
Q ss_pred CCCCeeeecccccCCceEEEEEE----ecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecC--C
Q 023591 19 DSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP--T 90 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~ 90 (280)
..++|++.+.||+|+||.||+++ +..+++.||+|++.... ...+.+.+|+.++++++||||+++++++..+ .
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 45779999999999999999999 56789999999987543 3346788999999999999999999999876 6
Q ss_pred eEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 91 HLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
..++||||+++++|.+++.. ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAI 176 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEEC
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECcccccccc
Confidence 78999999999999999954 457999999999999999999999999999999999999998876 999999998754
Q ss_pred ccCC----CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCC-----------CcchHHHHHhh
Q 023591 170 VLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-----------EPKNFRKTIHR 234 (280)
Q Consensus 170 ~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-----------~~~~~~~~~~~ 234 (280)
.... ......++..|+|||.+.+..++.. +||||||+++|+|++|..|+.... ...........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcc-hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 4332 2334457778999999988777655 999999999999999998864321 11112222222
Q ss_pred HhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 235 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.......+....+++++.+||.+||+.||.+||
T Consensus 256 -~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 288 (302)
T 4e5w_A 256 -LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRT 288 (302)
T ss_dssp -HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred -HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCC
Confidence 222223333347899999999999999999999
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=316.50 Aligned_cols=238 Identities=26% Similarity=0.389 Sum_probs=198.9
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCC-eEEEEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVM 96 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~ 96 (280)
...++|++.+.||+|+||.||++.+. ++.||+|.+.... ..+.+.+|+.++++++||||+++++++.... ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 45689999999999999999999885 6789999987654 5678899999999999999999999987654 799999
Q ss_pred eccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 97 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
||+++++|.+++...+. +++..+..++.||+.||+|||++|++||||+|+||+++.++. +||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST-- 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC----
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCccccccc--
Confidence 99999999999976543 799999999999999999999999999999999999998877 999999998743322
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
.....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||......+....... ....+....+++++.
T Consensus 343 ~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-----~~~~~~p~~~~~~l~ 416 (450)
T 1k9a_A 343 QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-----GYKMDAPDGCPPAVY 416 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT-----TCCCCCCTTCCHHHH
T ss_pred ccCCCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCCcCCHHHH
Confidence 223356788999999988877655 999999999999998 9999987665443333222 122223337899999
Q ss_pred HHHHHhcccCCCCcC
Q 023591 254 HLISRIFVADPAKSE 268 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp 268 (280)
+||.+||+.||++||
T Consensus 417 ~li~~cl~~dp~~Rp 431 (450)
T 1k9a_A 417 DVMKNCWHLDAATRP 431 (450)
T ss_dssp HHHHHHTCSSGGGSC
T ss_pred HHHHHHcCCChhHCc
Confidence 999999999999999
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=312.81 Aligned_cols=248 Identities=19% Similarity=0.207 Sum_probs=192.6
Q ss_pred CCCCeeeecccccCCceEEEEEEecC---CCcEEEEEEeeeCCc------------ccHHHHHHHHHhhhCCCCCeeeec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDK------------IDENVQREIINHRSLRHPNIVRFK 83 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~------------~~~~~~~e~~~l~~l~h~~iv~~~ 83 (280)
..++|++.+.||+|+||.||++.+.. ++..+|+|++..... ....+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 34789999999999999999999987 788999999876532 123456788888999999999999
Q ss_pred eEEec----CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEE
Q 023591 84 EVILT----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (280)
Q Consensus 84 ~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~ 159 (280)
+++.. ....++||||+ +++|.+++...+.+++..++.++.||+.||+|||+.|++||||+|+||+++.++...++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99987 67899999999 88999999877789999999999999999999999999999999999999988744599
Q ss_pred EeecCCccccccCCCC--------CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcch-HHH
Q 023591 160 ICDFGYSKSSVLHSQP--------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRK 230 (280)
Q Consensus 160 l~df~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~ 230 (280)
|+|||++......... ....+++.|+|||.+.+..++.. +||||||+++|+|++|..||........ ...
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR-SDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 9999999754332211 34468999999999988776555 9999999999999999999965332222 222
Q ss_pred HHhhHhcccc----cCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 231 TIHRILSVQY----SIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 231 ~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.......... .......+++++.++|.+||+.||++||
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 314 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKP 314 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCC
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCC
Confidence 2111111100 1111125889999999999999999999
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=311.60 Aligned_cols=243 Identities=23% Similarity=0.345 Sum_probs=199.4
Q ss_pred CCCCCeeeecccccCCceEEEEEEecC-------CCcEEEEEEeeeCCc--ccHHHHHHHHHhhhC-CCCCeeeeceEEe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 87 (280)
...++|++.+.||+|+||.||++++.. .+..||+|++..... ....+.+|+.+++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 345899999999999999999999753 335799999876432 235678999999999 9999999999999
Q ss_pred cCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEe
Q 023591 88 TPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (280)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~ 151 (280)
.++..++||||+++++|.+++.... .+++..++.++.||+.||++||+.|++||||||+||+++
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence 9999999999999999999997653 489999999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcch
Q 023591 152 GSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (280)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (280)
.++. +||+|||++....... ......+++.|+|||.+.+..++.. +||||||+++|+|++ |..||.......
T Consensus 226 ~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~ellt~g~~p~~~~~~~~- 301 (382)
T 3tt0_A 226 EDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEE- 301 (382)
T ss_dssp TTCC--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred CCCc--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 8877 9999999987543322 2233345678999999988777655 999999999999999 999998654322
Q ss_pred HHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 228 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....+... ........+++++.+||.+||+.||++||
T Consensus 302 ---~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 338 (382)
T 3tt0_A 302 ---LFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRP 338 (382)
T ss_dssp ---HHHHHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSC
T ss_pred ---HHHHHHcC-CCCCCCccCCHHHHHHHHHHcCCChhhCc
Confidence 22222222 12222236899999999999999999999
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=312.10 Aligned_cols=242 Identities=25% Similarity=0.396 Sum_probs=199.9
Q ss_pred CCCCCeeeecccccCCceEEEEEEec-----CCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCC
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 90 (280)
...++|++.+.||+|+||.||++++. .+++.||+|.+..... ..+.+.+|+.++++++||||+++++++..+.
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 35589999999999999999999987 3458899999876432 2356889999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCC
Q 023591 91 HLAIVMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~------------------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ 146 (280)
..++||||+++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 999999999999999998763 56899999999999999999999999999999999
Q ss_pred cEEEeCCCCCcEEEeecCCccccccC---CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCC
Q 023591 147 NTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDP 222 (280)
Q Consensus 147 ni~i~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~ 222 (280)
||+++.++. ++|+|||++...... .......+++.|+|||.+.+..++.. +||||||+++|+|++ |..||...
T Consensus 204 NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 204 NCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp GEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred eEEECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcc-cccHHHHHHHHHHHhcCCCcCCCC
Confidence 999998877 999999998643322 22234457888999999987777555 999999999999999 99999875
Q ss_pred CCcchHHHHHhhHhcccc-cCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 223 EEPKNFRKTIHRILSVQY-SIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.... ....+..... ..+. .+++++.+||.+||+.||++||
T Consensus 281 ~~~~----~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rp 321 (343)
T 1luf_A 281 AHEE----VIYYVRDGNILACPE--NCPLELYNLMRLCWSKLPADRP 321 (343)
T ss_dssp CHHH----HHHHHHTTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSC
T ss_pred ChHH----HHHHHhCCCcCCCCC--CCCHHHHHHHHHHcccCcccCC
Confidence 4332 2222222222 2233 6899999999999999999999
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=309.37 Aligned_cols=248 Identities=21% Similarity=0.238 Sum_probs=195.0
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCC----e
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----H 91 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~ 91 (280)
.....++|++.+.||+|+||.||++++. ++.||+|++...........+|+.++++++||||+++++++.... .
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 3456689999999999999999999885 788999999876655566677899999999999999999998743 4
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc----------CceecCCCCCcEEEeCCCCCcEEEe
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM----------QVCHRDLKLENTLLDGSPAPRLKIC 161 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~----------~i~h~dl~~~ni~i~~~~~~~~~l~ 161 (280)
+++||||+++++|.+++.. ..+++..++.++.|++.||+|||+. |++|+||||+||+++.++. +||+
T Consensus 97 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~ 173 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIA 173 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC--EEEC
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe--EEEc
Confidence 7999999999999999965 4599999999999999999999999 9999999999999998877 9999
Q ss_pred ecCCccccccCCC---CCCCcCCCcccCcccccCCcC----CCccchhhHHHHHHHHHHhCCCCCCCCCCcc--------
Q 023591 162 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-------- 226 (280)
Q Consensus 162 df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~----~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-------- 226 (280)
|||++........ .....+++.|+|||.+.+... .+.++||||||+++|+|++|..||....+..
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999975443322 233568999999999876322 2234899999999999999999997654321
Q ss_pred ----hHHHHHhhHhcccccCCC-----CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 227 ----NFRKTIHRILSVQYSIPD-----YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 227 ----~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.................. ....++++.+||.+||+.||++||
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 304 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCc
Confidence 111122222111111110 011234599999999999999999
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=301.33 Aligned_cols=245 Identities=28% Similarity=0.408 Sum_probs=191.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++..++..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 4578999999999999999999999999999999987532 233567789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 95 VMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFS 187 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCC-------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC--EEEEeccceeeec
Confidence 9999999999998864 456999999999999999999999999999999999999998876 9999999987443
Q ss_pred cCC-CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 171 LHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 171 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
... ......+++.|+|||.+.+..++.. +||||||+++|+|++|..||...... .......+....+.......++
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 264 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYS 264 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTC---CC--HHHHHHHHHTTCSCCCCTTTSC
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchh--HHHHHHHhhcccCCCCcccccC
Confidence 322 2234467889999999987777555 99999999999999999999764322 2222333333333222234689
Q ss_pred HHHHHHHHHhcccCCCCcC
Q 023591 250 PECRHLISRIFVADPAKSE 268 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp 268 (280)
+++.+||.+||+.||++||
T Consensus 265 ~~l~~li~~~l~~dp~~Rp 283 (310)
T 2wqm_A 265 EELRQLVNMCINPDPEKRP 283 (310)
T ss_dssp HHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHcCCChhhCC
Confidence 9999999999999999999
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=316.71 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=200.2
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC-----------CCCeeeeceEEe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVIL 87 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~ 87 (280)
..++|++.+.||+|+||.||++++..+++.||+|++.......+.+.+|+.++++++ |+||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 457999999999999999999999999999999999876555667888999988875 889999999987
Q ss_pred cCC----eEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CceecCCCCCcEEEeCCC----CC
Q 023591 88 TPT----HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSP----AP 156 (280)
Q Consensus 88 ~~~----~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~-~i~h~dl~~~ni~i~~~~----~~ 156 (280)
... ..+++||++ +++|.+++... ..+++..++.++.||+.||++||++ |++|+||||+||+++.++ ..
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 644 789999999 78999998763 4599999999999999999999998 999999999999996433 22
Q ss_pred cEEEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc------chHHH
Q 023591 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP------KNFRK 230 (280)
Q Consensus 157 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~------~~~~~ 230 (280)
.++|+|||++..... ......+++.|+|||.+.+..++.. +||||||+++|+|++|..||...... .....
T Consensus 176 ~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 252 (373)
T 1q8y_A 176 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252 (373)
T ss_dssp EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence 599999999875432 2344568999999999988877655 99999999999999999999865421 11111
Q ss_pred HHhhHhc--------------------------------------ccccCCCCCCCCHHHHHHHHHhcccCCCCcC----
Q 023591 231 TIHRILS--------------------------------------VQYSIPDYVHISPECRHLISRIFVADPAKSE---- 268 (280)
Q Consensus 231 ~~~~~~~--------------------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---- 268 (280)
....... ....++ ...++++.+||.+||+.||++||
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS--KDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC--HHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCC--cchHHHHHHHHHHHhccCccccCCHHH
Confidence 1111100 001111 13457899999999999999999
Q ss_pred --CCccccccc
Q 023591 269 --MHDWRRGCS 277 (280)
Q Consensus 269 --~h~~~~~~~ 277 (280)
.||||++..
T Consensus 331 ll~hp~f~~~~ 341 (373)
T 1q8y_A 331 LVNHPWLKDTL 341 (373)
T ss_dssp HHTCGGGTTCT
T ss_pred HhhChhhhccc
Confidence 999998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=315.23 Aligned_cols=244 Identities=20% Similarity=0.309 Sum_probs=197.2
Q ss_pred CCCCeeeecccccCCceEEEEEE-----ecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~-----~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
..++|++.+.||+|+||.||+++ +..+++.||+|.+.... .....+.+|+.++++++||||+++++++.....
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 34789999999999999999999 44567889999986532 233457789999999999999999999999889
Q ss_pred EEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-CCcEEEeec
Q 023591 92 LAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDF 163 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~-------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~~~~~l~df 163 (280)
.++||||+++++|.+++.... .++...++.++.||+.||+|||++|++||||||+||+++.++ ...+||+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 999999999999999997643 489999999999999999999999999999999999998544 234999999
Q ss_pred CCccccccC---CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhccc
Q 023591 164 GYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQ 239 (280)
Q Consensus 164 ~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 239 (280)
|++...... .......+++.|+|||.+.+..++.. +||||||+++|+|++ |..||....... ....+....
T Consensus 229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~pf~~~~~~~----~~~~i~~~~ 303 (367)
T 3l9p_A 229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEFVTSGG 303 (367)
T ss_dssp HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHHHHTTC
T ss_pred ccccccccccccccCCCcCCcccEECHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHcCC
Confidence 998643222 22334557889999999988777655 999999999999998 999998755432 222222222
Q ss_pred ccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 240 YSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.......+++.+.+||.+||+.||++||
T Consensus 304 -~~~~~~~~~~~l~~li~~~l~~dP~~Rp 331 (367)
T 3l9p_A 304 -RMDPPKNCPGPVYRIMTQCWQHQPEDRP 331 (367)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred -CCCCCccCCHHHHHHHHHHcCCCHhHCc
Confidence 1222236899999999999999999999
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=301.43 Aligned_cols=244 Identities=24% Similarity=0.335 Sum_probs=197.0
Q ss_pred CCCCCCCCeeeec-ccccCCceEEEEEE--ecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEec
Q 023591 15 PIMHDSDRYELVR-DIGSGNFGVARLMR--DKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT 88 (280)
Q Consensus 15 ~~~~~~~~y~~~~-~lg~G~~g~v~~~~--~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 88 (280)
......++|++.+ .||+|+||.||++. ...+++.||+|++..... ..+.+.+|+.++++++||||+++++++ .
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 3344568999999 99999999999995 456678999999876432 245688999999999999999999998 5
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
....++||||+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~ 166 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKA 166 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEE
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEccCCccee
Confidence 6678999999999999999988888999999999999999999999999999999999999998876 99999999874
Q ss_pred cccCCC----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcc-cccC
Q 023591 169 SVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV-QYSI 242 (280)
Q Consensus 169 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 242 (280)
...... .....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||........ ...+... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~~~~~~~~~~ 241 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEV----TAMLEKGERMGC 241 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHH----HHHHHTTCCCCC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCC
Confidence 433221 122335678999999987776554 999999999999999 9999987554222 2222221 1222
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 243 PDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
+ ..+++++.++|.+||+.||++||
T Consensus 242 ~--~~~~~~l~~li~~~l~~dp~~Rp 265 (291)
T 1xbb_A 242 P--AGCPREMYDLMNLCWTYDVENRP 265 (291)
T ss_dssp C--TTCCHHHHHHHHHHTCSSTTTSC
T ss_pred C--CCCCHHHHHHHHHHcCCChhhCc
Confidence 2 36899999999999999999999
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=319.85 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=200.7
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCC--eEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLA 93 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 93 (280)
...++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.... ..+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 34689999999999999999999999999999999987643 33466789999999999999999999988655 789
Q ss_pred EEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEe--CCCCCcEEEeecCCccc
Q 023591 94 IVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKS 168 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~--~~~~~~~~l~df~~~~~ 168 (280)
+||||+++++|.+++.... .+++..++.++.||+.||+|||+.|++||||||+||++. .++...+||+|||++..
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999999986543 399999999999999999999999999999999999982 22333499999999986
Q ss_pred cccCCCCCCCcCCCcccCcccccC--------CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc
Q 023591 169 SVLHSQPKSTVGTPAYIAPEVLLK--------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240 (280)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
...........+++.|+|||.+.+ ..+ +.++||||||+++|+|++|..||...............+.....
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred ccCCCccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 555555556678999999999865 333 34499999999999999999999765543333344433333221
Q ss_pred -------------------cCCCC----CCCCHHHHHHHHHhcccCCCCcC
Q 023591 241 -------------------SIPDY----VHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 241 -------------------~~~~~----~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..+.. ..+++.+.++|.+||+.||++||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~ 295 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhc
Confidence 11111 12446789999999999999999
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=308.58 Aligned_cols=244 Identities=24% Similarity=0.376 Sum_probs=200.3
Q ss_pred CCCCCeeeecccccCCceEEEEEEe-----cCCCcEEEEEEeeeC--CcccHHHHHHHHHhhhC-CCCCeeeeceEEecC
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 89 (280)
...++|++.+.||+|+||.||++.+ ..++..||+|.+... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457999999999999999999997 345678999998753 33456788999999999 999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCC
Q 023591 90 THLAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~-----------------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ 146 (280)
+..++||||+++++|.+++.... .+++..++.++.||+.||++||+.|++|+||+|+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 99999999999999999997643 2789999999999999999999999999999999
Q ss_pred cEEEeCCCCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCC
Q 023591 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDP 222 (280)
Q Consensus 147 ni~i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~ 222 (280)
||+++.++. ++|+|||++........ .....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||...
T Consensus 202 NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 202 NVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hEEEcCCCc--EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChh-HhHHHHHHHHHHHHcCCCCCcccC
Confidence 999998876 99999999875433322 123346778999999987777555 999999999999998 99999877
Q ss_pred CCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 223 EEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
............ ....+....+++++.+||.+||+.||.+||
T Consensus 279 ~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 320 (344)
T 1rjb_A 279 PVDANFYKLIQN----GFKMDQPFYATEEIYIIMQSCWAFDSRKRP 320 (344)
T ss_dssp CCSHHHHHHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CcHHHHHHHHhc----CCCCCCCCCCCHHHHHHHHHHcCCCchhCc
Confidence 654444433322 222222336899999999999999999999
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=322.58 Aligned_cols=242 Identities=21% Similarity=0.319 Sum_probs=205.3
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
..++|++.+.||+|+||.||++.+..++..||+|.+.......+.+.+|+.++++++||||+++++++..+..+++||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 45789999999999999999999998899999999988777778899999999999999999999999998999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC--C
Q 023591 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q 174 (280)
Q Consensus 99 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~--~ 174 (280)
+++++|.+++... ..+++..++.++.||+.||+|||++|++||||+|+||+++.++. +||+|||++....... .
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~ 375 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTA 375 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCCEEC
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCceee
Confidence 9999999999763 45899999999999999999999999999999999999988777 9999999987543221 1
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
.....++..|+|||.+.+..++.. +||||||+++|+|++ |..||............ ......+....+++++.
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~ 449 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-----EKDYRMERPEGCPEKVY 449 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-----HTTCCCCCCTTCCHHHH
T ss_pred cCCCcCCcceeCHhHHhcCCCCcH-HhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcCCCCCCCCCCCHHHH
Confidence 223345678999999987777655 999999999999999 99999876543322221 12223333347899999
Q ss_pred HHHHHhcccCCCCcC
Q 023591 254 HLISRIFVADPAKSE 268 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp 268 (280)
+||.+||+.||++||
T Consensus 450 ~li~~cl~~dP~~RP 464 (495)
T 1opk_A 450 ELMRACWQWNPSDRP 464 (495)
T ss_dssp HHHHHHTCSSGGGSC
T ss_pred HHHHHHcCcChhHCc
Confidence 999999999999999
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=312.70 Aligned_cols=244 Identities=23% Similarity=0.398 Sum_probs=199.7
Q ss_pred CCCCCeeeecccccCCceEEEEEE-----ecCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhC-CCCCeeeeceEEecC
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~-----~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 89 (280)
...++|++.+.||+|+||.||+++ +..+++.||+|.+..... ..+.+.+|+.+++++ +||||+++++++..+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 345899999999999999999999 556678999999976432 234688999999999 789999999998875
Q ss_pred C-eEEEEEeccCCCchHHHHHhcCC-------------------------------------------------------
Q 023591 90 T-HLAIVMEYASGGELFERICNAGR------------------------------------------------------- 113 (280)
Q Consensus 90 ~-~~~lv~e~~~~~~L~~~~~~~~~------------------------------------------------------- 113 (280)
+ ..++||||+++++|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 5 48999999999999999976432
Q ss_pred -----------CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC---CCCCc
Q 023591 114 -----------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTV 179 (280)
Q Consensus 114 -----------l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~---~~~~~ 179 (280)
+++..++.++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++........ .....
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC--CE
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhccccC
Confidence 899999999999999999999999999999999999998877 99999999874432221 23345
Q ss_pred CCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHH
Q 023591 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258 (280)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 258 (280)
+++.|+|||.+.+..++.. +||||||+++|+|++ |..||................ .....+ ..+++++.++|.+
T Consensus 257 ~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~l~~li~~ 331 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG--TRMRAP--DYTTPEMYQTMLD 331 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT--CCCCCC--TTCCHHHHHHHHH
T ss_pred CCceeEChhhhcCCCCCch-hhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC--CCCCCC--CCCCHHHHHHHHH
Confidence 6788999999988777655 999999999999998 999998766544443333221 122223 3688999999999
Q ss_pred hcccCCCCcC
Q 023591 259 IFVADPAKSE 268 (280)
Q Consensus 259 ~l~~dp~~Rp 268 (280)
||+.||.+||
T Consensus 332 ~l~~dP~~Rp 341 (359)
T 3vhe_A 332 CWHGEPSQRP 341 (359)
T ss_dssp HTCSSGGGSC
T ss_pred HccCChhhCC
Confidence 9999999999
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=303.79 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=198.6
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCC--CCCeeeeceEEecCCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR--HPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~ 93 (280)
..++|++.+.||+|+||.||++.+. +++.||+|++..... ..+.+.+|+.++++++ |+||+++++++..+...+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 4578999999999999999999986 488899999976432 2356788999999996 599999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
++||+ .+++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++. + .++|+|||++.......
T Consensus 105 lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~--~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 105 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCC-----
T ss_pred EEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C--eEEEeeccccccccCcc
Confidence 99995 47799999998889999999999999999999999999999999999999974 4 49999999987543322
Q ss_pred C---CCCCcCCCcccCcccccCC----------cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc
Q 023591 174 Q---PKSTVGTPAYIAPEVLLKK----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240 (280)
Q Consensus 174 ~---~~~~~~~~~~~aPE~~~~~----------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
. .....+++.|+|||.+.+. .....++||||||+++|+|++|..||....... ...........
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~ 257 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNH 257 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHHHHHCTTS
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---HHHHHHHhccc
Confidence 2 2344689999999998652 223445999999999999999999997654321 12222222222
Q ss_pred cCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 241 SIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
........++++.+||.+||+.||.+|| .||||+....
T Consensus 258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 2222235689999999999999999999 9999986543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=308.58 Aligned_cols=248 Identities=16% Similarity=0.196 Sum_probs=190.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCC-----CcEEEEEEeeeCCcc------------cHHHHHHHHHhhhCCCCCeee
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVR 81 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv~ 81 (280)
..++|++.+.||+|+||.||++.+..+ ++.||+|++...... ......|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345999999999999999999998764 578999998764321 122334555667778999999
Q ss_pred eceEEecC----CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCC
Q 023591 82 FKEVILTP----THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (280)
Q Consensus 82 ~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~ 156 (280)
+++++... ...++||||+ +++|.+++... ..+++..++.++.||+.||+|||+.|++||||||+||+++.+...
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998764 4589999999 88999999765 679999999999999999999999999999999999999943344
Q ss_pred cEEEeecCCccccccCCCC--------CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchH
Q 023591 157 RLKICDFGYSKSSVLHSQP--------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (280)
Q Consensus 157 ~~~l~df~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (280)
.++|+|||++......... ....+++.|+|||.+.+..++.. +||||||+++|+|++|..||.........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR-GDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 5999999999644332221 23348999999999988777555 99999999999999999999864433332
Q ss_pred HHHHhhHhcccc-----cCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 229 RKTIHRILSVQY-----SIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 229 ~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
............ .......+++++.+|+..||+.||.+||
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP 315 (364)
T 3op5_A 271 VRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKP 315 (364)
T ss_dssp HHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCC
T ss_pred HHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCC
Confidence 222211111100 0001136789999999999999999999
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=307.05 Aligned_cols=246 Identities=20% Similarity=0.340 Sum_probs=193.6
Q ss_pred CCCCCCCCCeeeecccccCCceEEEEEEecCCCcEE----EEEEeeeC--CcccHHHHHHHHHhhhCCCCCeeeeceEEe
Q 023591 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELV----AVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVIL 87 (280)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v----aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 87 (280)
.......++|++.+.||+|+||.||++++..+++.+ |+|.+... ....+.+.+|+.++++++||||+++++++.
T Consensus 8 ~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 87 (327)
T 3poz_A 8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp SSEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred HHhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 334456689999999999999999999988777654 77766543 234467889999999999999999999998
Q ss_pred cCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCc
Q 023591 88 TPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (280)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~ 166 (280)
... .+++++++.+++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++. +||+|||++
T Consensus 88 ~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a 164 (327)
T 3poz_A 88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLA 164 (327)
T ss_dssp SSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTHH
T ss_pred cCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcce
Confidence 654 7889999999999999876 457999999999999999999999999999999999999998887 999999998
Q ss_pred cccccCCCC---CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccC
Q 023591 167 KSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSI 242 (280)
Q Consensus 167 ~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
......... ....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||........ ..... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~----~~~~~ 238 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILE----KGERL 238 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHH----TTCCC
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCch-hhhhhhHHHHHHHHhcCCCCccCCCHHHH-HHHHH----cCCCC
Confidence 754333222 22335778999999988777655 999999999999999 9999987654332 22221 11222
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 243 PDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
+....++.++.+++.+||+.||.+||
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rp 264 (327)
T 3poz_A 239 PQPPICTIDVYMIMVKCWMIDADSRP 264 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSCGGGSC
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCC
Confidence 23336889999999999999999999
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=304.21 Aligned_cols=243 Identities=24% Similarity=0.373 Sum_probs=202.2
Q ss_pred CCCCeeeecccccCCceEEEEEEe-----cCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhC-CCCCeeeeceEEecCC
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 90 (280)
..++|++.+.||+|+||.||++.+ ..+++.||+|.+..... ..+.+.+|+.+++++ +||||+++++++..++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 457999999999999999999985 45678999999876542 235688999999999 9999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC
Q 023591 91 HLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~------------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~ 152 (280)
..++||||+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence 9999999999999999987654 4899999999999999999999999999999999999998
Q ss_pred CCCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchH
Q 023591 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (280)
Q Consensus 153 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~ 228 (280)
++. ++|+|||++........ .....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||.........
T Consensus 181 ~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 181 GRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp TTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred CCC--EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 876 99999999875443322 223446678999999987777555 999999999999998 99999876654444
Q ss_pred HHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
...... .........+++++.++|.+||+.||.+||
T Consensus 258 ~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 293 (313)
T 1t46_A 258 YKMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRP 293 (313)
T ss_dssp HHHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhcc----CCCCCCcccCCHHHHHHHHHHcCCCchhCc
Confidence 433332 122222336899999999999999999999
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=299.79 Aligned_cols=239 Identities=26% Similarity=0.382 Sum_probs=191.3
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecC-CeEEEE
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP-THLAIV 95 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv 95 (280)
....++|++.+.||+|++|.||++.+. ++.||+|.+.... ..+.+.+|+.++++++||||+++++++... ...++|
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 445689999999999999999999874 7889999987543 556788999999999999999999987654 478999
Q ss_pred EeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 96 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
|||+++++|.+++..... +++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST- 170 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC--------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeecccccccccc-
Confidence 999999999999876543 899999999999999999999999999999999999998876 999999988743322
Q ss_pred CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
.....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||............. . .........+++.+
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~l 243 (278)
T 1byg_A 171 -QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----K-GYKMDAPDGCPPAV 243 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT----T-TCCCCCCTTCCHHH
T ss_pred -ccCCCccccccCHHHhCCCCCCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh----c-CCCCCCcccCCHHH
Confidence 233456788999999987777555 999999999999998 999998765433322221 1 11222233689999
Q ss_pred HHHHHHhcccCCCCcC
Q 023591 253 RHLISRIFVADPAKSE 268 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp 268 (280)
.++|.+||+.||++||
T Consensus 244 ~~li~~~l~~~p~~Rp 259 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRP 259 (278)
T ss_dssp HHHHHHHTCSSGGGSC
T ss_pred HHHHHHHhcCChhhCC
Confidence 9999999999999999
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=306.25 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=203.2
Q ss_pred CCCCCCCCCCCCCCeeeecccccCCceEEEEEE----ecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeec
Q 023591 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFK 83 (280)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~ 83 (280)
++...+......++|++.+.||+|+||.||+++ +..+++.||+|.+.... ...+.+.+|+.++++++|+||++++
T Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 11 LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp ------CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred HhhcChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEE
Confidence 445566667788999999999999999999999 56788999999987653 2335588999999999999999999
Q ss_pred eEEe--cCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEE
Q 023591 84 EVIL--TPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (280)
Q Consensus 84 ~~~~--~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l 160 (280)
+++. .....++||||+++++|.+++.. ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl 168 (327)
T 3lxl_A 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKI 168 (327)
T ss_dssp EEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEE
T ss_pred EEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEE
Confidence 9886 45678999999999999999976 456999999999999999999999999999999999999998877 999
Q ss_pred eecCCccccccCC----CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc-----------
Q 023591 161 CDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----------- 225 (280)
Q Consensus 161 ~df~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~----------- 225 (280)
+|||++....... ......+++.|+|||.+.+..++.. +||||||+++|+|++|..||......
T Consensus 169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lxl_A 169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247 (327)
T ss_dssp CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----C
T ss_pred cccccceecccCCccceeeccCCccccccCHHHhccCCCChH-HhHHHHHHHHHHHHhCCCCCccccchhhhhccccccc
Confidence 9999987543322 2233457778999999987777555 99999999999999999998643211
Q ss_pred chHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 226 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....... .........+....+++++.+||.+||+.||++||
T Consensus 248 ~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 289 (327)
T 3lxl_A 248 PALSRLL-ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP 289 (327)
T ss_dssp CHHHHHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ccHHHHH-HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCc
Confidence 1111112 22222223333447899999999999999999999
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=299.31 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=188.5
Q ss_pred CCCCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEe
Q 023591 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVIL 87 (280)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 87 (280)
...-+.-...++|++.+.||+|+||.||++++.. .+|+|++..... ..+.+.+|+.++++++|+||++++++.
T Consensus 14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp ----CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred CCCCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 3344455567899999999999999999998753 499999875432 235678899999999999999999965
Q ss_pred cCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCc
Q 023591 88 TPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (280)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~ 166 (280)
.....++||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~ 167 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLA 167 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC--
T ss_pred cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEEccceec
Confidence 55678999999999999999854 456999999999999999999999999999999999999998876 999999998
Q ss_pred ccccc---CCCCCCCcCCCcccCccccc---CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc
Q 023591 167 KSSVL---HSQPKSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240 (280)
Q Consensus 167 ~~~~~---~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
..... ........+++.|+|||.+. +..+ +.++||||||+++|+|++|..||.................. ..
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~ 245 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL-SP 245 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC-CC
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc-Cc
Confidence 64332 12223446899999999986 3344 34599999999999999999999876654444433322111 11
Q ss_pred cCC-CCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 241 SIP-DYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 241 ~~~-~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
... ....+++++.+||.+||+.||.+||
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 274 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERP 274 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCC
Confidence 111 1236789999999999999999999
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=316.97 Aligned_cols=242 Identities=22% Similarity=0.364 Sum_probs=201.5
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
....++|++.+.||+|+||.||++.+. ++..||+|.+.......+.+.+|+.++++++||||+++++++. ....++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 345688999999999999999999986 4677999999887777788999999999999999999999986 56789999
Q ss_pred eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC--
Q 023591 97 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 172 (280)
Q Consensus 97 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-- 172 (280)
||+++++|.+++... ..++...+..++.||+.||+|||++|++||||+|+||+++.++. +||+|||+++.....
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEY 339 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCCHHH
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCCCce
Confidence 999999999999754 36899999999999999999999999999999999999998877 999999998754322
Q ss_pred CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
.......++..|+|||.+....++.. +||||||+++|+|++ |..||......+...... .....+....++++
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~ 413 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-----RGYRMPRPENCPEE 413 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-----HTCCCCCCTTSCHH
T ss_pred eccCCCcccccccCHHHhccCCCCcH-HHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCCHH
Confidence 11223345678999999987777555 999999999999999 999998755433222221 12233333478999
Q ss_pred HHHHHHHhcccCCCCcC
Q 023591 252 CRHLISRIFVADPAKSE 268 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp 268 (280)
+.+||.+||+.||++||
T Consensus 414 l~~li~~cl~~dp~~RP 430 (454)
T 1qcf_A 414 LYNIMMRCWKNRPEERP 430 (454)
T ss_dssp HHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHccCChhHCc
Confidence 99999999999999999
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=299.79 Aligned_cols=243 Identities=24% Similarity=0.370 Sum_probs=189.0
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCC---CcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
....++|++.+.||+|+||.||++.+..+ +..||+|.+.... ...+.+.+|+..+++++||||+++++++ .++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCc
Confidence 34568999999999999999999998653 4569999876532 2335678899999999999999999997 4567
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
.++||||+++++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYME 167 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC--------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECccccccccC
Confidence 899999999999999997654 6999999999999999999999999999999999999998876 9999999987543
Q ss_pred cCCC--CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 171 LHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 171 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
.... .....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||............... ..... ...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~---~~~~~--~~~ 241 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPM--PPN 241 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---CCCCC--CTT
T ss_pred cccccccccCCCcccccChhhcccCCCCCc-cCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC---CCCCC--CCC
Confidence 3222 223345678999999987777555 999999999999996 99999876554433322211 11222 236
Q ss_pred CCHHHHHHHHHhcccCCCCcC
Q 023591 248 ISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp 268 (280)
+++++.++|.+||+.||++||
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rp 262 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRP 262 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSC
T ss_pred CCHHHHHHHHHHccCChhhCc
Confidence 899999999999999999999
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=301.88 Aligned_cols=241 Identities=16% Similarity=0.161 Sum_probs=195.7
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCC-------cEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCC
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTE-------ELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~-------~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 90 (280)
..++|++.+.||+|+||.||++++..++ ..||+|.+.... ...+.+.+|+.++++++||||+++++++..++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 4689999999999999999999998776 469999986543 34467889999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCC------cEEEeec
Q 023591 91 HLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP------RLKICDF 163 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~------~~~l~df 163 (280)
..++||||+++++|.+++..... +++..++.++.|++.||.+||++|++|+||+|+||+++.++.. .++|+||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 99999999999999999977654 9999999999999999999999999999999999999877642 2899999
Q ss_pred CCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC
Q 023591 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243 (280)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (280)
|++..... .....+++.|+|||.+.+....+.++||||||+++|+|++|..|+............. ......+
T Consensus 166 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~----~~~~~~~ 238 (289)
T 4fvq_A 166 GISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY----EDRHQLP 238 (289)
T ss_dssp CSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HTTCCCC
T ss_pred cccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh----hccCCCC
Confidence 98863322 1233467889999999874444556999999999999999655544433322222221 2222333
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 244 DYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
. ..++++.+||.+||+.||++||
T Consensus 239 ~--~~~~~l~~li~~~l~~dp~~Rp 261 (289)
T 4fvq_A 239 A--PKAAELANLINNCMDYEPDHRP 261 (289)
T ss_dssp C--CSSCTTHHHHHHHSCSSGGGSC
T ss_pred C--CCCHHHHHHHHHHcCCChhHCc
Confidence 3 4678999999999999999999
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=312.42 Aligned_cols=243 Identities=23% Similarity=0.375 Sum_probs=190.6
Q ss_pred CCCCCeeeecccccCCceEEEEEEec---CCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
...++|++.+.||+|+||.||++++. .++..||+|.+.... ...+.+.+|+.++++++||||+++++++......
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34578999999999999999999876 467789999987543 2335688999999999999999999999988999
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
++||||+++++|.+++.... .+++..++.++.||+.||+|||+.|++||||+|+||+++.++. +||+|||++.....
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLED 199 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC--------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCcccccccc
Confidence 99999999999999997654 6999999999999999999999999999999999999988877 99999999875433
Q ss_pred CCCC----CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCC
Q 023591 172 HSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (280)
Q Consensus 172 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (280)
.... ....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||......... ..+. .....+...
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~SlG~il~ellt~g~~P~~~~~~~~~~----~~i~-~~~~~~~~~ 273 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVI----KAVD-EGYRLPPPM 273 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTC-CTTTTCCHHHHH----HHHH-TTEECCCCT
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHH-cCCCCCCCc
Confidence 2211 11224567999999988777655 999999999999998 99999875433222 2222 222333334
Q ss_pred CCCHHHHHHHHHhcccCCCCcC
Q 023591 247 HISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.++..+.++|.+||+.||.+||
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RP 295 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRP 295 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSC
T ss_pred cccHHHHHHHHHHhCcChhhCc
Confidence 6889999999999999999999
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=304.15 Aligned_cols=247 Identities=20% Similarity=0.333 Sum_probs=194.4
Q ss_pred CCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEE----EEEEeeeC--CcccHHHHHHHHHhhhCCCCCeeeeceEE
Q 023591 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELV----AVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVI 86 (280)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~v----aiK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 86 (280)
.+......++|++.+.||+|+||.||++++..+++.+ ++|.+... ....+.+.+|+.++++++||||+++++++
T Consensus 7 ~~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 7 ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp -CCEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred hhhcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 3344456789999999999999999999998887765 55555432 33456788999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCC
Q 023591 87 LTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (280)
Q Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~ 165 (280)
..+. .+++++++.+++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||+
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~ 163 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGL 163 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTC
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCcc
Confidence 8654 7889999999999999876 457999999999999999999999999999999999999998877 99999999
Q ss_pred ccccccCCCC---CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhccccc
Q 023591 166 SKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYS 241 (280)
Q Consensus 166 ~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
+......... ....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||........... .. ....
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-~~----~~~~ 237 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSI-LE----KGER 237 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HH----TTCC
T ss_pred eeEccCccccccccCCCccccccCHHHHcCCCCChH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HH----cCCC
Confidence 8754332222 22335678999999988777655 999999999999999 9999987655432222 21 1222
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 242 IPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+....++.++.+||.+||+.||.+||
T Consensus 238 ~~~~~~~~~~l~~li~~~l~~dp~~Rp 264 (327)
T 3lzb_A 238 LPQPPICTIDVYMIMRKCWMIDADSRP 264 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCccCCHHHHHHHHHHcCCChhHCc
Confidence 233336899999999999999999999
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=296.09 Aligned_cols=233 Identities=24% Similarity=0.366 Sum_probs=197.6
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEec-----------
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----------- 88 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----------- 88 (280)
.++|++.+.||+|+||.||++++..+++.||+|.+.... +.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 368999999999999999999999899999999997654 456789999999999999999998754
Q ss_pred -----CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEe
Q 023591 89 -----PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (280)
Q Consensus 89 -----~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~ 161 (280)
....++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~ 164 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIG 164 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEEC
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEEC
Confidence 34589999999999999999654 57999999999999999999999999999999999999998876 9999
Q ss_pred ecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccccc
Q 023591 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241 (280)
Q Consensus 162 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
|||++.............+++.|+|||.+.+..++.. +||||||+++|+|++|..|+... ......+... .
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~~--~ 235 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFET------SKFFTDLRDG--I 235 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTH-HHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHHTT--C
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcch-hhhHHHHHHHHHHHhcCCcchhH------HHHHHHhhcc--c
Confidence 9999886655555556678999999999988777655 99999999999999999887421 1122222221 1
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 242 IPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
++. .+++.+.++|.+||+.||.+||
T Consensus 236 ~~~--~~~~~~~~li~~~l~~dp~~Rp 260 (284)
T 2a19_B 236 ISD--IFDKKEKTLLQKLLSKKPEDRP 260 (284)
T ss_dssp CCT--TSCHHHHHHHHHHTCSSGGGSC
T ss_pred ccc--cCCHHHHHHHHHHccCChhhCc
Confidence 222 5789999999999999999999
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=296.82 Aligned_cols=241 Identities=22% Similarity=0.350 Sum_probs=199.2
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
...++|++.+.||+|+||.||++.+. ++..||+|.+.......+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 34589999999999999999999975 5677999999877666788999999999999999999999986 456899999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC--
Q 023591 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-- 173 (280)
|+++++|.+++.... .+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYT 165 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccccCcccc
Confidence 999999999986543 6999999999999999999999999999999999999998776 9999999987543322
Q ss_pred CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
......+++.|+|||.+.+..++.. +||||||+++|+|++ |..||........... +... ........+++++
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~l 239 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG-YRMVRPDNCPEEL 239 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHTT-CCCCCCTTCCHHH
T ss_pred cccCCCCccCccChhhhccCCCCch-hhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH----Hhcc-cCCCCcccccHHH
Confidence 1223345678999999987777555 999999999999999 9999987554322222 2211 1222223689999
Q ss_pred HHHHHHhcccCCCCcC
Q 023591 253 RHLISRIFVADPAKSE 268 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp 268 (280)
.++|.+||+.||++||
T Consensus 240 ~~li~~~l~~~p~~Rp 255 (279)
T 1qpc_A 240 YQLMRLCWKERPEDRP 255 (279)
T ss_dssp HHHHHHHTCSSGGGSC
T ss_pred HHHHHHHhccChhhCC
Confidence 9999999999999999
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=303.94 Aligned_cols=243 Identities=20% Similarity=0.288 Sum_probs=195.2
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcE----EEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCC
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~----vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 90 (280)
....++|++.+.||+|+||.||++.+..+++. |++|.+.... .....+.+|+.++++++||||+++++++. +.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 34568999999999999999999999888776 6677664332 23355678999999999999999999886 56
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++...
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~ 165 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLL 165 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGS
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCccccc
Confidence 689999999999999998764 57999999999999999999999999999999999999988877 999999999754
Q ss_pred ccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCC
Q 023591 170 VLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245 (280)
Q Consensus 170 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (280)
..... .....++..|+|||.+.+..++.. +||||||+++|+|++ |..||............ ... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~-~~~~~~ 239 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL----EKG-ERLAQP 239 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH----HTT-CBCCCC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChh-hHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH----HcC-CCCCCC
Confidence 33322 233456778999999987777655 999999999999999 99999876543322222 111 122222
Q ss_pred CCCCHHHHHHHHHhcccCCCCcC
Q 023591 246 VHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..++.++.++|.+||+.||.+||
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rp 262 (325)
T 3kex_A 240 QICTIDVYMVMVKCWMIDENIRP 262 (325)
T ss_dssp TTBCTTTTHHHHHHTCSCTTTSC
T ss_pred CcCcHHHHHHHHHHcCCChhhCc
Confidence 25788999999999999999999
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=308.57 Aligned_cols=243 Identities=12% Similarity=0.152 Sum_probs=196.0
Q ss_pred CCCeeeecccccCCceEEEEEEecC--------CCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeee----------
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKK--------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR---------- 81 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~---------- 81 (280)
.++|++.+.||+|+||.||++++.. +++.||+|.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 4899999999999999999999987 4789999998754 46788999999999999887
Q ss_pred -----eceEEec-CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC
Q 023591 82 -----FKEVILT-PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (280)
Q Consensus 82 -----~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~ 153 (280)
+++++.. +...++||||+ +++|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE 195 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence 5677765 67899999999 88999999875 689999999999999999999999999999999999999987
Q ss_pred CCCcEEEeecCCccccccCCC--------CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCC-C
Q 023591 154 PAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-E 224 (280)
Q Consensus 154 ~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~ 224 (280)
+..+++|+|||++........ .....+++.|+|||.+.+..++.. +||||||+++|+|++|..||.... .
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 733499999999964433221 133468899999999988776554 999999999999999999998764 2
Q ss_pred cchHHHHHhhHhcccccCCC----CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 225 PKNFRKTIHRILSVQYSIPD----YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.................+.. +..+++++.+||.+||+.||++||
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 322 (352)
T 2jii_A 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKP 322 (352)
T ss_dssp HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCC
T ss_pred HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCC
Confidence 22233333222222222211 225789999999999999999999
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=303.23 Aligned_cols=242 Identities=24% Similarity=0.366 Sum_probs=197.0
Q ss_pred CCCCeeeecccccCCceEEEEEEec-------CCCcEEEEEEeeeCC--cccHHHHHHHHHhhhC-CCCCeeeeceEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILT 88 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~-------~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 88 (280)
..++|++.+.||+|+||.||++++. .++..||+|++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4589999999999999999999975 456789999987643 2335678899999999 99999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC
Q 023591 89 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~ 152 (280)
++..++||||+++++|.+++.... .++...++.++.||+.||.+||+.|++|+||+|+||+++.
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence 999999999999999999997654 3899999999999999999999999999999999999998
Q ss_pred CCCCcEEEeecCCccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchH
Q 023591 153 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (280)
Q Consensus 153 ~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~ 228 (280)
++. ++|+|||++....... ......+++.|+|||.+.+..++.. +||||||+++|+|++ |..||.........
T Consensus 193 ~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 193 NNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp TCC--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCC--EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChH-HHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 877 9999999987443322 1223345778999999987777555 999999999999999 99999765432222
Q ss_pred HHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..+.... ..+....+++++.++|.+||+.||.+||
T Consensus 270 ----~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rp 304 (334)
T 2pvf_A 270 ----KLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRP 304 (334)
T ss_dssp ----HHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ----HHHhcCC-CCCCCccCCHHHHHHHHHHccCChhhCc
Confidence 2221111 1222236899999999999999999999
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=294.04 Aligned_cols=243 Identities=23% Similarity=0.243 Sum_probs=195.9
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEE-ecCCeEEEEEe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIVME 97 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e 97 (280)
..++|++.+.||+|+||.||++++..+++.||+|++.... ..+.+.+|+.+++.++|++++..+..+ ......++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 3589999999999999999999999999999999887654 345688999999999988766655544 56778899999
Q ss_pred ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEe---CCCCCcEEEeecCCccccccCC
Q 023591 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 98 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~---~~~~~~~~l~df~~~~~~~~~~ 173 (280)
|+ +++|.+++.. ...+++..++.++.|++.||+|||++|++|+||+|+||+++ .++. ++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCe--EEEeeCCCcccccccc
Confidence 99 8899999874 45799999999999999999999999999999999999994 5555 9999999987544332
Q ss_pred C--------CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc---chHHHHHhhHhcccc-c
Q 023591 174 Q--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQY-S 241 (280)
Q Consensus 174 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-~ 241 (280)
. .....+++.|+|||.+.+..++.. +||||||+++|+|++|..||...... ............... .
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 2 244568999999999988777554 99999999999999999999864432 222222222221111 1
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 242 IPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.. ..+|+++.+||.+||+.||++||
T Consensus 242 ~~--~~~~~~l~~li~~~l~~dp~~Rp 266 (296)
T 3uzp_A 242 LC--KGYPSEFATYLNFCRSLRFDDKP 266 (296)
T ss_dssp HT--TTSCHHHHHHHHHHHTSCTTCCC
T ss_pred HH--hhCCHHHHHHHHHHHhcCcCcCC
Confidence 11 25889999999999999999999
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=301.81 Aligned_cols=243 Identities=24% Similarity=0.323 Sum_probs=188.9
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhh--CCCCCeeeeceEEec----CCeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILT----PTHL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~----~~~~ 92 (280)
..++|++.+.||+|+||.||++++ +++.||+|++.... ...+.+|.+++.. ++||||+++++++.. ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 358999999999999999999988 58889999987543 3445556666655 799999999998654 3468
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh--------~~~i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
++||||+++++|.+++. ...+++..++.++.|++.||+||| +.|++||||||+||+++.++. +||+|||
T Consensus 82 ~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg 158 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLG 158 (301)
T ss_dssp EEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCT
T ss_pred EEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCC
Confidence 99999999999999994 457999999999999999999999 999999999999999998877 9999999
Q ss_pred CccccccCCC-----CCCCcCCCcccCcccccCCcCC-----CccchhhHHHHHHHHHHhC----------CCCCCCCCC
Q 023591 165 YSKSSVLHSQ-----PKSTVGTPAYIAPEVLLKKEYD-----GKIADVWSCGVTLYVMLVG----------AYPFEDPEE 224 (280)
Q Consensus 165 ~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~-----~~~~DiwslG~~l~~l~~g----------~~p~~~~~~ 224 (280)
++........ .....+++.|+|||.+.+.... +.++||||||+++|+|++| ..||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 9864333222 2334689999999999776322 2359999999999999999 888876543
Q ss_pred cchHHHHHhhHhcccccCCCC------CCCCHHHHHHHHHhcccCCCCcC
Q 023591 225 PKNFRKTIHRILSVQYSIPDY------VHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..................+.. ...++++.+||.+||+.||++||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 288 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288 (301)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred CCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCC
Confidence 333222232222221111110 12457899999999999999999
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=297.62 Aligned_cols=241 Identities=32% Similarity=0.537 Sum_probs=189.3
Q ss_pred CCCCCCCCCCCCeeee-cccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHh-hhCCCCCeeeeceEEec
Q 023591 11 GMDMPIMHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT 88 (280)
Q Consensus 11 ~~~~~~~~~~~~y~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~ 88 (280)
+..+..+...++|.+. +.||+|+||.||++.+..+++.||+|++.. .....+|+.++ +.++||||+++++++..
T Consensus 7 ~~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 7 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp CCCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 4555566667899998 789999999999999999999999999864 34567888887 55699999999999876
Q ss_pred ----CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-CCcEEEe
Q 023591 89 ----PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKIC 161 (280)
Q Consensus 89 ----~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~~~~~l~ 161 (280)
....++||||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ ...++|+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 667899999999999999997754 699999999999999999999999999999999999998732 2349999
Q ss_pred ecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccccc
Q 023591 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241 (280)
Q Consensus 162 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
|||++.... +..++ .++||||||+++|+|++|..||...............+......
T Consensus 163 Dfg~a~~~~---------------------~~~~~-~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 220 (299)
T 3m2w_A 163 DFGFAKETT---------------------GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 220 (299)
T ss_dssp CCTTCEECT---------------------TCGGG-GHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCS
T ss_pred ccccccccc---------------------cccCC-chhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcccc
Confidence 999876322 12333 34999999999999999999997654322111111111112222
Q ss_pred CCC--CCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 242 IPD--YVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 242 ~~~--~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
++. ...+++++.+||.+||+.||++|| .||||++..
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 221 136899999999999999999999 999997653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=295.45 Aligned_cols=243 Identities=27% Similarity=0.399 Sum_probs=197.9
Q ss_pred CCCCCCeeeec-ccccCCceEEEEEEec--CCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 17 MHDSDRYELVR-DIGSGNFGVARLMRDK--KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 17 ~~~~~~y~~~~-~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
....++|.+.+ .||+|+||.||++.+. .++..||+|.+.... ...+.+.+|+.++++++||||+++++++ ....
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA 83 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence 44568898887 9999999999999854 467889999997643 3345688999999999999999999998 4567
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
.++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALG 161 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECT
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC--EEECcccceeeec
Confidence 89999999999999998644 46999999999999999999999999999999999999998876 9999999987543
Q ss_pred cCCC----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCC
Q 023591 171 LHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245 (280)
Q Consensus 171 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (280)
.... .....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||.............. .....++
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~---~~~~~~~-- 235 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECP-- 235 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT---TCCCCCC--
T ss_pred cCcceeeccccccccccccCHHHhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc---CCcCCCC--
Confidence 2221 223345788999999987777555 999999999999998 9999987655332222211 1112233
Q ss_pred CCCCHHHHHHHHHhcccCCCCcC
Q 023591 246 VHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..+++++.++|.+||+.||++||
T Consensus 236 ~~~~~~l~~li~~~l~~~p~~Rp 258 (287)
T 1u59_A 236 PECPPELYALMSDCWIYKWEDRP 258 (287)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSC
T ss_pred CCcCHHHHHHHHHHcCCChhhCc
Confidence 36899999999999999999999
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=302.13 Aligned_cols=245 Identities=25% Similarity=0.405 Sum_probs=194.4
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEec----CCeE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHL 92 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 92 (280)
...++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 45689999999999999999999999999999999987643 334568899999999999999999999873 3478
Q ss_pred EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 93 AIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
++||||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~~ 183 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQ 183 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCEE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcchh
Confidence 999999999999998865 467999999999999999999999999999999999999988877 99999998764
Q ss_pred cccCCCC----------CCCcCCCcccCcccccCCcC--CCccchhhHHHHHHHHHHhCCCCCCCCCC-cchHHHHHhhH
Q 023591 169 SVLHSQP----------KSTVGTPAYIAPEVLLKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRI 235 (280)
Q Consensus 169 ~~~~~~~----------~~~~~~~~~~aPE~~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~ 235 (280)
....... ....+++.|+|||.+.+... ...++||||||+++|+|++|..||..... ........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--- 260 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV--- 260 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH---
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh---
Confidence 3221111 12235889999999865431 23449999999999999999999954211 11111111
Q ss_pred hcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
......+....+++++.++|.+||+.||.+||
T Consensus 261 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 292 (317)
T 2buj_A 261 -QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP 292 (317)
T ss_dssp -HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred -hccCCCCccccCCHHHHHHHHHHhhcChhhCC
Confidence 11233444447899999999999999999999
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=302.94 Aligned_cols=244 Identities=18% Similarity=0.278 Sum_probs=199.1
Q ss_pred CCCCCCeeeecccccCCceEEEEEEec-----CCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecC
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 89 (280)
....++|++.+.||+|+||.||++.+. .+++.||+|.+..... ....+.+|+.++++++|+||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345589999999999999999999876 3578899999875432 224577899999999999999999999998
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEE
Q 023591 90 THLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~ 159 (280)
...++||||+++++|.+++... ..++...++.++.|++.||.+||++|++|+||+|+||+++.++. ++
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~k 178 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VK 178 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--EE
Confidence 9999999999999999988642 35799999999999999999999999999999999999998877 99
Q ss_pred EeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhH
Q 023591 160 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRI 235 (280)
Q Consensus 160 l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 235 (280)
|+|||++........ .....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||........ ...+
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~----~~~~ 253 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQV----LRFV 253 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHH----HHHH
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCch-hhHHHHHHHHHHHHhcCCCccccCCHHHH----HHHH
Confidence 999999874433221 223345788999999987777555 999999999999999 8999977543222 2222
Q ss_pred hcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..... .+....+++.+.+||.+||+.||++||
T Consensus 254 ~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rp 285 (322)
T 1p4o_A 254 MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRP 285 (322)
T ss_dssp HTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCc
Confidence 22221 112236899999999999999999999
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=305.40 Aligned_cols=247 Identities=22% Similarity=0.254 Sum_probs=197.1
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
...++|++.+.||+|+||.||++.+. +++.||+|.+.... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 35589999999999999999999974 68899999887643 33467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 97 EYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
||+++++|.+++.... .+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGTEL 192 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECSSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence 9999999999886543 5899999999999999999999999999999999999998877 999999998743322
Q ss_pred CC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchH--HHHH-hhHhcccc------
Q 023591 173 SQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF--RKTI-HRILSVQY------ 240 (280)
Q Consensus 173 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~--~~~~-~~~~~~~~------ 240 (280)
.. .....+++.|+|||.+.+..++.. +||||||+++|+|++|..||......... .... ........
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence 21 223447889999999988777655 99999999999999999999765432211 1111 11111110
Q ss_pred cCC--CCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 241 SIP--DYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 241 ~~~--~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
... .....+..+.+++.+||+.||++||
T Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 301 (321)
T 2qkw_B 272 NLADKIRPESLRKFGDTAVKCLALSSEDRP 301 (321)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHTCSSGGGSC
T ss_pred hhccccCHHHHHHHHHHHHHHcCCCcccCc
Confidence 000 0112456799999999999999999
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=301.65 Aligned_cols=244 Identities=22% Similarity=0.337 Sum_probs=194.0
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCC----cEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCC
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 90 (280)
....++|++.+.||+|+||.||++.+..++ ..||+|.+..... ....+.+|+.++++++||||+++++++....
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 445689999999999999999999986543 3599999875432 2345778999999999999999999999989
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
..++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVL 197 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC----
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc--EEECCCCcchhh
Confidence 999999999999999998764 57999999999999999999999999999999999999998776 999999998754
Q ss_pred ccCCCC----CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCC
Q 023591 170 VLHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (280)
Q Consensus 170 ~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (280)
...... ....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||....... ....+... ...+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~----~~~~~~~~-~~~~~ 271 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHE----VMKAINDG-FRLPT 271 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTT-CCCCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCch-hhhHHHHHHHHHHHcCCCCCcccCCHHH----HHHHHHCC-CcCCC
Confidence 332211 12234678999999987777655 999999999999999 999997654322 22222221 22333
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 245 YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
...+++.+.++|.+||+.||++||
T Consensus 272 ~~~~~~~l~~li~~~l~~~p~~Rp 295 (333)
T 1mqb_A 272 PMDCPSAIYQLMMQCWQQERARRP 295 (333)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSC
T ss_pred cccCCHHHHHHHHHHcCCChhhCc
Confidence 336899999999999999999999
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=298.37 Aligned_cols=244 Identities=22% Similarity=0.331 Sum_probs=189.6
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecC---CCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCC
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 90 (280)
....++|++.+.||+|+||.||++.+.. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++....
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 3456899999999999999999998765 455899999876432 2356788999999999999999999988654
Q ss_pred -----eEEEEEeccCCCchHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEE
Q 023591 91 -----HLAIVMEYASGGELFERIC------NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (280)
Q Consensus 91 -----~~~lv~e~~~~~~L~~~~~------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~ 159 (280)
..+++|||+++++|.+++. ....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~k 187 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VC 187 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--EE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EE
Confidence 3599999999999999984 2356999999999999999999999999999999999999998877 99
Q ss_pred EeecCCccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhH
Q 023591 160 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRI 235 (280)
Q Consensus 160 l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 235 (280)
|+|||++....... ......+++.|+|||.+.+..++.. +||||||+++|+|++ |..||...............
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~- 265 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG- 265 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC-
Confidence 99999987543322 2233446778999999988777555 999999999999999 89999876554333332221
Q ss_pred hcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..... ...+++++.++|.+||+.||.+||
T Consensus 266 --~~~~~--~~~~~~~l~~li~~~l~~dp~~Rp 294 (313)
T 3brb_A 266 --HRLKQ--PEDCLDELYEIMYSCWRTDPLDRP 294 (313)
T ss_dssp --CCCCC--BTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred --CCCCC--CccccHHHHHHHHHHcCCChhhCc
Confidence 11222 236889999999999999999999
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=301.21 Aligned_cols=244 Identities=27% Similarity=0.400 Sum_probs=193.5
Q ss_pred CCeeeecccccCCceEEEEEE----ecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecC--CeE
Q 023591 21 DRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 92 (280)
..|++++.||+|+||.||++. +..+++.||+|++.... ...+.+.+|+.++++++||||+++++++... ..+
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 344999999999999998775 34578899999997653 2235688999999999999999999999874 678
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
++||||+++++|.+++... .+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECCTT
T ss_pred EEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--EEECCcccccccccc
Confidence 9999999999999998654 4999999999999999999999999999999999999998877 999999998754433
Q ss_pred C----CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCc----------chHHHHHhhHhcc
Q 023591 173 S----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----------KNFRKTIHRILSV 238 (280)
Q Consensus 173 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~----------~~~~~~~~~~~~~ 238 (280)
. ......+++.|+|||.+.+..++.. +||||||+++|+|++|..||...... .............
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 2 1233456778999999988777654 99999999999999999999753211 0001111122222
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 239 QYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....+....+++++.+||.+||+.||.+||
T Consensus 267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 296 (318)
T 3lxp_A 267 GERLPRPDKCPAEVYHLMKNCWETEASFRP 296 (318)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ccCCCCCccccHHHHHHHHHHcCCCcccCc
Confidence 223333447899999999999999999999
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=302.14 Aligned_cols=244 Identities=21% Similarity=0.349 Sum_probs=201.1
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCc-----EEEEEEeeeCC--cccHHHHHHHHHhhhC-CCCCeeeeceEEecC
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~-----~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 89 (280)
...++|++.+.||+|+||.||++.+..++. .||+|.+.... ...+.+.+|+.+++++ +||||+++++++..+
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345789999999999999999999876654 79999987643 2335678999999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC
Q 023591 90 THLAIVMEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~--------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~ 155 (280)
+..++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe
Confidence 9999999999999999998642 35799999999999999999999999999999999999998876
Q ss_pred CcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHH
Q 023591 156 PRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (280)
Q Consensus 156 ~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~ 231 (280)
++|+|||++........ .....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||............
T Consensus 203 --~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 203 --AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp --EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred --EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChH-HHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 99999999875433222 223445778999999987777554 999999999999998 99999876654444333
Q ss_pred HhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
... ..........++.+.++|.+||+.||.+||
T Consensus 280 ~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 312 (333)
T 2i1m_A 280 VKD----GYQMAQPAFAPKNIYSIMQACWALEPTHRP 312 (333)
T ss_dssp HHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred Hhc----CCCCCCCCCCCHHHHHHHHHHhccChhhCc
Confidence 322 222222335789999999999999999999
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=297.67 Aligned_cols=251 Identities=26% Similarity=0.416 Sum_probs=192.6
Q ss_pred CCCCCCCCCCCCCeeeecccccCCceEEEEEEecC-CCc--EEEEEEeeeCC----cccHHHHHHHHHhhhCCCCCeeee
Q 023591 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKK-TEE--LVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRF 82 (280)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~-~~~--~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~ 82 (280)
|..........++|++.+.||+|+||.||++++.. ++. .||+|++.... ...+.+.+|+.++++++||||+++
T Consensus 7 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 86 (291)
T 1u46_A 7 PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 86 (291)
T ss_dssp ----CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccE
Confidence 33444556677899999999999999999998643 333 68999887542 334567899999999999999999
Q ss_pred ceEEecCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEe
Q 023591 83 KEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (280)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~ 161 (280)
++++..+. .++|+||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+
T Consensus 87 ~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~ 163 (291)
T 1u46_A 87 YGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIG 163 (291)
T ss_dssp EEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEEC
T ss_pred EEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEEc
Confidence 99997655 88999999999999988664 56999999999999999999999999999999999999998876 9999
Q ss_pred ecCCccccccCCC----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHh
Q 023591 162 DFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRIL 236 (280)
Q Consensus 162 df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 236 (280)
|||++........ .....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||...... .....+.
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~~ 238 (291)
T 1u46_A 164 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKID 238 (291)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHH
T ss_pred cccccccccccccchhhhccCCCCceeeCchhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcccCCHH----HHHHHHH
Confidence 9999875433221 223346678999999987776544 999999999999999 99999875443 2333333
Q ss_pred cccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 237 SVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 237 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
......+....+++++.++|.+||+.||.+||
T Consensus 239 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 270 (291)
T 1u46_A 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRP 270 (291)
T ss_dssp TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ccCCCCCCCcCcCHHHHHHHHHHccCCcccCc
Confidence 33333444447899999999999999999999
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=295.01 Aligned_cols=243 Identities=23% Similarity=0.242 Sum_probs=191.5
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEE-ecCCeEEEEEe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIVME 97 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e 97 (280)
..++|++.+.||+|+||.||++++..+++.||+|++.... ..+.+.+|+.+++.++|++++..+..+ ......+++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 3488999999999999999999999999999999866543 334678899999999887766655544 56778899999
Q ss_pred ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEE---eCCCCCcEEEeecCCccccccCC
Q 023591 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 98 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i---~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
|+ +++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++. ++|+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~--~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe--EEEecCccceeccCcc
Confidence 99 8899999874 4579999999999999999999999999999999999999 56665 9999999987544332
Q ss_pred C--------CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHhhHhcccc-c
Q 023591 174 Q--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---NFRKTIHRILSVQY-S 241 (280)
Q Consensus 174 ~--------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~-~ 241 (280)
. .....+++.|+|||.+.+..++.. +||||||+++|+|++|..||....... .............. .
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCch-hHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 2 234568999999999988777554 999999999999999999998754332 22222222111111 1
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 242 IPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.. ..+|+++.+||.+||+.||++||
T Consensus 242 ~~--~~~~~~l~~li~~~l~~~p~~Rp 266 (296)
T 4hgt_A 242 LC--KGYPSEFATYLNFCRSLRFDDKP 266 (296)
T ss_dssp HT--TTSCHHHHHHHHHHHTSCTTCCC
T ss_pred hh--ccCCHHHHHHHHHHHhcCCCCCC
Confidence 11 25789999999999999999999
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=313.38 Aligned_cols=241 Identities=23% Similarity=0.340 Sum_probs=196.3
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
...++|++.+.||+|+||.||++.+.. +..||+|.+.......+.+.+|+.++++++||||+++++++.. ...++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 455789999999999999999999875 4569999998776666789999999999999999999999865 67899999
Q ss_pred ccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-
Q 023591 98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (280)
Q Consensus 98 ~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 174 (280)
|+++++|.+++.. ...+++..+..++.|++.||+|||++|++||||+|+||+++.++. +||+|||++........
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC--------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCCcee
Confidence 9999999999964 356999999999999999999999999999999999999988776 99999999875432221
Q ss_pred -CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
.....++..|+|||.+.+..++.. +||||||+++|+|++ |..||......+... .+.. ....+....+++.+
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~----~i~~-~~~~~~~~~~~~~l 410 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVER-GYRMPCPPECPESL 410 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHHT-TCCCCCCTTSCHHH
T ss_pred cccCCcccccccCHhHHhcCCCCcc-ccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHc-CCCCCCCCCCCHHH
Confidence 122345678999999987777555 999999999999999 999998755432222 2221 22233333789999
Q ss_pred HHHHHHhcccCCCCcC
Q 023591 253 RHLISRIFVADPAKSE 268 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp 268 (280)
.+||.+||+.||++||
T Consensus 411 ~~li~~cl~~dP~~Rp 426 (452)
T 1fmk_A 411 HDLMCQCWRKEPEERP 426 (452)
T ss_dssp HHHHHHHTCSSGGGSC
T ss_pred HHHHHHHccCChhhCc
Confidence 9999999999999999
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=300.52 Aligned_cols=242 Identities=23% Similarity=0.381 Sum_probs=187.6
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhh--CCCCCeeeeceEEecC----CeEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTP----THLA 93 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----~~~~ 93 (280)
.++|++.+.||+|+||.||++++. ++.||+|++..... ....+|.+++.. ++||||+++++++... ...+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 479999999999999999999985 88999999875443 334445555544 4999999999999876 6899
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------CceecCCCCCcEEEeCCCCCcEEEeecCC
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~--------~i~h~dl~~~ni~i~~~~~~~~~l~df~~ 165 (280)
+||||+++++|.+++... .+++..++.++.|++.||.|||+. |++|+||||+||+++.++. +||+|||+
T Consensus 112 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~ 188 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL 188 (337)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTT
T ss_pred EEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCC
Confidence 999999999999999654 699999999999999999999998 9999999999999998876 99999999
Q ss_pred ccccccCCCC-----CCCcCCCcccCcccccCCcCCCc-----cchhhHHHHHHHHHHhC----------CCCCCCCCCc
Q 023591 166 SKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYDGK-----IADVWSCGVTLYVMLVG----------AYPFEDPEEP 225 (280)
Q Consensus 166 ~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~-----~~DiwslG~~l~~l~~g----------~~p~~~~~~~ 225 (280)
+......... ....+++.|+|||.+.+...... ++||||||+++|+|++| ..||......
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 8644332221 24568999999999977655443 38999999999999999 7777654433
Q ss_pred chHHHHHhhHhc-ccc--cCCC---CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 226 KNFRKTIHRILS-VQY--SIPD---YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 226 ~~~~~~~~~~~~-~~~--~~~~---~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
............ ... .++. ...+++++.+||.+||+.||++||
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 317 (337)
T 3mdy_A 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317 (337)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSC
T ss_pred CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCC
Confidence 322222222221 111 1111 113557799999999999999999
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=293.59 Aligned_cols=243 Identities=23% Similarity=0.282 Sum_probs=195.0
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecC---CCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
....++|++.+.||+|+||.||++.+.. ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.. ..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 3456899999999999999999998653 34469999987643 234568889999999999999999999864 45
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
.++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIE 164 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC-
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCcccc
Confidence 68999999999999999765 45999999999999999999999999999999999999998876 9999999987543
Q ss_pred cCCC--CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 171 LHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 171 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
.... .....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||............... . ..+....
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~---~--~~~~~~~ 238 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG---D--RLPKPDL 238 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT---C--CCCCCTT
T ss_pred cccccccccCCCCcceeCchhhccCCCCch-hccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC---C--CCCCCCC
Confidence 3221 223445778999999977777554 999999999999998 99999866554333222211 1 2222236
Q ss_pred CCHHHHHHHHHhcccCCCCcC
Q 023591 248 ISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp 268 (280)
+++.+.++|.+||+.||++||
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rp 259 (281)
T 3cc6_A 239 CPPVLYTLMTRCWDYDPSDRP 259 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSC
T ss_pred CCHHHHHHHHHHccCCchhCc
Confidence 899999999999999999999
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=297.63 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=197.9
Q ss_pred CCCCCCCeeeecccccCCceEEEEEE----ecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCC
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 90 (280)
.....++|++.+.||+|+||.||+++ +..+++.||+|++.... ...+.+.+|+.++++++||||+++++++....
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 34456789999999999999999998 45688999999987643 33356889999999999999999999987644
Q ss_pred --eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 91 --HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 91 --~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
..++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~~ 193 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTK 193 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCE
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcchh
Confidence 689999999999999999775 46999999999999999999999999999999999999998876 9999999987
Q ss_pred ccccCCC----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCC----------c-chHHHHH
Q 023591 168 SSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE----------P-KNFRKTI 232 (280)
Q Consensus 168 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~----------~-~~~~~~~ 232 (280)
....... .....++..|+|||.+.+..++.. +||||||+++|+|++|..||..... . .......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCch-hhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 5433221 223346677999999987777554 9999999999999999998864210 0 0111111
Q ss_pred hhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..........+....+++++.++|.+||+.||++||
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 308 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 308 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCc
Confidence 111222222333347899999999999999999999
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=299.13 Aligned_cols=244 Identities=24% Similarity=0.414 Sum_probs=199.0
Q ss_pred CCCCCeeeecccccCCceEEEEEEe-----cCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhC-CCCCeeeeceEEecC
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 89 (280)
...++|++.+.||+|+||.||++.+ ..+++.||+|++..... ..+.+.+|+.+++++ +||||+++++++..+
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 3458999999999999999999985 35678999999876432 234678899999999 789999999998765
Q ss_pred C-eEEEEEeccCCCchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC
Q 023591 90 T-HLAIVMEYASGGELFERICNAGR----------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (280)
Q Consensus 90 ~-~~~lv~e~~~~~~L~~~~~~~~~----------------l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~ 152 (280)
+ .++++|||+++++|.+++..... +++..++.++.|++.||.+||+.|++|+||+|+||+++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 4 58999999999999999976553 899999999999999999999999999999999999988
Q ss_pred CCCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchH
Q 023591 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (280)
Q Consensus 153 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~ 228 (280)
++. ++|+|||++........ .....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||.........
T Consensus 184 ~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 184 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp GGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCC--EEECCCccccccccCccceeccCCCcceeecCchhhccccccch-hHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 777 99999999874433222 123346778999999987777555 999999999999998 99999876654433
Q ss_pred HHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
...... ......+. .+++++.++|.+||+.||.+||
T Consensus 261 ~~~~~~--~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rp 296 (316)
T 2xir_A 261 CRRLKE--GTRMRAPD--YTTPEMYQTMLDCWHGEPSQRP 296 (316)
T ss_dssp HHHHHH--TCCCCCCT--TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhcc--CccCCCCC--CCCHHHHHHHHHHcCCChhhCc
Confidence 333222 11122233 5889999999999999999999
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=294.36 Aligned_cols=239 Identities=30% Similarity=0.470 Sum_probs=189.5
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
...++|++.+.||+|+||.||++++. ++.||+|.+... ...+.+.+|+.++++++||||+++++++.+ ..++|||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 45689999999999999999999985 678999998653 345678899999999999999999998763 4789999
Q ss_pred ccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---cCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 98 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHS---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~Lh~---~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
|+++++|.+++.... .++...++.++.|++.||++||+ +|++|+||+|+||+++.++. .+||+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQT 158 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEccccccccccc
Confidence 999999999997655 37899999999999999999999 89999999999999987764 379999999874332
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
. .....+++.|+|||.+.+..++.. +||||||+++|+|++|..||........ ......... ...+....+++.
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~ 232 (307)
T 2eva_A 159 H--MTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNG-TRPPLIKNLPKP 232 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHHTT-CCCCCBTTCCHH
T ss_pred c--cccCCCCCceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHhcC-CCCCcccccCHH
Confidence 2 233458999999999988777655 9999999999999999999986543321 111111111 112222368999
Q ss_pred HHHHHHHhcccCCCCcC
Q 023591 252 CRHLISRIFVADPAKSE 268 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp 268 (280)
+.++|.+||+.||++||
T Consensus 233 l~~li~~~l~~dp~~Rp 249 (307)
T 2eva_A 233 IESLMTRCWSKDPSQRP 249 (307)
T ss_dssp HHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHhcCChhhCc
Confidence 99999999999999999
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=291.25 Aligned_cols=243 Identities=25% Similarity=0.353 Sum_probs=194.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCc---EEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE-
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL- 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~- 92 (280)
....|++.+.||+|+||.||++.+..++. .+|+|.+..... ..+.+.+|+.++++++||||+++++++..++..
T Consensus 19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 34567888999999999999999765444 799998875432 335678999999999999999999999876654
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
+++|||+.+++|.+++.. ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILD 176 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTTT
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCcccccC
Confidence 999999999999999976 456899999999999999999999999999999999999998877 99999999864322
Q ss_pred -----CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCC
Q 023591 172 -----HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (280)
Q Consensus 172 -----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (280)
........+++.|.|||.+.+..++.. +||||||+++|+|++|..|+............... ....+...
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 251 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ----GRRLPQPE 251 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT----TCCCCCCT
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChh-hchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc----CCCCCCCc
Confidence 122234456788999999988777655 99999999999999966555444433333332222 11222233
Q ss_pred CCCHHHHHHHHHhcccCCCCcC
Q 023591 247 HISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+++.+.++|.+||+.||.+||
T Consensus 252 ~~~~~l~~li~~~l~~~p~~Rp 273 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEADPAVRP 273 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSC
T ss_pred cchHHHHHHHHHHccCChhhCc
Confidence 6899999999999999999999
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=302.48 Aligned_cols=235 Identities=17% Similarity=0.171 Sum_probs=191.0
Q ss_pred CCCCeeeecccccCCceEEEEE-----EecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC---CCCeeeeceEEecCC
Q 023591 19 DSDRYELVRDIGSGNFGVARLM-----RDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPT 90 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~ 90 (280)
..++|++.+.||+|+||.||++ .+..+++.||+|++... ...++.+|+.++++++ |+|++.+++++..++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 4578999999999999999999 46678899999998754 3456778888888886 899999999999999
Q ss_pred eEEEEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC-----------CC
Q 023591 91 HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-----------SP 154 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~-----------~~ 154 (280)
..++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+||+++. ++
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 99999999999999999963 456999999999999999999999999999999999999987 45
Q ss_pred CCcEEEeecCCcccccc---CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHH
Q 023591 155 APRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (280)
Q Consensus 155 ~~~~~l~df~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (280)
. +||+|||++..... ........+++.|+|||.+.+..++.. +||||||+++|+|++|..||........
T Consensus 221 ~--~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~---- 293 (365)
T 3e7e_A 221 G--LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNEGGEC---- 293 (365)
T ss_dssp T--EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCCCEEEETTEE----
T ss_pred C--EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCccccCCCCce----
Confidence 5 99999999964332 222344568999999999988887665 9999999999999999999965432110
Q ss_pred HhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.....+... ..++.+.+++..||+.+|.+|+
T Consensus 294 -----~~~~~~~~~-~~~~~~~~~~~~~l~~~p~~r~ 324 (365)
T 3e7e_A 294 -----KPEGLFRRL-PHLDMWNEFFHVMLNIPDCHHL 324 (365)
T ss_dssp -----EECSCCTTC-SSHHHHHHHHHHHHCCCCTTCC
T ss_pred -----eechhcccc-CcHHHHHHHHHHHcCCCCCCcc
Confidence 000011111 2467899999999999999997
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=300.82 Aligned_cols=244 Identities=20% Similarity=0.311 Sum_probs=193.5
Q ss_pred CCCCeeeecccccCCceEEEEEE-----ecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~-----~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
..++|++.+.||+|+||.||+++ +..+++.||+|.+.... .....+.+|+.++++++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 45899999999999999999999 55678899999986432 233567889999999999999999999999889
Q ss_pred EEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-CCcEEEeec
Q 023591 92 LAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDF 163 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~-------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~~~~~l~df 163 (280)
.++||||+++++|.+++.... .++...++.++.|++.||.+||+.|++|+||+|+||+++.++ ...++|+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence 999999999999999997653 489999999999999999999999999999999999998543 235999999
Q ss_pred CCccccccC---CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhccc
Q 023591 164 GYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQ 239 (280)
Q Consensus 164 ~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 239 (280)
|++...... .......+++.|+|||.+.+..++.. +||||||+++|+|++ |..||....... ....+....
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~~~ 262 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEFVTSGG 262 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHHHHTTC
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCcCHHH----HHHHHhcCC
Confidence 988643222 22234456889999999987777554 999999999999998 999997654322 222222221
Q ss_pred ccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 240 YSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.......+++.+.++|.+||+.||.+||
T Consensus 263 -~~~~~~~~~~~l~~li~~~l~~dp~~Rp 290 (327)
T 2yfx_A 263 -RMDPPKNCPGPVYRIMTQCWQHQPEDRP 290 (327)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCChhhCc
Confidence 1222236899999999999999999999
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=326.41 Aligned_cols=257 Identities=26% Similarity=0.350 Sum_probs=200.5
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEec------CC
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT------PT 90 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 90 (280)
..++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.. ..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 4589999999999999999999999999999999987542 233567889999999999999999998755 56
Q ss_pred eEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC-CcEEEeecCCc
Q 023591 91 HLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYS 166 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~-~~~~l~df~~~ 166 (280)
..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ..++|+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7899999999999999997644 5899999999999999999999999999999999999987653 34899999999
Q ss_pred cccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHH-----H-----HhhHh
Q 023591 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK-----T-----IHRIL 236 (280)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~-----~-----~~~~~ 236 (280)
.............+++.|+|||.+.+..++.. +||||||+++|+|++|..||........+.. . .....
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred cccccccccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 86665555566778999999999988887666 9999999999999999999975422111000 0 00000
Q ss_pred cccccCCC--------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 237 SVQYSIPD--------YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 237 ~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.....+.. ...+++.+.+||.+||+.||++|| .||||+..
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 11111111 113568899999999999999999 89999754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=297.12 Aligned_cols=246 Identities=22% Similarity=0.276 Sum_probs=194.9
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
..++|++.+.||+|+||.||++++. +++.||+|++.... .....+.+|+.++++++||||+++++++..+...++||
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 106 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 106 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEE
T ss_pred HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEE
Confidence 4589999999999999999999864 58889999987643 23346889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhc---CceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 97 EYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~Lh~~---~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
||+++++|.+++.... ++++..++.++.|++.||++||+. |++|+||+|+||+++.++. ++|+|||++...
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~ 184 (326)
T 3uim_A 107 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLM 184 (326)
T ss_dssp ECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCEEC
T ss_pred EeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCcccccc
Confidence 9999999999997643 499999999999999999999999 9999999999999998877 999999998754
Q ss_pred ccCCC--CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCC----CCCcchHHHHHhhHhcccc-c-
Q 023591 170 VLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED----PEEPKNFRKTIHRILSVQY-S- 241 (280)
Q Consensus 170 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~----~~~~~~~~~~~~~~~~~~~-~- 241 (280)
..... .....+++.|+|||.+.+..++.. +||||||+++|+|++|..||.. ................... .
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHHSEECHH-HHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred CcccccccccccCCcCccCHHHhccCCCCcc-ccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence 32222 233458999999999987777555 9999999999999999999952 1111222222222111110 0
Q ss_pred -----C--CCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 242 -----I--PDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 242 -----~--~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
. ......+..+.+++.+||+.||.+||
T Consensus 264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 297 (326)
T 3uim_A 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP 297 (326)
T ss_dssp SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSC
T ss_pred hcChhhccccCHHHHHHHHHHHHHHhCcCCccCC
Confidence 0 00012236799999999999999999
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=297.78 Aligned_cols=237 Identities=27% Similarity=0.421 Sum_probs=176.6
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCC-CCCeeeeceEEe--------cC
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVIL--------TP 89 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--------~~ 89 (280)
..+|++.+.||+|+||.||++++..+++.||+|.+.... ...+.+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 458999999999999999999999999999999986654 23356788999999995 999999999984 33
Q ss_pred CeEEEEEeccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 90 THLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
..++++|||++ ++|.+++.. ..++++..++.++.||+.||.|||+.| ++|+||+|+||+++.++. ++|+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFG 183 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCCT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEecCc
Confidence 46899999996 589888754 457999999999999999999999999 999999999999998877 9999999
Q ss_pred CccccccCCCC-------------CCCcCCCcccCccccc---CCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchH
Q 023591 165 YSKSSVLHSQP-------------KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (280)
Q Consensus 165 ~~~~~~~~~~~-------------~~~~~~~~~~aPE~~~---~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (280)
++......... ....+++.|+|||.+. +..+ ..++||||||+++|+|++|..||.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~-- 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence 98754332221 1345788999999983 4444 445999999999999999999997644321
Q ss_pred HHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
+.......+.....++.+.+||.+||+.||.+||
T Consensus 261 ------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 294 (337)
T 3ll6_A 261 ------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL 294 (337)
T ss_dssp -----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSC
T ss_pred ------hhcCcccCCcccccchHHHHHHHHHccCChhhCc
Confidence 1222233333446788999999999999999999
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=292.07 Aligned_cols=246 Identities=22% Similarity=0.274 Sum_probs=193.6
Q ss_pred CCCCCCCCeeeecccccCCceEEEEEEecCC---CcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEe-c
Q 023591 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVIL-T 88 (280)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 88 (280)
.+.....+|++.+.||+|+||.||++.+..+ +..+|+|.+..... ..+.+.+|+.++++++||||+++++++. .
T Consensus 19 ~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp BCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred ecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 3445567899999999999999999996543 34588998865332 3356788999999999999999999854 4
Q ss_pred CCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 89 PTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
+...+++|||+++++|.+++.. ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~a~ 176 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR 176 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSCGGGC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC--EEECcccccc
Confidence 5678999999999999999975 446899999999999999999999999999999999999988876 9999999987
Q ss_pred ccccCC-----CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhccccc
Q 023591 168 SSVLHS-----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYS 241 (280)
Q Consensus 168 ~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
...... ......+++.|+|||.+.+..++.. +||||||+++|+|++ +.+||............... ....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 252 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---RRLL 252 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT---CCCC
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC---CCCC
Confidence 443222 1223346678999999987777655 999999999999999 56667665544333322221 1112
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 242 IPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+ ..+++.+.++|.+||+.||++||
T Consensus 253 ~~--~~~~~~l~~li~~~l~~~p~~Rp 277 (298)
T 3f66_A 253 QP--EYCPDPLYEVMLKCWHPKAEMRP 277 (298)
T ss_dssp CC--TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CC--ccCCHHHHHHHHHHcCCChhhCc
Confidence 22 25789999999999999999999
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=315.75 Aligned_cols=241 Identities=23% Similarity=0.345 Sum_probs=199.9
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
...++|++.+.||+|+||.||++.+.. +..||||++.......+.+.+|+.++++++|+||+++++++.. ...++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 456789999999999999999999875 4569999998776666789999999999999999999999865 67899999
Q ss_pred ccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC--C
Q 023591 98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S 173 (280)
Q Consensus 98 ~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~--~ 173 (280)
|+.+++|.+++.. ...+++..+..++.||+.||+|||++|++||||+|+||+++.++. +||+|||++...... .
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCHHHH
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCCcee
Confidence 9999999999964 356999999999999999999999999999999999999988776 999999998744321 1
Q ss_pred CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
......++..|+|||.+.+..++.. +||||||+++|+|++ |..||......+.. ..+.. ....+....+++++
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlGv~l~el~t~g~~P~~~~~~~~~~----~~i~~-~~~~~~~~~~~~~l 493 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVL----DQVER-GYRMPCPPECPESL 493 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTTCCSSTTCCHHHHH----HHHHT-TCCCCCCTTCCHHH
T ss_pred cccCCcCcccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHc-CCCCCCCCCCCHHH
Confidence 1223345678999999987777555 999999999999999 99999875443222 22221 22233333789999
Q ss_pred HHHHHHhcccCCCCcC
Q 023591 253 RHLISRIFVADPAKSE 268 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp 268 (280)
.+||.+||+.||++||
T Consensus 494 ~~li~~cl~~dP~~RP 509 (535)
T 2h8h_A 494 HDLMCQCWRKEPEERP 509 (535)
T ss_dssp HHHHHHHTCSSGGGSC
T ss_pred HHHHHHHcCCChhHCc
Confidence 9999999999999999
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=298.81 Aligned_cols=255 Identities=24% Similarity=0.286 Sum_probs=186.5
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEec-----CCeE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHL 92 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~ 92 (280)
...++|++.+.||+|+||.||+++. +++.||+|++............++..+..++|+||+++++.+.. ...+
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 3568999999999999999999977 57899999987654332233334444556899999999975542 2367
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---------CceecCCCCCcEEEeCCCCCcEEEeec
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---------QVCHRDLKLENTLLDGSPAPRLKICDF 163 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~---------~i~h~dl~~~ni~i~~~~~~~~~l~df 163 (280)
++||||+++++|.+++.... .++..++.++.||+.||.|||+. |++||||||+||+++.++. +||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC--EEECCC
T ss_pred EEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc--EEEeec
Confidence 89999999999999996544 58999999999999999999999 9999999999999998876 999999
Q ss_pred CCccccccCC---------CCCCCcCCCcccCcccccCC------cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcch-
Q 023591 164 GYSKSSVLHS---------QPKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN- 227 (280)
Q Consensus 164 ~~~~~~~~~~---------~~~~~~~~~~~~aPE~~~~~------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~- 227 (280)
|++....... ......+++.|+|||.+.+. ...+.++||||||+++|+|++|..||........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 9997543221 12244689999999998763 1223448999999999999999777644322111
Q ss_pred -------------HHHHHhhHhc--ccccCCC----CCCCCHHHHHHHHHhcccCCCCcC------------CCcccccc
Q 023591 228 -------------FRKTIHRILS--VQYSIPD----YVHISPECRHLISRIFVADPAKSE------------MHDWRRGC 276 (280)
Q Consensus 228 -------------~~~~~~~~~~--~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rp------------~h~~~~~~ 276 (280)
.......... ....++. ....++++.+||.+||+.||++|| .++|.++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 0111111111 1112221 112345799999999999999999 67887765
Q ss_pred c
Q 023591 277 S 277 (280)
Q Consensus 277 ~ 277 (280)
.
T Consensus 325 ~ 325 (336)
T 3g2f_A 325 S 325 (336)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=305.00 Aligned_cols=242 Identities=23% Similarity=0.253 Sum_probs=195.8
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCC-CCeeeeceEEecCCeEEEEEec
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
.++|++.+.||+|+||.||++++..+++.||||++.... ....+.+|+.+++.++| +++..+..++......++||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 478999999999999999999999999999999876543 33467889999999977 5566666677778889999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEE---eCCCCCcEEEeecCCccccccCCC
Q 023591 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 99 ~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i---~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||++ +.++. +||+|||++........
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~--vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKKYRDTST 161 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTTT
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe--EEEEeCCcceeccCCcc
Confidence 9 8899999975 5679999999999999999999999999999999999999 45555 99999999975443322
Q ss_pred --------CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHH---HHhhHhccc-ccC
Q 023591 175 --------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK---TIHRILSVQ-YSI 242 (280)
Q Consensus 175 --------~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~-~~~ 242 (280)
.....+++.|+|||.+.+..++.. +||||||+++|+|++|..||........... ......... ..+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 225568999999999988877555 9999999999999999999987654322221 111111111 011
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 243 PDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
. ..+++++.+||..||+.||++||
T Consensus 241 ~--~~~p~~l~~li~~cl~~dP~~RP 264 (483)
T 3sv0_A 241 C--RGYPTEFASYFHYCRSLRFDDKP 264 (483)
T ss_dssp H--TTSCHHHHHHHHHHHTCCTTCCC
T ss_pred h--cCCcHHHHHHHHHHhcCChhhCc
Confidence 1 25789999999999999999999
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=307.44 Aligned_cols=248 Identities=25% Similarity=0.308 Sum_probs=188.3
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEe
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
...+|++.+.||+|+||+|+. ....+++.||||.+.... ...+.+|+.+++++ +||||+++++++.+....++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 345799999999999999764 444578999999986543 23456899999999 89999999999999999999999
Q ss_pred ccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC---CCCCcEEEeecCCccccccCC
Q 023591 98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~---~~~~~~~l~df~~~~~~~~~~ 173 (280)
|++ ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++. ++..+++|+|||++.......
T Consensus 99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 996 59999987654 4566677899999999999999999999999999999953 444458899999987544332
Q ss_pred ----CCCCCcCCCcccCcccccC---CcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhccccc-CCC
Q 023591 174 ----QPKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYS-IPD 244 (280)
Q Consensus 174 ----~~~~~~~~~~~~aPE~~~~---~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 244 (280)
......+++.|+|||.+.+ ..+ +.++|||||||++|+|++ |..||....... ..... ...... ...
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~-t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--~~~~~--~~~~~~~~~~ 252 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--ANILL--GACSLDCLHP 252 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CC-CTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--HHHHT--TCCCCTTSCT
T ss_pred cceeeccccCCCcCccChhhhhcccccCC-CcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--HHHHh--ccCCccccCc
Confidence 2234568999999999874 333 335999999999999999 999996543221 11111 111111 111
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 245 YVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
....+..+.+||.+||+.||.+|| .||||..
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 123456689999999999999999 9999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=299.49 Aligned_cols=242 Identities=22% Similarity=0.268 Sum_probs=186.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCC---CcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEec-CCeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 92 (280)
...+|++.+.||+|+||.||++.+..+ +..||+|.+.... ...+.+.+|+.++++++||||+++++++.. ++..
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 445689999999999999999987543 2468999886533 233568899999999999999999998654 4578
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++||||+|+||+++.++. +||+|||++.....
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYD 244 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC--------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeeccccccccc
Confidence 9999999999999999764 45899999999999999999999999999999999999998876 99999999874432
Q ss_pred CCC-----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCC
Q 023591 172 HSQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245 (280)
Q Consensus 172 ~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (280)
... .....+++.|+|||.+.+..++.. +||||||+++|+|++ |.+||......+........ .....+
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~---~~~~~p-- 318 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---RRLLQP-- 318 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT---CCCCCC--
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcH-HHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC---CCCCCC--
Confidence 221 122345678999999987777655 999999999999999 77888766554433322221 111222
Q ss_pred CCCCHHHHHHHHHhcccCCCCcC
Q 023591 246 VHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..+++.+.++|.+||+.||++||
T Consensus 319 ~~~~~~l~~li~~cl~~dp~~RP 341 (373)
T 3c1x_A 319 EYCPDPLYEVMLKCWHPKAEMRP 341 (373)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCHHHHHHHHHHcCCChhhCc
Confidence 36899999999999999999999
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=305.53 Aligned_cols=244 Identities=26% Similarity=0.320 Sum_probs=185.2
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEEEecc
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
+.|.+.+.||+|+||+||.+. ..+|+.||+|.+.... .+.+.+|+.+++++ +||||+++++++.++..+++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 567778999999999998654 4578999999987532 35677899999876 8999999999999999999999999
Q ss_pred CCCchHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-----------CCcEEEe
Q 023591 100 SGGELFERICNAGRF-------SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-----------APRLKIC 161 (280)
Q Consensus 100 ~~~~L~~~~~~~~~l-------~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-----------~~~~~l~ 161 (280)
+ ++|.+++...... ++..++.++.||+.||+|||+.|++||||||+||+++.++ ..+++|+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 6 5999999765432 2334578999999999999999999999999999997642 3469999
Q ss_pred ecCCccccccCCC-----CCCCcCCCcccCcccccC-------CcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchH
Q 023591 162 DFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLK-------KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (280)
Q Consensus 162 df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~ 228 (280)
|||++........ .....+++.|+|||.+.+ ..+ +.++|||||||++|+|++ |..||.......
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-- 247 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRL-TRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-- 247 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCC-CTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCc-chhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence 9999975543321 223468999999999865 334 445999999999999999 999997654321
Q ss_pred HHHHhhHhcccccCCC-----CCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 229 RKTIHRILSVQYSIPD-----YVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 229 ~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
..... .....+. ...+++++.+||.+||+.||.+|| .||||..
T Consensus 248 ~~i~~----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 248 SNIIR----GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHHH----TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HHHhc----CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 12222 2222211 112457899999999999999999 9999964
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=314.32 Aligned_cols=241 Identities=27% Similarity=0.392 Sum_probs=193.2
Q ss_pred CCCCeeeec-ccccCCceEEEEEEec--CCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 19 DSDRYELVR-DIGSGNFGVARLMRDK--KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~-~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
..+++.+.+ .||+|+||.||++.+. .++..||||++.... ...+.+.+|+.++++++||||+++++++.. +.++
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 411 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence 345566666 8999999999999875 356679999997643 345678999999999999999999999876 5689
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||+|+||+++.++. +||+|||++......
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALGAD 489 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC--
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCcccccCC
Confidence 999999999999998654 46999999999999999999999999999999999999998876 999999999754322
Q ss_pred CCC----CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 173 SQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 173 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
... ....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||......+....+... .....+ ..
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~---~~~~~p--~~ 563 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRMECP--PE 563 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT---CCCCCC--TT
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---CCCCCC--Cc
Confidence 211 12234578999999987777655 999999999999998 99999886654333222211 122233 36
Q ss_pred CCHHHHHHHHHhcccCCCCcC
Q 023591 248 ISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp 268 (280)
+++++.+||.+||+.||++||
T Consensus 564 ~~~~l~~li~~cl~~dP~~RP 584 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRP 584 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSC
T ss_pred CCHHHHHHHHHHcCCChhHCc
Confidence 899999999999999999999
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=289.89 Aligned_cols=241 Identities=25% Similarity=0.313 Sum_probs=192.8
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-----cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
.|...+.||+|+||.||++.+ +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+....+++|
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 355568999999999999987 57789999987532 23456889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 97 EYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 97 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
||+++++|.+++.. ..++++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT--AKISDFGLARASEKFA 187 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSCS
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc--EEEeeccccccccccc
Confidence 99999999999863 346999999999999999999999999999999999999988776 9999999987443322
Q ss_pred C---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccccc--------C
Q 023591 174 Q---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--------I 242 (280)
Q Consensus 174 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~ 242 (280)
. .....+++.|+|||.+.+ .++. ++||||||+++|+|++|..||...............+...... .
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~-~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRG-EITP-KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTT-EECT-HHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred ccccccccCCCcCcCChHHhcC-CCCc-cchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 1 234468899999998865 3544 4999999999999999999998766544333333322221110 0
Q ss_pred C-CCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 243 P-DYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 243 ~-~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
+ .....++.+.+++.+||+.||.+||
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rp 292 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRP 292 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSC
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCc
Confidence 0 0112456799999999999999999
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=292.52 Aligned_cols=242 Identities=22% Similarity=0.333 Sum_probs=192.1
Q ss_pred CCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
....++|++.+.||+|+||.||++.+.. .+++|++.... ...+.+.+|+.++++++|+||+++++++..+...+
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 3456899999999999999999999854 38999987532 33355778999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-
Q 023591 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~- 171 (280)
++|||+++++|.+++...+ .+++..++.++.|++.||++||+.|++|+||+|+||+++ ++. ++|+|||++.....
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~--~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGK--VVITDFGLFSISGVL 182 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---C--CEECCCSCCC-----
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCC--EEEeecCCccccccc
Confidence 9999999999999997654 699999999999999999999999999999999999998 444 99999998763321
Q ss_pred -----CCCCCCCcCCCcccCcccccCC--------cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc
Q 023591 172 -----HSQPKSTVGTPAYIAPEVLLKK--------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238 (280)
Q Consensus 172 -----~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 238 (280)
........+++.|+|||.+.+. .....++||||||+++|+|++|..||......... ..+...
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~ 258 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII----WQMGTG 258 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH----HHHHTT
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHhccC
Confidence 1122334578899999998652 22345599999999999999999999875433222 222222
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 239 QYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.........++.++.++|.+||+.||++||
T Consensus 259 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 288 (319)
T 2y4i_B 259 MKPNLSQIGMGKEISDILLFCWAFEQEERP 288 (319)
T ss_dssp CCCCCCCSSCCTTHHHHHHHHHCSSTTTSC
T ss_pred CCCCCCcCCCCHHHHHHHHHHhcCChhhCc
Confidence 222222225788999999999999999999
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=314.41 Aligned_cols=237 Identities=24% Similarity=0.336 Sum_probs=191.1
Q ss_pred Ceeee-cccccCCceEEEEEEe--cCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 22 RYELV-RDIGSGNFGVARLMRD--KKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 22 ~y~~~-~~lg~G~~g~v~~~~~--~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
.+.+. +.||+|+||.||++.+ ..+++.||||++..... ..+.+.+|+.++++++||||+++++++.. ...++|
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv 447 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 447 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence 34443 4799999999999954 45678899999876432 34678899999999999999999999864 558899
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 174 (280)
|||+++++|.+++.....+++..++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||++........
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENY 525 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC----
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCccc
Confidence 999999999999988888999999999999999999999999999999999999998886 99999999874433221
Q ss_pred ---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcc-cccCCCCCCCC
Q 023591 175 ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHIS 249 (280)
Q Consensus 175 ---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 249 (280)
.....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||.......... .+... ....+. .++
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~----~i~~~~~~~~p~--~~~ 598 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA----MLEKGERMGCPA--GCP 598 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHHTTCCCCCCT--TCC
T ss_pred cccccCCCCceeeeChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHcCCCCCCCC--CCC
Confidence 122335678999999987777655 999999999999998 999998765432222 22221 222333 689
Q ss_pred HHHHHHHHHhcccCCCCcC
Q 023591 250 PECRHLISRIFVADPAKSE 268 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp 268 (280)
+++.+||.+||+.||++||
T Consensus 599 ~~l~~li~~cl~~dP~~RP 617 (635)
T 4fl3_A 599 REMYDLMNLCWTYDVENRP 617 (635)
T ss_dssp HHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHHHcCCCHhHCc
Confidence 9999999999999999999
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=291.15 Aligned_cols=242 Identities=24% Similarity=0.299 Sum_probs=192.9
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhh--CCCCCeeeeceEEecCC----eEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTPT----HLA 93 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~~ 93 (280)
.++|++.+.||+|+||.||++++ +++.||+|++... ....+.+|.++++. ++||||+++++++..+. ..+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 37899999999999999999998 4889999998653 33566778888877 79999999999998775 799
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hcCceecCCCCCcEEEeCCCCCcEEEeecCC
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh--------~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~ 165 (280)
+||||+++++|.+++.+ ..+++..++.++.|++.||.+|| +.|++|+||+|+||+++.++. ++|+|||+
T Consensus 117 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~ 193 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL 193 (342)
T ss_dssp EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTT
T ss_pred EEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCC
Confidence 99999999999999965 46899999999999999999999 899999999999999998887 99999999
Q ss_pred ccccccCC-----CCCCCcCCCcccCcccccCCcCCC-----ccchhhHHHHHHHHHHhC----------CCCCCCCCCc
Q 023591 166 SKSSVLHS-----QPKSTVGTPAYIAPEVLLKKEYDG-----KIADVWSCGVTLYVMLVG----------AYPFEDPEEP 225 (280)
Q Consensus 166 ~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~-----~~~DiwslG~~l~~l~~g----------~~p~~~~~~~ 225 (280)
+....... ......+++.|+|||.+.+..... .++||||||+++|+|++| ..||......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 87544333 234556899999999987653221 459999999999999999 7888765433
Q ss_pred ch-HHHHHhhHhccccc--CCC---CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 226 KN-FRKTIHRILSVQYS--IPD---YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 226 ~~-~~~~~~~~~~~~~~--~~~---~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.. .......+...... ++. ....++.+.+||.+||+.||++||
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 322 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322 (342)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCC
Confidence 22 22222332222221 111 112345799999999999999999
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=281.36 Aligned_cols=226 Identities=15% Similarity=0.118 Sum_probs=179.8
Q ss_pred CCCCCCCC--CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc----HHHHHHHHHhhhCCCCCeeeece
Q 023591 11 GMDMPIMH--DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKE 84 (280)
Q Consensus 11 ~~~~~~~~--~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~ 84 (280)
++.+..+. ..++|++.+.||+|+||.||++++..+++.||+|++....... +.+.+|+..+.+++||||+++++
T Consensus 19 ~~~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~ 98 (286)
T 3uqc_A 19 DVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD 98 (286)
T ss_dssp -CCCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CCcCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeE
Confidence 44444443 4478999999999999999999999999999999998754433 66888999999999999999999
Q ss_pred EEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
++..++..++||||+++++|.+++... .....+..++.|++.||+|||+.|++|+||||+||+++.++. ++|++++
T Consensus 99 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~ 174 (286)
T 3uqc_A 99 VVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA 174 (286)
T ss_dssp EEEETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCC
T ss_pred EEEECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEecc
Confidence 999999999999999999999998543 466788999999999999999999999999999999998887 8888543
Q ss_pred CccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC--
Q 023591 165 YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI-- 242 (280)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 242 (280)
. .+| + ..++||||||+++|+|++|..||...+............ ......
T Consensus 175 ~-------------------~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (286)
T 3uqc_A 175 T-------------------MPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPIEPA 226 (286)
T ss_dssp C-------------------CTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT-TSCBCCHH
T ss_pred c-------------------cCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh-ccCCCChh
Confidence 2 222 2 455999999999999999999998765432111000000 111100
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 243 PDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.....+++++.+||.+||+.||++|-
T Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rs 252 (286)
T 3uqc_A 227 DIDRDIPFQISAVAARSVQGDGGIRS 252 (286)
T ss_dssp HHCTTSCHHHHHHHHHHHCTTSSCCC
T ss_pred hcccCCCHHHHHHHHHHcccCCccCC
Confidence 01236899999999999999999993
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=309.04 Aligned_cols=241 Identities=24% Similarity=0.387 Sum_probs=193.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCC---CcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
..++|++.+.||+|+||.||++.+..+ +..||+|.+.... ...+.+.+|+.++++++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 457899999999999999999998643 4578999876533 22356889999999999999999999984 56689
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCCC-
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecCCC
Confidence 9999999999999997654 6999999999999999999999999999999999999998876 999999998754332
Q ss_pred CCC--CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 173 SQP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 173 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
... ....+++.|+|||.+.+..++.. +||||||+++|+|++ |..||.............. ......+ ..++
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~---~~~~~~~--~~~~ 618 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---GERLPMP--PNCP 618 (656)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH---TCCCCCC--TTCC
T ss_pred cceeccCCCCCcceeCHHHhcCCCCCch-hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc---CCCCCCC--cccc
Confidence 221 22345678999999987777555 999999999999997 9999987554332222211 1122233 3689
Q ss_pred HHHHHHHHHhcccCCCCcC
Q 023591 250 PECRHLISRIFVADPAKSE 268 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp 268 (280)
+.+.+||.+||+.||++||
T Consensus 619 ~~l~~li~~~l~~dP~~RP 637 (656)
T 2j0j_A 619 PTLYSLMTKCWAYDPSRRP 637 (656)
T ss_dssp HHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHcCCChhHCc
Confidence 9999999999999999999
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=297.92 Aligned_cols=241 Identities=14% Similarity=0.080 Sum_probs=184.4
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCC-CCe---------eeece
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH-PNI---------VRFKE 84 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h-~~i---------v~~~~ 84 (280)
...+|.+.+.||+|+||.||++++..+++.||||++... ....+.+.+|+.+++.++| +|. +...+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 335689999999999999999999999999999998733 2335678899999999977 321 11111
Q ss_pred E------------Eec-----CCeEEEEEeccCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCcee
Q 023591 85 V------------ILT-----PTHLAIVMEYASGGELFERICN-------AGRFSEDEARFFFQQLISGVSYCHSMQVCH 140 (280)
Q Consensus 85 ~------------~~~-----~~~~~lv~e~~~~~~L~~~~~~-------~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h 140 (280)
. +.. ...++++|+.+ +++|.+++.. ...+++..+..++.||+.||+|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 1 111 12467888876 5699888841 234778899999999999999999999999
Q ss_pred cCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcCCCcccCcccc----------cCCcCCCccchhhHHHHHHH
Q 023591 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL----------LKKEYDGKIADVWSCGVTLY 210 (280)
Q Consensus 141 ~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~~DiwslG~~l~ 210 (280)
|||||+||+++.++. +||+|||+++..... .....+ +.|+|||.+ .+..++ .++||||||+++|
T Consensus 235 rDiKp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~DvwSlGvil~ 308 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMT-FAFDTWTLGLAIY 308 (413)
T ss_dssp SCCCGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEEC-HHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCC-chhhHHHHHHHHH
Confidence 999999999998887 999999998754333 233456 999999998 333444 4599999999999
Q ss_pred HHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 211 VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 211 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
+|++|..||.......... ..+.....+|+++.+||.+||+.||++|| .||||++.
T Consensus 309 elltg~~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSE----------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSG----------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHCCCCCCCcchhhhHH----------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 9999999997654322111 11222236889999999999999999999 99999754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=312.94 Aligned_cols=227 Identities=22% Similarity=0.278 Sum_probs=184.6
Q ss_pred CCCeeeecccccCCceEEEEEEecC-CCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCe-----
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH----- 91 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 91 (280)
.++|++.+.||+|+||.||++.+.. +++.||||++.... .....+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4899999999999999999999976 78999999886543 223457789999999999999999999987554
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
.++||||+++++|.+.+.. .+++..++.++.||+.+|.|||+.||+||||||+||+++.+ . +||+|||++.....
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~--~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-Q--LKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-C--EEECCCTTCEETTC
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-c--EEEEecccchhccc
Confidence 7999999999999887754 79999999999999999999999999999999999999875 3 99999999875433
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
. ....+++.|+|||.+.+.. +.++||||||+++|+|++|..||......... ........++.
T Consensus 234 ~---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------~~~~~~~~~~~ 296 (681)
T 2pzi_A 234 F---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------EDDPVLKTYDS 296 (681)
T ss_dssp C---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------------TTCHHHHHCHH
T ss_pred C---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCccccccccc------------ccccccccCHH
Confidence 2 4556899999999986654 45599999999999999999888653211000 00000023578
Q ss_pred HHHHHHHhcccCCCCcC
Q 023591 252 CRHLISRIFVADPAKSE 268 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp 268 (280)
+.+||.+||+.||.+||
T Consensus 297 l~~li~~~l~~dP~~R~ 313 (681)
T 2pzi_A 297 YGRLLRRAIDPDPRQRF 313 (681)
T ss_dssp HHHHHHHHTCSSGGGSC
T ss_pred HHHHHhhhccCChhhCC
Confidence 99999999999999999
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=295.12 Aligned_cols=243 Identities=18% Similarity=0.212 Sum_probs=184.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---------ccHHHHHHHHHhhhCC---------CCCee
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLR---------HPNIV 80 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~---------h~~iv 80 (280)
..++|++.+.||+|+||+||++++ +++.||+|++..... ..+.+.+|+.+++.++ |+||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357899999999999999999998 679999999987532 2267888999888875 66666
Q ss_pred eeceEE-----------------ec-------------CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 023591 81 RFKEVI-----------------LT-------------PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130 (280)
Q Consensus 81 ~~~~~~-----------------~~-------------~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l 130 (280)
++.+++ .+ +..+++||||++++++.+.+.+ ..+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 666553 22 6789999999998876665533 5689999999999999999
Q ss_pred HHHH-hcCceecCCCCCcEEEeCCCC------------------CcEEEeecCCccccccCCCCCCCcCCCcccCccccc
Q 023591 131 SYCH-SMQVCHRDLKLENTLLDGSPA------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191 (280)
Q Consensus 131 ~~Lh-~~~i~h~dl~~~ni~i~~~~~------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 191 (280)
+||| +.||+||||||+||+++.++. ..+||+|||+++.... ....+++.|+|||.+.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhc
Confidence 9999 999999999999999998761 1499999999985442 2447899999999997
Q ss_pred CCcCCCccchhhHHHHH-HHHHHhCCCCCCCCCCcchH-HHHHhhHh-cccccCCC----CCCCCHHHHHHHHHhcccCC
Q 023591 192 KKEYDGKIADVWSCGVT-LYVMLVGAYPFEDPEEPKNF-RKTIHRIL-SVQYSIPD----YVHISPECRHLISRIFVADP 264 (280)
Q Consensus 192 ~~~~~~~~~DiwslG~~-l~~l~~g~~p~~~~~~~~~~-~~~~~~~~-~~~~~~~~----~~~~~~~l~~li~~~l~~dp 264 (280)
+.. ..++||||++++ .+++++|..||... .+ ......+. ........ ...+|+++.+||++||+.|.
T Consensus 251 g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~ds 324 (336)
T 2vuw_A 251 GDG--DYQFDIYRLMKKENNNRWGEYHPYSNV----LWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSS 324 (336)
T ss_dssp CCS--SHHHHHHHHHHHHHTTCTTSCCTHHHH----HHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSSS
T ss_pred CCC--ccceehhhhhCCCCcccccccCCCcch----hhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccCC
Confidence 665 445999998777 77788899988431 11 11111111 11111110 12467899999999999985
Q ss_pred CCcC--CCcccc
Q 023591 265 AKSE--MHDWRR 274 (280)
Q Consensus 265 ~~Rp--~h~~~~ 274 (280)
.+.. .||||+
T Consensus 325 a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 325 ATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHCGGGC
T ss_pred HHHHHhcCCCcC
Confidence 4444 599985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-33 Score=248.70 Aligned_cols=182 Identities=14% Similarity=0.050 Sum_probs=131.4
Q ss_pred ccccCCceEEEEEEecCCCcEEEEEEeeeCC-----------cccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeEEEE
Q 023591 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 28 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 95 (280)
.++.|+.|....++..-.|+.+++|++.+.. ...+++.+|+++|+++ .|+||++++++++++..+|+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4566777777777776778999999997642 2225688999999999 799999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CC
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~ 174 (280)
|||++|++|.+++...+++++. +++.||+.||+|+|++||+||||||+|||++.++. +||+|||+|+..... ..
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCcc
Confidence 9999999999999998888876 47899999999999999999999999999998887 999999998754332 22
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCC
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA 216 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~ 216 (280)
.....+|+.|+|||++.+.. ... +|+||+|+++++|.++.
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~-~~~-~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENK-SWN-GFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred ccCceechhhccHHHhCCCC-CCc-ccccccccchhhhcccc
Confidence 33456899999999987653 334 89999999888765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=216.65 Aligned_cols=180 Identities=20% Similarity=0.127 Sum_probs=137.9
Q ss_pred eecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---------cHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
..+.||+|+||.||++.. .++.+++|........ .+.+.+|+.++++++||||+++..++..++..++|
T Consensus 340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 356899999999999954 4677899986542211 23468999999999999999666666667778999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 174 (280)
|||+++++|.+++.. +..++.|++.+|.|||++||+||||||+||+++. . +||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~--~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--D--LYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--S--EEECCCTTCEECCCHHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--e--EEEEECccCEECCCcccc
Confidence 999999999998854 6789999999999999999999999999999987 4 99999999985543221
Q ss_pred -------CCCCcCCCcccCcccccC--CcCCCccchhhHHHHHHHHHHhCCCCC
Q 023591 175 -------PKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPF 219 (280)
Q Consensus 175 -------~~~~~~~~~~~aPE~~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~ 219 (280)
.....+|+.|+|||++.. ..|... +|+|+..+-..+...++.+|
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhcccc
Confidence 124468999999999876 445444 89999988888777766655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=182.67 Aligned_cols=141 Identities=18% Similarity=0.174 Sum_probs=112.8
Q ss_pred eeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-------------------ccHHHHHHHHHhhhCCCCCeeeece
Q 023591 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRFKE 84 (280)
Q Consensus 24 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~e~~~l~~l~h~~iv~~~~ 84 (280)
++.+.||+|+||.||++.+ .+++.||+|.+..... ....+.+|+.++++++ | +++.+
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 3449999999999999999 7899999999864321 2345789999999998 5 66666
Q ss_pred EEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
++.. +..++||||+++++|.+ +. ......++.|++.||.+||+.|++|+||||+||+++ ++. ++|+|||
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~--vkl~DFG 237 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG--IWIIDFP 237 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE--EEECCCT
T ss_pred EEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc--EEEEECC
Confidence 5543 45699999999999987 31 134557999999999999999999999999999999 665 9999999
Q ss_pred CccccccCCCCCCCcCCCcccCccccc
Q 023591 165 YSKSSVLHSQPKSTVGTPAYIAPEVLL 191 (280)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~aPE~~~ 191 (280)
++.. +..+.|||.+.
T Consensus 238 ~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 238 QSVE------------VGEEGWREILE 252 (282)
T ss_dssp TCEE------------TTSTTHHHHHH
T ss_pred CCeE------------CCCCCHHHHHH
Confidence 8872 23457788763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-22 Score=160.96 Aligned_cols=136 Identities=15% Similarity=0.097 Sum_probs=106.4
Q ss_pred CeeeecccccCCceEEEEEEecCCCcE--EEEEEeeeCCcc-------------------------cHHHHHHHHHhhhC
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGDKI-------------------------DENVQREIINHRSL 74 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~--vaiK~~~~~~~~-------------------------~~~~~~e~~~l~~l 74 (280)
-|++.+.||+|+||.||++.+..+|+. ||||++...... ...+.+|+..++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999999778888 999987543211 12577899999999
Q ss_pred CCCCe--eeeceEEecCCeEEEEEeccCC-C----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hcCceecCCCCC
Q 023591 75 RHPNI--VRFKEVILTPTHLAIVMEYASG-G----ELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLE 146 (280)
Q Consensus 75 ~h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh-~~~i~h~dl~~~ 146 (280)
.|+++ +.+++. ...++||||+.+ + +|.+.... .++..+..++.|++.+|.+|| +.|++||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 88764 333332 246899999942 3 67665432 235578899999999999999 999999999999
Q ss_pred cEEEeCCCCCcEEEeecCCccc
Q 023591 147 NTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 147 ni~i~~~~~~~~~l~df~~~~~ 168 (280)
||+++. . ++|+|||++..
T Consensus 201 NILl~~--~--~~liDFG~a~~ 218 (258)
T 1zth_A 201 NIMYID--K--VYFIDMGQAVT 218 (258)
T ss_dssp SEEESS--S--EEECCCTTCEE
T ss_pred HEEEcC--c--EEEEECccccc
Confidence 999986 3 99999998863
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.5e-19 Score=147.76 Aligned_cols=137 Identities=15% Similarity=0.125 Sum_probs=98.9
Q ss_pred CeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---------------cHH--------HHHHHHHhhhCCCCC
Q 023591 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------------DEN--------VQREIINHRSLRHPN 78 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---------------~~~--------~~~e~~~l~~l~h~~ 78 (280)
=|++.+.||+|++|.||+|.+. +|+.||||+++..... ... ..+|...+.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3899999999999999999985 6899999987532100 011 134666666664444
Q ss_pred eeeeceEEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCC--
Q 023591 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-- 156 (280)
Q Consensus 79 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~-- 156 (280)
+....-+... ..++||||++|.+|.++. +......++.|++.+|.+||+.|++||||||.|||++.++..
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 3222222222 237999999998886542 223456788999999999999999999999999999877632
Q ss_pred ------cEEEeecCCcc
Q 023591 157 ------RLKICDFGYSK 167 (280)
Q Consensus 157 ------~~~l~df~~~~ 167 (280)
.+.++||+.+.
T Consensus 247 ~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMV 263 (397)
T ss_dssp TTSEEEEEEECCCTTCE
T ss_pred ccccccceEEEEeCCcc
Confidence 37899998765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=6.8e-14 Score=112.71 Aligned_cols=139 Identities=17% Similarity=0.121 Sum_probs=110.0
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCC-CCCeeeeceEEecCCeEEEEEe
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 97 (280)
.+.|++...++.|+.+.||++... +..+++|...... .....+.+|+..++.+. +..+.++++++...+..++|||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 357999999999999999999754 5789999886532 23346889999998884 5667789998888889999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS------------------------------------------ 135 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~------------------------------------------ 135 (280)
+++|.+|.+.. .+......++.+++++|..||+
T Consensus 91 ~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 91 EADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred ecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 99999987652 1223345778899999999998
Q ss_pred -----------------cCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 136 -----------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 136 -----------------~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
..++|||++|.||+++.++. +.++||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV--SGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEE--EEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcE--EEEEEchhcc
Confidence 45899999999999986432 5699998654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.39 E-value=3.9e-12 Score=102.09 Aligned_cols=134 Identities=13% Similarity=0.112 Sum_probs=98.2
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCC--eeeeceEEecCCeEEEEEec
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~ 98 (280)
..|.+....+.|..+.||++.. .+|..+++|..... ....+.+|+..++.+.+.+ +.+++++...++..++|||+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 4567665555677799999965 45677999986654 3356788999998885444 45588888777789999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ----------------------------------------- 137 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~----------------------------------------- 137 (280)
++|.++. . ...+. ..++.+++..|..||+..
T Consensus 97 i~G~~l~--~---~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 97 VPGQDLL--S---SHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp CSSEETT--T---SCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cCCcccC--c---CcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 9998874 1 11222 256677777777777643
Q ss_pred -----------------ceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 138 -----------------VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 138 -----------------i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
++|+|++|.||+++.++. +.|+||+.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRF--SGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEE--EEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcE--EEEEcchhcc
Confidence 999999999999986543 5699999765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.2e-11 Score=104.17 Aligned_cols=141 Identities=14% Similarity=0.212 Sum_probs=104.9
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEee--eCC--cccHHHHHHHHHhhhCCC--CCeeeeceEEecC---CeEE
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGD--KIDENVQREIINHRSLRH--PNIVRFKEVILTP---THLA 93 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~--~~~--~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~---~~~~ 93 (280)
...++.|+.|.++.||++... +..+++|+.. ... .....+.+|+.+++.+.. ..+++++.++.+. +..+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 345678899999999999874 3568899776 332 234567889999998864 4467788877665 3578
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 023591 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------- 135 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-------------------------------------- 135 (280)
+|||+++|.++.+. ....++......++.+++.+|+.||+
T Consensus 118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999998777431 12347788889999999999999997
Q ss_pred --------------------cCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 136 --------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 136 --------------------~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
..++|||+++.||+++.++...+.++||+.+.
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 35899999999999987654335899999876
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.09 E-value=8.5e-11 Score=96.63 Aligned_cols=186 Identities=17% Similarity=0.131 Sum_probs=118.0
Q ss_pred ecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhC-CCCC--eeeeceEEecCC---eEEEEEecc
Q 023591 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPN--IVRFKEVILTPT---HLAIVMEYA 99 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~--iv~~~~~~~~~~---~~~lv~e~~ 99 (280)
++.++.|....||++. ..+++|+.... .....+.+|...++.+ .+.. +..++....... ..++||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4558899999999874 34899975432 3456788899999887 3333 333444433332 347899999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 023591 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------- 135 (280)
Q Consensus 100 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-------------------------------------------- 135 (280)
+|.++.+... ..++..+...++.+++..|+.||+
T Consensus 99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9988865432 247788888888888888888885
Q ss_pred --------------cCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCcCCCcccCcccccC--CcCCCc-
Q 023591 136 --------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGK- 198 (280)
Q Consensus 136 --------------~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~- 198 (280)
..++|+|++|.||+++.+....+.++||+.+....+............-..|+.... ..|...
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 136999999999999974222378999998764322111000000000012221110 000001
Q ss_pred ----------cchhhHHHHHHHHHHhCCCCC
Q 023591 199 ----------IADVWSCGVTLYVMLVGAYPF 219 (280)
Q Consensus 199 ----------~~DiwslG~~l~~l~~g~~p~ 219 (280)
-.+.|+++.+++.+.+|..+|
T Consensus 257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 158899999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=6.4e-08 Score=79.47 Aligned_cols=134 Identities=18% Similarity=0.139 Sum_probs=91.6
Q ss_pred ecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCC---CeeeeceEEe-cCCeEEEEEeccCC
Q 023591 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVIL-TPTHLAIVMEYASG 101 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~ 101 (280)
++.++.|....||++ +..+++|+. ........+.+|...++.+.+. .+.+++.++. ..+..+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~-~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFP-KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEE-SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEec-CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 455788888899988 355889974 2233446788999999998642 2455666653 34567899999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 023591 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------------------------------------------- 136 (280)
Q Consensus 102 ~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~--------------------------------------------- 136 (280)
.++.+..- ..++......++.++...|..||+.
T Consensus 98 ~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 98 QILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp EECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred eECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 88866321 1245555555566666666555532
Q ss_pred ---------------CceecCCCCCcEEEeC---CCCCcEEEeecCCccc
Q 023591 137 ---------------QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKS 168 (280)
Q Consensus 137 ---------------~i~h~dl~~~ni~i~~---~~~~~~~l~df~~~~~ 168 (280)
.++|+|+++.||+++. ++. .+.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~-~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTP-LTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCC-EEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCc-eEEEEehhhcCC
Confidence 3589999999999986 232 247999997763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=9.4e-08 Score=76.91 Aligned_cols=131 Identities=19% Similarity=0.220 Sum_probs=93.9
Q ss_pred cccCCce-EEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC-CCCeeeeceEEecCCeEEEEEeccCCCchHH
Q 023591 29 IGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFE 106 (280)
Q Consensus 29 lg~G~~g-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 106 (280)
+..|..+ .||++.....+..+++|..... ....+.+|...++.+. +--+.+++.++.+++..++||++++|.++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 3445555 6899988777788999976543 3456788999888874 2235677888888889999999999988876
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------------
Q 023591 107 RICNAGRFSEDEARFFFQQLISGVSYCHSM-------------------------------------------------- 136 (280)
Q Consensus 107 ~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-------------------------------------------------- 136 (280)
..... ......+..++...|..||..
T Consensus 110 ~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 185 (272)
T 4gkh_A 110 VLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK 185 (272)
T ss_dssp HHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred cccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence 55331 223334556666666666631
Q ss_pred --------CceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 137 --------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 137 --------~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
.++|||+.+.||+++.++. +-|+||+.+.
T Consensus 186 ~~~~~~~~~l~HGDl~~~Nil~~~~~~--~~viDwe~a~ 222 (272)
T 4gkh_A 186 LLPFSPDSVVTHGDFSLDNLIFDEGKL--IGCIDVGRVG 222 (272)
T ss_dssp TCCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred cccccCCcEEEcCCCCCCeEEEECCeE--EEEEECcccc
Confidence 1689999999999986553 6799998765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=6.2e-07 Score=76.28 Aligned_cols=76 Identities=17% Similarity=0.112 Sum_probs=49.3
Q ss_pred eecccccCCceEEEEEEecCCCcEEEEEEeeeCC--------cccHHHHHHHHHhhhCCC--CCe-eeeceEEecCCeEE
Q 023591 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------KIDENVQREIINHRSLRH--PNI-VRFKEVILTPTHLA 93 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~e~~~l~~l~h--~~i-v~~~~~~~~~~~~~ 93 (280)
..+.||.|..+.||++....+++.+++|...... ...+....|.+.++.+.. +.. .+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 4668899999999999876567789999764321 123456778888887732 333 345443 344567
Q ss_pred EEEeccCCC
Q 023591 94 IVMEYASGG 102 (280)
Q Consensus 94 lv~e~~~~~ 102 (280)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=6.9e-07 Score=74.84 Aligned_cols=82 Identities=9% Similarity=0.106 Sum_probs=55.0
Q ss_pred eeeeccc-ccCCceEEEEEEec--C----CCcEEEEEEeeeCC---c-ccHHHHHHHHHhhhCCC---CCeeeeceEEec
Q 023591 23 YELVRDI-GSGNFGVARLMRDK--K----TEELVAVKYIERGD---K-IDENVQREIINHRSLRH---PNIVRFKEVILT 88 (280)
Q Consensus 23 y~~~~~l-g~G~~g~v~~~~~~--~----~~~~vaiK~~~~~~---~-~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~ 88 (280)
....+.| +.|....+|++... . +++.+++|...... . ....+.+|...++.+.. -.+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3445677 88989999998753 1 15678999765433 1 23567788888887732 345667776654
Q ss_pred C---CeEEEEEeccCCCch
Q 023591 89 P---THLAIVMEYASGGEL 104 (280)
Q Consensus 89 ~---~~~~lv~e~~~~~~L 104 (280)
. ...++|||+++|.++
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 4 346899999987554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.25 E-value=1.4e-05 Score=66.25 Aligned_cols=74 Identities=15% Similarity=0.206 Sum_probs=41.5
Q ss_pred ecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCC--CCeeeece------EEecCCeEEEEEe
Q 023591 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKE------VILTPTHLAIVME 97 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~------~~~~~~~~~lv~e 97 (280)
++.|+.|..+.||++... ++ .+++|..... ...+..|..+++.+.. -.+.+++. +....+..+++|+
T Consensus 37 ~~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD-SG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEET-TE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeC-CC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 445666778899999864 23 4899988753 2344455555554421 12233332 1224567899999
Q ss_pred ccCCCch
Q 023591 98 YASGGEL 104 (280)
Q Consensus 98 ~~~~~~L 104 (280)
+++|.++
T Consensus 112 ~i~G~~~ 118 (346)
T 2q83_A 112 WIEGRPF 118 (346)
T ss_dssp CCCCBCC
T ss_pred eecCccC
Confidence 9988543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.17 E-value=9.1e-06 Score=66.34 Aligned_cols=71 Identities=13% Similarity=0.113 Sum_probs=45.0
Q ss_pred ecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCe-eeeceEEecCCeEEEEEecc-CCCc
Q 023591 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYA-SGGE 103 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~~~~ 103 (280)
++.|+.|....+|++ ..+++|+........-...+|...++.+...++ .+++.. .+..-+++++|+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 778888999999999 348999876543222234567777776643333 345443 343457899999 6655
Q ss_pred h
Q 023591 104 L 104 (280)
Q Consensus 104 L 104 (280)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.05 E-value=6.8e-05 Score=61.41 Aligned_cols=76 Identities=18% Similarity=0.105 Sum_probs=58.8
Q ss_pred eecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC---CCCeeeeceEEecCCeEEEEEeccCC
Q 023591 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYASG 101 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (280)
-.+.|+.|....+|++.. ++..+++|..... ....+..|...++.|. ...+++++.+....+..++|||++++
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 456789999999999986 3567889987643 3456788988888873 35577788888777889999999988
Q ss_pred Cch
Q 023591 102 GEL 104 (280)
Q Consensus 102 ~~L 104 (280)
.++
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.98 E-value=3.4e-05 Score=66.09 Aligned_cols=73 Identities=15% Similarity=0.182 Sum_probs=43.8
Q ss_pred eecccccCCceEEEEEEecCCCcEEEEEEeeeC-----Cc---ccHHHHHHHHHhhhC---CCCCeeeeceEEecCCeEE
Q 023591 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----DK---IDENVQREIINHRSL---RHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-----~~---~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~ 93 (280)
-++.||.|..+.||++.. ++..+++|...+. .. .......|.+.+..+ ....+.+++.+. +...+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 456789999999999964 4667999943221 11 112222333333222 233455666654 45678
Q ss_pred EEEecc-CC
Q 023591 94 IVMEYA-SG 101 (280)
Q Consensus 94 lv~e~~-~~ 101 (280)
+|||++ ++
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=4.3e-05 Score=64.29 Aligned_cols=138 Identities=16% Similarity=0.157 Sum_probs=79.7
Q ss_pred ecccccCCceEEEEEEecC-------CCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCe-eeeceEEecCCeEEEEEe
Q 023591 26 VRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVME 97 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e 97 (280)
++.|..|....+|++.... +++.+++|+............+|..+++.+...++ .++++.+. + .+|||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEE
Confidence 3456668888999998742 35789999865433344566789998887743233 45655543 2 39999
Q ss_pred ccCCCchH--------------HHHH---hc-----CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 023591 98 YASGGELF--------------ERIC---NA-----GRFS--EDEARFFFQQLIS-------------------GVSYCH 134 (280)
Q Consensus 98 ~~~~~~L~--------------~~~~---~~-----~~l~--~~~~~~~~~~i~~-------------------~l~~Lh 134 (280)
|++|.+|. +.+. .. ++.. ...+.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99875542 1111 11 1111 2455555544422 122222
Q ss_pred ----h----cCceecCCCCCcEEEeCC--CCCcEEEeecCCcc
Q 023591 135 ----S----MQVCHRDLKLENTLLDGS--PAPRLKICDFGYSK 167 (280)
Q Consensus 135 ----~----~~i~h~dl~~~ni~i~~~--~~~~~~l~df~~~~ 167 (280)
. ..++|+|+.+.||+++.+ ....+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 358999999999999876 12248999999875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.0002 Score=58.75 Aligned_cols=139 Identities=15% Similarity=0.116 Sum_probs=75.9
Q ss_pred eeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCC--eeeeceE------EecCCeEEEE
Q 023591 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAIV 95 (280)
Q Consensus 24 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~~lv 95 (280)
.-++.|+.|....+|++.... + .+++|..... ...+.+..|..+++.+...+ +.+++.. ....+..+++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEEECC---EEEEEEEESS-C-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 345677888889999998643 3 5889987653 22345667777776663212 2223211 1224567899
Q ss_pred EeccCCCchH-----------HH---HHh-cCCC--------CHHHHHHH---------------HHHHHHHHHHHH---
Q 023591 96 MEYASGGELF-----------ER---ICN-AGRF--------SEDEARFF---------------FQQLISGVSYCH--- 134 (280)
Q Consensus 96 ~e~~~~~~L~-----------~~---~~~-~~~l--------~~~~~~~~---------------~~~i~~~l~~Lh--- 134 (280)
+++++|.++. .. +.. ...+ ........ ...+...++.+.
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 9999875431 01 111 0010 11100000 011333444444
Q ss_pred ----hcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 135 ----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 135 ----~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
..+++|+|+.+.||+++.++. +.++||+.+.
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~--~~lIDf~~a~ 216 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 216 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred cccCCcccCCCCCCccCEEEeCCce--EEEecchhcc
Confidence 246999999999999986542 5799998765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00054 Score=55.32 Aligned_cols=78 Identities=12% Similarity=0.044 Sum_probs=53.6
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCC-C--eeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHP-N--IVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~-~--iv~~~~~~~~~~~~~lv~ 96 (280)
.+..-++.+|.|..+.||++... +|+.+++|+...... ....+..|...|+.|... . +.+++... + -+++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEEE
Confidence 34566788999999999999864 678899997654432 234577899998888432 2 33444432 2 36889
Q ss_pred eccCCCc
Q 023591 97 EYASGGE 103 (280)
Q Consensus 97 e~~~~~~ 103 (280)
|+.++..
T Consensus 90 e~l~~~~ 96 (288)
T 3f7w_A 90 EWVDERP 96 (288)
T ss_dssp ECCCCCC
T ss_pred EeecccC
Confidence 9987654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.69 E-value=0.0004 Score=57.13 Aligned_cols=75 Identities=9% Similarity=0.048 Sum_probs=48.0
Q ss_pred cccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCC--eeeeceE-----EecCCeEEEEEecc
Q 023591 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV-----ILTPTHLAIVMEYA 99 (280)
Q Consensus 27 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~-----~~~~~~~~lv~e~~ 99 (280)
..|+ |....||++... +|+.+++|.........+.+..|...++.+.... +++++.. ...++..+++++++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3455 778899988753 4567999988754444566777888877763222 3334332 12245668899999
Q ss_pred CCCc
Q 023591 100 SGGE 103 (280)
Q Consensus 100 ~~~~ 103 (280)
+|.+
T Consensus 110 ~G~~ 113 (328)
T 1zyl_A 110 GGRQ 113 (328)
T ss_dssp CCEE
T ss_pred CCCC
Confidence 8744
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00023 Score=61.06 Aligned_cols=74 Identities=12% Similarity=0.119 Sum_probs=49.1
Q ss_pred eecccccCCceEEEEEEecC-------CCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCe-eeeceEEecCCeEEEEE
Q 023591 25 LVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVM 96 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~ 96 (280)
-++.|+.|....+|++.... ++..+++|+.... ...+.+.+|..+++.+...++ .++++.+. + .+|+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 35677888889999998653 2577999987432 121556678888887743344 45665543 2 3899
Q ss_pred eccCCCc
Q 023591 97 EYASGGE 103 (280)
Q Consensus 97 e~~~~~~ 103 (280)
+|++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9997644
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00015 Score=60.83 Aligned_cols=74 Identities=15% Similarity=0.050 Sum_probs=43.9
Q ss_pred ecccccCCceEEEEEEecC--------CCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCe-eeeceEEecCCeEEEEE
Q 023591 26 VRDIGSGNFGVARLMRDKK--------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVM 96 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~ 96 (280)
++.|+.|....+|++.... .+..+++|+.............|...++.+...++ .++++.. ++ ++|+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 4567788888999998653 13678999876543222234577777777743333 3555443 22 6899
Q ss_pred eccCCCc
Q 023591 97 EYASGGE 103 (280)
Q Consensus 97 e~~~~~~ 103 (280)
+|++|.+
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998744
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.61 E-value=0.0009 Score=51.13 Aligned_cols=123 Identities=16% Similarity=0.078 Sum_probs=77.4
Q ss_pred CchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCCc
Q 023591 102 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179 (280)
Q Consensus 102 ~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 179 (280)
.||.+.+.. +.+++++++|.++.|.+.+|..+-. ..-...=+.|..|++..+|+ |.+.+ ..+. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s~-----------~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AADD-----------A 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-cccc-----------c
Confidence 478888865 5689999999999999999887622 11123445668999998888 66553 1110 1
Q ss_pred CCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHh
Q 023591 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259 (280)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 259 (280)
....+.|||... .....+.=|||||+++|.-+-=..|=.. ...+|+.|.+||..|
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e~e-----------------------E~eLS~~LE~LL~~M 153 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKENE-----------------------ERELSPPLEQLIDHM 153 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCTTE-----------------------EECCCHHHHHHHHHH
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCccc-----------------------chhhCHHHHHHHHHH
Confidence 223466787652 2223446899999999987742222100 115889999999999
Q ss_pred cccC
Q 023591 260 FVAD 263 (280)
Q Consensus 260 l~~d 263 (280)
.+.+
T Consensus 154 t~~~ 157 (229)
T 2yle_A 154 ANTV 157 (229)
T ss_dssp TTCC
T ss_pred Hhcc
Confidence 8763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00081 Score=55.48 Aligned_cols=138 Identities=14% Similarity=0.108 Sum_probs=69.2
Q ss_pred ecccccCCceE-EEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCC--eeeeceEEecCCeEEEEEeccCCC
Q 023591 26 VRDIGSGNFGV-ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGG 102 (280)
Q Consensus 26 ~~~lg~G~~g~-v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~ 102 (280)
.+.|+.|.... +|++... ++..+++|...... .+.+..|+.+++.+...+ +.+++.+....+ +++||.+++.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECT-TCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcC-CCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 45566665554 6677542 25667787654432 133455666666663222 445555533333 6899998776
Q ss_pred chHHHHHhc--------------------------CCCCHHHHHH--------HH------------HHHHHHHHHH---
Q 023591 103 ELFERICNA--------------------------GRFSEDEARF--------FF------------QQLISGVSYC--- 133 (280)
Q Consensus 103 ~L~~~~~~~--------------------------~~l~~~~~~~--------~~------------~~i~~~l~~L--- 133 (280)
++.+.+... ..++...... +. ..+...+..+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 664333210 1122221110 00 0111122222
Q ss_pred ---HhcCceecCCCCCcEEEeCCC--CCcEEEeecCCccc
Q 023591 134 ---HSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKS 168 (280)
Q Consensus 134 ---h~~~i~h~dl~~~ni~i~~~~--~~~~~l~df~~~~~ 168 (280)
+...++|||+.+.||+++.+. ...+.++||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 234699999999999998641 12489999998763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0008 Score=58.09 Aligned_cols=76 Identities=16% Similarity=0.104 Sum_probs=48.7
Q ss_pred eecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCe-eeeceEEecCCeEEEEEeccCCCc
Q 023591 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGE 103 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~ 103 (280)
-++.|+.|-...+|++.....+..+++|+........-...+|..+++.|...++ .++++.+ ++ ..|++|++|.+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA 187 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence 3557788888999999876545778999875432222223578888888865555 4566665 22 35999998744
Q ss_pred h
Q 023591 104 L 104 (280)
Q Consensus 104 L 104 (280)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0061 Score=50.39 Aligned_cols=30 Identities=23% Similarity=0.475 Sum_probs=25.7
Q ss_pred cCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 136 ~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
..++|+|+.+.||+++.++. +.++||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~--~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEES--IYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGC--EEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCe--EEEEECCCCe
Confidence 45899999999999986655 8999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0022 Score=54.71 Aligned_cols=76 Identities=17% Similarity=0.097 Sum_probs=48.6
Q ss_pred eecccccCCceEEEEEEecCC-------CcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCe-eeeceEEecCCeEEEEE
Q 023591 25 LVRDIGSGNFGVARLMRDKKT-------EELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVM 96 (280)
Q Consensus 25 ~~~~lg~G~~g~v~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~ 96 (280)
-++.+..|-...+|++..... +..+++|+........-...+|..+++.+...++ .++++.+ .+ +.|+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 345667788889999987521 5779999875543333334678888877743333 3455433 22 7899
Q ss_pred eccCCCch
Q 023591 97 EYASGGEL 104 (280)
Q Consensus 97 e~~~~~~L 104 (280)
+|++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99988553
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.82 E-value=0.039 Score=46.66 Aligned_cols=30 Identities=40% Similarity=0.606 Sum_probs=24.0
Q ss_pred ceecCCCCCcEEEeC----CCCCcEEEeecCCcc
Q 023591 138 VCHRDLKLENTLLDG----SPAPRLKICDFGYSK 167 (280)
Q Consensus 138 i~h~dl~~~ni~i~~----~~~~~~~l~df~~~~ 167 (280)
++|+|+.+.||++.. +....+.++||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 679999999999953 223359999999885
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.52 E-value=1.4 Score=33.61 Aligned_cols=83 Identities=17% Similarity=0.097 Sum_probs=59.9
Q ss_pred CCCCeeeeceEEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC
Q 023591 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154 (280)
Q Consensus 75 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~ 154 (280)
.||++ -..+-.+++.+.+.++..+++.-...+. .++....++++.+|+..... |...-+|--+.|+|++++.++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~-~~~~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKH-HSARRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSS-CCSSSEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHH-hhhCceeEEEeCceEEEeCCC
Confidence 67888 4455567788888888764333233343 37899999999999886651 234557888999999999888
Q ss_pred CCcEEEeecCC
Q 023591 155 APRLKICDFGY 165 (280)
Q Consensus 155 ~~~~~l~df~~ 165 (280)
. +++.-.|.
T Consensus 122 ~--p~i~hRGi 130 (219)
T 4ano_A 122 E--PFFLHVGV 130 (219)
T ss_dssp C--EEESCCEE
T ss_pred c--EEEEEcCC
Confidence 8 88876663
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.20 E-value=1.6 Score=33.21 Aligned_cols=116 Identities=9% Similarity=0.030 Sum_probs=75.6
Q ss_pred CCCCCeeeeceEEecCCeEEEEEeccC-CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC
Q 023591 74 LRHPNIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (280)
Q Consensus 74 l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~ 152 (280)
..||++++. .+-.+++.+.+.++..+ +.++.. +. .++....++++.+|+....++ ..-+|--+.|+|++++.
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTR 114 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECT
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcC
Confidence 368889977 56667777777777654 233333 32 378899999999999877433 44578889999999998
Q ss_pred CCCCcEEEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCC
Q 023591 153 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (280)
Q Consensus 153 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 220 (280)
++. +++.-.|.-.. ++|.. . ....-.-..=+++..++++...|.
T Consensus 115 ~~~--p~i~~RGik~~----------------l~P~~-----~-~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 115 DGL--PIAKTRGLQNV----------------VDPLP-----V-SEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TSC--EEESCCEETTT----------------BSCCC-----C-CHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CCC--EEEEEccCccC----------------CCCCC-----C-CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 887 78776553221 11211 1 110224456677778888877763
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.98 E-value=0.15 Score=43.92 Aligned_cols=61 Identities=10% Similarity=0.078 Sum_probs=18.1
Q ss_pred eeecccccCCceEEEEEEecCCCcEEEE------EEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEe
Q 023591 24 ELVRDIGSGNFGVARLMRDKKTEELVAV------KYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVIL 87 (280)
Q Consensus 24 ~~~~~lg~G~~g~v~~~~~~~~~~~vai------K~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 87 (280)
.+.+.|| ||.||++.......+||+ |...... .....+.++..+.+.++|+|+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4456666 999999998765567888 6554322 22234566777778889999999988765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 280 | ||||
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-75 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-73 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-73 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-73 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-71 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-71 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-70 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-68 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-68 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-67 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-66 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-66 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-64 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-63 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-62 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-60 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-60 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-58 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-58 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-55 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-54 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-52 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-52 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-51 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-51 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-51 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-50 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-49 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-49 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-48 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-47 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-42 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-40 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-35 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-14 |
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 230 bits (588), Expect = 6e-75
Identities = 68/250 (27%), Positives = 118/250 (47%), Gaps = 9/250 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNI 79
D Y+++ ++GSG FGV +K T + K+I +D V+ EI L HP +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQV 138
+ + + +++E+ SGGELF+RI + SE E + +Q G+ + H +
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
H D+K EN + + A +KI DFG + K T T + APE++ ++
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-F 207
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLI 256
D+W+ GV YV+L G PF ++ +T+ + + + + +SPE + I
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAG----EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263
Query: 257 SRIFVADPAK 266
+ +P K
Sbjct: 264 KNLLQKEPRK 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 1e-73
Identities = 82/250 (32%), Positives = 135/250 (54%), Gaps = 14/250 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLRH 76
+ +E+ R +G G FG L R+K+++ ++A+K + + V +RE+ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R T + +++EYA G ++ + +F E + +L + +SYCHS
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN LL + LKI DFG+S + S+ + GT Y+ PE++ + +D
Sbjct: 126 RVIHRDIKPENLLLGSA--GELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
K D+WS GV Y LVG PFE +++T RI V+++ PD ++ R LI
Sbjct: 183 EK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPD--FVTEGARDLI 235
Query: 257 SRIFVADPAK 266
SR+ +P++
Sbjct: 236 SRLLKHNPSQ 245
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 226 bits (577), Expect = 2e-73
Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 9/259 (3%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIIN 70
+++ H D Y++ ++G+G FGV + ++ T A K++ + D E V++EI
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 76
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISG 129
LRHP +V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + H H DLK EN + + LK+ DFG + K T GT + APEV
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVH 247
K D+WS GV Y++L G PF +N +T+ + S +++ D +
Sbjct: 197 AEGKPVGYY-TDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFSG 251
Query: 248 ISPECRHLISRIFVADPAK 266
IS + + I ++ +ADP
Sbjct: 252 ISEDGKDFIRKLLLADPNT 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 4e-73
Identities = 83/251 (33%), Positives = 134/251 (53%), Gaps = 10/251 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ ++LV+ +G G +G +L ++ TEE VAVK + +R EN+++EI ++ L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+F + +EY SGGELF+RI E +A+ FF QL++GV Y H + +
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKKEY 195
HRD+K EN LLD LKI DFG + +++ + GT Y+APE+L ++E+
Sbjct: 125 THRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
+ DVWSCG+ L ML G P++ P + + + + + I L
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDWKEKKTYLNPWKKIDSAPLAL 239
Query: 256 ISRIFVADPAK 266
+ +I V +P+
Sbjct: 240 LHKILVENPSA 250
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 1e-71
Identities = 61/249 (24%), Positives = 113/249 (45%), Gaps = 8/249 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++Y + D+G G FG+ + +++ K+++ V++EI RH NI+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
E + L ++ E+ SG ++FERI +A +E E + Q+ + + HS +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA- 183
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLIS 257
D+WS G +YV+L G PF + ++ I I++ +Y+ + + IS E +
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLA----ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 258 RIFVADPAK 266
R+ V +
Sbjct: 240 RLLVKERKS 248
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 219 bits (558), Expect = 5e-71
Identities = 88/252 (34%), Positives = 130/252 (51%), Gaps = 10/252 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
D Y+ +G+G F L DK+T++LVA+K I + + + +++ EI ++HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV ++ + HL ++M+ SGGELF+RI G ++E +A Q++ V Y H +
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 138 VCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK EN L ++ I DFG SK S + GTP Y+APEVL +K Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRH 254
D WS GV Y++L G PF D +N K +IL +Y P + IS +
Sbjct: 188 KA-VDCWSIGVIAYILLCGYPPFYD----ENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242
Query: 255 LISRIFVADPAK 266
I + DP K
Sbjct: 243 FIRHLMEKDPEK 254
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 2e-70
Identities = 71/253 (28%), Positives = 115/253 (45%), Gaps = 16/253 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRH 76
+ ++ + +G G+F L R+ T A+K +E+ I EN + L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 193
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L +K
Sbjct: 128 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
+D+W+ G +Y ++ G PF N +I+ ++Y P+ P+ R
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEYDFPE--KFFPKAR 238
Query: 254 HLISRIFVADPAK 266
L+ ++ V D K
Sbjct: 239 DLVEKLLVLDATK 251
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-68
Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 14/255 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D +E++ ++G G FG ++K+T L A K I+ + + E+ EI S HPN
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV+ + +L I++E+ +GG + + R +E + + +Q + ++Y H +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 196
+ HRDLK N L +K+ DFG S + Q + + +GTP ++APEV++ +
Sbjct: 131 IIHRDLKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 197 GKI----ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPE 251
+ ADVWS G+TL M P + N + + +I + ++ S
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHE----LNPMRVLLKIAKSEPPTLAQPSRWSSN 244
Query: 252 CRHLISRIFVADPAK 266
+ + + +
Sbjct: 245 FKDFLKKCLEKNVDA 259
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 5e-68
Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 45/287 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
D +E + ++G+GN GV + K + ++A K I E I + RE+ P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ- 137
IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 126 IMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEE--------------------------------- 224
+ +D+WS G++L M VG YP P+
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 225 -----PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
P + + I++ S E + +++ + +PA+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 6e-68
Identities = 67/249 (26%), Positives = 111/249 (44%), Gaps = 9/249 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
+Y IG G G D T + VA++ + + E + EI+ R ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + L L +VMEY +GG L + + E + ++ + + + HS QV
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
HRD+K +N LL +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 138 IHRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
K D+WS G+ M+ G P+ + + + + + +S R ++
Sbjct: 196 K-VDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFLN 251
Query: 258 RIFVADPAK 266
R D K
Sbjct: 252 RCLDMDVEK 260
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 211 bits (537), Expect = 8e-68
Identities = 69/254 (27%), Positives = 112/254 (44%), Gaps = 17/254 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR 75
+ +R+IG G+FG RD + E+VA+K + K +++ +E+ + LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HPN ++++ L +VMEY G + E E + G++Y HS
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---K 192
+ HRD+K N LL +K+ DFG + + + S VGTP ++APEV+L +
Sbjct: 134 HNMIHRDVKAGNILLSEP--GLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDE 188
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
+YDGK DVWS G+T + P + N ++ I + H S
Sbjct: 189 GQYDGK-VDVWSLGITCIELAERKPPLFN----MNAMSALYHIAQNESPALQSGHWSEYF 243
Query: 253 RHLISRIFVADPAK 266
R+ + P
Sbjct: 244 RNFVDSCLQKIPQD 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 208 bits (530), Expect = 3e-67
Identities = 79/262 (30%), Positives = 121/262 (46%), Gaps = 20/262 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREIIN 70
+ YE +G G V R K T + AVK I E ++ E +E+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 71 HRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
R + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 190 LLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
+ D GK D+WS GV +Y +L G+ PF ++ R + + Q+ P+
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE 238
Query: 245 YVHISPECRHLISRIFVADPAK 266
+ S + L+SR V P K
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQK 260
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 8e-66
Identities = 85/258 (32%), Positives = 138/258 (53%), Gaps = 16/258 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y+ ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS+Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248
+ AD+WS GV Y++L GA PF ++T+ + +V Y D + +
Sbjct: 189 NYEPLG-LEADMWSIGVITYILLSGASPFLG----DTKQETLANVSAVNYEFEDEYFSNT 243
Query: 249 SPECRHLISRIFVADPAK 266
S + I R+ V DP K
Sbjct: 244 SALAKDFIRRLLVKDPKK 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 9e-66
Identities = 85/267 (31%), Positives = 133/267 (49%), Gaps = 16/267 (5%)
Query: 11 GMDMPIMHDSDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI- 68
G+ + D Y++ +G G G + +K+T+E A+K ++ K +RE+
Sbjct: 1 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVE 56
Query: 69 INHRSLRHPNIVRFKEVILTP----THLAIVMEYASGGELFERICNAG--RFSEDEARFF 122
++ R+ + P+IVR +V L IVME GGELF RI + G F+E EA
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
+ + + Y HS+ + HRD+K EN L P LK+ DFG++K + H+ + T
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241
P Y+APEVL ++YD D+WS GV +Y++L G PF RI QY
Sbjct: 177 PYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 242 IPD--YVHISPECRHLISRIFVADPAK 266
P+ + +S E + LI + +P +
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQ 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 1e-64
Identities = 80/252 (31%), Positives = 128/252 (50%), Gaps = 15/252 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----DKIDENVQREIINHRSLR 75
+ + L + +G G+FG L KKT + A+K +++ D ++ + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HP + T +L VMEY +GG+L I + +F A F+ ++I G+ + HS
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 194
+ +RDLKL+N LLD +KI DFG K ++L +T GTP YIAPE+LL ++
Sbjct: 122 KGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
Y+ D WS GV LY ML+G PF ++ + H I P + E +
Sbjct: 180 YNHS-VDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMDNPFYPR--WLEKEAKD 232
Query: 255 LISRIFVADPAK 266
L+ ++FV +P K
Sbjct: 233 LLVKLFVREPEK 244
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 199 bits (506), Expect = 1e-63
Identities = 66/273 (24%), Positives = 106/273 (38%), Gaps = 19/273 (6%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRS 73
H SDRYEL +G G L RD + VAVK + R +RE N +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 74 LRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
L HP IV + T IVMEY G L + + G + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAP 187
+++ H + HRD+K N ++ + A ++ + S +Q + +GT Y++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
E D + +DV+S G LY +L G PF + + + +
Sbjct: 184 EQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE--G 240
Query: 248 ISPECRHLISRIFVADPAK-----SEM-HDWRR 274
+S + ++ + +P +EM D R
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-63
Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 23/261 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
+ YE++ IG+G++G + +R K +++ K ++ G + Q E+ R L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 78 NIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
NIVR+ + I+ T T L IVMEY GG+L I + E+ QL +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 132 YCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG-TPAYI 185
CH V HRDLK N LDG +K+ DFG ++ + TP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
+PE + + Y+ K +D+WS G LY + PF + ++ +I ++ Y
Sbjct: 182 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY 236
Query: 246 VHISPECRHLISRIFVADPAK 266
S E +I+R+
Sbjct: 237 -RYSDELNEIITRMLNLKDYH 256
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 197 bits (502), Expect = 7e-62
Identities = 72/253 (28%), Positives = 119/253 (47%), Gaps = 13/253 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-------S 73
+ + + R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 193
H+ V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL K
Sbjct: 124 HNRFVVYRDLKPANILLD--EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKG 180
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
AD +S G L+ +L G PF + K+ + L++ +PD SPE R
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPD--SFSPELR 237
Query: 254 HLISRIFVADPAK 266
L+ + D +
Sbjct: 238 SLLEGLLQRDVNR 250
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 192 bits (488), Expect = 2e-60
Identities = 76/250 (30%), Positives = 127/250 (50%), Gaps = 15/250 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
++++R +G+G+FG L+R + A+K +++ + E+ E + + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P I+R + ++M+Y GGELF + + RF A+F+ ++ + Y HS
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ +RDLK EN LLD + +KI DFG++K + + GTP YIAPEV+ K Y+
Sbjct: 124 DIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
D WS G+ +Y ML G PF D N KT +IL+ + P + + + L+
Sbjct: 180 KS-IDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRFPP--FFNEDVKDLL 232
Query: 257 SRIFVADPAK 266
SR+ D ++
Sbjct: 233 SRLITRDLSQ 242
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-60
Identities = 73/256 (28%), Positives = 112/256 (43%), Gaps = 24/256 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-------VQREIINHRS 73
+Y++ +GSG FG VA+K++E+ D V E++ +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 74 LR--HPNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGV 130
+ ++R + P +++E +LF+ I G E+ AR FF Q++ V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+CH+ V HRD+K EN L+D + LK+ DFG + + GT Y PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
Y G+ A VWS G+ LY M+ G PFE EE I+ Q +S
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSS 229
Query: 251 ECRHLISRIFVADPAK 266
EC+HLI P+
Sbjct: 230 ECQHLIRWCLALRPSD 245
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-60
Identities = 60/260 (23%), Positives = 111/260 (42%), Gaps = 16/260 (6%)
Query: 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHR 72
+ +D + +IG G+F D +T VA ++ + + E +
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 73 SLRHPNIVRFKEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
L+HPNIVRF + + + +V E + G L + R + +Q++
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123
Query: 129 GVSYCHSM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
G+ + H+ + HRDLK +N + G P +KI D G + S K+ +GTP ++A
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMA 181
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
PE+ +++YD DV++ G+ + M YP+ + +N + R+ S
Sbjct: 182 PEM-YEEKYDES-VDVYAFGMCMLEMATSEYPYSE---CQNAAQIYRRVTSGVKPASFDK 236
Query: 247 HISPECRHLISRIFVADPAK 266
PE + +I + +
Sbjct: 237 VAIPEVKEIIEGCIRQNKDE 256
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 6e-58
Identities = 57/257 (22%), Positives = 101/257 (39%), Gaps = 15/257 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLR 75
+ + + IGSG+FG + VAVK + + +Q E+ R R
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 134
H NI+ F T LAIV ++ G L+ + +F + +Q G+ Y H
Sbjct: 63 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
+ + HRDLK N L +KI DFG + Q + G+ ++APEV+
Sbjct: 122 AKSIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 192 KKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
++ + +DV++ G+ LY ++ G P+ + + R +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 250 PECRHLISRIFVADPAK 266
+ L++ +
Sbjct: 240 KAMKRLMAECLKKKRDE 256
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 9e-58
Identities = 81/251 (32%), Positives = 127/251 (50%), Gaps = 14/251 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRH 76
+ ++ ++ +G G FG L+R+K T A+K + + I ++ E ++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y HS
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEY 195
V +RD+KLEN +LD +KI DFG K + K+ GTP Y+APEVL +Y
Sbjct: 125 DVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
D W GV +Y M+ G PF + ++ + IL + P +SPE + L
Sbjct: 183 GRA-VDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEEIRFPR--TLSPEAKSL 235
Query: 256 ISRIFVADPAK 266
++ + DP +
Sbjct: 236 LAGLLKKDPKQ 246
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (457), Expect = 2e-55
Identities = 72/250 (28%), Positives = 130/250 (52%), Gaps = 15/250 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
D+++ ++ +G+G+FG L++ K++ A+K +++ + E+ E +++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ +RDLK EN L+D +++ DFG++K + + GTP +APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
D W+ GV +Y M G PF + +I+S + P H S + + L+
Sbjct: 217 KA-VDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAK 266
+ D K
Sbjct: 270 RNLLQVDLTK 279
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-55
Identities = 63/251 (25%), Positives = 99/251 (39%), Gaps = 15/251 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 61
Query: 79 IVRFKEVIL-TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + + + GR D F + + Y
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRDL N L+ K+ DFG +K S + + APE L +K++
Sbjct: 122 NNFVHRDLAARNVLVSED--NVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKF 177
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
K +DVWS G+ L+ + K+ + + + PD P +
Sbjct: 178 STK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--GYKMDAPD--GCPPAVYEV 232
Query: 256 ISRIFVADPAK 266
+ + D A
Sbjct: 233 MKNCWHLDAAM 243
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 1e-54
Identities = 73/292 (25%), Positives = 108/292 (36%), Gaps = 39/292 (13%)
Query: 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
T G G D P Y + IG+G+FGV + + ELVA+K + + R
Sbjct: 9 TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNR 62
Query: 67 EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGG---ELFERICNAGRFSED 117
E+ R L H NIVR + + +L +V++Y
Sbjct: 63 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ + QL ++Y HS +CHRD+K +N LLD A K+CDFG +K V S
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVS 181
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE------------- 224
+ + Y APE++ DVWS G L +L+G F
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 225 ----------PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
P +I + ++ PE L SR+ P
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 7e-54
Identities = 66/272 (24%), Positives = 108/272 (39%), Gaps = 31/272 (11%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHP 77
E + +G G F RDK T ++VA+K I+ G D I+ REI + L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NI+ + +++++V ++ N+ + + + + G+ Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK N LLD + LK+ DFG +KS + V T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------QYSIPDYV--- 246
G D+W+ G L +L+ + + + + S+PDYV
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 247 ------------HISPECRHLISRIFVADPAK 266
+ LI +F+ +P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCA 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 4e-53
Identities = 51/252 (20%), Positives = 100/252 (39%), Gaps = 13/252 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D ++++G+G FGV + + + + VA+K I+ G ++ E +L H
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ 137
+V+ V + I+ EY + G L + RF + + + + Y S Q
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 195
HRDL N L++ +K+ DFG S+ + S + PEVL+ ++
Sbjct: 121 FLHRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 196 DGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
K +D+W+ GV ++ + +G P+E + + S +
Sbjct: 179 SSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-----LRLYRPHLASEKVYT 232
Query: 255 LISRIFVADPAK 266
++ + +
Sbjct: 233 IMYSCWHEKADE 244
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (434), Expect = 1e-52
Identities = 51/252 (20%), Positives = 96/252 (38%), Gaps = 11/252 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + + R S + Q+ S + Y
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL N L+ + +K+ DFG S+ + ++ + APE L +
Sbjct: 135 NFIHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
+ K +DVW+ GV L+ + + ++ +L Y + +
Sbjct: 193 FSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEKDYRMERPEGCPEKVYE 247
Query: 255 LISRIFVADPAK 266
L+ + +P+
Sbjct: 248 LMRACWQWNPSD 259
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-52
Identities = 58/251 (23%), Positives = 102/251 (40%), Gaps = 11/251 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D V++IGSG FG+ L ++ VA+K I G +E+ E L HP
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPK 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+V+ V L + +V E+ G L + G F+ + + G++Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
V HRDL N L+ + +K+ DFG ++ ++ T + +PEV Y
Sbjct: 122 VIHRDLAARNCLVGEN--QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
K +DVWS GV ++ + P E ++ + + I + + + S +
Sbjct: 180 SSK-SDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDIST-GFRLYKPRLASTHVYQI 234
Query: 256 ISRIFVADPAK 266
++ + P
Sbjct: 235 MNHCWKERPED 245
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-52
Identities = 63/265 (23%), Positives = 105/265 (39%), Gaps = 19/265 (7%)
Query: 14 MPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKID----ENVQR 66
+ + L+ +G G+FGV VAVK ++ ++ R
Sbjct: 1 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 67 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQ 125
E+ SL H N++R V+LTP + +V E A G L +R+ + G F + Q
Sbjct: 61 EVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGT 181
+ G+ Y S + HRDL N LL +KI DFG + + + +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241
A+ APE L + + +D W GVTL+ M P N + +H+I
Sbjct: 178 FAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQE---PWIGLNGSQILHKIDKEGER 233
Query: 242 IPDYVHISPECRHLISRIFVADPAK 266
+P + +++ + + P
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPED 258
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 171 bits (434), Expect = 3e-52
Identities = 58/281 (20%), Positives = 113/281 (40%), Gaps = 41/281 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 79
D Y+LVR +G G + + E V VK ++ K + ++REI +LR PNI
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNI 92
Query: 80 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ +++ P A+V E+ + + + ++ + RF+ +++ + YCHSM
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRD+K N ++D +L++ D+G ++ + V + + PE+L+ +
Sbjct: 150 IMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY----------------- 240
D+WS G L M+ PF + + I ++L +
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 241 ---------------SIPDYVHISPECRHLISRIFVADPAK 266
+ +SPE + ++ D
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 309
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-51
Identities = 65/301 (21%), Positives = 112/301 (37%), Gaps = 52/301 (17%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREI 68
++ P + +YE + IG G FG R +KT + VA+K + + REI
Sbjct: 1 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60
Query: 69 INHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAGRFSEDEAR 120
+ L+H N+V E+ T + +V ++ +F+ E +
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQP 175
Q L++G+ Y H ++ HRD+K N L+ LK+ DFG ++ + ++
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRY 178
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
+ V T Y PE+LL + G D+W G + M + + + + I
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG----NTEQHQLALI 234
Query: 236 LSVQYSIPDYVH------------------------------ISPECRHLISRIFVADPA 265
+ SI V P LI ++ V DPA
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294
Query: 266 K 266
+
Sbjct: 295 Q 295
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-51
Identities = 69/256 (26%), Positives = 120/256 (46%), Gaps = 12/256 (4%)
Query: 21 DRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHR 72
+ +EL++ +G+G +G R + T +L A+K +++ K E+ + E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 73 SLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+R P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
+ H + + +RD+KLEN LLD + L + + GT Y+AP+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 192 -KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
K D WS GV +Y +L GA PF E + + RIL + P +S
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSA 261
Query: 251 ECRHLISRIFVADPAK 266
+ LI R+ + DP K
Sbjct: 262 LAKDLIQRLLMKDPKK 277
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 2e-51
Identities = 55/252 (21%), Positives = 96/252 (38%), Gaps = 13/252 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 73
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L + + + Q+ SG++Y M
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL+ N L+ + K+ DFG ++ ++ + + APE L
Sbjct: 133 NYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
+ K +DVWS G+ L + + + R Y +P
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPESLHD 245
Query: 255 LISRIFVADPAK 266
L+ + + +P +
Sbjct: 246 LMCQCWRKEPEE 257
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 4e-51
Identities = 62/268 (23%), Positives = 102/268 (38%), Gaps = 19/268 (7%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
M++ + +RY L R IGSG+FG L D E VA+K +E + E +
Sbjct: 1 MELRV---GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIY 56
Query: 72 RSLRHPN-IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ ++ I + + +VME + +FS Q+IS +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 131 SYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGT 181
Y HS HRD+K +N L+ G + I DFG +K + + + K+ GT
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241
Y + L E + D+ S G L +G+ P++ + +K RI + S
Sbjct: 177 ARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMS 234
Query: 242 IPDYV---HISPECRHLISRIFVADPAK 266
P V E ++
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDD 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 7e-51
Identities = 70/285 (24%), Positives = 110/285 (38%), Gaps = 46/285 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
RY + IG G +G+ D + VA+K I + REI RH N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 79 IVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
I+ ++I PT ++ + G +L++ + S D +F Q++ G+ Y H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 190
S V HRDLK N LL+ + LKICDFG ++ V T Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD------ 244
L + K D+WS G L ML F K++ ++ IL + S
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPG----KHYLDQLNHILGILGSPSQEDLNCI 240
Query: 245 -----------------------YVHISPECRHLISRIFVADPAK 266
+ + + L+ ++ +P K
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 285
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 9e-51
Identities = 51/252 (20%), Positives = 96/252 (38%), Gaps = 13/252 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +LV +G+G FG + + VAVK +++G + E + L+H
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR V+ T + I+ EY G L + + + + + ++ Q+ G+++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 194
HRDL+ N L+ KI DFG ++ + + APE +
Sbjct: 129 NYIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
+ K +DVWS G+ L ++ + + R Y + + E
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPEELYQ 241
Query: 255 LISRIFVADPAK 266
L+ + P
Sbjct: 242 LMRLCWKERPED 253
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-50
Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 30/274 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+ ++ V IG G +GV R+K T E+VA+K I + + REI + L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
NIV+ +VI T L +V E+ + F + + QL+ G+++CHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
+V HRDLK +N L++ +K+ DFG +++ + + + V T Y APE+LL +Y
Sbjct: 122 RVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-------RILSVQYSIPDYV-- 246
D+WS G M+ F E + + S+PDY
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 247 --------------HISPECRHLISRIFVADPAK 266
+ + R L+S++ DP K
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 273
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (421), Expect = 1e-50
Identities = 59/261 (22%), Positives = 107/261 (40%), Gaps = 21/261 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D ++ + IG+G FG L K E VA+K ++ G +K + E
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSY 132
HPN++ + V+ T + I+ E+ G L N G+F+ + + + +G+ Y
Sbjct: 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIA 186
M HRDL N L++ + K+ DFG S+ S ++ + A
Sbjct: 144 LADMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
PE + +++ +DVWS G+ ++ ++ G P+ D + I+ I Y +P
Sbjct: 202 PEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD----MTNQDVINAIEQ-DYRLPPP 255
Query: 246 VHISPECRHLISRIFVADPAK 266
+ L+ + D
Sbjct: 256 MDCPSALHQLMLDCWQKDRNH 276
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-50
Identities = 61/280 (21%), Positives = 110/280 (39%), Gaps = 40/280 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
Y ++ +GSG +G D +T VA+K + R + + RE+ + +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 78 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V T +VM + G ++ + ED +F Q++ G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y H+ + HRDLK N ++ LKI DFG ++ S+ V T Y APEV+L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV----- 246
+ D+WS G + M+ G F+ + ++ + + +
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 247 --------------------HISPECRHLISRIFVADPAK 266
+ SP +L+ ++ V D +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 291
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 2e-50
Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 16/256 (6%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+R EL R IG G FG M + VA+K + D + E +E + R
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSY 132
HP+IV+ VI T + I+ME + GEL + + QL + ++Y
Sbjct: 65 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
S + HRD+ N L+ + +K+ DFG S+ + K++ ++APE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
+ + +DVW GV ++ +L+ P + I RI + + +P + P
Sbjct: 182 NFRRFTSA-SDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRIENGER-LPMPPNCPP 236
Query: 251 ECRHLISRIFVADPAK 266
L+++ + DP++
Sbjct: 237 TLYSLMTKCWAYDPSR 252
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-49
Identities = 54/283 (19%), Positives = 100/283 (35%), Gaps = 42/283 (14%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL-----VAVKYI--ERGDKIDENVQREIINH 71
+ E + +GSG FG + VAVK + + E + E+
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---------------------- 108
L H NIV + ++ EY G+L +
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 109 -CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+ + ++ F Q+ G+ + HRDL N L+ +KICDFG ++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLAR 212
Query: 168 ---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPE 223
S + + ++APE L + Y K +DVWS G+ L+ + +G P+
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPG-- 269
Query: 224 EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
++++ + + + + E ++ + D K
Sbjct: 270 --IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRK 310
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 2e-49
Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 30/274 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHP 77
+YE + IG G +G ++++T E+VA+K + D + + REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIVR +V+ + L +V E+ G + + F QL+ G+ +CHS
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLKKEYD 196
V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL +
Sbjct: 122 VLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL--------SVQYSIPDYV-- 246
D+WS G + P + + K I R+L +PDY
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 247 --------------HISPECRHLISRIFVADPAK 266
++ R L+ + +P +
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 161 bits (409), Expect = 5e-49
Identities = 67/273 (24%), Positives = 111/273 (40%), Gaps = 30/273 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
++Y + IG G +GV ++ E A+K I + + I REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV+ +VI T L +V E+ G A+ F QL++G++YCH +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 196
V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+ +
Sbjct: 121 VLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV---------- 246
D+WS G M+ G F E + + + V
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 247 -------------HISPECRHLISRIFVADPAK 266
+ L+S++ DP +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ 271
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-48
Identities = 60/260 (23%), Positives = 98/260 (37%), Gaps = 24/260 (9%)
Query: 21 DRYELV---RDIGSGNFGVARL--MRDKKTEELVAVKYIERG---DKIDENVQREIINHR 72
DR L +++GSGNFG + + KK + VAVK ++ + + + E +
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
L +P IVR + + + +VME A G L + + + Q+ G+ Y
Sbjct: 64 QLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPE 188
HRDL N LL KI DFG SK+ + + APE
Sbjct: 123 LEESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 189 VLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYV 246
+ ++ K +DVWS GV ++ G P+ + + + P
Sbjct: 181 CINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG----MKGSEVTAMLEKGERMGCPA-- 233
Query: 247 HISPECRHLISRIFVADPAK 266
E L++ + D
Sbjct: 234 GCPREMYDLMNLCWTYDVEN 253
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (407), Expect = 1e-48
Identities = 49/261 (18%), Positives = 93/261 (35%), Gaps = 18/261 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
Y++ R IG G+FGV + + VA+K+ R ++ E ++ L I
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
H +V++ +FS +Q+++ V H +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 140 HRDLKLENTLLDGSPAP---RLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 188
+RD+K +N L+ + + + DFG K + + + K+ GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV-- 246
L +E + D+ + G L G+ P++ + N +K RI + S P
Sbjct: 184 THLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQK-YERIGEKKQSTPLRELC 241
Query: 247 -HISPECRHLISRIFVADPAK 266
E +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDA 262
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-48
Identities = 65/258 (25%), Positives = 103/258 (39%), Gaps = 22/258 (8%)
Query: 21 DRYELV-RDIGSGNFGVARL--MRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLR 75
D + ++G GNFG R R +K + VA+K +++G + E + RE L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 134
+P IVR V L +VME A GG L + + Q+ G+ Y
Sbjct: 68 NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 126
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 190
HRDL N LL + I DFG SK ++ + + APE +
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 191 LKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHI 248
+++ + +DVWS GVT++ L G P++ + + I + P
Sbjct: 185 NFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK----MKGPEVMAFIEQGKRMECPP--EC 237
Query: 249 SPECRHLISRIFVADPAK 266
PE L+S ++
Sbjct: 238 PPELYALMSDCWIYKWED 255
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 3e-48
Identities = 51/262 (19%), Positives = 100/262 (38%), Gaps = 17/262 (6%)
Query: 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI------ERGDKIDENVQRE 67
+ I+ +++ ++ ++ +GSG FG E V + K ++ + E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
S+ +P++ R + LT T I G L + + Q+
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAY 184
G++Y ++ HRDL N L+ +KI DFG +K + + +
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
+A E +L + Y + +DVWS GVT++ ++ D I IL +P
Sbjct: 180 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGERLPQ 234
Query: 245 YVHISPECRHLISRIFVADPAK 266
+ + ++ + ++ D
Sbjct: 235 PPICTIDVYMIMVKCWMIDADS 256
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 7e-48
Identities = 71/280 (25%), Positives = 106/280 (37%), Gaps = 37/280 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYI---ERGDKIDENVQREIINHRSL-- 74
+YE V +IG G +G RD K VA+K + + + + RE+ R L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 75 -RHPNIVRFKEVILTP-----THLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLI 127
HPN+VR +V T L +V E+ + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL----------- 236
EVLL+ Y D+WS G M F + K + I
Sbjct: 185 EVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 237 ----------SVQYSIPDYVHISPECRHLISRIFVADPAK 266
S Q I + L+ + +PAK
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 283
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-47
Identities = 59/269 (21%), Positives = 97/269 (36%), Gaps = 28/269 (10%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGDKID--ENVQREIINHRSL 74
D + + IG GNFG R KK A+K ++ D + E+ L
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 75 -RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSED 117
HPNI+ +L + +EYA G L + + A S
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ F + G+ Y Q HRDL N L+ + KI DFG S+ ++ +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTM 185
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237
++A E L Y +DVWS GV L+ ++ P + ++
Sbjct: 186 GRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGT---PYCGMTCAELYEKLPQ 241
Query: 238 VQYSIPDYVHISPECRHLISRIFVADPAK 266
Y + ++ E L+ + + P +
Sbjct: 242 -GYRLEKPLNCDDEVYDLMRQCWREKPYE 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 7e-47
Identities = 62/281 (22%), Positives = 107/281 (38%), Gaps = 43/281 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYI--ERGDKIDENVQREIINHRS 73
+ E VRDIG G FG R + +VAVK + E + + QRE
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 113
+PNIV+ V + ++ EY + G+L E + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 114 ----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-- 167
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNI 190
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
S+ + + ++ PE + Y + +DVW+ GV L+ + P
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQ---PYYGM 246
Query: 227 NFRKTIHRILSVQY-SIPDYVHISPECRHLISRIFVADPAK 266
+ I+ + + P+ + E +L+ + PA
Sbjct: 247 AHEEVIYYVRDGNILACPE--NCPLELYNLMRLCWSKLPAD 285
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-46
Identities = 60/280 (21%), Positives = 110/280 (39%), Gaps = 38/280 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRH 76
+RY+ + +GSG +G D KT VAVK + R + + RE+ + ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 77 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V L ++ + G I + ++D +F Q++ G+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y HS + HRDLK N ++ LKI DFG ++ + V T Y APE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIML 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD------- 244
+ + D+WS G + +L G F + + + + + +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 245 ------------------YVHISPECRHLISRIFVADPAK 266
++ +P L+ ++ V D K
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-45
Identities = 55/277 (19%), Positives = 95/277 (34%), Gaps = 35/277 (12%)
Query: 19 DSDRYELVRDIGSGNFGV-----ARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
+R + +G+G FG A + VAVK ++ + E + E+
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC------------------NAG 112
L H NIV ++ EY G+L + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172
++ F Q+ G+++ S HRDL N LL KICDFG ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKND 198
Query: 173 SQPKST---VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
S ++APE + Y + +DVWS G+ L+ +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGM---PVD 254
Query: 230 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
++++ + + H E ++ + ADP K
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 291
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-44
Identities = 51/266 (19%), Positives = 94/266 (35%), Gaps = 19/266 (7%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDE--NVQRE 67
+ I S IG G+FG L+ + + AVK + R I E E
Sbjct: 19 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 68 IINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQ 125
I + HPN++ + L + +V+ Y G+L + + F Q
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 180
+ G+ + S + HRDL N +LD +K+ DFG ++
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
++A E L +++ K +DVWS GV L+ ++ P + + +
Sbjct: 197 PVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----GR 251
Query: 241 SIPDYVHISPECRHLISRIFVADPAK 266
+ + ++ + +
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEM 277
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-44
Identities = 54/259 (20%), Positives = 99/259 (38%), Gaps = 18/259 (6%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKT----EELVAVKYIERG--DKIDENVQREIINHR 72
+ IG+G FG K + E VA+K ++ G +K + E
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVS 131
H NI+R + VI + I+ EY G L + + G FS + + + +G+
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAP 187
Y +M HRDL N L++ + K+ DFG S+ + AP
Sbjct: 125 YLANMNYVHRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
E + +++ +DVWS G+ ++ ++ K I+ + +P +
Sbjct: 183 EAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----GFRLPTPMD 237
Query: 248 ISPECRHLISRIFVADPAK 266
L+ + + + A+
Sbjct: 238 CPSAIYQLMMQCWQQERAR 256
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 3e-42
Identities = 54/276 (19%), Positives = 105/276 (38%), Gaps = 34/276 (12%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE-------LVAVKYI--ERGDKIDENVQREII 69
DR L + +G G FG L ++ VAVK + + +K ++ E+
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70
Query: 70 NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAG 112
+ + +H NI+ L +++EYAS G L E +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVL 171
+ S + Q+ G+ Y S + HRDL N L+ ++
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 230
+ + + ++APE L + Y + +DVWS GV L+ + +G P+ +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPV-----E 244
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
+ ++L + + + + E ++ + A P++
Sbjct: 245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQ 280
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-42
Identities = 65/279 (23%), Positives = 102/279 (36%), Gaps = 28/279 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ L IG G FG + + E VAVK ++ + EI LRH NI
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFREAEIYQTVMLRHENI 59
Query: 80 VRFKEVI----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+ F T T L +V +Y G LF+ + N + + SG+++ H
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 136 --------MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTP 182
+ HRDLK +N L+ + I D G S + + P VGT
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 183 AYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237
Y+APEVL +K K AD+++ G+ + + E+ + +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 238 VQYSIPDYVHISPECRHLISRIFVADPAKSEMHDWRRGC 276
+ V + R I + + A M R C
Sbjct: 237 SVEEMRKVV-CEQKLRPNIPNRWQSCEALRVMAKIMREC 274
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 4e-41
Identities = 62/291 (21%), Positives = 106/291 (36%), Gaps = 51/291 (17%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
RY+ ++ IGSG G+ D + VA+K + R + RE++ + + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 78 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
NI+ V + +VME + + Q++ G+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
+ HS + HRDLK N ++ LKI DFG ++++ V T Y APEV+L
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH---- 247
Y + D+WS G + M+ F + + K I ++ + +
Sbjct: 192 GMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 248 --------------------------------ISPECRHLISRIFVADPAK 266
+ + R L+S++ V DPAK
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 9e-41
Identities = 48/269 (17%), Positives = 102/269 (37%), Gaps = 29/269 (10%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKIDE--NVQREIINH 71
++ + R++G G+FG+ K + E VA+K + + E E
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF----------SEDEARF 121
+ ++VR V+ ++ME + G+L + + S +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 178
++ G++Y ++ + HRDL N ++ +KI DFG ++ + + +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
+ +++PE L + DVWS GV L+ + A P + + + + ++
Sbjct: 196 LLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQ---PYQGLSNEQVLRFVMEG 251
Query: 239 QY-SIPDYVHISPECRHLISRIFVADPAK 266
PD + L+ + +P
Sbjct: 252 GLLDKPD--NCPDMLFELMRMCWQYNPKM 278
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 2e-40
Identities = 57/276 (20%), Positives = 101/276 (36%), Gaps = 34/276 (12%)
Query: 19 DSDRYELVRDIGSGNFGV-----ARLMRDKKTEELVAVKYIERGDKIDEN---VQREIIN 70
DR +L + +G G FG A + T VAVK ++ G E+ + I
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 71 HRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGR---------------- 113
H N+V P L +++E+ G L + +
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 114 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 170
+ + + Q+ G+ + S + HRDL N LL +KICDFG ++
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDP 188
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+ + ++APE + + Y + +DVWS GV L+ + P +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGAS---PYPGVKIDE 244
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
R L + + +PE + + +P++
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQ 280
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 126 bits (317), Expect = 9e-35
Identities = 57/306 (18%), Positives = 102/306 (33%), Gaps = 62/306 (20%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 81
RY LVR +G G+F L +D VA+K + E + EI + + + +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 82 ---------------FKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQ 125
F H+ +V E L + + +Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 126 LISGVSYCHSMQ-VCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182
L+ G+ Y H + H D+K EN L++ SP ++I + +++ T
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRILSVQY 240
Y +PEVLL + AD+WS ++ ++ G + F ++ I +I+ +
Sbjct: 194 EYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 241 SIPDYV----------------------------------------HISPECRHLISRIF 260
+P Y+ + E +S +
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
Query: 261 VADPAK 266
DP K
Sbjct: 313 QLDPRK 318
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.5 bits (164), Expect = 3e-14
Identities = 29/202 (14%), Positives = 57/202 (28%), Gaps = 39/202 (19%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----------DKIDENVQREIINH 71
+ + +G G +K E VK+ + G D D + I
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 72 RSLRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
+ + + + + + A++ME R + ++
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMEL-------IDAKELYRVRVENPDEVLDMIL 113
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
V+ + + H DL N L+ + I DF SV + +
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFP---QSVEVGEEGW----REILER 163
Query: 188 EVL-----LKKEYDGKIADVWS 204
+V + Y D+ S
Sbjct: 164 DVRNIITYFSRTY-RTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 280 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.72 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.56 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.3 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.67 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.56 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.34 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-61 Score=388.41 Aligned_cols=248 Identities=34% Similarity=0.624 Sum_probs=219.2
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
.++|++.+.||+|+||+||+|++..+++.||+|++.+. ....+.+.+|+.++++++||||+++++++.+++.+++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999998753 33456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
|||+++++|.+++.+..++++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++..... ...
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~-~~~ 161 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRR 161 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCC-CCC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecCC-Ccc
Confidence 999999999999998889999999999999999999999999999999999999998887 99999999975433 233
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....||+.|+|||++.+..++.. +|||||||++|+|++|..||...+. ......+....+.++. .+|+++++|
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~l 234 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTY----QETYKRISRVEFTFPD--FVTEGARDL 234 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTTCCCCCT--TSCHHHHHH
T ss_pred cccCCCCcccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCCCCc--cCCHHHHHH
Confidence 45578999999999998887655 9999999999999999999976443 3344555566666665 689999999
Q ss_pred HHHhcccCCCCcC------CCccccccc
Q 023591 256 ISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 256 i~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
|.+||+.||++|| .||||++.+
T Consensus 235 i~~~L~~dp~~R~t~~eil~hp~~~~~s 262 (263)
T d2j4za1 235 ISRLLKHNPSQRPMLREVLEHPWITANS 262 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHccCCHhHCcCHHHHHcCcCcCCcC
Confidence 9999999999999 999998765
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-61 Score=391.25 Aligned_cols=252 Identities=33% Similarity=0.570 Sum_probs=214.5
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
.++|++++.||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 478999999999999999999999999999999987643 234568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC---CC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQ 174 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~---~~ 174 (280)
|+++++|.+++.....+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+|...... ..
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCcccc
Confidence 9999999999988888999999999999999999999999999999999999998887 999999999754322 22
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
.....||+.|+|||.+.+..+++.++||||+||++|+|++|..||............. .......+.+..+|+++.+
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---KEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH---HTTCTTSTTGGGSCHHHHH
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH---hcCCCCCCccccCCHHHHH
Confidence 3456799999999999888877666999999999999999999998765443333222 2222233333468999999
Q ss_pred HHHHhcccCCCCcC------CCcccccc
Q 023591 255 LISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
||.+||+.||++|| .||||++.
T Consensus 239 li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 99999999999999 99999854
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-60 Score=386.75 Aligned_cols=249 Identities=29% Similarity=0.516 Sum_probs=217.0
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
.+++|++.+.||+|+||+||+|++..+++.||||++.+. ....+.+.+|+.++++++||||+++++++.+++.+++
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 457899999999999999999999999999999999753 3444678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~- 173 (280)
||||+++++|.+++...+.+++..++.++.|++.||+|||+.||+||||||+||+++.++. +||+|||+|+......
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESK 163 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC----
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCc
Confidence 9999999999999998899999999999999999999999999999999999999998887 9999999997544322
Q ss_pred --CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 174 --~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
......||+.|+|||++.+..++.. +|||||||++|+|++|..||...+. ......+....+.++. .+|++
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~ 236 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPE--KFFPK 236 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHTTCCCCCT--TCCHH
T ss_pred ccccccccCCccccCceeeccCCCCcc-cceehhhHHHHHHhhCCCCCCCcCH----HHHHHHHHcCCCCCCc--cCCHH
Confidence 2234569999999999988887654 9999999999999999999987543 3344555566666665 68999
Q ss_pred HHHHHHHhcccCCCCcC------------CCcccccc
Q 023591 252 CRHLISRIFVADPAKSE------------MHDWRRGC 276 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp------------~h~~~~~~ 276 (280)
+++||.+||+.||++|| .||||++.
T Consensus 237 ~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 99999999999999999 69999865
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-60 Score=390.60 Aligned_cols=253 Identities=36% Similarity=0.627 Sum_probs=201.2
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
.++|++.+.||+|+||+||+|++..+++.||+|++.+.. .....+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 367999999999999999999999999999999997643 233457789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeC-CCCCcEEEeecCCccccccCCCCC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~-~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
|+++++|.+++...+.+++..+..++.||+.||+|||++|++||||||+||++.. +.++++||+|||++..........
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 167 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 167 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeee
Confidence 9999999999998889999999999999999999999999999999999999964 223459999999998666555556
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccC--CCCCCCCHHHHH
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRH 254 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 254 (280)
...||+.|+|||++.+..++.. +|||||||++|+|++|..||....... ....+......+ +....+|+++.+
T Consensus 168 ~~~GT~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~ 242 (307)
T d1a06a_ 168 TACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAK----LFEQILKAEYEFDSPYWDDISDSAKD 242 (307)
T ss_dssp -----CTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred eeeeCccccCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHhccCCCCCCccccCCCHHHHH
Confidence 6789999999999988888665 999999999999999999998754433 333344433332 334478999999
Q ss_pred HHHHhcccCCCCcC------CCccccccc
Q 023591 255 LISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 255 li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
||.+||+.||++|| .||||++..
T Consensus 243 li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 243 FIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred HHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 99999999999999 999998654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-59 Score=380.87 Aligned_cols=249 Identities=27% Similarity=0.432 Sum_probs=213.4
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
.++|++.+.||+|+||+||+|++..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 368999999999999999999999999999999997654 3346688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCCC
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (280)
+++++|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++....... ....
T Consensus 99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCC
T ss_pred cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--Eeeccchhheeeccccccccc
Confidence 999999988755 56999999999999999999999999999999999999998877 9999999998654333 3445
Q ss_pred CcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHHHH
Q 023591 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (280)
..||+.|+|||.+.+..++.. +|||||||++|+|++|..||...+......... ......++....+|+++++||.
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HHCSCCCSSGGGSCHHHHHHHH
T ss_pred cccCCCccChhhhcCCCCCch-hceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH---hCCCCCCCCcccCCHHHHHHHH
Confidence 679999999999998888665 999999999999999999998755433222222 2222333333468999999999
Q ss_pred HhcccCCCCcC------CCccccc
Q 023591 258 RIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 258 ~~l~~dp~~Rp------~h~~~~~ 275 (280)
+||+.||++|| .||||+.
T Consensus 252 ~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 252 RCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999 9999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.2e-59 Score=391.68 Aligned_cols=259 Identities=27% Similarity=0.495 Sum_probs=220.6
Q ss_pred CCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
....+...++|++++.||+|+||+||+|++..+|+.||+|++..... ....+.+|+.++++++|||||++++++.++..
T Consensus 21 ~~~~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 100 (352)
T ss_dssp CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred cCCCCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34444456789999999999999999999999999999999876542 33467789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
+++||||+++++|.+.+... .++++..++.++.||+.||+|||++||+||||||+||+++....+++||+|||+|....
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 99999999999998877554 46999999999999999999999999999999999999986555569999999998766
Q ss_pred cCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCC--CCCCC
Q 023591 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHI 248 (280)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 248 (280)
.........+++.|+|||++.+..++.. +|||||||++|+|++|..||...+... ....+....+.++ ....+
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~ 255 (352)
T d1koba_ 181 PDEIVKVTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLE----TLQNVKRCDWEFDEDAFSSV 255 (352)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHHCCCCCCSSTTTTS
T ss_pred CCCceeeccCcccccCHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCcccccCC
Confidence 6555566789999999999988888665 999999999999999999998755433 3333444443333 23478
Q ss_pred CHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 249 SPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
|+++.+||.+||+.||.+|| .||||++.
T Consensus 256 s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999 99999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-58 Score=383.76 Aligned_cols=249 Identities=33% Similarity=0.571 Sum_probs=220.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
..++|++++.||+|+||+||+|++..+++.||+|++.+. ....+.+.+|+.++++++||||+++++++.++..+++
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 347899999999999999999999999999999999763 3345678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-CC
Q 023591 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~-~~ 173 (280)
||||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+|+.... ..
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTC
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCCc
Confidence 9999999999999999999999999999999999999999999999999999999998887 99999999985443 33
Q ss_pred CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
......||+.|+|||++.+..++.. +|||||||++|+|++|..||...+. ......+......+|. .+|++++
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~ 233 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFPR--TLSPEAK 233 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcCH----HHHHHHHhcCCCCCCc--cCCHHHH
Confidence 3455679999999999999888665 9999999999999999999987553 3344455556666666 7999999
Q ss_pred HHHHHhcccCCCCcC-----------CCcccccc
Q 023591 254 HLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+||++||+.||.+|| .||||++.
T Consensus 234 dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 999999999999997 89999764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-59 Score=382.24 Aligned_cols=251 Identities=33% Similarity=0.624 Sum_probs=218.0
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-------cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
.++|++.+.||+|+||+||+|++..+|+.||+|++.+.. ...+.+.+|+.++++++|||||++++++.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 478999999999999999999999999999999997542 2236788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCC--CcEEEeecCCccccc
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSV 170 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~--~~~~l~df~~~~~~~ 170 (280)
++||||+++++|.+++...+.+++..++.++.|++.||+|||+.|++||||||+||+++.++. ..+|++|||++....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 999999999999999988889999999999999999999999999999999999999987663 359999999998766
Q ss_pred cCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC--CCCC
Q 023591 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248 (280)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 248 (280)
.........+++.|+|||.+.+..++.+ +||||+||++|+|++|..||...+..+. ...+......++. ...+
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~ 243 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQET----LANVSAVNYEFEDEYFSNT 243 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHTTCCCCCHHHHTTS
T ss_pred CCccccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCCHHHH----HHHHHhcCCCCCchhcCCC
Confidence 6666666788999999999988877655 9999999999999999999987554333 3333443333321 2368
Q ss_pred CHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 249 SPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
|+++++||.+||+.||++|| .||||++
T Consensus 244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999 9999985
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.4e-59 Score=391.19 Aligned_cols=260 Identities=30% Similarity=0.538 Sum_probs=220.5
Q ss_pred CCCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-ccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
.+......++|++++.||+|+||.||+|++..+|+.||+|++..... ..+.+.+|+.++++++|||||++++++.+++.
T Consensus 18 ~l~~~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 97 (350)
T d1koaa2 18 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 97 (350)
T ss_dssp CCBCSCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE
T ss_pred cCCCCCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 34344455799999999999999999999999999999999976542 33567889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 92 LAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
+++||||+++++|.+++. ..+.+++..+..++.||+.||+|||++|++||||||+||+++.+.++.+||+|||++....
T Consensus 98 ~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 98 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp EEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 999999999999999885 4457999999999999999999999999999999999999976655569999999998666
Q ss_pred cCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC--CCCC
Q 023591 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248 (280)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 248 (280)
.........+|+.|+|||++.+..++.. +|||||||++|+|++|..||...+..+ ....+......++. ...+
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~ 252 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDE----TLRNVKSCDWNMDDSAFSGI 252 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCSCCGGGGGC
T ss_pred cccccceecCcccccCHHHHcCCCCChh-HhhhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCcccccCC
Confidence 5555556789999999999988888655 999999999999999999998654433 33334443333332 2368
Q ss_pred CHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 249 SPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
|+++++||.+||+.||++|| .||||++..
T Consensus 253 s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999 999998653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-59 Score=386.30 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=211.8
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
..++|++++.||+|+||+||+|++..+|+.||+|+++... ...+.+.+|+.++++++|||||++++++.++..+++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4689999999999999999999999999999999997643 33457889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
||+++++|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++. +||+|||+|...... ..
T Consensus 84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~-~~ 160 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-MA 160 (322)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH-TC
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCCC-cc
Confidence 999999999999888899999999999999999999997 59999999999999998887 999999999854332 23
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHH--------------------------
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR-------------------------- 229 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~-------------------------- 229 (280)
....||+.|+|||++.+..++.. +||||+||++|+|++|+.||...+......
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred ccccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 45689999999999999888766 999999999999999999997654321100
Q ss_pred ------------HHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 230 ------------KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 230 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
+....+............+|.++++||.+||+.||.+|| +||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 001111111111111224689999999999999999999 999998643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-59 Score=379.23 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=211.5
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC-CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
+.|++++.||+|+||+||+|++..+++.||+|++... ....+.+.+|++++++++|||||++++++.+++.+++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5799999999999999999999999999999999764 344567889999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCCC
Q 023591 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (280)
Q Consensus 100 ~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~~ 177 (280)
++++|.+++.+ ..++++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||+|...... .....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcccccc
Confidence 99999998765 457999999999999999999999999999999999999998887 999999998643322 22345
Q ss_pred CcCCCcccCcccccC-----CcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 178 TVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 178 ~~~~~~~~aPE~~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
..|++.|+|||++.. ..++ .++|||||||++|+|++|..||...+..+...++... ....+.....+|+++
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~-~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS---EPPTLAQPSRWSSNF 245 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTT-THHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS---CCCCCSSGGGSCHHH
T ss_pred cccccccCCHHHHhhcccCCCCCC-hhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC---CCCCCCccccCCHHH
Confidence 678999999999842 3344 4599999999999999999999877655444433322 112223334689999
Q ss_pred HHHHHHhcccCCCCcC------CCcccccc
Q 023591 253 RHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
++||.+||+.||++|| .||||+..
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999 99999854
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8e-58 Score=377.28 Aligned_cols=246 Identities=32% Similarity=0.573 Sum_probs=217.6
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
.++|++++.||+|+||+||+|++..+|+.||+|++.+. ....+.+.+|+.++++++||||+++++++.+++.+++|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46899999999999999999999999999999999753 34456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
|||++|++|..++.....+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+|..... ..
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~~--~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--VT 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--CB
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEecc--cc
Confidence 999999999999999999999999999999999999999999999999999999998887 99999999975433 33
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....||+.|+|||++.+..++.. +|||||||++|+|++|..||...+. ......+......++. .+|+++.++
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~l 231 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNT----MKTYEKILNAELRFPP--FFNEDVKDL 231 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcCH----HHHHHHHHcCCCCCCC--CCCHHHHHH
Confidence 45679999999999988888765 9999999999999999999987543 3344455555556655 689999999
Q ss_pred HHHhcccCCCCcC-----------CCcccccc
Q 023591 256 ISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 256 i~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
|.+||+.||.+|+ .||||++.
T Consensus 232 i~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 9999999999995 89999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-58 Score=370.42 Aligned_cols=246 Identities=24% Similarity=0.389 Sum_probs=204.0
Q ss_pred CCe-eeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEec----CCeE
Q 023591 21 DRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHL 92 (280)
Q Consensus 21 ~~y-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 92 (280)
++| ++.++||+|+||+||+|++..+++.||+|.+.... ...+.+.+|++++++++|||||++++++.. +..+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 456 77889999999999999999999999999987643 233567899999999999999999999865 3568
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC--ceecCCCCCcEEEeC-CCCCcEEEeecCCcccc
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 169 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~--i~h~dl~~~ni~i~~-~~~~~~~l~df~~~~~~ 169 (280)
++||||+++++|.+++.+...+++..++.++.||+.||+|||+++ |+||||||+||+++. ++. +||+|||+++..
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLK 165 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGC
T ss_pred EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC--EEEeecCcceec
Confidence 999999999999999998889999999999999999999999999 999999999999964 555 999999999743
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
. ........||+.|+|||.+.+ .++.. +|||||||++|+|++|+.||......... ...+.............+
T Consensus 166 ~-~~~~~~~~GT~~Y~aPE~~~~-~~~~~-~DIwSlGvilyel~~g~~Pf~~~~~~~~~---~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 166 R-ASFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQI---YRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp C-TTSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHH---HHHHTTTCCCGGGGGCCC
T ss_pred c-CCccCCcccCccccCHHHhCC-CCCCc-CchhhHHHHHHHHHHCCCCCCCcccHHHH---HHHHHcCCCCcccCccCC
Confidence 2 223345679999999998865 46554 99999999999999999999765543332 233333222222223578
Q ss_pred HHHHHHHHHhcccCCCCcC------CCcccc
Q 023591 250 PECRHLISRIFVADPAKSE------MHDWRR 274 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp------~h~~~~ 274 (280)
+++.+||.+||+.||++|| +||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999 999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-59 Score=386.46 Aligned_cols=252 Identities=25% Similarity=0.468 Sum_probs=219.6
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEecc
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (280)
.++|++.+.||+|+||+||+|.+..+++.||+|++.........+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 47899999999999999999999999999999999877665667889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCCCC
Q 023591 100 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (280)
Q Consensus 100 ~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~~~ 178 (280)
++++|.+++...+ ++++.+++.++.||+.||+|||+.||+||||||+||+++.++..+++|+|||++............
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~ 163 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccccc
Confidence 9999999997655 799999999999999999999999999999999999998777667999999999866555545566
Q ss_pred cCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCC--CCCCCHHHHHHH
Q 023591 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLI 256 (280)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li 256 (280)
.+++.|+|||.+.+..++.. +||||+||++|+|++|..||...+... ....+....+.++. +..+|+++++||
T Consensus 164 ~~t~~y~ape~~~~~~~~~~-~DiWSlGvily~ll~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T d1tkia_ 164 FTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQ----IIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred ccccccccchhccCCCCCch-hhcccHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence 78999999999988887655 999999999999999999998765433 33344444433332 236899999999
Q ss_pred HHhcccCCCCcC------CCcccccc
Q 023591 257 SRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 257 ~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
.+||+.||.+|| .||||++.
T Consensus 239 ~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 239 DRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHccCChhHCcCHHHHhcCHhhccC
Confidence 999999999999 89999754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-58 Score=377.52 Aligned_cols=247 Identities=28% Similarity=0.410 Sum_probs=210.2
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCccc----HHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (280)
+.|+.++.||+|+||+||+|++..+++.||||++....... +.+.+|+.++++++|||||++++++.+++.+++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 36999999999999999999999999999999998654322 45778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCCC
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (280)
||+.+++|..++....++++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++..... ..
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~---~~ 169 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---AN 169 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---BC
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccCC---CC
Confidence 99999999887778888999999999999999999999999999999999999998877 99999999975432 34
Q ss_pred CCcCCCcccCcccccCC---cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 177 STVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
...||+.|+|||++.+. .++. ++|||||||++|+|++|..||........ ...+............+|++++
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~-~~DiwSlGvilyel~~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~s~~~~ 244 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQNESPALQSGHWSEYFR 244 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSCCCCCSCTTSCHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCc-hhhhhhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhCCCCCCCCCCCCHHHH
Confidence 56799999999998643 3444 49999999999999999999987544322 2333333333333346899999
Q ss_pred HHHHHhcccCCCCcC------CCccccccc
Q 023591 254 HLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
+||.+||+.||++|| .||||++..
T Consensus 245 ~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 999999999999999 999997543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7e-58 Score=370.86 Aligned_cols=250 Identities=32% Similarity=0.483 Sum_probs=214.8
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc----------cHHHHHHHHHhhhCC-CCCeeeeceEEec
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------DENVQREIINHRSLR-HPNIVRFKEVILT 88 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 88 (280)
.++|++.+.||+|+||+||+|++..+++.||+|++.+.... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999999999999999999765321 235778999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
++.+++||||+++++|.+++...+++++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeE
Confidence 9999999999999999999998889999999999999999999999999999999999999998887 99999999987
Q ss_pred cccCCCCCCCcCCCcccCcccccCC-----cCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc--c
Q 023591 169 SVLHSQPKSTVGTPAYIAPEVLLKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--S 241 (280)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~ 241 (280)
...........+++.|.|||.+.+. ...+.++||||+||++|+|++|+.||...+.... ...+..... .
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~----~~~i~~~~~~~~ 235 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM----LRMIMSGNYQFG 235 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCC
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH----HHHHHhCCCCCC
Confidence 6655555667789999999998642 2224459999999999999999999987654332 333333333 3
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 242 IPDYVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
.+....+|+++++||.+||+.||++|| .||||++
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 333447899999999999999999999 9999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-57 Score=379.60 Aligned_cols=246 Identities=30% Similarity=0.543 Sum_probs=217.3
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
.++|++++.||+|+||+||+|++..+|+.||||++.+. ....+.+.+|+.++++++||||+++++++......++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 47999999999999999999999999999999998753 34446788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
|||+.+++|...+.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+++.... ..
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~~--~~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--RT 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--CB
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC--EEeeeceeeeeccc--cc
Confidence 999999999999988889999999999999999999999999999999999999998887 99999999985543 23
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (280)
....|++.|+|||++.+..++.. +|||||||++|+|++|..||...+. ......+......++. .+|+++.+|
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~l 268 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQP----IQIYEKIVSGKVRFPS--HFSSDLKDL 268 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TCCHHHHHH
T ss_pred ccccCccccCCHHHHcCCCCCcc-ccccchhHHHHHHHhCCCCCCCcCH----HHHHHHHhcCCCCCCc--cCCHHHHHH
Confidence 45679999999999998888665 9999999999999999999976543 3344455555555555 799999999
Q ss_pred HHHhcccCCCCcC-----------CCcccccc
Q 023591 256 ISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 256 i~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
|++||+.||.+|+ .||||++.
T Consensus 269 i~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 9999999999994 89999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-58 Score=370.31 Aligned_cols=246 Identities=30% Similarity=0.501 Sum_probs=197.6
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---cHHHHHHHHHhhhCCCCCeeeeceEEec--CCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT--PTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 93 (280)
+.++|++++.||+|+||+||++++..+|+.||+|.+...... .+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 458899999999999999999999999999999998765432 3457789999999999999999999865 45689
Q ss_pred EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC-----ceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 94 IVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~-----i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
+||||+++|+|.+++.+ ...+++..++.++.||+.||+|||+.| |+||||||+||+++.++. +||+|||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG 159 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFG 159 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeecc
Confidence 99999999999998853 457999999999999999999999977 999999999999998887 9999999
Q ss_pred CccccccCC-CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-cC
Q 023591 165 YSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SI 242 (280)
Q Consensus 165 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 242 (280)
++....... ......+|+.|+|||.+.+..++.+ +|||||||++|+|++|..||...+.. .....+..... .+
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyel~tg~~Pf~~~~~~----~~~~~i~~~~~~~~ 234 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQK----ELAGKIREGKFRRI 234 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHTCCCCC
T ss_pred ceeecccCCCccccCCCCcccCCHHHHcCCCCChH-HHHHhhCHHHHHHhhCCCCCCCCCHH----HHHHHHHcCCCCCC
Confidence 997544332 2345678999999999988877655 99999999999999999999865433 23333333333 23
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCcC------CCccc
Q 023591 243 PDYVHISPECRHLISRIFVADPAKSE------MHDWR 273 (280)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~ 273 (280)
+. .+|+++.+||.+||+.||++|| +|||+
T Consensus 235 ~~--~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 235 PY--RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred Cc--ccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 33 6899999999999999999999 99996
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4e-57 Score=379.83 Aligned_cols=251 Identities=28% Similarity=0.425 Sum_probs=212.0
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC----cccHHHHH---HHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQR---EIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
.++|++.+.||+|+||.||+|++..+|+.||+|++.+.. .....+.+ ++.+++.++|||||++++++.+++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 478999999999999999999999999999999987532 12222333 46677778999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
++||||+++++|.+++.+...+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||+|+.....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK 160 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCCC
Confidence 999999999999999998889999999999999999999999999999999999999998887 999999999854433
Q ss_pred CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHH
Q 023591 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (280)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (280)
......||+.|+|||++.++...+.++|||||||++|+|++|..||....... .......+......++. .+|+++
T Consensus 161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~--~~s~~~ 236 (364)
T d1omwa3 161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPD--SFSPEL 236 (364)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-HHHHHHHSSSCCCCCCS--SSCHHH
T ss_pred -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccCCCCCCC--CCCHHH
Confidence 34456799999999999765544455999999999999999999998755432 33344444444445544 689999
Q ss_pred HHHHHHhcccCCCCcC-----------CCcccccc
Q 023591 253 RHLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 253 ~~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
++||.+||+.||++|| .||||++.
T Consensus 237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 9999999999999998 89999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-57 Score=372.95 Aligned_cols=247 Identities=34% Similarity=0.555 Sum_probs=214.3
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC----CcccHHHHHHHHHhh-hCCCCCeeeeceEEecCCeEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHR-SLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
++|++.+.||+|+||+||+|++..+++.||+|++.+. +...+.+..|..++. .++||||+++++++.+++.+++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6899999999999999999999999999999999753 333445666666654 68999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 174 (280)
|||+++|+|.+++.....+++..++.++.||+.||+|||++|++||||||+||+++.++. +||+|||++........
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhccccccc
Confidence 999999999999999899999999999999999999999999999999999999998887 99999999975443332
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
.....||+.|+|||++.+..++.. +||||+||++|+|++|..||...+. ......+....+.++. .+|+++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~PF~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~d 232 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIRMDNPFYPR--WLEKEAKD 232 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHHH
T ss_pred ccccCCCCCcCCHHHHcCCCCCch-hhhhhhhHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCc--cCCHHHHH
Confidence 344578999999999999888765 9999999999999999999987543 3334444555566665 68999999
Q ss_pred HHHHhcccCCCCcC-------CCcccccc
Q 023591 255 LISRIFVADPAKSE-------MHDWRRGC 276 (280)
Q Consensus 255 li~~~l~~dp~~Rp-------~h~~~~~~ 276 (280)
||.+||+.||.+|| .||||++.
T Consensus 233 li~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 99999999999999 89999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-57 Score=377.24 Aligned_cols=261 Identities=32% Similarity=0.517 Sum_probs=215.2
Q ss_pred CCCCCCCCCCCCeeeec-ccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhh-CCCCCeeeeceEEec
Q 023591 11 GMDMPIMHDSDRYELVR-DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-LRHPNIVRFKEVILT 88 (280)
Q Consensus 11 ~~~~~~~~~~~~y~~~~-~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 88 (280)
|+++......++|+++. .||+|+||+||+|++..+++.||||++... ..+.+|+.++.+ .+||||+++++++.+
T Consensus 1 ~~~~~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 1 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp CCCCBCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CccCCCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 34555555568999986 599999999999999999999999998643 467789988655 589999999999875
Q ss_pred ----CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCC-CCcEEEe
Q 023591 89 ----PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKIC 161 (280)
Q Consensus 89 ----~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~-~~~~~l~ 161 (280)
+..+++||||++||+|.+++.+. ..+++..++.++.||+.||+|||+.||+||||||+||+++.+. .+.+||+
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence 45789999999999999999764 3699999999999999999999999999999999999998643 3459999
Q ss_pred ecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccccc
Q 023591 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241 (280)
Q Consensus 162 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
|||+++............+++.|+|||++.+..++.. +|||||||++|+|++|..||...............+....+.
T Consensus 157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235 (335)
T ss_dssp CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred ccceeeeccCCCccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 9999987666666677789999999999988887655 999999999999999999998766555555555555555555
Q ss_pred CCC--CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 242 IPD--YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 242 ~~~--~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
++. +..+|+++.+||.+||+.||++|| .||||++.
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 443 235899999999999999999999 89999754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-56 Score=365.89 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=208.3
Q ss_pred eeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc------ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 24 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
+.++.||+|+||+||+|++..+|+.||||++..... ..+.+.+|+.++++++|||||++++++.+++.+++|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 357899999999999999999999999999865422 23568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC-CCCC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~-~~~~ 176 (280)
|+.++++..+......+++..+..+++||+.||+|||++|++||||||+||+++.++. +||+|||++...... ....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCccccc
Confidence 9988777776666778999999999999999999999999999999999999998887 999999999754433 2334
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-cC-------------
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SI------------- 242 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~------------- 242 (280)
...+|+.|+|||.+.+....+.++||||+||++|+|++|..||....+.+....+......... .+
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 5578999999999877665566699999999999999999999876655544444433221110 00
Q ss_pred --CC------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccccCCC
Q 023591 243 --PD------YVHISPECRHLISRIFVADPAKSE------MHDWRRGCSVSC 280 (280)
Q Consensus 243 --~~------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~~~ 280 (280)
+. ....++++.+||.+||+.||++|| +||||++.+.+|
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~ 290 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 290 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence 00 124688999999999999999999 999999876654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-56 Score=361.43 Aligned_cols=244 Identities=30% Similarity=0.487 Sum_probs=208.1
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc-------ccHHHHHHHHHhhhCC--CCCeeeeceEEecCC
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLR--HPNIVRFKEVILTPT 90 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 90 (280)
.++|++.+.||+|+||+||+|++..+++.||||++.+... ...++.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 4789999999999999999999999999999999875321 1234668999999886 899999999999999
Q ss_pred eEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 91 HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 91 ~~~lv~e~~~~-~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
..++||||+.+ +++.+++.+...+++..++.++.||+.||+|||++|++||||||+||+++.+.. .+||+|||++...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~-~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-EEEECCCTTCEEC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCC-eEEECccccceec
Confidence 99999999975 678888888889999999999999999999999999999999999999985532 3999999999744
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
.. .......||+.|+|||.+.+..+++.++||||+||++|+|++|..||...+ .+......++. .+|
T Consensus 162 ~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i~~~~~~~~~--~~s 228 (273)
T d1xwsa_ 162 KD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQ--RVS 228 (273)
T ss_dssp CS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCCCCCSS--CCC
T ss_pred cc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------HHhhcccCCCC--CCC
Confidence 32 233456789999999999888777676899999999999999999997521 22333444444 689
Q ss_pred HHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 250 PECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
+++++||++||+.||++|| +||||++..
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 9999999999999999999 999998764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=360.36 Aligned_cols=255 Identities=29% Similarity=0.451 Sum_probs=209.2
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|++++.||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.++..+++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999999999999999986542 345778899999999999999999999999999999999
Q ss_pred ccCCCchHHHH-Hh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc-CCC
Q 023591 98 YASGGELFERI-CN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (280)
Q Consensus 98 ~~~~~~L~~~~-~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~-~~~ 174 (280)
|+.+ .+.+++ .. ...+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||.+..... ...
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRT 158 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBC
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCccc
Confidence 9976 444444 33 456999999999999999999999999999999999999988877 99999999975543 333
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc--------------
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-------------- 240 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 240 (280)
.....+++.|+|||.+....+.+.++||||+|+++|+|++|..||...+.................
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 445678999999999888877677799999999999999999999876554444443332211110
Q ss_pred cCCC---------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 241 SIPD---------YVHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 241 ~~~~---------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
.++. ...+|+++.+||++||+.||++|| +||||++...
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 0000 125688999999999999999999 9999997654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-55 Score=358.86 Aligned_cols=246 Identities=20% Similarity=0.272 Sum_probs=208.0
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
.-...++|++.+.||+|+||+||+|++..+++.||+|++.......+++.+|+.++++++|||||++++++.+++..+++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 34566899999999999999999999999999999999988777778899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 96 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+++......
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDT 169 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCC
Confidence 9999999999998654 46899999999999999999999999999999999999998887 9999999997543322
Q ss_pred CC--CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHH
Q 023591 174 QP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (280)
Q Consensus 174 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (280)
.. ....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||....+.....+.. ......+....+|++
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k-~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i----~~~~~~~~~~~~~~~ 244 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDYRMERPEGCPEK 244 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----HTTCCCCCCTTCCHH
T ss_pred ceeeccccccccccChHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH----hcCCCCCCCccchHH
Confidence 21 22347888999999988888655 999999999999999777765544433333222 222333333478999
Q ss_pred HHHHHHHhcccCCCCcC
Q 023591 252 CRHLISRIFVADPAKSE 268 (280)
Q Consensus 252 l~~li~~~l~~dp~~Rp 268 (280)
+.+||.+||+.||++||
T Consensus 245 l~~li~~cl~~dP~~Rp 261 (287)
T d1opja_ 245 VYELMRACWQWNPSDRP 261 (287)
T ss_dssp HHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHcCCCHhHCc
Confidence 99999999999999999
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-54 Score=354.28 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=206.6
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|++++.||+|+||+||+|+++ +++.||+|++... +...+.+.+|+.++++++||||+++++.+.+++..+++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 79999999999999999999986 7899999999764 3335688999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (280)
++.++.+..+....+.+++..++.++.||+.||+|||+.||+||||||+||+++.++. +|++|||.+....... ...
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCccccc
Confidence 9988766766666788999999999999999999999999999999999999998887 9999999987543322 234
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-------c-------C
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-------S-------I 242 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~-------~ 242 (280)
...+++.|.|||.+.+..+.+.++||||||+++|+|++|+.||...+..+...+.......... . .
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 4568899999999987777666699999999999999999999876554444443322211100 0 0
Q ss_pred ---------CCCCCCCHHHHHHHHHhcccCCCCcC------CCccccc
Q 023591 243 ---------PDYVHISPECRHLISRIFVADPAKSE------MHDWRRG 275 (280)
Q Consensus 243 ---------~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~ 275 (280)
.....+++++.+||++||+.||++|| +||||++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 00135788999999999999999999 9999985
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.5e-55 Score=355.07 Aligned_cols=242 Identities=26% Similarity=0.371 Sum_probs=197.5
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc----cHHHHHHHHHhhhCCCCCeeeeceEEecCC----e
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPT----H 91 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~ 91 (280)
.++|++.+.||+|+||+||+|++..+++.||||++.+.... ...+.+|+.++++++||||+++++++..+. .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 47899999999999999999999999999999999765332 245788999999999999999999987643 4
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
+++||||+++++|.+++...+++++..+..++.||+.||+|||++|++||||||+||+++.++. .+++|||.+.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhcc
Confidence 8999999999999999988889999999999999999999999999999999999999998887 99999998764322
Q ss_pred CC----CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccccc--CCCC
Q 023591 172 HS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDY 245 (280)
Q Consensus 172 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 245 (280)
.. ......|++.|+|||++.+..++.. +||||||+++|+|++|..||...+..+...+. ...... ....
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~ 238 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH----VREDPIPPSARH 238 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----HHCCCCCGGGTS
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcc-eecccchHHHHHHHhCCCCCCCcCHHHHHHHH----HhcCCCCCchhc
Confidence 22 2344568999999999988777655 99999999999999999999875543332222 222221 1223
Q ss_pred CCCCHHHHHHHHHhcccCCCCcC
Q 023591 246 VHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 246 ~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..+|+++.+||.+||+.||++||
T Consensus 239 ~~~s~~l~~li~~~L~~dp~~R~ 261 (277)
T d1o6ya_ 239 EGLSADLDAVVLKALAKNPENRY 261 (277)
T ss_dssp SSCCHHHHHHHHHHTCSSGGGSC
T ss_pred cCCCHHHHHHHHHHccCCHhHCH
Confidence 46899999999999999999999
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-54 Score=346.27 Aligned_cols=242 Identities=24% Similarity=0.403 Sum_probs=194.1
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
.++++|++.+.||+|+||+||++++. +++.||||++.......+++.+|+.++++++||||+++++++..++..++|||
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 45689999999999999999999986 46789999998877777889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC--
Q 023591 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (280)
Q Consensus 98 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~-- 174 (280)
|+++++|.+++... ..+++..+..++.||+.||+|||+.+++||||||+||+++.++. +||+|||+++.......
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCcee
Confidence 99999999988654 56899999999999999999999999999999999999998887 99999999975443322
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhC-CCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
.....+++.|+|||.+.+..++.+ +||||||+++|||+++ .+||..... .. ....+... .........++++.
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k-~DVwS~Gvil~el~t~~~~~~~~~~~-~~---~~~~i~~~-~~~~~p~~~~~~l~ 232 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSN-SE---VVEDISTG-FRLYKPRLASTHVY 232 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSCCH-HH---HHHHHHHT-CCCCCCTTSCHHHH
T ss_pred ecceecCcccCChHHhcCCCCCch-hhhcchHHHHHHHHHCCCCCCCCCCH-HH---HHHHHHhc-CCCCCccccCHHHH
Confidence 233457899999999988887655 9999999999999995 555544332 22 22222222 12222236789999
Q ss_pred HHHHHhcccCCCCcC
Q 023591 254 HLISRIFVADPAKSE 268 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp 268 (280)
+||.+||+.||++||
T Consensus 233 ~li~~cl~~~p~~Rp 247 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRP 247 (263)
T ss_dssp HHHHHHTCSSGGGSC
T ss_pred HHHHHHccCCHhHCc
Confidence 999999999999999
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-54 Score=344.13 Aligned_cols=241 Identities=21% Similarity=0.369 Sum_probs=205.7
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEec
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
++++|++.++||+|+||+||+++++ ++..||||.+++.....+++.+|+.++++++||||+++++++.+++.+++||||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 4578999999999999999999985 678899999998887888999999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC--C
Q 023591 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (280)
Q Consensus 99 ~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~--~ 175 (280)
+++|+|.+++.. ...+++..+++++.|+++||+|||+.||+||||+|+||+++.++. +||+|||+++....... .
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceee
Confidence 999999988654 457999999999999999999999999999999999999998887 99999999974433322 2
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHHH
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (280)
....+++.|+|||.+.+..++.+ +||||||+++|||++ |..||...+..+. ...+... ...+.....++++.+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~k-sDiwS~G~~l~el~t~g~~Pf~~~~~~~~----~~~i~~~-~~~~~p~~~~~~l~~ 232 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSET----AEHIAQG-LRLYRPHLASEKVYT 232 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHH----HHHHHTT-CCCCCCTTCCHHHHH
T ss_pred cccCCCCCcCCcHHhcCCCCCcc-eeecccchhhHhHHhcCCCCCCCCCHHHH----HHHHHhC-CCCCCcccccHHHHH
Confidence 23557889999999988887655 999999999999998 8999987654332 2233322 222233378999999
Q ss_pred HHHHhcccCCCCcC
Q 023591 255 LISRIFVADPAKSE 268 (280)
Q Consensus 255 li~~~l~~dp~~Rp 268 (280)
||.+||+.||++||
T Consensus 233 li~~cl~~dP~~RP 246 (258)
T d1k2pa_ 233 IMYSCWHEKADERP 246 (258)
T ss_dssp HHHHTTCSSGGGSC
T ss_pred HHHHHccCCHhHCc
Confidence 99999999999999
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=350.59 Aligned_cols=256 Identities=28% Similarity=0.379 Sum_probs=206.5
Q ss_pred CCCCeeeecccccCCceEEEEEEecCC-CcEEEEEEeeeC---CcccHHHHHHHHHhhhC---CCCCeeeeceEEec---
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERG---DKIDENVQREIINHRSL---RHPNIVRFKEVILT--- 88 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~-~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~--- 88 (280)
..++|++++.||+|+||+||+|++..+ ++.||||++... +.....+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 458999999999999999999999755 677999998753 22334566777777665 89999999999853
Q ss_pred --CCeEEEEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCC
Q 023591 89 --PTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (280)
Q Consensus 89 --~~~~~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~ 165 (280)
...++++||+++++++..... ....+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||+
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~ 162 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGL 162 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCS
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhh
Confidence 346899999998876654443 3456999999999999999999999999999999999999998887 99999999
Q ss_pred ccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc-ccCC-
Q 023591 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIP- 243 (280)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~- 243 (280)
+.............+|+.|+|||.+.+..++.. +||||+||++|+|++|..||...+..+....+........ ..++
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhhcccccCCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 886666666677789999999999988888766 9999999999999999999987765444444433221100 0000
Q ss_pred -------------------CCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 244 -------------------DYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 244 -------------------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
....+++.+.+||.+||+.||++|| +||||++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 1235789999999999999999999 999998653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-53 Score=350.72 Aligned_cols=264 Identities=25% Similarity=0.342 Sum_probs=208.6
Q ss_pred CCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEec---
Q 023591 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT--- 88 (280)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 88 (280)
+.....++|++++.||+|+||+||+|++..+|+.||||++... +.....+.+|+.++++++|+|++++++++..
T Consensus 4 ~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 4 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83 (318)
T ss_dssp TTSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred CCCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence 3445679999999999999999999999999999999998654 3344678899999999999999999998754
Q ss_pred -----CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeec
Q 023591 89 -----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (280)
Q Consensus 89 -----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df 163 (280)
+...+++||++.++++.........+++..++.+++|++.||.|||+.||+||||||+||+++.++. +|++||
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~df 161 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADF 161 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCC
T ss_pred cccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeec
Confidence 3468999999987666655556678999999999999999999999999999999999999998887 999999
Q ss_pred CCccccccC-----CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc
Q 023591 164 GYSKSSVLH-----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238 (280)
Q Consensus 164 ~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 238 (280)
|++...... .......+|+.|+|||.+.+....+.++||||+||++|+|++|+.||....+......+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 998644322 222345689999999999877555556999999999999999999998765443333333322211
Q ss_pred cccCCCC--------------------------CCCCHHHHHHHHHhcccCCCCcC------CCcccccccCCC
Q 023591 239 QYSIPDY--------------------------VHISPECRHLISRIFVADPAKSE------MHDWRRGCSVSC 280 (280)
Q Consensus 239 ~~~~~~~--------------------------~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~~~ 280 (280)
....... ...++++.+||.+||+.||++|| .||||+..+.++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 1110000 01367889999999999999999 999999877654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=356.87 Aligned_cols=259 Identities=27% Similarity=0.397 Sum_probs=207.5
Q ss_pred CCCCCCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEec-----
Q 023591 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----- 88 (280)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 88 (280)
.|.....-+|+.++.||+|+||+||+|++..+++.||||++.+.... ..+|+.++++++|+||+++++++..
T Consensus 13 ~p~~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~ 89 (350)
T d1q5ka_ 13 GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89 (350)
T ss_dssp SSCCCEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred CCCCcccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence 44444456899999999999999999999999999999999875433 3479999999999999999999854
Q ss_pred -CCeEEEEEeccCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecC
Q 023591 89 -PTHLAIVMEYASGGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (280)
Q Consensus 89 -~~~~~lv~e~~~~~~L~~~---~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~ 164 (280)
...+++||||++++.+..+ ......+++..++.+++||+.||+|||++||+||||||+||+++.++. .+||+|||
T Consensus 90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG 168 (350)
T d1q5ka_ 90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFG 168 (350)
T ss_dssp SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCT
T ss_pred CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEeccc
Confidence 2357999999976543332 234567999999999999999999999999999999999999987652 39999999
Q ss_pred CccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc-------
Q 023591 165 YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------- 237 (280)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------- 237 (280)
++.............+++.|+|||.+.+......++||||+||++|+|++|..||......+....+......
T Consensus 169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 9987666666667789999999999877655556699999999999999999999876654443333221111
Q ss_pred ----c--cccCC----------CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 238 ----V--QYSIP----------DYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 238 ----~--~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
. ...++ .....++++.+||.+||+.||++|| +||||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0 00111 1235789999999999999999999 99999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=345.95 Aligned_cols=245 Identities=23% Similarity=0.307 Sum_probs=194.1
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeC---CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 94 (280)
...++|++.+.||+|+||+||+++.. ..||||++... ....+.+.+|+.++++++|||||++++++. +..+++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence 34688999999999999999999864 35999998754 233467889999999999999999999874 456899
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC
Q 023591 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (280)
Q Consensus 95 v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~ 173 (280)
||||+++++|.+++... .++++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+|.......
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC-----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccC
Confidence 99999999999998654 56999999999999999999999999999999999999998887 9999999987543222
Q ss_pred ---CCCCCcCCCcccCcccccCCc--CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCC
Q 023591 174 ---QPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (280)
Q Consensus 174 ---~~~~~~~~~~~~aPE~~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (280)
......+|+.|+|||.+.+.. ..+.++||||||+++|||++|..||...............-............+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 238 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence 223456899999999986532 224559999999999999999999987665444333332211111111112368
Q ss_pred CHHHHHHHHHhcccCCCCcC
Q 023591 249 SPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 249 ~~~l~~li~~~l~~dp~~Rp 268 (280)
|+++.+||.+||+.||++||
T Consensus 239 ~~~l~~li~~cl~~dp~~RP 258 (276)
T d1uwha_ 239 PKAMKRLMAECLKKKRDERP 258 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSC
T ss_pred hHHHHHHHHHHcCCCHhHCc
Confidence 99999999999999999999
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-53 Score=348.67 Aligned_cols=243 Identities=23% Similarity=0.378 Sum_probs=191.8
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCc---EEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
...++|++.+.||+|+||+||++++..+++ .||+|.+.... ...+.+.+|+.++++++|||||++++++..++.+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 345789999999999999999999876654 58888876542 2335688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
++||||+++|+|.+++... +.+++..+..++.||+.||+|||++|++||||||+||+++.++. +||+|||+++....
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLED 180 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC--------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccC
Confidence 9999999999999988764 46999999999999999999999999999999999999998887 99999999975443
Q ss_pred CCCC------CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCC
Q 023591 172 HSQP------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (280)
Q Consensus 172 ~~~~------~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (280)
.... ....+++.|+|||.+.+..++.. +|||||||++|||++ |..||......+ ....+.. ....+.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~~----~~~~i~~-~~~~~~ 254 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQD----VINAIEQ-DYRLPP 254 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHT-TCCCCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHHH----HHHHHHc-CCCCCC
Confidence 3222 12346789999999988877655 999999999999998 899998765432 2222222 223333
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 245 YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
...+++++.+||.+||+.||++||
T Consensus 255 ~~~~~~~l~~li~~cl~~~P~~RP 278 (299)
T d1jpaa_ 255 PMDCPSALHQLMLDCWQKDRNHRP 278 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSC
T ss_pred CccchHHHHHHHHHHcCCCHhHCc
Confidence 447899999999999999999999
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=343.58 Aligned_cols=248 Identities=21% Similarity=0.295 Sum_probs=202.0
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
...++|++.+.||+|+||+||+++++ ++..||||++.......+.+.+|+.++++++|||||++++++. ++..++|||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~E 87 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEE
Confidence 45589999999999999999999986 5678999999887777788999999999999999999999875 456799999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC--
Q 023591 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (280)
Q Consensus 98 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-- 173 (280)
|+++|+|.+++... .++++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||+|+......
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYT 165 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEE
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCCccc
Confidence 99999999876433 36999999999999999999999999999999999999998887 9999999997544322
Q ss_pred CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
......+++.|+|||.+.+..++.+ +||||||+++|||++|..|+........ ....+... ...+....+++++.
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~-sDvwS~Gvvl~ellt~~~~~~~~~~~~~---~~~~i~~~-~~~~~p~~~~~~l~ 240 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLERG-YRMVRPDNCPEELY 240 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTT-CCCCCCTTCCHHHH
T ss_pred cccccCCcccccChHHHhCCCCCch-hhhhhhHHHHHHHHhCCCCCCCCCCHHH---HHHHHHhc-CCCCCcccChHHHH
Confidence 2234567889999999988877655 9999999999999996555443332222 22222222 22222337899999
Q ss_pred HHHHHhcccCCCCcC--------CCcccc
Q 023591 254 HLISRIFVADPAKSE--------MHDWRR 274 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp--------~h~~~~ 274 (280)
+||.+||+.||++|| -|+||.
T Consensus 241 ~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 241 QLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 999999999999999 367764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=350.86 Aligned_cols=253 Identities=30% Similarity=0.522 Sum_probs=218.0
Q ss_pred CCCeeeecccccCCceEEEEEEec---CCCcEEEEEEeeeC-----CcccHHHHHHHHHhhhCCC-CCeeeeceEEecCC
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERG-----DKIDENVQREIINHRSLRH-PNIVRFKEVILTPT 90 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~---~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~ 90 (280)
.++|++++.||+|+||+||+|++. .+|+.||+|.+.+. ....+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 478999999999999999999873 46899999998643 2334567889999999976 89999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
..+++|||+.+++|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++. ++|+|||++....
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECC
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhc
Confidence 99999999999999999999889999999999999999999999999999999999999998877 9999999987543
Q ss_pred c--CCCCCCCcCCCcccCcccccCCc-CCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 171 L--HSQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 171 ~--~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
. ........+++.|.+||.+.+.. ....++|||||||++|+|++|..||......................++. .
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~--~ 258 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--E 258 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--T
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc--c
Confidence 3 22334567899999999987654 33455999999999999999999998887777777777666666666555 6
Q ss_pred CCHHHHHHHHHhcccCCCCcC-----------CCcccccc
Q 023591 248 ISPECRHLISRIFVADPAKSE-----------MHDWRRGC 276 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp-----------~h~~~~~~ 276 (280)
+|+++.+||.+||+.||++|| .||||++.
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 899999999999999999997 89999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=341.11 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=212.1
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC---cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
++|++++.||+|+||+||+|++..+++.||||++.... ....++.+|+.++++++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 68999999999999999999999999999999997643 334678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC-CCC
Q 023591 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (280)
Q Consensus 98 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (280)
++.++++..++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++. +|++|||.+....... ...
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCCC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccce
Confidence 9999898888888889999999999999999999999999999999999999998877 9999999998654433 333
Q ss_pred CCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc----------------
Q 023591 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY---------------- 240 (280)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------- 240 (280)
...+++.|.|||.+.+..+.+.++||||+||++|+|++|..||....+................
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 4456788999999887776566699999999999999999997655543332222221111100
Q ss_pred --------cCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccccC
Q 023591 241 --------SIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCSV 278 (280)
Q Consensus 241 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~~ 278 (280)
.......+++.+.+||++||+.||.+|| +||||++...
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 0001235688999999999999999999 9999987644
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-53 Score=343.46 Aligned_cols=242 Identities=27% Similarity=0.386 Sum_probs=198.7
Q ss_pred CCCCCCeeeecc-cccCCceEEEEEEecC--CCcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 17 MHDSDRYELVRD-IGSGNFGVARLMRDKK--TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 17 ~~~~~~y~~~~~-lg~G~~g~v~~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
....++|.+.+. ||+|+||+||++.+.. ++..||||++.... ...+++.+|+.++++++|||||++++++.. +.
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 345578999984 9999999999997753 45579999987643 334578899999999999999999999865 46
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 92 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
+++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++|++||||||+||+++.++. +||+|||+++...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALG 160 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECT
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhccc
Confidence 8999999999999998755 457999999999999999999999999999999999999998887 9999999997543
Q ss_pred cCC----CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcc-cccCCC
Q 023591 171 LHS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV-QYSIPD 244 (280)
Q Consensus 171 ~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 244 (280)
... ......+++.|+|||.+.+..++.+ +||||||+++|||++ |..||......+... .+..+ ....+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~----~i~~~~~~~~p~ 235 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIEQGKRMECPP 235 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----HHHTTCCCCCCT
T ss_pred ccccccccccccccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHHHHH----HHHcCCCCCCCC
Confidence 322 1233457889999999988877655 999999999999998 899998765533222 22222 223333
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 245 YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+|+++.+||.+||+.||++||
T Consensus 236 --~~~~~l~~li~~cl~~~p~~RP 257 (285)
T d1u59a_ 236 --ECPPELYALMSDCWIYKWEDRP 257 (285)
T ss_dssp --TCCHHHHHHHHHTTCSSGGGSC
T ss_pred --cCCHHHHHHHHHHcCCCHhHCc
Confidence 7899999999999999999999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=344.13 Aligned_cols=237 Identities=24% Similarity=0.339 Sum_probs=192.1
Q ss_pred Ceeee-cccccCCceEEEEEEec--CCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEE
Q 023591 22 RYELV-RDIGSGNFGVARLMRDK--KTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (280)
Q Consensus 22 ~y~~~-~~lg~G~~g~v~~~~~~--~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 95 (280)
.+.+. ++||+|+||+||++.+. .+++.||+|++..... ..+.+.+|+.++++++|||||++++++.. +..++|
T Consensus 7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lv 85 (277)
T d1xbba_ 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 85 (277)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEE
T ss_pred hCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEE
Confidence 34444 47999999999999864 4567899999865432 23568899999999999999999999865 457899
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC-
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~- 174 (280)
|||+++|+|.+++.+..++++..+..++.||+.||+|||++|++||||||+||+++.++. +|++|||+++.......
T Consensus 86 mE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENY 163 (277)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSE
T ss_pred EEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhccccccc
Confidence 999999999999998889999999999999999999999999999999999999998887 99999999975433222
Q ss_pred ---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcc-cccCCCCCCCC
Q 023591 175 ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHIS 249 (280)
Q Consensus 175 ---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 249 (280)
.....+++.|+|||.+.+..++.+ +||||||+++|||++ |..||......+ ....+... ....+ ..+|
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~~----~~~~i~~~~~~~~p--~~~~ 236 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEKGERMGCP--AGCP 236 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHHHTTCCCCCC--TTCC
T ss_pred cccccccCCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCCCHHH----HHHHHHcCCCCCCC--cccC
Confidence 233457889999999988877655 999999999999998 899998755432 22222222 22333 3789
Q ss_pred HHHHHHHHHhcccCCCCcC
Q 023591 250 PECRHLISRIFVADPAKSE 268 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp 268 (280)
+++.+||.+||+.||++||
T Consensus 237 ~~~~~li~~cl~~dp~~RP 255 (277)
T d1xbba_ 237 REMYDLMNLCWTYDVENRP 255 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHHHcCCCHhHCc
Confidence 9999999999999999999
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.3e-52 Score=347.70 Aligned_cols=252 Identities=23% Similarity=0.412 Sum_probs=207.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC-CCCeeeeceEEecC--CeEEEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIV 95 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv 95 (280)
..++|++++.||+|+||+||+|++..+++.||||++... ..+++.+|+.++++++ ||||+++++++... ..+++|
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 457899999999999999999999999999999998754 3467889999999985 99999999998743 569999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC
Q 023591 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (280)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~ 175 (280)
|||+++++|.... +.+++..++.++.||+.||+|||++||+||||||+||+++.++. .++|+|||++.........
T Consensus 111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCC
T ss_pred EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcc
Confidence 9999999987653 46999999999999999999999999999999999999986553 4899999999876666666
Q ss_pred CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc--------------c--
Q 023591 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------------Q-- 239 (280)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------~-- 239 (280)
....+++.|+|||.+.+....+.++||||+||++|+|++|..||....+.............. .
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 266 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence 777889999999998877655566999999999999999999998765432221111111100 0
Q ss_pred ----------------ccCCCCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 240 ----------------YSIPDYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 240 ----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
........+++++.+||++||+.||.+|| +||||+.+
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 00011124788999999999999999999 99999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-53 Score=342.11 Aligned_cols=250 Identities=22% Similarity=0.305 Sum_probs=200.8
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEEEEEe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (280)
.+.++|++.+.||+|+||+||++++..+ ..||||++.......+.+.+|+.++++++|+|||++++++. ++..++|||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~E 91 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 91 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEE
Confidence 4678999999999999999999998755 56999999877777788999999999999999999999985 456789999
Q ss_pred ccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCC--
Q 023591 98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (280)
Q Consensus 98 ~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~-- 173 (280)
|+++|+|..++.. ...+++..+..++.||+.||+|||++|++||||||+||+++.++. +||+|||+++......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC--------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCce
Confidence 9999999988743 456999999999999999999999999999999999999998887 9999999997543332
Q ss_pred CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
......+++.|+|||.+.++.++.+ +||||||+++|||++|..|+........... .+.. ....+....+|+++.
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~S~Giil~el~t~~~p~~~~~~~~~~~~---~i~~-~~~~~~~~~~~~~l~ 244 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLD---QVER-GYRMPCPPECPESLH 244 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHHT-TCCCCCCTTSCHHHH
T ss_pred eeccccccccccChHHHhCCCCCcH-HhhhcchHHHHHHHhCCCCCCCCCCHHHHHH---HHHh-cCCCCCCcccCHHHH
Confidence 2233557899999999988888655 9999999999999997666655443332222 2222 122233347899999
Q ss_pred HHHHHhcccCCCCcC--------CCcccccc
Q 023591 254 HLISRIFVADPAKSE--------MHDWRRGC 276 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp--------~h~~~~~~ 276 (280)
+||.+||+.||++|| -|+||...
T Consensus 245 ~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 245 DLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 999999999999999 36777543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-53 Score=349.22 Aligned_cols=243 Identities=24% Similarity=0.373 Sum_probs=201.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCc-----EEEEEEeeeC--CcccHHHHHHHHHhhhC-CCCCeeeeceEEecCC
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~-----~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 90 (280)
..++|++.+.||+|+||+||+|++..+++ .||+|.+... ......+.+|+.+++++ +|||||++++++.+++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 44789999999999999999999875543 6899988643 34456788999999988 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCc
Q 023591 91 HLAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~-----------------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~n 147 (280)
.+++||||+++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 9999999999999999986542 48899999999999999999999999999999999
Q ss_pred EEEeCCCCCcEEEeecCCccccccCCCC---CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCC
Q 023591 148 TLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPE 223 (280)
Q Consensus 148 i~i~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~ 223 (280)
|+++.++. +||+|||+|+........ ....+|+.|+|||.+.+..++.+ +|||||||++|||++ |..||....
T Consensus 195 ill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 195 VLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp EEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cccccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc-eeccchhHHHHHHHhCCCCCCCCCC
Confidence 99998887 999999999754443322 23457899999999988888655 999999999999997 899998766
Q ss_pred CcchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 224 EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
......+... ....++....+|+++.+||.+||+.||++||
T Consensus 272 ~~~~~~~~~~----~~~~~~~p~~~~~~l~~li~~cl~~dP~~RP 312 (325)
T d1rjba_ 272 VDANFYKLIQ----NGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312 (325)
T ss_dssp CSHHHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHh----cCCCCCCCCcCCHHHHHHHHHHcCCChhHCc
Confidence 5544444332 2333333347899999999999999999999
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=349.71 Aligned_cols=253 Identities=24% Similarity=0.392 Sum_probs=200.3
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEecCC-----
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 90 (280)
..++|++++.||+|+||+||+|++..+|+.||||++.+... ..+.+.+|+.++++++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 35899999999999999999999999999999999976432 2356788999999999999999999997654
Q ss_pred -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccc
Q 023591 91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (280)
Q Consensus 91 -~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~ 169 (280)
.+++||||+ +.+|.... +...+++..++.++.||+.||+|||++||+||||||+||+++.++. ++++|||++...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceecc
Confidence 579999999 55777665 4567999999999999999999999999999999999999998887 999999999754
Q ss_pred ccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-----------
Q 023591 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----------- 238 (280)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 238 (280)
.. ......+++.|+|||.+.+..+.+.++||||+||++|+|++|..||...+...............
T Consensus 172 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 172 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred CC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 32 33456789999999999877666666999999999999999999998765433332222211100
Q ss_pred ----------cc---cC-CCCCCCCHHHHHHHHHhcccCCCCcC------CCccccccc
Q 023591 239 ----------QY---SI-PDYVHISPECRHLISRIFVADPAKSE------MHDWRRGCS 277 (280)
Q Consensus 239 ----------~~---~~-~~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~~ 277 (280)
.. .+ ......++++.+||.+||..||++|| +||||++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00 00 01135789999999999999999999 999998643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-52 Score=346.29 Aligned_cols=253 Identities=28% Similarity=0.429 Sum_probs=199.1
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCC-----eE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT-----HL 92 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 92 (280)
.++|++++.||+|+||+||+|.+..+|+.||||++.+... ..+.+.+|+.++++++||||+++++++..+. .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4689999999999999999999999999999999976432 2356789999999999999999999987543 34
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
++++ ++.+++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++......
T Consensus 87 ~l~~-~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVT-HLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPD 162 (345)
T ss_dssp EEEE-ECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGG
T ss_pred EEEE-eecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCC
Confidence 5554 5568899999865 46999999999999999999999999999999999999998877 999999998754333
Q ss_pred CC----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhccc---------
Q 023591 173 SQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------- 239 (280)
Q Consensus 173 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 239 (280)
.. .....+++.|+|||.+........++||||+|+++|+|++|..||......+.............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 22 34456889999999987766666669999999999999999999977554322222211110000
Q ss_pred -------ccCC---------CCCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 240 -------YSIP---------DYVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 240 -------~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
...+ ..+.+|+++.+||.+||+.||.+|| +||||++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0000 0235788999999999999999999 99999854
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=334.76 Aligned_cols=244 Identities=21% Similarity=0.294 Sum_probs=192.6
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCC----cEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 91 (280)
+.++.|++.+.||+|+||+||+|....++ ..||||.+..... ...++.+|+.++++++|||||++++++.++..
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 34578999999999999999999987554 4699999865432 23467899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccc
Q 023591 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~ 170 (280)
.+++|||+.++++.+.+... ..+++..+..++.||+.||+|||+.+|+||||||+||+++.++. +||+|||+++...
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhccc
Confidence 99999999999998877654 57999999999999999999999999999999999999998887 9999999997543
Q ss_pred cCCC----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccccCCCCC
Q 023591 171 LHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (280)
Q Consensus 171 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (280)
.... .....+++.|+|||.+.+..++.+ +||||||+++|||+++..|+........ ....+.. ....+...
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~---~~~~i~~-~~~~~~~~ 236 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAIND-GFRLPTPM 236 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHT-TCCCCCCT
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCccccCCHHH---HHHHHhc-cCCCCCch
Confidence 3221 223457889999999988887665 9999999999999997666544333222 2222222 22333334
Q ss_pred CCCHHHHHHHHHhcccCCCCcC
Q 023591 247 HISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 247 ~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+++++.+||.+||+.||++||
T Consensus 237 ~~~~~l~~li~~cl~~~p~~RP 258 (283)
T d1mqba_ 237 DCPSAIYQLMMQCWQQERARRP 258 (283)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSC
T ss_pred hhHHHHHHHHHHHCcCCHhHCc
Confidence 7899999999999999999999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=345.93 Aligned_cols=252 Identities=24% Similarity=0.407 Sum_probs=201.7
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc---cHHHHHHHHHhhhCCCCCeeeeceEEecC-----Ce
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 91 (280)
+++|++++.||+|+||+||+|++..+|+.||||++.+.... .+.+.+|+.++++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57999999999999999999999999999999999765432 24577899999999999999999998643 23
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
.+++++++.+++|.+++.. +++++..++.++.||+.||+|||++||+||||||+||+++.++. ++++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCT-
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccC-
Confidence 4556667778999998854 57999999999999999999999999999999999999998887 9999999986432
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcccc-----------
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY----------- 240 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------- 240 (280)
.......+++.|+|||.+.+..+.+.++||||||+++|+|++|..||...+.......+.........
T Consensus 173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 23345668889999999888776666699999999999999999999876544333333322211110
Q ss_pred --------cCCC------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 241 --------SIPD------YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 241 --------~~~~------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
..+. ...+++++.+||++||+.||.+|| +||||++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0000 135789999999999999999999 99999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=332.75 Aligned_cols=245 Identities=26% Similarity=0.404 Sum_probs=192.9
Q ss_pred CCCCCCCeeeecccccCCceEEEEEEecCC-C--cEEEEEEeeeC----CcccHHHHHHHHHhhhCCCCCeeeeceEEec
Q 023591 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKT-E--ELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILT 88 (280)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~-~--~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 88 (280)
..+..++|++.+.||+|+||.||+|+...+ + ..||||++.+. ....+++.+|+.++++++||||+++++++.+
T Consensus 3 ~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82 (273)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred eEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 345678899999999999999999986432 2 46899988653 2333578899999999999999999999965
Q ss_pred CCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 89 PTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
...++||||++++++.+.+.. ..++++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||+++
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~ 159 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMR 159 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCE
T ss_pred -cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhh
Confidence 467899999999999887654 457999999999999999999999999999999999999998876 9999999988
Q ss_pred ccccCCC----CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccC
Q 023591 168 SSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSI 242 (280)
Q Consensus 168 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (280)
....... .....++..|+|||.+.+..++.. +||||||+++|||++ |..||...+.. .....+......+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~~----~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKIDKEGERL 234 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHHTSCCCC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCHH----HHHHHHHhCCCCC
Confidence 5433322 223446778999999988877655 999999999999998 89999875443 3334444444444
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 243 PDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
+....+|+++.+||.+||+.||++||
T Consensus 235 ~~~~~~~~~l~~li~~cl~~dp~~RP 260 (273)
T d1u46a_ 235 PRPEDCPQDIYNVMVQCWAHKPEDRP 260 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCcccccHHHHHHHHHHcCCChhHCc
Confidence 54557899999999999999999999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=343.94 Aligned_cols=250 Identities=26% Similarity=0.391 Sum_probs=192.0
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCc---ccHHHHHHHHHhhhCCCCCeeeeceEEec------CCe
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT------PTH 91 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~ 91 (280)
++|++++.||+|+||+||+|++..+|+.||||++.+... ...++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 789999999999999999999999999999999976532 23457899999999999999999999864 368
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
+|+||||+.+ ++.+.+ ...+++..++.++.||+.||+|||++||+||||||+||+++.++. ++++|||++.....
T Consensus 97 ~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT 171 (355)
T ss_dssp EEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC------
T ss_pred eEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhcccc
Confidence 8999999976 444444 346899999999999999999999999999999999999998887 99999999887666
Q ss_pred CCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhc--------------
Q 023591 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------------- 237 (280)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 237 (280)
........+|+.|+|||.+.+..++.. +||||+||++++|++|..||...+.......+......
T Consensus 172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 172 SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ---------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred ccccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 666667778999999999988877666 99999999999999999999876543333333222111
Q ss_pred ----ccccCCC------------------CCCCCHHHHHHHHHhcccCCCCcC------CCcccccc
Q 023591 238 ----VQYSIPD------------------YVHISPECRHLISRIFVADPAKSE------MHDWRRGC 276 (280)
Q Consensus 238 ----~~~~~~~------------------~~~~~~~l~~li~~~l~~dp~~Rp------~h~~~~~~ 276 (280)
....... ....++++.+||++||+.||++|| +||||+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0000000 011356789999999999999999 99999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=329.92 Aligned_cols=238 Identities=26% Similarity=0.390 Sum_probs=191.4
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEec-CCeEEEEE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVM 96 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 96 (280)
.+.++|++.+.||+|+||.||+++.+ |..||+|.++.. ...+.+.+|+.++++++||||+++++++.+ ++.+++||
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 45688999999999999999999984 678999999754 455789999999999999999999998854 45689999
Q ss_pred eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCC
Q 023591 97 EYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~ 174 (280)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+++||||+|+||+++.++. ++++|||+++.... .
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~~--~ 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS--T 156 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC---------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecCC--C
Confidence 9999999999986543 5899999999999999999999999999999999999998887 99999999874332 2
Q ss_pred CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCCHHHH
Q 023591 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (280)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (280)
.....+++.|+|||.+.+..++.+ +||||||+++|||++ |.+||......+....+.. .....++. .+++++.
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~-sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~---~~~~~~~~--~~~~~~~ 230 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPD--GCPPAVY 230 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT---TCCCCCCT--TCCHHHH
T ss_pred CccccccccCCChHHHhCCCCChH-HHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CCCCCCCc--cCCHHHH
Confidence 344567889999999988877555 999999999999998 6888876654433333221 12223333 6899999
Q ss_pred HHHHHhcccCCCCcC
Q 023591 254 HLISRIFVADPAKSE 268 (280)
Q Consensus 254 ~li~~~l~~dp~~Rp 268 (280)
+||.+||+.||.+||
T Consensus 231 ~li~~cl~~dP~~Rp 245 (262)
T d1byga_ 231 EVMKNCWHLDAAMRP 245 (262)
T ss_dssp HHHHHHTCSSGGGSC
T ss_pred HHHHHHcccCHhHCc
Confidence 999999999999999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=330.98 Aligned_cols=241 Identities=24% Similarity=0.376 Sum_probs=189.3
Q ss_pred CCCCeeeecccccCCceEEEEEEecCC---CcEEEEEEeeeCC--cccHHHHHHHHHhhhCCCCCeeeeceEEecCCeEE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (280)
..++|++.+.||+|+||.||+|++..+ +..||+|.+.... ...+.+.+|+.++++++||||+++++++. ++.++
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 357999999999999999999998654 3468888876533 22356889999999999999999999985 56789
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccC
Q 023591 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (280)
Q Consensus 94 lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~ 172 (280)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++. +||+|||+++.....
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC----------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCC
Confidence 99999999999988754 457999999999999999999999999999999999999998887 999999999754332
Q ss_pred CC--CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCCCC
Q 023591 173 SQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (280)
Q Consensus 173 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (280)
.. .....+++.|+|||.+.+..++.. +||||||+++|||++ |.+||......+....+.. .. ..+....+|
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~-~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~----~~-~~~~~~~~~ 235 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN----GE-RLPMPPNCP 235 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT----TC-CCCCCTTCC
T ss_pred cceeccceecCcccchhhHhccCCCCCc-cccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc----CC-CCCCCCCCC
Confidence 22 233457889999999988877655 999999999999998 8999987665444333322 21 222334799
Q ss_pred HHHHHHHHHhcccCCCCcC
Q 023591 250 PECRHLISRIFVADPAKSE 268 (280)
Q Consensus 250 ~~l~~li~~~l~~dp~~Rp 268 (280)
+++.+||.+||+.||++||
T Consensus 236 ~~~~~li~~cl~~dp~~Rp 254 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRP 254 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHcCCCHhHCc
Confidence 9999999999999999999
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-51 Score=334.82 Aligned_cols=243 Identities=23% Similarity=0.325 Sum_probs=199.6
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCCcE--EEEEEeeeC--CcccHHHHHHHHHhhhC-CCCCeeeeceEEecCCeE
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~--vaiK~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 92 (280)
++.++|++.+.||+|+||+||+|++..++.. ||||.+... ....+.+.+|+.+++++ +||||+++++++.+++.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 4668999999999999999999999888764 677776543 33445789999999998 799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCC
Q 023591 93 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~ 156 (280)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~- 165 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV- 165 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc-
Confidence 9999999999999998643 46899999999999999999999999999999999999998887
Q ss_pred cEEEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCC-CCCCCCCCcchHHHHHhhH
Q 023591 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIHRI 235 (280)
Q Consensus 157 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~ 235 (280)
+||+|||+++............++..|+|||.+.+..++.. +||||||+++|+|++|. +||...+.. .....+
T Consensus 166 -~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~~~----~~~~~i 239 (309)
T d1fvra_ 166 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEKL 239 (309)
T ss_dssp -EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHG
T ss_pred -eEEccccccccccccccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCCHH----HHHHHH
Confidence 99999999986665555556678999999999988888655 99999999999999975 567654432 223333
Q ss_pred hcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
... ..++....+++++.+||.+||+.||++||
T Consensus 240 ~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~RP 271 (309)
T d1fvra_ 240 PQG-YRLEKPLNCDDEVYDLMRQCWREKPYERP 271 (309)
T ss_dssp GGT-CCCCCCTTBCHHHHHHHHHHTCSSGGGSC
T ss_pred Hhc-CCCCCCccCCHHHHHHHHHHcCCChhHCc
Confidence 222 23333347899999999999999999999
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=331.23 Aligned_cols=241 Identities=20% Similarity=0.350 Sum_probs=192.3
Q ss_pred CCCCeeeecccccCCceEEEEEEecCCCc----EEEEEEeeeC--CcccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
..++|++++.||+|+||+||++.+..+|+ .||+|.+... ....+.+.+|+.++++++|||||++++++.++ ..
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 34679999999999999999999987775 5788877543 34456789999999999999999999999765 56
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCcccccc
Q 023591 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~ 171 (280)
+++++++.+++|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+++....
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceeccc
Confidence 778888888999887765 457999999999999999999999999999999999999998887 99999999875433
Q ss_pred CCCC---CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcchHHHHHhhHhcccccCCCCCC
Q 023591 172 HSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (280)
Q Consensus 172 ~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (280)
.... ....+++.|+|||.+.++.++.+ +||||||+++|||+| |..||........ ...... ....+....
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDvwS~Gvil~el~t~g~~p~~~~~~~~~-~~~i~~----~~~~~~p~~ 237 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEK----GERLPQPPI 237 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCGGGH-HHHHHH----TCCCCCCTT
T ss_pred ccccccccccccCccccChHHHhcCCCChh-hhhhhHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHc----CCCCCCCcc
Confidence 2222 22357899999999988887655 999999999999998 7889877654332 222221 122223337
Q ss_pred CCHHHHHHHHHhcccCCCCcC
Q 023591 248 ISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 248 ~~~~l~~li~~~l~~dp~~Rp 268 (280)
+++++.+||.+||+.||++||
T Consensus 238 ~~~~~~~li~~cl~~dP~~RP 258 (317)
T d1xkka_ 238 CTIDVYMIMVKCWMIDADSRP 258 (317)
T ss_dssp BCHHHHHHHHHHTCSSGGGSC
T ss_pred cCHHHHHHHHHhCCCChhhCc
Confidence 899999999999999999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=328.08 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=195.2
Q ss_pred CCCCCeeeecccccCCceEEEEEEecCCC-------cEEEEEEeeeCCc--ccHHHHHHHHHhhhC-CCCCeeeeceEEe
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKKTE-------ELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL 87 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~-------~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 87 (280)
...++|++.+.||+|+||.||+|+...++ ..||+|++++... ...++.+|...+.++ +|||||++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 44589999999999999999999976544 4799999876543 335677888888877 8999999999999
Q ss_pred cCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEe
Q 023591 88 TPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (280)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~~----------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~ 151 (280)
++...++||||+++|+|.+++.... .+++..++.++.||+.||+|||+.|++||||||+||+++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 9999999999999999999996542 489999999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcch
Q 023591 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (280)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (280)
.++. +||+|||++........ .....+++.|+|||.+.++.++.+ +||||||+++|+|++ |.+||.......
T Consensus 170 ~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell~~g~~p~~~~~~~~- 245 (299)
T d1fgka_ 170 EDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEE- 245 (299)
T ss_dssp TTCC--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred CCCC--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhccCCCCCCCCCCHHH-
Confidence 8887 99999999875544332 234567889999999988888655 999999999999998 788887654322
Q ss_pred HHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 228 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
....+.. ...++....+|+++.+||.+||+.||++||
T Consensus 246 ---~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~Rp 282 (299)
T d1fgka_ 246 ---LFKLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRP 282 (299)
T ss_dssp ---HHHHHHT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSC
T ss_pred ---HHHHHHc-CCCCCCCccchHHHHHHHHHHccCCHhHCc
Confidence 2222222 222333347899999999999999999999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-50 Score=329.63 Aligned_cols=241 Identities=24% Similarity=0.364 Sum_probs=197.3
Q ss_pred CCCeeeecccccCCceEEEEEEec-----CCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhCCCCCeeeeceEEecCCeE
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (280)
.++|++.+.||+|+||+||+|+.. .+++.||||++..... ..+++.+|+.++++++||||+++++++......
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 468999999999999999999975 3567899999875432 235688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcE
Q 023591 93 AIVMEYASGGELFERICNAG------------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148 (280)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~------------------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni 148 (280)
+++|||+++++|.+++.... .++...+..++.|++.||+|||+.+++||||||+||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence 99999999999999986432 378899999999999999999999999999999999
Q ss_pred EEeCCCCCcEEEeecCCccccccC---CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCC-CCCCCCCC
Q 023591 149 LLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEE 224 (280)
Q Consensus 149 ~i~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~-~p~~~~~~ 224 (280)
+++.++. +||+|||+++..... .......+++.|+|||.+.+..++.+ +||||||+++|||++|. .||.....
T Consensus 172 Lld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~k-sDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 172 LVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp EECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred EECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChh-hhhccchhhHHHHHccCCCCCCCCCH
Confidence 9998877 999999998744332 22234567889999999988888655 99999999999999985 56766544
Q ss_pred cchHHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.+.. ..+..... .+....+++++.+||.+||+.||++||
T Consensus 249 ~e~~----~~v~~~~~-~~~p~~~~~~~~~li~~cl~~~P~~RP 287 (301)
T d1lufa_ 249 EEVI----YYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRP 287 (301)
T ss_dssp HHHH----HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHH----HHHHcCCC-CCCCccchHHHHHHHHHHcCCChhHCc
Confidence 3322 23333222 122236899999999999999999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=324.30 Aligned_cols=243 Identities=23% Similarity=0.393 Sum_probs=187.1
Q ss_pred CCCCeeeecccccCCceEEEEEEecC-----CCcEEEEEEeeeCC--cccHHHHHHHHHhhhC-CCCCeeeeceEEecC-
Q 023591 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP- 89 (280)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~- 89 (280)
..++|++.+.||+|+||.||+|++.. +++.||+|.+.... ...+.+.+|...+.++ .|+||+.+++++..+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 34789999999999999999999754 34689999987543 2234566777777666 689999999987654
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC
Q 023591 90 THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~ 153 (280)
..+++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 4689999999999999998643 248899999999999999999999999999999999999988
Q ss_pred CCCcEEEeecCCccccccCC---CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhC-CCCCCCCCCcchHH
Q 023591 154 PAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFR 229 (280)
Q Consensus 154 ~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~~~~~ 229 (280)
+. +||+|||+|+...... ......+|+.|+|||.+.+..++.. +|||||||++|+|++| ..||..........
T Consensus 171 ~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 171 NV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp GC--EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred Cc--EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc-cceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 87 9999999997443322 2234568899999999988877655 9999999999999986 56787665544443
Q ss_pred HHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 230 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..... ......+. .+++++.+||.+||+.||++||
T Consensus 248 ~~~~~--~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rp 282 (299)
T d1ywna1 248 RRLKE--GTRMRAPD--YTTPEMYQTMLDCWHGEPSQRP 282 (299)
T ss_dssp HHHHH--TCCCCCCT--TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhc--CCCCCCCc--cCCHHHHHHHHHHcCCChhHCc
Confidence 33322 11223333 6899999999999999999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=325.44 Aligned_cols=251 Identities=18% Similarity=0.271 Sum_probs=203.7
Q ss_pred CCCCCeeeecccccCCceEEEEEEecC-----CCcEEEEEEeeeCCccc--HHHHHHHHHhhhCCCCCeeeeceEEecCC
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVILTPT 90 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~~-----~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 90 (280)
...++|++.+.||+|+||+||+|.+.. ++..||||+++...... ..+.+|+.++++++||||+++++++..+.
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 456899999999999999999998752 35789999997643222 35789999999999999999999999899
Q ss_pred eEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEE
Q 023591 91 HLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (280)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l 160 (280)
..++||||+++|+|.+++... ..++...+..++.|++.||.|||+++++||||||+||+++.++. +||
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~Kl 174 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKI 174 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEE
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EEE
Confidence 999999999999999987532 24789999999999999999999999999999999999998887 999
Q ss_pred eecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhC-CCCCCCCCCcchHHHHHhhHh
Q 023591 161 CDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRIL 236 (280)
Q Consensus 161 ~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~ 236 (280)
+|||+++....... .....+++.|+|||.+.+..++.. +||||||+++|||++| ..||...+... ....+.
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~G~il~El~t~~~~p~~~~~~~~----~~~~i~ 249 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQ----VLRFVM 249 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHH----HHHHHH
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcc-cccccHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH
Confidence 99999974433222 233457899999999988887655 9999999999999998 47776644332 222232
Q ss_pred cccccCCCCCCCCHHHHHHHHHhcccCCCCcC------------CCcccccc
Q 023591 237 SVQYSIPDYVHISPECRHLISRIFVADPAKSE------------MHDWRRGC 276 (280)
Q Consensus 237 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------------~h~~~~~~ 276 (280)
... ..+....+++.+.++|.+||+.||++|| .+|+|++.
T Consensus 250 ~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 250 EGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred hCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence 222 1222236899999999999999999999 48888753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-49 Score=322.97 Aligned_cols=244 Identities=24% Similarity=0.368 Sum_probs=200.3
Q ss_pred CCCCCeeeecccccCCceEEEEEEec-----CCCcEEEEEEeeeCCc--ccHHHHHHHHHhhhC-CCCCeeeeceEEecC
Q 023591 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (280)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 89 (280)
...++|++.+.||+|+||.||+|+.. .+++.||+|.++.... ....+.+|+.+++++ +|||||++++++.++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 34589999999999999999999863 4567899999976433 334578899999998 799999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEe
Q 023591 90 THLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (280)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~------------------~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~ 151 (280)
...+++|||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999986543 589999999999999999999999999999999999999
Q ss_pred CCCCCcEEEeecCCccccccCCC---CCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHh-CCCCCCCCCCcch
Q 023591 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (280)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (280)
.++. ++++|||.++....... .....+++.|+|||.+.+..++.. +||||||+++|+|++ |.+||........
T Consensus 180 ~~~~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 180 HGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp TTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred ccCc--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc-ccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 8887 99999999875443222 234567899999999988777655 999999999999998 5666655554444
Q ss_pred HHHHHhhHhcccccCCCCCCCCHHHHHHHHHhcccCCCCcC
Q 023591 228 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
+.+.... ..........|+++.+||.+||+.||.+||
T Consensus 257 ~~~~i~~----~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP 293 (311)
T d1t46a_ 257 FYKMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRP 293 (311)
T ss_dssp HHHHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHhc----CCCCCCcccccHHHHHHHHHHcCCChhHCc
Confidence 4433322 222333336899999999999999999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.5e-48 Score=317.76 Aligned_cols=249 Identities=20% Similarity=0.219 Sum_probs=200.7
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCC-CCeeeeceEEecCCeEEEEEec
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
.++|++.+.||+|+||+||+|++..+++.||+|++.... ..+.+.+|++.++.++| +|++.+++++..+...++||||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 479999999999999999999999999999999876543 34567889999999965 8999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC---CCCcEEEeecCCccccccC--
Q 023591 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS---PAPRLKICDFGYSKSSVLH-- 172 (280)
Q Consensus 99 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~---~~~~~~l~df~~~~~~~~~-- 172 (280)
+ +++|.+++... ..++...+..++.|++.+|++||++||+||||||+||+++.. ..+.++|+|||+|+.....
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 9 67999888664 469999999999999999999999999999999999999753 2345999999999754322
Q ss_pred ------CCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHH---HhhHhcc-cccC
Q 023591 173 ------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT---IHRILSV-QYSI 242 (280)
Q Consensus 173 ------~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~-~~~~ 242 (280)
.......||+.|+|||.+.+..++.. +||||||+++|+|++|..||............ ....... ...+
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence 12234568999999999988877655 99999999999999999999866543332221 1111111 1111
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCcCCCccc
Q 023591 243 PDYVHISPECRHLISRIFVADPAKSEMHDWR 273 (280)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rp~h~~~ 273 (280)
. ..+|+++.+++..|++.+|++||.+.++
T Consensus 241 ~--~~~p~~l~~ii~~~~~~~~~~rP~y~~l 269 (293)
T d1csna_ 241 C--AGFPEEFYKYMHYARNLAFDATPDYDYL 269 (293)
T ss_dssp T--TTSCHHHHHHHHHHHHCCTTCCCCHHHH
T ss_pred c--CCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 1 2588999999999999999999944443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-48 Score=319.58 Aligned_cols=244 Identities=23% Similarity=0.218 Sum_probs=191.1
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCe-eeeceEEecCCeEEEEEec
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~ 98 (280)
.++|++.+.||+|+||+||+|++..+++.||||++.... ..+++..|++++++++|+++ +.+.+++.+....++||||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 368999999999999999999999999999999877643 34567889999999987664 5556666778889999999
Q ss_pred cCCCchHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCC-CCCcEEEeecCCccccccCC---
Q 023591 99 ASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHS--- 173 (280)
Q Consensus 99 ~~~~~L~~~~-~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~-~~~~~~l~df~~~~~~~~~~--- 173 (280)
+++ ++.+.+ .....+++..+..++.|++.||+|||++||+||||||+||+++.. ....++++|||+|+......
T Consensus 85 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (299)
T d1ckia_ 85 LGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163 (299)
T ss_dssp CCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred cCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence 954 665555 445679999999999999999999999999999999999998643 23459999999997544322
Q ss_pred -----CCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHH---hhHhccc-ccCCC
Q 023591 174 -----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---HRILSVQ-YSIPD 244 (280)
Q Consensus 174 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~-~~~~~ 244 (280)
......+|+.|+|||.+.+..++.. +|||||||++|+|++|..||............. ....... ....
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 241 (299)
T d1ckia_ 164 HIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC- 241 (299)
T ss_dssp BCCCCBCCSCCCCSSSCCHHHHTTBCCCHH-HHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHT-
T ss_pred ceeccccCCcCCCccccCHHHHhCCCCCCh-hhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhc-
Confidence 2234568999999999988877655 999999999999999999998765433322221 1111111 1112
Q ss_pred CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 245 YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
..+|+++.+||.+||+.||++||
T Consensus 242 -~~~p~~~~~li~~cl~~~p~~RP 264 (299)
T d1ckia_ 242 -KGYPSEFATYLNFCRSLRFDDKP 264 (299)
T ss_dssp -TTSCHHHHHHHHHHHHSCTTCCC
T ss_pred -cCCCHHHHHHHHHHccCChhHCc
Confidence 26899999999999999999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=316.67 Aligned_cols=237 Identities=21% Similarity=0.259 Sum_probs=187.9
Q ss_pred eeecccccCCceEEEEEEecCCC---cEEEEEEeeeC--CcccHHHHHHHHHhhhCCCCCeeeeceEEec-CCeEEEEEe
Q 023591 24 ELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME 97 (280)
Q Consensus 24 ~~~~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 97 (280)
.+.+.||+|+||+||+|++..++ ..||||.+.+. ....+++.+|+.++++++||||+++++++.. +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 34678999999999999986543 35899998653 2334678999999999999999999999765 568999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeecCCccccccCCCC-
Q 023591 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (280)
Q Consensus 98 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~~~~~~~~- 175 (280)
|+++++|.+++... ..++...+..++.|++.||.|||+.+++||||||+||++++++. +||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhcccccccc
Confidence 99999999988754 35788899999999999999999999999999999999998877 999999999754333222
Q ss_pred ----CCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcchHHHHHhhHhcc-cccCCCCCCCCH
Q 023591 176 ----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISP 250 (280)
Q Consensus 176 ----~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 250 (280)
....+++.|+|||.+.+..++.+ +||||||+++|||++|..||........... .+..+ ....+ ..+++
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~~~~~---~i~~g~~~~~p--~~~~~ 261 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGRRLLQP--EYCPD 261 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC------CHH---HHHTTCCCCCC--TTCCH
T ss_pred ceecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH---HHHcCCCCCCc--ccCcH
Confidence 22457889999999988887655 9999999999999998887765433222222 22222 22233 36889
Q ss_pred HHHHHHHHhcccCCCCcC
Q 023591 251 ECRHLISRIFVADPAKSE 268 (280)
Q Consensus 251 ~l~~li~~~l~~dp~~Rp 268 (280)
++.+||.+||+.||++||
T Consensus 262 ~l~~li~~cl~~dP~~RP 279 (311)
T d1r0pa_ 262 PLYEVMLKCWHPKAEMRP 279 (311)
T ss_dssp HHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHcCCCHhHCc
Confidence 999999999999999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=311.08 Aligned_cols=243 Identities=23% Similarity=0.265 Sum_probs=184.2
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCeeeeceEEecCC----eEEEEE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM 96 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~ 96 (280)
.+|.+.+.||+|+||.||+++. +|+.||||.+............|+..+.+++||||+++++++..++ .+++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5799999999999999999987 5789999998765433333344555666789999999999997643 689999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------cCceecCCCCCcEEEeCCCCCcEEEeecCCccc
Q 023591 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (280)
Q Consensus 97 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~--------~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~~ 168 (280)
||+++++|.+++.+. +++...+..++.|++.+|++||+ +||+||||||+||+++.++. +||+|||++..
T Consensus 81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCcccc
Confidence 999999999999764 68999999999999999999996 59999999999999998887 99999999875
Q ss_pred cccCC-----CCCCCcCCCcccCcccccCCcC-----CCccchhhHHHHHHHHHHhCCCCCCCCCCc-----------ch
Q 023591 169 SVLHS-----QPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----------KN 227 (280)
Q Consensus 169 ~~~~~-----~~~~~~~~~~~~aPE~~~~~~~-----~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----------~~ 227 (280)
..... ......+++.|+|||.+.+... .+.++||||||+++|||++|..||...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 43332 2234568999999999865432 133489999999999999998877543211 11
Q ss_pred HHHHHhhHhccccc--CCC---CCCCCHHHHHHHHHhcccCCCCcC
Q 023591 228 FRKTIHRILSVQYS--IPD---YVHISPECRHLISRIFVADPAKSE 268 (280)
Q Consensus 228 ~~~~~~~~~~~~~~--~~~---~~~~~~~l~~li~~~l~~dp~~Rp 268 (280)
.............+ ++. ....+..+.+|+.+||+.||.+||
T Consensus 238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 283 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSC
T ss_pred HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCc
Confidence 22222222222221 111 011234589999999999999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-44 Score=304.64 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=190.6
Q ss_pred CCCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCC-----------CCCeeeeceEEec
Q 023591 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVILT 88 (280)
Q Consensus 20 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~ 88 (280)
.+||++++.||+|+||+||+|++..+|+.||||++.+.....+.+.+|+.+++.+. |+||+++++++..
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35799999999999999999999999999999999876655567788998888774 5789999988764
Q ss_pred --CCeEEEEEeccCCCch-HHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHh-cCceecCCCCCcEEEeCCCC----CcE
Q 023591 89 --PTHLAIVMEYASGGEL-FERI--CNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPA----PRL 158 (280)
Q Consensus 89 --~~~~~lv~e~~~~~~L-~~~~--~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~i~h~dl~~~ni~i~~~~~----~~~ 158 (280)
....++++++...... .... .....+++..++.++.||+.||++||+ .||+||||||+||+++.++. ..+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 3456666666544433 2222 234578999999999999999999997 99999999999999986553 248
Q ss_pred EEeecCCccccccCCCCCCCcCCCcccCcccccCCcCCCccchhhHHHHHHHHHHhCCCCCCCCCCcc------hHHHHH
Q 023591 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK------NFRKTI 232 (280)
Q Consensus 159 ~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~------~~~~~~ 232 (280)
+++|||.+.... .......+++.|+|||.+.+..++.. +|+||+|+++++|++|..||....... ......
T Consensus 172 kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~ 248 (362)
T d1q8ya_ 172 KIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248 (362)
T ss_dssp EECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred eEeecccccccc--cccccccccccccChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence 999999987433 34456679999999999998888765 999999999999999999997543211 011111
Q ss_pred hhHhcc----------------------c--------------ccCCCCCCCCHHHHHHHHHhcccCCCCcC------CC
Q 023591 233 HRILSV----------------------Q--------------YSIPDYVHISPECRHLISRIFVADPAKSE------MH 270 (280)
Q Consensus 233 ~~~~~~----------------------~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------~h 270 (280)
...... . .........++++.+||.+||+.||.+|| +|
T Consensus 249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 100000 0 00000112457899999999999999999 99
Q ss_pred cccccc
Q 023591 271 DWRRGC 276 (280)
Q Consensus 271 ~~~~~~ 276 (280)
|||++.
T Consensus 329 p~f~~~ 334 (362)
T d1q8ya_ 329 PWLKDT 334 (362)
T ss_dssp GGGTTC
T ss_pred cccCCC
Confidence 999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=6.4e-26 Score=172.92 Aligned_cols=131 Identities=17% Similarity=0.156 Sum_probs=104.8
Q ss_pred eeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcc-------------------cHHHHHHHHHhhhCCCCCeeeec
Q 023591 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-------------------DENVQREIINHRSLRHPNIVRFK 83 (280)
Q Consensus 23 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-------------------~~~~~~e~~~l~~l~h~~iv~~~ 83 (280)
+.+.++||+|+||+||+|++. +|+.||||+++..... .....+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468899999999999999985 6889999987532110 12234678888899999998887
Q ss_pred eEEecCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCceecCCCCCcEEEeCCCCCcEEEeec
Q 023591 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (280)
Q Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~i~h~dl~~~ni~i~~~~~~~~~l~df 163 (280)
++.. .+++||++++..+.+ ++......++.|++.+|++||+.|++||||||+||++++++ ++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCC
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEEC
Confidence 6642 279999998765533 55566778999999999999999999999999999998654 899999
Q ss_pred CCccc
Q 023591 164 GYSKS 168 (280)
Q Consensus 164 ~~~~~ 168 (280)
|.|..
T Consensus 147 G~a~~ 151 (191)
T d1zara2 147 PQSVE 151 (191)
T ss_dssp TTCEE
T ss_pred CCccc
Confidence 98864
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.72 E-value=8.5e-08 Score=74.84 Aligned_cols=138 Identities=17% Similarity=0.129 Sum_probs=90.5
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCC-cccHHHHHHHHHhhhCC-CCCeeeeceEEecCCeEEEEEec
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY 98 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 98 (280)
++|+.++..+.++.+.||++.. ++..+++|...... .....+.+|...+..+. +--+.+++.+...++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 5677777655555678998864 45567888776542 33445778888887763 32356677777788889999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 023591 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS------------------------------------------- 135 (280)
Q Consensus 99 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~------------------------------------------- 135 (280)
.+|.++.+.... ......++.++...++.||+
T Consensus 92 l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 92 ADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred cccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 998777543311 11122233334444444442
Q ss_pred ----------------cCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 136 ----------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 136 ----------------~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
..++|+|+.|.||++++++. +.|+||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~--~~lIDwe~a~ 212 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV--SGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCce--EEEeechhcc
Confidence 12689999999999986553 5699998665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.56 E-value=3.7e-07 Score=75.49 Aligned_cols=77 Identities=18% Similarity=0.163 Sum_probs=49.3
Q ss_pred ecccccCCceEEEEEEecCCCcEEEEEEeeeC--------CcccHHHHHHHHHhhhC-CC-CC-eeeeceEEecCCeEEE
Q 023591 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERG--------DKIDENVQREIINHRSL-RH-PN-IVRFKEVILTPTHLAI 94 (280)
Q Consensus 26 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~e~~~l~~l-~h-~~-iv~~~~~~~~~~~~~l 94 (280)
.+.||.|....||++.+..+++.+++|.-... ....++...|...++.+ .+ |. +++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 55789999999999998877888999975431 12334566788887766 22 33 4445443 4455678
Q ss_pred EEeccCCCch
Q 023591 95 VMEYASGGEL 104 (280)
Q Consensus 95 v~e~~~~~~L 104 (280)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.30 E-value=2.7e-06 Score=65.68 Aligned_cols=73 Identities=14% Similarity=0.076 Sum_probs=50.5
Q ss_pred cccCCc-eEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCC--eeeeceEEecCCeEEEEEeccCCCch
Q 023591 29 IGSGNF-GVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGGEL 104 (280)
Q Consensus 29 lg~G~~-g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (280)
+..|.. +.||++... ++..+++|...... ...+..|...++.+.... +.+++.+..+++..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344443 578988764 46668899765443 345677888887774323 55677777778889999999987655
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.67 E-value=0.00012 Score=60.13 Aligned_cols=77 Identities=13% Similarity=0.148 Sum_probs=51.0
Q ss_pred CeeeecccccCCceEEEEEEecC-------CCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCe-eeeceEEecCCeEE
Q 023591 22 RYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLA 93 (280)
Q Consensus 22 ~y~~~~~lg~G~~g~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~ 93 (280)
..++ +.|+.|-.-.+|++.... ..+.|++++... ....-...+|..+++.+.-.++ .++++++.. +
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 3444 567778888999998753 245678887663 3333456678888888743344 466666532 6
Q ss_pred EEEeccCCCch
Q 023591 94 IVMEYASGGEL 104 (280)
Q Consensus 94 lv~e~~~~~~L 104 (280)
.|++|.+|.++
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 78999877444
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.56 E-value=0.00023 Score=56.66 Aligned_cols=68 Identities=10% Similarity=0.046 Sum_probs=46.2
Q ss_pred ceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCCCCe--eeec-----eEEecCCeEEEEEeccCCC
Q 023591 34 FGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI--VRFK-----EVILTPTHLAIVMEYASGG 102 (280)
Q Consensus 34 ~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~~ 102 (280)
--.||++... +|+.+++|+..+.....+++..|...+..|...++ +..+ ..+..+...+.++++.+|.
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 3589999874 67889999988776677888889988877742221 1111 1223456778899988763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.34 E-value=0.00041 Score=54.85 Aligned_cols=142 Identities=16% Similarity=0.088 Sum_probs=73.8
Q ss_pred CCeeeecccccCCceEEEEEEecCCCcEEEEEEeeeCCcccHHHHHHHHHhhhCCC-----CCeeeec---eEEecCCeE
Q 023591 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-----PNIVRFK---EVILTPTHL 92 (280)
Q Consensus 21 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-----~~iv~~~---~~~~~~~~~ 92 (280)
++..-.+.|..|.--+.|++.... | .+++|++... ...+++..|+.++..|.. |..+... .+...+...
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~ 94 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 94 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred CCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeeccc
Confidence 344445667778888999998753 4 4899988653 234556667777766632 2222110 011123445
Q ss_pred EEEEeccCCCch-----HH------HH---Hh---cC------CCCHH------------------HHHHHHHHHHHHHH
Q 023591 93 AIVMEYASGGEL-----FE------RI---CN---AG------RFSED------------------EARFFFQQLISGVS 131 (280)
Q Consensus 93 ~lv~e~~~~~~L-----~~------~~---~~---~~------~l~~~------------------~~~~~~~~i~~~l~ 131 (280)
..++.+..+... .. .+ .. .. ..... .....+..+...+.
T Consensus 95 ~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 174 (316)
T d2ppqa1 95 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 174 (316)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred ceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhh
Confidence 566665544221 00 00 00 00 00010 11122223333333
Q ss_pred HHH----hcCceecCCCCCcEEEeCCCCCcEEEeecCCcc
Q 023591 132 YCH----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (280)
Q Consensus 132 ~Lh----~~~i~h~dl~~~ni~i~~~~~~~~~l~df~~~~ 167 (280)
..+ ..|++|+|+.++||+++.+.. .-+.||+.+.
T Consensus 175 ~~~~~~L~~giIHgDl~~dNvl~~~~~v--~gvIDF~~~~ 212 (316)
T d2ppqa1 175 AHWPKDLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 212 (316)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred ccCccccccccccCCcchhhhhcccccc--eeEecccccc
Confidence 333 257999999999999987654 6899999876
|